data_2kk4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kk4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 C--O 1.24 0.578 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -76.49 111.88 12.42 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.359 0.664 . . . . 0.0 110.124 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.16 111.65 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.097 0.559 . . . . 0.0 109.908 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -103.0 124.59 48.79 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.817 0.847 . . . . 0.0 110.135 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 51.1 tttm -77.67 85.43 3.99 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.86 -94.99 0.89 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -173.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -110.63 -30.15 7.73 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.97 0.908 . . . . 0.0 110.658 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 12.9 pt-20 -77.58 141.02 39.76 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -175.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.9 t -70.68 108.77 4.56 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -85.26 -55.55 3.97 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.866 0.466 . . . . 0.0 110.44 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.24 -146.88 5.98 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.282 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -140.1 145.34 37.49 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.75 0.82 . . . . 0.0 110.346 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.7 p -77.0 111.89 13.05 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.805 0.442 . . . . 0.0 109.839 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.65 -40.37 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.452 0.701 . . . . 0.0 110.25 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.472 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 18.0 t70 -148.36 160.66 42.78 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.919 0.487 . . . . 0.0 109.817 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.42 HG21 HD11 ' A' ' 29' ' ' LEU . 20.6 t -139.59 118.78 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -132.5 126.99 34.24 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.643 0.656 . . . . 0.0 109.503 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.04 -119.76 19.8 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.487 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -102.24 22.81 12.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.592 0.757 . . . . 0.0 111.347 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -133.29 124.86 28.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.834 0.454 . . . . 0.0 111.357 -176.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.42 HD11 HG21 ' A' ' 24' ' ' VAL . 45.2 tp -85.2 109.6 18.42 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 167.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 23.5 mm -70.85 107.1 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.04 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.64 119.31 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.337 177.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -75.99 113.65 13.75 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.171 0.588 . . . . 0.0 109.496 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.35 126.56 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 124.124 0.97 . . . . 0.0 109.481 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.95 -91.44 0.05 OUTLIER Glycine 0 CA--C 1.535 1.316 0 CA-C-N 116.57 -0.287 . . . . 0.0 113.429 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.9 m -125.2 -23.82 4.11 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.404 1.082 . . . . 0.0 110.778 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -110.82 179.16 4.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.72 0.808 . . . . 0.0 111.319 -171.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.412 ' HB3' HG23 ' A' ' 30' ' ' ILE . 87.6 m-85 -119.23 110.35 16.92 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.515 0.726 . . . . 0.0 109.887 -175.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -91.55 105.9 18.09 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.299 1.04 . . . . 0.0 109.151 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.458 ' HB2' HD12 ' A' ' 66' ' ' LEU . . . -83.23 92.49 7.49 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.193 0.597 . . . . 0.0 109.83 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.3 m -80.18 134.66 55.38 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -65.59 154.44 73.77 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.621 2.214 . . . . 0.0 111.674 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.539 ' HA ' HD12 ' A' ' 45' ' ' ILE . 13.7 mmmm -63.16 -28.1 69.83 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.591 0.756 . . . . 0.0 111.652 -176.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -65.72 -21.89 66.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.413 0.685 . . . . 0.0 111.583 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 t -74.33 -43.61 55.95 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 42' ' ' LYS . 2.8 mp -61.73 112.47 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.442 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.484 ' HE3' ' HA3' ' A' ' 56' ' ' GLY . 32.1 mmtp -78.51 -63.13 1.48 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.881 0.872 . . . . 0.0 110.154 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 t -146.02 132.83 20.05 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 122.915 0.486 . . . . 0.0 110.094 -175.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.8 p -77.68 109.61 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 5.8 mm-40 -86.16 174.3 9.23 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.324 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.56 86.5 2.09 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.166 0.508 . . . . 0.0 109.719 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.21 13.44 63.9 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.979 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.642 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 2.4 mpt_? -135.6 159.67 40.91 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.444 0.622 . . . . 0.0 109.64 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 mm -124.25 103.96 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 69.7 t -79.14 116.45 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.7 pt -105.87 164.0 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.484 ' HA3' ' HE3' ' A' ' 46' ' ' LYS . . . -104.4 -107.01 3.16 Favored Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -122.69 156.82 33.6 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.837 0.855 . . . . 0.0 109.807 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -167.09 160.17 13.71 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.723 1.209 . . . . 0.0 108.715 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -75.17 98.23 3.68 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -43.29 96.08 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.373 1.069 . . . . 0.0 112.896 -175.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -67.92 -33.87 75.53 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.341 0.401 . . . . 0.0 110.747 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 37.7 mt-10 -69.65 -49.44 53.66 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.366 174.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.01 -28.51 66.46 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.597 0.759 . . . . 0.0 111.383 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.59 -45.26 46.42 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.762 1.225 . . . . 0.0 110.867 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.417 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 2.9 pp20? -75.37 -36.93 60.85 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -175.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.509 ' HA ' ' HB3' ' A' ' 69' ' ' LYS . 4.4 pp -81.84 -15.14 55.08 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.846 0.355 . . . . 0.0 110.441 174.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -66.5 -47.82 67.13 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.747 166.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.488 ' HA ' HD22 ' A' ' 71' ' ' LEU . 9.2 ptp180 -76.32 -21.49 56.13 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 117.344 0.572 . . . . 0.0 111.458 177.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -68.18 -32.87 73.41 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.139 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.407 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 74.2 t90 -67.1 -40.49 86.91 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.196 169.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' A' ' 68' ' ' ARG . 4.1 mm? -57.89 -24.89 59.72 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.503 0.321 . . . . 0.0 111.232 175.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 CA--C 1.55 0.974 0 C-N-CA 122.478 0.311 . . . . 0.0 111.19 173.134 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.528 ' HB2' HG12 ' A' ' 53' ' ' ILE . 2.1 mpt? . . . . . 0 CA--C 1.554 1.103 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -75.13 110.46 9.46 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.307 1.043 . . . . 0.0 109.89 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.496 HG23 ' HB ' ' A' ' 53' ' ' ILE . 75.5 t -79.28 127.5 39.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 122.878 0.471 . . . . 0.0 110.814 -173.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -110.56 129.71 55.73 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.623 1.169 . . . . 0.0 110.045 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -78.01 85.01 4.25 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.561 1.144 . . . . 0.0 108.011 172.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.25 -96.64 0.34 Allowed Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.623 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -94.91 -40.71 9.55 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.496 0.719 . . . . 0.0 110.474 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -83.66 151.63 25.19 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.946 -170.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 t -75.72 119.08 19.25 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -87.51 -48.89 7.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.521 0.728 . . . . 0.0 110.456 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.51 -150.54 12.15 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -176.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -127.43 146.32 50.52 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 171.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 68.7 p -70.55 162.79 28.2 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 168.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.38 -39.56 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -153.24 171.92 17.79 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.608 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.491 ' HB ' HD12 ' A' ' 29' ' ' LEU . 2.4 p -151.72 133.75 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 172.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.46 ' CE2' HD12 ' A' ' 30' ' ' ILE . 50.6 p90 -135.81 135.24 39.69 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 172.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.48 -107.23 1.29 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 123.886 0.741 . . . . 0.0 112.704 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -116.11 12.84 15.66 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.764 0.826 . . . . 0.0 110.996 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.572 ' HB3' ' HB2' ' A' ' 39' ' ' ALA . 89.7 m-85 -123.17 109.34 13.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.198 0.599 . . . . 0.0 111.426 -172.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.491 HD12 ' HB ' ' A' ' 24' ' ' VAL . 45.5 tp -80.37 106.87 12.71 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 169.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.46 HD12 ' CE2' ' A' ' 25' ' ' TYR . 28.4 mm -71.24 108.81 3.07 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 C-N-CA 123.698 0.799 . . . . 0.0 110.041 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 65.6 t -102.72 119.44 51.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 O-C-N 124.263 0.977 . . . . 0.0 109.575 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.46 118.66 18.57 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.41 124.01 64.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.688 0.795 . . . . 0.0 108.99 172.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.81 -90.44 0.05 OUTLIER Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.493 0.496 . . . . 0.0 114.334 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.3 p -123.5 -21.71 5.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.187 0.995 . . . . 0.0 111.5 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -110.37 171.62 7.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.641 0.776 . . . . 0.0 111.612 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -120.05 110.17 16.35 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.253 1.021 . . . . 0.0 108.942 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.1 mp -106.76 115.18 29.75 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.371 1.069 . . . . 0.0 108.381 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.572 ' HB2' ' HB3' ' A' ' 28' ' ' TYR . . . -79.94 103.82 10.09 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.619 0.768 . . . . 0.0 111.021 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 m -78.13 132.58 66.51 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 172.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 37.4 Cg_endo -65.62 150.22 86.63 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 121.714 1.609 . . . . 0.0 110.286 172.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.542 ' HA ' HD11 ' A' ' 45' ' ' ILE . 31.6 mmmt -61.13 -29.98 70.1 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.116 0.566 . . . . 0.0 111.409 -176.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.472 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 60.1 pttt -68.97 -23.09 64.08 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.052 0.941 . . . . 0.0 111.902 177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.8 t -68.9 -29.72 68.06 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.759 0.424 . . . . 0.0 110.714 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.542 HD11 ' HA ' ' A' ' 42' ' ' LYS . 1.9 mp -64.06 114.58 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 75.1 mmtt -71.69 -45.98 60.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.394 1.078 . . . . 0.0 110.0 176.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 44.1 p -157.14 155.15 30.5 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.952 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 p -113.12 114.2 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.916 0.886 . . . . 0.0 110.175 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 6.5 mm-40 -97.74 163.66 12.72 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.765 0.826 . . . . 0.0 109.1 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.75 -35.34 74.4 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.715 0.806 . . . . 0.0 111.301 -171.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.07 19.35 4.37 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.484 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.607 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 44.1 mtm180 -143.62 156.09 44.46 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 117.486 0.643 . . . . 0.0 110.85 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.528 HG12 ' HB2' ' A' ' 9' ' ' MET . 41.3 mm -126.43 104.37 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 173.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.7 t -83.24 114.89 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.9 pt -108.22 163.99 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.539 0.736 . . . . 0.0 109.499 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.445 ' HA3' ' HE2' ' A' ' 46' ' ' LYS . . . -92.87 -86.51 1.56 Allowed Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 175.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -160.5 168.44 25.07 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.563 0.745 . . . . 0.0 110.474 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -164.89 -179.03 5.54 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.898 1.279 . . . . 0.0 108.905 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -93.52 110.38 21.97 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -64.44 -37.22 86.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.12 0.968 . . . . 0.0 111.595 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.31 -50.39 60.4 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.044 0.84 . . . . 0.0 110.167 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.424 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 37.6 mt-10 -64.16 -38.87 92.63 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.07 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.21 -40.84 86.48 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.416 0.686 . . . . 0.0 111.93 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.445 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 9.9 ptp85 -75.3 -31.5 60.68 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 118.97 -0.538 . . . . 0.0 112.266 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -75.98 -38.8 57.06 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.394 0.543 . . . . 0.0 111.349 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 62' ' ' GLU . 4.4 pp -81.76 -13.26 57.99 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.25 0.548 . . . . 0.0 109.828 170.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.82 -33.93 66.17 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.168 165.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 64' ' ' ARG . 78.5 mtm180 -64.85 -40.33 94.99 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 123.317 0.647 . . . . 0.0 109.682 172.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -55.09 -39.76 69.66 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.789 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.417 ' CD1' HG13 ' A' ' 30' ' ' ILE . 88.6 t90 -65.49 -34.92 79.4 Favored 'General case' 0 C--N 1.361 1.105 0 CA-C-O 119.316 -0.373 . . . . 0.0 111.681 174.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.2 mm? -57.22 -22.14 38.74 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 118.839 0.745 . . . . 0.0 110.634 173.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 CA--C 1.574 1.883 0 C-N-CA 123.397 0.679 . . . . 0.0 111.924 164.645 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.6 ttm . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -69.51 106.42 2.98 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.41 0.684 . . . . 0.0 109.823 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.09 132.82 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.029 0.532 . . . . 0.0 109.791 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -113.8 127.49 56.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.795 1.238 . . . . 0.0 110.337 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.98 88.49 3.52 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 171.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.4 -95.48 0.6 Allowed Glycine 0 C--N 1.342 0.91 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -121.25 1.3 10.23 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.073 0.949 . . . . 0.0 112.196 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -117.04 151.72 36.18 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.254 0.621 . . . . 0.0 110.456 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.5 t -67.43 112.8 4.83 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.733 0.813 . . . . 0.0 111.334 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -84.79 -54.65 4.55 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.438 0.695 . . . . 0.0 110.199 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.31 -137.83 3.99 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.877 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -138.28 136.48 36.51 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.192 0.997 . . . . 0.0 109.694 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.461 ' HB2' HD13 ' A' ' 29' ' ' LEU . 68.8 p -72.08 112.26 8.01 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.87 -36.43 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.054 0.541 . . . . 0.0 109.839 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -153.49 176.66 11.78 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.272 0.629 . . . . 0.0 109.338 -173.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.22 136.85 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.988 0.915 . . . . 0.0 108.951 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -137.11 127.64 26.8 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 173.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.37 -109.62 2.43 Favored Glycine 0 C--N 1.346 1.117 0 O-C-N 123.537 0.523 . . . . 0.0 113.501 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -109.92 19.2 19.32 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.04 0.936 . . . . 0.0 111.493 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -131.91 115.41 15.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.876 0.47 . . . . 0.0 111.665 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' A' ' 21' ' ' SER . 64.6 tp -79.22 113.85 17.68 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.131 0.972 . . . . 0.0 109.528 169.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.3 mm -74.77 106.92 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.5 t -104.53 113.44 41.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -76.3 109.67 10.19 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.6 m -95.15 156.08 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.415 1.086 . . . . 0.0 108.794 169.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -43.61 -28.23 1.01 Allowed Glycine 0 N--CA 1.482 1.711 0 N-CA-C 116.544 1.378 . . . . 0.0 116.544 -174.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.0 p -95.04 -48.39 5.99 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.13 0.572 . . . . 0.0 111.625 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -139.83 -179.65 6.06 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.443 0.64 . . . . 0.0 112.715 -163.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -101.78 107.83 19.16 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 164.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.6 mt -104.05 106.76 17.37 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.35 95.19 6.3 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.269 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 m -80.61 134.41 54.27 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.509 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 38.2 Cg_endo -63.41 159.13 41.52 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.21 1.94 . . . . 0.0 112.011 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -59.16 -34.73 72.45 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.385 0.674 . . . . 0.0 110.78 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.509 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 19.9 ptmt -68.19 -26.99 66.01 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.339 1.056 . . . . 0.0 112.191 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.7 t -59.46 -38.52 80.98 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.811 0.444 . . . . 0.0 109.87 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.99 114.01 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HD2' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -79.97 -53.8 6.4 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.571 1.149 . . . . 0.0 110.072 177.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.4 m -144.82 141.12 28.89 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.272 -171.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.0 p -99.19 110.62 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 169.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.77 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 11.7 mm-40 -105.21 174.25 5.96 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.555 0.742 . . . . 0.0 109.821 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.47 102.0 1.06 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.195 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.52 18.17 78.3 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 115.538 -0.755 . . . . 0.0 113.467 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.77 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 17.6 mtp180 -136.64 140.18 42.58 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.209 0.604 . . . . 0.0 110.359 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.1 mm -116.57 101.89 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 168.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.1 t -79.4 118.93 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.3 pt -112.13 146.38 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.716 0.806 . . . . 0.0 109.264 172.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.444 ' HA3' ' HD2' ' A' ' 46' ' ' LYS . . . -105.49 -56.33 0.69 Allowed Glycine 0 C--N 1.339 0.743 0 CA-C-N 116.362 -0.381 . . . . 0.0 112.418 -170.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.21 141.44 23.17 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.582 0.753 . . . . 0.0 110.627 -171.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -169.4 146.54 3.47 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 124.618 1.167 . . . . 0.0 108.011 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.66 106.79 7.4 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -64.15 -29.34 70.47 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.043 0.937 . . . . 0.0 111.706 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.432 ' HG2' ' NH1' ' A' ' 64' ' ' ARG . 38.8 mt-10 -67.08 -40.41 87.01 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.579 0.549 . . . . 0.0 110.584 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -68.73 -45.51 71.3 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.314 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.24 74.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.898 0.879 . . . . 0.0 111.865 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.432 ' NH1' ' HG2' ' A' ' 61' ' ' GLU . 6.2 ptp180 -75.69 -41.81 52.7 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.769 0.428 . . . . 0.0 111.765 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.44 -39.48 64.95 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 118.075 0.398 . . . . 0.0 111.902 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.55 -16.61 44.78 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.766 0.426 . . . . 0.0 110.466 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.81 -39.0 34.97 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.595 0.559 . . . . 0.0 112.487 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -77.06 -24.95 51.92 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.843 0.457 . . . . 0.0 109.981 173.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -65.63 -38.14 88.58 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.6 t90 -60.74 -49.39 77.68 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 123.513 0.508 . . . . 0.0 109.883 171.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.4 mt -50.92 -34.68 29.58 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.954 0.902 . . . . 0.0 112.072 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 . . . . . 0 CA--C 1.553 1.094 0 C-N-CA 123.623 0.769 . . . . 0.0 111.074 175.504 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 53.0 mtt . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 120.899 0.38 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -101.75 130.08 48.08 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 85.4 t -91.54 126.27 44.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.346 0.659 . . . . 0.0 109.762 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -115.46 118.52 33.43 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.782 1.233 . . . . 0.0 109.102 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 65.5 tttm -78.68 90.23 4.59 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.1 -95.56 0.66 Allowed Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -121.48 4.22 10.18 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.802 0.841 . . . . 0.0 112.406 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 11.5 pt-20 -111.84 147.41 35.81 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.997 0.519 . . . . 0.0 109.704 176.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.3 t -72.62 108.79 5.84 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -78.45 -49.34 13.64 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.358 0.663 . . . . 0.0 110.231 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.0 -136.54 3.33 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.521 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -142.33 136.93 30.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.138 0.975 . . . . 0.0 109.483 -178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.2 p -71.58 106.96 4.22 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.421 HG22 ' HD2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -92.59 -40.31 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.083 0.553 . . . . 0.0 109.67 -176.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -160.35 168.91 24.23 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.438 0.295 . . . . 0.0 110.919 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.15 141.22 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.011 0.924 . . . . 0.0 109.102 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -138.91 97.41 3.31 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.457 1.103 . . . . 0.0 108.389 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.1 -109.01 2.3 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.771 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -107.17 16.85 23.65 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.104 0.962 . . . . 0.0 110.36 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.432 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 93.8 m-85 -127.81 117.86 22.64 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.447 0.699 . . . . 0.0 109.895 -174.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.5 tp -76.62 111.0 11.66 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 172.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mm -71.02 112.88 6.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -107.26 120.02 57.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.355 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -74.84 109.18 8.09 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.05 89.56 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.577 1.151 . . . . 0.0 110.659 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.12 -76.02 1.68 Allowed Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.237 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.5 m -125.07 -29.47 3.32 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.141 0.977 . . . . 0.0 110.856 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -110.45 168.89 9.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 122.155 -0.341 . . . . 0.0 110.551 -172.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.421 ' HD2' HG22 ' A' ' 22' ' ' ILE . 64.5 m-85 -113.22 110.37 20.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.133 0.973 . . . . 0.0 109.466 177.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.0 mt -107.39 124.74 50.28 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.124 0.57 . . . . 0.0 109.63 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.432 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -89.62 99.49 12.48 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.016 -174.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.1 m -86.46 129.13 54.37 Favored Pre-proline 0 CA--C 1.552 1.056 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.13 158.42 54.65 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.363 2.042 . . . . 0.0 111.871 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.55 ' HA ' HD13 ' A' ' 45' ' ' ILE . 13.9 mmmm -64.6 -29.54 70.55 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.256 0.622 . . . . 0.0 112.166 -177.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.416 ' H ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -72.84 -17.79 61.51 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.142 0.177 . . . . 0.0 111.219 174.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.5 t -73.13 -34.9 66.38 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 171.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.55 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.9 mp -61.18 115.38 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.173 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 mmpm? -82.28 -61.28 1.94 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.212 1.005 . . . . 0.0 109.414 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.0 m -138.69 126.6 22.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.149 -172.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 p -92.53 109.37 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 171.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.634 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 22.0 mm-40 -98.63 177.01 5.44 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 124.546 1.138 . . . . 0.0 110.225 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -68.11 91.15 0.35 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.185 0.594 . . . . 0.0 110.452 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.36 17.81 77.23 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.303 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.634 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 49.7 mtt180 -137.33 129.55 29.43 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.54 0.736 . . . . 0.0 109.382 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.4 mm -105.03 103.37 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.76 115.93 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.8 pt -108.57 175.15 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.377 0.671 . . . . 0.0 109.457 173.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.43 -117.75 3.01 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -118.71 160.29 22.11 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.267 0.627 . . . . 0.0 110.602 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -159.8 179.21 9.02 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.156 1.382 . . . . 0.0 108.477 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.28 114.44 26.52 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -63.86 -36.2 83.13 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.844 0.858 . . . . 0.0 112.52 -175.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -69.21 -40.85 77.74 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.981 0.512 . . . . 0.0 110.185 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.42 -44.98 73.84 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 123.415 0.447 . . . . 0.0 110.33 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.04 -25.52 68.42 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.376 0.67 . . . . 0.0 111.292 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -73.89 -51.48 16.07 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.893 0.877 . . . . 0.0 110.971 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.11 -40.81 59.62 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.993 0.517 . . . . 0.0 111.799 -171.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 69' ' ' LYS . 2.4 pp -84.1 -20.77 31.99 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.06 -44.83 87.02 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 169.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.498 ' HA ' HD21 ' A' ' 71' ' ' LEU . 35.2 ptt180 -75.45 -14.2 60.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.508 0.723 . . . . 0.0 110.406 175.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 6.3 tppt? -67.74 -31.85 72.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.982 0.513 . . . . 0.0 109.831 167.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.421 ' HE3' HD22 ' A' ' 71' ' ' LEU . 81.8 t90 -71.37 -38.6 71.53 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.805 0.442 . . . . 0.0 110.795 170.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.498 HD21 ' HA ' ' A' ' 68' ' ' ARG . 3.8 mm? -65.55 -29.66 70.31 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 120.807 0.337 . . . . 0.0 110.163 171.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 . . . . . 0 N--CA 1.471 0.623 0 C-N-CA 123.78 0.832 . . . . 0.0 109.479 172.757 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 41.4 mtt . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -71.31 106.93 4.04 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.477 HG21 ' HB ' ' A' ' 53' ' ' ILE . 57.8 t -78.93 110.04 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.879 -177.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 54.5 m-85 -97.23 120.9 38.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.128 0.971 . . . . 0.0 109.163 174.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -78.21 87.71 4.29 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.02 -95.51 0.74 Allowed Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -107.63 -29.66 9.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.792 0.837 . . . . 0.0 111.11 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.65 146.54 28.2 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.57 0.348 . . . . 0.0 110.449 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.0 t -77.15 105.63 8.36 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -79.89 -55.71 4.78 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.527 0.731 . . . . 0.0 111.158 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.535 ' HA3' HG13 ' A' ' 33' ' ' VAL . . . -179.03 -147.87 7.39 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.261 0.351 . . . . 0.0 112.456 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -137.49 135.36 36.73 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.843 0.857 . . . . 0.0 109.779 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.5 p -76.66 108.27 9.55 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.21 -37.73 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.349 0.659 . . . . 0.0 109.556 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -160.73 177.92 9.98 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -173.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.474 ' HB ' HD13 ' A' ' 29' ' ' LEU . 5.5 p -155.58 135.14 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 123.962 0.905 . . . . 0.0 109.056 173.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.424 ' CD2' HD13 ' A' ' 30' ' ' ILE . 34.3 p90 -132.13 131.81 42.65 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 171.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.19 -107.06 1.18 Allowed Glycine 0 C--N 1.343 0.958 0 O-C-N 123.764 0.665 . . . . 0.0 113.293 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -119.65 27.94 8.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.977 0.911 . . . . 0.0 111.261 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -133.29 108.97 9.07 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.063 0.545 . . . . 0.0 110.227 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.474 HD13 ' HB ' ' A' ' 24' ' ' VAL . 51.0 tp -81.37 113.47 19.49 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.356 0.662 . . . . 0.0 109.404 175.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.424 HD13 ' CD2' ' A' ' 25' ' ' TYR . 8.0 mm -80.1 104.79 8.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 C-N-CA 123.172 0.589 . . . . 0.0 109.685 -176.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.2 t -105.95 113.58 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.756 0.822 . . . . 0.0 109.834 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -75.86 117.0 17.13 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.387 0.675 . . . . 0.0 109.638 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.535 HG13 ' HA3' ' A' ' 19' ' ' GLY . 11.1 m -133.18 148.78 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.95 0.9 . . . . 0.0 109.409 176.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.23 -106.04 0.43 Allowed Glycine 0 CA--C 1.531 1.09 0 O-C-N 123.426 0.454 . . . . 0.0 113.04 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.8 m -109.53 -29.91 8.18 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.648 0.779 . . . . 0.0 110.888 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -116.44 176.5 5.08 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.623 0.725 . . . . 0.0 112.158 -169.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -104.28 109.92 21.94 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.653 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.12 102.97 15.51 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.208 1.003 . . . . 0.0 108.577 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.485 ' HB1' HD11 ' A' ' 66' ' ' LEU . . . -84.83 94.66 8.78 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.673 0.789 . . . . 0.0 109.526 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.1 m -75.35 128.66 83.96 Favored Pre-proline 0 CA--C 1.558 1.255 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.699 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -60.81 161.26 22.19 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.017 2.478 . . . . 0.0 112.192 174.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.484 ' HA ' HG12 ' A' ' 45' ' ' ILE . 14.6 mmmm -68.42 -21.27 64.68 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.69 -17.39 62.84 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.711 0.404 . . . . 0.0 111.014 174.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.524 ' HG ' ' HB ' ' A' ' 55' ' ' ILE . 26.8 t -80.5 -29.47 37.31 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.102 0.561 . . . . 0.0 110.353 175.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.484 HG12 ' HA ' ' A' ' 42' ' ' LYS . 25.5 mm -68.23 115.18 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 122.837 0.455 . . . . 0.0 110.406 -175.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -84.01 -66.69 0.86 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.596 0.758 . . . . 0.0 110.448 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.0 m -143.71 126.79 16.46 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.626 0.371 . . . . 0.0 110.654 -171.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -82.82 111.63 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.775 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 11.1 mm-40 -99.41 175.96 5.68 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.78 0.832 . . . . 0.0 109.986 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -70.31 97.55 1.26 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.12 0.568 . . . . 0.0 110.05 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.81 21.94 77.78 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.841 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.775 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 79.6 mtt180 -142.62 151.24 41.27 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.931 0.892 . . . . 0.0 110.031 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.477 ' HB ' HG21 ' A' ' 11' ' ' VAL . 43.5 mm -124.4 107.11 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 170.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 57.4 t -78.46 117.76 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.524 ' HB ' ' HG ' ' A' ' 44' ' ' SER . 47.4 pt -108.81 171.4 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.698 0.799 . . . . 0.0 109.54 171.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.66 -81.08 0.68 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -139.75 146.11 39.12 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-O 121.846 0.831 . . . . 0.0 110.711 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -160.66 165.48 30.51 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.471 1.508 . . . . 0.0 107.589 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -94.1 108.6 20.43 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.63 -39.11 92.77 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.889 0.876 . . . . 0.0 112.952 -170.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.55 -33.09 75.11 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.3 0.64 . . . . 0.0 110.712 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -76.73 -45.9 27.47 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.435 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.91 -26.78 68.46 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.674 0.79 . . . . 0.0 110.671 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -74.7 -44.4 50.29 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.589 0.756 . . . . 0.0 110.609 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.86 -39.33 64.05 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.491 ' HA ' ' HB2' ' A' ' 69' ' ' LYS . 4.3 pp -82.41 -13.67 56.44 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 121.702 0.763 . . . . 0.0 110.037 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.18 -43.08 96.0 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 161.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.4 ' HA ' HD23 ' A' ' 71' ' ' LEU . 62.8 mtp180 -70.07 -16.69 63.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.92 0.888 . . . . 0.0 111.582 174.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 4.0 tppp? -67.28 -38.78 85.62 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.692 0.797 . . . . 0.0 109.559 170.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.423 ' HE3' HD21 ' A' ' 71' ' ' LEU . 68.7 t90 -62.19 -45.29 94.05 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.344 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.423 HD21 ' HE3' ' A' ' 70' ' ' TRP . 3.7 mm? -63.22 -25.38 68.3 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.564 0.345 . . . . 0.0 111.209 174.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 N--CA 1.476 0.833 0 C-N-CA 123.867 0.867 . . . . 0.0 111.311 -179.328 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.412 ' HG2' ' HA2' ' A' ' 51' ' ' GLY . 58.2 mtt . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.342 0.115 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -66.43 113.81 4.96 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.513 0.725 . . . . 0.0 110.568 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.1 t -83.1 123.73 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.505 0.722 . . . . 0.0 110.386 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -108.55 120.73 43.3 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.161 0.984 . . . . 0.0 109.418 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 49.7 tttm -77.24 85.43 3.69 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.59 -94.18 0.84 Allowed Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -110.81 -23.58 10.93 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.313 1.045 . . . . 0.0 111.229 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 11.3 pt-20 -91.18 144.41 25.65 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.065 0.546 . . . . 0.0 110.451 -173.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.6 t -71.4 111.4 6.69 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.406 0.682 . . . . 0.0 109.507 176.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -91.35 -56.55 3.1 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.801 0.44 . . . . 0.0 111.166 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . -179.35 -140.35 4.03 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.57 -174.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.26 139.25 35.5 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.601 0.76 . . . . 0.0 110.619 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.0 t -79.16 108.87 12.97 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.664 0.785 . . . . 0.0 109.241 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.413 HD11 ' HB2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -92.18 -39.13 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.156 0.582 . . . . 0.0 109.599 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.413 ' HB2' HD11 ' A' ' 22' ' ' ILE . 19.0 t70 -154.26 169.11 24.43 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.743 0.306 . . . . 0.0 111.082 -174.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.408 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.7 p -151.17 137.9 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.352 1.061 . . . . 0.0 108.46 172.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -146.54 135.38 22.34 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.96 -106.8 1.08 Allowed Glycine 0 C--N 1.34 0.799 0 O-C-N 123.29 0.369 . . . . 0.0 113.955 174.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -119.51 13.07 12.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.099 0.959 . . . . 0.0 110.915 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.477 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 83.8 m-85 -130.74 150.14 52.06 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.509 0.723 . . . . 0.0 111.049 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.408 HD12 ' HB ' ' A' ' 24' ' ' VAL . 45.3 tp -117.25 112.46 20.81 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.592 1.557 . . . . 0.0 107.725 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.0 mm -76.52 109.15 10.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.816 0 C-N-CA 123.128 0.571 . . . . 0.0 109.757 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.5 t -110.13 117.94 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.053 0.941 . . . . 0.0 108.648 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.537 ' HZ2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -88.78 118.68 28.64 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.508 HG21 HD21 ' A' ' 38' ' ' LEU . 19.7 m -123.07 128.49 75.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 171.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.99 -99.71 0.21 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 116.604 -0.271 . . . . 0.0 113.305 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.0 m -125.05 -5.11 7.39 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.856 0.862 . . . . 0.0 111.081 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -116.83 154.2 31.15 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.246 0.618 . . . . 0.0 111.236 -173.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -112.01 109.66 19.54 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.31 1.044 . . . . 0.0 109.154 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.508 HD21 HG21 ' A' ' 33' ' ' VAL . 3.6 mm? -95.55 106.75 18.86 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.39 1.076 . . . . 0.0 109.131 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -79.84 95.29 6.0 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.086 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.4 m -87.06 126.42 62.99 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.479 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 38.2 Cg_endo -62.13 152.03 78.33 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.503 2.135 . . . . 0.0 112.492 -176.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.577 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.7 mmmm -64.94 -23.04 67.1 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.583 0.753 . . . . 0.0 111.808 -175.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.479 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 21.6 ptmt -70.88 -25.58 62.86 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.461 0.705 . . . . 0.0 111.307 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.9 t -72.22 -31.43 65.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.888 0.475 . . . . 0.0 110.094 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.577 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.6 mp -62.0 114.68 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.099 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -90.62 -55.6 3.51 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.824 1.25 . . . . 0.0 110.818 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.5 m -134.37 126.87 30.5 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.349 0.66 . . . . 0.0 110.108 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 p -96.04 109.88 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 172.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 47.4 mm-40 -111.39 168.47 9.51 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 124.224 1.01 . . . . 0.0 109.918 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -65.34 98.53 0.34 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.811 0.844 . . . . 0.0 110.803 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.412 ' HA2' ' HG2' ' A' ' 9' ' ' MET . . . 77.29 11.96 85.03 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 116.333 -0.394 . . . . 0.0 113.963 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.464 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 97.4 mtt180 -137.6 127.3 25.33 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.957 0.903 . . . . 0.0 109.48 178.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.9 mm -110.37 102.99 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.9 t -80.71 113.48 20.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 33.3 pt -106.63 178.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.102 0.961 . . . . 0.0 108.466 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.43 -119.71 4.54 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -131.63 166.54 21.22 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.732 0.813 . . . . 0.0 109.165 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -163.53 168.5 20.03 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.115 0.966 . . . . 0.0 109.297 -168.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -81.75 99.57 9.03 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -62.95 -30.55 71.66 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.006 0.922 . . . . 0.0 111.883 -175.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -62.83 -51.84 65.46 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.688 0.756 . . . . 0.0 109.747 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.07 -35.17 76.23 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.972 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.3 -34.77 73.14 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.029 0.532 . . . . 0.0 111.867 -175.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -77.13 -34.27 56.65 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 177.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.97 -37.99 54.1 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 117.725 0.238 . . . . 0.0 111.048 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 pp -82.98 -15.53 50.85 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.06 -42.71 35.82 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.053 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.543 ' HA ' HD22 ' A' ' 71' ' ' LEU . 4.9 ptp180 -70.97 -27.06 63.45 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -63.56 -33.55 75.84 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 170.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -64.52 -37.1 86.36 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.696 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.543 HD22 ' HA ' ' A' ' 68' ' ' ARG . 4.0 mm? -61.52 -29.4 69.97 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 118.139 0.427 . . . . 0.0 110.717 173.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 CA--C 1.552 1.034 0 C-N-CA 123.314 0.645 . . . . 0.0 110.685 172.276 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 85.2 mtp . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 120.482 0.182 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -72.33 107.69 5.06 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.69 0.796 . . . . 0.0 109.929 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.59 116.23 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 122.92 0.488 . . . . 0.0 109.929 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -111.13 129.56 55.9 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.243 1.017 . . . . 0.0 109.262 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -85.19 92.25 8.35 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.55 -95.81 0.4 Allowed Glycine 0 C--N 1.351 1.4 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.014 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -104.51 -31.83 9.27 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.609 0.764 . . . . 0.0 111.479 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -83.4 144.2 29.78 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 120.659 0.266 . . . . 0.0 110.911 -172.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.5 t -72.41 111.09 7.29 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.561 0.745 . . . . 0.0 109.359 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -84.85 -57.04 3.27 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.553 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 178.15 -136.18 2.91 Favored Glycine 0 C--N 1.347 1.143 0 O-C-N 123.149 0.28 . . . . 0.0 112.465 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.79 139.13 24.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.238 1.015 . . . . 0.0 109.687 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.3 t -68.23 138.5 55.62 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.06 -38.11 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -156.14 164.55 38.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.732 0.413 . . . . 0.0 110.039 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.0 p -121.16 136.45 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.468 ' OH ' ' HD2' ' A' ' 69' ' ' LYS . 4.6 t80 -136.95 101.25 4.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.982 0.913 . . . . 0.0 109.602 -173.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.0 -113.04 5.37 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.423 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -98.57 21.53 11.12 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.027 0.931 . . . . 0.0 110.873 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -135.58 162.24 33.25 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.047 0.939 . . . . 0.0 109.792 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 59.0 tp -123.66 113.07 18.15 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 39' ' ' ALA . 23.7 mm -70.43 106.88 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.0 t -108.32 117.71 54.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -76.22 115.85 16.35 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.555 HG23 HD23 ' A' ' 38' ' ' LEU . 4.0 m -123.38 121.19 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.86 -86.97 0.06 OUTLIER Glycine 0 CA--C 1.532 1.115 0 CA-C-N 116.326 -0.397 . . . . 0.0 113.487 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 m -124.56 -25.84 3.96 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.683 1.193 . . . . 0.0 110.663 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -106.88 163.78 12.67 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.579 0.752 . . . . 0.0 111.24 -167.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -111.0 109.07 19.02 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.156 0.982 . . . . 0.0 108.772 177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.555 HD23 HG23 ' A' ' 33' ' ' VAL . 4.3 mm? -105.73 111.95 24.82 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.572 1.149 . . . . 0.0 108.836 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.402 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -82.93 94.81 7.8 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.212 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.48 131.28 58.79 Favored Pre-proline 0 N--CA 1.473 0.723 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.567 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 35.8 Cg_endo -60.67 153.41 62.15 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.275 1.983 . . . . 0.0 111.703 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.52 ' HA ' HD11 ' A' ' 45' ' ' ILE . 14.4 mmmm -63.27 -27.13 69.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.603 0.761 . . . . 0.0 111.416 -178.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.567 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 20.9 ptmt -67.74 -21.7 65.27 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.676 0.79 . . . . 0.0 111.793 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.5 t -70.18 -43.15 71.38 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 42' ' ' LYS . 2.3 mp -60.98 113.77 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.209 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.533 ' HE3' ' HA3' ' A' ' 56' ' ' GLY . 33.9 mmtp -79.17 -58.65 3.12 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.857 0.863 . . . . 0.0 109.421 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.8 m -154.45 156.72 37.27 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.378 0.671 . . . . 0.0 110.613 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.4 t -93.37 111.76 25.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.822 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.629 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 7.3 mm-40 -86.62 167.21 14.74 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.348 0.659 . . . . 0.0 109.363 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -69.13 93.85 0.63 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.57 -6.76 65.43 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.852 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.629 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 49.9 mtm180 -129.01 158.99 37.34 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.009 0.523 . . . . 0.0 110.952 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 mm -124.17 104.44 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.2 t -79.98 118.75 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.2 pt -108.81 174.08 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 123.893 0.877 . . . . 0.0 109.336 172.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.533 ' HA3' ' HE3' ' A' ' 46' ' ' LYS . . . -135.38 -90.04 0.31 Allowed Glycine 0 C--N 1.34 0.757 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.065 -173.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -107.73 130.45 54.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.09 0.472 . . . . 0.0 111.882 -168.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -164.12 -176.4 4.47 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.278 1.031 . . . . 0.0 108.768 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -128.79 122.72 31.14 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.98 -32.66 69.57 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.753 0.421 . . . . 0.0 112.114 -173.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.88 -34.62 69.33 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.43 -38.69 68.26 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.379 172.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.464 ' HB3' HD12 ' A' ' 38' ' ' LEU . . . -70.06 -28.47 65.47 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.926 0.49 . . . . 0.0 111.629 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -78.63 -36.25 44.33 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.037 0.535 . . . . 0.0 112.027 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.402 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 11.9 pt-20 -74.61 -41.96 59.49 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 120.838 0.352 . . . . 0.0 110.859 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 pp -81.46 -21.27 38.88 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.21 -41.38 86.49 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.959 170.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.546 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -73.59 -21.0 60.46 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 117.346 0.573 . . . . 0.0 111.032 177.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.468 ' HD2' ' OH ' ' A' ' 25' ' ' TYR . 2.6 ttmp? -57.98 -46.85 84.51 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 166.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.488 ' HE3' HD11 ' A' ' 71' ' ' LEU . 89.3 t90 -62.34 -42.64 99.55 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.117 174.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.546 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . 9.8 mp -54.55 -31.7 57.02 Favored 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 123.54 0.736 . . . . 0.0 111.879 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 . . . . . 0 CA--C 1.551 0.983 0 C-N-CA 122.924 0.49 . . . . 0.0 109.908 179.359 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.471 0.605 0 CA-C-O 120.878 0.371 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -74.13 108.41 6.91 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.34 1.056 . . . . 0.0 109.883 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.452 HG22 ' HB ' ' A' ' 53' ' ' ILE . 61.5 t -80.01 123.7 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.927 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -106.09 122.58 46.46 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.135 0.974 . . . . 0.0 109.836 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -78.82 80.76 5.15 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.57 -95.61 0.39 Allowed Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.786 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -104.3 0.38 29.17 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.844 0.858 . . . . 0.0 112.124 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -131.42 149.6 52.47 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.134 0.574 . . . . 0.0 110.422 -175.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.6 t -71.94 111.62 7.35 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.419 0.688 . . . . 0.0 109.762 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -77.37 -55.92 4.99 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.32 0.648 . . . . 0.0 109.327 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.88 -142.99 6.09 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.36 151.71 35.79 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.445 0.698 . . . . 0.0 109.748 172.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.2 t -71.62 146.9 48.04 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.955 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.42 -37.73 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.081 0.952 . . . . 0.0 109.405 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.73 173.24 14.42 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -173.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.419 ' HB ' HD11 ' A' ' 29' ' ' LEU . 8.9 p -155.96 134.1 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.565 0.746 . . . . 0.0 109.516 171.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -133.77 125.24 28.1 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.17 -107.07 1.18 Allowed Glycine 0 CA--C 1.531 1.072 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.398 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -102.93 -9.4 19.89 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.004 0.921 . . . . 0.0 111.603 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.564 ' HB3' ' HB2' ' A' ' 39' ' ' ALA . 86.6 m-85 -108.7 108.48 19.34 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.815 -0.553 . . . . 0.0 111.979 -169.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.419 HD11 ' HB ' ' A' ' 24' ' ' VAL . 26.8 tp -77.65 109.35 11.55 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.37 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 mm -72.03 99.73 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.2 t -96.1 112.71 28.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.513 ' HZ2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -85.89 113.91 22.39 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.95 86.86 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 CA-C-O 122.164 0.983 . . . . 0.0 110.532 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.53 -89.26 0.36 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.392 177.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.522 HG21 ' HG2' ' A' ' 36' ' ' GLU . 10.5 t -101.5 -16.71 16.72 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.39 0.676 . . . . 0.0 110.93 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.522 ' HG2' HG21 ' A' ' 35' ' ' THR . 6.3 mm-40 -109.6 162.73 14.13 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.443 0.697 . . . . 0.0 111.156 -167.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -121.39 108.48 13.73 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 170.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.85 106.68 17.29 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.501 1.121 . . . . 0.0 108.755 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.564 ' HB2' ' HB3' ' A' ' 28' ' ' TYR . . . -87.24 94.74 9.75 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.559 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.6 m -78.98 140.04 57.57 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.531 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.36 155.05 72.06 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.554 2.169 . . . . 0.0 110.767 172.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.41 ' HA ' HD12 ' A' ' 45' ' ' ILE . 31.8 mmmt -64.71 -22.94 67.1 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -76.57 -17.21 59.34 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.267 0.627 . . . . 0.0 111.921 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.1 t -66.66 -30.59 70.89 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.272 0.629 . . . . 0.0 110.727 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 42' ' ' LYS . 2.6 mp -72.49 115.48 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.729 0.812 . . . . 0.0 109.733 -177.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -85.85 -44.35 12.52 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.765 0.826 . . . . 0.0 110.184 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.3 m -139.46 133.5 31.02 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.545 0.738 . . . . 0.0 111.436 -172.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.1 t -105.08 110.75 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 170.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 40.0 mm-40 -111.37 175.5 5.4 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.973 0.909 . . . . 0.0 110.488 -177.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -40.47 -56.6 2.01 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 125.648 1.579 . . . . 0.0 113.013 -171.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.492 ' H ' ' HD2' ' A' ' 52' ' ' ARG . . . -140.3 35.73 1.86 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.492 ' HD2' ' H ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -137.86 151.56 48.19 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.524 0.73 . . . . 0.0 109.564 -176.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.452 ' HB ' HG22 ' A' ' 11' ' ' VAL . 31.1 mm -132.11 104.06 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 124.556 1.142 . . . . 0.0 108.432 172.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.8 t -84.48 115.88 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.1 pt -107.3 141.33 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.68 0.792 . . . . 0.0 109.518 173.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.82 -61.45 1.77 Allowed Glycine 0 C--N 1.345 1.047 0 N-CA-C 112.231 -0.348 . . . . 0.0 112.231 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -156.48 162.65 39.96 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.834 0.853 . . . . 0.0 109.451 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -171.01 162.72 7.28 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.76 0.824 . . . . 0.0 109.947 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.03 86.7 1.03 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.52 -36.55 71.08 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.98 0.912 . . . . 0.0 113.241 -171.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -68.05 -38.22 82.2 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.416 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 41.4 mt-10 -74.14 -34.66 63.93 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.842 176.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.21 -24.54 63.13 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.836 0.455 . . . . 0.0 110.959 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -74.2 -44.59 52.65 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.104 0.962 . . . . 0.0 110.161 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.7 pt-20 -70.11 -38.47 75.63 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.44 HD12 ' HB3' ' A' ' 39' ' ' ALA . 4.5 pp -82.97 -13.41 56.04 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 120.983 0.42 . . . . 0.0 110.651 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.69 -43.77 50.63 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.133 169.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.51 ' HA ' HD22 ' A' ' 71' ' ' LEU . 25.7 ptt85 -73.83 -22.5 59.76 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 116.766 0.283 . . . . 0.0 110.542 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 24.8 ttpp -64.82 -33.9 77.08 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 169.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -66.45 -35.6 80.7 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 119.638 -0.22 . . . . 0.0 110.832 170.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.51 HD22 ' HA ' ' A' ' 68' ' ' ARG . 4.4 mm? -61.43 -23.0 65.53 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.29 0.496 . . . . 0.0 111.407 173.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 69' ' ' LYS . 13.3 tp10 . . . . . 0 CA--C 1.56 1.345 0 C-N-CA 123.305 0.642 . . . . 0.0 110.47 169.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -79.13 111.22 15.13 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.435 HG23 ' HB ' ' A' ' 53' ' ' ILE . 61.6 t -86.78 127.93 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.702 0.801 . . . . 0.0 110.781 -175.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -108.82 123.02 48.39 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.323 1.449 . . . . 0.0 109.167 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 87.1 tttt -80.94 90.13 5.92 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.2 -95.58 0.59 Allowed Glycine 0 C--N 1.342 0.914 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.329 -173.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -117.65 -10.52 10.55 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.918 0.887 . . . . 0.0 111.887 -176.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 11.3 pt-20 -90.87 146.61 23.78 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.4 t -81.67 102.28 10.6 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -76.32 -55.64 5.37 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.443 0.697 . . . . 0.0 111.14 -172.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.557 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 178.75 -137.26 3.16 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-O 120.066 -0.297 . . . . 0.0 112.513 -177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -145.2 136.53 25.07 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.062 0.945 . . . . 0.0 109.68 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 31.6 p -76.85 118.25 19.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.729 0.812 . . . . 0.0 110.161 175.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.04 -35.05 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.965 0.906 . . . . 0.0 109.82 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -150.09 175.34 11.82 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.963 0.505 . . . . 0.0 110.455 -173.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.443 ' HB ' HD11 ' A' ' 29' ' ' LEU . 7.1 p -152.8 139.34 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.503 1.121 . . . . 0.0 108.773 171.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -141.46 127.12 19.04 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.99 -106.37 0.98 Allowed Glycine 0 CA--C 1.531 1.068 0 O-C-N 123.514 0.509 . . . . 0.0 113.733 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -109.81 15.12 22.92 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.154 0.982 . . . . 0.0 111.709 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.588 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 96.9 m-85 -135.16 113.82 11.74 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 118.302 0.501 . . . . 0.0 111.888 -172.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.443 HD11 ' HB ' ' A' ' 24' ' ' VAL . 42.8 tp -80.29 111.81 17.03 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.909 1.283 . . . . 0.0 109.367 172.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.6 mm -71.77 99.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.343 0.657 . . . . 0.0 109.72 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 47.6 t -100.34 112.42 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.762 0.825 . . . . 0.0 109.046 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -89.3 123.05 33.14 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.557 HG12 ' HA3' ' A' ' 19' ' ' GLY . 1.3 m -128.08 133.33 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 173.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.81 -91.64 0.05 OUTLIER Glycine 0 N--CA 1.474 1.171 0 C-N-CA 123.287 0.47 . . . . 0.0 113.82 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 t -125.03 -13.26 6.86 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.308 1.043 . . . . 0.0 112.039 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -111.25 156.13 21.94 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -170.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -104.39 108.77 20.35 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 172.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.23 104.53 14.67 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.588 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -83.55 93.99 7.96 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.413 HG11 ' CE2' ' A' ' 58' ' ' PHE . 3.9 m -78.04 137.34 61.34 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.499 ' HG2' ' HB2' ' A' ' 44' ' ' SER . 31.1 Cg_endo -62.37 138.43 71.19 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.241 1.961 . . . . 0.0 111.287 175.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.505 ' HA ' HD11 ' A' ' 45' ' ' ILE . 14.5 mmmm -62.75 -29.94 71.06 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.653 0.781 . . . . 0.0 111.528 -177.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -70.82 -18.24 62.73 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.028 0.931 . . . . 0.0 112.244 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.499 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 26.0 t -72.55 -27.12 62.03 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.918 0.487 . . . . 0.0 111.186 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.505 HD11 ' HA ' ' A' ' 42' ' ' LYS . 1.6 mp -61.98 115.5 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.811 0.444 . . . . 0.0 110.25 -176.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -76.41 -47.69 22.34 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.326 1.05 . . . . 0.0 110.599 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.9 m -143.45 124.69 14.58 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.136 0.574 . . . . 0.0 110.676 -173.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.0 t -93.21 109.24 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 166.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.653 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 16.3 mm-40 -108.53 165.71 11.32 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.125 1.37 . . . . 0.0 108.607 174.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.08 99.48 1.11 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.829 0.452 . . . . 0.0 110.453 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.7 14.12 73.85 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.201 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.653 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 28.3 mtm180 -142.83 125.51 15.92 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.172 0.989 . . . . 0.0 108.761 -175.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.435 ' HB ' HG23 ' A' ' 11' ' ' VAL . 34.8 mm -118.86 101.2 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 63.8 t -84.26 117.57 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.429 HG22 HG13 ' A' ' 45' ' ' ILE . 12.9 pt -109.74 164.56 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.876 0.871 . . . . 0.0 109.648 176.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.59 -87.65 1.36 Allowed Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 -173.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -142.95 144.42 32.36 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.113 0.965 . . . . 0.0 108.95 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.413 ' CE2' HG11 ' A' ' 40' ' ' VAL . 6.1 p90 -167.19 150.97 6.6 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -87.14 99.7 12.12 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.66 -29.54 69.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.186 0.994 . . . . 0.0 112.707 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.83 -42.72 85.34 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.971 0.415 . . . . 0.0 110.188 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.72 -37.5 82.32 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.26 -24.6 65.81 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.042 0.937 . . . . 0.0 111.379 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.63 -46.36 38.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.47 1.108 . . . . 0.0 110.216 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.36 -37.95 74.7 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 123.237 0.335 . . . . 0.0 111.259 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 39' ' ' ALA . 4.3 pp -82.26 -16.28 50.05 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-O 120.647 0.26 . . . . 0.0 110.441 175.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -76.55 -35.95 39.77 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.653 173.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -77.89 -21.96 50.47 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 172.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -65.0 -35.62 81.79 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 169.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.407 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 59.9 t90 -59.89 -51.49 69.49 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 123.395 0.434 . . . . 0.0 109.87 170.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.4 mt -49.49 -38.63 30.87 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 123.616 0.766 . . . . 0.0 111.504 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 . . . . . 0 CA--C 1.55 0.948 0 C-N-CA 124.55 1.14 . . . . 0.0 111.593 179.869 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.426 ' SD ' ' HA2' ' A' ' 51' ' ' GLY . 42.1 tpp . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -69.9 128.96 38.2 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.0 t -100.21 139.06 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.228 0.611 . . . . 0.0 110.31 -177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -130.1 127.54 40.05 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.205 1.402 . . . . 0.0 108.89 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -76.96 96.27 4.33 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.07 -95.25 0.34 Allowed Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -168.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -117.58 -23.45 7.66 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.746 0.818 . . . . 0.0 111.783 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -79.99 145.2 32.67 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.7 t -71.52 111.12 6.56 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.843 0.354 . . . . 0.0 110.586 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -83.91 -55.66 4.11 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.334 0.654 . . . . 0.0 109.729 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.28 -131.41 1.43 Allowed Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.827 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -148.82 137.12 21.03 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.202 1.401 . . . . 0.0 108.022 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.3 t -74.11 135.25 42.91 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.79 -35.42 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.761 0.824 . . . . 0.0 109.541 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -151.4 165.8 33.0 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.267 0.627 . . . . 0.0 110.205 -173.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.406 ' HB ' HD13 ' A' ' 29' ' ' LEU . 7.1 p -147.91 132.47 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.115 0.966 . . . . 0.0 108.461 169.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -141.1 138.98 33.91 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.55 -105.37 0.97 Allowed Glycine 0 CA--C 1.528 0.865 0 O-C-N 123.226 0.329 . . . . 0.0 112.527 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -120.07 5.25 10.84 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.71 0.804 . . . . 0.0 111.644 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -115.66 119.22 35.39 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.174 0.59 . . . . 0.0 111.53 -169.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.406 HD13 ' HB ' ' A' ' 24' ' ' VAL . 30.1 tp -79.52 109.14 13.62 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.871 0.868 . . . . 0.0 108.921 171.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.1 mm -73.53 104.39 2.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.3 t -99.52 112.56 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.952 0.901 . . . . 0.0 109.74 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -75.92 107.29 8.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.676 0.791 . . . . 0.0 109.2 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -91.8 155.92 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 167.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -44.98 -28.35 1.76 Allowed Glycine 0 CA--C 1.541 1.688 0 N-CA-C 116.258 1.263 . . . . 0.0 116.258 -172.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.9 p -96.16 -47.52 6.02 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.649 0.779 . . . . 0.0 112.339 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -143.1 -175.07 4.38 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.285 0.634 . . . . 0.0 111.714 -164.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.434 ' HB2' HD22 ' A' ' 71' ' ' LEU . 38.1 m-85 -115.43 109.84 18.44 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.097 0.959 . . . . 0.0 108.792 175.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.62 115.07 27.18 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.268 1.027 . . . . 0.0 108.467 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.472 ' HB2' HD12 ' A' ' 66' ' ' LEU . . . -82.2 92.96 6.98 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.409 0.623 . . . . 0.0 109.77 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.7 t -85.84 118.43 70.54 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.322 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.502 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 43.2 Cg_endo -62.07 148.66 92.75 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.215 1.943 . . . . 0.0 111.594 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.552 ' HA ' HD12 ' A' ' 45' ' ' ILE . 14.4 mmmm -66.1 -25.12 66.86 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.567 0.747 . . . . 0.0 112.04 -174.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.502 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 15.1 ptmm? -66.75 -23.38 66.08 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.894 0.878 . . . . 0.0 111.452 174.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.8 t -82.85 -30.11 28.9 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 123.034 0.534 . . . . 0.0 110.317 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 42' ' ' LYS . 1.7 mp -62.77 114.05 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.264 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 174.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -85.68 -52.16 5.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.385 1.074 . . . . 0.0 110.161 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.0 m -144.22 154.24 42.91 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.059 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.19 109.37 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.429 1.092 . . . . 0.0 108.887 174.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.715 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 13.0 mm-40 -102.72 169.73 8.44 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.14 0.976 . . . . 0.0 109.644 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.87 93.63 1.35 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.952 0.501 . . . . 0.0 109.885 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.426 ' HA2' ' SD ' ' A' ' 9' ' ' MET . . . 93.32 2.77 65.59 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.261 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.715 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 92.7 mtt180 -133.6 141.19 47.55 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.355 0.662 . . . . 0.0 110.166 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.2 mm -118.16 103.72 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 168.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.7 t -76.7 113.78 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.434 HG23 HG13 ' A' ' 45' ' ' ILE . 31.4 pt -109.2 156.95 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.299 0.64 . . . . 0.0 109.492 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.67 -140.22 6.72 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.382 -168.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -78.49 123.03 26.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.389 0.676 . . . . 0.0 111.183 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -158.84 148.63 19.24 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 125.111 1.365 . . . . 0.0 108.035 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -72.19 101.75 2.89 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.18 -28.99 64.63 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.894 0.878 . . . . 0.0 112.154 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -72.21 -39.45 68.54 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.728 0.775 . . . . 0.0 110.094 176.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.19 -30.89 62.44 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.02 175.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.21 -25.02 64.11 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.271 0.629 . . . . 0.0 110.226 172.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -74.19 -41.12 61.94 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.486 0.714 . . . . 0.0 110.018 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.22 -42.22 69.19 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 118.128 0.422 . . . . 0.0 111.478 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 39' ' ' ALA . 4.5 pp -81.84 -14.54 56.14 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 120.839 0.352 . . . . 0.0 110.293 176.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -75.15 -44.4 23.22 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.469 171.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -28.57 63.17 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.318 0.559 . . . . 0.0 109.703 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -60.72 -39.66 89.42 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.619 170.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.481 ' HE3' HD21 ' A' ' 71' ' ' LEU . 86.1 t90 -59.46 -44.68 92.95 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.561 175.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.481 HD21 ' HE3' ' A' ' 70' ' ' TRP . 3.9 mm? -59.13 -32.15 69.6 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 176.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 CA--C 1.546 0.789 0 C-N-CA 122.826 0.45 . . . . 0.0 110.391 178.221 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.8 ttm . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -82.95 156.03 23.7 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.164 0.585 . . . . 0.0 109.737 170.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.453 HG21 ' HB ' ' A' ' 53' ' ' ILE . 81.3 t -121.7 129.72 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.986 0.915 . . . . 0.0 109.968 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 24.8 m-85 -119.8 121.28 38.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.787 1.235 . . . . 0.0 108.726 176.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -78.86 86.48 4.77 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.38 -96.57 0.64 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.879 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -105.82 -18.74 13.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.635 0.774 . . . . 0.0 111.579 -176.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -98.25 156.45 16.7 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.832 0.453 . . . . 0.0 110.332 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 t -81.69 119.67 24.14 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -93.69 -55.75 3.15 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.263 0.625 . . . . 0.0 110.78 -173.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.05 -151.63 7.95 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.201 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -135.1 123.22 22.85 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.425 0.69 . . . . 0.0 109.431 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.489 ' HB2' HD12 ' A' ' 29' ' ' LEU . 12.9 p -71.14 108.43 4.66 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -39.15 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 123.507 0.723 . . . . 0.0 109.707 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -142.97 166.22 25.22 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.468 0.707 . . . . 0.0 109.59 -175.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -152.27 130.27 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.792 0.837 . . . . 0.0 108.819 173.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -142.22 134.3 27.45 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.05 -106.71 1.18 Allowed Glycine 0 CA--C 1.531 1.073 0 O-C-N 123.441 0.463 . . . . 0.0 113.277 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -119.63 18.14 12.74 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.778 0.831 . . . . 0.0 111.234 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.574 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 55.4 m-85 -126.08 113.17 16.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.927 0.491 . . . . 0.0 111.21 -175.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 21' ' ' SER . 62.6 tp -82.61 108.08 15.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.0 0.92 . . . . 0.0 109.219 171.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.2 mm -71.54 106.08 2.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.19 119.72 59.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.574 0.75 . . . . 0.0 109.861 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -74.31 109.18 7.59 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.285 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.6 m -116.15 103.19 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.521 1.128 . . . . 0.0 110.62 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.46 -89.03 0.05 OUTLIER Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.179 -0.919 . . . . 0.0 113.911 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.2 p -85.76 -41.19 15.3 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.222 1.009 . . . . 0.0 111.909 -174.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -150.03 -175.45 5.06 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -165.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -104.17 111.61 24.28 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.457 1.103 . . . . 0.0 110.686 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.1 mp -104.38 127.43 52.04 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -86.32 93.63 9.14 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.001 -175.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -72.14 115.54 39.66 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.586 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.5 149.97 89.14 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.735 2.29 . . . . 0.0 112.09 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.55 ' HA ' HD12 ' A' ' 45' ' ' ILE . 14.5 mmmm -67.26 -16.87 64.53 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -65.5 -30.9 71.72 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.085 0.554 . . . . 0.0 110.816 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.503 ' HB2' ' HB3' ' A' ' 58' ' ' PHE . 37.3 t -76.68 -32.62 58.03 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.649 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 42' ' ' LYS . 1.8 mp -63.75 114.62 2.06 Favored 'Isoleucine or valine' 0 C--N 1.359 0.98 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -95.57 -53.55 3.69 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.36 1.064 . . . . 0.0 110.771 -172.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.0 t -150.09 134.26 17.13 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 122.998 0.519 . . . . 0.0 110.003 -173.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 p -98.66 111.75 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.466 0.65 . . . . 0.0 110.178 177.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 30.6 mm-40 -103.81 173.11 6.44 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.159 0.984 . . . . 0.0 111.07 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.31 101.06 1.43 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.153 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.76 12.5 83.49 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.446 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.647 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 61.5 mtp180 -141.42 135.7 30.63 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.645 0.778 . . . . 0.0 110.044 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.453 ' HB ' HG21 ' A' ' 11' ' ' VAL . 30.8 mm -109.11 103.04 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 167.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 96.8 t -78.36 112.06 15.92 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.6 pt -112.01 177.7 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.648 0.779 . . . . 0.0 109.826 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.05 -146.18 7.43 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 172.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.25 165.91 21.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.063 0.545 . . . . 0.0 110.072 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.503 ' HB3' ' HB2' ' A' ' 44' ' ' SER . 29.1 p90 -167.0 174.04 8.75 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.867 0.867 . . . . 0.0 109.209 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.14 86.28 1.38 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -70.86 -36.51 72.85 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.612 1.165 . . . . 0.0 112.417 -171.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -71.08 -33.83 70.58 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.045 0.538 . . . . 0.0 110.154 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -71.38 -40.56 70.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.093 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.98 -28.05 69.55 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.834 0.854 . . . . 0.0 111.303 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.36 -48.96 20.61 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.253 1.021 . . . . 0.0 110.414 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.09 -40.32 78.48 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.633 0.373 . . . . 0.0 111.561 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 pp -82.61 -17.18 45.68 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 122.185 -0.322 . . . . 0.0 110.441 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.05 -44.07 46.55 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.346 0.404 . . . . 0.0 112.362 174.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -71.02 -30.72 67.0 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -62.2 -42.33 99.19 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 53.2 t90 -58.23 -44.97 88.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.889 0.743 . . . . 0.0 110.672 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.8 mt -57.54 -28.58 63.64 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.298 0.639 . . . . 0.0 111.686 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 CA--C 1.557 1.241 0 C-N-CA 123.086 0.554 . . . . 0.0 111.242 172.877 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -90.59 135.98 33.35 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.006 0.432 . . . . 0.0 111.165 -173.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.402 HG23 HG22 ' A' ' 31' ' ' VAL . 99.9 t -91.78 130.38 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.72 0.808 . . . . 0.0 109.719 -177.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -118.27 127.37 53.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.664 1.186 . . . . 0.0 109.576 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 28.5 tptp -78.26 91.16 4.37 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 172.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.97 -95.67 0.65 Allowed Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 -171.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.71 -21.48 7.85 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.421 0.689 . . . . 0.0 110.74 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 14.8 pt-20 -79.43 144.23 34.28 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.5 t -70.28 111.18 5.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.794 0.438 . . . . 0.0 110.345 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -82.32 -51.18 8.14 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.096 0.558 . . . . 0.0 110.531 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.458 ' HA3' HG11 ' A' ' 33' ' ' VAL . . . -179.55 -143.2 5.35 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.885 -177.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -136.96 133.52 35.71 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.72 0.808 . . . . 0.0 109.956 -177.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.401 ' OG ' HD13 ' A' ' 29' ' ' LEU . 30.2 t -75.02 106.5 6.55 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 172.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.27 -40.82 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.294 0.638 . . . . 0.0 109.313 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 22.8 t70 -149.14 172.22 15.16 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.372 0.669 . . . . 0.0 109.815 -171.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.9 p -152.1 145.17 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 124.334 1.054 . . . . 0.0 108.538 172.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -143.12 127.22 17.46 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 171.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.2 -106.86 1.12 Allowed Glycine 0 C--N 1.343 0.938 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.728 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 28.7 t70 -107.05 -15.18 14.75 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.071 0.948 . . . . 0.0 111.114 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.48 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 95.3 m-85 -97.34 107.56 20.1 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.558 0.695 . . . . 0.0 111.186 -171.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.401 HD13 ' OG ' ' A' ' 21' ' ' SER . 41.7 tp -76.31 113.29 13.72 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.956 174.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 49.7 mm -75.44 107.77 6.6 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.015 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.402 HG22 HG23 ' A' ' 11' ' ' VAL . 43.0 t -103.76 113.63 41.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 123.992 0.917 . . . . 0.0 109.314 178.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -75.94 114.99 15.19 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.458 HG11 ' HA3' ' A' ' 19' ' ' GLY . 34.1 m -127.45 129.84 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.959 0.904 . . . . 0.0 109.36 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.9 -100.11 0.27 Allowed Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.848 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.6 p -126.1 5.15 7.16 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.214 1.005 . . . . 0.0 112.008 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -134.21 169.65 16.87 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.154 0.582 . . . . 0.0 112.164 -173.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -112.9 123.87 51.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.364 1.065 . . . . 0.0 109.457 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.8 mp -107.22 115.61 30.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.964 0.906 . . . . 0.0 109.008 175.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -78.97 93.63 5.11 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.786 0.835 . . . . 0.0 109.724 177.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.45 HG13 ' CE2' ' A' ' 58' ' ' PHE . 4.0 m -89.04 134.5 33.21 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -176.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 97.9 Cg_endo -73.45 153.05 49.84 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.254 1.969 . . . . 0.0 111.242 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.558 ' HA ' HD11 ' A' ' 45' ' ' ILE . 13.8 mmmm -65.77 -24.28 66.91 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.465 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 7.8 ptpp? -66.38 -25.83 66.97 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.713 0.405 . . . . 0.0 111.361 173.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.3 t -69.1 -41.22 77.75 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.558 HD11 ' HA ' ' A' ' 42' ' ' LYS . 2.7 mp -66.71 114.49 3.69 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -78.71 -48.79 14.25 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.474 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.2 t -158.46 139.53 13.11 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.301 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 p -77.89 133.18 31.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 168.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.787 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 17.8 mm-40 -116.23 177.58 4.64 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.187 0.995 . . . . 0.0 110.04 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -64.02 93.14 0.08 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.858 0.863 . . . . 0.0 110.463 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.86 5.72 88.66 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 114.906 -1.043 . . . . 0.0 114.213 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.787 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 69.9 mtt85 -127.71 162.21 27.1 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.079 0.552 . . . . 0.0 110.728 -174.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.0 mm -133.27 103.34 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 174.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.5 t -83.45 120.64 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.0 pt -109.06 145.21 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 123.943 0.897 . . . . 0.0 109.174 170.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.26 -55.03 1.88 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 112.135 -0.386 . . . . 0.0 112.135 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.405 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 9.9 pt-20 -174.03 159.27 3.26 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.949 0.9 . . . . 0.0 110.552 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.45 ' CE2' HG13 ' A' ' 40' ' ' VAL . 8.1 p90 -171.11 174.18 4.75 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.463 0.705 . . . . 0.0 110.779 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -74.44 86.51 2.03 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.495 0.718 . . . . 0.0 109.483 172.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.15 -38.73 72.22 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.285 0.634 . . . . 0.0 112.669 -174.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.481 ' HG3' ' HG3' ' A' ' 62' ' ' GLU . 7.4 pt-20 -65.4 -38.24 89.37 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.491 0.717 . . . . 0.0 110.817 177.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.508 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 44.6 mt-10 -80.88 -32.79 34.74 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.809 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.75 -26.31 66.92 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.276 0.631 . . . . 0.0 110.611 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -72.69 -51.87 17.54 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.243 1.017 . . . . 0.0 111.179 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.7 pt-20 -69.84 -35.74 74.99 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.311 0.577 . . . . 0.0 110.809 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.22 -13.79 54.64 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.66 -27.53 69.09 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 165.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -69.96 -37.44 75.81 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.83 0.852 . . . . 0.0 108.854 167.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -59.59 -36.52 76.42 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 122.912 0.485 . . . . 0.0 110.875 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 59.7 t90 -60.95 -54.21 47.79 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 173.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.7 mt -54.92 -35.11 63.81 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.48 0.712 . . . . 0.0 111.447 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 CA--C 1.546 0.816 0 C-N-CA 124.224 1.01 . . . . 0.0 110.452 -176.773 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.413 ' SD ' HD11 ' A' ' 53' ' ' ILE . 61.0 mtt . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -84.28 130.33 34.82 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.403 0.681 . . . . 0.0 109.475 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.0 t -86.62 115.24 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.076 0.55 . . . . 0.0 109.937 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.64 117.58 35.19 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.116 0.967 . . . . 0.0 109.692 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 85.3 tttt -77.94 94.41 4.58 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.12 -94.85 0.47 Allowed Glycine 0 C--N 1.344 1.002 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -102.5 -42.91 5.8 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.735 0.814 . . . . 0.0 110.824 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.35 145.42 37.33 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.959 0.504 . . . . 0.0 110.935 -168.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.7 t -69.8 104.87 2.58 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.456 ' HB2' ' HB2' ' A' ' 13' ' ' LYS . 46.9 t80 -74.95 -50.05 18.02 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.713 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.73 -141.4 3.94 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.82 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -140.18 130.73 25.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.371 0.668 . . . . 0.0 110.221 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.406 ' OG ' HD13 ' A' ' 29' ' ' LEU . 25.9 t -68.07 109.96 3.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.155 0.982 . . . . 0.0 109.542 174.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.05 -43.71 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.028 0.531 . . . . 0.0 109.851 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.426 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 22.6 t70 -143.35 167.61 21.75 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.74 0.416 . . . . 0.0 110.466 -171.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.2 t -139.71 140.97 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 124.421 1.089 . . . . 0.0 108.133 174.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.404 ' HH ' HD11 ' A' ' 66' ' ' LEU . 1.8 p90 -141.39 129.91 22.61 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 169.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.36 -107.4 1.35 Allowed Glycine 0 C--N 1.35 1.326 0 O-C-N 123.304 0.378 . . . . 0.0 113.268 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -119.21 24.53 10.7 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.55 0.74 . . . . 0.0 110.918 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.502 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 96.0 m-85 -133.39 124.85 27.9 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.247 0.619 . . . . 0.0 111.375 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.406 HD13 ' OG ' ' A' ' 21' ' ' SER . 55.8 tp -80.55 113.99 19.13 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.406 1.083 . . . . 0.0 109.562 170.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 42.8 mm -72.74 106.07 2.69 Favored 'Isoleucine or valine' 0 C--O 1.249 1.063 0 C-N-CA 123.234 0.614 . . . . 0.0 109.51 175.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.0 t -103.28 118.42 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.151 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -74.97 116.87 16.18 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 m -126.05 99.2 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.953 0.901 . . . . 0.0 110.614 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.29 -89.53 0.1 Allowed Glycine 0 CA--C 1.531 1.073 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.873 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 72.5 p -114.91 -21.99 9.83 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.121 0.968 . . . . 0.0 111.272 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -109.07 174.44 5.87 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.647 0.737 . . . . 0.0 111.363 -172.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -120.96 108.6 14.07 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.238 173.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -96.66 106.07 18.28 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -82.83 93.33 7.44 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.297 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.6 m -77.67 136.7 63.2 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.539 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 35.8 Cg_endo -62.4 149.37 91.06 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 121.905 1.737 . . . . 0.0 111.289 176.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.541 ' HA ' HD12 ' A' ' 45' ' ' ILE . 32.0 mmmt -63.59 -26.21 68.58 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.013 0.525 . . . . 0.0 111.8 -178.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.578 ' HB3' ' HZ1' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -67.71 -23.43 65.28 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.677 0.791 . . . . 0.0 111.449 175.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -72.3 -27.36 62.41 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.784 0.434 . . . . 0.0 110.616 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 42' ' ' LYS . 2.1 mp -67.91 115.65 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -92.03 -48.54 6.69 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.254 1.022 . . . . 0.0 110.974 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.1 t -138.49 147.63 43.4 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.402 -175.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.5 p -122.0 126.05 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.357 1.063 . . . . 0.0 109.099 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 40.5 mt-10 -138.11 168.54 19.52 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.286 1.035 . . . . 0.0 109.537 -175.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.72 99.87 0.25 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.124 0.57 . . . . 0.0 110.432 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.15 1.06 88.65 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 115.905 -0.589 . . . . 0.0 113.643 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.539 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 33.7 mtm180 -130.97 124.94 32.09 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.514 0.657 . . . . 0.0 110.284 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.413 HD11 ' SD ' ' A' ' 9' ' ' MET . 50.8 mm -115.06 102.14 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 170.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.9 t -86.11 115.23 27.02 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.7 pt -107.04 175.14 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 123.569 0.747 . . . . 0.0 109.357 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.04 -142.88 8.21 Favored Glycine 0 C--O 1.24 0.507 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -81.56 157.12 24.89 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 174.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -167.37 170.66 11.27 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.892 0.877 . . . . 0.0 109.201 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -81.16 93.52 6.47 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -71.23 -39.94 71.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.074 0.95 . . . . 0.0 112.74 -171.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -65.34 -37.88 88.41 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.009 0.433 . . . . 0.0 110.491 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -71.9 -37.64 70.09 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.568 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.12 -34.32 77.35 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.508 0.723 . . . . 0.0 111.333 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 6.7 ptp85 -74.39 -44.72 50.87 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 119.112 -0.47 . . . . 0.0 111.157 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.98 -37.57 86.32 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 118.275 0.489 . . . . 0.0 111.602 -175.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.404 HD11 ' HH ' ' A' ' 25' ' ' TYR . 4.0 pp -81.63 -21.15 38.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 122.478 0.311 . . . . 0.0 110.399 176.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.43 -33.78 68.15 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.039 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 64' ' ' ARG . 59.0 mtp180 -77.41 -30.55 53.55 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.359 1.064 . . . . 0.0 109.853 175.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -63.28 -39.51 94.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.141 0.576 . . . . 0.0 109.715 170.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -60.24 -45.36 93.52 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.985 0.514 . . . . 0.0 109.917 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.456 HD11 ' HA ' ' A' ' 68' ' ' ARG . 50.4 mt -58.53 -23.41 58.18 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.797 0.839 . . . . 0.0 112.517 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 CA--C 1.554 1.115 0 C-N-CA 122.706 0.402 . . . . 0.0 110.728 174.719 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.406 ' SD ' HD13 ' A' ' 53' ' ' ILE . 18.5 ttt . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.875 -0.416 . . . . 0.0 109.875 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -72.82 141.27 48.02 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.6 t -119.49 127.75 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.578 0.751 . . . . 0.0 110.02 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -109.35 132.91 53.68 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.228 1.011 . . . . 0.0 109.044 171.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -83.98 82.39 8.37 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.83 -100.58 0.85 Allowed Glycine 0 C--N 1.344 0.986 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.239 -177.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -97.16 -28.07 14.27 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.851 0.86 . . . . 0.0 110.879 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -92.15 152.31 19.96 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.811 0.444 . . . . 0.0 110.119 -176.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.1 t -74.16 125.14 27.71 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.305 0.642 . . . . 0.0 109.349 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -98.46 -58.59 1.93 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 121.957 0.103 . . . . 0.0 110.848 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.513 ' HA3' HG13 ' A' ' 33' ' ' VAL . . . 172.66 -141.43 6.22 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.413 0.446 . . . . 0.0 112.196 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -144.86 137.98 26.68 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.826 0.85 . . . . 0.0 110.13 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.7 p -73.61 118.2 16.28 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 175.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.21 -37.82 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.589 0.756 . . . . 0.0 109.042 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -156.27 176.83 12.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.977 0.511 . . . . 0.0 110.822 -175.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.4 p -150.17 138.28 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.46 1.104 . . . . 0.0 108.868 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -136.21 133.69 37.36 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.67 -106.62 1.22 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 123.463 0.477 . . . . 0.0 113.793 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -117.14 11.63 14.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.903 0.881 . . . . 0.0 111.026 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.558 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 81.8 m-85 -125.15 111.56 15.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.039 0.535 . . . . 0.0 111.549 -173.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 57.7 tp -77.82 110.35 12.62 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.507 1.123 . . . . 0.0 109.485 173.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.0 mm -71.94 100.11 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.26 0.624 . . . . 0.0 109.606 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.06 113.22 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.428 0.691 . . . . 0.0 109.787 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -76.24 120.05 20.98 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.669 0.787 . . . . 0.0 109.882 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.513 HG13 ' HA3' ' A' ' 19' ' ' GLY . 1.3 m -132.45 142.04 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.7 -96.21 0.03 OUTLIER Glycine 0 CA--C 1.537 1.456 0 O-C-N 123.274 0.359 . . . . 0.0 113.966 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.3 m -124.49 -16.39 6.34 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.509 1.124 . . . . 0.0 111.023 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -114.72 166.88 11.27 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.934 0.893 . . . . 0.0 112.149 -170.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -113.65 112.25 23.18 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.211 1.004 . . . . 0.0 109.751 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.55 105.95 17.92 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.932 0.893 . . . . 0.0 109.175 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.558 ' HB3' ' HB3' ' A' ' 28' ' ' TYR . . . -77.82 92.37 4.22 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 172.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.9 m -86.22 136.63 35.54 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.65 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.519 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 37.7 Cg_endo -63.33 151.28 85.68 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.221 1.947 . . . . 0.0 111.36 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.545 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.4 mmmm -67.3 -23.26 65.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.953 0.501 . . . . 0.0 111.457 -176.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.519 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 22.4 ptmt -69.61 -26.55 64.5 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.686 0.794 . . . . 0.0 111.457 174.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.3 t -65.35 -31.29 72.33 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.269 0.628 . . . . 0.0 110.604 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.545 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.0 mp -64.95 116.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HZ3' ' HB3' ' A' ' 46' ' ' LYS . 2.8 mmmp? -92.28 -52.1 4.84 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.153 0.981 . . . . 0.0 110.936 -177.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 t -148.83 139.87 23.02 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.566 -171.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.2 t -102.92 110.75 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 173.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.09 130.89 22.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 63.28 33.88 13.73 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.415 1.086 . . . . 0.0 112.944 166.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.92 15.98 80.71 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 121.316 0.398 . . . . 0.0 112.326 -177.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -125.15 158.21 34.48 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.68 1.192 . . . . 0.0 109.063 -175.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.406 HD13 ' SD ' ' A' ' 9' ' ' MET . 28.6 mm -120.47 104.91 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.634 0.774 . . . . 0.0 109.55 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.9 t -80.0 113.01 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.435 HG23 ' HA ' ' A' ' 45' ' ' ILE . 37.4 pt -109.49 142.75 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.79 -74.48 1.2 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -152.73 164.19 38.24 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.63 0.772 . . . . 0.0 109.685 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -170.51 163.89 8.43 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 124.377 1.071 . . . . 0.0 108.298 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -77.77 97.09 5.09 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.05 -35.99 82.92 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.589 0.756 . . . . 0.0 112.007 -174.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -62.6 -45.54 92.42 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.682 0.614 . . . . 0.0 110.484 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 35.1 mt-10 -70.29 -38.7 75.08 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.887 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.17 -38.55 91.46 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.569 0.748 . . . . 0.0 111.363 -176.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -74.41 -38.4 63.08 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.326 0.25 . . . . 0.0 111.582 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.8 pt-20 -76.75 -40.86 47.01 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -176.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 pp -82.47 -12.99 57.46 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.0 0.429 . . . . 0.0 109.996 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.99 -48.45 75.72 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 162.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.0 mtt-85 -63.48 -31.94 73.25 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.901 0.881 . . . . 0.0 111.511 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -55.9 -48.78 75.01 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.115 0.566 . . . . 0.0 109.514 172.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.555 ' HE3' HD13 ' A' ' 71' ' ' LEU . 79.9 t90 -60.25 -42.56 95.57 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 123.309 0.38 . . . . 0.0 110.663 174.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.555 HD13 ' HE3' ' A' ' 70' ' ' TRP . 10.6 mp -57.0 -28.95 62.89 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 122.666 0.387 . . . . 0.0 112.027 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 122.958 0.503 . . . . 0.0 110.285 176.444 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.2 mtt . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -71.65 110.88 6.5 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.304 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.5 t -79.27 124.7 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.813 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -113.61 121.89 45.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.032 0.933 . . . . 0.0 109.035 175.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 52.6 tttm -84.1 79.3 9.56 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.65 0.738 . . . . 0.0 109.624 175.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.61 -94.26 0.41 Allowed Glycine 0 C--N 1.342 0.9 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.831 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -96.9 -13.26 22.57 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.71 0.804 . . . . 0.0 111.591 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 10.0 pt-20 -116.09 153.6 31.45 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.533 0.733 . . . . 0.0 109.609 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.3 t -85.02 112.73 20.88 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -80.34 -56.8 3.94 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.531 0.333 . . . . 0.0 110.535 -172.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 178.18 -135.43 2.67 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.124 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -148.91 142.79 25.72 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.986 0.914 . . . . 0.0 109.985 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.1 p -74.52 108.3 7.19 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.497 0.719 . . . . 0.0 110.69 -178.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.87 -38.72 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.193 0.597 . . . . 0.0 110.117 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -153.66 172.4 17.31 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.39 0.676 . . . . 0.0 109.888 -172.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 p -155.66 132.68 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.888 0.875 . . . . 0.0 109.069 173.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.428 ' CE1' HD11 ' A' ' 30' ' ' ILE . 3.9 p90 -135.66 133.63 38.35 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.64 -105.43 1.23 Allowed Glycine 0 C--N 1.346 1.116 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -117.57 -0.85 11.78 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.841 0.856 . . . . 0.0 110.083 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.529 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 30.5 m-85 -104.1 106.21 16.64 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.706 -166.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 50.1 tp -75.84 105.65 6.99 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.428 HD11 ' CE1' ' A' ' 25' ' ' TYR . 38.0 mm -68.51 106.69 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.895 176.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.2 t -99.66 116.24 42.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -72.7 107.65 5.28 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 174.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.42 HG21 ' HB2' ' A' ' 36' ' ' GLU . 19.1 m -113.63 83.6 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.434 1.094 . . . . 0.0 110.579 -173.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.61 -82.06 0.5 Allowed Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.066 -0.97 . . . . 0.0 113.612 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 t -122.48 -11.08 8.35 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.853 0.861 . . . . 0.0 110.847 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.42 ' HB2' HG21 ' A' ' 33' ' ' VAL . 65.0 mm-40 -111.62 177.91 4.5 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.605 0.762 . . . . 0.0 110.55 -178.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.581 ' HB2' HD12 ' A' ' 71' ' ' LEU . 42.7 m-85 -134.29 110.93 9.82 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 169.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -105.54 126.82 52.56 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 28' ' ' TYR . . . -95.37 100.74 12.47 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.971 0.908 . . . . 0.0 110.472 -173.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.1 m -85.32 137.47 36.9 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 122.95 0.5 . . . . 0.0 109.896 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.16 160.47 41.82 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.392 2.061 . . . . 0.0 111.565 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -67.07 -23.69 65.89 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.504 0.322 . . . . 0.0 111.671 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -70.81 -22.78 62.3 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.262 0.625 . . . . 0.0 111.933 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.2 t -64.1 -32.44 74.0 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.079 0.552 . . . . 0.0 110.932 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mp -68.32 114.0 4.71 Favored 'Isoleucine or valine' 0 C--N 1.356 0.856 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -87.11 -41.26 13.94 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.596 1.158 . . . . 0.0 111.268 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.9 m -149.68 147.89 28.62 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.517 0.727 . . . . 0.0 110.594 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 p -110.48 117.09 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.624 0.77 . . . . 0.0 109.516 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 9.7 mm-40 -98.91 166.82 11.11 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.91 -26.98 39.55 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.198 0.999 . . . . 0.0 113.413 -174.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.49 22.27 1.2 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 112.148 -0.381 . . . . 0.0 112.148 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.648 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 95.4 mtt180 -136.53 159.08 42.87 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.444 0.698 . . . . 0.0 109.78 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.0 mm -126.58 103.22 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.1 t -82.03 113.17 20.93 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.401 HG13 ' HA ' ' A' ' 13' ' ' LYS . 37.4 pt -106.51 162.25 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 168.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -123.33 -65.17 0.21 Allowed Glycine 0 CA--C 1.503 -0.706 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -177.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -128.4 143.21 50.97 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.379 0.672 . . . . 0.0 110.16 -170.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -173.85 150.92 1.72 Allowed 'General case' 0 C--O 1.246 0.92 0 C-N-CA 125.578 1.551 . . . . 0.0 107.192 173.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -71.5 106.12 3.85 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -70.07 -35.53 74.29 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.096 0.958 . . . . 0.0 112.429 -169.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -69.18 -36.0 76.86 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.962 0.505 . . . . 0.0 110.735 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -67.69 -43.01 81.14 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.306 175.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.83 -25.67 66.55 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.68 0.792 . . . . 0.0 111.145 175.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -49.03 25.37 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.642 0.777 . . . . 0.0 109.33 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.61 -41.04 66.01 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.759 0.424 . . . . 0.0 111.738 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 pp -82.46 -15.86 50.98 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 120.889 0.376 . . . . 0.0 110.25 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.5 -54.25 13.66 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.863 170.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.405 ' HA ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -68.27 -23.08 64.73 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.461 0.704 . . . . 0.0 110.874 178.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -57.85 -48.81 78.7 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.93 0.892 . . . . 0.0 109.978 168.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -60.22 -35.71 76.06 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.225 0.61 . . . . 0.0 111.251 174.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.581 HD12 ' HB2' ' A' ' 37' ' ' PHE . 10.7 mp -63.16 -30.32 71.49 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 122.976 0.511 . . . . 0.0 111.647 174.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.642 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.542 ' HB3' HG12 ' A' ' 53' ' ' ILE . 14.7 mmt . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.34 0.114 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -85.65 121.17 27.94 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.516 0.726 . . . . 0.0 109.388 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.415 HG23 HG21 ' A' ' 31' ' ' VAL . 88.0 t -86.4 124.75 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.26 0.624 . . . . 0.0 110.67 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.02 124.01 48.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.327 1.051 . . . . 0.0 110.262 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 63.9 tttm -82.78 93.92 7.53 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.67 -100.48 1.32 Allowed Glycine 0 C--N 1.34 0.767 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -167.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.46 -1.33 9.11 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.493 0.717 . . . . 0.0 111.741 177.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 10.8 pt-20 -90.4 148.42 22.81 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 118.682 0.674 . . . . 0.0 110.995 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 t -67.42 97.79 0.6 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.844 0.857 . . . . 0.0 109.703 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -85.7 -53.29 5.24 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.637 0.375 . . . . 0.0 110.245 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.58 -152.5 10.1 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.344 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -141.96 134.07 27.59 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.778 0.831 . . . . 0.0 109.815 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.7 t -66.76 105.63 1.62 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.15 -34.28 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.592 0.757 . . . . 0.0 109.596 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -158.39 178.21 10.41 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.403 ' HB ' HD13 ' A' ' 29' ' ' LEU . 7.1 p -155.52 142.22 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.739 0.816 . . . . 0.0 109.206 173.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -139.9 128.29 22.73 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.52 -105.78 0.9 Allowed Glycine 0 CA--C 1.531 1.045 0 O-C-N 123.512 0.507 . . . . 0.0 113.786 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -116.95 11.49 14.36 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.204 1.001 . . . . 0.0 111.723 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 57.3 m-85 -125.29 115.93 21.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.727 0.411 . . . . 0.0 110.457 -176.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.403 HD13 ' HB ' ' A' ' 24' ' ' VAL . 45.0 tp -78.63 111.66 14.93 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.285 1.034 . . . . 0.0 109.255 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.8 mm -71.19 109.42 3.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 123.105 0.562 . . . . 0.0 109.635 178.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.415 HG21 HG23 ' A' ' 11' ' ' VAL . 60.8 t -107.43 114.63 46.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.306 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -74.85 109.6 8.45 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.2 m -107.1 85.41 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 124.494 1.118 . . . . 0.0 110.459 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.91 -83.09 0.31 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.207 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.4 p -110.37 -27.51 9.02 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.207 1.003 . . . . 0.0 111.889 -176.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -111.23 162.25 15.16 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.112 0.565 . . . . 0.0 111.356 -173.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -108.78 109.32 20.43 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 170.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.6 mt -105.36 118.73 37.3 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 28' ' ' TYR . . . -83.47 97.36 8.95 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.608 -177.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.1 t -78.64 115.93 55.61 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.168 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.77 145.48 49.66 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.015 2.477 . . . . 0.0 112.779 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -68.92 -21.12 64.23 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.953 0.901 . . . . 0.0 112.032 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.609 ' HZ2' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -74.58 -13.64 60.68 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.048 0.539 . . . . 0.0 111.635 174.498 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.8 m -94.89 3.46 54.95 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.127 0.971 . . . . 0.0 111.99 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.0 mm -82.36 122.78 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -72.55 -51.2 20.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.61 0.764 . . . . 0.0 110.067 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.1 t -166.03 149.02 7.38 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.43 0.692 . . . . 0.0 110.38 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.3 t -97.6 111.19 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.668 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 31.8 mt-10 -91.6 179.14 5.73 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.065 0.546 . . . . 0.0 110.655 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -40.07 -53.29 2.43 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.782 1.633 . . . . 0.0 113.429 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -140.5 33.24 2.08 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.668 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 68.9 mtt180 -135.26 147.55 49.3 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.449 0.699 . . . . 0.0 110.138 -175.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.542 HG12 ' HB3' ' A' ' 9' ' ' MET . 35.9 mm -116.71 101.63 12.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 168.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 50.8 t -80.17 115.06 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.6 pt -109.58 159.33 9.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.881 0.872 . . . . 0.0 109.207 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.45 -81.77 1.38 Allowed Glycine 0 C--O 1.242 0.629 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -159.87 176.25 12.12 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.061 0.945 . . . . 0.0 109.309 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -164.44 165.35 21.53 Favored 'General case' 0 C--O 1.25 1.127 0 C-N-CA 124.663 1.185 . . . . 0.0 108.13 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -82.1 108.45 15.59 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.61 -20.43 65.35 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.85 -173.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -69.21 -43.67 73.64 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.499 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 50.2 mt-10 -64.26 -55.97 17.78 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.857 175.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.67 -25.05 59.67 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.594 0.758 . . . . 0.0 112.532 -176.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -70.61 -52.67 19.85 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.909 0.884 . . . . 0.0 110.865 175.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -76.38 -38.19 56.11 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -171.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 62' ' ' GLU . 4.6 pp -81.83 -25.13 35.42 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 122.274 -0.266 . . . . 0.0 110.473 174.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.9 -44.67 94.27 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.523 ' HA ' HD21 ' A' ' 71' ' ' LEU . 3.5 ptm180 -74.75 -21.16 59.5 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.411 0.685 . . . . 0.0 110.605 178.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -67.57 -31.87 72.23 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.457 ' HE3' HD22 ' A' ' 71' ' ' LEU . 85.4 t90 -69.71 -36.85 76.27 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 171.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' A' ' 68' ' ' ARG . 4.3 mm? -59.32 -29.81 67.9 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 172.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 CA--C 1.554 1.125 0 C-N-CA 123.104 0.562 . . . . 0.0 110.712 173.81 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -83.87 123.79 30.29 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.754 0.822 . . . . 0.0 109.945 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.406 HG23 HG22 ' A' ' 31' ' ' VAL . 54.5 t -85.47 105.57 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.352 0.661 . . . . 0.0 110.533 -175.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -100.41 123.73 45.0 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.837 0.855 . . . . 0.0 109.898 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -78.44 89.45 4.42 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.3 -96.85 0.57 Allowed Glycine 0 C--N 1.346 1.086 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.807 -170.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -107.69 -32.12 7.78 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.887 0.875 . . . . 0.0 110.692 177.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -74.68 142.33 44.47 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -174.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.3 t -76.3 104.29 6.75 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -76.19 -53.49 8.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.85 -163.32 28.9 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.594 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -120.27 144.22 47.9 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -74.9 147.42 41.02 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.39 -32.21 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -164.63 168.81 17.72 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.79 0.436 . . . . 0.0 110.373 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.491 ' HB ' HD13 ' A' ' 29' ' ' LEU . 3.1 p -150.52 140.2 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.342 1.057 . . . . 0.0 108.884 172.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.635 ' HE1' HD11 ' A' ' 30' ' ' ILE . 42.3 p90 -145.87 136.37 24.09 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.767 0.827 . . . . 0.0 109.608 174.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.79 -106.96 1.1 Allowed Glycine 0 C--N 1.344 0.999 0 O-C-N 123.826 0.703 . . . . 0.0 113.942 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -115.68 19.47 15.25 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.946 0.898 . . . . 0.0 110.682 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.528 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 73.9 m-85 -138.0 118.46 13.82 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.779 0.431 . . . . 0.0 111.802 -172.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.491 HD13 ' HB ' ' A' ' 24' ' ' VAL . 44.2 tp -88.32 116.53 26.6 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.133 0.973 . . . . 0.0 109.403 172.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.635 HD11 ' HE1' ' A' ' 25' ' ' TYR . 33.5 mm -78.8 111.8 16.09 Favored 'Isoleucine or valine' 0 C--O 1.251 1.182 0 C-N-CA 123.05 0.54 . . . . 0.0 109.857 176.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.406 HG22 HG23 ' A' ' 11' ' ' VAL . 44.5 t -111.19 125.0 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.65 1.18 . . . . 0.0 109.847 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -74.49 124.9 27.45 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.352 0.661 . . . . 0.0 109.514 170.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 m -135.47 107.78 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 125.309 1.443 . . . . 0.0 108.945 176.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.29 -105.17 1.5 Allowed Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.549 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 77.8 p -110.54 -5.7 15.05 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.18 0.992 . . . . 0.0 110.823 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -109.7 165.38 11.73 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.769 0.828 . . . . 0.0 110.872 -166.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.17 110.71 15.61 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.0 mp -102.96 117.27 34.22 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.306 1.042 . . . . 0.0 109.418 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -77.81 91.41 4.12 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.438 0.695 . . . . 0.0 109.986 176.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.05 118.81 73.39 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.095 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.474 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 36.3 Cg_endo -60.71 145.05 99.54 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.488 2.125 . . . . 0.0 111.672 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.596 ' HA ' HD11 ' A' ' 45' ' ' ILE . 12.5 mmmm -61.68 -24.13 66.55 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.196 0.999 . . . . 0.0 112.205 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.474 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 14.9 ptmm? -72.96 -21.43 60.86 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.575 0.75 . . . . 0.0 111.865 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.1 t -78.24 -28.02 47.73 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.058 0.543 . . . . 0.0 110.49 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.596 HD11 ' HA ' ' A' ' 42' ' ' LYS . 1.7 mp -65.14 115.02 2.95 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.527 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 75.1 mmtt -68.76 -53.73 20.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.974 0.91 . . . . 0.0 109.784 175.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 73.6 m -159.25 143.48 15.23 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.68 0.792 . . . . 0.0 110.844 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.4 p -85.92 115.76 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 168.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.723 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 8.2 mm-40 -107.68 178.71 4.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.12 0.968 . . . . 0.0 110.67 -175.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -66.54 95.41 0.33 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.223 0.609 . . . . 0.0 110.187 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.46 13.81 81.46 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.315 -0.402 . . . . 0.0 113.354 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.723 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 25.3 mtp180 -130.01 149.61 51.66 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.526 0.73 . . . . 0.0 110.189 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.1 mm -119.62 103.95 15.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 164.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.457 HG21 HH21 ' A' ' 52' ' ' ARG . 92.5 t -84.22 113.26 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.9 pt -109.51 179.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.53 1.132 . . . . 0.0 109.434 174.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.527 ' HA3' ' HE2' ' A' ' 46' ' ' LYS . . . -144.54 -112.74 0.83 Allowed Glycine 0 C--N 1.343 0.958 0 N-CA-C 112.138 -0.385 . . . . 0.0 112.138 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -89.26 136.23 33.14 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.469 0.708 . . . . 0.0 110.634 -172.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -167.0 174.24 8.57 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.821 1.248 . . . . 0.0 108.21 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -99.64 119.46 38.13 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.22 -28.05 66.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.717 0.807 . . . . 0.0 111.821 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -74.29 -37.21 63.74 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.57 0.544 . . . . 0.0 110.652 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -58.26 -50.6 73.03 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.24 -31.49 72.71 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.581 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -75.66 -48.75 20.76 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.138 0.575 . . . . 0.0 110.237 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.48 -38.98 74.47 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.389 0.614 . . . . 0.0 111.22 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.421 ' HG ' ' HB2' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -84.55 -20.0 32.23 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.394 0.678 . . . . 0.0 109.95 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -74.57 -41.97 34.25 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 172.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.543 ' HA ' HD21 ' A' ' 71' ' ' LEU . 8.5 ptm180 -74.35 -17.45 60.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.993 0.517 . . . . 0.0 109.834 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -65.78 -40.04 91.56 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 123.217 0.607 . . . . 0.0 109.484 169.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.433 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 78.2 t90 -60.34 -42.95 96.75 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.94 0.896 . . . . 0.0 111.188 174.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.543 HD21 ' HA ' ' A' ' 68' ' ' ARG . 3.2 mm? -59.99 -37.1 78.68 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.548 171.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 . . . . . 0 CA--C 1.555 1.145 0 C-N-CA 124.131 0.972 . . . . 0.0 111.371 179.144 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 47.7 mtt . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.371 0.605 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -84.86 108.79 17.69 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.985 -170.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.487 HG22 ' HB ' ' A' ' 53' ' ' ILE . 97.0 t -80.55 117.91 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.948 0.899 . . . . 0.0 110.994 -175.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -112.9 117.7 32.84 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.229 1.012 . . . . 0.0 109.552 175.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 51.3 tttm -77.92 91.04 4.15 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.22 -92.22 0.85 Allowed Glycine 0 C--N 1.345 1.066 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -170.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -118.95 -23.64 6.83 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.889 0.876 . . . . 0.0 111.353 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 12.6 pt-20 -78.94 142.11 36.98 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.528 0.331 . . . . 0.0 110.159 -172.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.6 t -69.11 99.11 1.07 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.538 0.735 . . . . 0.0 109.262 176.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -79.48 -57.53 3.65 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.05 -137.41 3.17 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.413 0.446 . . . . 0.0 112.639 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -148.3 136.91 21.55 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.962 0.905 . . . . 0.0 110.51 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.5 p -72.55 108.54 5.66 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.91 -32.57 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.177 0.591 . . . . 0.0 110.174 -176.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -160.35 178.49 9.54 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.704 0.402 . . . . 0.0 110.423 -174.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.8 p -154.6 139.6 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 124.299 1.04 . . . . 0.0 109.593 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -141.47 132.4 26.0 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.372 0.669 . . . . 0.0 109.203 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.36 -103.86 0.46 Allowed Glycine 0 C--N 1.349 1.288 0 O-C-N 123.548 0.53 . . . . 0.0 113.814 170.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -115.07 16.74 17.01 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.519 1.128 . . . . 0.0 111.228 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 39' ' ' ALA . 84.1 m-85 -141.64 125.64 17.23 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.619 -0.676 . . . . 0.0 111.97 -174.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 60.6 tp -82.59 111.7 18.81 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.222 1.009 . . . . 0.0 109.11 170.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.446 HD11 ' HB1' ' A' ' 39' ' ' ALA . 28.1 mm -70.94 112.96 6.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 122.899 0.48 . . . . 0.0 109.725 177.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 88.4 t -112.47 118.11 56.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 123.186 0.594 . . . . 0.0 109.643 176.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -77.79 126.12 30.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.444 0.698 . . . . 0.0 109.792 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 m -131.99 74.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 C-N-CA 124.612 1.165 . . . . 0.0 109.886 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.63 -81.08 0.02 OUTLIER Glycine 0 C--N 1.354 1.55 0 CA-C-N 115.148 -0.933 . . . . 0.0 114.393 173.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.4 p -70.54 -49.46 47.85 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.272 1.029 . . . . 0.0 111.577 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -138.9 176.55 8.6 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.503 0.668 . . . . 0.0 112.258 -166.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -105.87 108.67 20.3 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.955 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 mp -95.39 105.5 17.47 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 28' ' ' TYR . . . -80.07 94.35 5.95 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.848 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.18 124.59 91.04 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.137 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -56.77 141.56 92.24 Favored 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 122.732 2.288 . . . . 0.0 111.411 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.508 ' HA ' HD11 ' A' ' 45' ' ' ILE . 2.2 mmmp? -60.74 -34.34 74.28 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -172.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -21.49 64.62 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.404 0.282 . . . . 0.0 111.576 177.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.2 t -75.0 -27.75 60.26 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 122.733 0.413 . . . . 0.0 111.081 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.552 HG13 HG22 ' A' ' 55' ' ' ILE . 2.0 mp -64.66 113.45 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.187 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -79.88 -50.05 11.04 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.859 0.864 . . . . 0.0 110.177 -175.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.7 m -148.22 126.84 12.48 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.241 -175.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.96 109.75 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 166.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -110.07 172.53 6.81 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.471 1.108 . . . . 0.0 110.415 -174.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.54 97.12 0.41 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.24 0.616 . . . . 0.0 110.423 -175.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.06 4.83 84.18 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.454 -0.794 . . . . 0.0 113.994 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -131.58 132.97 44.53 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.084 0.953 . . . . 0.0 109.053 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.487 ' HB ' HG22 ' A' ' 11' ' ' VAL . 43.4 mm -109.32 103.2 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.6 t -81.95 114.04 22.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.552 HG22 HG13 ' A' ' 45' ' ' ILE . 34.0 pt -109.25 170.41 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.552 0.741 . . . . 0.0 109.012 175.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.95 -159.27 14.92 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 116.611 -0.268 . . . . 0.0 112.877 -173.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -85.71 120.15 26.83 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.655 0.74 . . . . 0.0 109.562 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -142.29 171.3 14.24 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.989 1.316 . . . . 0.0 107.478 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -86.97 111.87 21.26 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.79 -23.44 63.34 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.414 0.686 . . . . 0.0 112.05 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -69.87 -37.29 76.03 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 123.86 0.725 . . . . 0.0 109.905 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -60.71 -54.86 40.1 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 170.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.03 77.03 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.258 -173.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.03 -44.45 54.33 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.947 -176.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.19 -40.21 86.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.917 0.326 . . . . 0.0 111.264 -174.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 pp -82.38 -16.31 49.57 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.704 0.401 . . . . 0.0 110.58 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.29 -32.75 57.74 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 168.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 -76.72 -28.45 55.82 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.246 1.019 . . . . 0.0 110.174 173.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -65.18 -34.98 79.67 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 169.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 56.8 t90 -65.27 -38.19 89.52 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.312 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.24 -27.79 67.52 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.313 0.645 . . . . 0.0 111.486 173.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 CA--C 1.554 1.133 0 C-N-CA 123.724 0.81 . . . . 0.0 111.315 179.004 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.0 mtt . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -78.67 110.94 14.26 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.915 0.486 . . . . 0.0 109.878 176.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.52 130.7 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.061 0.544 . . . . 0.0 109.838 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -116.97 124.74 50.12 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.61 1.164 . . . . 0.0 110.023 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -79.73 92.61 5.44 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.87 -96.08 0.58 Allowed Glycine 0 C--N 1.342 0.914 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -173.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.03 -21.92 10.32 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.47 0.708 . . . . 0.0 111.572 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.02 155.68 19.7 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 122.861 0.464 . . . . 0.0 110.396 -176.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.7 t -71.13 112.44 7.28 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.054 0.542 . . . . 0.0 110.134 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -80.74 -52.55 7.4 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.29 -139.85 5.14 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.844 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -139.23 132.32 29.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.137 0.975 . . . . 0.0 108.869 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.4 p -69.8 124.13 23.22 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 172.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.55 -37.6 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.64 0.776 . . . . 0.0 109.195 -177.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -150.46 167.91 25.75 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.357 -171.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.3 p -127.61 138.96 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -148.67 100.29 3.09 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.144 0.978 . . . . 0.0 109.486 -169.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.86 -109.14 2.72 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.741 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.516 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 21.1 t70 -104.67 -5.5 21.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.188 0.595 . . . . 0.0 109.413 171.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -100.04 113.67 26.43 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.306 0.642 . . . . 0.0 111.089 -171.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 66.0 tp -74.1 106.69 5.89 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.0 mm -68.28 106.51 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.177 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.7 t -100.33 117.68 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.83 111.09 7.65 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 173.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.459 HG22 HD23 ' A' ' 38' ' ' LEU . 18.9 m -111.18 85.55 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-O 122.04 0.924 . . . . 0.0 110.48 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.35 -91.16 0.24 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.062 -0.972 . . . . 0.0 113.3 176.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.0 p -105.43 -10.29 17.03 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.824 0.85 . . . . 0.0 111.389 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -124.51 -176.68 3.58 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.505 0.722 . . . . 0.0 111.49 -173.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -131.22 110.25 11.0 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.966 1.307 . . . . 0.0 109.308 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.459 HD23 HG22 ' A' ' 33' ' ' VAL . 2.4 mm? -102.9 109.25 20.74 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.648 1.179 . . . . 0.0 108.821 174.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.02 93.74 9.44 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.262 -174.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.31 131.81 51.97 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.505 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 54.9 Cg_endo -65.3 159.83 45.37 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.359 2.04 . . . . 0.0 112.129 177.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 27' ' ' ASP . 31.0 mmmt -66.75 -22.45 66.04 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.724 0.81 . . . . 0.0 111.433 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.505 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 8.6 ptpp? -76.01 -18.99 59.04 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.99 0.916 . . . . 0.0 112.065 175.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.7 t -71.71 -29.26 64.36 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.712 0.405 . . . . 0.0 110.747 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.492 HD11 ' HA ' ' A' ' 42' ' ' LYS . 2.2 mp -70.22 118.45 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.068 0.547 . . . . 0.0 109.911 -177.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -85.67 -54.5 4.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.272 1.029 . . . . 0.0 111.046 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.2 m -134.26 146.93 50.51 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.788 -172.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.5 p -114.91 126.4 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.061 0.944 . . . . 0.0 109.297 173.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.782 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 42.3 mm-40 -121.85 173.22 7.63 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.986 0.914 . . . . 0.0 109.171 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.03 97.47 1.17 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.822 0.82 . . . . 0.0 110.271 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.56 18.12 71.63 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.272 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.782 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 54.1 mtt180 -140.63 149.76 42.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.631 0.772 . . . . 0.0 110.516 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.5 mm -134.81 104.24 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.484 1.114 . . . . 0.0 108.822 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.08 122.31 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.4 pt -112.4 153.99 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.109 0.963 . . . . 0.0 109.442 174.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -104.1 -64.36 0.68 Allowed Glycine 0 C--N 1.344 1.004 0 CA-C-O 120.158 -0.246 . . . . 0.0 112.537 -173.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -157.26 159.76 37.93 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.106 0.562 . . . . 0.0 110.034 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -166.26 173.07 10.47 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.519 1.128 . . . . 0.0 109.239 -177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.78 99.66 7.58 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -67.86 -57.51 6.13 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.263 1.025 . . . . 0.0 112.702 -167.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.89 -30.32 69.65 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.151 0.58 . . . . 0.0 110.776 -176.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.47 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 43.7 mt-10 -70.25 -39.61 74.9 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.795 173.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.12 -25.55 65.35 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.021 0.528 . . . . 0.0 110.734 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -74.53 -45.81 43.27 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.678 0.791 . . . . 0.0 109.838 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.47 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.9 pt-20 -72.72 -36.42 67.78 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.445 0.298 . . . . 0.0 111.779 -177.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.442 ' HA ' ' HB3' ' A' ' 69' ' ' LYS . 4.1 pp -83.39 -13.6 54.53 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 122.157 -0.339 . . . . 0.0 110.529 174.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.04 -46.27 52.34 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.747 168.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.462 ' HA ' HD11 ' A' ' 71' ' ' LEU . 34.6 ptt180 -72.05 -23.89 61.44 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 175.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.442 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 22.4 ttmm -62.3 -39.21 92.25 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 123.087 0.555 . . . . 0.0 109.715 170.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.442 ' HE3' HD12 ' A' ' 71' ' ' LEU . 70.6 t90 -60.87 -38.29 85.1 Favored 'General case' 0 CA--C 1.553 1.088 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 172.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 68' ' ' ARG . 11.2 mp -60.83 -39.73 90.12 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 177.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 N--CA 1.485 1.31 0 O-C-N 121.701 -0.625 . . . . 0.0 111.194 -179.799 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 79.4 mtp . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -62.42 123.07 17.32 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.162 0.585 . . . . 0.0 110.889 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.6 t -93.85 131.25 41.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 124.075 0.95 . . . . 0.0 110.076 -173.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.56 ' HE1' ' HD2' ' A' ' 52' ' ' ARG . 70.0 m-85 -118.93 127.01 53.08 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.536 1.134 . . . . 0.0 108.625 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -78.43 87.34 4.44 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.105 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.36 -94.75 0.74 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -172.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.85 -27.27 8.54 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.84 0.856 . . . . 0.0 111.785 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 12.0 pt-20 -81.42 145.82 30.59 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -174.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 t -69.78 113.75 7.32 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -93.83 -50.21 5.46 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.078 0.551 . . . . 0.0 110.524 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.18 -137.93 4.06 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.766 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.571 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 8.9 pt-20 -141.13 144.11 34.66 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.238 1.015 . . . . 0.0 109.966 -177.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.414 ' HG ' HD13 ' A' ' 29' ' ' LEU . 39.8 t -77.17 149.83 35.56 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.24 -40.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -151.52 170.01 20.68 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -176.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.481 ' HB ' HD12 ' A' ' 29' ' ' LEU . 2.8 p -155.8 123.07 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.067 0.947 . . . . 0.0 109.069 172.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.404 ' CE1' HD11 ' A' ' 30' ' ' ILE . 7.3 p90 -124.29 132.8 53.59 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.89 -105.87 0.95 Allowed Glycine 0 C--N 1.338 0.686 0 O-C-N 123.543 0.527 . . . . 0.0 114.044 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -118.94 17.96 13.29 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.615 0.766 . . . . 0.0 111.527 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.483 ' HB3' ' HB2' ' A' ' 39' ' ' ALA . 80.8 m-85 -133.03 112.79 12.11 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.142 0.496 . . . . 0.0 111.427 -175.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.481 HD12 ' HB ' ' A' ' 24' ' ' VAL . 44.8 tp -78.21 111.68 14.4 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.12 1.368 . . . . 0.0 109.552 173.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.404 HD11 ' CE1' ' A' ' 25' ' ' TYR . 33.2 mm -72.38 112.05 7.53 Favored 'Isoleucine or valine' 0 C--O 1.249 1.053 0 C-N-CA 123.578 0.751 . . . . 0.0 109.832 178.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.8 t -110.72 125.9 68.04 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 C-N-CA 124.369 1.068 . . . . 0.0 109.879 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.571 ' HB3' ' HG3' ' A' ' 20' ' ' GLU . 4.2 tppp? -73.96 120.02 18.96 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.92 0.888 . . . . 0.0 109.25 171.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.8 m -137.73 133.83 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.499 1.119 . . . . 0.0 109.627 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.58 -100.15 0.46 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.023 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.3 p -124.84 -11.53 7.17 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.602 1.161 . . . . 0.0 111.021 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -124.41 -171.98 2.46 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.562 0.745 . . . . 0.0 111.829 -171.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -121.11 111.37 17.35 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.144 0.977 . . . . 0.0 110.474 -174.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 mp -102.08 117.17 34.23 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 171.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.483 ' HB2' ' HB3' ' A' ' 28' ' ' TYR . . . -89.68 108.59 19.77 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.698 0.799 . . . . 0.0 110.954 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.464 HG22 HG23 ' A' ' 55' ' ' ILE . 16.5 m -83.52 139.28 41.2 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.405 0.682 . . . . 0.0 109.896 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' A' ' 44' ' ' SER . 56.9 Cg_endo -69.89 156.2 63.59 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 122.146 1.897 . . . . 0.0 112.624 176.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -68.24 -28.53 67.3 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.206 1.002 . . . . 0.0 111.39 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.477 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 21.5 pttp -74.9 -9.37 58.48 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.775 0.83 . . . . 0.0 111.572 176.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.5 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 28.5 t -88.43 -18.67 27.82 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.056 0.543 . . . . 0.0 111.083 175.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.508 HD11 HG22 ' A' ' 55' ' ' ILE . 29.5 mm -64.46 112.91 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 11.1 mmpt? -70.5 -45.46 65.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.534 0.734 . . . . 0.0 110.194 177.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.5 t -160.0 145.88 15.57 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.64 -176.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.8 p -110.02 119.69 59.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.767 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 20.7 mm-40 -104.23 166.51 10.35 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.84 0.856 . . . . 0.0 109.423 176.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -65.04 102.8 0.66 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.312 0.577 . . . . 0.0 109.572 174.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.44 4.92 90.06 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.605 -0.725 . . . . 0.0 114.363 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.767 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 77.5 mmt-85 -131.92 147.98 52.5 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 117.57 0.685 . . . . 0.0 110.171 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.82 132.43 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.923 0.889 . . . . 0.0 108.845 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.13 123.42 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.508 HG22 HD11 ' A' ' 45' ' ' ILE . 49.4 pt -118.95 164.82 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.648 0.779 . . . . 0.0 110.641 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.93 -171.99 22.58 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.31 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.69 130.51 41.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.824 0.449 . . . . 0.0 109.946 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -135.46 166.51 23.02 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.94 1.296 . . . . 0.0 108.826 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.01 109.16 14.2 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -67.01 -28.56 68.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.724 0.81 . . . . 0.0 111.284 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -67.33 -43.3 81.91 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.475 1.11 . . . . 0.0 110.722 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -68.63 -42.35 78.16 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.675 0.274 . . . . 0.0 110.475 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.64 89.93 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.74 0.816 . . . . 0.0 112.006 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -76.19 -34.28 59.3 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.465 0.478 . . . . 0.0 112.057 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 12.9 pt-20 -77.71 -40.71 40.38 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -177.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 pp -80.7 -25.5 38.11 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -69.05 -34.62 76.67 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.815 171.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -77.05 -18.02 58.37 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 117.296 0.548 . . . . 0.0 110.205 175.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.613 ' HB3' ' HZ1' ' A' ' 69' ' ' LYS . 6.3 ttpm? -68.85 -32.17 71.66 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.162 0.506 . . . . 0.0 109.787 166.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.403 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 85.5 t90 -67.09 -32.74 74.1 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 169.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.92 -31.6 72.29 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.161 0.584 . . . . 0.0 112.133 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-N 118.38 0.537 . . . . 0.0 109.942 174.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.51 -153.4 16.95 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 123.481 0.488 . . . . 0.0 111.895 -175.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -144.92 176.29 9.58 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.068 0.947 . . . . 0.0 110.824 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.1 mmt -94.35 177.27 6.0 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.89 0.876 . . . . 0.0 110.379 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.416 ' HB2' ' HA3' ' A' ' 51' ' ' GLY . 7.7 m-20 55.6 47.79 20.0 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.092 1.357 . . . . 0.0 111.753 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt -71.49 -16.24 62.34 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.11 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.7 tp -65.51 -38.4 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.424 1.089 . . . . 0.0 111.43 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.3 p -167.1 102.13 0.53 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.81 0.844 . . . . 0.0 109.318 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.7 mtt -82.47 126.84 32.69 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.307 0.643 . . . . 0.0 109.478 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -76.49 111.88 12.42 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.359 0.664 . . . . 0.0 110.124 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.16 111.65 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.097 0.559 . . . . 0.0 109.908 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -103.0 124.59 48.79 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.817 0.847 . . . . 0.0 110.135 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 51.1 tttm -77.67 85.43 3.99 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.86 -94.99 0.89 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -173.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -110.63 -30.15 7.73 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.97 0.908 . . . . 0.0 110.658 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 12.9 pt-20 -77.58 141.02 39.76 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -175.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.9 t -70.68 108.77 4.56 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -85.26 -55.55 3.97 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.866 0.466 . . . . 0.0 110.44 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.24 -146.88 5.98 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.282 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -140.1 145.34 37.49 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.75 0.82 . . . . 0.0 110.346 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.7 p -77.0 111.89 13.05 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.805 0.442 . . . . 0.0 109.839 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.65 -40.37 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.452 0.701 . . . . 0.0 110.25 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.472 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 18.0 t70 -148.36 160.66 42.78 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.919 0.487 . . . . 0.0 109.817 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.448 ' HB ' ' HA ' ' A' ' 83' ' ' LEU . 20.6 t -139.59 118.78 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -132.5 126.99 34.24 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.643 0.656 . . . . 0.0 109.503 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.04 -119.76 19.8 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.487 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -102.24 22.81 12.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.592 0.757 . . . . 0.0 111.347 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -133.29 124.86 28.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.834 0.454 . . . . 0.0 111.357 -176.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.42 HD11 HG21 ' A' ' 24' ' ' VAL . 45.2 tp -85.2 109.6 18.42 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 167.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 23.5 mm -70.85 107.1 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.04 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.64 119.31 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.337 177.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -75.99 113.65 13.75 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.171 0.588 . . . . 0.0 109.496 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.35 126.56 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 124.124 0.97 . . . . 0.0 109.481 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.95 -91.44 0.05 OUTLIER Glycine 0 CA--C 1.535 1.316 0 CA-C-N 116.57 -0.287 . . . . 0.0 113.429 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.9 m -125.2 -23.82 4.11 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.404 1.082 . . . . 0.0 110.778 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -110.82 179.16 4.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.72 0.808 . . . . 0.0 111.319 -171.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.412 ' HB3' HG23 ' A' ' 30' ' ' ILE . 87.6 m-85 -119.23 110.35 16.92 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.515 0.726 . . . . 0.0 109.887 -175.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -91.55 105.9 18.09 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.299 1.04 . . . . 0.0 109.151 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.458 ' HB2' HD12 ' A' ' 66' ' ' LEU . . . -83.23 92.49 7.49 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.193 0.597 . . . . 0.0 109.83 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.3 m -80.18 134.66 55.38 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -65.59 154.44 73.77 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.621 2.214 . . . . 0.0 111.674 176.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.539 ' HA ' HD12 ' A' ' 45' ' ' ILE . 13.7 mmmm -63.16 -28.1 69.83 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.591 0.756 . . . . 0.0 111.652 -176.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -65.72 -21.89 66.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.413 0.685 . . . . 0.0 111.583 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 t -74.33 -43.61 55.95 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 42' ' ' LYS . 2.8 mp -61.73 112.47 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.442 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.484 ' HE3' ' HA3' ' A' ' 56' ' ' GLY . 32.1 mmtp -78.51 -63.13 1.48 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.881 0.872 . . . . 0.0 110.154 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 t -146.02 132.83 20.05 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 122.915 0.486 . . . . 0.0 110.094 -175.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.8 p -77.68 109.61 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 5.8 mm-40 -86.16 174.3 9.23 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.324 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.56 86.5 2.09 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.166 0.508 . . . . 0.0 109.719 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.416 ' HA3' ' HB2' ' A' ' 5' ' ' ASP . . . 88.21 13.44 63.9 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.979 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.642 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 2.4 mpt_? -135.6 159.67 40.91 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.444 0.622 . . . . 0.0 109.64 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 mm -124.25 103.96 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 69.7 t -79.14 116.45 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.7 pt -105.87 164.0 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.484 ' HA3' ' HE3' ' A' ' 46' ' ' LYS . . . -104.4 -107.01 3.16 Favored Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -122.69 156.82 33.6 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.837 0.855 . . . . 0.0 109.807 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -167.09 160.17 13.71 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.723 1.209 . . . . 0.0 108.715 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -75.17 98.23 3.68 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -43.29 96.08 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.373 1.069 . . . . 0.0 112.896 -175.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -67.92 -33.87 75.53 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.341 0.401 . . . . 0.0 110.747 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.475 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 37.7 mt-10 -69.65 -49.44 53.66 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.366 174.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.01 -28.51 66.46 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.597 0.759 . . . . 0.0 111.383 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.59 -45.26 46.42 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.762 1.225 . . . . 0.0 110.867 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.417 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 2.9 pp20? -75.37 -36.93 60.85 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -175.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.509 ' HA ' ' HB3' ' A' ' 69' ' ' LYS . 4.4 pp -81.84 -15.14 55.08 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.846 0.355 . . . . 0.0 110.441 174.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -66.5 -47.82 67.13 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.747 166.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.488 ' HA ' HD22 ' A' ' 71' ' ' LEU . 9.2 ptp180 -76.32 -21.49 56.13 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 117.344 0.572 . . . . 0.0 111.458 177.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.509 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -68.18 -32.87 73.41 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.139 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.572 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 74.2 t90 -67.1 -40.49 86.91 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.196 169.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' A' ' 68' ' ' ARG . 4.1 mm? -57.89 -24.89 59.72 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.503 0.321 . . . . 0.0 111.232 175.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -79.33 -50.54 10.72 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 122.478 0.311 . . . . 0.0 111.19 173.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.572 ' HG2' ' HA ' ' A' ' 70' ' ' TRP . 10.1 pt-20 -75.79 -19.14 59.21 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -170.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -12.77 59.33 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.367 0.667 . . . . 0.0 112.258 -176.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.2 p -60.55 -20.79 61.42 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.653 1.181 . . . . 0.0 112.626 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -64.91 146.1 98.84 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 124.209 1.004 . . . . 0.0 110.326 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.54 152.0 83.13 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.736 2.291 . . . . 0.0 112.095 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.1 p -69.44 97.08 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-O 122.077 0.941 . . . . 0.0 112.054 -171.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.9 m -137.17 6.94 2.86 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.745 0.818 . . . . 0.0 109.68 172.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.55 108.94 4.02 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -96.31 -19.08 19.52 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.684 0.793 . . . . 0.0 110.668 -172.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -69.08 -19.54 64.07 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.86 1.264 . . . . 0.0 111.326 -173.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.448 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.2 tt -58.74 -47.32 85.04 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.152 0.981 . . . . 0.0 109.218 172.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -64.81 94.73 0.13 Allowed 'General case' 0 C--N 1.349 0.582 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.185 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.6 p -118.62 141.93 48.13 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -68.35 -32.31 72.33 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.459 0.303 . . . . 0.0 111.369 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.95 59.21 2.82 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -168.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -72.8 -0.87 14.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.129 0.971 . . . . 0.0 111.994 -174.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.97 86.38 0.22 Allowed Glycine 0 C--N 1.352 1.435 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.07 -24.15 63.19 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.061 0.944 . . . . 0.0 110.946 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -79.14 174.12 11.89 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.491 1.116 . . . . 0.0 110.679 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.47 -146.5 14.91 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.565 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.4 -23.99 52.69 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.607 1.163 . . . . 0.0 112.733 174.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.84 174.06 38.27 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.671 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.6 t . . . . . 0 C--O 1.252 1.211 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -179.897 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.2 151.77 21.56 Favored Glycine 0 C--N 1.344 0.975 0 O-C-N 123.571 0.545 . . . . 0.0 111.963 -178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -132.37 95.64 3.68 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.768 0.827 . . . . 0.0 109.515 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.502 ' SD ' HD11 ' A' ' 6' ' ' LEU . 40.3 tpp -76.4 95.34 3.79 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 168.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -67.76 -9.25 42.38 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.784 0.834 . . . . 0.0 112.87 -172.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.502 HD11 ' SD ' ' A' ' 4' ' ' MET . 9.8 mp -64.59 -19.46 65.67 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.849 0.86 . . . . 0.0 111.087 172.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.6 tp -52.02 -34.45 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 124.007 0.923 . . . . 0.0 110.609 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.414 ' SG ' HD12 ' A' ' 83' ' ' LEU . 58.1 m -86.46 99.86 11.95 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.528 ' HB2' HG12 ' A' ' 53' ' ' ILE . 2.1 mpt? -61.37 153.62 26.3 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.994 0.918 . . . . 0.0 112.796 -170.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -75.13 110.46 9.46 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.307 1.043 . . . . 0.0 109.89 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.496 HG23 ' HB ' ' A' ' 53' ' ' ILE . 75.5 t -79.28 127.5 39.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 122.878 0.471 . . . . 0.0 110.814 -173.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -110.56 129.71 55.73 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.623 1.169 . . . . 0.0 110.045 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -78.01 85.01 4.25 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.561 1.144 . . . . 0.0 108.011 172.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.25 -96.64 0.34 Allowed Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.623 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -94.91 -40.71 9.55 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.496 0.719 . . . . 0.0 110.474 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -83.66 151.63 25.19 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.946 -170.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 t -75.72 119.08 19.25 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -87.51 -48.89 7.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.521 0.728 . . . . 0.0 110.456 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.51 -150.54 12.15 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -176.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -127.43 146.32 50.52 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 171.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 68.7 p -70.55 162.79 28.2 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 168.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.38 -39.56 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.56 ' HA ' HD13 ' A' ' 83' ' ' LEU . 36.1 t70 -153.24 171.92 17.79 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.608 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.532 HG11 ' HG3' ' A' ' 82' ' ' GLU . 2.4 p -151.72 133.75 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 172.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.46 ' CE2' HD12 ' A' ' 30' ' ' ILE . 50.6 p90 -135.81 135.24 39.69 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 172.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.48 -107.23 1.29 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 123.886 0.741 . . . . 0.0 112.704 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -116.11 12.84 15.66 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.764 0.826 . . . . 0.0 110.996 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.572 ' HB3' ' HB2' ' A' ' 39' ' ' ALA . 89.7 m-85 -123.17 109.34 13.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.198 0.599 . . . . 0.0 111.426 -172.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.491 HD12 ' HB ' ' A' ' 24' ' ' VAL . 45.5 tp -80.37 106.87 12.71 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 169.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.46 HD12 ' CE2' ' A' ' 25' ' ' TYR . 28.4 mm -71.24 108.81 3.07 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 C-N-CA 123.698 0.799 . . . . 0.0 110.041 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 65.6 t -102.72 119.44 51.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 O-C-N 124.263 0.977 . . . . 0.0 109.575 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.46 118.66 18.57 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.41 124.01 64.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.688 0.795 . . . . 0.0 108.99 172.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.81 -90.44 0.05 OUTLIER Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.493 0.496 . . . . 0.0 114.334 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.3 p -123.5 -21.71 5.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.187 0.995 . . . . 0.0 111.5 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -110.37 171.62 7.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.641 0.776 . . . . 0.0 111.612 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -120.05 110.17 16.35 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.253 1.021 . . . . 0.0 108.942 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.1 mp -106.76 115.18 29.75 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.371 1.069 . . . . 0.0 108.381 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.572 ' HB2' ' HB3' ' A' ' 28' ' ' TYR . . . -79.94 103.82 10.09 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.619 0.768 . . . . 0.0 111.021 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 m -78.13 132.58 66.51 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 172.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 37.4 Cg_endo -65.62 150.22 86.63 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 121.714 1.609 . . . . 0.0 110.286 172.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.542 ' HA ' HD11 ' A' ' 45' ' ' ILE . 31.6 mmmt -61.13 -29.98 70.1 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.116 0.566 . . . . 0.0 111.409 -176.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.472 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 60.1 pttt -68.97 -23.09 64.08 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.052 0.941 . . . . 0.0 111.902 177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.8 t -68.9 -29.72 68.06 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.759 0.424 . . . . 0.0 110.714 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.542 HD11 ' HA ' ' A' ' 42' ' ' LYS . 1.9 mp -64.06 114.58 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 75.1 mmtt -71.69 -45.98 60.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.394 1.078 . . . . 0.0 110.0 176.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 44.1 p -157.14 155.15 30.5 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.952 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 p -113.12 114.2 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.916 0.886 . . . . 0.0 110.175 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 6.5 mm-40 -97.74 163.66 12.72 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.765 0.826 . . . . 0.0 109.1 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.546 ' HB2' ' HB2' ' A' ' 91' ' ' GLU . 5.3 m-20 -59.75 -35.34 74.4 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.715 0.806 . . . . 0.0 111.301 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.477 ' HA2' ' HE1' ' A' ' 88' ' ' PHE . . . -133.07 19.35 4.37 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.484 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.607 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 44.1 mtm180 -143.62 156.09 44.46 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 117.486 0.643 . . . . 0.0 110.85 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.528 HG12 ' HB2' ' A' ' 9' ' ' MET . 41.3 mm -126.43 104.37 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 173.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.7 t -83.24 114.89 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.9 pt -108.22 163.99 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.539 0.736 . . . . 0.0 109.499 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.445 ' HA3' ' HE2' ' A' ' 46' ' ' LYS . . . -92.87 -86.51 1.56 Allowed Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 175.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -160.5 168.44 25.07 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.563 0.745 . . . . 0.0 110.474 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -164.89 -179.03 5.54 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.898 1.279 . . . . 0.0 108.905 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -93.52 110.38 21.97 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -64.44 -37.22 86.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.12 0.968 . . . . 0.0 111.595 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.31 -50.39 60.4 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.044 0.84 . . . . 0.0 110.167 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.424 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 37.6 mt-10 -64.16 -38.87 92.63 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.07 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.21 -40.84 86.48 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.416 0.686 . . . . 0.0 111.93 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.445 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 9.9 ptp85 -75.3 -31.5 60.68 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 118.97 -0.538 . . . . 0.0 112.266 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -75.98 -38.8 57.06 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.394 0.543 . . . . 0.0 111.349 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 62' ' ' GLU . 4.4 pp -81.76 -13.26 57.99 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.25 0.548 . . . . 0.0 109.828 170.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.82 -33.93 66.17 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.168 165.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 64' ' ' ARG . 78.5 mtm180 -64.85 -40.33 94.99 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 123.317 0.647 . . . . 0.0 109.682 172.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 38.4 ttpt -55.09 -39.76 69.66 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.789 170.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.476 ' HA ' ' HB2' ' A' ' 73' ' ' GLU . 88.6 t90 -65.49 -34.92 79.4 Favored 'General case' 0 C--N 1.361 1.105 0 CA-C-O 119.316 -0.373 . . . . 0.0 111.681 174.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.2 mm? -57.22 -22.14 38.74 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 118.839 0.745 . . . . 0.0 110.634 173.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -85.71 -47.33 9.88 Favored 'General case' 0 CA--C 1.574 1.883 0 C-N-CA 123.397 0.679 . . . . 0.0 111.924 164.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 69' ' ' LYS . 11.1 mm-40 -63.12 -21.13 65.98 Favored 'General case' 0 N--CA 1.507 2.413 0 C-N-CA 124.532 1.133 . . . . 0.0 113.573 -172.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -20.72 62.99 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.007 0.923 . . . . 0.0 111.737 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 t -85.25 12.39 8.17 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.125 0.97 . . . . 0.0 111.355 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -60.49 146.93 84.07 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 123.682 0.793 . . . . 0.0 110.978 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.16 161.93 42.36 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.484 2.123 . . . . 0.0 112.387 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.7 87.64 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.677 0.791 . . . . 0.0 108.951 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.8 m -146.1 -40.28 0.22 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.251 1.02 . . . . 0.0 109.699 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.93 128.59 35.95 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.954 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.472 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 43.9 tt0 -108.87 1.18 20.67 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.736 1.215 . . . . 0.0 109.285 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.532 ' HG3' HG11 ' A' ' 24' ' ' VAL . 11.6 tp10 -53.88 -38.11 64.42 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.006 1.322 . . . . 0.0 112.231 -176.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.56 HD13 ' HA ' ' A' ' 23' ' ' ASP . 41.5 tp -72.31 -38.64 68.65 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.958 0.503 . . . . 0.0 111.871 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.472 ' HE3' ' HG3' ' A' ' 81' ' ' GLU . 28.8 ttpp -77.9 126.57 31.04 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.637 0.375 . . . . 0.0 110.9 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.2 p -103.17 -158.94 0.7 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.625 1.17 . . . . 0.0 109.689 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -67.88 -29.79 68.99 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.174 0.59 . . . . 0.0 109.971 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 147.9 162.85 10.34 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.906 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.477 ' HE1' ' HA2' ' A' ' 51' ' ' GLY . 32.3 t80 -69.87 130.56 42.58 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.942 0.497 . . . . 0.0 110.257 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -84.41 123.52 6.27 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -71.4 82.31 0.78 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.307 0.575 . . . . 0.0 109.602 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.546 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . 42.6 tt0 -81.5 -36.14 29.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.028 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 140.25 -157.44 25.54 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.379 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -153.3 -61.19 0.14 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 65.5 26.26 71.78 Favored Glycine 0 C--N 1.355 1.614 0 O-C-N 124.097 0.873 . . . . 0.0 114.164 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.9 t . . . . . 0 C--O 1.254 1.307 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.256 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.751 0.31 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.07 174.89 37.73 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -79.91 74.9 6.64 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.488 0.661 . . . . 0.0 109.402 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -19.43 61.87 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.734 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.29 94.76 0.06 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.057 165.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.0 mt -92.61 82.22 4.8 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.4 tp -65.94 83.49 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.064 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 21' ' ' SER . 26.3 p -141.43 115.77 9.46 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.51 -175.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.6 ttm -155.42 149.42 25.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.547 0.739 . . . . 0.0 109.257 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -69.51 106.42 2.98 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.41 0.684 . . . . 0.0 109.823 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.09 132.82 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.029 0.532 . . . . 0.0 109.791 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -113.8 127.49 56.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.795 1.238 . . . . 0.0 110.337 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.98 88.49 3.52 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 171.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.4 -95.48 0.6 Allowed Glycine 0 C--N 1.342 0.91 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -121.25 1.3 10.23 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.073 0.949 . . . . 0.0 112.196 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -117.04 151.72 36.18 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.254 0.621 . . . . 0.0 110.456 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.5 t -67.43 112.8 4.83 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.733 0.813 . . . . 0.0 111.334 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -84.79 -54.65 4.55 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.438 0.695 . . . . 0.0 110.199 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.31 -137.83 3.99 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.877 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -138.28 136.48 36.51 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.192 0.997 . . . . 0.0 109.694 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 68.8 p -72.08 112.26 8.01 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.87 -36.43 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.054 0.541 . . . . 0.0 109.839 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -153.49 176.66 11.78 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.272 0.629 . . . . 0.0 109.338 -173.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.22 136.85 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.988 0.915 . . . . 0.0 108.951 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -137.11 127.64 26.8 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 173.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.37 -109.62 2.43 Favored Glycine 0 C--N 1.346 1.117 0 O-C-N 123.537 0.523 . . . . 0.0 113.501 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -109.92 19.2 19.32 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.04 0.936 . . . . 0.0 111.493 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -131.91 115.41 15.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.876 0.47 . . . . 0.0 111.665 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' A' ' 21' ' ' SER . 64.6 tp -79.22 113.85 17.68 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.131 0.972 . . . . 0.0 109.528 169.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.3 mm -74.77 106.92 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.5 t -104.53 113.44 41.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -76.3 109.67 10.19 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.6 m -95.15 156.08 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.415 1.086 . . . . 0.0 108.794 169.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -43.61 -28.23 1.01 Allowed Glycine 0 N--CA 1.482 1.711 0 N-CA-C 116.544 1.378 . . . . 0.0 116.544 -174.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.0 p -95.04 -48.39 5.99 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.13 0.572 . . . . 0.0 111.625 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -139.83 -179.65 6.06 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.443 0.64 . . . . 0.0 112.715 -163.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -101.78 107.83 19.16 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 164.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.6 mt -104.05 106.76 17.37 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.35 95.19 6.3 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.269 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 m -80.61 134.41 54.27 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.509 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 38.2 Cg_endo -63.41 159.13 41.52 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.21 1.94 . . . . 0.0 112.011 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -59.16 -34.73 72.45 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.385 0.674 . . . . 0.0 110.78 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.509 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 19.9 ptmt -68.19 -26.99 66.01 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.339 1.056 . . . . 0.0 112.191 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.7 t -59.46 -38.52 80.98 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.811 0.444 . . . . 0.0 109.87 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.99 114.01 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HD2' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -79.97 -53.8 6.4 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.571 1.149 . . . . 0.0 110.072 177.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.4 m -144.82 141.12 28.89 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.272 -171.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.0 p -99.19 110.62 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 169.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.77 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 11.7 mm-40 -105.21 174.25 5.96 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.555 0.742 . . . . 0.0 109.821 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.47 102.0 1.06 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.195 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.52 18.17 78.3 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 115.538 -0.755 . . . . 0.0 113.467 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.77 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 17.6 mtp180 -136.64 140.18 42.58 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.209 0.604 . . . . 0.0 110.359 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.1 mm -116.57 101.89 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 168.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.1 t -79.4 118.93 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.3 pt -112.13 146.38 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.716 0.806 . . . . 0.0 109.264 172.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.444 ' HA3' ' HD2' ' A' ' 46' ' ' LYS . . . -105.49 -56.33 0.69 Allowed Glycine 0 C--N 1.339 0.743 0 CA-C-N 116.362 -0.381 . . . . 0.0 112.418 -170.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.21 141.44 23.17 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.582 0.753 . . . . 0.0 110.627 -171.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -169.4 146.54 3.47 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 124.618 1.167 . . . . 0.0 108.011 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.66 106.79 7.4 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -64.15 -29.34 70.47 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.043 0.937 . . . . 0.0 111.706 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.432 ' HG2' ' NH1' ' A' ' 64' ' ' ARG . 38.8 mt-10 -67.08 -40.41 87.01 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.579 0.549 . . . . 0.0 110.584 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -68.73 -45.51 71.3 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.314 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.24 74.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.898 0.879 . . . . 0.0 111.865 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.432 ' NH1' ' HG2' ' A' ' 61' ' ' GLU . 6.2 ptp180 -75.69 -41.81 52.7 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.769 0.428 . . . . 0.0 111.765 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.44 -39.48 64.95 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 118.075 0.398 . . . . 0.0 111.902 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.55 -16.61 44.78 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.766 0.426 . . . . 0.0 110.466 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.81 -39.0 34.97 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.595 0.559 . . . . 0.0 112.487 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -77.06 -24.95 51.92 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.843 0.457 . . . . 0.0 109.981 173.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -65.63 -38.14 88.58 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.555 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 66.6 t90 -60.74 -49.39 77.68 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 123.513 0.508 . . . . 0.0 109.883 171.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.4 mt -50.92 -34.68 29.58 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.954 0.902 . . . . 0.0 112.072 178.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -75.19 -56.8 4.36 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.623 0.769 . . . . 0.0 111.074 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.555 ' HG2' ' HA ' ' A' ' 70' ' ' TRP . 12.1 pt-20 -76.6 -20.3 56.91 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -167.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -13.62 22.04 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.471 0.708 . . . . 0.0 112.362 -172.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.8 t -68.89 80.04 0.3 Allowed 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 164.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -92.56 146.0 31.52 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.951 -177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.09 166.26 29.46 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.175 1.917 . . . . 0.0 112.193 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.17 -21.23 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 124.015 0.926 . . . . 0.0 111.364 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.7 p -69.53 -8.86 50.81 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.288 1.035 . . . . 0.0 112.716 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.71 106.71 0.43 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.102 0.961 . . . . 0.0 109.602 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -88.14 -24.95 23.22 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.423 0.689 . . . . 0.0 112.722 -169.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -72.41 -30.7 64.87 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.432 0.693 . . . . 0.0 110.799 -172.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.8 tp -69.88 -21.2 63.34 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.44 0.696 . . . . 0.0 111.529 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -69.68 155.7 40.11 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.144 0.577 . . . . 0.0 111.775 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -75.05 100.11 4.1 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.938 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -76.82 -49.17 16.44 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.614 0.766 . . . . 0.0 109.741 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 140.93 -69.77 0.45 Allowed Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.75 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -69.77 133.02 46.98 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.508 0.723 . . . . 0.0 110.054 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.1 -89.13 0.08 OUTLIER Glycine 0 C--N 1.342 0.874 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.99 93.99 2.78 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.395 0.678 . . . . 0.0 110.416 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -98.12 50.32 1.01 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.018 0.527 . . . . 0.0 110.921 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.38 17.42 74.35 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.187 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.73 -41.12 19.64 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.347 1.059 . . . . 0.0 111.2 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.59 85.55 0.6 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 C--O 1.251 1.179 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.084 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.23 -129.72 6.14 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 173.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -97.08 147.75 23.71 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.93 0.492 . . . . 0.0 109.754 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 59.7 mtt -123.8 166.22 15.97 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.147 0.979 . . . . 0.0 109.466 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.7 t70 77.09 -26.36 0.19 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.597 1.559 . . . . 0.0 113.047 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.424 ' HB2' ' HE3' ' A' ' 9' ' ' MET . 1.8 pt? -71.28 -4.9 28.37 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.011 0.925 . . . . 0.0 112.356 -176.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tt -55.47 -32.76 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.205 1.002 . . . . 0.0 111.419 174.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.8 p -135.5 91.21 2.69 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.889 0.876 . . . . 0.0 109.389 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.424 ' HE3' ' HB2' ' A' ' 6' ' ' LEU . 53.0 mtt -84.1 171.79 12.56 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.374 0.669 . . . . 0.0 110.578 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -101.75 130.08 48.08 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 85.4 t -91.54 126.27 44.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.346 0.659 . . . . 0.0 109.762 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -115.46 118.52 33.43 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.782 1.233 . . . . 0.0 109.102 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 65.5 tttm -78.68 90.23 4.59 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.1 -95.56 0.66 Allowed Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -121.48 4.22 10.18 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.802 0.841 . . . . 0.0 112.406 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 11.5 pt-20 -111.84 147.41 35.81 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.997 0.519 . . . . 0.0 109.704 176.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.3 t -72.62 108.79 5.84 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -78.45 -49.34 13.64 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.358 0.663 . . . . 0.0 110.231 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.0 -136.54 3.33 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.521 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -142.33 136.93 30.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.138 0.975 . . . . 0.0 109.483 -178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.2 p -71.58 106.96 4.22 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.421 HG22 ' HD2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -92.59 -40.31 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.083 0.553 . . . . 0.0 109.67 -176.243 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -160.35 168.91 24.23 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.438 0.295 . . . . 0.0 110.919 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.15 141.22 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.011 0.924 . . . . 0.0 109.102 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -138.91 97.41 3.31 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.457 1.103 . . . . 0.0 108.389 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.1 -109.01 2.3 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.771 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -107.17 16.85 23.65 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.104 0.962 . . . . 0.0 110.36 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.432 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 93.8 m-85 -127.81 117.86 22.64 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.447 0.699 . . . . 0.0 109.895 -174.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.5 tp -76.62 111.0 11.66 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 172.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mm -71.02 112.88 6.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -107.26 120.02 57.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.355 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -74.84 109.18 8.09 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.05 89.56 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.577 1.151 . . . . 0.0 110.659 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.12 -76.02 1.68 Allowed Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.237 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.5 m -125.07 -29.47 3.32 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.141 0.977 . . . . 0.0 110.856 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -110.45 168.89 9.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 122.155 -0.341 . . . . 0.0 110.551 -172.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.421 ' HD2' HG22 ' A' ' 22' ' ' ILE . 64.5 m-85 -113.22 110.37 20.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.133 0.973 . . . . 0.0 109.466 177.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.0 mt -107.39 124.74 50.28 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.124 0.57 . . . . 0.0 109.63 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.432 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -89.62 99.49 12.48 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.016 -174.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.1 m -86.46 129.13 54.37 Favored Pre-proline 0 CA--C 1.552 1.056 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.13 158.42 54.65 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.363 2.042 . . . . 0.0 111.871 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.55 ' HA ' HD13 ' A' ' 45' ' ' ILE . 13.9 mmmm -64.6 -29.54 70.55 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.256 0.622 . . . . 0.0 112.166 -177.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.416 ' H ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -72.84 -17.79 61.51 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.142 0.177 . . . . 0.0 111.219 174.664 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.5 t -73.13 -34.9 66.38 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 171.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.55 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.9 mp -61.18 115.38 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.173 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 mmpm? -82.28 -61.28 1.94 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.212 1.005 . . . . 0.0 109.414 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.0 m -138.69 126.6 22.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.149 -172.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 p -92.53 109.37 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 171.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.634 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 22.0 mm-40 -98.63 177.01 5.44 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 124.546 1.138 . . . . 0.0 110.225 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -68.11 91.15 0.35 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.185 0.594 . . . . 0.0 110.452 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.36 17.81 77.23 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.303 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.634 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 49.7 mtt180 -137.33 129.55 29.43 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.54 0.736 . . . . 0.0 109.382 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.4 mm -105.03 103.37 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.76 115.93 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.8 pt -108.57 175.15 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.377 0.671 . . . . 0.0 109.457 173.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.43 -117.75 3.01 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -118.71 160.29 22.11 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.267 0.627 . . . . 0.0 110.602 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -159.8 179.21 9.02 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.156 1.382 . . . . 0.0 108.477 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.28 114.44 26.52 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -63.86 -36.2 83.13 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.844 0.858 . . . . 0.0 112.52 -175.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -69.21 -40.85 77.74 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.981 0.512 . . . . 0.0 110.185 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.42 -44.98 73.84 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 123.415 0.447 . . . . 0.0 110.33 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.04 -25.52 68.42 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.376 0.67 . . . . 0.0 111.292 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -73.89 -51.48 16.07 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.893 0.877 . . . . 0.0 110.971 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.11 -40.81 59.62 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.993 0.517 . . . . 0.0 111.799 -171.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 69' ' ' LYS . 2.4 pp -84.1 -20.77 31.99 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.06 -44.83 87.02 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 169.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.498 ' HA ' HD21 ' A' ' 71' ' ' LEU . 35.2 ptt180 -75.45 -14.2 60.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.508 0.723 . . . . 0.0 110.406 175.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 6.3 tppt? -67.74 -31.85 72.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.982 0.513 . . . . 0.0 109.831 167.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.421 ' HE3' HD22 ' A' ' 71' ' ' LEU . 81.8 t90 -71.37 -38.6 71.53 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.805 0.442 . . . . 0.0 110.795 170.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.498 HD21 ' HA ' ' A' ' 68' ' ' ARG . 3.8 mm? -65.55 -29.66 70.31 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 120.807 0.337 . . . . 0.0 110.163 171.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.43 -35.8 65.85 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.78 0.832 . . . . 0.0 109.479 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.431 ' HA ' ' HG2' ' A' ' 76' ' ' LYS . 14.2 tp10 -63.54 -23.67 67.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.29 1.036 . . . . 0.0 110.791 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -76.74 -35.6 57.66 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.879 0.871 . . . . 0.0 112.113 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.7 p -84.17 -27.83 27.79 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 73' ' ' GLU . 16.4 ptmt -86.74 168.52 18.0 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 123.759 0.824 . . . . 0.0 109.341 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.15 162.02 37.41 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.176 1.917 . . . . 0.0 112.058 166.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.0 m -81.97 27.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.784 0.833 . . . . 0.0 112.765 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.3 t -68.2 104.34 1.79 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.629 0.772 . . . . 0.0 110.52 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.9 tt -168.4 -43.95 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.557 1.143 . . . . 0.0 107.944 -177.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.46 -2.66 17.45 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.398 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -60.84 -35.73 77.32 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.535 0.734 . . . . 0.0 110.173 170.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 tt -59.61 -42.92 93.72 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.496 1.118 . . . . 0.0 109.472 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -70.76 86.83 0.68 Allowed 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.66 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.4 t -77.45 -23.48 50.48 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.762 0.825 . . . . 0.0 110.9 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -137.07 145.82 44.43 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.106 0.962 . . . . 0.0 108.809 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.31 79.83 0.07 OUTLIER Glycine 0 C--N 1.339 0.749 0 N-CA-C 112.027 -0.429 . . . . 0.0 112.027 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -118.05 114.4 23.06 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.021 0.928 . . . . 0.0 109.861 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.3 41.76 0.41 Allowed Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 175.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -108.47 88.54 2.75 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.964 0.906 . . . . 0.0 110.168 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -88.98 166.19 14.07 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.518 0.727 . . . . 0.0 109.834 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.75 123.65 7.25 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.111 -175.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 64.41 84.75 0.15 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.779 1.231 . . . . 0.0 111.767 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.33 129.39 9.31 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 173.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.9 t . . . . . 0 C--O 1.255 1.359 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -175.633 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.53 55.6 0.72 Allowed Glycine 0 C--N 1.341 0.837 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -175.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -66.2 92.94 0.19 Allowed 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.433 0.693 . . . . 0.0 110.037 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.1 ttt -76.33 108.29 9.17 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 166.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -71.2 89.92 0.88 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 pp -114.59 1.57 14.3 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.744 1.218 . . . . 0.0 110.711 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.5 tt -74.07 140.6 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.353 0.661 . . . . 0.0 109.539 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.5 t 60.14 49.92 6.94 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 124.174 0.99 . . . . 0.0 111.514 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 41.4 mtt -67.61 124.46 23.3 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.49 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -71.31 106.93 4.04 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.477 HG21 ' HB ' ' A' ' 53' ' ' ILE . 57.8 t -78.93 110.04 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.879 -177.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 54.5 m-85 -97.23 120.9 38.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.128 0.971 . . . . 0.0 109.163 174.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -78.21 87.71 4.29 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.02 -95.51 0.74 Allowed Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -107.63 -29.66 9.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.792 0.837 . . . . 0.0 111.11 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.65 146.54 28.2 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.57 0.348 . . . . 0.0 110.449 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.0 t -77.15 105.63 8.36 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -79.89 -55.71 4.78 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.527 0.731 . . . . 0.0 111.158 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.535 ' HA3' HG13 ' A' ' 33' ' ' VAL . . . -179.03 -147.87 7.39 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.261 0.351 . . . . 0.0 112.456 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -137.49 135.36 36.73 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.843 0.857 . . . . 0.0 109.779 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.5 p -76.66 108.27 9.55 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.21 -37.73 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.349 0.659 . . . . 0.0 109.556 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -160.73 177.92 9.98 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -173.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.474 ' HB ' HD13 ' A' ' 29' ' ' LEU . 5.5 p -155.58 135.14 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 123.962 0.905 . . . . 0.0 109.056 173.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.424 ' CD2' HD13 ' A' ' 30' ' ' ILE . 34.3 p90 -132.13 131.81 42.65 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 171.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.19 -107.06 1.18 Allowed Glycine 0 C--N 1.343 0.958 0 O-C-N 123.764 0.665 . . . . 0.0 113.293 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -119.65 27.94 8.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.977 0.911 . . . . 0.0 111.261 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -133.29 108.97 9.07 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.063 0.545 . . . . 0.0 110.227 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.474 HD13 ' HB ' ' A' ' 24' ' ' VAL . 51.0 tp -81.37 113.47 19.49 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.356 0.662 . . . . 0.0 109.404 175.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.424 HD13 ' CD2' ' A' ' 25' ' ' TYR . 8.0 mm -80.1 104.79 8.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 C-N-CA 123.172 0.589 . . . . 0.0 109.685 -176.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.2 t -105.95 113.58 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.756 0.822 . . . . 0.0 109.834 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -75.86 117.0 17.13 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.387 0.675 . . . . 0.0 109.638 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.535 HG13 ' HA3' ' A' ' 19' ' ' GLY . 11.1 m -133.18 148.78 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.95 0.9 . . . . 0.0 109.409 176.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.23 -106.04 0.43 Allowed Glycine 0 CA--C 1.531 1.09 0 O-C-N 123.426 0.454 . . . . 0.0 113.04 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.8 m -109.53 -29.91 8.18 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.648 0.779 . . . . 0.0 110.888 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -116.44 176.5 5.08 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.623 0.725 . . . . 0.0 112.158 -169.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -104.28 109.92 21.94 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.653 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.12 102.97 15.51 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.208 1.003 . . . . 0.0 108.577 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.485 ' HB1' HD11 ' A' ' 66' ' ' LEU . . . -84.83 94.66 8.78 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.673 0.789 . . . . 0.0 109.526 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.1 m -75.35 128.66 83.96 Favored Pre-proline 0 CA--C 1.558 1.255 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.699 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -60.81 161.26 22.19 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.017 2.478 . . . . 0.0 112.192 174.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.484 ' HA ' HG12 ' A' ' 45' ' ' ILE . 14.6 mmmm -68.42 -21.27 64.68 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.69 -17.39 62.84 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.711 0.404 . . . . 0.0 111.014 174.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.524 ' HG ' ' HB ' ' A' ' 55' ' ' ILE . 26.8 t -80.5 -29.47 37.31 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.102 0.561 . . . . 0.0 110.353 175.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.484 HG12 ' HA ' ' A' ' 42' ' ' LYS . 25.5 mm -68.23 115.18 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 122.837 0.455 . . . . 0.0 110.406 -175.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -84.01 -66.69 0.86 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.596 0.758 . . . . 0.0 110.448 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.0 m -143.71 126.79 16.46 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.626 0.371 . . . . 0.0 110.654 -171.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -82.82 111.63 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.775 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 11.1 mm-40 -99.41 175.96 5.68 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.78 0.832 . . . . 0.0 109.986 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -70.31 97.55 1.26 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.12 0.568 . . . . 0.0 110.05 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.81 21.94 77.78 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.841 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.775 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 79.6 mtt180 -142.62 151.24 41.27 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.931 0.892 . . . . 0.0 110.031 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.477 ' HB ' HG21 ' A' ' 11' ' ' VAL . 43.5 mm -124.4 107.11 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 170.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 57.4 t -78.46 117.76 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.524 ' HB ' ' HG ' ' A' ' 44' ' ' SER . 47.4 pt -108.81 171.4 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.698 0.799 . . . . 0.0 109.54 171.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.66 -81.08 0.68 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -139.75 146.11 39.12 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-O 121.846 0.831 . . . . 0.0 110.711 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -160.66 165.48 30.51 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.471 1.508 . . . . 0.0 107.589 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -94.1 108.6 20.43 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.63 -39.11 92.77 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.889 0.876 . . . . 0.0 112.952 -170.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.55 -33.09 75.11 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.3 0.64 . . . . 0.0 110.712 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -76.73 -45.9 27.47 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.435 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.91 -26.78 68.46 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.674 0.79 . . . . 0.0 110.671 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -74.7 -44.4 50.29 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.589 0.756 . . . . 0.0 110.609 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.86 -39.33 64.05 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.491 ' HA ' ' HB2' ' A' ' 69' ' ' LYS . 4.3 pp -82.41 -13.67 56.44 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 121.702 0.763 . . . . 0.0 110.037 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.18 -43.08 96.0 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 161.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.4 ' HA ' HD23 ' A' ' 71' ' ' LEU . 62.8 mtp180 -70.07 -16.69 63.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.92 0.888 . . . . 0.0 111.582 174.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.491 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 4.0 tppp? -67.28 -38.78 85.62 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.692 0.797 . . . . 0.0 109.559 170.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.431 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 68.7 t90 -62.19 -45.29 94.05 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.344 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 3.7 mm? -63.22 -25.38 68.3 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.564 0.345 . . . . 0.0 111.209 174.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -74.67 -35.78 62.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.867 0.867 . . . . 0.0 111.311 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.653 ' HA ' ' HG2' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -71.52 -28.74 64.1 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 71' ' ' LEU . 28.0 mtpp -69.01 -23.93 64.15 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.747 0.819 . . . . 0.0 111.686 172.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.2 m -83.12 -44.84 14.66 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.613 0.765 . . . . 0.0 111.106 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.653 ' HG2' ' HA ' ' A' ' 73' ' ' GLU . 15.8 ptpt -81.51 170.89 13.59 Favored Pre-proline 0 N--CA 1.487 1.408 0 C-N-CA 123.917 0.887 . . . . 0.0 109.364 177.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 76' ' ' LYS . 18.9 Cg_endo -55.65 138.84 82.18 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 122.071 1.847 . . . . 0.0 111.145 173.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.16 90.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.664 0.786 . . . . 0.0 109.897 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.2 p -130.26 29.2 4.91 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.914 1.286 . . . . 0.0 109.813 -175.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.6 tp -73.5 92.11 1.86 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.78 0.832 . . . . 0.0 110.31 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -11.2 59.73 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.979 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -61.48 -25.33 67.18 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.224 1.01 . . . . 0.0 110.964 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -58.03 -32.52 68.04 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.496 1.118 . . . . 0.0 110.129 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -71.44 139.11 49.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.823 0.849 . . . . 0.0 111.363 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.5 t -168.59 176.7 5.55 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.092 1.357 . . . . 0.0 108.685 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -72.72 179.43 3.62 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.399 0.68 . . . . 0.0 111.61 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.57 33.06 6.3 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.041 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -72.0 109.54 5.88 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.185 0.994 . . . . 0.0 110.033 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.63 167.31 13.13 Favored Glycine 0 C--N 1.343 0.955 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -134.21 21.39 3.74 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.599 0.76 . . . . 0.0 111.035 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.0 -41.2 71.24 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 132.69 -167.98 22.97 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.826 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -157.62 -56.86 0.08 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.502 1.121 . . . . 0.0 108.08 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.95 175.69 23.11 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.333 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.2 p . . . . . 0 C--O 1.254 1.338 0 C-N-CA 123.535 0.734 . . . . 0.0 109.303 178.73 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.11 153.43 28.09 Favored Glycine 0 C--N 1.353 1.483 0 O-C-N 123.609 0.568 . . . . 0.0 112.513 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -103.0 144.8 30.8 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.117 0.967 . . . . 0.0 109.394 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.415 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 63.1 mtt -136.21 167.8 20.59 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.451 1.1 . . . . 0.0 108.901 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -122.9 44.66 2.59 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.879 0.872 . . . . 0.0 109.252 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.415 ' HG ' ' HB3' ' A' ' 4' ' ' MET . 86.3 mt -86.07 -51.69 6.16 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.022 -172.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.8 tp -69.94 114.71 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-O 121.504 0.669 . . . . 0.0 111.902 -171.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.3 m -86.97 93.4 9.33 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.412 ' HG2' ' HA2' ' A' ' 51' ' ' GLY . 58.2 mtt -71.64 126.51 29.89 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.976 -173.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -66.43 113.81 4.96 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.513 0.725 . . . . 0.0 110.568 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.1 t -83.1 123.73 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.505 0.722 . . . . 0.0 110.386 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -108.55 120.73 43.3 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.161 0.984 . . . . 0.0 109.418 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 49.7 tttm -77.24 85.43 3.69 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.59 -94.18 0.84 Allowed Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -110.81 -23.58 10.93 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.313 1.045 . . . . 0.0 111.229 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 11.3 pt-20 -91.18 144.41 25.65 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.065 0.546 . . . . 0.0 110.451 -173.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.6 t -71.4 111.4 6.69 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.406 0.682 . . . . 0.0 109.507 176.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -91.35 -56.55 3.1 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.801 0.44 . . . . 0.0 111.166 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . -179.35 -140.35 4.03 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.57 -174.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.26 139.25 35.5 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.601 0.76 . . . . 0.0 110.619 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.0 t -79.16 108.87 12.97 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.664 0.785 . . . . 0.0 109.241 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.413 HD11 ' HB2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -92.18 -39.13 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.156 0.582 . . . . 0.0 109.599 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.413 ' HB2' HD11 ' A' ' 22' ' ' ILE . 19.0 t70 -154.26 169.11 24.43 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.743 0.306 . . . . 0.0 111.082 -174.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.408 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.7 p -151.17 137.9 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.352 1.061 . . . . 0.0 108.46 172.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -146.54 135.38 22.34 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.96 -106.8 1.08 Allowed Glycine 0 C--N 1.34 0.799 0 O-C-N 123.29 0.369 . . . . 0.0 113.955 174.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -119.51 13.07 12.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.099 0.959 . . . . 0.0 110.915 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.477 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 83.8 m-85 -130.74 150.14 52.06 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.509 0.723 . . . . 0.0 111.049 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.408 HD12 ' HB ' ' A' ' 24' ' ' VAL . 45.3 tp -117.25 112.46 20.81 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.592 1.557 . . . . 0.0 107.725 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.0 mm -76.52 109.15 10.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.816 0 C-N-CA 123.128 0.571 . . . . 0.0 109.757 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.5 t -110.13 117.94 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.053 0.941 . . . . 0.0 108.648 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.537 ' HZ2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -88.78 118.68 28.64 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.508 HG21 HD21 ' A' ' 38' ' ' LEU . 19.7 m -123.07 128.49 75.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 171.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.99 -99.71 0.21 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 116.604 -0.271 . . . . 0.0 113.305 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.0 m -125.05 -5.11 7.39 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.856 0.862 . . . . 0.0 111.081 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -116.83 154.2 31.15 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.246 0.618 . . . . 0.0 111.236 -173.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -112.01 109.66 19.54 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.31 1.044 . . . . 0.0 109.154 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.508 HD21 HG21 ' A' ' 33' ' ' VAL . 3.6 mm? -95.55 106.75 18.86 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.39 1.076 . . . . 0.0 109.131 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -79.84 95.29 6.0 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.086 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.4 m -87.06 126.42 62.99 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.479 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 38.2 Cg_endo -62.13 152.03 78.33 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.503 2.135 . . . . 0.0 112.492 -176.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.577 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.7 mmmm -64.94 -23.04 67.1 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.583 0.753 . . . . 0.0 111.808 -175.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.479 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 21.6 ptmt -70.88 -25.58 62.86 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.461 0.705 . . . . 0.0 111.307 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.9 t -72.22 -31.43 65.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.888 0.475 . . . . 0.0 110.094 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.577 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.6 mp -62.0 114.68 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.099 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -90.62 -55.6 3.51 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.824 1.25 . . . . 0.0 110.818 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.5 m -134.37 126.87 30.5 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.349 0.66 . . . . 0.0 110.108 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 p -96.04 109.88 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 172.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 47.4 mm-40 -111.39 168.47 9.51 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 124.224 1.01 . . . . 0.0 109.918 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -65.34 98.53 0.34 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.811 0.844 . . . . 0.0 110.803 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.412 ' HA2' ' HG2' ' A' ' 9' ' ' MET . . . 77.29 11.96 85.03 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 116.333 -0.394 . . . . 0.0 113.963 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.464 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 97.4 mtt180 -137.6 127.3 25.33 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.957 0.903 . . . . 0.0 109.48 178.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.9 mm -110.37 102.99 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.9 t -80.71 113.48 20.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 33.3 pt -106.63 178.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.102 0.961 . . . . 0.0 108.466 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.43 -119.71 4.54 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -131.63 166.54 21.22 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.732 0.813 . . . . 0.0 109.165 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -163.53 168.5 20.03 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.115 0.966 . . . . 0.0 109.297 -168.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -81.75 99.57 9.03 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -62.95 -30.55 71.66 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.006 0.922 . . . . 0.0 111.883 -175.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -62.83 -51.84 65.46 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.688 0.756 . . . . 0.0 109.747 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.07 -35.17 76.23 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.972 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.3 -34.77 73.14 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.029 0.532 . . . . 0.0 111.867 -175.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -77.13 -34.27 56.65 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 177.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.97 -37.99 54.1 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 117.725 0.238 . . . . 0.0 111.048 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 pp -82.98 -15.53 50.85 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.06 -42.71 35.82 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.053 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.543 ' HA ' HD22 ' A' ' 71' ' ' LEU . 4.9 ptp180 -70.97 -27.06 63.45 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 24.2 ttmm -63.56 -33.55 75.84 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 170.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -64.52 -37.1 86.36 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.696 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.543 HD22 ' HA ' ' A' ' 68' ' ' ARG . 4.0 mm? -61.52 -29.4 69.97 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 118.139 0.427 . . . . 0.0 110.717 173.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -77.01 -33.9 57.46 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.314 0.645 . . . . 0.0 110.685 172.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 44.1 mt-10 -71.61 -44.06 65.1 Favored 'General case' 0 C--O 1.206 -1.196 0 C-N-CA 123.57 0.748 . . . . 0.0 111.764 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -14.16 61.99 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.738 -0.601 . . . . 0.0 110.974 177.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.8 t -101.01 31.45 3.6 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 124.618 1.167 . . . . 0.0 109.893 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -65.46 159.99 62.96 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 123.547 0.739 . . . . 0.0 112.02 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.7 -177.38 0.24 Allowed 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 122.832 2.354 . . . . 0.0 113.168 176.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.5 m -71.94 8.91 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -173.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.3 t -60.45 129.46 41.72 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.316 0.646 . . . . 0.0 110.844 168.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.512 HD11 ' HB3' ' A' ' 82' ' ' GLU . 1.5 pp -83.75 157.08 22.24 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.349 172.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -104.12 4.96 34.74 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.272 0.629 . . . . 0.0 111.259 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.512 ' HB3' HD11 ' A' ' 80' ' ' LEU . 12.2 tp10 -54.88 -35.66 64.3 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.244 1.018 . . . . 0.0 111.078 170.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -70.83 -51.09 28.79 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.2 0.6 . . . . 0.0 110.425 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -83.86 171.06 13.44 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.522 0.677 . . . . 0.0 111.638 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 m -87.93 158.77 18.59 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.679 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -104.9 155.75 18.65 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.727 0.811 . . . . 0.0 109.073 174.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.76 145.5 49.85 Favored Glycine 0 C--N 1.341 0.806 0 O-C-N 123.564 0.54 . . . . 0.0 113.359 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -67.07 133.91 50.81 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.493 0.717 . . . . 0.0 110.294 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.69 -115.01 3.45 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -89.13 83.03 6.52 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.092 0.557 . . . . 0.0 109.695 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.43 95.86 3.92 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -168.61 -174.73 37.55 Favored Glycine 0 C--O 1.242 0.605 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.027 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -77.39 78.1 3.91 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.822 0.849 . . . . 0.0 109.062 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.44 134.57 18.11 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.126 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.301 -0.856 . . . . 0.0 109.24 179.026 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.763 0.316 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -145.95 -106.47 0.49 Allowed Glycine 0 C--N 1.341 0.82 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -79.75 86.31 5.34 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 172.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.0 ttt -77.68 89.73 3.97 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -78.3 -8.25 58.18 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.105 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mp -90.75 55.08 2.85 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.045 1.338 . . . . 0.0 107.55 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.473 ' HB ' ' HG3' ' A' ' 9' ' ' MET . 41.3 pt -69.61 133.59 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.479 -170.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 21' ' ' SER . 23.2 p -116.01 30.34 7.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.608 1.163 . . . . 0.0 109.582 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.473 ' HG3' ' HB ' ' A' ' 7' ' ' ILE . 85.2 mtp -65.12 142.97 58.19 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.651 -173.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -72.33 107.69 5.06 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.69 0.796 . . . . 0.0 109.929 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.59 116.23 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 122.92 0.488 . . . . 0.0 109.929 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -111.13 129.56 55.9 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.243 1.017 . . . . 0.0 109.262 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -85.19 92.25 8.35 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.55 -95.81 0.4 Allowed Glycine 0 C--N 1.351 1.4 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.014 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -104.51 -31.83 9.27 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.609 0.764 . . . . 0.0 111.479 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -83.4 144.2 29.78 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 120.659 0.266 . . . . 0.0 110.911 -172.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.5 t -72.41 111.09 7.29 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.561 0.745 . . . . 0.0 109.359 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -84.85 -57.04 3.27 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.553 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 178.15 -136.18 2.91 Favored Glycine 0 C--N 1.347 1.143 0 O-C-N 123.149 0.28 . . . . 0.0 112.465 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.79 139.13 24.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.238 1.015 . . . . 0.0 109.687 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 47.3 t -68.23 138.5 55.62 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.06 -38.11 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -156.14 164.55 38.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.732 0.413 . . . . 0.0 110.039 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.0 p -121.16 136.45 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.468 ' OH ' ' HD2' ' A' ' 69' ' ' LYS . 4.6 t80 -136.95 101.25 4.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.982 0.913 . . . . 0.0 109.602 -173.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.0 -113.04 5.37 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.423 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -98.57 21.53 11.12 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.027 0.931 . . . . 0.0 110.873 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -135.58 162.24 33.25 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.047 0.939 . . . . 0.0 109.792 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 59.0 tp -123.66 113.07 18.15 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 39' ' ' ALA . 23.7 mm -70.43 106.88 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.0 t -108.32 117.71 54.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -76.22 115.85 16.35 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.555 HG23 HD23 ' A' ' 38' ' ' LEU . 4.0 m -123.38 121.19 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.86 -86.97 0.06 OUTLIER Glycine 0 CA--C 1.532 1.115 0 CA-C-N 116.326 -0.397 . . . . 0.0 113.487 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 m -124.56 -25.84 3.96 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.683 1.193 . . . . 0.0 110.663 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -106.88 163.78 12.67 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.579 0.752 . . . . 0.0 111.24 -167.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -111.0 109.07 19.02 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.156 0.982 . . . . 0.0 108.772 177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.555 HD23 HG23 ' A' ' 33' ' ' VAL . 4.3 mm? -105.73 111.95 24.82 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.572 1.149 . . . . 0.0 108.836 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.402 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -82.93 94.81 7.8 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.212 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.48 131.28 58.79 Favored Pre-proline 0 N--CA 1.473 0.723 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.567 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 35.8 Cg_endo -60.67 153.41 62.15 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.275 1.983 . . . . 0.0 111.703 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.52 ' HA ' HD11 ' A' ' 45' ' ' ILE . 14.4 mmmm -63.27 -27.13 69.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.603 0.761 . . . . 0.0 111.416 -178.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.567 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 20.9 ptmt -67.74 -21.7 65.27 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.676 0.79 . . . . 0.0 111.793 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.5 t -70.18 -43.15 71.38 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 42' ' ' LYS . 2.3 mp -60.98 113.77 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.209 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.533 ' HE3' ' HA3' ' A' ' 56' ' ' GLY . 33.9 mmtp -79.17 -58.65 3.12 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.857 0.863 . . . . 0.0 109.421 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.8 m -154.45 156.72 37.27 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.378 0.671 . . . . 0.0 110.613 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.4 t -93.37 111.76 25.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.822 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.629 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 7.3 mm-40 -86.62 167.21 14.74 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.348 0.659 . . . . 0.0 109.363 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -69.13 93.85 0.63 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.57 -6.76 65.43 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.852 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.629 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 49.9 mtm180 -129.01 158.99 37.34 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.009 0.523 . . . . 0.0 110.952 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 mm -124.17 104.44 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.2 t -79.98 118.75 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.2 pt -108.81 174.08 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 123.893 0.877 . . . . 0.0 109.336 172.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.533 ' HA3' ' HE3' ' A' ' 46' ' ' LYS . . . -135.38 -90.04 0.31 Allowed Glycine 0 C--N 1.34 0.757 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.065 -173.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -107.73 130.45 54.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.09 0.472 . . . . 0.0 111.882 -168.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -164.12 -176.4 4.47 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.278 1.031 . . . . 0.0 108.768 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -128.79 122.72 31.14 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.98 -32.66 69.57 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.753 0.421 . . . . 0.0 112.114 -173.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.88 -34.62 69.33 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.43 -38.69 68.26 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.379 172.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.464 ' HB3' HD12 ' A' ' 38' ' ' LEU . . . -70.06 -28.47 65.47 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.926 0.49 . . . . 0.0 111.629 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -78.63 -36.25 44.33 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.037 0.535 . . . . 0.0 112.027 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.402 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 11.9 pt-20 -74.61 -41.96 59.49 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 120.838 0.352 . . . . 0.0 110.859 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 pp -81.46 -21.27 38.88 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.21 -41.38 86.49 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.959 170.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.546 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -73.59 -21.0 60.46 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 117.346 0.573 . . . . 0.0 111.032 177.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.468 ' HD2' ' OH ' ' A' ' 25' ' ' TYR . 2.6 ttmp? -57.98 -46.85 84.51 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 166.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.488 ' HE3' HD11 ' A' ' 71' ' ' LEU . 89.3 t90 -62.34 -42.64 99.55 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.117 174.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.546 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . 9.8 mp -54.55 -31.7 57.02 Favored 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 123.54 0.736 . . . . 0.0 111.879 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -80.3 -54.09 6.04 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 122.924 0.49 . . . . 0.0 109.908 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.482 ' HG2' ' HA ' ' A' ' 70' ' ' TRP . 12.7 pt-20 -75.92 -17.15 59.87 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -170.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -25.34 66.93 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 123.566 0.746 . . . . 0.0 111.802 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m -59.7 -26.46 65.61 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.934 0.894 . . . . 0.0 111.396 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -89.35 120.12 69.7 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.078 0.951 . . . . 0.0 109.481 174.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.83 143.5 55.68 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.691 2.26 . . . . 0.0 112.254 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.8 p -69.86 101.79 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 C-N-CA 123.49 0.716 . . . . 0.0 111.261 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 t -76.03 102.15 5.54 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.622 0.725 . . . . 0.0 110.168 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.6 tp -67.0 -35.35 79.76 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.952 -176.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.65 -38.35 89.95 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.672 0.789 . . . . 0.0 111.891 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -83.01 -22.45 33.61 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.853 0.461 . . . . 0.0 110.911 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.5 tp -65.8 -32.58 74.19 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.583 0.753 . . . . 0.0 110.701 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -75.8 96.23 3.63 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.175 0.59 . . . . 0.0 110.001 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t -154.48 135.79 14.08 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.023 0.929 . . . . 0.0 109.441 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -77.76 137.08 38.26 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.582 0.753 . . . . 0.0 111.12 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -80.12 -172.49 44.5 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.155 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -83.6 97.37 9.02 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.473 0.709 . . . . 0.0 111.272 -173.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -100.53 92.33 1.07 Allowed Glycine 0 C--N 1.345 1.047 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -70.94 -20.8 62.43 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.401 0.68 . . . . 0.0 111.337 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.25 134.8 57.01 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.879 0.872 . . . . 0.0 110.218 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 154.29 82.93 0.04 OUTLIER Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -175.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -87.14 -20.8 26.51 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.365 0.666 . . . . 0.0 111.159 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 93.99 -96.66 2.09 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.911 -0.383 . . . . 0.0 112.176 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 C--O 1.248 1.026 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.049 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.682 0.277 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.83 168.44 44.46 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.186 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -80.52 87.0 5.74 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.011 0.524 . . . . 0.0 110.754 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.9 ttt -101.15 15.26 29.31 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.62 0.724 . . . . 0.0 109.777 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -85.01 45.24 1.15 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.07 0.948 . . . . 0.0 111.88 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -124.12 6.52 8.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.789 0.836 . . . . 0.0 109.709 171.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.579 HG13 ' H ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -80.05 89.19 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 CA-C-O 122.209 1.004 . . . . 0.0 108.805 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.9 p -166.47 79.26 0.24 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.253 -1.34 . . . . 0.0 107.489 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -66.14 134.38 52.66 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.713 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -74.13 108.41 6.91 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.34 1.056 . . . . 0.0 109.883 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.452 HG22 ' HB ' ' A' ' 53' ' ' ILE . 61.5 t -80.01 123.7 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.927 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -106.09 122.58 46.46 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.135 0.974 . . . . 0.0 109.836 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -78.82 80.76 5.15 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.57 -95.61 0.39 Allowed Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.786 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -104.3 0.38 29.17 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.844 0.858 . . . . 0.0 112.124 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -131.42 149.6 52.47 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.134 0.574 . . . . 0.0 110.422 -175.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.6 t -71.94 111.62 7.35 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.419 0.688 . . . . 0.0 109.762 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -77.37 -55.92 4.99 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.32 0.648 . . . . 0.0 109.327 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.88 -142.99 6.09 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.36 151.71 35.79 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.445 0.698 . . . . 0.0 109.748 172.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.2 t -71.62 146.9 48.04 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.955 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.42 -37.73 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.081 0.952 . . . . 0.0 109.405 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.73 173.24 14.42 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -173.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.419 ' HB ' HD11 ' A' ' 29' ' ' LEU . 8.9 p -155.96 134.1 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.565 0.746 . . . . 0.0 109.516 171.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -133.77 125.24 28.1 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.17 -107.07 1.18 Allowed Glycine 0 CA--C 1.531 1.072 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.398 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -102.93 -9.4 19.89 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.004 0.921 . . . . 0.0 111.603 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.564 ' HB3' ' HB2' ' A' ' 39' ' ' ALA . 86.6 m-85 -108.7 108.48 19.34 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.815 -0.553 . . . . 0.0 111.979 -169.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.419 HD11 ' HB ' ' A' ' 24' ' ' VAL . 26.8 tp -77.65 109.35 11.55 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.37 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 mm -72.03 99.73 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.2 t -96.1 112.71 28.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.513 ' HZ2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -85.89 113.91 22.39 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.95 86.86 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 CA-C-O 122.164 0.983 . . . . 0.0 110.532 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.53 -89.26 0.36 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.392 177.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.522 HG21 ' HG2' ' A' ' 36' ' ' GLU . 10.5 t -101.5 -16.71 16.72 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.39 0.676 . . . . 0.0 110.93 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.522 ' HG2' HG21 ' A' ' 35' ' ' THR . 6.3 mm-40 -109.6 162.73 14.13 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.443 0.697 . . . . 0.0 111.156 -167.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -121.39 108.48 13.73 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 170.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.85 106.68 17.29 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.501 1.121 . . . . 0.0 108.755 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.564 ' HB2' ' HB3' ' A' ' 28' ' ' TYR . . . -87.24 94.74 9.75 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.559 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.6 m -78.98 140.04 57.57 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.531 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.36 155.05 72.06 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.554 2.169 . . . . 0.0 110.767 172.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.41 ' HA ' HD12 ' A' ' 45' ' ' ILE . 31.8 mmmt -64.71 -22.94 67.1 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -76.57 -17.21 59.34 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.267 0.627 . . . . 0.0 111.921 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.1 t -66.66 -30.59 70.89 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.272 0.629 . . . . 0.0 110.727 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 42' ' ' LYS . 2.6 mp -72.49 115.48 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.729 0.812 . . . . 0.0 109.733 -177.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -85.85 -44.35 12.52 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.765 0.826 . . . . 0.0 110.184 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.3 m -139.46 133.5 31.02 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.545 0.738 . . . . 0.0 111.436 -172.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.1 t -105.08 110.75 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 170.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 40.0 mm-40 -111.37 175.5 5.4 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.973 0.909 . . . . 0.0 110.488 -177.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -40.47 -56.6 2.01 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 125.648 1.579 . . . . 0.0 113.013 -171.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.492 ' H ' ' HD2' ' A' ' 52' ' ' ARG . . . -140.3 35.73 1.86 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.492 ' HD2' ' H ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -137.86 151.56 48.19 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.524 0.73 . . . . 0.0 109.564 -176.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.452 ' HB ' HG22 ' A' ' 11' ' ' VAL . 31.1 mm -132.11 104.06 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 124.556 1.142 . . . . 0.0 108.432 172.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.8 t -84.48 115.88 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.1 pt -107.3 141.33 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.68 0.792 . . . . 0.0 109.518 173.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.82 -61.45 1.77 Allowed Glycine 0 C--N 1.345 1.047 0 N-CA-C 112.231 -0.348 . . . . 0.0 112.231 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -156.48 162.65 39.96 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.834 0.853 . . . . 0.0 109.451 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -171.01 162.72 7.28 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.76 0.824 . . . . 0.0 109.947 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.03 86.7 1.03 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.52 -36.55 71.08 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.98 0.912 . . . . 0.0 113.241 -171.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -68.05 -38.22 82.2 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.416 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 41.4 mt-10 -74.14 -34.66 63.93 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.842 176.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.21 -24.54 63.13 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.836 0.455 . . . . 0.0 110.959 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -74.2 -44.59 52.65 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.104 0.962 . . . . 0.0 110.161 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.7 pt-20 -70.11 -38.47 75.63 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.44 HD12 ' HB3' ' A' ' 39' ' ' ALA . 4.5 pp -82.97 -13.41 56.04 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 120.983 0.42 . . . . 0.0 110.651 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.69 -43.77 50.63 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.133 169.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.51 ' HA ' HD22 ' A' ' 71' ' ' LEU . 25.7 ptt85 -73.83 -22.5 59.76 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 116.766 0.283 . . . . 0.0 110.542 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 24.8 ttpp -64.82 -33.9 77.08 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 169.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -66.45 -35.6 80.7 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 119.638 -0.22 . . . . 0.0 110.832 170.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.51 HD22 ' HA ' ' A' ' 68' ' ' ARG . 4.4 mm? -61.43 -23.0 65.53 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.29 0.496 . . . . 0.0 111.407 173.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 69' ' ' LYS . 13.3 tp10 -77.28 -40.03 45.98 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 123.305 0.642 . . . . 0.0 110.47 169.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 69' ' ' LYS . 9.6 mm-40 -75.26 -29.17 60.09 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -174.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.413 ' HE3' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -64.4 -21.73 66.73 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 120.861 0.362 . . . . 0.0 111.936 -179.266 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.6 m -75.02 -10.85 59.86 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.303 0.641 . . . . 0.0 111.738 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 73' ' ' GLU . 11.1 mptt -89.92 144.69 31.87 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 170.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.34 168.59 4.79 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.158 2.572 . . . . 0.0 112.674 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.3 t -73.31 80.63 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -91.32 -29.47 17.11 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.894 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.6 tp -75.02 99.92 4.02 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 172.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -70.49 -24.6 62.88 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.551 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.3 -18.61 64.77 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.914 0.885 . . . . 0.0 112.305 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.9 tt -61.12 -24.89 66.6 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.875 0.87 . . . . 0.0 110.299 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -54.56 107.43 0.28 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.545 1.138 . . . . 0.0 110.404 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.5 p -136.53 127.8 28.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.764 0.825 . . . . 0.0 110.62 -173.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -135.56 116.95 14.67 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.15 0.98 . . . . 0.0 109.032 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.579 ' H ' HG13 ' A' ' 7' ' ' ILE . . . -88.64 70.05 2.64 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -93.44 -173.72 3.29 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.729 0.811 . . . . 0.0 110.03 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.92 28.64 73.82 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.63 95.44 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.195 1.398 . . . . 0.0 111.269 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -153.16 140.16 19.24 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.504 -175.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 116.74 145.23 8.15 Favored Glycine 0 C--O 1.24 0.499 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -150.79 165.83 32.35 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 123.627 0.771 . . . . 0.0 110.513 -169.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.69 102.35 0.34 Allowed Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 CA--C 1.559 1.325 0 C-N-CA 124.286 1.034 . . . . 0.0 111.318 -178.094 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.51 156.77 9.42 Favored Glycine 0 C--N 1.345 1.03 0 C-N-CA 121.565 -0.35 . . . . 0.0 113.784 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -163.86 126.79 2.55 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.068 1.347 . . . . 0.0 108.874 173.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.1 mmt 61.77 28.2 17.31 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.849 1.26 . . . . 0.0 112.628 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -73.49 -8.83 57.54 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.896 0.878 . . . . 0.0 111.163 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.6 mt -69.74 96.16 0.95 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.469 1.107 . . . . 0.0 110.785 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.83 -42.8 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.346 1.058 . . . . 0.0 108.398 174.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.2 t -77.36 100.49 5.95 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 123.76 0.824 . . . . 0.0 109.609 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.0 mtt -134.69 161.25 35.68 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.319 1.048 . . . . 0.0 109.935 -175.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -79.13 111.22 15.13 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.435 HG23 ' HB ' ' A' ' 53' ' ' ILE . 61.6 t -86.78 127.93 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.702 0.801 . . . . 0.0 110.781 -175.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -108.82 123.02 48.39 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.323 1.449 . . . . 0.0 109.167 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 87.1 tttt -80.94 90.13 5.92 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.2 -95.58 0.59 Allowed Glycine 0 C--N 1.342 0.914 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.329 -173.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -117.65 -10.52 10.55 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.918 0.887 . . . . 0.0 111.887 -176.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.423 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 11.3 pt-20 -90.87 146.61 23.78 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.4 t -81.67 102.28 10.6 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -76.32 -55.64 5.37 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.443 0.697 . . . . 0.0 111.14 -172.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.557 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 178.75 -137.26 3.16 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-O 120.066 -0.297 . . . . 0.0 112.513 -177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -145.2 136.53 25.07 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.062 0.945 . . . . 0.0 109.68 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 31.6 p -76.85 118.25 19.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.729 0.812 . . . . 0.0 110.161 175.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.04 -35.05 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.965 0.906 . . . . 0.0 109.82 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -150.09 175.34 11.82 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.963 0.505 . . . . 0.0 110.455 -173.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.443 ' HB ' HD11 ' A' ' 29' ' ' LEU . 7.1 p -152.8 139.34 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.503 1.121 . . . . 0.0 108.773 171.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -141.46 127.12 19.04 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.99 -106.37 0.98 Allowed Glycine 0 CA--C 1.531 1.068 0 O-C-N 123.514 0.509 . . . . 0.0 113.733 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -109.81 15.12 22.92 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.154 0.982 . . . . 0.0 111.709 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.588 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 96.9 m-85 -135.16 113.82 11.74 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 118.302 0.501 . . . . 0.0 111.888 -172.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.443 HD11 ' HB ' ' A' ' 24' ' ' VAL . 42.8 tp -80.29 111.81 17.03 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.909 1.283 . . . . 0.0 109.367 172.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.6 mm -71.77 99.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.343 0.657 . . . . 0.0 109.72 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 47.6 t -100.34 112.42 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.762 0.825 . . . . 0.0 109.046 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -89.3 123.05 33.14 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.557 HG12 ' HA3' ' A' ' 19' ' ' GLY . 1.3 m -128.08 133.33 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 173.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.81 -91.64 0.05 OUTLIER Glycine 0 N--CA 1.474 1.171 0 C-N-CA 123.287 0.47 . . . . 0.0 113.82 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 t -125.03 -13.26 6.86 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.308 1.043 . . . . 0.0 112.039 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -111.25 156.13 21.94 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -170.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -104.39 108.77 20.35 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 172.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.23 104.53 14.67 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.588 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -83.55 93.99 7.96 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.413 HG11 ' CE2' ' A' ' 58' ' ' PHE . 3.9 m -78.04 137.34 61.34 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.499 ' HG2' ' HB2' ' A' ' 44' ' ' SER . 31.1 Cg_endo -62.37 138.43 71.19 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.241 1.961 . . . . 0.0 111.287 175.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.505 ' HA ' HD11 ' A' ' 45' ' ' ILE . 14.5 mmmm -62.75 -29.94 71.06 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.653 0.781 . . . . 0.0 111.528 -177.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -70.82 -18.24 62.73 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.028 0.931 . . . . 0.0 112.244 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.499 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 26.0 t -72.55 -27.12 62.03 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.918 0.487 . . . . 0.0 111.186 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.505 HD11 ' HA ' ' A' ' 42' ' ' LYS . 1.6 mp -61.98 115.5 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.811 0.444 . . . . 0.0 110.25 -176.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -76.41 -47.69 22.34 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.326 1.05 . . . . 0.0 110.599 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.9 m -143.45 124.69 14.58 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.136 0.574 . . . . 0.0 110.676 -173.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.0 t -93.21 109.24 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 166.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.653 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 16.3 mm-40 -108.53 165.71 11.32 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.125 1.37 . . . . 0.0 108.607 174.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.08 99.48 1.11 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.829 0.452 . . . . 0.0 110.453 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.7 14.12 73.85 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.201 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.653 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 28.3 mtm180 -142.83 125.51 15.92 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.172 0.989 . . . . 0.0 108.761 -175.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.435 ' HB ' HG23 ' A' ' 11' ' ' VAL . 34.8 mm -118.86 101.2 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 63.8 t -84.26 117.57 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.429 HG22 HG13 ' A' ' 45' ' ' ILE . 12.9 pt -109.74 164.56 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.876 0.871 . . . . 0.0 109.648 176.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.59 -87.65 1.36 Allowed Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 -173.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -142.95 144.42 32.36 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.113 0.965 . . . . 0.0 108.95 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.413 ' CE2' HG11 ' A' ' 40' ' ' VAL . 6.1 p90 -167.19 150.97 6.6 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -87.14 99.7 12.12 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.66 -29.54 69.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.186 0.994 . . . . 0.0 112.707 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.83 -42.72 85.34 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.971 0.415 . . . . 0.0 110.188 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.72 -37.5 82.32 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.26 -24.6 65.81 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.042 0.937 . . . . 0.0 111.379 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.63 -46.36 38.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.47 1.108 . . . . 0.0 110.216 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.36 -37.95 74.7 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 123.237 0.335 . . . . 0.0 111.259 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 39' ' ' ALA . 4.3 pp -82.26 -16.28 50.05 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-O 120.647 0.26 . . . . 0.0 110.441 175.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -76.55 -35.95 39.77 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.653 173.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -77.89 -21.96 50.47 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 172.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -65.0 -35.62 81.79 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 169.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.448 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 59.9 t90 -59.89 -51.49 69.49 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 123.395 0.434 . . . . 0.0 109.87 170.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.4 mt -49.49 -38.63 30.87 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 123.616 0.766 . . . . 0.0 111.504 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -71.42 -52.31 19.25 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.55 1.14 . . . . 0.0 111.593 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 70' ' ' TRP . 12.8 pt-20 -76.52 -22.8 53.94 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.158 0.583 . . . . 0.0 112.365 -170.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.14 -23.58 23.61 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.3 t -75.98 79.78 2.85 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-O 121.791 0.805 . . . . 0.0 109.177 175.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -81.32 147.08 59.41 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.455 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.25 -167.73 0.3 Allowed 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.854 2.369 . . . . 0.0 112.208 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -61.19 -33.22 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.116 0.566 . . . . 0.0 112.03 -176.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t -65.99 87.2 0.1 Allowed 'General case' 0 C--N 1.365 1.259 0 CA-C-O 122.49 1.138 . . . . 0.0 110.03 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.409 ' HB3' ' H ' ' A' ' 83' ' ' LEU . 13.2 mt -137.67 117.13 12.85 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.591 -174.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -64.84 -18.5 65.19 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.182 163.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.45 -47.85 71.8 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.392 1.077 . . . . 0.0 110.471 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.409 ' H ' ' HB3' ' A' ' 80' ' ' LEU . 3.3 tm? -67.93 -44.78 76.07 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -80.99 76.58 7.94 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.348 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.5 m -137.46 147.98 45.74 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.076 0.95 . . . . 0.0 109.628 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -76.85 92.39 3.62 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.04 -140.32 18.43 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.458 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 70.48 3.96 4.73 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.179 1.392 . . . . 0.0 113.776 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.99 30.49 2.03 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 175.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.23 70.23 5.58 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.541 1.162 . . . . 0.0 109.54 -177.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -162.78 168.7 21.05 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.868 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.07 90.44 0.18 Allowed Glycine 0 C--N 1.338 0.651 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -76.23 -29.65 57.62 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.253 0.549 . . . . 0.0 110.14 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 144.51 -35.13 1.56 Allowed Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 -175.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.245 0.852 0 C-N-CA 124.874 1.27 . . . . 0.0 108.227 173.556 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.86 -145.49 4.18 Favored Glycine 0 C--N 1.344 0.974 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -158.0 108.04 2.13 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.219 0.608 . . . . 0.0 109.493 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.0 tpp -100.15 55.52 0.92 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 174.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -75.68 -1.72 26.1 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.588 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.4 mp -63.72 -23.71 67.48 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.522 1.129 . . . . 0.0 110.542 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.8 tt -68.03 -33.43 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.223 0.609 . . . . 0.0 110.773 174.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 21' ' ' SER . 42.1 t -88.0 57.97 4.58 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.579 0.704 . . . . 0.0 110.075 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.426 ' SD ' ' HA2' ' A' ' 51' ' ' GLY . 42.1 tpp -100.68 147.13 26.35 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.338 1.055 . . . . 0.0 108.618 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -69.9 128.96 38.2 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.0 t -100.21 139.06 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.228 0.611 . . . . 0.0 110.31 -177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -130.1 127.54 40.05 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.205 1.402 . . . . 0.0 108.89 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -76.96 96.27 4.33 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.07 -95.25 0.34 Allowed Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -168.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -117.58 -23.45 7.66 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.746 0.818 . . . . 0.0 111.783 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -79.99 145.2 32.67 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.7 t -71.52 111.12 6.56 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.843 0.354 . . . . 0.0 110.586 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -83.91 -55.66 4.11 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.334 0.654 . . . . 0.0 109.729 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.28 -131.41 1.43 Allowed Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.827 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -148.82 137.12 21.03 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.202 1.401 . . . . 0.0 108.022 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 43.3 t -74.11 135.25 42.91 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 174.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.79 -35.42 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.761 0.824 . . . . 0.0 109.541 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -151.4 165.8 33.0 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.267 0.627 . . . . 0.0 110.205 -173.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.406 ' HB ' HD13 ' A' ' 29' ' ' LEU . 7.1 p -147.91 132.47 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.115 0.966 . . . . 0.0 108.461 169.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -141.1 138.98 33.91 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.55 -105.37 0.97 Allowed Glycine 0 CA--C 1.528 0.865 0 O-C-N 123.226 0.329 . . . . 0.0 112.527 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -120.07 5.25 10.84 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.71 0.804 . . . . 0.0 111.644 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -115.66 119.22 35.39 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.174 0.59 . . . . 0.0 111.53 -169.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.406 HD13 ' HB ' ' A' ' 24' ' ' VAL . 30.1 tp -79.52 109.14 13.62 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.871 0.868 . . . . 0.0 108.921 171.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.1 mm -73.53 104.39 2.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.3 t -99.52 112.56 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.952 0.901 . . . . 0.0 109.74 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -75.92 107.29 8.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.676 0.791 . . . . 0.0 109.2 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -91.8 155.92 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 167.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -44.98 -28.35 1.76 Allowed Glycine 0 CA--C 1.541 1.688 0 N-CA-C 116.258 1.263 . . . . 0.0 116.258 -172.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.9 p -96.16 -47.52 6.02 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.649 0.779 . . . . 0.0 112.339 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -143.1 -175.07 4.38 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.285 0.634 . . . . 0.0 111.714 -164.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.434 ' HB2' HD22 ' A' ' 71' ' ' LEU . 38.1 m-85 -115.43 109.84 18.44 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.097 0.959 . . . . 0.0 108.792 175.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.62 115.07 27.18 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.268 1.027 . . . . 0.0 108.467 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.472 ' HB2' HD12 ' A' ' 66' ' ' LEU . . . -82.2 92.96 6.98 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.409 0.623 . . . . 0.0 109.77 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.7 t -85.84 118.43 70.54 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.322 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.502 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 43.2 Cg_endo -62.07 148.66 92.75 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.215 1.943 . . . . 0.0 111.594 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.552 ' HA ' HD12 ' A' ' 45' ' ' ILE . 14.4 mmmm -66.1 -25.12 66.86 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.567 0.747 . . . . 0.0 112.04 -174.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.502 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 15.1 ptmm? -66.75 -23.38 66.08 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.894 0.878 . . . . 0.0 111.452 174.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.8 t -82.85 -30.11 28.9 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 123.034 0.534 . . . . 0.0 110.317 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.552 HD12 ' HA ' ' A' ' 42' ' ' LYS . 1.7 mp -62.77 114.05 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.264 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 174.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -85.68 -52.16 5.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.385 1.074 . . . . 0.0 110.161 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.0 m -144.22 154.24 42.91 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.059 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.19 109.37 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.429 1.092 . . . . 0.0 108.887 174.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.715 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 13.0 mm-40 -102.72 169.73 8.44 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.14 0.976 . . . . 0.0 109.644 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.87 93.63 1.35 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.952 0.501 . . . . 0.0 109.885 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.426 ' HA2' ' SD ' ' A' ' 9' ' ' MET . . . 93.32 2.77 65.59 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.261 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.715 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 92.7 mtt180 -133.6 141.19 47.55 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.355 0.662 . . . . 0.0 110.166 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.2 mm -118.16 103.72 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 168.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.7 t -76.7 113.78 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.434 HG23 HG13 ' A' ' 45' ' ' ILE . 31.4 pt -109.2 156.95 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.299 0.64 . . . . 0.0 109.492 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.67 -140.22 6.72 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.382 -168.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -78.49 123.03 26.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.389 0.676 . . . . 0.0 111.183 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -158.84 148.63 19.24 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 125.111 1.365 . . . . 0.0 108.035 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -72.19 101.75 2.89 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.18 -28.99 64.63 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.894 0.878 . . . . 0.0 112.154 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -72.21 -39.45 68.54 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.728 0.775 . . . . 0.0 110.094 176.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.19 -30.89 62.44 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.02 175.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.21 -25.02 64.11 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.271 0.629 . . . . 0.0 110.226 172.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -74.19 -41.12 61.94 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.486 0.714 . . . . 0.0 110.018 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.22 -42.22 69.19 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 118.128 0.422 . . . . 0.0 111.478 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 39' ' ' ALA . 4.5 pp -81.84 -14.54 56.14 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 120.839 0.352 . . . . 0.0 110.293 176.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -75.15 -44.4 23.22 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.469 171.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -28.57 63.17 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.318 0.559 . . . . 0.0 109.703 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -60.72 -39.66 89.42 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.619 170.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.517 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 86.1 t90 -59.46 -44.68 92.95 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.561 175.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.481 HD21 ' HE3' ' A' ' 70' ' ' TRP . 3.9 mm? -59.13 -32.15 69.6 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 176.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -72.75 -46.95 50.79 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.826 0.45 . . . . 0.0 110.391 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.533 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 12.6 pt-20 -77.71 -31.28 52.24 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -173.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -1.0 2.56 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -166.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.9 t -72.05 -3.96 26.01 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.462 0.705 . . . . 0.0 111.468 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 73' ' ' GLU . 28.5 mmtp -63.72 148.09 94.9 Favored Pre-proline 0 N--CA 1.484 1.272 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 169.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.5 139.8 66.24 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 121.974 1.783 . . . . 0.0 111.964 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.9 p -68.77 -21.05 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.84 173.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.514 ' HB ' HD21 ' A' ' 83' ' ' LEU . 36.3 p 64.83 172.23 0.2 Allowed 'General case' 0 C--N 1.361 1.068 0 C-N-CA 126.839 2.056 . . . . 0.0 112.154 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -157.87 179.83 8.83 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.33 -172.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -23.96 63.71 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.419 0.688 . . . . 0.0 112.345 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -56.85 -39.89 75.11 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.171 0.989 . . . . 0.0 112.679 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.514 HD21 ' HB ' ' A' ' 79' ' ' THR . 2.7 pp -86.08 2.29 47.16 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -130.32 -169.97 2.24 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.147 0.579 . . . . 0.0 109.784 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.3 m -70.05 129.45 39.47 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -74.51 91.47 2.28 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.36 140.28 3.23 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.573 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -160.11 -42.24 0.05 OUTLIER 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.731 0.812 . . . . 0.0 108.907 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.78 64.9 2.44 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.795 -175.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -58.31 112.53 1.59 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.858 0.863 . . . . 0.0 111.544 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -109.41 91.97 3.86 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.774 0.83 . . . . 0.0 110.135 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.88 89.87 1.52 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 173.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.64 119.48 9.32 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.23 0.612 . . . . 0.0 110.552 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 111.45 -135.84 13.12 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -172.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.5 m . . . . . 0 C--O 1.252 1.207 0 C-N-CA 123.948 0.899 . . . . 0.0 108.685 177.907 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -60.79 98.3 0.15 Allowed Glycine 0 C--N 1.347 1.164 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -63.22 101.26 0.28 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.548 0.739 . . . . 0.0 110.192 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 69.1 mtm -84.79 105.83 15.87 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.15 84.17 0.53 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.396 0.617 . . . . 0.0 110.318 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.7 mt -77.53 -19.25 56.05 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.48 168.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 35.3 pt -79.22 157.5 4.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.675 1.59 . . . . 0.0 110.425 173.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.5 p -79.89 -36.8 35.99 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.804 0.441 . . . . 0.0 110.03 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.8 ttm -166.93 165.13 16.14 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.395 0.678 . . . . 0.0 109.793 -174.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -82.95 156.03 23.7 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.164 0.585 . . . . 0.0 109.737 170.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.453 HG21 ' HB ' ' A' ' 53' ' ' ILE . 81.3 t -121.7 129.72 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.986 0.915 . . . . 0.0 109.968 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 24.8 m-85 -119.8 121.28 38.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.787 1.235 . . . . 0.0 108.726 176.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -78.86 86.48 4.77 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.38 -96.57 0.64 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.879 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -105.82 -18.74 13.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.635 0.774 . . . . 0.0 111.579 -176.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -98.25 156.45 16.7 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.832 0.453 . . . . 0.0 110.332 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 t -81.69 119.67 24.14 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -93.69 -55.75 3.15 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.263 0.625 . . . . 0.0 110.78 -173.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.05 -151.63 7.95 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.201 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -135.1 123.22 22.85 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.425 0.69 . . . . 0.0 109.431 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.489 ' HB2' HD12 ' A' ' 29' ' ' LEU . 12.9 p -71.14 108.43 4.66 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -93.35 -39.15 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 123.507 0.723 . . . . 0.0 109.707 -177.441 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -142.97 166.22 25.22 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.468 0.707 . . . . 0.0 109.59 -175.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -152.27 130.27 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.792 0.837 . . . . 0.0 108.819 173.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -142.22 134.3 27.45 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.05 -106.71 1.18 Allowed Glycine 0 CA--C 1.531 1.073 0 O-C-N 123.441 0.463 . . . . 0.0 113.277 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -119.63 18.14 12.74 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.778 0.831 . . . . 0.0 111.234 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.574 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 55.4 m-85 -126.08 113.17 16.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.927 0.491 . . . . 0.0 111.21 -175.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 21' ' ' SER . 62.6 tp -82.61 108.08 15.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.0 0.92 . . . . 0.0 109.219 171.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.2 mm -71.54 106.08 2.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.19 119.72 59.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.574 0.75 . . . . 0.0 109.861 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -74.31 109.18 7.59 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.285 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.6 m -116.15 103.19 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.521 1.128 . . . . 0.0 110.62 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.46 -89.03 0.05 OUTLIER Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.179 -0.919 . . . . 0.0 113.911 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.2 p -85.76 -41.19 15.3 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.222 1.009 . . . . 0.0 111.909 -174.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -150.03 -175.45 5.06 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -165.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -104.17 111.61 24.28 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.457 1.103 . . . . 0.0 110.686 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.1 mp -104.38 127.43 52.04 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -86.32 93.63 9.14 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.001 -175.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -72.14 115.54 39.66 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.586 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.5 149.97 89.14 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.735 2.29 . . . . 0.0 112.09 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.55 ' HA ' HD12 ' A' ' 45' ' ' ILE . 14.5 mmmm -67.26 -16.87 64.53 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -65.5 -30.9 71.72 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.085 0.554 . . . . 0.0 110.816 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.503 ' HB2' ' HB3' ' A' ' 58' ' ' PHE . 37.3 t -76.68 -32.62 58.03 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.649 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 42' ' ' LYS . 1.8 mp -63.75 114.62 2.06 Favored 'Isoleucine or valine' 0 C--N 1.359 0.98 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -95.57 -53.55 3.69 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.36 1.064 . . . . 0.0 110.771 -172.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.0 t -150.09 134.26 17.13 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 122.998 0.519 . . . . 0.0 110.003 -173.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 p -98.66 111.75 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.466 0.65 . . . . 0.0 110.178 177.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.647 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 30.6 mm-40 -103.81 173.11 6.44 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.159 0.984 . . . . 0.0 111.07 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.31 101.06 1.43 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.153 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.76 12.5 83.49 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.446 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.647 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 61.5 mtp180 -141.42 135.7 30.63 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.645 0.778 . . . . 0.0 110.044 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.453 ' HB ' HG21 ' A' ' 11' ' ' VAL . 30.8 mm -109.11 103.04 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 167.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 96.8 t -78.36 112.06 15.92 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.6 pt -112.01 177.7 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.648 0.779 . . . . 0.0 109.826 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.05 -146.18 7.43 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 172.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.25 165.91 21.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.063 0.545 . . . . 0.0 110.072 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.503 ' HB3' ' HB2' ' A' ' 44' ' ' SER . 29.1 p90 -167.0 174.04 8.75 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.867 0.867 . . . . 0.0 109.209 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.14 86.28 1.38 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -70.86 -36.51 72.85 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.612 1.165 . . . . 0.0 112.417 -171.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -71.08 -33.83 70.58 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.045 0.538 . . . . 0.0 110.154 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -71.38 -40.56 70.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.093 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.98 -28.05 69.55 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.834 0.854 . . . . 0.0 111.303 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.36 -48.96 20.61 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.253 1.021 . . . . 0.0 110.414 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.09 -40.32 78.48 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.633 0.373 . . . . 0.0 111.561 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 pp -82.61 -17.18 45.68 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 122.185 -0.322 . . . . 0.0 110.441 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.05 -44.07 46.55 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.346 0.404 . . . . 0.0 112.362 174.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -71.02 -30.72 67.0 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 39.4 ttmt -62.2 -42.33 99.19 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.447 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 53.2 t90 -58.23 -44.97 88.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.889 0.743 . . . . 0.0 110.672 176.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.8 mt -57.54 -28.58 63.64 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.298 0.639 . . . . 0.0 111.686 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -82.87 -35.87 25.86 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.086 0.554 . . . . 0.0 111.242 172.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 44.3 mt-10 -65.86 -22.8 66.56 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 124.44 1.096 . . . . 0.0 111.217 -178.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 70' ' ' TRP . 27.3 mtpp -65.15 -38.66 91.29 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.5 172.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.7 t -85.27 -30.05 24.1 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.773 0.829 . . . . 0.0 111.145 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -84.42 154.49 62.68 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 123.893 0.877 . . . . 0.0 110.72 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.03 136.07 33.94 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 121.973 1.782 . . . . 0.0 109.875 163.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.4 p -64.71 93.31 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 CA-C-O 121.858 0.837 . . . . 0.0 109.87 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.4 t -80.54 76.89 7.38 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.813 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.8 tp -151.33 137.97 18.78 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.556 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.53 0.99 7.61 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.141 0.977 . . . . 0.0 111.132 176.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -66.46 -30.58 70.96 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.949 0.5 . . . . 0.0 111.389 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -66.39 -30.9 71.37 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.56 0.344 . . . . 0.0 110.577 173.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? 58.59 30.13 19.41 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.031 1.332 . . . . 0.0 111.228 172.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.7 t -88.44 98.42 11.62 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.477 -169.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -96.01 -61.05 1.51 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.173 0.589 . . . . 0.0 109.883 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.4 -58.53 0.09 OUTLIER Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.79 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 59.75 19.2 7.97 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.83 0.852 . . . . 0.0 111.676 -172.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -140.18 38.1 1.63 Allowed Glycine 0 C--N 1.343 0.919 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -128.78 106.75 9.14 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 113.902 -1.149 . . . . 0.0 109.76 -169.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -89.18 90.72 8.49 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -164.72 80.87 0.12 Allowed Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.61 -59.77 4.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.807 0.843 . . . . 0.0 110.223 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -87.87 73.57 2.3 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.137 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.7 m . . . . . 0 C--O 1.254 1.292 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.915 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.633 0.254 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.29 -173.62 41.01 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 116.124 -0.489 . . . . 0.0 113.223 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -140.89 -167.32 2.34 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.12 0.968 . . . . 0.0 109.683 -175.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.3 mtp -74.61 -179.07 3.88 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.357 0.663 . . . . 0.0 110.815 171.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.85 -18.25 26.56 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -170.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.5 -20.14 26.95 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.918 0.487 . . . . 0.0 111.909 -173.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.2 tt -67.52 137.58 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.424 0.69 . . . . 0.0 111.034 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 61.2 m -114.35 81.58 1.57 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.815 0.846 . . . . 0.0 109.652 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 71.1 mtm -70.23 154.06 42.36 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.791 0.836 . . . . 0.0 110.549 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -90.59 135.98 33.35 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.006 0.432 . . . . 0.0 111.165 -173.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.402 HG23 HG22 ' A' ' 31' ' ' VAL . 99.9 t -91.78 130.38 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.72 0.808 . . . . 0.0 109.719 -177.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -118.27 127.37 53.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.664 1.186 . . . . 0.0 109.576 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.504 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 28.5 tptp -78.26 91.16 4.37 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 172.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.97 -95.67 0.65 Allowed Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 -171.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.71 -21.48 7.85 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.421 0.689 . . . . 0.0 110.74 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 14.8 pt-20 -79.43 144.23 34.28 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.5 t -70.28 111.18 5.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.794 0.438 . . . . 0.0 110.345 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -82.32 -51.18 8.14 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.096 0.558 . . . . 0.0 110.531 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.458 ' HA3' HG11 ' A' ' 33' ' ' VAL . . . -179.55 -143.2 5.35 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.885 -177.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -136.96 133.52 35.71 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.72 0.808 . . . . 0.0 109.956 -177.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.401 ' OG ' HD13 ' A' ' 29' ' ' LEU . 30.2 t -75.02 106.5 6.55 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 172.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.27 -40.82 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.294 0.638 . . . . 0.0 109.313 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 22.8 t70 -149.14 172.22 15.16 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.372 0.669 . . . . 0.0 109.815 -171.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.9 p -152.1 145.17 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 124.334 1.054 . . . . 0.0 108.538 172.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -143.12 127.22 17.46 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 171.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.2 -106.86 1.12 Allowed Glycine 0 C--N 1.343 0.938 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.728 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 28.7 t70 -107.05 -15.18 14.75 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.071 0.948 . . . . 0.0 111.114 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.48 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 95.3 m-85 -97.34 107.56 20.1 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.558 0.695 . . . . 0.0 111.186 -171.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.401 HD13 ' OG ' ' A' ' 21' ' ' SER . 41.7 tp -76.31 113.29 13.72 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.956 174.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 49.7 mm -75.44 107.77 6.6 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.015 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.402 HG22 HG23 ' A' ' 11' ' ' VAL . 43.0 t -103.76 113.63 41.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 123.992 0.917 . . . . 0.0 109.314 178.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -75.94 114.99 15.19 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.458 HG11 ' HA3' ' A' ' 19' ' ' GLY . 34.1 m -127.45 129.84 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.959 0.904 . . . . 0.0 109.36 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.9 -100.11 0.27 Allowed Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.848 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.6 p -126.1 5.15 7.16 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.214 1.005 . . . . 0.0 112.008 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -134.21 169.65 16.87 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.154 0.582 . . . . 0.0 112.164 -173.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -112.9 123.87 51.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.364 1.065 . . . . 0.0 109.457 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.8 mp -107.22 115.61 30.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.964 0.906 . . . . 0.0 109.008 175.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -78.97 93.63 5.11 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.786 0.835 . . . . 0.0 109.724 177.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.45 HG13 ' CE2' ' A' ' 58' ' ' PHE . 4.0 m -89.04 134.5 33.21 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -176.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 97.9 Cg_endo -73.45 153.05 49.84 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.254 1.969 . . . . 0.0 111.242 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.558 ' HA ' HD11 ' A' ' 45' ' ' ILE . 13.8 mmmm -65.77 -24.28 66.91 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.465 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 7.8 ptpp? -66.38 -25.83 66.97 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.713 0.405 . . . . 0.0 111.361 173.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.3 t -69.1 -41.22 77.75 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.558 HD11 ' HA ' ' A' ' 42' ' ' LYS . 2.7 mp -66.71 114.49 3.69 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -78.71 -48.79 14.25 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.474 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.2 t -158.46 139.53 13.11 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.301 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 p -77.89 133.18 31.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 168.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.787 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 17.8 mm-40 -116.23 177.58 4.64 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.187 0.995 . . . . 0.0 110.04 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -64.02 93.14 0.08 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.858 0.863 . . . . 0.0 110.463 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.86 5.72 88.66 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 114.906 -1.043 . . . . 0.0 114.213 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.787 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 69.9 mtt85 -127.71 162.21 27.1 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.079 0.552 . . . . 0.0 110.728 -174.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.0 mm -133.27 103.34 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 174.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.5 t -83.45 120.64 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.0 pt -109.06 145.21 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 123.943 0.897 . . . . 0.0 109.174 170.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.26 -55.03 1.88 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 112.135 -0.386 . . . . 0.0 112.135 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.405 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 9.9 pt-20 -174.03 159.27 3.26 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.949 0.9 . . . . 0.0 110.552 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.45 ' CE2' HG13 ' A' ' 40' ' ' VAL . 8.1 p90 -171.11 174.18 4.75 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.463 0.705 . . . . 0.0 110.779 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -74.44 86.51 2.03 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.495 0.718 . . . . 0.0 109.483 172.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.15 -38.73 72.22 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.285 0.634 . . . . 0.0 112.669 -174.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.481 ' HG3' ' HG3' ' A' ' 62' ' ' GLU . 7.4 pt-20 -65.4 -38.24 89.37 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.491 0.717 . . . . 0.0 110.817 177.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.508 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 44.6 mt-10 -80.88 -32.79 34.74 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.809 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.75 -26.31 66.92 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.276 0.631 . . . . 0.0 110.611 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -72.69 -51.87 17.54 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.243 1.017 . . . . 0.0 111.179 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.7 pt-20 -69.84 -35.74 74.99 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.311 0.577 . . . . 0.0 110.809 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.22 -13.79 54.64 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.66 -27.53 69.09 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 165.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -69.96 -37.44 75.81 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.83 0.852 . . . . 0.0 108.854 167.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -59.59 -36.52 76.42 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 122.912 0.485 . . . . 0.0 110.875 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.544 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 59.7 t90 -60.95 -54.21 47.79 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 173.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.7 mt -54.92 -35.11 63.81 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.48 0.712 . . . . 0.0 111.447 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.16 -35.44 66.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.224 1.01 . . . . 0.0 110.452 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -77.07 -23.67 51.94 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.818 0.447 . . . . 0.0 109.864 175.342 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 70' ' ' TRP . 31.1 mmmt -68.74 -5.95 23.52 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.746 0.418 . . . . 0.0 111.097 171.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.4 m 69.94 40.07 1.32 Allowed 'General case' 0 C--N 1.354 0.762 0 C-N-CA 125.001 1.32 . . . . 0.0 110.251 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.508 ' HB3' HD11 ' A' ' 83' ' ' LEU . 71.2 mmtt -59.99 131.97 89.51 Favored Pre-proline 0 C--N 1.355 0.843 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.048 173.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.46 138.98 68.29 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.507 2.138 . . . . 0.0 112.809 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 84' ' ' LYS . 34.3 m -76.62 10.22 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 C-N-CA 124.156 0.982 . . . . 0.0 112.356 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.4 m -51.85 -42.92 62.98 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.414 1.086 . . . . 0.0 111.592 176.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.64 135.17 48.19 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 171.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -66.42 -39.87 89.19 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 123.457 0.473 . . . . 0.0 110.955 -173.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -62.41 -37.1 84.52 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.702 0.801 . . . . 0.0 111.06 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 76' ' ' LYS . 1.5 tt -77.9 -22.6 49.45 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.986 0.914 . . . . 0.0 110.203 -176.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.618 ' HB2' ' HZ1' ' A' ' 84' ' ' LYS . 4.4 ttmp? -72.03 -10.78 60.25 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.704 0.802 . . . . 0.0 112.419 -176.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.9 p -63.39 92.07 0.06 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.117 0.567 . . . . 0.0 110.944 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -73.96 124.18 25.7 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.15 0.98 . . . . 0.0 108.92 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -81.76 -78.66 0.98 Allowed Glycine 0 C--N 1.339 0.747 0 O-C-N 123.349 0.406 . . . . 0.0 112.147 -176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -139.06 -59.53 0.59 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.681 0.792 . . . . 0.0 110.792 -171.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.04 62.34 0.17 Allowed Glycine 0 C--N 1.339 0.726 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -173.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -96.46 -9.36 29.92 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.598 0.759 . . . . 0.0 111.042 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -123.45 122.27 37.82 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.29 -92.74 0.09 OUTLIER Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 58.68 28.38 17.15 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.59 1.156 . . . . 0.0 112.512 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.51 -158.38 17.95 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.674 -0.693 . . . . 0.0 113.21 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.7 m . . . . . 0 C--O 1.251 1.134 0 C-N-CA 123.007 0.523 . . . . 0.0 110.24 178.229 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.678 0.275 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.19 18.56 49.48 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 113.648 176.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -109.98 96.23 6.1 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.631 0.772 . . . . 0.0 109.018 177.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.429 ' SD ' ' N ' ' A' ' 4' ' ' MET . 1.4 mpt? -82.05 95.62 7.5 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.58 0.752 . . . . 0.0 109.512 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -82.27 -5.4 58.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.616 0.766 . . . . 0.0 111.332 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.6 12.9 11.4 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.889 0.876 . . . . 0.0 110.574 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.0 tp -72.27 154.74 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 C-N-CA 123.841 0.856 . . . . 0.0 110.701 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 80.6 m -67.75 88.57 0.25 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.195 0.598 . . . . 0.0 109.628 174.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.413 ' SD ' HD11 ' A' ' 53' ' ' ILE . 61.0 mtt -70.52 141.66 51.9 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.093 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -84.28 130.33 34.82 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.403 0.681 . . . . 0.0 109.475 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.0 t -86.62 115.24 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.076 0.55 . . . . 0.0 109.937 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.64 117.58 35.19 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.116 0.967 . . . . 0.0 109.692 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 85.3 tttt -77.94 94.41 4.58 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.12 -94.85 0.47 Allowed Glycine 0 C--N 1.344 1.002 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -102.5 -42.91 5.8 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.735 0.814 . . . . 0.0 110.824 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.35 145.42 37.33 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.959 0.504 . . . . 0.0 110.935 -168.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.7 t -69.8 104.87 2.58 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.456 ' HB2' ' HB2' ' A' ' 13' ' ' LYS . 46.9 t80 -74.95 -50.05 18.02 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.713 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.73 -141.4 3.94 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.82 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -140.18 130.73 25.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.371 0.668 . . . . 0.0 110.221 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.406 ' OG ' HD13 ' A' ' 29' ' ' LEU . 25.9 t -68.07 109.96 3.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.155 0.982 . . . . 0.0 109.542 174.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.05 -43.71 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.028 0.531 . . . . 0.0 109.851 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.426 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 22.6 t70 -143.35 167.61 21.75 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.74 0.416 . . . . 0.0 110.466 -171.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.2 t -139.71 140.97 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 124.421 1.089 . . . . 0.0 108.133 174.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.404 ' HH ' HD11 ' A' ' 66' ' ' LEU . 1.8 p90 -141.39 129.91 22.61 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 169.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.36 -107.4 1.35 Allowed Glycine 0 C--N 1.35 1.326 0 O-C-N 123.304 0.378 . . . . 0.0 113.268 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -119.21 24.53 10.7 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.55 0.74 . . . . 0.0 110.918 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.502 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 96.0 m-85 -133.39 124.85 27.9 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.247 0.619 . . . . 0.0 111.375 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.406 HD13 ' OG ' ' A' ' 21' ' ' SER . 55.8 tp -80.55 113.99 19.13 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.406 1.083 . . . . 0.0 109.562 170.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 42.8 mm -72.74 106.07 2.69 Favored 'Isoleucine or valine' 0 C--O 1.249 1.063 0 C-N-CA 123.234 0.614 . . . . 0.0 109.51 175.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.0 t -103.28 118.42 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.151 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -74.97 116.87 16.18 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 m -126.05 99.2 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.953 0.901 . . . . 0.0 110.614 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.29 -89.53 0.1 Allowed Glycine 0 CA--C 1.531 1.073 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.873 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 72.5 p -114.91 -21.99 9.83 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.121 0.968 . . . . 0.0 111.272 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -109.07 174.44 5.87 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.647 0.737 . . . . 0.0 111.363 -172.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -120.96 108.6 14.07 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.238 173.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -96.66 106.07 18.28 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.502 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -82.83 93.33 7.44 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.297 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.6 m -77.67 136.7 63.2 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.539 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 35.8 Cg_endo -62.4 149.37 91.06 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 121.905 1.737 . . . . 0.0 111.289 176.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.541 ' HA ' HD12 ' A' ' 45' ' ' ILE . 32.0 mmmt -63.59 -26.21 68.58 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.013 0.525 . . . . 0.0 111.8 -178.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.578 ' HB3' ' HZ1' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -67.71 -23.43 65.28 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.677 0.791 . . . . 0.0 111.449 175.725 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -72.3 -27.36 62.41 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.784 0.434 . . . . 0.0 110.616 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 42' ' ' LYS . 2.1 mp -67.91 115.65 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -92.03 -48.54 6.69 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.254 1.022 . . . . 0.0 110.974 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.1 t -138.49 147.63 43.4 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.402 -175.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.5 p -122.0 126.05 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.357 1.063 . . . . 0.0 109.099 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 40.5 mt-10 -138.11 168.54 19.52 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.286 1.035 . . . . 0.0 109.537 -175.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.72 99.87 0.25 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.124 0.57 . . . . 0.0 110.432 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.15 1.06 88.65 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 115.905 -0.589 . . . . 0.0 113.643 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.539 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 33.7 mtm180 -130.97 124.94 32.09 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.514 0.657 . . . . 0.0 110.284 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.413 HD11 ' SD ' ' A' ' 9' ' ' MET . 50.8 mm -115.06 102.14 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 170.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.9 t -86.11 115.23 27.02 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.7 pt -107.04 175.14 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 123.569 0.747 . . . . 0.0 109.357 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.04 -142.88 8.21 Favored Glycine 0 C--O 1.24 0.507 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -81.56 157.12 24.89 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 174.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -167.37 170.66 11.27 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.892 0.877 . . . . 0.0 109.201 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -81.16 93.52 6.47 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -71.23 -39.94 71.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.074 0.95 . . . . 0.0 112.74 -171.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -65.34 -37.88 88.41 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.009 0.433 . . . . 0.0 110.491 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -71.9 -37.64 70.09 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.568 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.12 -34.32 77.35 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.508 0.723 . . . . 0.0 111.333 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 6.7 ptp85 -74.39 -44.72 50.87 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 119.112 -0.47 . . . . 0.0 111.157 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.98 -37.57 86.32 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 118.275 0.489 . . . . 0.0 111.602 -175.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.404 HD11 ' HH ' ' A' ' 25' ' ' TYR . 4.0 pp -81.63 -21.15 38.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 122.478 0.311 . . . . 0.0 110.399 176.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.43 -33.78 68.15 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.039 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 64' ' ' ARG . 59.0 mtp180 -77.41 -30.55 53.55 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.359 1.064 . . . . 0.0 109.853 175.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -63.28 -39.51 94.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.141 0.576 . . . . 0.0 109.715 170.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -60.24 -45.36 93.52 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.985 0.514 . . . . 0.0 109.917 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.456 HD11 ' HA ' ' A' ' 68' ' ' ARG . 50.4 mt -58.53 -23.41 58.18 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.797 0.839 . . . . 0.0 112.517 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -83.65 -53.4 5.68 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.706 0.402 . . . . 0.0 110.728 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.85 -15.37 60.23 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.991 0.916 . . . . 0.0 113.379 -170.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -57.33 -14.42 4.56 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.204 1.001 . . . . 0.0 112.947 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -64.63 4.85 0.35 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.288 1.435 . . . . 0.0 114.412 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.85 145.43 96.78 Favored Pre-proline 0 CA--C 1.551 1.009 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.58 137.73 60.96 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.106 1.871 . . . . 0.0 111.044 175.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.2 p -79.76 64.51 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 CA-C-O 123.209 1.48 . . . . 0.0 110.084 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.0 t -87.98 -11.24 48.0 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.315 177.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.457 HD22 ' HB2' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -79.21 81.93 5.42 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.017 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.47 -24.43 61.18 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.804 1.242 . . . . 0.0 110.949 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.99 -29.02 67.95 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.951 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.457 ' HB2' HD22 ' A' ' 80' ' ' LEU . 6.6 tt -70.13 -39.0 75.69 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -60.99 -70.61 0.17 Allowed 'General case' 0 C--N 1.353 0.739 0 O-C-N 123.835 0.709 . . . . 0.0 109.929 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.1 p -93.02 62.22 3.56 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.496 0.718 . . . . 0.0 109.532 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -71.43 127.21 31.82 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.057 -172.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.83 79.82 0.96 Allowed Glycine 0 C--N 1.35 1.358 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.331 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -133.99 -49.5 0.81 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.563 1.145 . . . . 0.0 108.177 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.02 136.43 8.82 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.734 173.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -66.49 115.13 6.04 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.46 111.94 3.82 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.333 176.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.06 -34.85 51.33 Favored Glycine 0 C--N 1.342 0.904 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 174.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -114.44 28.15 8.95 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.259 1.024 . . . . 0.0 110.491 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.96 80.25 1.1 Allowed Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.487 -0.324 . . . . 0.0 113.741 -174.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--O 1.248 1.02 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.323 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.526 ' HB3' ' HB3' ' A' ' 88' ' ' PHE . 8.2 pm0 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.34 138.53 3.93 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.19 0.307 . . . . 0.0 112.505 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -81.62 106.54 13.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 172.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 83.3 mtp -74.94 95.63 3.01 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.6 0.76 . . . . 0.0 110.196 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -91.11 62.41 4.82 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.6 0.715 . . . . 0.0 109.923 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.51 0.09 10.96 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.73 0.812 . . . . 0.0 109.506 173.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.1 tt -69.14 120.56 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 123.501 0.721 . . . . 0.0 111.298 -173.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.0 p -171.36 143.49 1.85 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.019 1.328 . . . . 0.0 107.758 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.406 ' SD ' HD13 ' A' ' 53' ' ' ILE . 18.5 ttt -149.0 140.67 23.51 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 109.875 -0.416 . . . . 0.0 109.875 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -72.82 141.27 48.02 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.6 t -119.49 127.75 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.578 0.751 . . . . 0.0 110.02 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -109.35 132.91 53.68 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.228 1.011 . . . . 0.0 109.044 171.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -83.98 82.39 8.37 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.83 -100.58 0.85 Allowed Glycine 0 C--N 1.344 0.986 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.239 -177.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -97.16 -28.07 14.27 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.851 0.86 . . . . 0.0 110.879 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -92.15 152.31 19.96 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.811 0.444 . . . . 0.0 110.119 -176.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.1 t -74.16 125.14 27.71 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.305 0.642 . . . . 0.0 109.349 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -98.46 -58.59 1.93 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 121.957 0.103 . . . . 0.0 110.848 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.513 ' HA3' HG13 ' A' ' 33' ' ' VAL . . . 172.66 -141.43 6.22 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.413 0.446 . . . . 0.0 112.196 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -144.86 137.98 26.68 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.826 0.85 . . . . 0.0 110.13 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.7 p -73.61 118.2 16.28 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 175.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.21 -37.82 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.589 0.756 . . . . 0.0 109.042 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -156.27 176.83 12.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.977 0.511 . . . . 0.0 110.822 -175.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.4 p -150.17 138.28 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.46 1.104 . . . . 0.0 108.868 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -136.21 133.69 37.36 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.67 -106.62 1.22 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 123.463 0.477 . . . . 0.0 113.793 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -117.14 11.63 14.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.903 0.881 . . . . 0.0 111.026 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.558 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 81.8 m-85 -125.15 111.56 15.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.039 0.535 . . . . 0.0 111.549 -173.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 57.7 tp -77.82 110.35 12.62 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.507 1.123 . . . . 0.0 109.485 173.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.0 mm -71.94 100.11 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.26 0.624 . . . . 0.0 109.606 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.06 113.22 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.428 0.691 . . . . 0.0 109.787 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -76.24 120.05 20.98 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.669 0.787 . . . . 0.0 109.882 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.513 HG13 ' HA3' ' A' ' 19' ' ' GLY . 1.3 m -132.45 142.04 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.7 -96.21 0.03 OUTLIER Glycine 0 CA--C 1.537 1.456 0 O-C-N 123.274 0.359 . . . . 0.0 113.966 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.3 m -124.49 -16.39 6.34 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.509 1.124 . . . . 0.0 111.023 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -114.72 166.88 11.27 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.934 0.893 . . . . 0.0 112.149 -170.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -113.65 112.25 23.18 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.211 1.004 . . . . 0.0 109.751 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.55 105.95 17.92 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.932 0.893 . . . . 0.0 109.175 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.558 ' HB3' ' HB3' ' A' ' 28' ' ' TYR . . . -77.82 92.37 4.22 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 172.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.9 m -86.22 136.63 35.54 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.65 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.519 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 37.7 Cg_endo -63.33 151.28 85.68 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.221 1.947 . . . . 0.0 111.36 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.545 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.4 mmmm -67.3 -23.26 65.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.953 0.501 . . . . 0.0 111.457 -176.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.519 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 22.4 ptmt -69.61 -26.55 64.5 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.686 0.794 . . . . 0.0 111.457 174.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.3 t -65.35 -31.29 72.33 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.269 0.628 . . . . 0.0 110.604 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.545 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.0 mp -64.95 116.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HZ3' ' HB3' ' A' ' 46' ' ' LYS . 2.8 mmmp? -92.28 -52.1 4.84 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.153 0.981 . . . . 0.0 110.936 -177.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 t -148.83 139.87 23.02 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.566 -171.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.2 t -102.92 110.75 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 173.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.09 130.89 22.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 63.28 33.88 13.73 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.415 1.086 . . . . 0.0 112.944 166.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.92 15.98 80.71 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 121.316 0.398 . . . . 0.0 112.326 -177.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -125.15 158.21 34.48 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.68 1.192 . . . . 0.0 109.063 -175.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.406 HD13 ' SD ' ' A' ' 9' ' ' MET . 28.6 mm -120.47 104.91 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.634 0.774 . . . . 0.0 109.55 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.9 t -80.0 113.01 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.435 HG23 ' HA ' ' A' ' 45' ' ' ILE . 37.4 pt -109.49 142.75 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.79 -74.48 1.2 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -152.73 164.19 38.24 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.63 0.772 . . . . 0.0 109.685 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -170.51 163.89 8.43 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 124.377 1.071 . . . . 0.0 108.298 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -77.77 97.09 5.09 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.05 -35.99 82.92 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.589 0.756 . . . . 0.0 112.007 -174.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -62.6 -45.54 92.42 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.682 0.614 . . . . 0.0 110.484 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 35.1 mt-10 -70.29 -38.7 75.08 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.887 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.17 -38.55 91.46 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.569 0.748 . . . . 0.0 111.363 -176.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -74.41 -38.4 63.08 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.326 0.25 . . . . 0.0 111.582 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.8 pt-20 -76.75 -40.86 47.01 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -176.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 pp -82.47 -12.99 57.46 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.0 0.429 . . . . 0.0 109.996 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.99 -48.45 75.72 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 162.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.0 mtt-85 -63.48 -31.94 73.25 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.901 0.881 . . . . 0.0 111.511 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 22.8 ttmm -55.9 -48.78 75.01 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.115 0.566 . . . . 0.0 109.514 172.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.555 ' HE3' HD13 ' A' ' 71' ' ' LEU . 79.9 t90 -60.25 -42.56 95.57 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 123.309 0.38 . . . . 0.0 110.663 174.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.555 HD13 ' HE3' ' A' ' 70' ' ' TRP . 10.6 mp -57.0 -28.95 62.89 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 122.666 0.387 . . . . 0.0 112.027 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -77.91 -54.43 6.32 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 122.958 0.503 . . . . 0.0 110.285 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 33.7 mt-10 -76.45 -18.24 58.89 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.472 1.109 . . . . 0.0 113.04 -168.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -61.21 -19.19 61.35 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.356 0.662 . . . . 0.0 112.263 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.3 m -66.48 83.51 0.1 Allowed 'General case' 0 C--N 1.354 0.764 0 C-N-CA 124.378 1.071 . . . . 0.0 112.05 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -96.07 143.69 26.55 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.468 0.707 . . . . 0.0 109.145 167.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -80.22 -161.72 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.888 2.392 . . . . 0.0 113.103 -174.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.32 -29.95 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.339 0.656 . . . . 0.0 110.552 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.9 p -76.71 92.08 3.51 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 168.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.01 26.0 1.72 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.445 0.641 . . . . 0.0 109.779 174.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.67 -4.45 0.28 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.402 1.481 . . . . 0.0 114.191 177.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -49.41 -46.14 47.12 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 125.318 1.447 . . . . 0.0 113.246 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -84.91 -12.65 52.94 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 122.778 0.431 . . . . 0.0 111.022 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -74.75 -23.4 58.54 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.518 0.727 . . . . 0.0 109.911 172.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.2 t -78.96 87.98 4.76 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -104.38 -38.4 6.84 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.358 1.063 . . . . 0.0 110.78 -174.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.35 64.97 0.2 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 112.264 -0.334 . . . . 0.0 112.264 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.526 ' HB3' ' HB3' ' A' ' 1' ' ' GLN . 25.3 p90 -83.21 88.18 6.92 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.333 0.587 . . . . 0.0 109.658 176.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.98 -78.89 0.08 OUTLIER Glycine 0 C--N 1.344 0.98 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.193 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -63.4 -34.88 78.71 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.571 0.748 . . . . 0.0 111.06 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -73.04 106.33 4.87 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.43 -178.39 48.34 Favored Glycine 0 C--O 1.241 0.55 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.145 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.79 -32.77 69.97 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.871 0.468 . . . . 0.0 110.524 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 159.16 -116.11 0.7 Allowed Glycine 0 C--N 1.34 0.788 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 CA--C 1.548 0.88 0 C-N-CA 124.221 1.008 . . . . 0.0 108.511 177.466 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.46 40.83 2.29 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 116.518 -0.31 . . . . 0.0 112.619 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -96.54 -45.51 6.71 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.469 0.708 . . . . 0.0 110.399 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.1 mmt -93.13 95.46 9.43 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -65.55 -20.42 66.32 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.557 1.143 . . . . 0.0 110.894 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 mp -81.49 33.32 0.36 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.342 1.057 . . . . 0.0 111.534 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -37.25 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 169.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 21' ' ' SER . 60.7 m -90.56 82.54 5.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.61 0.764 . . . . 0.0 109.939 176.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.2 mtt -94.87 143.62 26.31 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.271 0.628 . . . . 0.0 109.857 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -71.65 110.88 6.5 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.304 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.5 t -79.27 124.7 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.813 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -113.61 121.89 45.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.032 0.933 . . . . 0.0 109.035 175.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 52.6 tttm -84.1 79.3 9.56 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.65 0.738 . . . . 0.0 109.624 175.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.61 -94.26 0.41 Allowed Glycine 0 C--N 1.342 0.9 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.831 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -96.9 -13.26 22.57 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.71 0.804 . . . . 0.0 111.591 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 10.0 pt-20 -116.09 153.6 31.45 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.533 0.733 . . . . 0.0 109.609 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.3 t -85.02 112.73 20.88 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -80.34 -56.8 3.94 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.531 0.333 . . . . 0.0 110.535 -172.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 178.18 -135.43 2.67 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.124 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -148.91 142.79 25.72 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.986 0.914 . . . . 0.0 109.985 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 39.1 p -74.52 108.3 7.19 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.497 0.719 . . . . 0.0 110.69 -178.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.87 -38.72 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.193 0.597 . . . . 0.0 110.117 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -153.66 172.4 17.31 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.39 0.676 . . . . 0.0 109.888 -172.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 p -155.66 132.68 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.888 0.875 . . . . 0.0 109.069 173.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.428 ' CE1' HD11 ' A' ' 30' ' ' ILE . 3.9 p90 -135.66 133.63 38.35 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.64 -105.43 1.23 Allowed Glycine 0 C--N 1.346 1.116 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -117.57 -0.85 11.78 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.841 0.856 . . . . 0.0 110.083 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.529 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 30.5 m-85 -104.1 106.21 16.64 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.706 -166.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 50.1 tp -75.84 105.65 6.99 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.428 HD11 ' CE1' ' A' ' 25' ' ' TYR . 38.0 mm -68.51 106.69 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.895 176.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.2 t -99.66 116.24 42.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -72.7 107.65 5.28 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 174.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.42 HG21 ' HB2' ' A' ' 36' ' ' GLU . 19.1 m -113.63 83.6 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.434 1.094 . . . . 0.0 110.579 -173.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.61 -82.06 0.5 Allowed Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.066 -0.97 . . . . 0.0 113.612 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 t -122.48 -11.08 8.35 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.853 0.861 . . . . 0.0 110.847 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.42 ' HB2' HG21 ' A' ' 33' ' ' VAL . 65.0 mm-40 -111.62 177.91 4.5 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.605 0.762 . . . . 0.0 110.55 -178.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.581 ' HB2' HD12 ' A' ' 71' ' ' LEU . 42.7 m-85 -134.29 110.93 9.82 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 169.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -105.54 126.82 52.56 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 28' ' ' TYR . . . -95.37 100.74 12.47 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.971 0.908 . . . . 0.0 110.472 -173.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.1 m -85.32 137.47 36.9 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 122.95 0.5 . . . . 0.0 109.896 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.16 160.47 41.82 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.392 2.061 . . . . 0.0 111.565 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -67.07 -23.69 65.89 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.504 0.322 . . . . 0.0 111.671 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -70.81 -22.78 62.3 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.262 0.625 . . . . 0.0 111.933 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.2 t -64.1 -32.44 74.0 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.079 0.552 . . . . 0.0 110.932 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mp -68.32 114.0 4.71 Favored 'Isoleucine or valine' 0 C--N 1.356 0.856 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -87.11 -41.26 13.94 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.596 1.158 . . . . 0.0 111.268 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.9 m -149.68 147.89 28.62 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.517 0.727 . . . . 0.0 110.594 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 p -110.48 117.09 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.624 0.77 . . . . 0.0 109.516 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.648 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 9.7 mm-40 -98.91 166.82 11.11 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.91 -26.98 39.55 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.198 0.999 . . . . 0.0 113.413 -174.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.49 22.27 1.2 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 112.148 -0.381 . . . . 0.0 112.148 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.648 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 95.4 mtt180 -136.53 159.08 42.87 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.444 0.698 . . . . 0.0 109.78 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.0 mm -126.58 103.22 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 172.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.1 t -82.03 113.17 20.93 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.401 HG13 ' HA ' ' A' ' 13' ' ' LYS . 37.4 pt -106.51 162.25 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 168.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -123.33 -65.17 0.21 Allowed Glycine 0 CA--C 1.503 -0.706 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -177.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -128.4 143.21 50.97 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.379 0.672 . . . . 0.0 110.16 -170.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -173.85 150.92 1.72 Allowed 'General case' 0 C--O 1.246 0.92 0 C-N-CA 125.578 1.551 . . . . 0.0 107.192 173.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -71.5 106.12 3.85 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -70.07 -35.53 74.29 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.096 0.958 . . . . 0.0 112.429 -169.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -69.18 -36.0 76.86 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.962 0.505 . . . . 0.0 110.735 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -67.69 -43.01 81.14 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.306 175.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.83 -25.67 66.55 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.68 0.792 . . . . 0.0 111.145 175.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -49.03 25.37 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.642 0.777 . . . . 0.0 109.33 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.61 -41.04 66.01 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.759 0.424 . . . . 0.0 111.738 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.6 pp -82.46 -15.86 50.98 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 120.889 0.376 . . . . 0.0 110.25 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.5 -54.25 13.66 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.863 170.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.405 ' HA ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -68.27 -23.08 64.73 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.461 0.704 . . . . 0.0 110.874 178.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.475 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 38.7 tttm -57.85 -48.81 78.7 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.93 0.892 . . . . 0.0 109.978 168.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -60.22 -35.71 76.06 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.225 0.61 . . . . 0.0 111.251 174.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.581 HD12 ' HB2' ' A' ' 37' ' ' PHE . 10.7 mp -63.16 -30.32 71.49 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 122.976 0.511 . . . . 0.0 111.647 174.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -78.59 -39.16 38.26 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 46.1 mt-10 -70.72 -36.9 73.44 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.819 0.848 . . . . 0.0 112.269 -175.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -32.24 72.34 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.103 0.477 . . . . 0.0 110.524 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.8 t -84.13 86.75 7.17 Favored 'General case' 0 C--N 1.348 0.528 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -73.19 136.63 78.96 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.555 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -46.32 -47.5 14.97 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 124.445 3.43 . . . . 0.0 115.01 -169.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.6 p -148.98 -34.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.523 0.329 . . . . 0.0 111.544 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -59.29 -30.29 68.22 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.628 0.771 . . . . 0.0 112.806 -174.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.2 tp -102.43 107.26 18.18 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -16.89 51.51 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.258 1.023 . . . . 0.0 110.928 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.28 -35.35 80.75 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.044 0.938 . . . . 0.0 112.16 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -91.21 9.34 31.65 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.965 0.506 . . . . 0.0 111.926 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -90.62 93.24 9.18 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.7 t -136.25 146.19 46.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.184 0.594 . . . . 0.0 110.142 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -90.48 176.68 6.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.901 0.88 . . . . 0.0 111.05 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.87 -78.4 1.81 Allowed Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -175.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -84.72 107.69 17.04 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.6 74.49 0.06 OUTLIER Glycine 0 C--N 1.345 1.028 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -175.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.13 37.39 1.27 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.934 0.894 . . . . 0.0 110.48 -170.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -73.97 77.64 1.68 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.27 34.15 2.87 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.056 -174.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -79.41 -9.52 59.62 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.3 0.64 . . . . 0.0 111.954 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.39 82.81 0.14 Allowed Glycine 0 C--N 1.349 1.267 0 N-CA-C 111.881 -0.487 . . . . 0.0 111.881 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 CA--C 1.552 1.035 0 C-N-CA 124.868 1.267 . . . . 0.0 111.416 -172.41 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.783 0.325 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.64 -60.93 0.01 OUTLIER Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -84.71 102.13 12.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.02 0.528 . . . . 0.0 110.424 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.4 mtm -70.49 -46.73 63.15 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 167.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.6 t70 59.82 94.61 0.03 OUTLIER 'General case' 0 C--N 1.356 0.889 0 C-N-CA 125.49 1.516 . . . . 0.0 111.922 170.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.4 mt -98.65 8.95 44.32 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.208 0.603 . . . . 0.0 112.272 -171.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.0 tt -66.94 -47.1 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -172.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 67.1 m -124.72 34.7 4.95 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.86 0.864 . . . . 0.0 111.262 -171.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.542 ' HB3' HG12 ' A' ' 53' ' ' ILE . 14.7 mmt -61.94 118.52 7.36 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.76 0.824 . . . . 0.0 111.182 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -85.65 121.17 27.94 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.516 0.726 . . . . 0.0 109.388 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.415 HG23 HG21 ' A' ' 31' ' ' VAL . 88.0 t -86.4 124.75 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.26 0.624 . . . . 0.0 110.67 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.02 124.01 48.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.327 1.051 . . . . 0.0 110.262 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 63.9 tttm -82.78 93.92 7.53 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.67 -100.48 1.32 Allowed Glycine 0 C--N 1.34 0.767 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -167.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.46 -1.33 9.11 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.493 0.717 . . . . 0.0 111.741 177.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 10.8 pt-20 -90.4 148.42 22.81 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 118.682 0.674 . . . . 0.0 110.995 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 t -67.42 97.79 0.6 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.844 0.857 . . . . 0.0 109.703 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -85.7 -53.29 5.24 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.637 0.375 . . . . 0.0 110.245 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.58 -152.5 10.1 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.344 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -141.96 134.07 27.59 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.778 0.831 . . . . 0.0 109.815 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.7 t -66.76 105.63 1.62 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.15 -34.28 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.592 0.757 . . . . 0.0 109.596 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -158.39 178.21 10.41 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.403 ' HB ' HD13 ' A' ' 29' ' ' LEU . 7.1 p -155.52 142.22 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.739 0.816 . . . . 0.0 109.206 173.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -139.9 128.29 22.73 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.52 -105.78 0.9 Allowed Glycine 0 CA--C 1.531 1.045 0 O-C-N 123.512 0.507 . . . . 0.0 113.786 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -116.95 11.49 14.36 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.204 1.001 . . . . 0.0 111.723 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' A' ' 39' ' ' ALA . 57.3 m-85 -125.29 115.93 21.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.727 0.411 . . . . 0.0 110.457 -176.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.403 HD13 ' HB ' ' A' ' 24' ' ' VAL . 45.0 tp -78.63 111.66 14.93 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.285 1.034 . . . . 0.0 109.255 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.8 mm -71.19 109.42 3.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 123.105 0.562 . . . . 0.0 109.635 178.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.415 HG21 HG23 ' A' ' 11' ' ' VAL . 60.8 t -107.43 114.63 46.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.306 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -74.85 109.6 8.45 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.2 m -107.1 85.41 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 124.494 1.118 . . . . 0.0 110.459 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.91 -83.09 0.31 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.207 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.4 p -110.37 -27.51 9.02 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.207 1.003 . . . . 0.0 111.889 -176.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -111.23 162.25 15.16 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.112 0.565 . . . . 0.0 111.356 -173.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -108.78 109.32 20.43 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 170.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.6 mt -105.36 118.73 37.3 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 28' ' ' TYR . . . -83.47 97.36 8.95 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.608 -177.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.1 t -78.64 115.93 55.61 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.168 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.77 145.48 49.66 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.015 2.477 . . . . 0.0 112.779 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -68.92 -21.12 64.23 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.953 0.901 . . . . 0.0 112.032 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.609 ' HZ2' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -74.58 -13.64 60.68 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.048 0.539 . . . . 0.0 111.635 174.498 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.8 m -94.89 3.46 54.95 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.127 0.971 . . . . 0.0 111.99 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.0 mm -82.36 122.78 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -72.55 -51.2 20.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.61 0.764 . . . . 0.0 110.067 174.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.1 t -166.03 149.02 7.38 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.43 0.692 . . . . 0.0 110.38 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.3 t -97.6 111.19 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.668 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 31.8 mt-10 -91.6 179.14 5.73 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.065 0.546 . . . . 0.0 110.655 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -40.07 -53.29 2.43 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.782 1.633 . . . . 0.0 113.429 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -140.5 33.24 2.08 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.668 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 68.9 mtt180 -135.26 147.55 49.3 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.449 0.699 . . . . 0.0 110.138 -175.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.542 HG12 ' HB3' ' A' ' 9' ' ' MET . 35.9 mm -116.71 101.63 12.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 168.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 50.8 t -80.17 115.06 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.6 pt -109.58 159.33 9.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.881 0.872 . . . . 0.0 109.207 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.45 -81.77 1.38 Allowed Glycine 0 C--O 1.242 0.629 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -159.87 176.25 12.12 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.061 0.945 . . . . 0.0 109.309 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -164.44 165.35 21.53 Favored 'General case' 0 C--O 1.25 1.127 0 C-N-CA 124.663 1.185 . . . . 0.0 108.13 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -82.1 108.45 15.59 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.61 -20.43 65.35 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.85 -173.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -69.21 -43.67 73.64 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.499 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 50.2 mt-10 -64.26 -55.97 17.78 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.857 175.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.67 -25.05 59.67 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.594 0.758 . . . . 0.0 112.532 -176.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -70.61 -52.67 19.85 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.909 0.884 . . . . 0.0 110.865 175.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -76.38 -38.19 56.11 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -171.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 62' ' ' GLU . 4.6 pp -81.83 -25.13 35.42 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 122.274 -0.266 . . . . 0.0 110.473 174.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.9 -44.67 94.27 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.523 ' HA ' HD21 ' A' ' 71' ' ' LEU . 3.5 ptm180 -74.75 -21.16 59.5 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.411 0.685 . . . . 0.0 110.605 178.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -67.57 -31.87 72.23 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.457 ' HE3' HD22 ' A' ' 71' ' ' LEU . 85.4 t90 -69.71 -36.85 76.27 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 171.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' A' ' 68' ' ' ARG . 4.3 mm? -59.32 -29.81 67.9 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 172.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -75.4 -33.05 60.95 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.104 0.562 . . . . 0.0 110.712 173.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -66.16 -36.51 83.3 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.568 0.747 . . . . 0.0 111.647 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.418 ' HE2' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -81.45 1.13 34.55 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.68 0.392 . . . . 0.0 111.111 175.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.7 t 77.08 93.24 0.07 Allowed 'General case' 0 C--N 1.357 0.902 0 C-N-CA 126.005 1.722 . . . . 0.0 110.906 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.54 ' HZ1' ' HB2' ' A' ' 76' ' ' LYS . 10.5 mtmp? -70.26 148.47 95.73 Favored Pre-proline 0 N--CA 1.48 1.071 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.061 166.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.39 -161.54 0.1 OUTLIER 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.001 2.467 . . . . 0.0 111.928 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.87 40.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.556 0.742 . . . . 0.0 111.578 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.9 m -65.47 -51.03 62.99 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.355 1.062 . . . . 0.0 111.598 -174.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 pp -134.97 150.03 50.3 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.497 0.665 . . . . 0.0 111.744 -177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.508 ' HA ' ' HE2' ' A' ' 84' ' ' LYS . 8.9 mm-40 -91.16 -21.44 21.16 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.822 1.249 . . . . 0.0 110.529 174.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.03 -40.3 84.6 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.496 1.518 . . . . 0.0 113.878 -166.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.3 tt -75.66 -29.94 59.27 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 118.026 0.375 . . . . 0.0 110.773 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.508 ' HE2' ' HA ' ' A' ' 81' ' ' GLU . 38.1 mtmt -63.23 91.51 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.389 0.676 . . . . 0.0 111.587 -172.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.8 p -147.98 -71.19 0.22 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -142.46 148.82 38.36 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.777 0.831 . . . . 0.0 109.838 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.36 70.35 0.38 Allowed Glycine 0 C--N 1.341 0.857 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -73.45 110.04 7.42 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.546 0.739 . . . . 0.0 109.597 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.8 -32.71 0.02 OUTLIER Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.476 -176.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -63.16 97.51 0.12 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.147 0.579 . . . . 0.0 109.714 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -160.39 141.91 12.41 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.868 0.867 . . . . 0.0 109.946 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 133.02 104.09 0.87 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -77.41 130.4 37.02 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.707 0.803 . . . . 0.0 111.191 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.74 131.95 1.66 Allowed Glycine 0 CA--C 1.528 0.902 0 O-C-N 124.021 0.826 . . . . 0.0 111.275 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 C--O 1.249 1.07 0 C-N-CA 123.722 0.809 . . . . 0.0 110.005 178.614 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 121.064 0.459 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.14 -84.18 0.87 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 173.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 62.26 16.92 8.85 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.544 1.138 . . . . 0.0 111.929 174.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 87.8 mtp -95.14 178.02 5.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.949 0.9 . . . . 0.0 110.72 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.418 ' HB3' HG21 ' A' ' 7' ' ' ILE . 7.1 m-20 -58.54 -48.79 79.71 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.849 0.86 . . . . 0.0 111.865 -177.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.7 mt 65.31 7.04 3.96 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 125.233 1.413 . . . . 0.0 112.586 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.418 HG21 ' HB3' ' A' ' 5' ' ' ASP . 9.9 tt -77.07 -41.13 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.387 1.075 . . . . 0.0 111.171 -174.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 60.7 m -90.8 49.41 1.65 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.075 0.95 . . . . 0.0 110.293 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.0 mtt -137.29 133.09 34.59 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.886 0.874 . . . . 0.0 109.498 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -83.87 123.79 30.29 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.754 0.822 . . . . 0.0 109.945 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.406 HG23 HG22 ' A' ' 31' ' ' VAL . 54.5 t -85.47 105.57 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.352 0.661 . . . . 0.0 110.533 -175.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -100.41 123.73 45.0 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.837 0.855 . . . . 0.0 109.898 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -78.44 89.45 4.42 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.3 -96.85 0.57 Allowed Glycine 0 C--N 1.346 1.086 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.807 -170.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -107.69 -32.12 7.78 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.887 0.875 . . . . 0.0 110.692 177.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -74.68 142.33 44.47 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -174.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.3 t -76.3 104.29 6.75 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -76.19 -53.49 8.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.85 -163.32 28.9 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.594 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -120.27 144.22 47.9 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -74.9 147.42 41.02 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.39 -32.21 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -164.63 168.81 17.72 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.79 0.436 . . . . 0.0 110.373 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.491 ' HB ' HD13 ' A' ' 29' ' ' LEU . 3.1 p -150.52 140.2 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.342 1.057 . . . . 0.0 108.884 172.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.635 ' HE1' HD11 ' A' ' 30' ' ' ILE . 42.3 p90 -145.87 136.37 24.09 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.767 0.827 . . . . 0.0 109.608 174.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.79 -106.96 1.1 Allowed Glycine 0 C--N 1.344 0.999 0 O-C-N 123.826 0.703 . . . . 0.0 113.942 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -115.68 19.47 15.25 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.946 0.898 . . . . 0.0 110.682 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.528 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 73.9 m-85 -138.0 118.46 13.82 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.779 0.431 . . . . 0.0 111.802 -172.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.491 HD13 ' HB ' ' A' ' 24' ' ' VAL . 44.2 tp -88.32 116.53 26.6 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.133 0.973 . . . . 0.0 109.403 172.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.635 HD11 ' HE1' ' A' ' 25' ' ' TYR . 33.5 mm -78.8 111.8 16.09 Favored 'Isoleucine or valine' 0 C--O 1.251 1.182 0 C-N-CA 123.05 0.54 . . . . 0.0 109.857 176.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.406 HG22 HG23 ' A' ' 11' ' ' VAL . 44.5 t -111.19 125.0 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.65 1.18 . . . . 0.0 109.847 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -74.49 124.9 27.45 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.352 0.661 . . . . 0.0 109.514 170.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 m -135.47 107.78 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 125.309 1.443 . . . . 0.0 108.945 176.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.29 -105.17 1.5 Allowed Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.549 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 77.8 p -110.54 -5.7 15.05 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.18 0.992 . . . . 0.0 110.823 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -109.7 165.38 11.73 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.769 0.828 . . . . 0.0 110.872 -166.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.17 110.71 15.61 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.0 mp -102.96 117.27 34.22 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.306 1.042 . . . . 0.0 109.418 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -77.81 91.41 4.12 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.438 0.695 . . . . 0.0 109.986 176.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.05 118.81 73.39 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.095 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.474 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 36.3 Cg_endo -60.71 145.05 99.54 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.488 2.125 . . . . 0.0 111.672 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.596 ' HA ' HD11 ' A' ' 45' ' ' ILE . 12.5 mmmm -61.68 -24.13 66.55 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.196 0.999 . . . . 0.0 112.205 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.474 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 14.9 ptmm? -72.96 -21.43 60.86 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.575 0.75 . . . . 0.0 111.865 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.1 t -78.24 -28.02 47.73 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.058 0.543 . . . . 0.0 110.49 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.596 HD11 ' HA ' ' A' ' 42' ' ' LYS . 1.7 mp -65.14 115.02 2.95 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.527 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 75.1 mmtt -68.76 -53.73 20.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.974 0.91 . . . . 0.0 109.784 175.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 73.6 m -159.25 143.48 15.23 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.68 0.792 . . . . 0.0 110.844 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.4 p -85.92 115.76 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 168.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.723 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 8.2 mm-40 -107.68 178.71 4.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.12 0.968 . . . . 0.0 110.67 -175.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -66.54 95.41 0.33 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.223 0.609 . . . . 0.0 110.187 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.46 13.81 81.46 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.315 -0.402 . . . . 0.0 113.354 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.723 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 25.3 mtp180 -130.01 149.61 51.66 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.526 0.73 . . . . 0.0 110.189 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.1 mm -119.62 103.95 15.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 164.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.457 HG21 HH21 ' A' ' 52' ' ' ARG . 92.5 t -84.22 113.26 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.9 pt -109.51 179.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.53 1.132 . . . . 0.0 109.434 174.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.527 ' HA3' ' HE2' ' A' ' 46' ' ' LYS . . . -144.54 -112.74 0.83 Allowed Glycine 0 C--N 1.343 0.958 0 N-CA-C 112.138 -0.385 . . . . 0.0 112.138 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -89.26 136.23 33.14 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.469 0.708 . . . . 0.0 110.634 -172.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -167.0 174.24 8.57 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.821 1.248 . . . . 0.0 108.21 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -99.64 119.46 38.13 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.22 -28.05 66.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.717 0.807 . . . . 0.0 111.821 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -74.29 -37.21 63.74 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.57 0.544 . . . . 0.0 110.652 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -58.26 -50.6 73.03 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.24 -31.49 72.71 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.581 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -75.66 -48.75 20.76 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.138 0.575 . . . . 0.0 110.237 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.48 -38.98 74.47 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.389 0.614 . . . . 0.0 111.22 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' HG ' ' HB2' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -84.55 -20.0 32.23 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.394 0.678 . . . . 0.0 109.95 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -74.57 -41.97 34.25 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 172.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.543 ' HA ' HD21 ' A' ' 71' ' ' LEU . 8.5 ptm180 -74.35 -17.45 60.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.993 0.517 . . . . 0.0 109.834 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 3.1 tppp? -65.78 -40.04 91.56 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 123.217 0.607 . . . . 0.0 109.484 169.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.433 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 78.2 t90 -60.34 -42.95 96.75 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.94 0.896 . . . . 0.0 111.188 174.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.681 HD12 ' HD3' ' A' ' 76' ' ' LYS . 3.2 mm? -59.99 -37.1 78.68 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.548 171.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -75.29 -24.45 57.5 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.131 0.972 . . . . 0.0 111.371 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 69' ' ' LYS . 34.6 mm-40 -64.68 -38.95 92.75 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.195 0.521 . . . . 0.0 109.908 174.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -84.89 -18.5 34.56 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.933 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.2 m 67.26 52.7 0.82 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.982 1.313 . . . . 0.0 110.671 173.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.681 ' HD3' HD12 ' A' ' 71' ' ' LEU . 26.2 mtpp -72.15 127.07 90.89 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.85 -176.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -81.59 -158.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.386 2.724 . . . . 0.0 113.737 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.1 t -59.87 92.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 C-N-CA 125.043 1.337 . . . . 0.0 111.015 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.6 t -149.64 -1.68 0.44 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.598 0.759 . . . . 0.0 111.752 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.7 tp -84.75 -52.08 6.32 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.251 0.62 . . . . 0.0 111.229 -171.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.442 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -62.82 -28.65 70.15 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.442 0.697 . . . . 0.0 111.3 174.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -59.73 -40.47 88.15 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.06 0.944 . . . . 0.0 111.822 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 pp -84.25 1.14 46.08 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.623 0.369 . . . . 0.0 111.926 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.473 ' HB2' ' HZ1' ' A' ' 84' ' ' LYS . 10.0 mtmp? -104.47 55.34 0.72 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.769 0.828 . . . . 0.0 108.847 174.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.1 t -67.34 -20.16 65.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.327 1.051 . . . . 0.0 112.944 -173.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -70.45 -24.92 62.97 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.394 0.678 . . . . 0.0 111.599 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.18 -106.97 2.09 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 123.495 0.497 . . . . 0.0 111.995 -177.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -157.7 166.37 32.98 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.163 0.985 . . . . 0.0 109.856 176.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.94 -47.55 0.52 Allowed Glycine 0 C--N 1.346 1.091 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -90.3 0.74 57.1 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.962 0.905 . . . . 0.0 111.782 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.22 113.42 6.55 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.043 0.537 . . . . 0.0 110.145 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -164.23 -126.46 0.82 Allowed Glycine 0 C--N 1.347 1.193 0 CA-C-N 116.236 -0.438 . . . . 0.0 113.006 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.23 -35.5 73.89 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.858 0.863 . . . . 0.0 112.215 -171.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.48 -88.51 1.0 Allowed Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 C--O 1.253 1.271 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.189 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.71 -113.31 3.62 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -174.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -159.33 -0.65 0.08 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.142 0.577 . . . . 0.0 110.9 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.0 mtt -88.54 -65.57 1.0 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.65 17.63 6.41 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.416 1.087 . . . . 0.0 112.895 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.5 mt -90.12 -27.96 19.28 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.382 0.673 . . . . 0.0 110.176 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.2 pt -111.61 177.29 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.321 1.049 . . . . 0.0 111.243 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 57.9 m 65.67 2.9 2.25 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.404 1.481 . . . . 0.0 113.537 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 47.7 mtt -92.26 145.72 24.27 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.371 0.605 . . . . 0.0 110.361 -177.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -84.86 108.79 17.69 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.985 -170.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.487 HG22 ' HB ' ' A' ' 53' ' ' ILE . 97.0 t -80.55 117.91 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.948 0.899 . . . . 0.0 110.994 -175.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -112.9 117.7 32.84 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.229 1.012 . . . . 0.0 109.552 175.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 51.3 tttm -77.92 91.04 4.15 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.22 -92.22 0.85 Allowed Glycine 0 C--N 1.345 1.066 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -170.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -118.95 -23.64 6.83 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.889 0.876 . . . . 0.0 111.353 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 12.6 pt-20 -78.94 142.11 36.98 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.528 0.331 . . . . 0.0 110.159 -172.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.6 t -69.11 99.11 1.07 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.538 0.735 . . . . 0.0 109.262 176.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -79.48 -57.53 3.65 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.05 -137.41 3.17 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.413 0.446 . . . . 0.0 112.639 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -148.3 136.91 21.55 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.962 0.905 . . . . 0.0 110.51 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.5 p -72.55 108.54 5.66 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.91 -32.57 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.177 0.591 . . . . 0.0 110.174 -176.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -160.35 178.49 9.54 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.704 0.402 . . . . 0.0 110.423 -174.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.8 p -154.6 139.6 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 124.299 1.04 . . . . 0.0 109.593 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -141.47 132.4 26.0 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.372 0.669 . . . . 0.0 109.203 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.36 -103.86 0.46 Allowed Glycine 0 C--N 1.349 1.288 0 O-C-N 123.548 0.53 . . . . 0.0 113.814 170.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -115.07 16.74 17.01 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.519 1.128 . . . . 0.0 111.228 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.476 ' HB3' ' HB2' ' A' ' 39' ' ' ALA . 84.1 m-85 -141.64 125.64 17.23 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.619 -0.676 . . . . 0.0 111.97 -174.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 60.6 tp -82.59 111.7 18.81 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.222 1.009 . . . . 0.0 109.11 170.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.446 HD11 ' HB1' ' A' ' 39' ' ' ALA . 28.1 mm -70.94 112.96 6.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 122.899 0.48 . . . . 0.0 109.725 177.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 88.4 t -112.47 118.11 56.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 123.186 0.594 . . . . 0.0 109.643 176.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -77.79 126.12 30.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.444 0.698 . . . . 0.0 109.792 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 m -131.99 74.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 C-N-CA 124.612 1.165 . . . . 0.0 109.886 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.63 -81.08 0.02 OUTLIER Glycine 0 C--N 1.354 1.55 0 CA-C-N 115.148 -0.933 . . . . 0.0 114.393 173.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.4 p -70.54 -49.46 47.85 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.272 1.029 . . . . 0.0 111.577 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -138.9 176.55 8.6 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.503 0.668 . . . . 0.0 112.258 -166.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -105.87 108.67 20.3 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.955 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 mp -95.39 105.5 17.47 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' A' ' 28' ' ' TYR . . . -80.07 94.35 5.95 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.848 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.18 124.59 91.04 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.137 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -56.77 141.56 92.24 Favored 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 122.732 2.288 . . . . 0.0 111.411 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.508 ' HA ' HD11 ' A' ' 45' ' ' ILE . 2.2 mmmp? -60.74 -34.34 74.28 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -172.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.47 -21.49 64.62 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.404 0.282 . . . . 0.0 111.576 177.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.2 t -75.0 -27.75 60.26 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 122.733 0.413 . . . . 0.0 111.081 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.552 HG13 HG22 ' A' ' 55' ' ' ILE . 2.0 mp -64.66 113.45 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.187 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -79.88 -50.05 11.04 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.859 0.864 . . . . 0.0 110.177 -175.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.7 m -148.22 126.84 12.48 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.241 -175.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.96 109.75 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 166.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -110.07 172.53 6.81 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.471 1.108 . . . . 0.0 110.415 -174.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.54 97.12 0.41 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.24 0.616 . . . . 0.0 110.423 -175.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.06 4.83 84.18 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.454 -0.794 . . . . 0.0 113.994 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -131.58 132.97 44.53 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.084 0.953 . . . . 0.0 109.053 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.487 ' HB ' HG22 ' A' ' 11' ' ' VAL . 43.4 mm -109.32 103.2 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.6 t -81.95 114.04 22.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.552 HG22 HG13 ' A' ' 45' ' ' ILE . 34.0 pt -109.25 170.41 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.552 0.741 . . . . 0.0 109.012 175.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.95 -159.27 14.92 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 116.611 -0.268 . . . . 0.0 112.877 -173.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -85.71 120.15 26.83 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.655 0.74 . . . . 0.0 109.562 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -142.29 171.3 14.24 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.989 1.316 . . . . 0.0 107.478 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -86.97 111.87 21.26 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.79 -23.44 63.34 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.414 0.686 . . . . 0.0 112.05 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -69.87 -37.29 76.03 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 123.86 0.725 . . . . 0.0 109.905 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -60.71 -54.86 40.1 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 170.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.03 77.03 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.258 -173.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.03 -44.45 54.33 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.947 -176.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.19 -40.21 86.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.917 0.326 . . . . 0.0 111.264 -174.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 pp -82.38 -16.31 49.57 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.704 0.401 . . . . 0.0 110.58 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.29 -32.75 57.74 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 168.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 -76.72 -28.45 55.82 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.246 1.019 . . . . 0.0 110.174 173.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -65.18 -34.98 79.67 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 169.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.449 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 56.8 t90 -65.27 -38.19 89.52 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.312 175.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.24 -27.79 67.52 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.313 0.645 . . . . 0.0 111.486 173.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -78.68 -42.05 29.55 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.724 0.81 . . . . 0.0 111.315 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HG2' ' HA ' ' A' ' 70' ' ' TRP . 11.8 pt-20 -76.37 -32.6 58.68 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.307 0.643 . . . . 0.0 111.757 -173.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -24.79 63.42 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.584 0.353 . . . . 0.0 110.623 177.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.6 t -62.35 -31.51 72.16 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.693 0.797 . . . . 0.0 110.691 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -85.32 146.13 44.14 Favored Pre-proline 0 N--CA 1.478 0.93 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 169.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.58 157.07 43.67 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.611 2.208 . . . . 0.0 111.805 174.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 p -65.8 88.38 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-O 121.966 0.889 . . . . 0.0 109.768 176.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.2 t -80.08 -32.17 39.27 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.784 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tt -172.26 97.3 0.15 Allowed 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -95.54 -11.63 27.08 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.199 0.6 . . . . 0.0 111.543 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -68.9 -26.65 65.21 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.713 0.405 . . . . 0.0 110.949 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.5 tp -74.46 -22.43 59.11 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.275 0.63 . . . . 0.0 110.581 175.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -77.62 -28.15 51.37 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.348 0.659 . . . . 0.0 109.995 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.8 m -70.7 116.02 10.53 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.756 0.822 . . . . 0.0 109.358 176.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -77.48 143.88 38.17 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.934 0.494 . . . . 0.0 111.585 -175.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -137.25 -52.4 0.06 OUTLIER Glycine 0 C--N 1.338 0.682 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 173.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.1 t80 67.53 12.36 8.85 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.825 1.25 . . . . 0.0 111.833 166.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.07 71.78 0.05 OUTLIER Glycine 0 C--N 1.343 0.941 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -80.41 69.54 6.89 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.639 0.776 . . . . 0.0 109.954 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -171.2 146.68 2.41 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.804 1.242 . . . . 0.0 108.347 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.43 142.22 8.73 Favored Glycine 0 C--N 1.341 0.827 0 O-C-N 123.239 0.337 . . . . 0.0 112.519 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.57 -28.42 60.93 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.502 0.721 . . . . 0.0 110.717 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.33 113.81 0.53 Allowed Glycine 0 C--N 1.343 0.966 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.969 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.25 1.086 0 C-N-CA 123.688 0.795 . . . . 0.0 109.158 177.531 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.604 0.24 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.71 -142.96 3.59 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.337 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -116.0 81.69 1.65 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.239 0.616 . . . . 0.0 110.919 -175.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 95.6 mmm -88.4 97.49 11.08 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 172.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -83.87 84.28 7.63 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.314 0.578 . . . . 0.0 111.399 -174.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.0 mt -103.69 11.19 36.28 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.323 1.049 . . . . 0.0 108.576 166.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.437 HG21 ' SG ' ' A' ' 8' ' ' CYS . 10.4 tp -73.2 -30.2 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 125.37 1.468 . . . . 0.0 111.425 -171.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.437 ' SG ' HG21 ' A' ' 7' ' ' ILE . 19.0 m -135.71 92.69 2.85 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.427 0.691 . . . . 0.0 109.784 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.0 mtt -148.76 157.69 43.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.636 1.174 . . . . 0.0 109.122 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -78.67 110.94 14.26 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.915 0.486 . . . . 0.0 109.878 176.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.52 130.7 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.061 0.544 . . . . 0.0 109.838 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -116.97 124.74 50.12 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.61 1.164 . . . . 0.0 110.023 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -79.73 92.61 5.44 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.87 -96.08 0.58 Allowed Glycine 0 C--N 1.342 0.914 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -173.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.03 -21.92 10.32 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.47 0.708 . . . . 0.0 111.572 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.02 155.68 19.7 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 122.861 0.464 . . . . 0.0 110.396 -176.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.7 t -71.13 112.44 7.28 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.054 0.542 . . . . 0.0 110.134 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -80.74 -52.55 7.4 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.29 -139.85 5.14 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.844 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -139.23 132.32 29.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.137 0.975 . . . . 0.0 108.869 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.4 p -69.8 124.13 23.22 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 172.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.55 -37.6 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.64 0.776 . . . . 0.0 109.195 -177.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -150.46 167.91 25.75 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.357 -171.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.3 p -127.61 138.96 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -148.67 100.29 3.09 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.144 0.978 . . . . 0.0 109.486 -169.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.86 -109.14 2.72 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.741 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.516 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 21.1 t70 -104.67 -5.5 21.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.188 0.595 . . . . 0.0 109.413 171.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -100.04 113.67 26.43 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.306 0.642 . . . . 0.0 111.089 -171.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 66.0 tp -74.1 106.69 5.89 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.0 mm -68.28 106.51 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.177 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.7 t -100.33 117.68 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.83 111.09 7.65 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 173.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.459 HG22 HD23 ' A' ' 38' ' ' LEU . 18.9 m -111.18 85.55 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-O 122.04 0.924 . . . . 0.0 110.48 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.35 -91.16 0.24 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.062 -0.972 . . . . 0.0 113.3 176.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.0 p -105.43 -10.29 17.03 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.824 0.85 . . . . 0.0 111.389 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -124.51 -176.68 3.58 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.505 0.722 . . . . 0.0 111.49 -173.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -131.22 110.25 11.0 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.966 1.307 . . . . 0.0 109.308 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.459 HD23 HG22 ' A' ' 33' ' ' VAL . 2.4 mm? -102.9 109.25 20.74 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.648 1.179 . . . . 0.0 108.821 174.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.02 93.74 9.44 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.262 -174.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.31 131.81 51.97 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.505 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 54.9 Cg_endo -65.3 159.83 45.37 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.359 2.04 . . . . 0.0 112.129 177.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 27' ' ' ASP . 31.0 mmmt -66.75 -22.45 66.04 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.724 0.81 . . . . 0.0 111.433 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.505 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 8.6 ptpp? -76.01 -18.99 59.04 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.99 0.916 . . . . 0.0 112.065 175.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.7 t -71.71 -29.26 64.36 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.712 0.405 . . . . 0.0 110.747 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.492 HD11 ' HA ' ' A' ' 42' ' ' LYS . 2.2 mp -70.22 118.45 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.068 0.547 . . . . 0.0 109.911 -177.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -85.67 -54.5 4.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.272 1.029 . . . . 0.0 111.046 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.2 m -134.26 146.93 50.51 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.788 -172.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.5 p -114.91 126.4 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.061 0.944 . . . . 0.0 109.297 173.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.782 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 42.3 mm-40 -121.85 173.22 7.63 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.986 0.914 . . . . 0.0 109.171 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.03 97.47 1.17 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.822 0.82 . . . . 0.0 110.271 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.56 18.12 71.63 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.272 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.782 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 54.1 mtt180 -140.63 149.76 42.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.631 0.772 . . . . 0.0 110.516 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.5 mm -134.81 104.24 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.484 1.114 . . . . 0.0 108.822 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.08 122.31 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.4 pt -112.4 153.99 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.109 0.963 . . . . 0.0 109.442 174.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -104.1 -64.36 0.68 Allowed Glycine 0 C--N 1.344 1.004 0 CA-C-O 120.158 -0.246 . . . . 0.0 112.537 -173.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -157.26 159.76 37.93 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.106 0.562 . . . . 0.0 110.034 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -166.26 173.07 10.47 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.519 1.128 . . . . 0.0 109.239 -177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.78 99.66 7.58 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -67.86 -57.51 6.13 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.263 1.025 . . . . 0.0 112.702 -167.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.89 -30.32 69.65 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.151 0.58 . . . . 0.0 110.776 -176.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.47 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 43.7 mt-10 -70.25 -39.61 74.9 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.795 173.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.12 -25.55 65.35 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.021 0.528 . . . . 0.0 110.734 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -74.53 -45.81 43.27 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.678 0.791 . . . . 0.0 109.838 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.47 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.9 pt-20 -72.72 -36.42 67.78 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.445 0.298 . . . . 0.0 111.779 -177.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.442 ' HA ' ' HB3' ' A' ' 69' ' ' LYS . 4.1 pp -83.39 -13.6 54.53 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 122.157 -0.339 . . . . 0.0 110.529 174.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.04 -46.27 52.34 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.747 168.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.462 ' HA ' HD11 ' A' ' 71' ' ' LEU . 34.6 ptt180 -72.05 -23.89 61.44 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 175.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 22.4 ttmm -62.3 -39.21 92.25 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 123.087 0.555 . . . . 0.0 109.715 170.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.442 ' HE3' HD12 ' A' ' 71' ' ' LEU . 70.6 t90 -60.87 -38.29 85.1 Favored 'General case' 0 CA--C 1.553 1.088 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 172.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.462 HD11 ' HA ' ' A' ' 68' ' ' ARG . 11.2 mp -60.83 -39.73 90.12 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 177.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.56 -29.14 46.16 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.701 -0.625 . . . . 0.0 111.194 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 69.2 mt-10 -77.8 -31.1 51.6 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -6.8 47.73 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 171.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.6 t 73.45 82.12 0.12 Allowed 'General case' 0 C--N 1.363 1.159 0 C-N-CA 126.152 1.781 . . . . 0.0 110.023 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -83.2 158.41 64.1 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.802 171.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.92 146.05 87.02 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.153 1.902 . . . . 0.0 111.347 168.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.0 m -71.68 -19.96 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.707 0.403 . . . . 0.0 110.96 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.7 t 50.17 23.42 1.16 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 126.659 1.983 . . . . 0.0 114.088 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 1.0 OUTLIER -163.28 124.77 2.44 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -171.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -71.55 -27.84 63.45 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.737 0.815 . . . . 0.0 111.748 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -72.57 -28.41 62.8 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.108 0.48 . . . . 0.0 110.28 174.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -78.37 -5.83 53.42 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 123.692 0.797 . . . . 0.0 110.365 177.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -60.56 -43.91 96.73 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.542 0.737 . . . . 0.0 111.01 176.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 91.0 p -92.04 14.42 15.94 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.157 0.583 . . . . 0.0 111.473 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -127.96 151.59 48.94 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.714 0.806 . . . . 0.0 110.408 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 159.15 87.76 0.06 OUTLIER Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -126.77 165.86 18.5 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.158 0.583 . . . . 0.0 110.458 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.46 -159.37 27.9 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -92.66 134.48 34.97 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 175.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.72 107.15 16.76 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 117.988 0.358 . . . . 0.0 111.011 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.49 -167.37 32.94 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 124.076 0.86 . . . . 0.0 114.889 168.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.31 -5.36 15.89 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.134 0.974 . . . . 0.0 109.97 170.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.69 18.05 80.03 Favored Glycine 0 C--N 1.356 1.658 0 CA-C-O 119.182 -0.788 . . . . 0.0 114.424 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.4 t . . . . . 0 C--O 1.254 1.322 0 C-N-CA 124.76 1.224 . . . . 0.0 109.866 -176.442 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.44 178.64 34.04 Favored Glycine 0 C--N 1.344 1.004 0 O-C-N 123.369 0.418 . . . . 0.0 113.157 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -136.04 133.05 37.01 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.742 0.817 . . . . 0.0 109.685 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.417 ' O ' HG23 ' A' ' 7' ' ' ILE . 64.9 mtt -84.51 98.37 10.08 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.44 -1.0 14.06 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.21 1.004 . . . . 0.0 112.151 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -90.03 -5.62 56.42 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.172 0.989 . . . . 0.0 111.493 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 4' ' ' MET . 10.9 tp -80.79 142.59 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 122.973 0.509 . . . . 0.0 111.129 -176.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 59.1 m -85.0 94.88 8.91 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 79.4 mtp -72.08 108.4 5.26 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.176 0.59 . . . . 0.0 110.102 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -62.42 123.07 17.32 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.162 0.585 . . . . 0.0 110.889 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.6 t -93.85 131.25 41.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 124.075 0.95 . . . . 0.0 110.076 -173.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.56 ' HE1' ' HD2' ' A' ' 52' ' ' ARG . 70.0 m-85 -118.93 127.01 53.08 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.536 1.134 . . . . 0.0 108.625 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.426 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -78.43 87.34 4.44 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.105 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.36 -94.75 0.74 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -172.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.85 -27.27 8.54 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.84 0.856 . . . . 0.0 111.785 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 12.0 pt-20 -81.42 145.82 30.59 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -174.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 t -69.78 113.75 7.32 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -93.83 -50.21 5.46 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.078 0.551 . . . . 0.0 110.524 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.18 -137.93 4.06 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.766 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.571 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 8.9 pt-20 -141.13 144.11 34.66 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.238 1.015 . . . . 0.0 109.966 -177.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.414 ' HG ' HD13 ' A' ' 29' ' ' LEU . 39.8 t -77.17 149.83 35.56 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.24 -40.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -151.52 170.01 20.68 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -176.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.481 ' HB ' HD12 ' A' ' 29' ' ' LEU . 2.8 p -155.8 123.07 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.067 0.947 . . . . 0.0 109.069 172.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.404 ' CE1' HD11 ' A' ' 30' ' ' ILE . 7.3 p90 -124.29 132.8 53.59 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 88' ' ' PHE . . . 60.89 -105.87 0.95 Allowed Glycine 0 C--N 1.338 0.686 0 O-C-N 123.543 0.527 . . . . 0.0 114.044 178.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -118.94 17.96 13.29 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.615 0.766 . . . . 0.0 111.527 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.483 ' HB3' ' HB2' ' A' ' 39' ' ' ALA . 80.8 m-85 -133.03 112.79 12.11 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.142 0.496 . . . . 0.0 111.427 -175.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.481 HD12 ' HB ' ' A' ' 24' ' ' VAL . 44.8 tp -78.21 111.68 14.4 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.12 1.368 . . . . 0.0 109.552 173.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.404 HD11 ' CE1' ' A' ' 25' ' ' TYR . 33.2 mm -72.38 112.05 7.53 Favored 'Isoleucine or valine' 0 C--O 1.249 1.053 0 C-N-CA 123.578 0.751 . . . . 0.0 109.832 178.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.8 t -110.72 125.9 68.04 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 C-N-CA 124.369 1.068 . . . . 0.0 109.879 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.571 ' HB3' ' HG3' ' A' ' 20' ' ' GLU . 4.2 tppp? -73.96 120.02 18.96 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.92 0.888 . . . . 0.0 109.25 171.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.8 m -137.73 133.83 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.499 1.119 . . . . 0.0 109.627 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.58 -100.15 0.46 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.023 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.3 p -124.84 -11.53 7.17 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.602 1.161 . . . . 0.0 111.021 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -124.41 -171.98 2.46 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.562 0.745 . . . . 0.0 111.829 -171.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -121.11 111.37 17.35 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.144 0.977 . . . . 0.0 110.474 -174.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 mp -102.08 117.17 34.23 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 171.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.483 ' HB2' ' HB3' ' A' ' 28' ' ' TYR . . . -89.68 108.59 19.77 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.698 0.799 . . . . 0.0 110.954 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.464 HG22 HG23 ' A' ' 55' ' ' ILE . 16.5 m -83.52 139.28 41.2 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.405 0.682 . . . . 0.0 109.896 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HG2' ' HB2' ' A' ' 44' ' ' SER . 56.9 Cg_endo -69.89 156.2 63.59 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 122.146 1.897 . . . . 0.0 112.624 176.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -68.24 -28.53 67.3 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.206 1.002 . . . . 0.0 111.39 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.477 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 21.5 pttp -74.9 -9.37 58.48 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.775 0.83 . . . . 0.0 111.572 176.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.5 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 28.5 t -88.43 -18.67 27.82 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.056 0.543 . . . . 0.0 111.083 175.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.508 HD11 HG22 ' A' ' 55' ' ' ILE . 29.5 mm -64.46 112.91 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 46' ' ' LYS . 11.1 mmpt? -70.5 -45.46 65.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.534 0.734 . . . . 0.0 110.194 177.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.5 t -160.0 145.88 15.57 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.64 -176.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.8 p -110.02 119.69 59.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.767 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 20.7 mm-40 -104.23 166.51 10.35 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.84 0.856 . . . . 0.0 109.423 176.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -65.04 102.8 0.66 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.312 0.577 . . . . 0.0 109.572 174.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.44 4.92 90.06 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.605 -0.725 . . . . 0.0 114.363 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.767 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 77.5 mmt-85 -131.92 147.98 52.5 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 117.57 0.685 . . . . 0.0 110.171 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.82 132.43 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.923 0.889 . . . . 0.0 108.845 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.13 123.42 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.508 HG22 HD11 ' A' ' 45' ' ' ILE . 49.4 pt -118.95 164.82 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.648 0.779 . . . . 0.0 110.641 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.93 -171.99 22.58 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.31 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.69 130.51 41.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.824 0.449 . . . . 0.0 109.946 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -135.46 166.51 23.02 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.94 1.296 . . . . 0.0 108.826 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.01 109.16 14.2 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -67.01 -28.56 68.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.724 0.81 . . . . 0.0 111.284 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -67.33 -43.3 81.91 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.475 1.11 . . . . 0.0 110.722 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -68.63 -42.35 78.16 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.675 0.274 . . . . 0.0 110.475 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.64 89.93 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.74 0.816 . . . . 0.0 112.006 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -76.19 -34.28 59.3 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.465 0.478 . . . . 0.0 112.057 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 12.9 pt-20 -77.71 -40.71 40.38 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -177.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 pp -80.7 -25.5 38.11 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -69.05 -34.62 76.67 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.815 171.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -77.05 -18.02 58.37 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 117.296 0.548 . . . . 0.0 110.205 175.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.613 ' HZ1' ' HB3' ' A' ' 69' ' ' LYS . 6.3 ttpm? -68.85 -32.17 71.66 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.162 0.506 . . . . 0.0 109.787 166.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.403 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 85.5 t90 -67.09 -32.74 74.1 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 169.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.593 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 8.8 mp -66.92 -31.6 72.29 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.161 0.584 . . . . 0.0 112.133 173.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER -81.34 -25.7 36.19 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.38 0.537 . . . . 0.0 109.942 174.727 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -66.25 -30.99 71.54 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.463 0.705 . . . . 0.0 110.188 170.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.593 ' HD3' ' HA ' ' A' ' 71' ' ' LEU . 52.8 mtpt -61.73 -54.58 40.57 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.233 0.613 . . . . 0.0 110.194 173.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -109.23 100.5 9.63 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.534 0.734 . . . . 0.0 109.447 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -61.04 145.98 88.6 Favored Pre-proline 0 N--CA 1.484 1.237 0 C-N-CA 125.036 1.334 . . . . 0.0 112.224 -171.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.36 177.05 8.09 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.747 2.298 . . . . 0.0 112.955 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.39 -24.09 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-O 120.989 0.423 . . . . 0.0 110.621 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.8 m -69.66 138.44 53.0 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.324 0.649 . . . . 0.0 109.836 171.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.2 tp -56.02 117.23 3.53 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.84 0.856 . . . . 0.0 109.523 174.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -74.78 -6.07 46.93 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 120.738 0.304 . . . . 0.0 111.328 -174.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -66.73 -30.22 70.39 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.209 0.528 . . . . 0.0 109.922 169.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.17 -25.43 62.54 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.998 0.919 . . . . 0.0 111.162 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -64.69 89.72 0.07 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.6 t -103.83 124.25 48.59 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.723 0.809 . . . . 0.0 109.3 -174.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -179.41 -39.57 0.01 OUTLIER 'General case' 0 C--O 1.245 0.823 0 C-N-CA 125.384 1.474 . . . . 0.0 107.904 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.41 -106.71 1.92 Allowed Glycine 0 C--N 1.349 1.273 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.152 -172.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.436 ' HB3' ' HA2' ' A' ' 26' ' ' GLY . 89.8 m-85 -137.41 -9.76 1.68 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.058 0.943 . . . . 0.0 110.013 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.37 38.91 81.26 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -61.73 109.89 1.35 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.432 1.093 . . . . 0.0 110.988 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -159.14 128.07 5.32 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.02 160.91 31.6 Favored Glycine 0 C--N 1.346 1.122 0 N-CA-C 112.148 -0.381 . . . . 0.0 112.148 -174.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.76 -179.37 6.94 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.444 0.697 . . . . 0.0 110.783 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 164.01 -60.63 0.26 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.5 p . . . . . 0 C--O 1.251 1.167 0 C-N-CA 124.079 0.952 . . . . 0.0 108.628 176.442 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 C--O 1.24 0.578 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -76.49 111.88 12.42 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.359 0.664 . . . . 0.0 110.124 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.16 111.65 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.097 0.559 . . . . 0.0 109.908 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -103.0 124.59 48.79 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.817 0.847 . . . . 0.0 110.135 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 51.1 tttm -77.67 85.43 3.99 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.86 -94.99 0.89 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -173.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -110.63 -30.15 7.73 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.97 0.908 . . . . 0.0 110.658 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 12.9 pt-20 -77.58 141.02 39.76 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -175.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.9 t -70.68 108.77 4.56 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -85.26 -55.55 3.97 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.866 0.466 . . . . 0.0 110.44 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.24 -146.88 5.98 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.282 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -140.1 145.34 37.49 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.75 0.82 . . . . 0.0 110.346 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.7 p -77.0 111.89 13.05 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.805 0.442 . . . . 0.0 109.839 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.65 -40.37 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.452 0.701 . . . . 0.0 110.25 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 18.0 t70 -148.36 160.66 42.78 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.919 0.487 . . . . 0.0 109.817 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.419 HG22 HD12 ' A' ' 29' ' ' LEU . 20.6 t -139.59 118.78 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -132.5 126.99 34.24 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.643 0.656 . . . . 0.0 109.503 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.04 -119.76 19.8 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.487 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -102.24 22.81 12.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.592 0.757 . . . . 0.0 111.347 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.423 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 66.3 m-85 -133.29 124.86 28.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.834 0.454 . . . . 0.0 111.357 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.419 HD12 HG22 ' A' ' 24' ' ' VAL . 45.2 tp -85.2 109.6 18.42 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 167.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 39' ' ' ALA . 23.5 mm -70.85 107.1 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.04 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.64 119.31 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.337 177.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -75.99 113.65 13.75 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.171 0.588 . . . . 0.0 109.496 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.35 126.56 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 124.124 0.97 . . . . 0.0 109.481 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.95 -91.44 0.05 OUTLIER Glycine 0 CA--C 1.535 1.316 0 CA-C-N 116.57 -0.287 . . . . 0.0 113.429 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.9 m -125.2 -23.82 4.11 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.404 1.082 . . . . 0.0 110.778 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -110.82 179.16 4.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.72 0.808 . . . . 0.0 111.319 -171.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.413 ' HB3' HG23 ' A' ' 30' ' ' ILE . 87.6 m-85 -119.23 110.35 16.92 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.515 0.726 . . . . 0.0 109.887 -175.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -91.55 105.9 18.09 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.299 1.04 . . . . 0.0 109.151 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.503 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -83.23 92.49 7.49 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.193 0.597 . . . . 0.0 109.83 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.3 m -80.18 134.66 55.38 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.414 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 48.0 Cg_endo -65.59 154.44 73.77 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.621 2.214 . . . . 0.0 111.674 176.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.561 ' HA ' HD13 ' A' ' 45' ' ' ILE . 13.7 mmmm -63.16 -28.1 69.83 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.591 0.756 . . . . 0.0 111.652 -176.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.414 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 7.7 ptpp? -65.72 -21.89 66.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.413 0.685 . . . . 0.0 111.583 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 t -74.33 -43.61 55.95 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.561 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.8 mp -61.73 112.47 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.442 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HE3' ' HA3' ' A' ' 56' ' ' GLY . 32.1 mmtp -78.51 -63.13 1.48 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.881 0.872 . . . . 0.0 110.154 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 t -146.02 132.83 20.05 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 122.915 0.486 . . . . 0.0 110.094 -175.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.8 p -77.68 109.61 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.65 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 5.8 mm-40 -86.16 174.3 9.23 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.324 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.56 86.5 2.09 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.166 0.508 . . . . 0.0 109.719 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.21 13.44 63.9 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.979 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.65 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 2.4 mpt_? -135.6 159.67 40.91 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.444 0.622 . . . . 0.0 109.64 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 mm -124.25 103.96 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 69.7 t -79.14 116.45 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.409 HG22 HG13 ' A' ' 45' ' ' ILE . 40.7 pt -105.87 164.0 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.499 ' HA3' ' HE3' ' A' ' 46' ' ' LYS . . . -104.4 -107.01 3.16 Favored Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -122.69 156.82 33.6 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.837 0.855 . . . . 0.0 109.807 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -167.09 160.17 13.71 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.723 1.209 . . . . 0.0 108.715 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -75.17 98.23 3.68 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -43.29 96.08 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.373 1.069 . . . . 0.0 112.896 -175.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -67.92 -33.87 75.53 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.341 0.401 . . . . 0.0 110.747 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 37.7 mt-10 -69.65 -49.44 53.66 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.366 174.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.01 -28.51 66.46 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.597 0.759 . . . . 0.0 111.383 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.59 -45.26 46.42 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.762 1.225 . . . . 0.0 110.867 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.415 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 2.9 pp20? -75.37 -36.93 60.85 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -175.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.523 ' HA ' ' HB3' ' A' ' 69' ' ' LYS . 4.4 pp -81.84 -15.14 55.08 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.846 0.355 . . . . 0.0 110.441 174.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -66.5 -47.82 67.13 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.747 166.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.494 ' HA ' HD23 ' A' ' 71' ' ' LEU . 9.2 ptp180 -76.32 -21.49 56.13 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 117.344 0.572 . . . . 0.0 111.458 177.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -68.18 -32.87 73.41 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.139 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.418 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 74.2 t90 -67.1 -40.49 86.91 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.196 169.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.1 mm? -57.89 -24.89 59.72 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.503 0.321 . . . . 0.0 111.232 175.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 CA--C 1.55 0.974 0 C-N-CA 122.478 0.311 . . . . 0.0 111.19 173.134 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.549 ' HB2' HG12 ' A' ' 53' ' ' ILE . 2.1 mpt? . . . . . 0 CA--C 1.554 1.103 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -75.13 110.46 9.46 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.307 1.043 . . . . 0.0 109.89 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.518 HG22 ' HB ' ' A' ' 53' ' ' ILE . 75.5 t -79.28 127.5 39.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 122.878 0.471 . . . . 0.0 110.814 -173.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -110.56 129.71 55.73 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.623 1.169 . . . . 0.0 110.045 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -78.01 85.01 4.25 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.561 1.144 . . . . 0.0 108.011 172.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.25 -96.64 0.34 Allowed Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.623 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -94.91 -40.71 9.55 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.496 0.719 . . . . 0.0 110.474 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -83.66 151.63 25.19 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.946 -170.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 t -75.72 119.08 19.25 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -87.51 -48.89 7.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.521 0.728 . . . . 0.0 110.456 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.51 -150.54 12.15 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -176.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -127.43 146.32 50.52 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 171.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 68.7 p -70.55 162.79 28.2 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 168.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.38 -39.56 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -153.24 171.92 17.79 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.608 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.485 ' HB ' HD12 ' A' ' 29' ' ' LEU . 2.4 p -151.72 133.75 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 172.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.489 ' CE2' HD11 ' A' ' 30' ' ' ILE . 50.6 p90 -135.81 135.24 39.69 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 172.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.48 -107.23 1.29 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 123.886 0.741 . . . . 0.0 112.704 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -116.11 12.84 15.66 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.764 0.826 . . . . 0.0 110.996 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.589 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 89.7 m-85 -123.17 109.34 13.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.198 0.599 . . . . 0.0 111.426 -172.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.485 HD12 ' HB ' ' A' ' 24' ' ' VAL . 45.5 tp -80.37 106.87 12.71 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 169.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.489 HD11 ' CE2' ' A' ' 25' ' ' TYR . 28.4 mm -71.24 108.81 3.07 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 C-N-CA 123.698 0.799 . . . . 0.0 110.041 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 65.6 t -102.72 119.44 51.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 O-C-N 124.263 0.977 . . . . 0.0 109.575 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.46 118.66 18.57 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.41 124.01 64.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.688 0.795 . . . . 0.0 108.99 172.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.81 -90.44 0.05 OUTLIER Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.493 0.496 . . . . 0.0 114.334 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.3 p -123.5 -21.71 5.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.187 0.995 . . . . 0.0 111.5 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -110.37 171.62 7.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.641 0.776 . . . . 0.0 111.612 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -120.05 110.17 16.35 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.253 1.021 . . . . 0.0 108.942 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.1 mp -106.76 115.18 29.75 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.371 1.069 . . . . 0.0 108.381 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -79.94 103.82 10.09 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.619 0.768 . . . . 0.0 111.021 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 m -78.13 132.58 66.51 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 172.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.483 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 37.4 Cg_endo -65.62 150.22 86.63 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 121.714 1.609 . . . . 0.0 110.286 172.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.566 ' HA ' HD13 ' A' ' 45' ' ' ILE . 31.6 mmmt -61.13 -29.98 70.1 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.116 0.566 . . . . 0.0 111.409 -176.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.483 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 60.1 pttt -68.97 -23.09 64.08 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.052 0.941 . . . . 0.0 111.902 177.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.8 t -68.9 -29.72 68.06 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.759 0.424 . . . . 0.0 110.714 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.566 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.9 mp -64.06 114.58 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.488 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 75.1 mmtt -71.69 -45.98 60.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.394 1.078 . . . . 0.0 110.0 176.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 44.1 p -157.14 155.15 30.5 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.952 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 p -113.12 114.2 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.916 0.886 . . . . 0.0 110.175 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 6.5 mm-40 -97.74 163.66 12.72 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.765 0.826 . . . . 0.0 109.1 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.75 -35.34 74.4 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.715 0.806 . . . . 0.0 111.301 -171.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.07 19.35 4.37 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.484 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.602 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 44.1 mtm180 -143.62 156.09 44.46 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 117.486 0.643 . . . . 0.0 110.85 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.549 HG12 ' HB2' ' A' ' 9' ' ' MET . 41.3 mm -126.43 104.37 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 173.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.7 t -83.24 114.89 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.9 pt -108.22 163.99 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.539 0.736 . . . . 0.0 109.499 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.488 ' HA3' ' HE2' ' A' ' 46' ' ' LYS . . . -92.87 -86.51 1.56 Allowed Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 175.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -160.5 168.44 25.07 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.563 0.745 . . . . 0.0 110.474 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -164.89 -179.03 5.54 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.898 1.279 . . . . 0.0 108.905 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -93.52 110.38 21.97 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -64.44 -37.22 86.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.12 0.968 . . . . 0.0 111.595 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.31 -50.39 60.4 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.044 0.84 . . . . 0.0 110.167 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.425 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 37.6 mt-10 -64.16 -38.87 92.63 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.07 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.21 -40.84 86.48 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.416 0.686 . . . . 0.0 111.93 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 9.9 ptp85 -75.3 -31.5 60.68 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 118.97 -0.538 . . . . 0.0 112.266 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -75.98 -38.8 57.06 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.394 0.543 . . . . 0.0 111.349 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 62' ' ' GLU . 4.4 pp -81.76 -13.26 57.99 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.25 0.548 . . . . 0.0 109.828 170.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.82 -33.93 66.17 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.168 165.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 64' ' ' ARG . 78.5 mtm180 -64.85 -40.33 94.99 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 123.317 0.647 . . . . 0.0 109.682 172.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -55.09 -39.76 69.66 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.789 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.417 ' CD1' HG13 ' A' ' 30' ' ' ILE . 88.6 t90 -65.49 -34.92 79.4 Favored 'General case' 0 C--N 1.361 1.105 0 CA-C-O 119.316 -0.373 . . . . 0.0 111.681 174.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.2 mm? -57.22 -22.14 38.74 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 118.839 0.745 . . . . 0.0 110.634 173.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 CA--C 1.574 1.883 0 C-N-CA 123.397 0.679 . . . . 0.0 111.924 164.645 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.6 ttm . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -69.51 106.42 2.98 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.41 0.684 . . . . 0.0 109.823 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.09 132.82 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.029 0.532 . . . . 0.0 109.791 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -113.8 127.49 56.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.795 1.238 . . . . 0.0 110.337 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.98 88.49 3.52 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 171.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.4 -95.48 0.6 Allowed Glycine 0 C--N 1.342 0.91 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -121.25 1.3 10.23 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.073 0.949 . . . . 0.0 112.196 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -117.04 151.72 36.18 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.254 0.621 . . . . 0.0 110.456 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.5 t -67.43 112.8 4.83 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.733 0.813 . . . . 0.0 111.334 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -84.79 -54.65 4.55 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.438 0.695 . . . . 0.0 110.199 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.31 -137.83 3.99 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.877 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -138.28 136.48 36.51 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.192 0.997 . . . . 0.0 109.694 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.485 ' HB2' HD11 ' A' ' 29' ' ' LEU . 68.8 p -72.08 112.26 8.01 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.87 -36.43 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.054 0.541 . . . . 0.0 109.839 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -153.49 176.66 11.78 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.272 0.629 . . . . 0.0 109.338 -173.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.22 136.85 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.988 0.915 . . . . 0.0 108.951 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.408 ' CD1' HD11 ' A' ' 30' ' ' ILE . 9.6 p90 -137.11 127.64 26.8 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 173.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.37 -109.62 2.43 Favored Glycine 0 C--N 1.346 1.117 0 O-C-N 123.537 0.523 . . . . 0.0 113.501 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -109.92 19.2 19.32 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.04 0.936 . . . . 0.0 111.493 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.404 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 78.9 m-85 -131.91 115.41 15.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.876 0.47 . . . . 0.0 111.665 -176.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 21' ' ' SER . 64.6 tp -79.22 113.85 17.68 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.131 0.972 . . . . 0.0 109.528 169.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.408 HD11 ' CD1' ' A' ' 25' ' ' TYR . 26.3 mm -74.77 106.92 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.5 t -104.53 113.44 41.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -76.3 109.67 10.19 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.6 m -95.15 156.08 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.415 1.086 . . . . 0.0 108.794 169.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -43.61 -28.23 1.01 Allowed Glycine 0 N--CA 1.482 1.711 0 N-CA-C 116.544 1.378 . . . . 0.0 116.544 -174.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.0 p -95.04 -48.39 5.99 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.13 0.572 . . . . 0.0 111.625 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -139.83 -179.65 6.06 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.443 0.64 . . . . 0.0 112.715 -163.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -101.78 107.83 19.16 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 164.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.6 mt -104.05 106.76 17.37 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -80.35 95.19 6.3 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.269 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 m -80.61 134.41 54.27 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.527 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 38.2 Cg_endo -63.41 159.13 41.52 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.21 1.94 . . . . 0.0 112.011 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -59.16 -34.73 72.45 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.385 0.674 . . . . 0.0 110.78 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.527 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 19.9 ptmt -68.19 -26.99 66.01 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.339 1.056 . . . . 0.0 112.191 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.7 t -59.46 -38.52 80.98 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.811 0.444 . . . . 0.0 109.87 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.99 114.01 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.459 ' HD2' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -79.97 -53.8 6.4 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.571 1.149 . . . . 0.0 110.072 177.592 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.4 m -144.82 141.12 28.89 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.272 -171.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.0 p -99.19 110.62 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 169.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.788 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 11.7 mm-40 -105.21 174.25 5.96 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.555 0.742 . . . . 0.0 109.821 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.47 102.0 1.06 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.195 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.52 18.17 78.3 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 115.538 -0.755 . . . . 0.0 113.467 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.788 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 17.6 mtp180 -136.64 140.18 42.58 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.209 0.604 . . . . 0.0 110.359 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.1 mm -116.57 101.89 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 168.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.1 t -79.4 118.93 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.3 pt -112.13 146.38 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.716 0.806 . . . . 0.0 109.264 172.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.459 ' HA3' ' HD2' ' A' ' 46' ' ' LYS . . . -105.49 -56.33 0.69 Allowed Glycine 0 C--N 1.339 0.743 0 CA-C-N 116.362 -0.381 . . . . 0.0 112.418 -170.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.21 141.44 23.17 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.582 0.753 . . . . 0.0 110.627 -171.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -169.4 146.54 3.47 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 124.618 1.167 . . . . 0.0 108.011 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.66 106.79 7.4 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -64.15 -29.34 70.47 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.043 0.937 . . . . 0.0 111.706 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.437 ' HG2' ' NH1' ' A' ' 64' ' ' ARG . 38.8 mt-10 -67.08 -40.41 87.01 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.579 0.549 . . . . 0.0 110.584 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -68.73 -45.51 71.3 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.314 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.24 74.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.898 0.879 . . . . 0.0 111.865 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.437 ' NH1' ' HG2' ' A' ' 61' ' ' GLU . 6.2 ptp180 -75.69 -41.81 52.7 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.769 0.428 . . . . 0.0 111.765 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.44 -39.48 64.95 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 118.075 0.398 . . . . 0.0 111.902 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.55 -16.61 44.78 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.766 0.426 . . . . 0.0 110.466 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.81 -39.0 34.97 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.595 0.559 . . . . 0.0 112.487 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.406 ' HA ' HD12 ' A' ' 71' ' ' LEU . 54.3 ptt85 -77.06 -24.95 51.92 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.843 0.457 . . . . 0.0 109.981 173.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -65.63 -38.14 88.58 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.6 t90 -60.74 -49.39 77.68 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 123.513 0.508 . . . . 0.0 109.883 171.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 68' ' ' ARG . 75.4 mt -50.92 -34.68 29.58 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.954 0.902 . . . . 0.0 112.072 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 . . . . . 0 CA--C 1.553 1.094 0 C-N-CA 123.623 0.769 . . . . 0.0 111.074 175.504 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 53.0 mtt . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 120.899 0.38 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -101.75 130.08 48.08 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.418 HG22 ' HB ' ' A' ' 53' ' ' ILE . 85.4 t -91.54 126.27 44.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.346 0.659 . . . . 0.0 109.762 -177.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -115.46 118.52 33.43 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.782 1.233 . . . . 0.0 109.102 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 65.5 tttm -78.68 90.23 4.59 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.1 -95.56 0.66 Allowed Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -175.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -121.48 4.22 10.18 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.802 0.841 . . . . 0.0 112.406 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 11.5 pt-20 -111.84 147.41 35.81 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.997 0.519 . . . . 0.0 109.704 176.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.3 t -72.62 108.79 5.84 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -78.45 -49.34 13.64 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.358 0.663 . . . . 0.0 110.231 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.0 -136.54 3.33 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.521 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -142.33 136.93 30.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.138 0.975 . . . . 0.0 109.483 -178.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.41 ' HB2' HD11 ' A' ' 29' ' ' LEU . 62.2 p -71.58 106.96 4.22 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 175.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.424 HG21 ' HD2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -92.59 -40.31 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.083 0.553 . . . . 0.0 109.67 -176.243 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -160.35 168.91 24.23 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.438 0.295 . . . . 0.0 110.919 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.15 141.22 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.011 0.924 . . . . 0.0 109.102 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -138.91 97.41 3.31 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.457 1.103 . . . . 0.0 108.389 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.1 -109.01 2.3 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.771 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -107.17 16.85 23.65 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.104 0.962 . . . . 0.0 110.36 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.456 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 93.8 m-85 -127.81 117.86 22.64 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.447 0.699 . . . . 0.0 109.895 -174.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.41 HD11 ' HB2' ' A' ' 21' ' ' SER . 64.5 tp -76.62 111.0 11.66 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 172.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mm -71.02 112.88 6.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -107.26 120.02 57.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.355 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -74.84 109.18 8.09 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.05 89.56 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.577 1.151 . . . . 0.0 110.659 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.12 -76.02 1.68 Allowed Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.237 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.5 m -125.07 -29.47 3.32 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.141 0.977 . . . . 0.0 110.856 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -110.45 168.89 9.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 122.155 -0.341 . . . . 0.0 110.551 -172.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.424 ' HD2' HG21 ' A' ' 22' ' ' ILE . 64.5 m-85 -113.22 110.37 20.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.133 0.973 . . . . 0.0 109.466 177.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.0 mt -107.39 124.74 50.28 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.124 0.57 . . . . 0.0 109.63 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -89.62 99.49 12.48 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.016 -174.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.1 m -86.46 129.13 54.37 Favored Pre-proline 0 CA--C 1.552 1.056 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.13 158.42 54.65 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.363 2.042 . . . . 0.0 111.871 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.578 ' HA ' HD13 ' A' ' 45' ' ' ILE . 13.9 mmmm -64.6 -29.54 70.55 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.256 0.622 . . . . 0.0 112.166 -177.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.495 ' H ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -72.84 -17.79 61.51 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.142 0.177 . . . . 0.0 111.219 174.664 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.5 t -73.13 -34.9 66.38 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 171.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.9 mp -61.18 115.38 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.173 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 mmpm? -82.28 -61.28 1.94 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.212 1.005 . . . . 0.0 109.414 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.0 m -138.69 126.6 22.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.149 -172.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 p -92.53 109.37 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 171.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.653 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 22.0 mm-40 -98.63 177.01 5.44 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 124.546 1.138 . . . . 0.0 110.225 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -68.11 91.15 0.35 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.185 0.594 . . . . 0.0 110.452 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.36 17.81 77.23 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.303 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.653 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 49.7 mtt180 -137.33 129.55 29.43 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.54 0.736 . . . . 0.0 109.382 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.418 ' HB ' HG22 ' A' ' 11' ' ' VAL . 38.4 mm -105.03 103.37 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.76 115.93 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.8 pt -108.57 175.15 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.377 0.671 . . . . 0.0 109.457 173.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.43 -117.75 3.01 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -118.71 160.29 22.11 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.267 0.627 . . . . 0.0 110.602 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -159.8 179.21 9.02 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.156 1.382 . . . . 0.0 108.477 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.28 114.44 26.52 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -63.86 -36.2 83.13 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.844 0.858 . . . . 0.0 112.52 -175.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -69.21 -40.85 77.74 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.981 0.512 . . . . 0.0 110.185 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.42 -44.98 73.84 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 123.415 0.447 . . . . 0.0 110.33 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.04 -25.52 68.42 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.376 0.67 . . . . 0.0 111.292 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -73.89 -51.48 16.07 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.893 0.877 . . . . 0.0 110.971 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.11 -40.81 59.62 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.993 0.517 . . . . 0.0 111.799 -171.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 69' ' ' LYS . 2.4 pp -84.1 -20.77 31.99 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.06 -44.83 87.02 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 169.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.503 ' HA ' HD23 ' A' ' 71' ' ' LEU . 35.2 ptt180 -75.45 -14.2 60.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.508 0.723 . . . . 0.0 110.406 175.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 6.3 tppt? -67.74 -31.85 72.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.982 0.513 . . . . 0.0 109.831 167.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.422 ' HE3' HD22 ' A' ' 71' ' ' LEU . 81.8 t90 -71.37 -38.6 71.53 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.805 0.442 . . . . 0.0 110.795 170.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.503 HD23 ' HA ' ' A' ' 68' ' ' ARG . 3.8 mm? -65.55 -29.66 70.31 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 120.807 0.337 . . . . 0.0 110.163 171.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 . . . . . 0 N--CA 1.471 0.623 0 C-N-CA 123.78 0.832 . . . . 0.0 109.479 172.757 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 41.4 mtt . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -71.31 106.93 4.04 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.491 HG22 ' HB ' ' A' ' 53' ' ' ILE . 57.8 t -78.93 110.04 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.879 -177.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 54.5 m-85 -97.23 120.9 38.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.128 0.971 . . . . 0.0 109.163 174.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -78.21 87.71 4.29 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.02 -95.51 0.74 Allowed Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -107.63 -29.66 9.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.792 0.837 . . . . 0.0 111.11 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.65 146.54 28.2 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.57 0.348 . . . . 0.0 110.449 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.0 t -77.15 105.63 8.36 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -79.89 -55.71 4.78 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.527 0.731 . . . . 0.0 111.158 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.532 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . -179.03 -147.87 7.39 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.261 0.351 . . . . 0.0 112.456 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -137.49 135.36 36.73 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.843 0.857 . . . . 0.0 109.779 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.5 p -76.66 108.27 9.55 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.21 -37.73 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.349 0.659 . . . . 0.0 109.556 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -160.73 177.92 9.98 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -173.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.483 ' HB ' HD12 ' A' ' 29' ' ' LEU . 5.5 p -155.58 135.14 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 123.962 0.905 . . . . 0.0 109.056 173.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.444 ' CD2' HD11 ' A' ' 30' ' ' ILE . 34.3 p90 -132.13 131.81 42.65 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 171.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.19 -107.06 1.18 Allowed Glycine 0 C--N 1.343 0.958 0 O-C-N 123.764 0.665 . . . . 0.0 113.293 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -119.65 27.94 8.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.977 0.911 . . . . 0.0 111.261 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -133.29 108.97 9.07 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.063 0.545 . . . . 0.0 110.227 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.483 HD12 ' HB ' ' A' ' 24' ' ' VAL . 51.0 tp -81.37 113.47 19.49 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.356 0.662 . . . . 0.0 109.404 175.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.444 HD11 ' CD2' ' A' ' 25' ' ' TYR . 8.0 mm -80.1 104.79 8.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 C-N-CA 123.172 0.589 . . . . 0.0 109.685 -176.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.2 t -105.95 113.58 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.756 0.822 . . . . 0.0 109.834 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -75.86 117.0 17.13 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.387 0.675 . . . . 0.0 109.638 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.532 HG12 ' HA3' ' A' ' 19' ' ' GLY . 11.1 m -133.18 148.78 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.95 0.9 . . . . 0.0 109.409 176.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.23 -106.04 0.43 Allowed Glycine 0 CA--C 1.531 1.09 0 O-C-N 123.426 0.454 . . . . 0.0 113.04 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.8 m -109.53 -29.91 8.18 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.648 0.779 . . . . 0.0 110.888 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -116.44 176.5 5.08 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.623 0.725 . . . . 0.0 112.158 -169.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -104.28 109.92 21.94 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.653 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.12 102.97 15.51 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.208 1.003 . . . . 0.0 108.577 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB3' HD12 ' A' ' 66' ' ' LEU . . . -84.83 94.66 8.78 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.673 0.789 . . . . 0.0 109.526 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.1 m -75.35 128.66 83.96 Favored Pre-proline 0 CA--C 1.558 1.255 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.699 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -60.81 161.26 22.19 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.017 2.478 . . . . 0.0 112.192 174.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.504 ' HA ' HG12 ' A' ' 45' ' ' ILE . 14.6 mmmm -68.42 -21.27 64.68 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.69 -17.39 62.84 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.711 0.404 . . . . 0.0 111.014 174.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.8 t -80.5 -29.47 37.31 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.102 0.561 . . . . 0.0 110.353 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.513 HD13 HG22 ' A' ' 55' ' ' ILE . 25.5 mm -68.23 115.18 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 122.837 0.455 . . . . 0.0 110.406 -175.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -84.01 -66.69 0.86 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.596 0.758 . . . . 0.0 110.448 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.0 m -143.71 126.79 16.46 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.626 0.371 . . . . 0.0 110.654 -171.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -82.82 111.63 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.783 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 11.1 mm-40 -99.41 175.96 5.68 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.78 0.832 . . . . 0.0 109.986 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -70.31 97.55 1.26 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.12 0.568 . . . . 0.0 110.05 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.81 21.94 77.78 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.841 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.783 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 79.6 mtt180 -142.62 151.24 41.27 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.931 0.892 . . . . 0.0 110.031 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.491 ' HB ' HG22 ' A' ' 11' ' ' VAL . 43.5 mm -124.4 107.11 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 170.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 57.4 t -78.46 117.76 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.513 HG22 HD13 ' A' ' 45' ' ' ILE . 47.4 pt -108.81 171.4 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.698 0.799 . . . . 0.0 109.54 171.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.66 -81.08 0.68 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -139.75 146.11 39.12 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-O 121.846 0.831 . . . . 0.0 110.711 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -160.66 165.48 30.51 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.471 1.508 . . . . 0.0 107.589 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -94.1 108.6 20.43 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.63 -39.11 92.77 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.889 0.876 . . . . 0.0 112.952 -170.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.55 -33.09 75.11 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.3 0.64 . . . . 0.0 110.712 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -76.73 -45.9 27.47 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.435 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.91 -26.78 68.46 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.674 0.79 . . . . 0.0 110.671 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -74.7 -44.4 50.29 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.589 0.756 . . . . 0.0 110.609 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.86 -39.33 64.05 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 39' ' ' ALA . 4.3 pp -82.41 -13.67 56.44 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 121.702 0.763 . . . . 0.0 110.037 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.18 -43.08 96.0 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 161.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -70.07 -16.69 63.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.92 0.888 . . . . 0.0 111.582 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.512 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 4.0 tppp? -67.28 -38.78 85.62 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.692 0.797 . . . . 0.0 109.559 170.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.41 ' HE3' HD22 ' A' ' 71' ' ' LEU . 68.7 t90 -62.19 -45.29 94.05 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.344 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.41 HD22 ' HE3' ' A' ' 70' ' ' TRP . 3.7 mm? -63.22 -25.38 68.3 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.564 0.345 . . . . 0.0 111.209 174.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 N--CA 1.476 0.833 0 C-N-CA 123.867 0.867 . . . . 0.0 111.311 -179.328 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.4 ' HG2' ' HA2' ' A' ' 51' ' ' GLY . 58.2 mtt . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.342 0.115 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -66.43 113.81 4.96 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.513 0.725 . . . . 0.0 110.568 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.1 t -83.1 123.73 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.505 0.722 . . . . 0.0 110.386 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -108.55 120.73 43.3 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.161 0.984 . . . . 0.0 109.418 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 49.7 tttm -77.24 85.43 3.69 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.59 -94.18 0.84 Allowed Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -110.81 -23.58 10.93 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.313 1.045 . . . . 0.0 111.229 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 11.3 pt-20 -91.18 144.41 25.65 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.065 0.546 . . . . 0.0 110.451 -173.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.6 t -71.4 111.4 6.69 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.406 0.682 . . . . 0.0 109.507 176.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -91.35 -56.55 3.1 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.801 0.44 . . . . 0.0 111.166 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.434 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . -179.35 -140.35 4.03 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.57 -174.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.26 139.25 35.5 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.601 0.76 . . . . 0.0 110.619 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.0 t -79.16 108.87 12.97 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.664 0.785 . . . . 0.0 109.241 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.42 HD13 ' HB2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -92.18 -39.13 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.156 0.582 . . . . 0.0 109.599 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.42 ' HB2' HD13 ' A' ' 22' ' ' ILE . 19.0 t70 -154.26 169.11 24.43 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.743 0.306 . . . . 0.0 111.082 -174.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.407 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.7 p -151.17 137.9 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.352 1.061 . . . . 0.0 108.46 172.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.417 ' CE1' HD11 ' A' ' 30' ' ' ILE . 2.4 p90 -146.54 135.38 22.34 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.96 -106.8 1.08 Allowed Glycine 0 C--N 1.34 0.799 0 O-C-N 123.29 0.369 . . . . 0.0 113.955 174.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -119.51 13.07 12.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.099 0.959 . . . . 0.0 110.915 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.479 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 83.8 m-85 -130.74 150.14 52.06 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.509 0.723 . . . . 0.0 111.049 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.407 HD12 ' HB ' ' A' ' 24' ' ' VAL . 45.3 tp -117.25 112.46 20.81 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.592 1.557 . . . . 0.0 107.725 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.417 HD11 ' CE1' ' A' ' 25' ' ' TYR . 39.0 mm -76.52 109.15 10.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.816 0 C-N-CA 123.128 0.571 . . . . 0.0 109.757 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.5 t -110.13 117.94 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.053 0.941 . . . . 0.0 108.648 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.78 118.68 28.64 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.566 HG22 HD23 ' A' ' 38' ' ' LEU . 19.7 m -123.07 128.49 75.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 171.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.99 -99.71 0.21 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 116.604 -0.271 . . . . 0.0 113.305 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.0 m -125.05 -5.11 7.39 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.856 0.862 . . . . 0.0 111.081 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -116.83 154.2 31.15 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.246 0.618 . . . . 0.0 111.236 -173.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -112.01 109.66 19.54 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.31 1.044 . . . . 0.0 109.154 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.566 HD23 HG22 ' A' ' 33' ' ' VAL . 3.6 mm? -95.55 106.75 18.86 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.39 1.076 . . . . 0.0 109.131 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -79.84 95.29 6.0 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.086 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.4 m -87.06 126.42 62.99 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.497 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 38.2 Cg_endo -62.13 152.03 78.33 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.503 2.135 . . . . 0.0 112.492 -176.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.598 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.7 mmmm -64.94 -23.04 67.1 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.583 0.753 . . . . 0.0 111.808 -175.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.497 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 21.6 ptmt -70.88 -25.58 62.86 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.461 0.705 . . . . 0.0 111.307 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.9 t -72.22 -31.43 65.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.888 0.475 . . . . 0.0 110.094 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.598 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.6 mp -62.0 114.68 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.099 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -90.62 -55.6 3.51 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.824 1.25 . . . . 0.0 110.818 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.5 m -134.37 126.87 30.5 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.349 0.66 . . . . 0.0 110.108 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 p -96.04 109.88 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 172.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 47.4 mm-40 -111.39 168.47 9.51 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 124.224 1.01 . . . . 0.0 109.918 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -65.34 98.53 0.34 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.811 0.844 . . . . 0.0 110.803 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' A' ' 9' ' ' MET . . . 77.29 11.96 85.03 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 116.333 -0.394 . . . . 0.0 113.963 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.483 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 97.4 mtt180 -137.6 127.3 25.33 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.957 0.903 . . . . 0.0 109.48 178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.9 mm -110.37 102.99 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.9 t -80.71 113.48 20.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 33.3 pt -106.63 178.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.102 0.961 . . . . 0.0 108.466 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.43 -119.71 4.54 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -131.63 166.54 21.22 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.732 0.813 . . . . 0.0 109.165 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -163.53 168.5 20.03 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.115 0.966 . . . . 0.0 109.297 -168.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -81.75 99.57 9.03 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -62.95 -30.55 71.66 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.006 0.922 . . . . 0.0 111.883 -175.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -62.83 -51.84 65.46 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.688 0.756 . . . . 0.0 109.747 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.07 -35.17 76.23 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.972 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.3 -34.77 73.14 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.029 0.532 . . . . 0.0 111.867 -175.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -77.13 -34.27 56.65 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 177.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.97 -37.99 54.1 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 117.725 0.238 . . . . 0.0 111.048 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 pp -82.98 -15.53 50.85 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.06 -42.71 35.82 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.053 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.572 ' HA ' HD23 ' A' ' 71' ' ' LEU . 4.9 ptp180 -70.97 -27.06 63.45 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -63.56 -33.55 75.84 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 170.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -64.52 -37.1 86.36 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.696 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.572 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.0 mm? -61.52 -29.4 69.97 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 118.139 0.427 . . . . 0.0 110.717 173.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 CA--C 1.552 1.034 0 C-N-CA 123.314 0.645 . . . . 0.0 110.685 172.276 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 85.2 mtp . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 120.482 0.182 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -72.33 107.69 5.06 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.69 0.796 . . . . 0.0 109.929 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.59 116.23 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 122.92 0.488 . . . . 0.0 109.929 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -111.13 129.56 55.9 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.243 1.017 . . . . 0.0 109.262 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -85.19 92.25 8.35 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.55 -95.81 0.4 Allowed Glycine 0 C--N 1.351 1.4 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.014 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -104.51 -31.83 9.27 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.609 0.764 . . . . 0.0 111.479 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -83.4 144.2 29.78 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 120.659 0.266 . . . . 0.0 110.911 -172.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.5 t -72.41 111.09 7.29 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.561 0.745 . . . . 0.0 109.359 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -84.85 -57.04 3.27 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.56 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 178.15 -136.18 2.91 Favored Glycine 0 C--N 1.347 1.143 0 O-C-N 123.149 0.28 . . . . 0.0 112.465 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.79 139.13 24.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.238 1.015 . . . . 0.0 109.687 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.3 t -68.23 138.5 55.62 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.06 -38.11 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -156.14 164.55 38.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.732 0.413 . . . . 0.0 110.039 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.0 p -121.16 136.45 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.474 ' OH ' ' HD2' ' A' ' 69' ' ' LYS . 4.6 t80 -136.95 101.25 4.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.982 0.913 . . . . 0.0 109.602 -173.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.0 -113.04 5.37 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.423 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -98.57 21.53 11.12 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.027 0.931 . . . . 0.0 110.873 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -135.58 162.24 33.25 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.047 0.939 . . . . 0.0 109.792 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 59.0 tp -123.66 113.07 18.15 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' ' 39' ' ' ALA . 23.7 mm -70.43 106.88 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.0 t -108.32 117.71 54.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -76.22 115.85 16.35 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.638 HG22 HD23 ' A' ' 38' ' ' LEU . 4.0 m -123.38 121.19 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.86 -86.97 0.06 OUTLIER Glycine 0 CA--C 1.532 1.115 0 CA-C-N 116.326 -0.397 . . . . 0.0 113.487 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 m -124.56 -25.84 3.96 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.683 1.193 . . . . 0.0 110.663 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -106.88 163.78 12.67 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.579 0.752 . . . . 0.0 111.24 -167.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -111.0 109.07 19.02 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.156 0.982 . . . . 0.0 108.772 177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.638 HD23 HG22 ' A' ' 33' ' ' VAL . 4.3 mm? -105.73 111.95 24.82 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.572 1.149 . . . . 0.0 108.836 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.447 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -82.93 94.81 7.8 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.212 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.48 131.28 58.79 Favored Pre-proline 0 N--CA 1.473 0.723 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.574 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 35.8 Cg_endo -60.67 153.41 62.15 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.275 1.983 . . . . 0.0 111.703 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.543 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.4 mmmm -63.27 -27.13 69.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.603 0.761 . . . . 0.0 111.416 -178.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.574 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 20.9 ptmt -67.74 -21.7 65.27 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.676 0.79 . . . . 0.0 111.793 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.5 t -70.18 -43.15 71.38 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.543 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.3 mp -60.98 113.77 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.209 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.547 ' HE3' ' HA3' ' A' ' 56' ' ' GLY . 33.9 mmtp -79.17 -58.65 3.12 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.857 0.863 . . . . 0.0 109.421 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.8 m -154.45 156.72 37.27 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.378 0.671 . . . . 0.0 110.613 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.4 t -93.37 111.76 25.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.822 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 7.3 mm-40 -86.62 167.21 14.74 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.348 0.659 . . . . 0.0 109.363 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -69.13 93.85 0.63 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.57 -6.76 65.43 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.852 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.63 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 49.9 mtm180 -129.01 158.99 37.34 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.009 0.523 . . . . 0.0 110.952 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 mm -124.17 104.44 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.2 t -79.98 118.75 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.2 pt -108.81 174.08 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 123.893 0.877 . . . . 0.0 109.336 172.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.547 ' HA3' ' HE3' ' A' ' 46' ' ' LYS . . . -135.38 -90.04 0.31 Allowed Glycine 0 C--N 1.34 0.757 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.065 -173.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -107.73 130.45 54.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.09 0.472 . . . . 0.0 111.882 -168.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -164.12 -176.4 4.47 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.278 1.031 . . . . 0.0 108.768 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -128.79 122.72 31.14 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.98 -32.66 69.57 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.753 0.421 . . . . 0.0 112.114 -173.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.88 -34.62 69.33 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.43 -38.69 68.26 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.379 172.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.434 ' HB3' HD12 ' A' ' 38' ' ' LEU . . . -70.06 -28.47 65.47 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.926 0.49 . . . . 0.0 111.629 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -78.63 -36.25 44.33 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.037 0.535 . . . . 0.0 112.027 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.61 -41.96 59.49 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 120.838 0.352 . . . . 0.0 110.859 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 pp -81.46 -21.27 38.88 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.21 -41.38 86.49 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.959 170.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.523 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -73.59 -21.0 60.46 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 117.346 0.573 . . . . 0.0 111.032 177.418 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.474 ' HD2' ' OH ' ' A' ' 25' ' ' TYR . 2.6 ttmp? -57.98 -46.85 84.51 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 166.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.492 ' HE3' HD12 ' A' ' 71' ' ' LEU . 89.3 t90 -62.34 -42.64 99.55 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.117 174.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . 9.8 mp -54.55 -31.7 57.02 Favored 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 123.54 0.736 . . . . 0.0 111.879 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 . . . . . 0 CA--C 1.551 0.983 0 C-N-CA 122.924 0.49 . . . . 0.0 109.908 179.359 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.471 0.605 0 CA-C-O 120.878 0.371 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -74.13 108.41 6.91 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.34 1.056 . . . . 0.0 109.883 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.461 HG22 ' HB ' ' A' ' 53' ' ' ILE . 61.5 t -80.01 123.7 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.927 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -106.09 122.58 46.46 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.135 0.974 . . . . 0.0 109.836 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -78.82 80.76 5.15 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.57 -95.61 0.39 Allowed Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.786 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -104.3 0.38 29.17 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.844 0.858 . . . . 0.0 112.124 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -131.42 149.6 52.47 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.134 0.574 . . . . 0.0 110.422 -175.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.6 t -71.94 111.62 7.35 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.419 0.688 . . . . 0.0 109.762 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -77.37 -55.92 4.99 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.32 0.648 . . . . 0.0 109.327 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.88 -142.99 6.09 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.36 151.71 35.79 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.445 0.698 . . . . 0.0 109.748 172.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.2 t -71.62 146.9 48.04 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.955 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.42 -37.73 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.081 0.952 . . . . 0.0 109.405 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.73 173.24 14.42 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -173.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.418 ' HB ' HD12 ' A' ' 29' ' ' LEU . 8.9 p -155.96 134.1 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.565 0.746 . . . . 0.0 109.516 171.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.438 ' CE1' HD11 ' A' ' 30' ' ' ILE . 8.8 p90 -133.77 125.24 28.1 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.17 -107.07 1.18 Allowed Glycine 0 CA--C 1.531 1.072 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.398 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -102.93 -9.4 19.89 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.004 0.921 . . . . 0.0 111.603 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.599 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 86.6 m-85 -108.7 108.48 19.34 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.815 -0.553 . . . . 0.0 111.979 -169.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.418 HD12 ' HB ' ' A' ' 24' ' ' VAL . 26.8 tp -77.65 109.35 11.55 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.37 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.438 HD11 ' CE1' ' A' ' 25' ' ' TYR . 24.3 mm -72.03 99.73 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.2 t -96.1 112.71 28.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -85.89 113.91 22.39 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.95 86.86 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 CA-C-O 122.164 0.983 . . . . 0.0 110.532 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.53 -89.26 0.36 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.392 177.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.561 HG23 ' HG2' ' A' ' 36' ' ' GLU . 10.5 t -101.5 -16.71 16.72 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.39 0.676 . . . . 0.0 110.93 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.561 ' HG2' HG23 ' A' ' 35' ' ' THR . 6.3 mm-40 -109.6 162.73 14.13 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.443 0.697 . . . . 0.0 111.156 -167.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -121.39 108.48 13.73 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 170.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.85 106.68 17.29 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.501 1.121 . . . . 0.0 108.755 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.599 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -87.24 94.74 9.75 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.559 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.6 m -78.98 140.04 57.57 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.531 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.36 155.05 72.06 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.554 2.169 . . . . 0.0 110.767 172.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.419 ' HA ' HD13 ' A' ' 45' ' ' ILE . 31.8 mmmt -64.71 -22.94 67.1 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -76.57 -17.21 59.34 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.267 0.627 . . . . 0.0 111.921 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.1 t -66.66 -30.59 70.89 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.272 0.629 . . . . 0.0 110.727 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.6 mp -72.49 115.48 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.729 0.812 . . . . 0.0 109.733 -177.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -85.85 -44.35 12.52 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.765 0.826 . . . . 0.0 110.184 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.3 m -139.46 133.5 31.02 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.545 0.738 . . . . 0.0 111.436 -172.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.1 t -105.08 110.75 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 170.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 40.0 mm-40 -111.37 175.5 5.4 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.973 0.909 . . . . 0.0 110.488 -177.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -40.47 -56.6 2.01 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 125.648 1.579 . . . . 0.0 113.013 -171.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.541 ' H ' ' HD2' ' A' ' 52' ' ' ARG . . . -140.3 35.73 1.86 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HD2' ' H ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -137.86 151.56 48.19 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.524 0.73 . . . . 0.0 109.564 -176.431 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.461 ' HB ' HG22 ' A' ' 11' ' ' VAL . 31.1 mm -132.11 104.06 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 124.556 1.142 . . . . 0.0 108.432 172.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.8 t -84.48 115.88 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.1 pt -107.3 141.33 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.68 0.792 . . . . 0.0 109.518 173.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.82 -61.45 1.77 Allowed Glycine 0 C--N 1.345 1.047 0 N-CA-C 112.231 -0.348 . . . . 0.0 112.231 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -156.48 162.65 39.96 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.834 0.853 . . . . 0.0 109.451 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -171.01 162.72 7.28 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.76 0.824 . . . . 0.0 109.947 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.03 86.7 1.03 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.52 -36.55 71.08 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.98 0.912 . . . . 0.0 113.241 -171.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -68.05 -38.22 82.2 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 41.4 mt-10 -74.14 -34.66 63.93 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.842 176.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.21 -24.54 63.13 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.836 0.455 . . . . 0.0 110.959 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -74.2 -44.59 52.65 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.104 0.962 . . . . 0.0 110.161 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.7 pt-20 -70.11 -38.47 75.63 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 39' ' ' ALA . 4.5 pp -82.97 -13.41 56.04 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 120.983 0.42 . . . . 0.0 110.651 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.69 -43.77 50.63 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.133 169.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.518 ' HA ' HD23 ' A' ' 71' ' ' LEU . 25.7 ptt85 -73.83 -22.5 59.76 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 116.766 0.283 . . . . 0.0 110.542 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 24.8 ttpp -64.82 -33.9 77.08 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 169.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -66.45 -35.6 80.7 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 119.638 -0.22 . . . . 0.0 110.832 170.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.4 mm? -61.43 -23.0 65.53 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.29 0.496 . . . . 0.0 111.407 173.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 69' ' ' LYS . 13.3 tp10 . . . . . 0 CA--C 1.56 1.345 0 C-N-CA 123.305 0.642 . . . . 0.0 110.47 169.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.403 ' HB2' HG12 ' A' ' 53' ' ' ILE . 59.0 mtt . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -79.13 111.22 15.13 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.443 HG22 ' HB ' ' A' ' 53' ' ' ILE . 61.6 t -86.78 127.93 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.702 0.801 . . . . 0.0 110.781 -175.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -108.82 123.02 48.39 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.323 1.449 . . . . 0.0 109.167 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 87.1 tttt -80.94 90.13 5.92 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.2 -95.58 0.59 Allowed Glycine 0 C--N 1.342 0.914 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.329 -173.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -117.65 -10.52 10.55 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.918 0.887 . . . . 0.0 111.887 -176.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 11.3 pt-20 -90.87 146.61 23.78 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.4 t -81.67 102.28 10.6 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -76.32 -55.64 5.37 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.443 0.697 . . . . 0.0 111.14 -172.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.589 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 178.75 -137.26 3.16 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-O 120.066 -0.297 . . . . 0.0 112.513 -177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -145.2 136.53 25.07 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.062 0.945 . . . . 0.0 109.68 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 31.6 p -76.85 118.25 19.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.729 0.812 . . . . 0.0 110.161 175.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.04 -35.05 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.965 0.906 . . . . 0.0 109.82 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -150.09 175.34 11.82 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.963 0.505 . . . . 0.0 110.455 -173.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.438 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.1 p -152.8 139.34 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.503 1.121 . . . . 0.0 108.773 171.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -141.46 127.12 19.04 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.99 -106.37 0.98 Allowed Glycine 0 CA--C 1.531 1.068 0 O-C-N 123.514 0.509 . . . . 0.0 113.733 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -109.81 15.12 22.92 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.154 0.982 . . . . 0.0 111.709 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.61 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 96.9 m-85 -135.16 113.82 11.74 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 118.302 0.501 . . . . 0.0 111.888 -172.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.438 HD12 ' HB ' ' A' ' 24' ' ' VAL . 42.8 tp -80.29 111.81 17.03 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.909 1.283 . . . . 0.0 109.367 172.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.6 mm -71.77 99.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.343 0.657 . . . . 0.0 109.72 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 47.6 t -100.34 112.42 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.762 0.825 . . . . 0.0 109.046 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -89.3 123.05 33.14 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.589 HG12 ' HA3' ' A' ' 19' ' ' GLY . 1.3 m -128.08 133.33 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 173.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.81 -91.64 0.05 OUTLIER Glycine 0 N--CA 1.474 1.171 0 C-N-CA 123.287 0.47 . . . . 0.0 113.82 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 t -125.03 -13.26 6.86 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.308 1.043 . . . . 0.0 112.039 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -111.25 156.13 21.94 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -170.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -104.39 108.77 20.35 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 172.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.23 104.53 14.67 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.61 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -83.55 93.99 7.96 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.442 HG12 ' CE2' ' A' ' 58' ' ' PHE . 3.9 m -78.04 137.34 61.34 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 44' ' ' SER . 31.1 Cg_endo -62.37 138.43 71.19 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.241 1.961 . . . . 0.0 111.287 175.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.514 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.5 mmmm -62.75 -29.94 71.06 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.653 0.781 . . . . 0.0 111.528 -177.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -70.82 -18.24 62.73 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.028 0.931 . . . . 0.0 112.244 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.516 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 26.0 t -72.55 -27.12 62.03 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.918 0.487 . . . . 0.0 111.186 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.6 mp -61.98 115.5 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.811 0.444 . . . . 0.0 110.25 -176.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -76.41 -47.69 22.34 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.326 1.05 . . . . 0.0 110.599 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.9 m -143.45 124.69 14.58 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.136 0.574 . . . . 0.0 110.676 -173.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.0 t -93.21 109.24 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 166.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.675 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 16.3 mm-40 -108.53 165.71 11.32 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.125 1.37 . . . . 0.0 108.607 174.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.08 99.48 1.11 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.829 0.452 . . . . 0.0 110.453 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.7 14.12 73.85 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.201 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.675 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 28.3 mtm180 -142.83 125.51 15.92 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.172 0.989 . . . . 0.0 108.761 -175.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.443 ' HB ' HG22 ' A' ' 11' ' ' VAL . 34.8 mm -118.86 101.2 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 63.8 t -84.26 117.57 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 12.9 pt -109.74 164.56 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.876 0.871 . . . . 0.0 109.648 176.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.59 -87.65 1.36 Allowed Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 -173.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -142.95 144.42 32.36 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.113 0.965 . . . . 0.0 108.95 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.442 ' CE2' HG12 ' A' ' 40' ' ' VAL . 6.1 p90 -167.19 150.97 6.6 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -87.14 99.7 12.12 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.66 -29.54 69.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.186 0.994 . . . . 0.0 112.707 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.83 -42.72 85.34 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.971 0.415 . . . . 0.0 110.188 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.72 -37.5 82.32 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.26 -24.6 65.81 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.042 0.937 . . . . 0.0 111.379 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.63 -46.36 38.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.47 1.108 . . . . 0.0 110.216 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.36 -37.95 74.7 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 123.237 0.335 . . . . 0.0 111.259 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 39' ' ' ALA . 4.3 pp -82.26 -16.28 50.05 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-O 120.647 0.26 . . . . 0.0 110.441 175.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -76.55 -35.95 39.77 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.653 173.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -77.89 -21.96 50.47 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 172.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -65.0 -35.62 81.79 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 169.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.416 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 59.9 t90 -59.89 -51.49 69.49 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 123.395 0.434 . . . . 0.0 109.87 170.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.4 mt -49.49 -38.63 30.87 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 123.616 0.766 . . . . 0.0 111.504 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 . . . . . 0 CA--C 1.55 0.948 0 C-N-CA 124.55 1.14 . . . . 0.0 111.593 179.869 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.407 ' SD ' ' HA2' ' A' ' 51' ' ' GLY . 42.1 tpp . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -69.9 128.96 38.2 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.0 t -100.21 139.06 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.228 0.611 . . . . 0.0 110.31 -177.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -130.1 127.54 40.05 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.205 1.402 . . . . 0.0 108.89 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -76.96 96.27 4.33 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.07 -95.25 0.34 Allowed Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -168.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -117.58 -23.45 7.66 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.746 0.818 . . . . 0.0 111.783 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -79.99 145.2 32.67 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.7 t -71.52 111.12 6.56 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.843 0.354 . . . . 0.0 110.586 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -83.91 -55.66 4.11 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.334 0.654 . . . . 0.0 109.729 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.28 -131.41 1.43 Allowed Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.827 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -148.82 137.12 21.03 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.202 1.401 . . . . 0.0 108.022 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.3 t -74.11 135.25 42.91 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.79 -35.42 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.761 0.824 . . . . 0.0 109.541 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -151.4 165.8 33.0 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.267 0.627 . . . . 0.0 110.205 -173.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.414 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.1 p -147.91 132.47 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.115 0.966 . . . . 0.0 108.461 169.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.422 ' CE1' HD11 ' A' ' 30' ' ' ILE . 1.4 p90 -141.1 138.98 33.91 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.55 -105.37 0.97 Allowed Glycine 0 CA--C 1.528 0.865 0 O-C-N 123.226 0.329 . . . . 0.0 112.527 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -120.07 5.25 10.84 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.71 0.804 . . . . 0.0 111.644 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -115.66 119.22 35.39 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.174 0.59 . . . . 0.0 111.53 -169.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.414 HD12 ' HB ' ' A' ' 24' ' ' VAL . 30.1 tp -79.52 109.14 13.62 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.871 0.868 . . . . 0.0 108.921 171.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.422 HD11 ' CE1' ' A' ' 25' ' ' TYR . 43.1 mm -73.53 104.39 2.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.3 t -99.52 112.56 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.952 0.901 . . . . 0.0 109.74 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -75.92 107.29 8.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.676 0.791 . . . . 0.0 109.2 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -91.8 155.92 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 167.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -44.98 -28.35 1.76 Allowed Glycine 0 CA--C 1.541 1.688 0 N-CA-C 116.258 1.263 . . . . 0.0 116.258 -172.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.9 p -96.16 -47.52 6.02 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.649 0.779 . . . . 0.0 112.339 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -143.1 -175.07 4.38 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.285 0.634 . . . . 0.0 111.714 -164.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.42 ' HB2' HD21 ' A' ' 71' ' ' LEU . 38.1 m-85 -115.43 109.84 18.44 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.097 0.959 . . . . 0.0 108.792 175.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.62 115.07 27.18 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.268 1.027 . . . . 0.0 108.467 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.503 ' HB3' HD12 ' A' ' 66' ' ' LEU . . . -82.2 92.96 6.98 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.409 0.623 . . . . 0.0 109.77 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.7 t -85.84 118.43 70.54 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.322 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.508 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 43.2 Cg_endo -62.07 148.66 92.75 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.215 1.943 . . . . 0.0 111.594 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.57 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.4 mmmm -66.1 -25.12 66.86 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.567 0.747 . . . . 0.0 112.04 -174.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.508 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 15.1 ptmm? -66.75 -23.38 66.08 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.894 0.878 . . . . 0.0 111.452 174.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.8 t -82.85 -30.11 28.9 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 123.034 0.534 . . . . 0.0 110.317 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.57 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.7 mp -62.77 114.05 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.264 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 174.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -85.68 -52.16 5.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.385 1.074 . . . . 0.0 110.161 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.0 m -144.22 154.24 42.91 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.059 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.19 109.37 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.429 1.092 . . . . 0.0 108.887 174.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.715 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 13.0 mm-40 -102.72 169.73 8.44 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.14 0.976 . . . . 0.0 109.644 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.87 93.63 1.35 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.952 0.501 . . . . 0.0 109.885 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.407 ' HA2' ' SD ' ' A' ' 9' ' ' MET . . . 93.32 2.77 65.59 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.261 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.715 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 92.7 mtt180 -133.6 141.19 47.55 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.355 0.662 . . . . 0.0 110.166 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.2 mm -118.16 103.72 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 168.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.7 t -76.7 113.78 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.428 HG22 HG13 ' A' ' 45' ' ' ILE . 31.4 pt -109.2 156.95 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.299 0.64 . . . . 0.0 109.492 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.67 -140.22 6.72 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.382 -168.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -78.49 123.03 26.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.389 0.676 . . . . 0.0 111.183 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -158.84 148.63 19.24 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 125.111 1.365 . . . . 0.0 108.035 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -72.19 101.75 2.89 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.18 -28.99 64.63 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.894 0.878 . . . . 0.0 112.154 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -72.21 -39.45 68.54 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.728 0.775 . . . . 0.0 110.094 176.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.19 -30.89 62.44 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.02 175.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.21 -25.02 64.11 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.271 0.629 . . . . 0.0 110.226 172.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -74.19 -41.12 61.94 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.486 0.714 . . . . 0.0 110.018 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.22 -42.22 69.19 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 118.128 0.422 . . . . 0.0 111.478 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 39' ' ' ALA . 4.5 pp -81.84 -14.54 56.14 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 120.839 0.352 . . . . 0.0 110.293 176.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -75.15 -44.4 23.22 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.469 171.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -28.57 63.17 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.318 0.559 . . . . 0.0 109.703 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -60.72 -39.66 89.42 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.619 170.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.483 ' HE3' HD22 ' A' ' 71' ' ' LEU . 86.1 t90 -59.46 -44.68 92.95 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.561 175.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.483 HD22 ' HE3' ' A' ' 70' ' ' TRP . 3.9 mm? -59.13 -32.15 69.6 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 176.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 CA--C 1.546 0.789 0 C-N-CA 122.826 0.45 . . . . 0.0 110.391 178.221 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.8 ttm . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -82.95 156.03 23.7 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.164 0.585 . . . . 0.0 109.737 170.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.465 HG22 ' HB ' ' A' ' 53' ' ' ILE . 81.3 t -121.7 129.72 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.986 0.915 . . . . 0.0 109.968 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -119.8 121.28 38.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.787 1.235 . . . . 0.0 108.726 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -78.86 86.48 4.77 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.38 -96.57 0.64 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.879 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -105.82 -18.74 13.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.635 0.774 . . . . 0.0 111.579 -176.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -98.25 156.45 16.7 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.832 0.453 . . . . 0.0 110.332 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 t -81.69 119.67 24.14 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -93.69 -55.75 3.15 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.263 0.625 . . . . 0.0 110.78 -173.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.05 -151.63 7.95 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.201 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -135.1 123.22 22.85 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.425 0.69 . . . . 0.0 109.431 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.514 ' HB2' HD11 ' A' ' 29' ' ' LEU . 12.9 p -71.14 108.43 4.66 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -39.15 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 123.507 0.723 . . . . 0.0 109.707 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -142.97 166.22 25.22 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.468 0.707 . . . . 0.0 109.59 -175.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -152.27 130.27 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.792 0.837 . . . . 0.0 108.819 173.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.411 ' HE1' HD11 ' A' ' 30' ' ' ILE . 3.4 p90 -142.22 134.3 27.45 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.05 -106.71 1.18 Allowed Glycine 0 CA--C 1.531 1.073 0 O-C-N 123.441 0.463 . . . . 0.0 113.277 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -119.63 18.14 12.74 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.778 0.831 . . . . 0.0 111.234 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.595 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 55.4 m-85 -126.08 113.17 16.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.927 0.491 . . . . 0.0 111.21 -175.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 21' ' ' SER . 62.6 tp -82.61 108.08 15.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.0 0.92 . . . . 0.0 109.219 171.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.411 HD11 ' HE1' ' A' ' 25' ' ' TYR . 39.2 mm -71.54 106.08 2.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.19 119.72 59.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.574 0.75 . . . . 0.0 109.861 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -74.31 109.18 7.59 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.285 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.6 m -116.15 103.19 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.521 1.128 . . . . 0.0 110.62 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.46 -89.03 0.05 OUTLIER Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.179 -0.919 . . . . 0.0 113.911 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.2 p -85.76 -41.19 15.3 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.222 1.009 . . . . 0.0 111.909 -174.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -150.03 -175.45 5.06 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -165.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -104.17 111.61 24.28 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.457 1.103 . . . . 0.0 110.686 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.1 mp -104.38 127.43 52.04 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -86.32 93.63 9.14 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.001 -175.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -72.14 115.54 39.66 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.586 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.5 149.97 89.14 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.735 2.29 . . . . 0.0 112.09 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.5 mmmm -67.26 -16.87 64.53 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -65.5 -30.9 71.72 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.085 0.554 . . . . 0.0 110.816 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' A' ' 58' ' ' PHE . 37.3 t -76.68 -32.62 58.03 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.649 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.58 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.8 mp -63.75 114.62 2.06 Favored 'Isoleucine or valine' 0 C--N 1.359 0.98 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -95.57 -53.55 3.69 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.36 1.064 . . . . 0.0 110.771 -172.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.0 t -150.09 134.26 17.13 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 122.998 0.519 . . . . 0.0 110.003 -173.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 p -98.66 111.75 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.466 0.65 . . . . 0.0 110.178 177.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 30.6 mm-40 -103.81 173.11 6.44 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.159 0.984 . . . . 0.0 111.07 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.31 101.06 1.43 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.153 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.76 12.5 83.49 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.446 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.655 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 61.5 mtp180 -141.42 135.7 30.63 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.645 0.778 . . . . 0.0 110.044 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.465 ' HB ' HG22 ' A' ' 11' ' ' VAL . 30.8 mm -109.11 103.04 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 167.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.8 t -78.36 112.06 15.92 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.6 pt -112.01 177.7 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.648 0.779 . . . . 0.0 109.826 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.05 -146.18 7.43 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 172.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.25 165.91 21.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.063 0.545 . . . . 0.0 110.072 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.51 ' HB3' ' HB2' ' A' ' 44' ' ' SER . 29.1 p90 -167.0 174.04 8.75 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.867 0.867 . . . . 0.0 109.209 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.14 86.28 1.38 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -70.86 -36.51 72.85 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.612 1.165 . . . . 0.0 112.417 -171.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -71.08 -33.83 70.58 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.045 0.538 . . . . 0.0 110.154 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -71.38 -40.56 70.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.093 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.98 -28.05 69.55 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.834 0.854 . . . . 0.0 111.303 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.36 -48.96 20.61 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.253 1.021 . . . . 0.0 110.414 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.09 -40.32 78.48 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.633 0.373 . . . . 0.0 111.561 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 pp -82.61 -17.18 45.68 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 122.185 -0.322 . . . . 0.0 110.441 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.05 -44.07 46.55 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.346 0.404 . . . . 0.0 112.362 174.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -71.02 -30.72 67.0 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -62.2 -42.33 99.19 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 53.2 t90 -58.23 -44.97 88.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.889 0.743 . . . . 0.0 110.672 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.8 mt -57.54 -28.58 63.64 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.298 0.639 . . . . 0.0 111.686 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 CA--C 1.557 1.241 0 C-N-CA 123.086 0.554 . . . . 0.0 111.242 172.877 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -90.59 135.98 33.35 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.006 0.432 . . . . 0.0 111.165 -173.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.426 HG21 HG22 ' A' ' 31' ' ' VAL . 99.9 t -91.78 130.38 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.72 0.808 . . . . 0.0 109.719 -177.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -118.27 127.37 53.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.664 1.186 . . . . 0.0 109.576 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 28.5 tptp -78.26 91.16 4.37 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 172.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.97 -95.67 0.65 Allowed Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 -171.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.71 -21.48 7.85 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.421 0.689 . . . . 0.0 110.74 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 14.8 pt-20 -79.43 144.23 34.28 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.5 t -70.28 111.18 5.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.794 0.438 . . . . 0.0 110.345 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -82.32 -51.18 8.14 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.096 0.558 . . . . 0.0 110.531 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.462 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . -179.55 -143.2 5.35 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.885 -177.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -136.96 133.52 35.71 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.72 0.808 . . . . 0.0 109.956 -177.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.413 ' OG ' HD11 ' A' ' 29' ' ' LEU . 30.2 t -75.02 106.5 6.55 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 172.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.27 -40.82 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.294 0.638 . . . . 0.0 109.313 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.446 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 22.8 t70 -149.14 172.22 15.16 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.372 0.669 . . . . 0.0 109.815 -171.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.404 ' HB ' HD12 ' A' ' 29' ' ' LEU . 9.9 p -152.1 145.17 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 124.334 1.054 . . . . 0.0 108.538 172.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -143.12 127.22 17.46 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 171.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.2 -106.86 1.12 Allowed Glycine 0 C--N 1.343 0.938 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.728 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 28.7 t70 -107.05 -15.18 14.75 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.071 0.948 . . . . 0.0 111.114 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.493 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 95.3 m-85 -97.34 107.56 20.1 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.558 0.695 . . . . 0.0 111.186 -171.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.413 HD11 ' OG ' ' A' ' 21' ' ' SER . 41.7 tp -76.31 113.29 13.72 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.956 174.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 49.7 mm -75.44 107.77 6.6 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.015 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.426 HG22 HG21 ' A' ' 11' ' ' VAL . 43.0 t -103.76 113.63 41.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 123.992 0.917 . . . . 0.0 109.314 178.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -75.94 114.99 15.19 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.462 HG12 ' HA3' ' A' ' 19' ' ' GLY . 34.1 m -127.45 129.84 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.959 0.904 . . . . 0.0 109.36 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.9 -100.11 0.27 Allowed Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.848 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.6 p -126.1 5.15 7.16 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.214 1.005 . . . . 0.0 112.008 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -134.21 169.65 16.87 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.154 0.582 . . . . 0.0 112.164 -173.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -112.9 123.87 51.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.364 1.065 . . . . 0.0 109.457 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.8 mp -107.22 115.61 30.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.964 0.906 . . . . 0.0 109.008 175.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.493 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -78.97 93.63 5.11 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.786 0.835 . . . . 0.0 109.724 177.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.484 HG12 ' CE2' ' A' ' 58' ' ' PHE . 4.0 m -89.04 134.5 33.21 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -176.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 97.9 Cg_endo -73.45 153.05 49.84 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.254 1.969 . . . . 0.0 111.242 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.584 ' HA ' HD13 ' A' ' 45' ' ' ILE . 13.8 mmmm -65.77 -24.28 66.91 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.487 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 7.8 ptpp? -66.38 -25.83 66.97 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.713 0.405 . . . . 0.0 111.361 173.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.3 t -69.1 -41.22 77.75 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.584 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.7 mp -66.71 114.49 3.69 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -78.71 -48.79 14.25 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.474 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.2 t -158.46 139.53 13.11 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.301 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 p -77.89 133.18 31.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 168.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.803 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 17.8 mm-40 -116.23 177.58 4.64 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.187 0.995 . . . . 0.0 110.04 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -64.02 93.14 0.08 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.858 0.863 . . . . 0.0 110.463 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.86 5.72 88.66 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 114.906 -1.043 . . . . 0.0 114.213 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.803 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 69.9 mtt85 -127.71 162.21 27.1 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.079 0.552 . . . . 0.0 110.728 -174.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.0 mm -133.27 103.34 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 174.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.5 t -83.45 120.64 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.0 pt -109.06 145.21 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 123.943 0.897 . . . . 0.0 109.174 170.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.26 -55.03 1.88 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 112.135 -0.386 . . . . 0.0 112.135 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 9.9 pt-20 -174.03 159.27 3.26 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.949 0.9 . . . . 0.0 110.552 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.484 ' CE2' HG12 ' A' ' 40' ' ' VAL . 8.1 p90 -171.11 174.18 4.75 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.463 0.705 . . . . 0.0 110.779 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -74.44 86.51 2.03 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.495 0.718 . . . . 0.0 109.483 172.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.15 -38.73 72.22 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.285 0.634 . . . . 0.0 112.669 -174.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.487 ' HG3' ' HG3' ' A' ' 62' ' ' GLU . 7.4 pt-20 -65.4 -38.24 89.37 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.491 0.717 . . . . 0.0 110.817 177.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.523 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 44.6 mt-10 -80.88 -32.79 34.74 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.809 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.75 -26.31 66.92 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.276 0.631 . . . . 0.0 110.611 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -72.69 -51.87 17.54 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.243 1.017 . . . . 0.0 111.179 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.523 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.7 pt-20 -69.84 -35.74 74.99 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.311 0.577 . . . . 0.0 110.809 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.22 -13.79 54.64 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.66 -27.53 69.09 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 165.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -69.96 -37.44 75.81 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.83 0.852 . . . . 0.0 108.854 167.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -59.59 -36.52 76.42 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 122.912 0.485 . . . . 0.0 110.875 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 59.7 t90 -60.95 -54.21 47.79 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 173.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.7 mt -54.92 -35.11 63.81 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.48 0.712 . . . . 0.0 111.447 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 CA--C 1.546 0.816 0 C-N-CA 124.224 1.01 . . . . 0.0 110.452 -176.773 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.453 ' SD ' HD11 ' A' ' 53' ' ' ILE . 61.0 mtt . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -84.28 130.33 34.82 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.403 0.681 . . . . 0.0 109.475 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.0 t -86.62 115.24 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.076 0.55 . . . . 0.0 109.937 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.64 117.58 35.19 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.116 0.967 . . . . 0.0 109.692 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 85.3 tttt -77.94 94.41 4.58 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.12 -94.85 0.47 Allowed Glycine 0 C--N 1.344 1.002 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -102.5 -42.91 5.8 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.735 0.814 . . . . 0.0 110.824 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.35 145.42 37.33 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.959 0.504 . . . . 0.0 110.935 -168.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.7 t -69.8 104.87 2.58 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 13' ' ' LYS . 46.9 t80 -74.95 -50.05 18.02 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.713 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.73 -141.4 3.94 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.82 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -140.18 130.73 25.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.371 0.668 . . . . 0.0 110.221 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.418 ' OG ' HD11 ' A' ' 29' ' ' LEU . 25.9 t -68.07 109.96 3.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.155 0.982 . . . . 0.0 109.542 174.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.05 -43.71 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.028 0.531 . . . . 0.0 109.851 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.428 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 22.6 t70 -143.35 167.61 21.75 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.74 0.416 . . . . 0.0 110.466 -171.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.2 t -139.71 140.97 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 124.421 1.089 . . . . 0.0 108.133 174.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -141.39 129.91 22.61 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 169.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.36 -107.4 1.35 Allowed Glycine 0 C--N 1.35 1.326 0 O-C-N 123.304 0.378 . . . . 0.0 113.268 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -119.21 24.53 10.7 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.55 0.74 . . . . 0.0 110.918 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.53 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 96.0 m-85 -133.39 124.85 27.9 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.247 0.619 . . . . 0.0 111.375 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.418 HD11 ' OG ' ' A' ' 21' ' ' SER . 55.8 tp -80.55 113.99 19.13 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.406 1.083 . . . . 0.0 109.562 170.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 42.8 mm -72.74 106.07 2.69 Favored 'Isoleucine or valine' 0 C--O 1.249 1.063 0 C-N-CA 123.234 0.614 . . . . 0.0 109.51 175.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.0 t -103.28 118.42 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.151 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -74.97 116.87 16.18 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 m -126.05 99.2 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.953 0.901 . . . . 0.0 110.614 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.29 -89.53 0.1 Allowed Glycine 0 CA--C 1.531 1.073 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.873 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 72.5 p -114.91 -21.99 9.83 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.121 0.968 . . . . 0.0 111.272 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -109.07 174.44 5.87 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.647 0.737 . . . . 0.0 111.363 -172.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -120.96 108.6 14.07 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.238 173.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -96.66 106.07 18.28 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -82.83 93.33 7.44 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.297 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.6 m -77.67 136.7 63.2 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.554 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 35.8 Cg_endo -62.4 149.37 91.06 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 121.905 1.737 . . . . 0.0 111.289 176.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.566 ' HA ' HD13 ' A' ' 45' ' ' ILE . 32.0 mmmt -63.59 -26.21 68.58 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.013 0.525 . . . . 0.0 111.8 -178.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.554 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 0.4 OUTLIER -67.71 -23.43 65.28 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.677 0.791 . . . . 0.0 111.449 175.725 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -72.3 -27.36 62.41 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.784 0.434 . . . . 0.0 110.616 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.566 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.1 mp -67.91 115.65 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -92.03 -48.54 6.69 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.254 1.022 . . . . 0.0 110.974 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.1 t -138.49 147.63 43.4 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.402 -175.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.5 p -122.0 126.05 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.357 1.063 . . . . 0.0 109.099 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 40.5 mt-10 -138.11 168.54 19.52 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.286 1.035 . . . . 0.0 109.537 -175.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.72 99.87 0.25 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.124 0.57 . . . . 0.0 110.432 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.15 1.06 88.65 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 115.905 -0.589 . . . . 0.0 113.643 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 33.7 mtm180 -130.97 124.94 32.09 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.514 0.657 . . . . 0.0 110.284 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.453 HD11 ' SD ' ' A' ' 9' ' ' MET . 50.8 mm -115.06 102.14 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 170.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.9 t -86.11 115.23 27.02 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.7 pt -107.04 175.14 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 123.569 0.747 . . . . 0.0 109.357 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.04 -142.88 8.21 Favored Glycine 0 C--O 1.24 0.507 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -81.56 157.12 24.89 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 174.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -167.37 170.66 11.27 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.892 0.877 . . . . 0.0 109.201 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -81.16 93.52 6.47 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -71.23 -39.94 71.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.074 0.95 . . . . 0.0 112.74 -171.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -65.34 -37.88 88.41 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.009 0.433 . . . . 0.0 110.491 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -71.9 -37.64 70.09 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.568 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.12 -34.32 77.35 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.508 0.723 . . . . 0.0 111.333 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 6.7 ptp85 -74.39 -44.72 50.87 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 119.112 -0.47 . . . . 0.0 111.157 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.98 -37.57 86.32 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 118.275 0.489 . . . . 0.0 111.602 -175.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -81.63 -21.15 38.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 122.478 0.311 . . . . 0.0 110.399 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.43 -33.78 68.15 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.039 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.465 ' HA ' HD12 ' A' ' 71' ' ' LEU . 59.0 mtp180 -77.41 -30.55 53.55 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.359 1.064 . . . . 0.0 109.853 175.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -63.28 -39.51 94.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.141 0.576 . . . . 0.0 109.715 170.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -60.24 -45.36 93.52 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.985 0.514 . . . . 0.0 109.917 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 68' ' ' ARG . 50.4 mt -58.53 -23.41 58.18 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.797 0.839 . . . . 0.0 112.517 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 CA--C 1.554 1.115 0 C-N-CA 122.706 0.402 . . . . 0.0 110.728 174.719 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.406 ' SD ' HD11 ' A' ' 53' ' ' ILE . 18.5 ttt . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.875 -0.416 . . . . 0.0 109.875 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -72.82 141.27 48.02 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.6 t -119.49 127.75 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.578 0.751 . . . . 0.0 110.02 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -109.35 132.91 53.68 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.228 1.011 . . . . 0.0 109.044 171.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -83.98 82.39 8.37 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.83 -100.58 0.85 Allowed Glycine 0 C--N 1.344 0.986 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.239 -177.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -97.16 -28.07 14.27 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.851 0.86 . . . . 0.0 110.879 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -92.15 152.31 19.96 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.811 0.444 . . . . 0.0 110.119 -176.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.1 t -74.16 125.14 27.71 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.305 0.642 . . . . 0.0 109.349 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -98.46 -58.59 1.93 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 121.957 0.103 . . . . 0.0 110.848 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.53 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 172.66 -141.43 6.22 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.413 0.446 . . . . 0.0 112.196 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -144.86 137.98 26.68 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.826 0.85 . . . . 0.0 110.13 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.7 p -73.61 118.2 16.28 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 175.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.21 -37.82 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.589 0.756 . . . . 0.0 109.042 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -156.27 176.83 12.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.977 0.511 . . . . 0.0 110.822 -175.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.4 p -150.17 138.28 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.46 1.104 . . . . 0.0 108.868 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -136.21 133.69 37.36 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.67 -106.62 1.22 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 123.463 0.477 . . . . 0.0 113.793 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -117.14 11.63 14.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.903 0.881 . . . . 0.0 111.026 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.577 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 81.8 m-85 -125.15 111.56 15.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.039 0.535 . . . . 0.0 111.549 -173.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 57.7 tp -77.82 110.35 12.62 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.507 1.123 . . . . 0.0 109.485 173.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.0 mm -71.94 100.11 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.26 0.624 . . . . 0.0 109.606 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.06 113.22 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.428 0.691 . . . . 0.0 109.787 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -76.24 120.05 20.98 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.669 0.787 . . . . 0.0 109.882 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.53 HG12 ' HA3' ' A' ' 19' ' ' GLY . 1.3 m -132.45 142.04 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.7 -96.21 0.03 OUTLIER Glycine 0 CA--C 1.537 1.456 0 O-C-N 123.274 0.359 . . . . 0.0 113.966 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.3 m -124.49 -16.39 6.34 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.509 1.124 . . . . 0.0 111.023 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -114.72 166.88 11.27 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.934 0.893 . . . . 0.0 112.149 -170.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -113.65 112.25 23.18 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.211 1.004 . . . . 0.0 109.751 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.424 HD23 HG22 ' A' ' 33' ' ' VAL . 3.5 mm? -94.55 105.95 17.92 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.932 0.893 . . . . 0.0 109.175 176.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.577 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -77.82 92.37 4.22 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 172.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.9 m -86.22 136.63 35.54 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.65 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.542 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 37.7 Cg_endo -63.33 151.28 85.68 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.221 1.947 . . . . 0.0 111.36 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.565 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.4 mmmm -67.3 -23.26 65.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.953 0.501 . . . . 0.0 111.457 -176.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.542 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 22.4 ptmt -69.61 -26.55 64.5 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.686 0.794 . . . . 0.0 111.457 174.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.3 t -65.35 -31.29 72.33 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.269 0.628 . . . . 0.0 110.604 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.565 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.0 mp -64.95 116.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -92.28 -52.1 4.84 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.153 0.981 . . . . 0.0 110.936 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 t -148.83 139.87 23.02 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.566 -171.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.2 t -102.92 110.75 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 173.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.09 130.89 22.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 63.28 33.88 13.73 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.415 1.086 . . . . 0.0 112.944 166.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.92 15.98 80.71 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 121.316 0.398 . . . . 0.0 112.326 -177.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -125.15 158.21 34.48 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.68 1.192 . . . . 0.0 109.063 -175.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.406 HD11 ' SD ' ' A' ' 9' ' ' MET . 28.6 mm -120.47 104.91 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.634 0.774 . . . . 0.0 109.55 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.9 t -80.0 113.01 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' A' ' 45' ' ' ILE . 37.4 pt -109.49 142.75 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.79 -74.48 1.2 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -152.73 164.19 38.24 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.63 0.772 . . . . 0.0 109.685 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -170.51 163.89 8.43 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 124.377 1.071 . . . . 0.0 108.298 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -77.77 97.09 5.09 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.05 -35.99 82.92 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.589 0.756 . . . . 0.0 112.007 -174.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -62.6 -45.54 92.42 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.682 0.614 . . . . 0.0 110.484 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.412 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 35.1 mt-10 -70.29 -38.7 75.08 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.887 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.17 -38.55 91.46 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.569 0.748 . . . . 0.0 111.363 -176.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -74.41 -38.4 63.08 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.326 0.25 . . . . 0.0 111.582 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.412 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.8 pt-20 -76.75 -40.86 47.01 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -176.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 pp -82.47 -12.99 57.46 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.0 0.429 . . . . 0.0 109.996 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.99 -48.45 75.72 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 162.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.0 mtt-85 -63.48 -31.94 73.25 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.901 0.881 . . . . 0.0 111.511 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -55.9 -48.78 75.01 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.115 0.566 . . . . 0.0 109.514 172.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.577 ' HE3' HD12 ' A' ' 71' ' ' LEU . 79.9 t90 -60.25 -42.56 95.57 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 123.309 0.38 . . . . 0.0 110.663 174.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.577 HD12 ' HE3' ' A' ' 70' ' ' TRP . 10.6 mp -57.0 -28.95 62.89 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 122.666 0.387 . . . . 0.0 112.027 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 122.958 0.503 . . . . 0.0 110.285 176.444 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.2 mtt . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -71.65 110.88 6.5 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.304 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.4 HG22 ' HB ' ' A' ' 53' ' ' ILE . 58.5 t -79.27 124.7 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.813 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -113.61 121.89 45.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.032 0.933 . . . . 0.0 109.035 175.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 52.6 tttm -84.1 79.3 9.56 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.65 0.738 . . . . 0.0 109.624 175.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.61 -94.26 0.41 Allowed Glycine 0 C--N 1.342 0.9 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.831 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -96.9 -13.26 22.57 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.71 0.804 . . . . 0.0 111.591 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 10.0 pt-20 -116.09 153.6 31.45 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.533 0.733 . . . . 0.0 109.609 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.3 t -85.02 112.73 20.88 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -80.34 -56.8 3.94 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.531 0.333 . . . . 0.0 110.535 -172.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 178.18 -135.43 2.67 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.124 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -148.91 142.79 25.72 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.986 0.914 . . . . 0.0 109.985 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.1 p -74.52 108.3 7.19 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.497 0.719 . . . . 0.0 110.69 -178.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.87 -38.72 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.193 0.597 . . . . 0.0 110.117 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -153.66 172.4 17.31 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.39 0.676 . . . . 0.0 109.888 -172.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 p -155.66 132.68 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.888 0.875 . . . . 0.0 109.069 173.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.457 ' CE1' HD11 ' A' ' 30' ' ' ILE . 3.9 p90 -135.66 133.63 38.35 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.64 -105.43 1.23 Allowed Glycine 0 C--N 1.346 1.116 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -117.57 -0.85 11.78 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.841 0.856 . . . . 0.0 110.083 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.562 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 30.5 m-85 -104.1 106.21 16.64 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.706 -166.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 50.1 tp -75.84 105.65 6.99 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.457 HD11 ' CE1' ' A' ' 25' ' ' TYR . 38.0 mm -68.51 106.69 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.895 176.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.2 t -99.66 116.24 42.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -72.7 107.65 5.28 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 174.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.43 HG23 ' HB2' ' A' ' 36' ' ' GLU . 19.1 m -113.63 83.6 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.434 1.094 . . . . 0.0 110.579 -173.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.61 -82.06 0.5 Allowed Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.066 -0.97 . . . . 0.0 113.612 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 t -122.48 -11.08 8.35 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.853 0.861 . . . . 0.0 110.847 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.43 ' HB2' HG23 ' A' ' 33' ' ' VAL . 65.0 mm-40 -111.62 177.91 4.5 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.605 0.762 . . . . 0.0 110.55 -178.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.568 ' HB2' HD11 ' A' ' 71' ' ' LEU . 42.7 m-85 -134.29 110.93 9.82 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 169.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -105.54 126.82 52.56 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.562 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -95.37 100.74 12.47 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.971 0.908 . . . . 0.0 110.472 -173.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.1 m -85.32 137.47 36.9 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 122.95 0.5 . . . . 0.0 109.896 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.16 160.47 41.82 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.392 2.061 . . . . 0.0 111.565 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -67.07 -23.69 65.89 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.504 0.322 . . . . 0.0 111.671 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -70.81 -22.78 62.3 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.262 0.625 . . . . 0.0 111.933 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.2 t -64.1 -32.44 74.0 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.079 0.552 . . . . 0.0 110.932 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mp -68.32 114.0 4.71 Favored 'Isoleucine or valine' 0 C--N 1.356 0.856 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -87.11 -41.26 13.94 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.596 1.158 . . . . 0.0 111.268 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.9 m -149.68 147.89 28.62 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.517 0.727 . . . . 0.0 110.594 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 p -110.48 117.09 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.624 0.77 . . . . 0.0 109.516 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 9.7 mm-40 -98.91 166.82 11.11 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.91 -26.98 39.55 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.198 0.999 . . . . 0.0 113.413 -174.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.49 22.27 1.2 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 112.148 -0.381 . . . . 0.0 112.148 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.64 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 95.4 mtt180 -136.53 159.08 42.87 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.444 0.698 . . . . 0.0 109.78 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.4 ' HB ' HG22 ' A' ' 11' ' ' VAL . 48.0 mm -126.58 103.22 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 172.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.1 t -82.03 113.17 20.93 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.425 HG13 ' HA ' ' A' ' 13' ' ' LYS . 37.4 pt -106.51 162.25 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 168.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -123.33 -65.17 0.21 Allowed Glycine 0 CA--C 1.503 -0.706 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -177.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -128.4 143.21 50.97 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.379 0.672 . . . . 0.0 110.16 -170.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -173.85 150.92 1.72 Allowed 'General case' 0 C--O 1.246 0.92 0 C-N-CA 125.578 1.551 . . . . 0.0 107.192 173.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -71.5 106.12 3.85 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -70.07 -35.53 74.29 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.096 0.958 . . . . 0.0 112.429 -169.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -69.18 -36.0 76.86 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.962 0.505 . . . . 0.0 110.735 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -67.69 -43.01 81.14 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.306 175.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.83 -25.67 66.55 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.68 0.792 . . . . 0.0 111.145 175.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -49.03 25.37 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.642 0.777 . . . . 0.0 109.33 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.61 -41.04 66.01 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.759 0.424 . . . . 0.0 111.738 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 69' ' ' LYS . 2.6 pp -82.46 -15.86 50.98 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 120.889 0.376 . . . . 0.0 110.25 176.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.5 -54.25 13.66 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.863 170.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.415 ' HA ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -68.27 -23.08 64.73 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.461 0.704 . . . . 0.0 110.874 178.931 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 38.7 tttm -57.85 -48.81 78.7 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.93 0.892 . . . . 0.0 109.978 168.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -60.22 -35.71 76.06 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.225 0.61 . . . . 0.0 111.251 174.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 37' ' ' PHE . 10.7 mp -63.16 -30.32 71.49 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 122.976 0.511 . . . . 0.0 111.647 174.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.642 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.552 ' HB3' HG12 ' A' ' 53' ' ' ILE . 14.7 mmt . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.34 0.114 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -85.65 121.17 27.94 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.516 0.726 . . . . 0.0 109.388 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.433 HG21 HG22 ' A' ' 31' ' ' VAL . 88.0 t -86.4 124.75 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.26 0.624 . . . . 0.0 110.67 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.02 124.01 48.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.327 1.051 . . . . 0.0 110.262 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 63.9 tttm -82.78 93.92 7.53 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.67 -100.48 1.32 Allowed Glycine 0 C--N 1.34 0.767 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -167.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.46 -1.33 9.11 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.493 0.717 . . . . 0.0 111.741 177.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 10.8 pt-20 -90.4 148.42 22.81 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 118.682 0.674 . . . . 0.0 110.995 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 t -67.42 97.79 0.6 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.844 0.857 . . . . 0.0 109.703 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -85.7 -53.29 5.24 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.637 0.375 . . . . 0.0 110.245 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.58 -152.5 10.1 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.344 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -141.96 134.07 27.59 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.778 0.831 . . . . 0.0 109.815 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.7 t -66.76 105.63 1.62 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.15 -34.28 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.592 0.757 . . . . 0.0 109.596 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -158.39 178.21 10.41 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.406 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.1 p -155.52 142.22 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.739 0.816 . . . . 0.0 109.206 173.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -139.9 128.29 22.73 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.52 -105.78 0.9 Allowed Glycine 0 CA--C 1.531 1.045 0 O-C-N 123.512 0.507 . . . . 0.0 113.786 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -116.95 11.49 14.36 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.204 1.001 . . . . 0.0 111.723 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.546 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 57.3 m-85 -125.29 115.93 21.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.727 0.411 . . . . 0.0 110.457 -176.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.406 HD12 ' HB ' ' A' ' 24' ' ' VAL . 45.0 tp -78.63 111.66 14.93 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.285 1.034 . . . . 0.0 109.255 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' A' ' 39' ' ' ALA . 39.8 mm -71.19 109.42 3.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 123.105 0.562 . . . . 0.0 109.635 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.433 HG22 HG21 ' A' ' 11' ' ' VAL . 60.8 t -107.43 114.63 46.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.306 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -74.85 109.6 8.45 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.2 m -107.1 85.41 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 124.494 1.118 . . . . 0.0 110.459 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.91 -83.09 0.31 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.207 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.4 p -110.37 -27.51 9.02 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.207 1.003 . . . . 0.0 111.889 -176.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -111.23 162.25 15.16 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.112 0.565 . . . . 0.0 111.356 -173.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -108.78 109.32 20.43 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 170.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.6 mt -105.36 118.73 37.3 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.546 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -83.47 97.36 8.95 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.608 -177.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.1 t -78.64 115.93 55.61 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.168 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.77 145.48 49.66 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.015 2.477 . . . . 0.0 112.779 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -68.92 -21.12 64.23 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.953 0.901 . . . . 0.0 112.032 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.422 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -74.58 -13.64 60.68 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.048 0.539 . . . . 0.0 111.635 174.498 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.8 m -94.89 3.46 54.95 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.127 0.971 . . . . 0.0 111.99 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.0 mm -82.36 122.78 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.418 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 72.8 mmtt -72.55 -51.2 20.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.61 0.764 . . . . 0.0 110.067 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.1 t -166.03 149.02 7.38 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.43 0.692 . . . . 0.0 110.38 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.3 t -97.6 111.19 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.671 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 31.8 mt-10 -91.6 179.14 5.73 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.065 0.546 . . . . 0.0 110.655 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -40.07 -53.29 2.43 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.782 1.633 . . . . 0.0 113.429 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -140.5 33.24 2.08 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.671 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 68.9 mtt180 -135.26 147.55 49.3 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.449 0.699 . . . . 0.0 110.138 -175.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.552 HG12 ' HB3' ' A' ' 9' ' ' MET . 35.9 mm -116.71 101.63 12.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 168.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 50.8 t -80.17 115.06 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.6 pt -109.58 159.33 9.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.881 0.872 . . . . 0.0 109.207 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.418 ' HA3' ' HE2' ' A' ' 46' ' ' LYS . . . -90.45 -81.77 1.38 Allowed Glycine 0 C--O 1.242 0.629 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -159.87 176.25 12.12 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.061 0.945 . . . . 0.0 109.309 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -164.44 165.35 21.53 Favored 'General case' 0 C--O 1.25 1.127 0 C-N-CA 124.663 1.185 . . . . 0.0 108.13 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -82.1 108.45 15.59 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.61 -20.43 65.35 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.85 -173.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -69.21 -43.67 73.64 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.507 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 50.2 mt-10 -64.26 -55.97 17.78 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.857 175.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.67 -25.05 59.67 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.594 0.758 . . . . 0.0 112.532 -176.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -70.61 -52.67 19.85 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.909 0.884 . . . . 0.0 110.865 175.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -76.38 -38.19 56.11 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -171.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 62' ' ' GLU . 4.6 pp -81.83 -25.13 35.42 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 122.274 -0.266 . . . . 0.0 110.473 174.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.9 -44.67 94.27 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.547 ' HA ' HD23 ' A' ' 71' ' ' LEU . 3.5 ptm180 -74.75 -21.16 59.5 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.411 0.685 . . . . 0.0 110.605 178.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -67.57 -31.87 72.23 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.467 ' HE3' HD22 ' A' ' 71' ' ' LEU . 85.4 t90 -69.71 -36.85 76.27 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 171.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.3 mm? -59.32 -29.81 67.9 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 172.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 CA--C 1.554 1.125 0 C-N-CA 123.104 0.562 . . . . 0.0 110.712 173.81 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -83.87 123.79 30.29 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.754 0.822 . . . . 0.0 109.945 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.444 HG21 HG22 ' A' ' 31' ' ' VAL . 54.5 t -85.47 105.57 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.352 0.661 . . . . 0.0 110.533 -175.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -100.41 123.73 45.0 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.837 0.855 . . . . 0.0 109.898 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -78.44 89.45 4.42 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.3 -96.85 0.57 Allowed Glycine 0 C--N 1.346 1.086 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.807 -170.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -107.69 -32.12 7.78 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.887 0.875 . . . . 0.0 110.692 177.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -74.68 142.33 44.47 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -174.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.3 t -76.3 104.29 6.75 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -76.19 -53.49 8.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.85 -163.32 28.9 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.594 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -120.27 144.22 47.9 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -74.9 147.42 41.02 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.39 -32.21 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -164.63 168.81 17.72 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.79 0.436 . . . . 0.0 110.373 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.501 ' HB ' HD12 ' A' ' 29' ' ' LEU . 3.1 p -150.52 140.2 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.342 1.057 . . . . 0.0 108.884 172.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.646 ' HE1' HD11 ' A' ' 30' ' ' ILE . 42.3 p90 -145.87 136.37 24.09 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.767 0.827 . . . . 0.0 109.608 174.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.79 -106.96 1.1 Allowed Glycine 0 C--N 1.344 0.999 0 O-C-N 123.826 0.703 . . . . 0.0 113.942 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -115.68 19.47 15.25 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.946 0.898 . . . . 0.0 110.682 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.534 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 73.9 m-85 -138.0 118.46 13.82 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.779 0.431 . . . . 0.0 111.802 -172.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.501 HD12 ' HB ' ' A' ' 24' ' ' VAL . 44.2 tp -88.32 116.53 26.6 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.133 0.973 . . . . 0.0 109.403 172.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.646 HD11 ' HE1' ' A' ' 25' ' ' TYR . 33.5 mm -78.8 111.8 16.09 Favored 'Isoleucine or valine' 0 C--O 1.251 1.182 0 C-N-CA 123.05 0.54 . . . . 0.0 109.857 176.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.444 HG22 HG21 ' A' ' 11' ' ' VAL . 44.5 t -111.19 125.0 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.65 1.18 . . . . 0.0 109.847 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -74.49 124.9 27.45 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.352 0.661 . . . . 0.0 109.514 170.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 m -135.47 107.78 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 125.309 1.443 . . . . 0.0 108.945 176.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.29 -105.17 1.5 Allowed Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.549 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 77.8 p -110.54 -5.7 15.05 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.18 0.992 . . . . 0.0 110.823 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -109.7 165.38 11.73 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.769 0.828 . . . . 0.0 110.872 -166.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.17 110.71 15.61 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.0 mp -102.96 117.27 34.22 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.306 1.042 . . . . 0.0 109.418 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.534 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -77.81 91.41 4.12 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.438 0.695 . . . . 0.0 109.986 176.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.05 118.81 73.39 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.095 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.489 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 36.3 Cg_endo -60.71 145.05 99.54 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.488 2.125 . . . . 0.0 111.672 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.621 ' HA ' HD13 ' A' ' 45' ' ' ILE . 12.5 mmmm -61.68 -24.13 66.55 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.196 0.999 . . . . 0.0 112.205 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.489 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 14.9 ptmm? -72.96 -21.43 60.86 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.575 0.75 . . . . 0.0 111.865 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.1 t -78.24 -28.02 47.73 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.058 0.543 . . . . 0.0 110.49 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.621 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.7 mp -65.14 115.02 2.95 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.537 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 75.1 mmtt -68.76 -53.73 20.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.974 0.91 . . . . 0.0 109.784 175.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 73.6 m -159.25 143.48 15.23 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.68 0.792 . . . . 0.0 110.844 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.4 p -85.92 115.76 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 168.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.756 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 8.2 mm-40 -107.68 178.71 4.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.12 0.968 . . . . 0.0 110.67 -175.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -66.54 95.41 0.33 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.223 0.609 . . . . 0.0 110.187 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.46 13.81 81.46 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.315 -0.402 . . . . 0.0 113.354 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.756 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 25.3 mtp180 -130.01 149.61 51.66 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.526 0.73 . . . . 0.0 110.189 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.1 mm -119.62 103.95 15.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 164.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.474 HG22 HH21 ' A' ' 52' ' ' ARG . 92.5 t -84.22 113.26 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.9 pt -109.51 179.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.53 1.132 . . . . 0.0 109.434 174.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' HA3' ' HE2' ' A' ' 46' ' ' LYS . . . -144.54 -112.74 0.83 Allowed Glycine 0 C--N 1.343 0.958 0 N-CA-C 112.138 -0.385 . . . . 0.0 112.138 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -89.26 136.23 33.14 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.469 0.708 . . . . 0.0 110.634 -172.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -167.0 174.24 8.57 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.821 1.248 . . . . 0.0 108.21 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -99.64 119.46 38.13 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.22 -28.05 66.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.717 0.807 . . . . 0.0 111.821 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -74.29 -37.21 63.74 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.57 0.544 . . . . 0.0 110.652 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -58.26 -50.6 73.03 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.24 -31.49 72.71 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.581 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -75.66 -48.75 20.76 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.138 0.575 . . . . 0.0 110.237 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.48 -38.98 74.47 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.389 0.614 . . . . 0.0 111.22 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.422 ' HG ' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -84.55 -20.0 32.23 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.394 0.678 . . . . 0.0 109.95 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -74.57 -41.97 34.25 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 172.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.612 ' HA ' HD23 ' A' ' 71' ' ' LEU . 8.5 ptm180 -74.35 -17.45 60.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.993 0.517 . . . . 0.0 109.834 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -65.78 -40.04 91.56 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 123.217 0.607 . . . . 0.0 109.484 169.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.446 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 78.2 t90 -60.34 -42.95 96.75 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.94 0.896 . . . . 0.0 111.188 174.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 68' ' ' ARG . 3.2 mm? -59.99 -37.1 78.68 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.548 171.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 . . . . . 0 CA--C 1.555 1.145 0 C-N-CA 124.131 0.972 . . . . 0.0 111.371 179.144 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 47.7 mtt . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.371 0.605 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -84.86 108.79 17.69 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.985 -170.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' A' ' 53' ' ' ILE . 97.0 t -80.55 117.91 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.948 0.899 . . . . 0.0 110.994 -175.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -112.9 117.7 32.84 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.229 1.012 . . . . 0.0 109.552 175.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 51.3 tttm -77.92 91.04 4.15 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.22 -92.22 0.85 Allowed Glycine 0 C--N 1.345 1.066 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -170.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -118.95 -23.64 6.83 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.889 0.876 . . . . 0.0 111.353 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 12.6 pt-20 -78.94 142.11 36.98 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.528 0.331 . . . . 0.0 110.159 -172.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.6 t -69.11 99.11 1.07 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.538 0.735 . . . . 0.0 109.262 176.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -79.48 -57.53 3.65 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.05 -137.41 3.17 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.413 0.446 . . . . 0.0 112.639 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -148.3 136.91 21.55 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.962 0.905 . . . . 0.0 110.51 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.5 p -72.55 108.54 5.66 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.91 -32.57 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.177 0.591 . . . . 0.0 110.174 -176.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -160.35 178.49 9.54 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.704 0.402 . . . . 0.0 110.423 -174.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.8 p -154.6 139.6 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 124.299 1.04 . . . . 0.0 109.593 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -141.47 132.4 26.0 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.372 0.669 . . . . 0.0 109.203 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.36 -103.86 0.46 Allowed Glycine 0 C--N 1.349 1.288 0 O-C-N 123.548 0.53 . . . . 0.0 113.814 170.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -115.07 16.74 17.01 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.519 1.128 . . . . 0.0 111.228 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.51 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 84.1 m-85 -141.64 125.64 17.23 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.619 -0.676 . . . . 0.0 111.97 -174.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 60.6 tp -82.59 111.7 18.81 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.222 1.009 . . . . 0.0 109.11 170.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 39' ' ' ALA . 28.1 mm -70.94 112.96 6.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 122.899 0.48 . . . . 0.0 109.725 177.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 88.4 t -112.47 118.11 56.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 123.186 0.594 . . . . 0.0 109.643 176.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -77.79 126.12 30.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.444 0.698 . . . . 0.0 109.792 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 m -131.99 74.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 C-N-CA 124.612 1.165 . . . . 0.0 109.886 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.63 -81.08 0.02 OUTLIER Glycine 0 C--N 1.354 1.55 0 CA-C-N 115.148 -0.933 . . . . 0.0 114.393 173.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.4 p -70.54 -49.46 47.85 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.272 1.029 . . . . 0.0 111.577 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -138.9 176.55 8.6 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.503 0.668 . . . . 0.0 112.258 -166.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -105.87 108.67 20.3 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.955 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 mp -95.39 105.5 17.47 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -80.07 94.35 5.95 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.848 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.18 124.59 91.04 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.137 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -56.77 141.56 92.24 Favored 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 122.732 2.288 . . . . 0.0 111.411 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.534 ' HA ' HD13 ' A' ' 45' ' ' ILE . 2.2 mmmp? -60.74 -34.34 74.28 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -172.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.434 ' H ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -68.47 -21.49 64.62 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.404 0.282 . . . . 0.0 111.576 177.792 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.2 t -75.0 -27.75 60.26 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 122.733 0.413 . . . . 0.0 111.081 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.57 HG13 HG22 ' A' ' 55' ' ' ILE . 2.0 mp -64.66 113.45 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.187 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -79.88 -50.05 11.04 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.859 0.864 . . . . 0.0 110.177 -175.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.7 m -148.22 126.84 12.48 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.241 -175.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.96 109.75 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 166.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -110.07 172.53 6.81 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.471 1.108 . . . . 0.0 110.415 -174.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.54 97.12 0.41 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.24 0.616 . . . . 0.0 110.423 -175.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.06 4.83 84.18 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.454 -0.794 . . . . 0.0 113.994 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -131.58 132.97 44.53 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.084 0.953 . . . . 0.0 109.053 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.534 ' HB ' HG22 ' A' ' 11' ' ' VAL . 43.4 mm -109.32 103.2 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.6 t -81.95 114.04 22.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.57 HG22 HG13 ' A' ' 45' ' ' ILE . 34.0 pt -109.25 170.41 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.552 0.741 . . . . 0.0 109.012 175.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.95 -159.27 14.92 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 116.611 -0.268 . . . . 0.0 112.877 -173.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -85.71 120.15 26.83 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.655 0.74 . . . . 0.0 109.562 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -142.29 171.3 14.24 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.989 1.316 . . . . 0.0 107.478 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -86.97 111.87 21.26 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.79 -23.44 63.34 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.414 0.686 . . . . 0.0 112.05 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -69.87 -37.29 76.03 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 123.86 0.725 . . . . 0.0 109.905 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -60.71 -54.86 40.1 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 170.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.03 77.03 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.258 -173.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.03 -44.45 54.33 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.947 -176.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.19 -40.21 86.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.917 0.326 . . . . 0.0 111.264 -174.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 pp -82.38 -16.31 49.57 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.704 0.401 . . . . 0.0 110.58 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.29 -32.75 57.74 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 168.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 -76.72 -28.45 55.82 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.246 1.019 . . . . 0.0 110.174 173.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -65.18 -34.98 79.67 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 169.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 56.8 t90 -65.27 -38.19 89.52 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.312 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.24 -27.79 67.52 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.313 0.645 . . . . 0.0 111.486 173.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 CA--C 1.554 1.133 0 C-N-CA 123.724 0.81 . . . . 0.0 111.315 179.004 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.0 mtt . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -78.67 110.94 14.26 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.915 0.486 . . . . 0.0 109.878 176.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.52 130.7 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.061 0.544 . . . . 0.0 109.838 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -116.97 124.74 50.12 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.61 1.164 . . . . 0.0 110.023 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -79.73 92.61 5.44 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.87 -96.08 0.58 Allowed Glycine 0 C--N 1.342 0.914 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -173.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.03 -21.92 10.32 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.47 0.708 . . . . 0.0 111.572 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.02 155.68 19.7 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 122.861 0.464 . . . . 0.0 110.396 -176.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.7 t -71.13 112.44 7.28 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.054 0.542 . . . . 0.0 110.134 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -80.74 -52.55 7.4 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.29 -139.85 5.14 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.844 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -139.23 132.32 29.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.137 0.975 . . . . 0.0 108.869 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.408 ' HB2' HD11 ' A' ' 29' ' ' LEU . 73.4 p -69.8 124.13 23.22 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 172.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.55 -37.6 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.64 0.776 . . . . 0.0 109.195 -177.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -150.46 167.91 25.75 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.357 -171.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.3 p -127.61 138.96 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -148.67 100.29 3.09 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.144 0.978 . . . . 0.0 109.486 -169.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.86 -109.14 2.72 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.741 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 21.1 t70 -104.67 -5.5 21.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.188 0.595 . . . . 0.0 109.413 171.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.445 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 64.8 m-85 -100.04 113.67 26.43 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.306 0.642 . . . . 0.0 111.089 -171.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 21' ' ' SER . 66.0 tp -74.1 106.69 5.89 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.0 mm -68.28 106.51 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.177 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.7 t -100.33 117.68 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.83 111.09 7.65 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 173.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.463 HG21 HD23 ' A' ' 38' ' ' LEU . 18.9 m -111.18 85.55 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-O 122.04 0.924 . . . . 0.0 110.48 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.35 -91.16 0.24 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.062 -0.972 . . . . 0.0 113.3 176.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.0 p -105.43 -10.29 17.03 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.824 0.85 . . . . 0.0 111.389 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -124.51 -176.68 3.58 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.505 0.722 . . . . 0.0 111.49 -173.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -131.22 110.25 11.0 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.966 1.307 . . . . 0.0 109.308 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.463 HD23 HG21 ' A' ' 33' ' ' VAL . 2.4 mm? -102.9 109.25 20.74 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.648 1.179 . . . . 0.0 108.821 174.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -87.02 93.74 9.44 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.262 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.31 131.81 51.97 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.515 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 54.9 Cg_endo -65.3 159.83 45.37 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.359 2.04 . . . . 0.0 112.129 177.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 27' ' ' ASP . 31.0 mmmt -66.75 -22.45 66.04 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.724 0.81 . . . . 0.0 111.433 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.515 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 8.6 ptpp? -76.01 -18.99 59.04 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.99 0.916 . . . . 0.0 112.065 175.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.7 t -71.71 -29.26 64.36 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.712 0.405 . . . . 0.0 110.747 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.517 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.2 mp -70.22 118.45 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.068 0.547 . . . . 0.0 109.911 -177.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -85.67 -54.5 4.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.272 1.029 . . . . 0.0 111.046 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.2 m -134.26 146.93 50.51 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.788 -172.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.5 p -114.91 126.4 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.061 0.944 . . . . 0.0 109.297 173.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.799 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 42.3 mm-40 -121.85 173.22 7.63 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.986 0.914 . . . . 0.0 109.171 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.03 97.47 1.17 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.822 0.82 . . . . 0.0 110.271 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.56 18.12 71.63 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.272 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.799 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 54.1 mtt180 -140.63 149.76 42.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.631 0.772 . . . . 0.0 110.516 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.5 mm -134.81 104.24 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.484 1.114 . . . . 0.0 108.822 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.08 122.31 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.4 pt -112.4 153.99 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.109 0.963 . . . . 0.0 109.442 174.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -104.1 -64.36 0.68 Allowed Glycine 0 C--N 1.344 1.004 0 CA-C-O 120.158 -0.246 . . . . 0.0 112.537 -173.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -157.26 159.76 37.93 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.106 0.562 . . . . 0.0 110.034 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -166.26 173.07 10.47 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.519 1.128 . . . . 0.0 109.239 -177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.78 99.66 7.58 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -67.86 -57.51 6.13 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.263 1.025 . . . . 0.0 112.702 -167.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.89 -30.32 69.65 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.151 0.58 . . . . 0.0 110.776 -176.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 43.7 mt-10 -70.25 -39.61 74.9 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.795 173.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.12 -25.55 65.35 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.021 0.528 . . . . 0.0 110.734 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -74.53 -45.81 43.27 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.678 0.791 . . . . 0.0 109.838 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.9 pt-20 -72.72 -36.42 67.78 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.445 0.298 . . . . 0.0 111.779 -177.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 69' ' ' LYS . 4.1 pp -83.39 -13.6 54.53 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 122.157 -0.339 . . . . 0.0 110.529 174.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.04 -46.27 52.34 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.747 168.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.471 ' HA ' HD13 ' A' ' 71' ' ' LEU . 34.6 ptt180 -72.05 -23.89 61.44 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 175.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.479 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 22.4 ttmm -62.3 -39.21 92.25 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 123.087 0.555 . . . . 0.0 109.715 170.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.462 ' HE3' HD12 ' A' ' 71' ' ' LEU . 70.6 t90 -60.87 -38.29 85.1 Favored 'General case' 0 CA--C 1.553 1.088 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 172.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' A' ' 68' ' ' ARG . 11.2 mp -60.83 -39.73 90.12 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 177.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 N--CA 1.485 1.31 0 O-C-N 121.701 -0.625 . . . . 0.0 111.194 -179.799 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 79.4 mtp . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -62.42 123.07 17.32 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.162 0.585 . . . . 0.0 110.889 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.6 t -93.85 131.25 41.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 124.075 0.95 . . . . 0.0 110.076 -173.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.567 ' HE1' ' HD2' ' A' ' 52' ' ' ARG . 70.0 m-85 -118.93 127.01 53.08 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.536 1.134 . . . . 0.0 108.625 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -78.43 87.34 4.44 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.105 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.36 -94.75 0.74 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -172.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.85 -27.27 8.54 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.84 0.856 . . . . 0.0 111.785 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 12.0 pt-20 -81.42 145.82 30.59 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -174.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 t -69.78 113.75 7.32 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -93.83 -50.21 5.46 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.078 0.551 . . . . 0.0 110.524 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.18 -137.93 4.06 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.766 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.581 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 8.9 pt-20 -141.13 144.11 34.66 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.238 1.015 . . . . 0.0 109.966 -177.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.8 t -77.17 149.83 35.56 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.24 -40.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -151.52 170.01 20.68 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -176.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' A' ' 29' ' ' LEU . 2.8 p -155.8 123.07 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.067 0.947 . . . . 0.0 109.069 172.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.442 ' CE1' HD11 ' A' ' 30' ' ' ILE . 7.3 p90 -124.29 132.8 53.59 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.89 -105.87 0.95 Allowed Glycine 0 C--N 1.338 0.686 0 O-C-N 123.543 0.527 . . . . 0.0 114.044 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -118.94 17.96 13.29 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.615 0.766 . . . . 0.0 111.527 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.511 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 80.8 m-85 -133.03 112.79 12.11 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.142 0.496 . . . . 0.0 111.427 -175.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.493 HD12 ' HB ' ' A' ' 24' ' ' VAL . 44.8 tp -78.21 111.68 14.4 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.12 1.368 . . . . 0.0 109.552 173.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.442 HD11 ' CE1' ' A' ' 25' ' ' TYR . 33.2 mm -72.38 112.05 7.53 Favored 'Isoleucine or valine' 0 C--O 1.249 1.053 0 C-N-CA 123.578 0.751 . . . . 0.0 109.832 178.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.8 t -110.72 125.9 68.04 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 C-N-CA 124.369 1.068 . . . . 0.0 109.879 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.581 ' HB3' ' HG3' ' A' ' 20' ' ' GLU . 4.2 tppp? -73.96 120.02 18.96 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.92 0.888 . . . . 0.0 109.25 171.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.8 m -137.73 133.83 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.499 1.119 . . . . 0.0 109.627 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.58 -100.15 0.46 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.023 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.3 p -124.84 -11.53 7.17 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.602 1.161 . . . . 0.0 111.021 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -124.41 -171.98 2.46 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.562 0.745 . . . . 0.0 111.829 -171.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -121.11 111.37 17.35 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.144 0.977 . . . . 0.0 110.474 -174.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 mp -102.08 117.17 34.23 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 171.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.511 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -89.68 108.59 19.77 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.698 0.799 . . . . 0.0 110.954 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.469 HG21 HG21 ' A' ' 55' ' ' ILE . 16.5 m -83.52 139.28 41.2 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.405 0.682 . . . . 0.0 109.896 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.528 ' HG2' ' HB2' ' A' ' 44' ' ' SER . 56.9 Cg_endo -69.89 156.2 63.59 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 122.146 1.897 . . . . 0.0 112.624 176.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -68.24 -28.53 67.3 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.206 1.002 . . . . 0.0 111.39 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.498 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 21.5 pttp -74.9 -9.37 58.48 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.775 0.83 . . . . 0.0 111.572 176.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.528 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 28.5 t -88.43 -18.67 27.82 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.056 0.543 . . . . 0.0 111.083 175.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.531 HD13 HG22 ' A' ' 55' ' ' ILE . 29.5 mm -64.46 112.91 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 11.1 mmpt? -70.5 -45.46 65.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.534 0.734 . . . . 0.0 110.194 177.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.5 t -160.0 145.88 15.57 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.64 -176.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.8 p -110.02 119.69 59.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.782 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 20.7 mm-40 -104.23 166.51 10.35 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.84 0.856 . . . . 0.0 109.423 176.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -65.04 102.8 0.66 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.312 0.577 . . . . 0.0 109.572 174.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.44 4.92 90.06 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.605 -0.725 . . . . 0.0 114.363 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.782 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 77.5 mmt-85 -131.92 147.98 52.5 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 117.57 0.685 . . . . 0.0 110.171 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.82 132.43 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.923 0.889 . . . . 0.0 108.845 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.13 123.42 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.531 HG22 HD13 ' A' ' 45' ' ' ILE . 49.4 pt -118.95 164.82 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.648 0.779 . . . . 0.0 110.641 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.93 -171.99 22.58 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.31 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.69 130.51 41.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.824 0.449 . . . . 0.0 109.946 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -135.46 166.51 23.02 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.94 1.296 . . . . 0.0 108.826 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.01 109.16 14.2 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -67.01 -28.56 68.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.724 0.81 . . . . 0.0 111.284 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -67.33 -43.3 81.91 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.475 1.11 . . . . 0.0 110.722 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -68.63 -42.35 78.16 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.675 0.274 . . . . 0.0 110.475 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.64 89.93 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.74 0.816 . . . . 0.0 112.006 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -76.19 -34.28 59.3 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.465 0.478 . . . . 0.0 112.057 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 12.9 pt-20 -77.71 -40.71 40.38 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -177.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 pp -80.7 -25.5 38.11 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -69.05 -34.62 76.67 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.815 171.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -77.05 -18.02 58.37 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 117.296 0.548 . . . . 0.0 110.205 175.776 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 6.3 ttpm? -68.85 -32.17 71.66 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.162 0.506 . . . . 0.0 109.787 166.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.416 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 85.5 t90 -67.09 -32.74 74.1 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 169.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.92 -31.6 72.29 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.161 0.584 . . . . 0.0 112.133 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-N 118.38 0.537 . . . . 0.0 109.942 174.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.51 -153.4 16.95 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 123.481 0.488 . . . . 0.0 111.895 -175.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -144.92 176.29 9.58 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.068 0.947 . . . . 0.0 110.824 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.1 mmt -94.35 177.27 6.0 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.89 0.876 . . . . 0.0 110.379 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.416 ' HB2' ' CA ' ' A' ' 51' ' ' GLY . 7.7 m-20 55.6 47.79 20.0 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.092 1.357 . . . . 0.0 111.753 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt -71.49 -16.24 62.34 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.11 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.7 tp -65.51 -38.4 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.424 1.089 . . . . 0.0 111.43 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.3 p -167.1 102.13 0.53 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.81 0.844 . . . . 0.0 109.318 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.7 mtt -82.47 126.84 32.69 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.307 0.643 . . . . 0.0 109.478 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -76.49 111.88 12.42 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.359 0.664 . . . . 0.0 110.124 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.16 111.65 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.097 0.559 . . . . 0.0 109.908 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -103.0 124.59 48.79 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.817 0.847 . . . . 0.0 110.135 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 51.1 tttm -77.67 85.43 3.99 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.86 -94.99 0.89 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -173.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -110.63 -30.15 7.73 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.97 0.908 . . . . 0.0 110.658 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 12.9 pt-20 -77.58 141.02 39.76 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -175.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.9 t -70.68 108.77 4.56 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -85.26 -55.55 3.97 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.866 0.466 . . . . 0.0 110.44 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.24 -146.88 5.98 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.282 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -140.1 145.34 37.49 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.75 0.82 . . . . 0.0 110.346 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.7 p -77.0 111.89 13.05 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.805 0.442 . . . . 0.0 109.839 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.65 -40.37 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.452 0.701 . . . . 0.0 110.25 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 18.0 t70 -148.36 160.66 42.78 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.919 0.487 . . . . 0.0 109.817 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.462 ' HB ' ' HA ' ' A' ' 83' ' ' LEU . 20.6 t -139.59 118.78 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -132.5 126.99 34.24 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.643 0.656 . . . . 0.0 109.503 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.04 -119.76 19.8 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.487 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -102.24 22.81 12.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.592 0.757 . . . . 0.0 111.347 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.423 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 66.3 m-85 -133.29 124.86 28.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.834 0.454 . . . . 0.0 111.357 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.419 HD12 HG22 ' A' ' 24' ' ' VAL . 45.2 tp -85.2 109.6 18.42 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 167.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 39' ' ' ALA . 23.5 mm -70.85 107.1 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.04 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.64 119.31 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.337 177.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -75.99 113.65 13.75 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.171 0.588 . . . . 0.0 109.496 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.35 126.56 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 124.124 0.97 . . . . 0.0 109.481 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.95 -91.44 0.05 OUTLIER Glycine 0 CA--C 1.535 1.316 0 CA-C-N 116.57 -0.287 . . . . 0.0 113.429 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.9 m -125.2 -23.82 4.11 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.404 1.082 . . . . 0.0 110.778 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -110.82 179.16 4.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.72 0.808 . . . . 0.0 111.319 -171.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.413 ' HB3' HG23 ' A' ' 30' ' ' ILE . 87.6 m-85 -119.23 110.35 16.92 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.515 0.726 . . . . 0.0 109.887 -175.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -91.55 105.9 18.09 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.299 1.04 . . . . 0.0 109.151 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.503 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -83.23 92.49 7.49 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.193 0.597 . . . . 0.0 109.83 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.3 m -80.18 134.66 55.38 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.414 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 48.0 Cg_endo -65.59 154.44 73.77 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.621 2.214 . . . . 0.0 111.674 176.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.561 ' HA ' HD13 ' A' ' 45' ' ' ILE . 13.7 mmmm -63.16 -28.1 69.83 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.591 0.756 . . . . 0.0 111.652 -176.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.414 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 7.7 ptpp? -65.72 -21.89 66.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.413 0.685 . . . . 0.0 111.583 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 t -74.33 -43.61 55.95 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.561 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.8 mp -61.73 112.47 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.442 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HE3' ' HA3' ' A' ' 56' ' ' GLY . 32.1 mmtp -78.51 -63.13 1.48 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.881 0.872 . . . . 0.0 110.154 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 t -146.02 132.83 20.05 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 122.915 0.486 . . . . 0.0 110.094 -175.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.8 p -77.68 109.61 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.65 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 5.8 mm-40 -86.16 174.3 9.23 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.324 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.56 86.5 2.09 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.166 0.508 . . . . 0.0 109.719 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.416 ' CA ' ' HB2' ' A' ' 5' ' ' ASP . . . 88.21 13.44 63.9 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.979 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.65 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 2.4 mpt_? -135.6 159.67 40.91 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.444 0.622 . . . . 0.0 109.64 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 mm -124.25 103.96 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 69.7 t -79.14 116.45 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.409 HG22 HG13 ' A' ' 45' ' ' ILE . 40.7 pt -105.87 164.0 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.499 ' HA3' ' HE3' ' A' ' 46' ' ' LYS . . . -104.4 -107.01 3.16 Favored Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -122.69 156.82 33.6 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.837 0.855 . . . . 0.0 109.807 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -167.09 160.17 13.71 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.723 1.209 . . . . 0.0 108.715 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -75.17 98.23 3.68 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -43.29 96.08 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.373 1.069 . . . . 0.0 112.896 -175.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -67.92 -33.87 75.53 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.341 0.401 . . . . 0.0 110.747 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 37.7 mt-10 -69.65 -49.44 53.66 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.366 174.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.01 -28.51 66.46 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.597 0.759 . . . . 0.0 111.383 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.59 -45.26 46.42 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.762 1.225 . . . . 0.0 110.867 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.415 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 2.9 pp20? -75.37 -36.93 60.85 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -175.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.523 ' HA ' ' HB3' ' A' ' 69' ' ' LYS . 4.4 pp -81.84 -15.14 55.08 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.846 0.355 . . . . 0.0 110.441 174.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -66.5 -47.82 67.13 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.747 166.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.494 ' HA ' HD23 ' A' ' 71' ' ' LEU . 9.2 ptp180 -76.32 -21.49 56.13 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 117.344 0.572 . . . . 0.0 111.458 177.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -68.18 -32.87 73.41 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.139 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.573 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 74.2 t90 -67.1 -40.49 86.91 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.196 169.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.1 mm? -57.89 -24.89 59.72 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.503 0.321 . . . . 0.0 111.232 175.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -79.33 -50.54 10.72 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 122.478 0.311 . . . . 0.0 111.19 173.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.573 ' HG2' ' HA ' ' A' ' 70' ' ' TRP . 10.1 pt-20 -75.79 -19.14 59.21 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -170.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -12.77 59.33 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.367 0.667 . . . . 0.0 112.258 -176.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.2 p -60.55 -20.79 61.42 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.653 1.181 . . . . 0.0 112.626 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -64.91 146.1 98.84 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 124.209 1.004 . . . . 0.0 110.326 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.54 152.0 83.13 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.736 2.291 . . . . 0.0 112.095 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.1 p -69.44 97.08 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-O 122.077 0.941 . . . . 0.0 112.054 -171.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.9 m -137.17 6.94 2.86 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.745 0.818 . . . . 0.0 109.68 172.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.55 108.94 4.02 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -96.31 -19.08 19.52 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.684 0.793 . . . . 0.0 110.668 -172.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -69.08 -19.54 64.07 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.86 1.264 . . . . 0.0 111.326 -173.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.2 tt -58.74 -47.32 85.04 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.152 0.981 . . . . 0.0 109.218 172.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -64.81 94.73 0.13 Allowed 'General case' 0 C--N 1.349 0.582 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.185 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.6 p -118.62 141.93 48.13 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -68.35 -32.31 72.33 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.459 0.303 . . . . 0.0 111.369 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.95 59.21 2.82 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -168.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -72.8 -0.87 14.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.129 0.971 . . . . 0.0 111.994 -174.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.97 86.38 0.22 Allowed Glycine 0 C--N 1.352 1.435 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.07 -24.15 63.19 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.061 0.944 . . . . 0.0 110.946 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -79.14 174.12 11.89 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.491 1.116 . . . . 0.0 110.679 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.47 -146.5 14.91 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.565 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.4 -23.99 52.69 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.607 1.163 . . . . 0.0 112.733 174.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.84 174.06 38.27 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.671 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.6 t . . . . . 0 C--O 1.252 1.211 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -179.897 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.2 151.77 21.56 Favored Glycine 0 C--N 1.344 0.975 0 O-C-N 123.571 0.545 . . . . 0.0 111.963 -178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -132.37 95.64 3.68 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.768 0.827 . . . . 0.0 109.515 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.519 ' SD ' HD13 ' A' ' 6' ' ' LEU . 40.3 tpp -76.4 95.34 3.79 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 168.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -67.76 -9.25 42.38 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.784 0.834 . . . . 0.0 112.87 -172.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.519 HD13 ' SD ' ' A' ' 4' ' ' MET . 9.8 mp -64.59 -19.46 65.67 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.849 0.86 . . . . 0.0 111.087 172.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.6 tp -52.02 -34.45 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 124.007 0.923 . . . . 0.0 110.609 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.425 ' SG ' HD11 ' A' ' 83' ' ' LEU . 58.1 m -86.46 99.86 11.95 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.549 ' HB2' HG12 ' A' ' 53' ' ' ILE . 2.1 mpt? -61.37 153.62 26.3 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.994 0.918 . . . . 0.0 112.796 -170.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -75.13 110.46 9.46 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.307 1.043 . . . . 0.0 109.89 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.518 HG22 ' HB ' ' A' ' 53' ' ' ILE . 75.5 t -79.28 127.5 39.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 122.878 0.471 . . . . 0.0 110.814 -173.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -110.56 129.71 55.73 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.623 1.169 . . . . 0.0 110.045 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -78.01 85.01 4.25 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.561 1.144 . . . . 0.0 108.011 172.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.25 -96.64 0.34 Allowed Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.623 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -94.91 -40.71 9.55 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.496 0.719 . . . . 0.0 110.474 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -83.66 151.63 25.19 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.946 -170.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 t -75.72 119.08 19.25 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -87.51 -48.89 7.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.521 0.728 . . . . 0.0 110.456 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.51 -150.54 12.15 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -176.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -127.43 146.32 50.52 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 171.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 68.7 p -70.55 162.79 28.2 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 168.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.38 -39.56 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.56 ' HA ' HD13 ' A' ' 83' ' ' LEU . 36.1 t70 -153.24 171.92 17.79 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.608 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.527 HG13 ' HG3' ' A' ' 82' ' ' GLU . 2.4 p -151.72 133.75 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 172.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.489 ' CE2' HD11 ' A' ' 30' ' ' ILE . 50.6 p90 -135.81 135.24 39.69 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 172.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.48 -107.23 1.29 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 123.886 0.741 . . . . 0.0 112.704 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -116.11 12.84 15.66 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.764 0.826 . . . . 0.0 110.996 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.589 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 89.7 m-85 -123.17 109.34 13.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.198 0.599 . . . . 0.0 111.426 -172.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.485 HD12 ' HB ' ' A' ' 24' ' ' VAL . 45.5 tp -80.37 106.87 12.71 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 169.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.489 HD11 ' CE2' ' A' ' 25' ' ' TYR . 28.4 mm -71.24 108.81 3.07 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 C-N-CA 123.698 0.799 . . . . 0.0 110.041 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 65.6 t -102.72 119.44 51.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 O-C-N 124.263 0.977 . . . . 0.0 109.575 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.46 118.66 18.57 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.41 124.01 64.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.688 0.795 . . . . 0.0 108.99 172.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.81 -90.44 0.05 OUTLIER Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.493 0.496 . . . . 0.0 114.334 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.3 p -123.5 -21.71 5.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.187 0.995 . . . . 0.0 111.5 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -110.37 171.62 7.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.641 0.776 . . . . 0.0 111.612 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -120.05 110.17 16.35 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.253 1.021 . . . . 0.0 108.942 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.1 mp -106.76 115.18 29.75 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.371 1.069 . . . . 0.0 108.381 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -79.94 103.82 10.09 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.619 0.768 . . . . 0.0 111.021 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 m -78.13 132.58 66.51 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 172.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.483 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 37.4 Cg_endo -65.62 150.22 86.63 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 121.714 1.609 . . . . 0.0 110.286 172.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.566 ' HA ' HD13 ' A' ' 45' ' ' ILE . 31.6 mmmt -61.13 -29.98 70.1 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.116 0.566 . . . . 0.0 111.409 -176.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.483 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 60.1 pttt -68.97 -23.09 64.08 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.052 0.941 . . . . 0.0 111.902 177.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.8 t -68.9 -29.72 68.06 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.759 0.424 . . . . 0.0 110.714 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.566 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.9 mp -64.06 114.58 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.488 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 75.1 mmtt -71.69 -45.98 60.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.394 1.078 . . . . 0.0 110.0 176.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 44.1 p -157.14 155.15 30.5 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.952 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 p -113.12 114.2 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.916 0.886 . . . . 0.0 110.175 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 6.5 mm-40 -97.74 163.66 12.72 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.765 0.826 . . . . 0.0 109.1 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 91' ' ' GLU . 5.3 m-20 -59.75 -35.34 74.4 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.715 0.806 . . . . 0.0 111.301 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.476 ' HA2' ' HE1' ' A' ' 88' ' ' PHE . . . -133.07 19.35 4.37 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.484 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.602 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 44.1 mtm180 -143.62 156.09 44.46 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 117.486 0.643 . . . . 0.0 110.85 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.549 HG12 ' HB2' ' A' ' 9' ' ' MET . 41.3 mm -126.43 104.37 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 173.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.7 t -83.24 114.89 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.9 pt -108.22 163.99 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.539 0.736 . . . . 0.0 109.499 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.488 ' HA3' ' HE2' ' A' ' 46' ' ' LYS . . . -92.87 -86.51 1.56 Allowed Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 175.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -160.5 168.44 25.07 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.563 0.745 . . . . 0.0 110.474 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -164.89 -179.03 5.54 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.898 1.279 . . . . 0.0 108.905 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -93.52 110.38 21.97 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -64.44 -37.22 86.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.12 0.968 . . . . 0.0 111.595 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.31 -50.39 60.4 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.044 0.84 . . . . 0.0 110.167 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.425 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 37.6 mt-10 -64.16 -38.87 92.63 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.07 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.21 -40.84 86.48 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.416 0.686 . . . . 0.0 111.93 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 9.9 ptp85 -75.3 -31.5 60.68 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 118.97 -0.538 . . . . 0.0 112.266 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -75.98 -38.8 57.06 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.394 0.543 . . . . 0.0 111.349 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 62' ' ' GLU . 4.4 pp -81.76 -13.26 57.99 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.25 0.548 . . . . 0.0 109.828 170.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.82 -33.93 66.17 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.168 165.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 64' ' ' ARG . 78.5 mtm180 -64.85 -40.33 94.99 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 123.317 0.647 . . . . 0.0 109.682 172.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.535 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 38.4 ttpt -55.09 -39.76 69.66 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.789 170.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 73' ' ' GLU . 88.6 t90 -65.49 -34.92 79.4 Favored 'General case' 0 C--N 1.361 1.105 0 CA-C-O 119.316 -0.373 . . . . 0.0 111.681 174.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.2 mm? -57.22 -22.14 38.74 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 118.839 0.745 . . . . 0.0 110.634 173.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -85.71 -47.33 9.88 Favored 'General case' 0 CA--C 1.574 1.883 0 C-N-CA 123.397 0.679 . . . . 0.0 111.924 164.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 69' ' ' LYS . 11.1 mm-40 -63.12 -21.13 65.98 Favored 'General case' 0 N--CA 1.507 2.413 0 C-N-CA 124.532 1.133 . . . . 0.0 113.573 -172.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -20.72 62.99 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.007 0.923 . . . . 0.0 111.737 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 t -85.25 12.39 8.17 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.125 0.97 . . . . 0.0 111.355 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -60.49 146.93 84.07 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 123.682 0.793 . . . . 0.0 110.978 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.16 161.93 42.36 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.484 2.123 . . . . 0.0 112.387 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.7 87.64 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.677 0.791 . . . . 0.0 108.951 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.8 m -146.1 -40.28 0.22 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.251 1.02 . . . . 0.0 109.699 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.93 128.59 35.95 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.954 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.483 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 43.9 tt0 -108.87 1.18 20.67 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.736 1.215 . . . . 0.0 109.285 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.527 ' HG3' HG13 ' A' ' 24' ' ' VAL . 11.6 tp10 -53.88 -38.11 64.42 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.006 1.322 . . . . 0.0 112.231 -176.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.56 HD13 ' HA ' ' A' ' 23' ' ' ASP . 41.5 tp -72.31 -38.64 68.65 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.958 0.503 . . . . 0.0 111.871 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.483 ' HE3' ' HG3' ' A' ' 81' ' ' GLU . 28.8 ttpp -77.9 126.57 31.04 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.637 0.375 . . . . 0.0 110.9 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.2 p -103.17 -158.94 0.7 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.625 1.17 . . . . 0.0 109.689 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -67.88 -29.79 68.99 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.174 0.59 . . . . 0.0 109.971 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 147.9 162.85 10.34 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.906 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.476 ' HE1' ' HA2' ' A' ' 51' ' ' GLY . 32.3 t80 -69.87 130.56 42.58 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.942 0.497 . . . . 0.0 110.257 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -84.41 123.52 6.27 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -71.4 82.31 0.78 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.307 0.575 . . . . 0.0 109.602 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . 42.6 tt0 -81.5 -36.14 29.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.028 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 140.25 -157.44 25.54 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.379 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -153.3 -61.19 0.14 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 65.5 26.26 71.78 Favored Glycine 0 C--N 1.355 1.614 0 O-C-N 124.097 0.873 . . . . 0.0 114.164 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.9 t . . . . . 0 C--O 1.254 1.307 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.256 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.751 0.31 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.07 174.89 37.73 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -79.91 74.9 6.64 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.488 0.661 . . . . 0.0 109.402 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -19.43 61.87 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.734 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.29 94.76 0.06 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.057 165.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.0 mt -92.61 82.22 4.8 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.4 tp -65.94 83.49 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.064 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 21' ' ' SER . 26.3 p -141.43 115.77 9.46 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.51 -175.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.6 ttm -155.42 149.42 25.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.547 0.739 . . . . 0.0 109.257 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -69.51 106.42 2.98 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.41 0.684 . . . . 0.0 109.823 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.09 132.82 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.029 0.532 . . . . 0.0 109.791 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -113.8 127.49 56.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.795 1.238 . . . . 0.0 110.337 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.98 88.49 3.52 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 171.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.4 -95.48 0.6 Allowed Glycine 0 C--N 1.342 0.91 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -121.25 1.3 10.23 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.073 0.949 . . . . 0.0 112.196 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -117.04 151.72 36.18 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.254 0.621 . . . . 0.0 110.456 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.5 t -67.43 112.8 4.83 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.733 0.813 . . . . 0.0 111.334 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -84.79 -54.65 4.55 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.438 0.695 . . . . 0.0 110.199 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.31 -137.83 3.99 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.877 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -138.28 136.48 36.51 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.192 0.997 . . . . 0.0 109.694 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 68.8 p -72.08 112.26 8.01 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.87 -36.43 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.054 0.541 . . . . 0.0 109.839 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -153.49 176.66 11.78 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.272 0.629 . . . . 0.0 109.338 -173.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.22 136.85 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.988 0.915 . . . . 0.0 108.951 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.408 ' CD1' HD11 ' A' ' 30' ' ' ILE . 9.6 p90 -137.11 127.64 26.8 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 173.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.37 -109.62 2.43 Favored Glycine 0 C--N 1.346 1.117 0 O-C-N 123.537 0.523 . . . . 0.0 113.501 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -109.92 19.2 19.32 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.04 0.936 . . . . 0.0 111.493 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.404 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 78.9 m-85 -131.91 115.41 15.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.876 0.47 . . . . 0.0 111.665 -176.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 21' ' ' SER . 64.6 tp -79.22 113.85 17.68 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.131 0.972 . . . . 0.0 109.528 169.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.408 HD11 ' CD1' ' A' ' 25' ' ' TYR . 26.3 mm -74.77 106.92 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.5 t -104.53 113.44 41.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -76.3 109.67 10.19 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.6 m -95.15 156.08 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.415 1.086 . . . . 0.0 108.794 169.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -43.61 -28.23 1.01 Allowed Glycine 0 N--CA 1.482 1.711 0 N-CA-C 116.544 1.378 . . . . 0.0 116.544 -174.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.0 p -95.04 -48.39 5.99 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.13 0.572 . . . . 0.0 111.625 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -139.83 -179.65 6.06 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.443 0.64 . . . . 0.0 112.715 -163.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -101.78 107.83 19.16 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 164.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.6 mt -104.05 106.76 17.37 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -80.35 95.19 6.3 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.269 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 m -80.61 134.41 54.27 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.527 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 38.2 Cg_endo -63.41 159.13 41.52 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.21 1.94 . . . . 0.0 112.011 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -59.16 -34.73 72.45 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.385 0.674 . . . . 0.0 110.78 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.527 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 19.9 ptmt -68.19 -26.99 66.01 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.339 1.056 . . . . 0.0 112.191 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.7 t -59.46 -38.52 80.98 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.811 0.444 . . . . 0.0 109.87 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.99 114.01 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.459 ' HD2' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -79.97 -53.8 6.4 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.571 1.149 . . . . 0.0 110.072 177.592 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.4 m -144.82 141.12 28.89 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.272 -171.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.0 p -99.19 110.62 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 169.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.788 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 11.7 mm-40 -105.21 174.25 5.96 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.555 0.742 . . . . 0.0 109.821 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.47 102.0 1.06 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.195 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.52 18.17 78.3 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 115.538 -0.755 . . . . 0.0 113.467 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.788 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 17.6 mtp180 -136.64 140.18 42.58 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.209 0.604 . . . . 0.0 110.359 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.1 mm -116.57 101.89 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 168.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.1 t -79.4 118.93 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.3 pt -112.13 146.38 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.716 0.806 . . . . 0.0 109.264 172.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.459 ' HA3' ' HD2' ' A' ' 46' ' ' LYS . . . -105.49 -56.33 0.69 Allowed Glycine 0 C--N 1.339 0.743 0 CA-C-N 116.362 -0.381 . . . . 0.0 112.418 -170.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.21 141.44 23.17 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.582 0.753 . . . . 0.0 110.627 -171.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -169.4 146.54 3.47 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 124.618 1.167 . . . . 0.0 108.011 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.66 106.79 7.4 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -64.15 -29.34 70.47 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.043 0.937 . . . . 0.0 111.706 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.437 ' HG2' ' NH1' ' A' ' 64' ' ' ARG . 38.8 mt-10 -67.08 -40.41 87.01 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.579 0.549 . . . . 0.0 110.584 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -68.73 -45.51 71.3 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.314 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.24 74.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.898 0.879 . . . . 0.0 111.865 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.437 ' NH1' ' HG2' ' A' ' 61' ' ' GLU . 6.2 ptp180 -75.69 -41.81 52.7 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.769 0.428 . . . . 0.0 111.765 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.44 -39.48 64.95 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 118.075 0.398 . . . . 0.0 111.902 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.55 -16.61 44.78 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.766 0.426 . . . . 0.0 110.466 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.81 -39.0 34.97 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.595 0.559 . . . . 0.0 112.487 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.406 ' HA ' HD12 ' A' ' 71' ' ' LEU . 54.3 ptt85 -77.06 -24.95 51.92 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.843 0.457 . . . . 0.0 109.981 173.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -65.63 -38.14 88.58 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.552 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 66.6 t90 -60.74 -49.39 77.68 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 123.513 0.508 . . . . 0.0 109.883 171.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 68' ' ' ARG . 75.4 mt -50.92 -34.68 29.58 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.954 0.902 . . . . 0.0 112.072 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -75.19 -56.8 4.36 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.623 0.769 . . . . 0.0 111.074 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.552 ' HG2' ' HA ' ' A' ' 70' ' ' TRP . 12.1 pt-20 -76.6 -20.3 56.91 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -167.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -13.62 22.04 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.471 0.708 . . . . 0.0 112.362 -172.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.8 t -68.89 80.04 0.3 Allowed 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 164.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -92.56 146.0 31.52 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.951 -177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.09 166.26 29.46 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.175 1.917 . . . . 0.0 112.193 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.17 -21.23 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 124.015 0.926 . . . . 0.0 111.364 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.7 p -69.53 -8.86 50.81 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.288 1.035 . . . . 0.0 112.716 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.71 106.71 0.43 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.102 0.961 . . . . 0.0 109.602 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -88.14 -24.95 23.22 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.423 0.689 . . . . 0.0 112.722 -169.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -72.41 -30.7 64.87 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.432 0.693 . . . . 0.0 110.799 -172.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.8 tp -69.88 -21.2 63.34 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.44 0.696 . . . . 0.0 111.529 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -69.68 155.7 40.11 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.144 0.577 . . . . 0.0 111.775 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -75.05 100.11 4.1 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.938 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -76.82 -49.17 16.44 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.614 0.766 . . . . 0.0 109.741 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 140.93 -69.77 0.45 Allowed Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.75 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -69.77 133.02 46.98 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.508 0.723 . . . . 0.0 110.054 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.1 -89.13 0.08 OUTLIER Glycine 0 C--N 1.342 0.874 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.99 93.99 2.78 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.395 0.678 . . . . 0.0 110.416 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -98.12 50.32 1.01 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.018 0.527 . . . . 0.0 110.921 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.38 17.42 74.35 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.187 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.73 -41.12 19.64 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.347 1.059 . . . . 0.0 111.2 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.59 85.55 0.6 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 C--O 1.251 1.179 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.084 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.23 -129.72 6.14 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 173.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -97.08 147.75 23.71 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.93 0.492 . . . . 0.0 109.754 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 59.7 mtt -123.8 166.22 15.97 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.147 0.979 . . . . 0.0 109.466 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.7 t70 77.09 -26.36 0.19 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.597 1.559 . . . . 0.0 113.047 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -71.28 -4.9 28.37 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.011 0.925 . . . . 0.0 112.356 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tt -55.47 -32.76 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.205 1.002 . . . . 0.0 111.419 174.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.8 p -135.5 91.21 2.69 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.889 0.876 . . . . 0.0 109.389 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 53.0 mtt -84.1 171.79 12.56 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.374 0.669 . . . . 0.0 110.578 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -101.75 130.08 48.08 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.418 HG22 ' HB ' ' A' ' 53' ' ' ILE . 85.4 t -91.54 126.27 44.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.346 0.659 . . . . 0.0 109.762 -177.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -115.46 118.52 33.43 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.782 1.233 . . . . 0.0 109.102 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 65.5 tttm -78.68 90.23 4.59 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.1 -95.56 0.66 Allowed Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -175.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -121.48 4.22 10.18 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.802 0.841 . . . . 0.0 112.406 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 11.5 pt-20 -111.84 147.41 35.81 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.997 0.519 . . . . 0.0 109.704 176.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.3 t -72.62 108.79 5.84 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -78.45 -49.34 13.64 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.358 0.663 . . . . 0.0 110.231 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.0 -136.54 3.33 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.521 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -142.33 136.93 30.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.138 0.975 . . . . 0.0 109.483 -178.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.41 ' HB2' HD11 ' A' ' 29' ' ' LEU . 62.2 p -71.58 106.96 4.22 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 175.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.424 HG21 ' HD2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -92.59 -40.31 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.083 0.553 . . . . 0.0 109.67 -176.243 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -160.35 168.91 24.23 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.438 0.295 . . . . 0.0 110.919 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.15 141.22 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.011 0.924 . . . . 0.0 109.102 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -138.91 97.41 3.31 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.457 1.103 . . . . 0.0 108.389 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.1 -109.01 2.3 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.771 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -107.17 16.85 23.65 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.104 0.962 . . . . 0.0 110.36 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.456 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 93.8 m-85 -127.81 117.86 22.64 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.447 0.699 . . . . 0.0 109.895 -174.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.41 HD11 ' HB2' ' A' ' 21' ' ' SER . 64.5 tp -76.62 111.0 11.66 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 172.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mm -71.02 112.88 6.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -107.26 120.02 57.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.355 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -74.84 109.18 8.09 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.05 89.56 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.577 1.151 . . . . 0.0 110.659 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.12 -76.02 1.68 Allowed Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.237 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.5 m -125.07 -29.47 3.32 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.141 0.977 . . . . 0.0 110.856 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -110.45 168.89 9.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 122.155 -0.341 . . . . 0.0 110.551 -172.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.424 ' HD2' HG21 ' A' ' 22' ' ' ILE . 64.5 m-85 -113.22 110.37 20.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.133 0.973 . . . . 0.0 109.466 177.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.0 mt -107.39 124.74 50.28 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.124 0.57 . . . . 0.0 109.63 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -89.62 99.49 12.48 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.016 -174.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.1 m -86.46 129.13 54.37 Favored Pre-proline 0 CA--C 1.552 1.056 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.13 158.42 54.65 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.363 2.042 . . . . 0.0 111.871 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.578 ' HA ' HD13 ' A' ' 45' ' ' ILE . 13.9 mmmm -64.6 -29.54 70.55 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.256 0.622 . . . . 0.0 112.166 -177.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.495 ' H ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -72.84 -17.79 61.51 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.142 0.177 . . . . 0.0 111.219 174.664 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.5 t -73.13 -34.9 66.38 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 171.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.9 mp -61.18 115.38 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.173 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 mmpm? -82.28 -61.28 1.94 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.212 1.005 . . . . 0.0 109.414 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.0 m -138.69 126.6 22.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.149 -172.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 p -92.53 109.37 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 171.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.653 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 22.0 mm-40 -98.63 177.01 5.44 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 124.546 1.138 . . . . 0.0 110.225 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -68.11 91.15 0.35 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.185 0.594 . . . . 0.0 110.452 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.36 17.81 77.23 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.303 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.653 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 49.7 mtt180 -137.33 129.55 29.43 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.54 0.736 . . . . 0.0 109.382 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.418 ' HB ' HG22 ' A' ' 11' ' ' VAL . 38.4 mm -105.03 103.37 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.76 115.93 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.8 pt -108.57 175.15 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.377 0.671 . . . . 0.0 109.457 173.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.43 -117.75 3.01 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -118.71 160.29 22.11 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.267 0.627 . . . . 0.0 110.602 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -159.8 179.21 9.02 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.156 1.382 . . . . 0.0 108.477 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.28 114.44 26.52 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -63.86 -36.2 83.13 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.844 0.858 . . . . 0.0 112.52 -175.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -69.21 -40.85 77.74 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.981 0.512 . . . . 0.0 110.185 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.42 -44.98 73.84 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 123.415 0.447 . . . . 0.0 110.33 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.04 -25.52 68.42 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.376 0.67 . . . . 0.0 111.292 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -73.89 -51.48 16.07 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.893 0.877 . . . . 0.0 110.971 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.11 -40.81 59.62 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.993 0.517 . . . . 0.0 111.799 -171.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 69' ' ' LYS . 2.4 pp -84.1 -20.77 31.99 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.06 -44.83 87.02 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 169.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.503 ' HA ' HD23 ' A' ' 71' ' ' LEU . 35.2 ptt180 -75.45 -14.2 60.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.508 0.723 . . . . 0.0 110.406 175.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 6.3 tppt? -67.74 -31.85 72.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.982 0.513 . . . . 0.0 109.831 167.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.422 ' HE3' HD22 ' A' ' 71' ' ' LEU . 81.8 t90 -71.37 -38.6 71.53 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.805 0.442 . . . . 0.0 110.795 170.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.503 HD23 ' HA ' ' A' ' 68' ' ' ARG . 3.8 mm? -65.55 -29.66 70.31 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 120.807 0.337 . . . . 0.0 110.163 171.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.43 -35.8 65.85 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.78 0.832 . . . . 0.0 109.479 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.453 ' HA ' ' HG2' ' A' ' 76' ' ' LYS . 14.2 tp10 -63.54 -23.67 67.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.29 1.036 . . . . 0.0 110.791 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -76.74 -35.6 57.66 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.879 0.871 . . . . 0.0 112.113 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.7 p -84.17 -27.83 27.79 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.453 ' HG2' ' HA ' ' A' ' 73' ' ' GLU . 16.4 ptmt -86.74 168.52 18.0 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 123.759 0.824 . . . . 0.0 109.341 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.15 162.02 37.41 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.176 1.917 . . . . 0.0 112.058 166.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.0 m -81.97 27.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.784 0.833 . . . . 0.0 112.765 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.3 t -68.2 104.34 1.79 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.629 0.772 . . . . 0.0 110.52 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.9 tt -168.4 -43.95 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.557 1.143 . . . . 0.0 107.944 -177.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.46 -2.66 17.45 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.398 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -60.84 -35.73 77.32 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.535 0.734 . . . . 0.0 110.173 170.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 tt -59.61 -42.92 93.72 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.496 1.118 . . . . 0.0 109.472 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -70.76 86.83 0.68 Allowed 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.66 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.4 t -77.45 -23.48 50.48 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.762 0.825 . . . . 0.0 110.9 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -137.07 145.82 44.43 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.106 0.962 . . . . 0.0 108.809 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.31 79.83 0.07 OUTLIER Glycine 0 C--N 1.339 0.749 0 N-CA-C 112.027 -0.429 . . . . 0.0 112.027 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -118.05 114.4 23.06 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.021 0.928 . . . . 0.0 109.861 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.3 41.76 0.41 Allowed Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 175.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -108.47 88.54 2.75 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.964 0.906 . . . . 0.0 110.168 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -88.98 166.19 14.07 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.518 0.727 . . . . 0.0 109.834 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.75 123.65 7.25 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.111 -175.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 64.41 84.75 0.15 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.779 1.231 . . . . 0.0 111.767 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.33 129.39 9.31 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 173.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.9 t . . . . . 0 C--O 1.255 1.359 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -175.633 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.53 55.6 0.72 Allowed Glycine 0 C--N 1.341 0.837 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -175.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -66.2 92.94 0.19 Allowed 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.433 0.693 . . . . 0.0 110.037 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.1 ttt -76.33 108.29 9.17 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 166.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -71.2 89.92 0.88 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 pp -114.59 1.57 14.3 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.744 1.218 . . . . 0.0 110.711 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.5 tt -74.07 140.6 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.353 0.661 . . . . 0.0 109.539 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.5 t 60.14 49.92 6.94 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 124.174 0.99 . . . . 0.0 111.514 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 41.4 mtt -67.61 124.46 23.3 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.49 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -71.31 106.93 4.04 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.491 HG22 ' HB ' ' A' ' 53' ' ' ILE . 57.8 t -78.93 110.04 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.879 -177.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 54.5 m-85 -97.23 120.9 38.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.128 0.971 . . . . 0.0 109.163 174.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -78.21 87.71 4.29 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.02 -95.51 0.74 Allowed Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -107.63 -29.66 9.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.792 0.837 . . . . 0.0 111.11 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.65 146.54 28.2 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.57 0.348 . . . . 0.0 110.449 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.0 t -77.15 105.63 8.36 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -79.89 -55.71 4.78 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.527 0.731 . . . . 0.0 111.158 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.532 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . -179.03 -147.87 7.39 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.261 0.351 . . . . 0.0 112.456 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -137.49 135.36 36.73 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.843 0.857 . . . . 0.0 109.779 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.5 p -76.66 108.27 9.55 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.21 -37.73 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.349 0.659 . . . . 0.0 109.556 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -160.73 177.92 9.98 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -173.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.483 ' HB ' HD12 ' A' ' 29' ' ' LEU . 5.5 p -155.58 135.14 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 123.962 0.905 . . . . 0.0 109.056 173.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.444 ' CD2' HD11 ' A' ' 30' ' ' ILE . 34.3 p90 -132.13 131.81 42.65 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 171.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.19 -107.06 1.18 Allowed Glycine 0 C--N 1.343 0.958 0 O-C-N 123.764 0.665 . . . . 0.0 113.293 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -119.65 27.94 8.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.977 0.911 . . . . 0.0 111.261 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -133.29 108.97 9.07 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.063 0.545 . . . . 0.0 110.227 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.483 HD12 ' HB ' ' A' ' 24' ' ' VAL . 51.0 tp -81.37 113.47 19.49 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.356 0.662 . . . . 0.0 109.404 175.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.444 HD11 ' CD2' ' A' ' 25' ' ' TYR . 8.0 mm -80.1 104.79 8.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 C-N-CA 123.172 0.589 . . . . 0.0 109.685 -176.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.2 t -105.95 113.58 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.756 0.822 . . . . 0.0 109.834 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -75.86 117.0 17.13 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.387 0.675 . . . . 0.0 109.638 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.532 HG12 ' HA3' ' A' ' 19' ' ' GLY . 11.1 m -133.18 148.78 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.95 0.9 . . . . 0.0 109.409 176.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.23 -106.04 0.43 Allowed Glycine 0 CA--C 1.531 1.09 0 O-C-N 123.426 0.454 . . . . 0.0 113.04 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.8 m -109.53 -29.91 8.18 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.648 0.779 . . . . 0.0 110.888 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -116.44 176.5 5.08 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.623 0.725 . . . . 0.0 112.158 -169.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -104.28 109.92 21.94 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.653 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.12 102.97 15.51 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.208 1.003 . . . . 0.0 108.577 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB3' HD12 ' A' ' 66' ' ' LEU . . . -84.83 94.66 8.78 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.673 0.789 . . . . 0.0 109.526 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.1 m -75.35 128.66 83.96 Favored Pre-proline 0 CA--C 1.558 1.255 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.699 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -60.81 161.26 22.19 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.017 2.478 . . . . 0.0 112.192 174.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.504 ' HA ' HG12 ' A' ' 45' ' ' ILE . 14.6 mmmm -68.42 -21.27 64.68 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.69 -17.39 62.84 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.711 0.404 . . . . 0.0 111.014 174.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.8 t -80.5 -29.47 37.31 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.102 0.561 . . . . 0.0 110.353 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.513 HD13 HG22 ' A' ' 55' ' ' ILE . 25.5 mm -68.23 115.18 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 122.837 0.455 . . . . 0.0 110.406 -175.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -84.01 -66.69 0.86 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.596 0.758 . . . . 0.0 110.448 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.0 m -143.71 126.79 16.46 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.626 0.371 . . . . 0.0 110.654 -171.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -82.82 111.63 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.783 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 11.1 mm-40 -99.41 175.96 5.68 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.78 0.832 . . . . 0.0 109.986 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -70.31 97.55 1.26 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.12 0.568 . . . . 0.0 110.05 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.81 21.94 77.78 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.841 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.783 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 79.6 mtt180 -142.62 151.24 41.27 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.931 0.892 . . . . 0.0 110.031 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.491 ' HB ' HG22 ' A' ' 11' ' ' VAL . 43.5 mm -124.4 107.11 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 170.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 57.4 t -78.46 117.76 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.513 HG22 HD13 ' A' ' 45' ' ' ILE . 47.4 pt -108.81 171.4 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.698 0.799 . . . . 0.0 109.54 171.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.66 -81.08 0.68 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -139.75 146.11 39.12 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-O 121.846 0.831 . . . . 0.0 110.711 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -160.66 165.48 30.51 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.471 1.508 . . . . 0.0 107.589 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -94.1 108.6 20.43 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.63 -39.11 92.77 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.889 0.876 . . . . 0.0 112.952 -170.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.55 -33.09 75.11 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.3 0.64 . . . . 0.0 110.712 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -76.73 -45.9 27.47 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.435 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.91 -26.78 68.46 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.674 0.79 . . . . 0.0 110.671 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -74.7 -44.4 50.29 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.589 0.756 . . . . 0.0 110.609 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.86 -39.33 64.05 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 39' ' ' ALA . 4.3 pp -82.41 -13.67 56.44 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 121.702 0.763 . . . . 0.0 110.037 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.18 -43.08 96.0 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 161.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -70.07 -16.69 63.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.92 0.888 . . . . 0.0 111.582 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.512 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 4.0 tppp? -67.28 -38.78 85.62 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.692 0.797 . . . . 0.0 109.559 170.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.438 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 68.7 t90 -62.19 -45.29 94.05 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.344 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.483 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 3.7 mm? -63.22 -25.38 68.3 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.564 0.345 . . . . 0.0 111.209 174.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -74.67 -35.78 62.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.867 0.867 . . . . 0.0 111.311 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.635 ' HA ' ' HG2' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -71.52 -28.74 64.1 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.483 ' HD3' ' HA ' ' A' ' 71' ' ' LEU . 28.0 mtpp -69.01 -23.93 64.15 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.747 0.819 . . . . 0.0 111.686 172.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.2 m -83.12 -44.84 14.66 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.613 0.765 . . . . 0.0 111.106 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.635 ' HG2' ' HA ' ' A' ' 73' ' ' GLU . 15.8 ptpt -81.51 170.89 13.59 Favored Pre-proline 0 N--CA 1.487 1.408 0 C-N-CA 123.917 0.887 . . . . 0.0 109.364 177.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 76' ' ' LYS . 18.9 Cg_endo -55.65 138.84 82.18 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 122.071 1.847 . . . . 0.0 111.145 173.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.16 90.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.664 0.786 . . . . 0.0 109.897 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.2 p -130.26 29.2 4.91 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.914 1.286 . . . . 0.0 109.813 -175.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.6 tp -73.5 92.11 1.86 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.78 0.832 . . . . 0.0 110.31 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -11.2 59.73 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.979 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -61.48 -25.33 67.18 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.224 1.01 . . . . 0.0 110.964 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -58.03 -32.52 68.04 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.496 1.118 . . . . 0.0 110.129 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -71.44 139.11 49.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.823 0.849 . . . . 0.0 111.363 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.5 t -168.59 176.7 5.55 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.092 1.357 . . . . 0.0 108.685 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -72.72 179.43 3.62 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.399 0.68 . . . . 0.0 111.61 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.57 33.06 6.3 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.041 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -72.0 109.54 5.88 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.185 0.994 . . . . 0.0 110.033 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.63 167.31 13.13 Favored Glycine 0 C--N 1.343 0.955 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -134.21 21.39 3.74 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.599 0.76 . . . . 0.0 111.035 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.0 -41.2 71.24 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 132.69 -167.98 22.97 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.826 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -157.62 -56.86 0.08 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.502 1.121 . . . . 0.0 108.08 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.95 175.69 23.11 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.333 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.2 p . . . . . 0 C--O 1.254 1.338 0 C-N-CA 123.535 0.734 . . . . 0.0 109.303 178.73 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.11 153.43 28.09 Favored Glycine 0 C--N 1.353 1.483 0 O-C-N 123.609 0.568 . . . . 0.0 112.513 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -103.0 144.8 30.8 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.117 0.967 . . . . 0.0 109.394 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.426 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 63.1 mtt -136.21 167.8 20.59 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.451 1.1 . . . . 0.0 108.901 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -122.9 44.66 2.59 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.879 0.872 . . . . 0.0 109.252 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.426 ' HG ' ' HB3' ' A' ' 4' ' ' MET . 86.3 mt -86.07 -51.69 6.16 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.022 -172.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.8 tp -69.94 114.71 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-O 121.504 0.669 . . . . 0.0 111.902 -171.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.3 m -86.97 93.4 9.33 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.4 ' HG2' ' HA2' ' A' ' 51' ' ' GLY . 58.2 mtt -71.64 126.51 29.89 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.976 -173.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -66.43 113.81 4.96 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.513 0.725 . . . . 0.0 110.568 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.1 t -83.1 123.73 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.505 0.722 . . . . 0.0 110.386 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -108.55 120.73 43.3 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.161 0.984 . . . . 0.0 109.418 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 49.7 tttm -77.24 85.43 3.69 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.59 -94.18 0.84 Allowed Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -110.81 -23.58 10.93 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.313 1.045 . . . . 0.0 111.229 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 11.3 pt-20 -91.18 144.41 25.65 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.065 0.546 . . . . 0.0 110.451 -173.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.6 t -71.4 111.4 6.69 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.406 0.682 . . . . 0.0 109.507 176.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -91.35 -56.55 3.1 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.801 0.44 . . . . 0.0 111.166 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.434 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . -179.35 -140.35 4.03 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.57 -174.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.26 139.25 35.5 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.601 0.76 . . . . 0.0 110.619 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.0 t -79.16 108.87 12.97 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.664 0.785 . . . . 0.0 109.241 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.42 HD13 ' HB2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -92.18 -39.13 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.156 0.582 . . . . 0.0 109.599 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' HB2' HD13 ' A' ' 22' ' ' ILE . 19.0 t70 -154.26 169.11 24.43 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.743 0.306 . . . . 0.0 111.082 -174.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.407 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.7 p -151.17 137.9 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.352 1.061 . . . . 0.0 108.46 172.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.417 ' CE1' HD11 ' A' ' 30' ' ' ILE . 2.4 p90 -146.54 135.38 22.34 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.96 -106.8 1.08 Allowed Glycine 0 C--N 1.34 0.799 0 O-C-N 123.29 0.369 . . . . 0.0 113.955 174.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -119.51 13.07 12.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.099 0.959 . . . . 0.0 110.915 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.479 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 83.8 m-85 -130.74 150.14 52.06 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.509 0.723 . . . . 0.0 111.049 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.407 HD12 ' HB ' ' A' ' 24' ' ' VAL . 45.3 tp -117.25 112.46 20.81 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.592 1.557 . . . . 0.0 107.725 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.417 HD11 ' CE1' ' A' ' 25' ' ' TYR . 39.0 mm -76.52 109.15 10.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.816 0 C-N-CA 123.128 0.571 . . . . 0.0 109.757 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.5 t -110.13 117.94 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.053 0.941 . . . . 0.0 108.648 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.78 118.68 28.64 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.566 HG22 HD23 ' A' ' 38' ' ' LEU . 19.7 m -123.07 128.49 75.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 171.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.99 -99.71 0.21 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 116.604 -0.271 . . . . 0.0 113.305 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.0 m -125.05 -5.11 7.39 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.856 0.862 . . . . 0.0 111.081 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -116.83 154.2 31.15 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.246 0.618 . . . . 0.0 111.236 -173.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -112.01 109.66 19.54 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.31 1.044 . . . . 0.0 109.154 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.566 HD23 HG22 ' A' ' 33' ' ' VAL . 3.6 mm? -95.55 106.75 18.86 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.39 1.076 . . . . 0.0 109.131 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -79.84 95.29 6.0 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.086 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.4 m -87.06 126.42 62.99 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.497 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 38.2 Cg_endo -62.13 152.03 78.33 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.503 2.135 . . . . 0.0 112.492 -176.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.598 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.7 mmmm -64.94 -23.04 67.1 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.583 0.753 . . . . 0.0 111.808 -175.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.497 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 21.6 ptmt -70.88 -25.58 62.86 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.461 0.705 . . . . 0.0 111.307 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.9 t -72.22 -31.43 65.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.888 0.475 . . . . 0.0 110.094 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.598 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.6 mp -62.0 114.68 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.099 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -90.62 -55.6 3.51 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.824 1.25 . . . . 0.0 110.818 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.5 m -134.37 126.87 30.5 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.349 0.66 . . . . 0.0 110.108 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 p -96.04 109.88 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 172.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 47.4 mm-40 -111.39 168.47 9.51 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 124.224 1.01 . . . . 0.0 109.918 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -65.34 98.53 0.34 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.811 0.844 . . . . 0.0 110.803 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' A' ' 9' ' ' MET . . . 77.29 11.96 85.03 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 116.333 -0.394 . . . . 0.0 113.963 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.483 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 97.4 mtt180 -137.6 127.3 25.33 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.957 0.903 . . . . 0.0 109.48 178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.9 mm -110.37 102.99 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.9 t -80.71 113.48 20.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 33.3 pt -106.63 178.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.102 0.961 . . . . 0.0 108.466 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.43 -119.71 4.54 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -131.63 166.54 21.22 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.732 0.813 . . . . 0.0 109.165 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -163.53 168.5 20.03 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.115 0.966 . . . . 0.0 109.297 -168.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -81.75 99.57 9.03 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -62.95 -30.55 71.66 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.006 0.922 . . . . 0.0 111.883 -175.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -62.83 -51.84 65.46 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.688 0.756 . . . . 0.0 109.747 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.07 -35.17 76.23 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.972 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.3 -34.77 73.14 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.029 0.532 . . . . 0.0 111.867 -175.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -77.13 -34.27 56.65 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 177.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.97 -37.99 54.1 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 117.725 0.238 . . . . 0.0 111.048 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 pp -82.98 -15.53 50.85 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.06 -42.71 35.82 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.053 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.572 ' HA ' HD23 ' A' ' 71' ' ' LEU . 4.9 ptp180 -70.97 -27.06 63.45 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 24.2 ttmm -63.56 -33.55 75.84 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 170.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -64.52 -37.1 86.36 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.696 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.572 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.0 mm? -61.52 -29.4 69.97 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 118.139 0.427 . . . . 0.0 110.717 173.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -77.01 -33.9 57.46 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.314 0.645 . . . . 0.0 110.685 172.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 44.1 mt-10 -71.61 -44.06 65.1 Favored 'General case' 0 C--O 1.206 -1.196 0 C-N-CA 123.57 0.748 . . . . 0.0 111.764 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -14.16 61.99 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.738 -0.601 . . . . 0.0 110.974 177.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.8 t -101.01 31.45 3.6 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 124.618 1.167 . . . . 0.0 109.893 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -65.46 159.99 62.96 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 123.547 0.739 . . . . 0.0 112.02 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.7 -177.38 0.24 Allowed 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 122.832 2.354 . . . . 0.0 113.168 176.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.5 m -71.94 8.91 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -173.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.3 t -60.45 129.46 41.72 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.316 0.646 . . . . 0.0 110.844 168.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.528 HD13 ' HB3' ' A' ' 82' ' ' GLU . 1.5 pp -83.75 157.08 22.24 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.349 172.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -104.12 4.96 34.74 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.272 0.629 . . . . 0.0 111.259 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.528 ' HB3' HD13 ' A' ' 80' ' ' LEU . 12.2 tp10 -54.88 -35.66 64.3 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.244 1.018 . . . . 0.0 111.078 170.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -70.83 -51.09 28.79 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.2 0.6 . . . . 0.0 110.425 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -83.86 171.06 13.44 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.522 0.677 . . . . 0.0 111.638 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 m -87.93 158.77 18.59 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.679 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -104.9 155.75 18.65 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.727 0.811 . . . . 0.0 109.073 174.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.76 145.5 49.85 Favored Glycine 0 C--N 1.341 0.806 0 O-C-N 123.564 0.54 . . . . 0.0 113.359 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -67.07 133.91 50.81 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.493 0.717 . . . . 0.0 110.294 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.69 -115.01 3.45 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -89.13 83.03 6.52 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.092 0.557 . . . . 0.0 109.695 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.43 95.86 3.92 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -168.61 -174.73 37.55 Favored Glycine 0 C--O 1.242 0.605 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.027 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -77.39 78.1 3.91 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.822 0.849 . . . . 0.0 109.062 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.44 134.57 18.11 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.126 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.301 -0.856 . . . . 0.0 109.24 179.026 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.763 0.316 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -145.95 -106.47 0.49 Allowed Glycine 0 C--N 1.341 0.82 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -79.75 86.31 5.34 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 172.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.0 ttt -77.68 89.73 3.97 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -78.3 -8.25 58.18 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.105 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mp -90.75 55.08 2.85 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.045 1.338 . . . . 0.0 107.55 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.464 ' HB ' ' HG3' ' A' ' 9' ' ' MET . 41.3 pt -69.61 133.59 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.479 -170.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 21' ' ' SER . 23.2 p -116.01 30.34 7.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.608 1.163 . . . . 0.0 109.582 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.464 ' HG3' ' HB ' ' A' ' 7' ' ' ILE . 85.2 mtp -65.12 142.97 58.19 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.651 -173.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -72.33 107.69 5.06 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.69 0.796 . . . . 0.0 109.929 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.59 116.23 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 122.92 0.488 . . . . 0.0 109.929 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -111.13 129.56 55.9 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.243 1.017 . . . . 0.0 109.262 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -85.19 92.25 8.35 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.55 -95.81 0.4 Allowed Glycine 0 C--N 1.351 1.4 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.014 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -104.51 -31.83 9.27 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.609 0.764 . . . . 0.0 111.479 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -83.4 144.2 29.78 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 120.659 0.266 . . . . 0.0 110.911 -172.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.5 t -72.41 111.09 7.29 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.561 0.745 . . . . 0.0 109.359 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -84.85 -57.04 3.27 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.56 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 178.15 -136.18 2.91 Favored Glycine 0 C--N 1.347 1.143 0 O-C-N 123.149 0.28 . . . . 0.0 112.465 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.79 139.13 24.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.238 1.015 . . . . 0.0 109.687 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 47.3 t -68.23 138.5 55.62 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.06 -38.11 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -156.14 164.55 38.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.732 0.413 . . . . 0.0 110.039 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.0 p -121.16 136.45 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.474 ' OH ' ' HD2' ' A' ' 69' ' ' LYS . 4.6 t80 -136.95 101.25 4.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.982 0.913 . . . . 0.0 109.602 -173.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.0 -113.04 5.37 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.423 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -98.57 21.53 11.12 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.027 0.931 . . . . 0.0 110.873 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -135.58 162.24 33.25 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.047 0.939 . . . . 0.0 109.792 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 59.0 tp -123.66 113.07 18.15 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' ' 39' ' ' ALA . 23.7 mm -70.43 106.88 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.0 t -108.32 117.71 54.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -76.22 115.85 16.35 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.638 HG22 HD23 ' A' ' 38' ' ' LEU . 4.0 m -123.38 121.19 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.86 -86.97 0.06 OUTLIER Glycine 0 CA--C 1.532 1.115 0 CA-C-N 116.326 -0.397 . . . . 0.0 113.487 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 m -124.56 -25.84 3.96 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.683 1.193 . . . . 0.0 110.663 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -106.88 163.78 12.67 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.579 0.752 . . . . 0.0 111.24 -167.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -111.0 109.07 19.02 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.156 0.982 . . . . 0.0 108.772 177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.638 HD23 HG22 ' A' ' 33' ' ' VAL . 4.3 mm? -105.73 111.95 24.82 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.572 1.149 . . . . 0.0 108.836 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.447 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -82.93 94.81 7.8 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.212 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.48 131.28 58.79 Favored Pre-proline 0 N--CA 1.473 0.723 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.574 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 35.8 Cg_endo -60.67 153.41 62.15 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.275 1.983 . . . . 0.0 111.703 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.543 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.4 mmmm -63.27 -27.13 69.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.603 0.761 . . . . 0.0 111.416 -178.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.574 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 20.9 ptmt -67.74 -21.7 65.27 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.676 0.79 . . . . 0.0 111.793 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.5 t -70.18 -43.15 71.38 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.543 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.3 mp -60.98 113.77 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.209 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.547 ' HE3' ' HA3' ' A' ' 56' ' ' GLY . 33.9 mmtp -79.17 -58.65 3.12 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.857 0.863 . . . . 0.0 109.421 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.8 m -154.45 156.72 37.27 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.378 0.671 . . . . 0.0 110.613 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.4 t -93.37 111.76 25.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.822 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 7.3 mm-40 -86.62 167.21 14.74 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.348 0.659 . . . . 0.0 109.363 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -69.13 93.85 0.63 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.57 -6.76 65.43 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.852 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.63 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 49.9 mtm180 -129.01 158.99 37.34 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.009 0.523 . . . . 0.0 110.952 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 mm -124.17 104.44 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.2 t -79.98 118.75 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.2 pt -108.81 174.08 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 123.893 0.877 . . . . 0.0 109.336 172.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.547 ' HA3' ' HE3' ' A' ' 46' ' ' LYS . . . -135.38 -90.04 0.31 Allowed Glycine 0 C--N 1.34 0.757 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.065 -173.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -107.73 130.45 54.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.09 0.472 . . . . 0.0 111.882 -168.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -164.12 -176.4 4.47 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.278 1.031 . . . . 0.0 108.768 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -128.79 122.72 31.14 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.98 -32.66 69.57 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.753 0.421 . . . . 0.0 112.114 -173.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.88 -34.62 69.33 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.43 -38.69 68.26 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.379 172.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.434 ' HB3' HD12 ' A' ' 38' ' ' LEU . . . -70.06 -28.47 65.47 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.926 0.49 . . . . 0.0 111.629 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -78.63 -36.25 44.33 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.037 0.535 . . . . 0.0 112.027 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.61 -41.96 59.49 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 120.838 0.352 . . . . 0.0 110.859 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 pp -81.46 -21.27 38.88 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.21 -41.38 86.49 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.959 170.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.523 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -73.59 -21.0 60.46 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 117.346 0.573 . . . . 0.0 111.032 177.418 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.474 ' HD2' ' OH ' ' A' ' 25' ' ' TYR . 2.6 ttmp? -57.98 -46.85 84.51 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 166.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.492 ' HE3' HD12 ' A' ' 71' ' ' LEU . 89.3 t90 -62.34 -42.64 99.55 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.117 174.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . 9.8 mp -54.55 -31.7 57.02 Favored 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 123.54 0.736 . . . . 0.0 111.879 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -80.3 -54.09 6.04 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 122.924 0.49 . . . . 0.0 109.908 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.488 ' HG2' ' HA ' ' A' ' 70' ' ' TRP . 12.7 pt-20 -75.92 -17.15 59.87 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -170.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -25.34 66.93 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 123.566 0.746 . . . . 0.0 111.802 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m -59.7 -26.46 65.61 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.934 0.894 . . . . 0.0 111.396 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -89.35 120.12 69.7 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.078 0.951 . . . . 0.0 109.481 174.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.83 143.5 55.68 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.691 2.26 . . . . 0.0 112.254 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.8 p -69.86 101.79 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 C-N-CA 123.49 0.716 . . . . 0.0 111.261 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 t -76.03 102.15 5.54 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.622 0.725 . . . . 0.0 110.168 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.6 tp -67.0 -35.35 79.76 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.952 -176.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.65 -38.35 89.95 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.672 0.789 . . . . 0.0 111.891 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -83.01 -22.45 33.61 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.853 0.461 . . . . 0.0 110.911 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.5 tp -65.8 -32.58 74.19 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.583 0.753 . . . . 0.0 110.701 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -75.8 96.23 3.63 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.175 0.59 . . . . 0.0 110.001 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t -154.48 135.79 14.08 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.023 0.929 . . . . 0.0 109.441 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -77.76 137.08 38.26 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.582 0.753 . . . . 0.0 111.12 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -80.12 -172.49 44.5 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.155 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -83.6 97.37 9.02 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.473 0.709 . . . . 0.0 111.272 -173.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -100.53 92.33 1.07 Allowed Glycine 0 C--N 1.345 1.047 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -70.94 -20.8 62.43 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.401 0.68 . . . . 0.0 111.337 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.25 134.8 57.01 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.879 0.872 . . . . 0.0 110.218 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 154.29 82.93 0.04 OUTLIER Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -175.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -87.14 -20.8 26.51 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.365 0.666 . . . . 0.0 111.159 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 93.99 -96.66 2.09 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.911 -0.383 . . . . 0.0 112.176 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 C--O 1.248 1.026 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.049 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.682 0.277 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.83 168.44 44.46 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.186 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -80.52 87.0 5.74 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.011 0.524 . . . . 0.0 110.754 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.9 ttt -101.15 15.26 29.31 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.62 0.724 . . . . 0.0 109.777 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -85.01 45.24 1.15 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.07 0.948 . . . . 0.0 111.88 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.45 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.6 pt? -124.12 6.52 8.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.789 0.836 . . . . 0.0 109.709 171.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.658 HG13 ' H ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -80.05 89.19 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 CA-C-O 122.209 1.004 . . . . 0.0 108.805 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.9 p -166.47 79.26 0.24 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.253 -1.34 . . . . 0.0 107.489 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -66.14 134.38 52.66 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.713 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -74.13 108.41 6.91 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.34 1.056 . . . . 0.0 109.883 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.461 HG22 ' HB ' ' A' ' 53' ' ' ILE . 61.5 t -80.01 123.7 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.927 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -106.09 122.58 46.46 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.135 0.974 . . . . 0.0 109.836 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -78.82 80.76 5.15 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.57 -95.61 0.39 Allowed Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.786 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -104.3 0.38 29.17 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.844 0.858 . . . . 0.0 112.124 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -131.42 149.6 52.47 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.134 0.574 . . . . 0.0 110.422 -175.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.6 t -71.94 111.62 7.35 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.419 0.688 . . . . 0.0 109.762 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -77.37 -55.92 4.99 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.32 0.648 . . . . 0.0 109.327 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.88 -142.99 6.09 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.36 151.71 35.79 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.445 0.698 . . . . 0.0 109.748 172.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.2 t -71.62 146.9 48.04 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.955 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.42 -37.73 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.081 0.952 . . . . 0.0 109.405 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.73 173.24 14.42 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -173.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.418 ' HB ' HD12 ' A' ' 29' ' ' LEU . 8.9 p -155.96 134.1 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.565 0.746 . . . . 0.0 109.516 171.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.438 ' CE1' HD11 ' A' ' 30' ' ' ILE . 8.8 p90 -133.77 125.24 28.1 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.17 -107.07 1.18 Allowed Glycine 0 CA--C 1.531 1.072 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.398 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -102.93 -9.4 19.89 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.004 0.921 . . . . 0.0 111.603 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.599 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 86.6 m-85 -108.7 108.48 19.34 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.815 -0.553 . . . . 0.0 111.979 -169.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.418 HD12 ' HB ' ' A' ' 24' ' ' VAL . 26.8 tp -77.65 109.35 11.55 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.37 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.438 HD11 ' CE1' ' A' ' 25' ' ' TYR . 24.3 mm -72.03 99.73 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.2 t -96.1 112.71 28.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -85.89 113.91 22.39 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.95 86.86 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 CA-C-O 122.164 0.983 . . . . 0.0 110.532 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.53 -89.26 0.36 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.392 177.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.561 HG23 ' HG2' ' A' ' 36' ' ' GLU . 10.5 t -101.5 -16.71 16.72 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.39 0.676 . . . . 0.0 110.93 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.561 ' HG2' HG23 ' A' ' 35' ' ' THR . 6.3 mm-40 -109.6 162.73 14.13 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.443 0.697 . . . . 0.0 111.156 -167.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -121.39 108.48 13.73 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 170.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.85 106.68 17.29 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.501 1.121 . . . . 0.0 108.755 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.599 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -87.24 94.74 9.75 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.559 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.6 m -78.98 140.04 57.57 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.531 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.36 155.05 72.06 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.554 2.169 . . . . 0.0 110.767 172.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.419 ' HA ' HD13 ' A' ' 45' ' ' ILE . 31.8 mmmt -64.71 -22.94 67.1 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -76.57 -17.21 59.34 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.267 0.627 . . . . 0.0 111.921 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.1 t -66.66 -30.59 70.89 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.272 0.629 . . . . 0.0 110.727 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.6 mp -72.49 115.48 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.729 0.812 . . . . 0.0 109.733 -177.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -85.85 -44.35 12.52 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.765 0.826 . . . . 0.0 110.184 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.3 m -139.46 133.5 31.02 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.545 0.738 . . . . 0.0 111.436 -172.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.1 t -105.08 110.75 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 170.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 40.0 mm-40 -111.37 175.5 5.4 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.973 0.909 . . . . 0.0 110.488 -177.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -40.47 -56.6 2.01 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 125.648 1.579 . . . . 0.0 113.013 -171.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.541 ' H ' ' HD2' ' A' ' 52' ' ' ARG . . . -140.3 35.73 1.86 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HD2' ' H ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -137.86 151.56 48.19 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.524 0.73 . . . . 0.0 109.564 -176.431 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.461 ' HB ' HG22 ' A' ' 11' ' ' VAL . 31.1 mm -132.11 104.06 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 124.556 1.142 . . . . 0.0 108.432 172.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.8 t -84.48 115.88 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.1 pt -107.3 141.33 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.68 0.792 . . . . 0.0 109.518 173.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.82 -61.45 1.77 Allowed Glycine 0 C--N 1.345 1.047 0 N-CA-C 112.231 -0.348 . . . . 0.0 112.231 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -156.48 162.65 39.96 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.834 0.853 . . . . 0.0 109.451 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -171.01 162.72 7.28 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.76 0.824 . . . . 0.0 109.947 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.03 86.7 1.03 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.52 -36.55 71.08 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.98 0.912 . . . . 0.0 113.241 -171.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -68.05 -38.22 82.2 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 41.4 mt-10 -74.14 -34.66 63.93 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.842 176.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.21 -24.54 63.13 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.836 0.455 . . . . 0.0 110.959 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -74.2 -44.59 52.65 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.104 0.962 . . . . 0.0 110.161 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.7 pt-20 -70.11 -38.47 75.63 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 39' ' ' ALA . 4.5 pp -82.97 -13.41 56.04 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 120.983 0.42 . . . . 0.0 110.651 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.69 -43.77 50.63 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.133 169.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.518 ' HA ' HD23 ' A' ' 71' ' ' LEU . 25.7 ptt85 -73.83 -22.5 59.76 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 116.766 0.283 . . . . 0.0 110.542 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 24.8 ttpp -64.82 -33.9 77.08 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 169.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -66.45 -35.6 80.7 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 119.638 -0.22 . . . . 0.0 110.832 170.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.4 mm? -61.43 -23.0 65.53 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.29 0.496 . . . . 0.0 111.407 173.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 69' ' ' LYS . 13.3 tp10 -77.28 -40.03 45.98 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 123.305 0.642 . . . . 0.0 110.47 169.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 69' ' ' LYS . 9.6 mm-40 -75.26 -29.17 60.09 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -174.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.424 ' HE3' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -64.4 -21.73 66.73 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 120.861 0.362 . . . . 0.0 111.936 -179.266 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.6 m -75.02 -10.85 59.86 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.303 0.641 . . . . 0.0 111.738 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 73' ' ' GLU . 11.1 mptt -89.92 144.69 31.87 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 170.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.34 168.59 4.79 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.158 2.572 . . . . 0.0 112.674 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.3 t -73.31 80.63 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -91.32 -29.47 17.11 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.894 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.6 tp -75.02 99.92 4.02 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 172.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -70.49 -24.6 62.88 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.551 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.3 -18.61 64.77 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.914 0.885 . . . . 0.0 112.305 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.9 tt -61.12 -24.89 66.6 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.875 0.87 . . . . 0.0 110.299 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -54.56 107.43 0.28 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.545 1.138 . . . . 0.0 110.404 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.5 p -136.53 127.8 28.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.764 0.825 . . . . 0.0 110.62 -173.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -135.56 116.95 14.67 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.15 0.98 . . . . 0.0 109.032 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.658 ' H ' HG13 ' A' ' 7' ' ' ILE . . . -88.64 70.05 2.64 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -93.44 -173.72 3.29 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.729 0.811 . . . . 0.0 110.03 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.92 28.64 73.82 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.63 95.44 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.195 1.398 . . . . 0.0 111.269 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -153.16 140.16 19.24 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.504 -175.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 116.74 145.23 8.15 Favored Glycine 0 C--O 1.24 0.499 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -150.79 165.83 32.35 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 123.627 0.771 . . . . 0.0 110.513 -169.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.69 102.35 0.34 Allowed Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 CA--C 1.559 1.325 0 C-N-CA 124.286 1.034 . . . . 0.0 111.318 -178.094 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.51 156.77 9.42 Favored Glycine 0 C--N 1.345 1.03 0 C-N-CA 121.565 -0.35 . . . . 0.0 113.784 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -163.86 126.79 2.55 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.068 1.347 . . . . 0.0 108.874 173.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.1 mmt 61.77 28.2 17.31 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.849 1.26 . . . . 0.0 112.628 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -73.49 -8.83 57.54 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.896 0.878 . . . . 0.0 111.163 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.6 mt -69.74 96.16 0.95 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.469 1.107 . . . . 0.0 110.785 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.83 -42.8 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.346 1.058 . . . . 0.0 108.398 174.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.2 t -77.36 100.49 5.95 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 123.76 0.824 . . . . 0.0 109.609 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.403 ' HB2' HG12 ' A' ' 53' ' ' ILE . 59.0 mtt -134.69 161.25 35.68 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.319 1.048 . . . . 0.0 109.935 -175.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -79.13 111.22 15.13 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.443 HG22 ' HB ' ' A' ' 53' ' ' ILE . 61.6 t -86.78 127.93 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.702 0.801 . . . . 0.0 110.781 -175.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -108.82 123.02 48.39 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.323 1.449 . . . . 0.0 109.167 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 87.1 tttt -80.94 90.13 5.92 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.2 -95.58 0.59 Allowed Glycine 0 C--N 1.342 0.914 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.329 -173.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -117.65 -10.52 10.55 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.918 0.887 . . . . 0.0 111.887 -176.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 11.3 pt-20 -90.87 146.61 23.78 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.4 t -81.67 102.28 10.6 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -76.32 -55.64 5.37 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.443 0.697 . . . . 0.0 111.14 -172.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.589 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 178.75 -137.26 3.16 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-O 120.066 -0.297 . . . . 0.0 112.513 -177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -145.2 136.53 25.07 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.062 0.945 . . . . 0.0 109.68 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 31.6 p -76.85 118.25 19.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.729 0.812 . . . . 0.0 110.161 175.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.04 -35.05 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.965 0.906 . . . . 0.0 109.82 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -150.09 175.34 11.82 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.963 0.505 . . . . 0.0 110.455 -173.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.438 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.1 p -152.8 139.34 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.503 1.121 . . . . 0.0 108.773 171.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -141.46 127.12 19.04 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.99 -106.37 0.98 Allowed Glycine 0 CA--C 1.531 1.068 0 O-C-N 123.514 0.509 . . . . 0.0 113.733 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -109.81 15.12 22.92 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.154 0.982 . . . . 0.0 111.709 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.61 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 96.9 m-85 -135.16 113.82 11.74 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 118.302 0.501 . . . . 0.0 111.888 -172.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.438 HD12 ' HB ' ' A' ' 24' ' ' VAL . 42.8 tp -80.29 111.81 17.03 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.909 1.283 . . . . 0.0 109.367 172.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.6 mm -71.77 99.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.343 0.657 . . . . 0.0 109.72 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 47.6 t -100.34 112.42 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.762 0.825 . . . . 0.0 109.046 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -89.3 123.05 33.14 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.589 HG12 ' HA3' ' A' ' 19' ' ' GLY . 1.3 m -128.08 133.33 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 173.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.81 -91.64 0.05 OUTLIER Glycine 0 N--CA 1.474 1.171 0 C-N-CA 123.287 0.47 . . . . 0.0 113.82 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 t -125.03 -13.26 6.86 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.308 1.043 . . . . 0.0 112.039 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -111.25 156.13 21.94 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -170.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -104.39 108.77 20.35 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 172.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.23 104.53 14.67 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.61 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -83.55 93.99 7.96 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.442 HG12 ' CE2' ' A' ' 58' ' ' PHE . 3.9 m -78.04 137.34 61.34 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 44' ' ' SER . 31.1 Cg_endo -62.37 138.43 71.19 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.241 1.961 . . . . 0.0 111.287 175.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.514 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.5 mmmm -62.75 -29.94 71.06 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.653 0.781 . . . . 0.0 111.528 -177.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -70.82 -18.24 62.73 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.028 0.931 . . . . 0.0 112.244 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.516 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 26.0 t -72.55 -27.12 62.03 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.918 0.487 . . . . 0.0 111.186 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.6 mp -61.98 115.5 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.811 0.444 . . . . 0.0 110.25 -176.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -76.41 -47.69 22.34 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.326 1.05 . . . . 0.0 110.599 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.9 m -143.45 124.69 14.58 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.136 0.574 . . . . 0.0 110.676 -173.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.0 t -93.21 109.24 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 166.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.675 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 16.3 mm-40 -108.53 165.71 11.32 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.125 1.37 . . . . 0.0 108.607 174.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.08 99.48 1.11 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.829 0.452 . . . . 0.0 110.453 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.7 14.12 73.85 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.201 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.675 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 28.3 mtm180 -142.83 125.51 15.92 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.172 0.989 . . . . 0.0 108.761 -175.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.443 ' HB ' HG22 ' A' ' 11' ' ' VAL . 34.8 mm -118.86 101.2 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 63.8 t -84.26 117.57 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 12.9 pt -109.74 164.56 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.876 0.871 . . . . 0.0 109.648 176.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.59 -87.65 1.36 Allowed Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 -173.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -142.95 144.42 32.36 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.113 0.965 . . . . 0.0 108.95 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.442 ' CE2' HG12 ' A' ' 40' ' ' VAL . 6.1 p90 -167.19 150.97 6.6 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -87.14 99.7 12.12 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.66 -29.54 69.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.186 0.994 . . . . 0.0 112.707 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.83 -42.72 85.34 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.971 0.415 . . . . 0.0 110.188 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.72 -37.5 82.32 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.26 -24.6 65.81 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.042 0.937 . . . . 0.0 111.379 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.63 -46.36 38.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.47 1.108 . . . . 0.0 110.216 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.36 -37.95 74.7 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 123.237 0.335 . . . . 0.0 111.259 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 39' ' ' ALA . 4.3 pp -82.26 -16.28 50.05 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-O 120.647 0.26 . . . . 0.0 110.441 175.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -76.55 -35.95 39.77 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.653 173.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -77.89 -21.96 50.47 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 172.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -65.0 -35.62 81.79 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 169.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.434 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 59.9 t90 -59.89 -51.49 69.49 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 123.395 0.434 . . . . 0.0 109.87 170.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.4 mt -49.49 -38.63 30.87 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 123.616 0.766 . . . . 0.0 111.504 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -71.42 -52.31 19.25 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.55 1.14 . . . . 0.0 111.593 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 70' ' ' TRP . 12.8 pt-20 -76.52 -22.8 53.94 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.158 0.583 . . . . 0.0 112.365 -170.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.14 -23.58 23.61 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.3 t -75.98 79.78 2.85 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-O 121.791 0.805 . . . . 0.0 109.177 175.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -81.32 147.08 59.41 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.455 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.25 -167.73 0.3 Allowed 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.854 2.369 . . . . 0.0 112.208 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -61.19 -33.22 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.116 0.566 . . . . 0.0 112.03 -176.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t -65.99 87.2 0.1 Allowed 'General case' 0 C--N 1.365 1.259 0 CA-C-O 122.49 1.138 . . . . 0.0 110.03 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.44 ' HB3' ' H ' ' A' ' 83' ' ' LEU . 13.2 mt -137.67 117.13 12.85 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.591 -174.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -64.84 -18.5 65.19 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.182 163.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.45 -47.85 71.8 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.392 1.077 . . . . 0.0 110.471 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.44 ' H ' ' HB3' ' A' ' 80' ' ' LEU . 3.3 tm? -67.93 -44.78 76.07 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -80.99 76.58 7.94 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.348 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.5 m -137.46 147.98 45.74 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.076 0.95 . . . . 0.0 109.628 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -76.85 92.39 3.62 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.04 -140.32 18.43 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.458 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 70.48 3.96 4.73 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.179 1.392 . . . . 0.0 113.776 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.99 30.49 2.03 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 175.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.23 70.23 5.58 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.541 1.162 . . . . 0.0 109.54 -177.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -162.78 168.7 21.05 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.868 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.07 90.44 0.18 Allowed Glycine 0 C--N 1.338 0.651 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -76.23 -29.65 57.62 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.253 0.549 . . . . 0.0 110.14 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 144.51 -35.13 1.56 Allowed Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 -175.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.245 0.852 0 C-N-CA 124.874 1.27 . . . . 0.0 108.227 173.556 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.86 -145.49 4.18 Favored Glycine 0 C--N 1.344 0.974 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -158.0 108.04 2.13 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.219 0.608 . . . . 0.0 109.493 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.431 ' O ' HG22 ' A' ' 7' ' ' ILE . 47.0 tpp -100.15 55.52 0.92 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 174.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -75.68 -1.72 26.1 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.588 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.4 mp -63.72 -23.71 67.48 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.522 1.129 . . . . 0.0 110.542 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 4' ' ' MET . 12.8 tt -68.03 -33.43 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.223 0.609 . . . . 0.0 110.773 174.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 21' ' ' SER . 42.1 t -88.0 57.97 4.58 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.579 0.704 . . . . 0.0 110.075 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.407 ' SD ' ' HA2' ' A' ' 51' ' ' GLY . 42.1 tpp -100.68 147.13 26.35 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.338 1.055 . . . . 0.0 108.618 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -69.9 128.96 38.2 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.0 t -100.21 139.06 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.228 0.611 . . . . 0.0 110.31 -177.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -130.1 127.54 40.05 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.205 1.402 . . . . 0.0 108.89 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -76.96 96.27 4.33 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.07 -95.25 0.34 Allowed Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -168.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -117.58 -23.45 7.66 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.746 0.818 . . . . 0.0 111.783 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -79.99 145.2 32.67 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.7 t -71.52 111.12 6.56 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.843 0.354 . . . . 0.0 110.586 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -83.91 -55.66 4.11 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.334 0.654 . . . . 0.0 109.729 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.28 -131.41 1.43 Allowed Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.827 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -148.82 137.12 21.03 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.202 1.401 . . . . 0.0 108.022 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 43.3 t -74.11 135.25 42.91 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 174.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.79 -35.42 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.761 0.824 . . . . 0.0 109.541 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -151.4 165.8 33.0 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.267 0.627 . . . . 0.0 110.205 -173.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.414 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.1 p -147.91 132.47 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.115 0.966 . . . . 0.0 108.461 169.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.422 ' CE1' HD11 ' A' ' 30' ' ' ILE . 1.4 p90 -141.1 138.98 33.91 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.55 -105.37 0.97 Allowed Glycine 0 CA--C 1.528 0.865 0 O-C-N 123.226 0.329 . . . . 0.0 112.527 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -120.07 5.25 10.84 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.71 0.804 . . . . 0.0 111.644 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -115.66 119.22 35.39 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.174 0.59 . . . . 0.0 111.53 -169.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.414 HD12 ' HB ' ' A' ' 24' ' ' VAL . 30.1 tp -79.52 109.14 13.62 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.871 0.868 . . . . 0.0 108.921 171.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.422 HD11 ' CE1' ' A' ' 25' ' ' TYR . 43.1 mm -73.53 104.39 2.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.3 t -99.52 112.56 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.952 0.901 . . . . 0.0 109.74 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -75.92 107.29 8.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.676 0.791 . . . . 0.0 109.2 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -91.8 155.92 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 167.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -44.98 -28.35 1.76 Allowed Glycine 0 CA--C 1.541 1.688 0 N-CA-C 116.258 1.263 . . . . 0.0 116.258 -172.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.9 p -96.16 -47.52 6.02 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.649 0.779 . . . . 0.0 112.339 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -143.1 -175.07 4.38 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.285 0.634 . . . . 0.0 111.714 -164.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.42 ' HB2' HD21 ' A' ' 71' ' ' LEU . 38.1 m-85 -115.43 109.84 18.44 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.097 0.959 . . . . 0.0 108.792 175.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.62 115.07 27.18 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.268 1.027 . . . . 0.0 108.467 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.503 ' HB3' HD12 ' A' ' 66' ' ' LEU . . . -82.2 92.96 6.98 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.409 0.623 . . . . 0.0 109.77 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.7 t -85.84 118.43 70.54 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.322 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.508 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 43.2 Cg_endo -62.07 148.66 92.75 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.215 1.943 . . . . 0.0 111.594 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.57 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.4 mmmm -66.1 -25.12 66.86 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.567 0.747 . . . . 0.0 112.04 -174.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.508 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 15.1 ptmm? -66.75 -23.38 66.08 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.894 0.878 . . . . 0.0 111.452 174.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.8 t -82.85 -30.11 28.9 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 123.034 0.534 . . . . 0.0 110.317 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.57 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.7 mp -62.77 114.05 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.264 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 174.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -85.68 -52.16 5.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.385 1.074 . . . . 0.0 110.161 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.0 m -144.22 154.24 42.91 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.059 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.19 109.37 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.429 1.092 . . . . 0.0 108.887 174.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.715 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 13.0 mm-40 -102.72 169.73 8.44 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.14 0.976 . . . . 0.0 109.644 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.87 93.63 1.35 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.952 0.501 . . . . 0.0 109.885 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.407 ' HA2' ' SD ' ' A' ' 9' ' ' MET . . . 93.32 2.77 65.59 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.261 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.715 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 92.7 mtt180 -133.6 141.19 47.55 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.355 0.662 . . . . 0.0 110.166 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.2 mm -118.16 103.72 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 168.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.7 t -76.7 113.78 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.428 HG22 HG13 ' A' ' 45' ' ' ILE . 31.4 pt -109.2 156.95 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.299 0.64 . . . . 0.0 109.492 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.67 -140.22 6.72 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.382 -168.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -78.49 123.03 26.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.389 0.676 . . . . 0.0 111.183 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -158.84 148.63 19.24 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 125.111 1.365 . . . . 0.0 108.035 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -72.19 101.75 2.89 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.18 -28.99 64.63 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.894 0.878 . . . . 0.0 112.154 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -72.21 -39.45 68.54 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.728 0.775 . . . . 0.0 110.094 176.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.19 -30.89 62.44 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.02 175.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.21 -25.02 64.11 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.271 0.629 . . . . 0.0 110.226 172.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -74.19 -41.12 61.94 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.486 0.714 . . . . 0.0 110.018 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.22 -42.22 69.19 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 118.128 0.422 . . . . 0.0 111.478 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 39' ' ' ALA . 4.5 pp -81.84 -14.54 56.14 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 120.839 0.352 . . . . 0.0 110.293 176.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -75.15 -44.4 23.22 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.469 171.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -28.57 63.17 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.318 0.559 . . . . 0.0 109.703 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -60.72 -39.66 89.42 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.619 170.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.512 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 86.1 t90 -59.46 -44.68 92.95 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.561 175.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.483 HD22 ' HE3' ' A' ' 70' ' ' TRP . 3.9 mm? -59.13 -32.15 69.6 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 176.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -72.75 -46.95 50.79 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.826 0.45 . . . . 0.0 110.391 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.543 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 12.6 pt-20 -77.71 -31.28 52.24 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -173.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -1.0 2.56 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -166.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.9 t -72.05 -3.96 26.01 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.462 0.705 . . . . 0.0 111.468 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 73' ' ' GLU . 28.5 mmtp -63.72 148.09 94.9 Favored Pre-proline 0 N--CA 1.484 1.272 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 169.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.5 139.8 66.24 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 121.974 1.783 . . . . 0.0 111.964 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.9 p -68.77 -21.05 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.84 173.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.541 ' HB ' HD21 ' A' ' 83' ' ' LEU . 36.3 p 64.83 172.23 0.2 Allowed 'General case' 0 C--N 1.361 1.068 0 C-N-CA 126.839 2.056 . . . . 0.0 112.154 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.472 ' HG ' ' H ' ' A' ' 82' ' ' GLU . 2.3 pt? -157.87 179.83 8.83 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.33 -172.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -23.96 63.71 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.419 0.688 . . . . 0.0 112.345 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.472 ' H ' ' HG ' ' A' ' 80' ' ' LEU . 37.2 tt0 -56.85 -39.89 75.11 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.171 0.989 . . . . 0.0 112.679 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.541 HD21 ' HB ' ' A' ' 79' ' ' THR . 2.7 pp -86.08 2.29 47.16 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -130.32 -169.97 2.24 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.147 0.579 . . . . 0.0 109.784 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.3 m -70.05 129.45 39.47 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -74.51 91.47 2.28 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.36 140.28 3.23 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.573 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -160.11 -42.24 0.05 OUTLIER 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.731 0.812 . . . . 0.0 108.907 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.78 64.9 2.44 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.795 -175.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -58.31 112.53 1.59 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.858 0.863 . . . . 0.0 111.544 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -109.41 91.97 3.86 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.774 0.83 . . . . 0.0 110.135 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.88 89.87 1.52 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 173.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.64 119.48 9.32 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.23 0.612 . . . . 0.0 110.552 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 111.45 -135.84 13.12 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -172.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.5 m . . . . . 0 C--O 1.252 1.207 0 C-N-CA 123.948 0.899 . . . . 0.0 108.685 177.907 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -60.79 98.3 0.15 Allowed Glycine 0 C--N 1.347 1.164 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -63.22 101.26 0.28 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.548 0.739 . . . . 0.0 110.192 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 69.1 mtm -84.79 105.83 15.87 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.15 84.17 0.53 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.396 0.617 . . . . 0.0 110.318 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.7 mt -77.53 -19.25 56.05 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.48 168.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 35.3 pt -79.22 157.5 4.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.675 1.59 . . . . 0.0 110.425 173.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.5 p -79.89 -36.8 35.99 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.804 0.441 . . . . 0.0 110.03 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.8 ttm -166.93 165.13 16.14 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.395 0.678 . . . . 0.0 109.793 -174.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -82.95 156.03 23.7 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.164 0.585 . . . . 0.0 109.737 170.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.465 HG22 ' HB ' ' A' ' 53' ' ' ILE . 81.3 t -121.7 129.72 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.986 0.915 . . . . 0.0 109.968 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -119.8 121.28 38.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.787 1.235 . . . . 0.0 108.726 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -78.86 86.48 4.77 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.38 -96.57 0.64 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.879 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -105.82 -18.74 13.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.635 0.774 . . . . 0.0 111.579 -176.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -98.25 156.45 16.7 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.832 0.453 . . . . 0.0 110.332 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 t -81.69 119.67 24.14 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -93.69 -55.75 3.15 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.263 0.625 . . . . 0.0 110.78 -173.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.05 -151.63 7.95 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.201 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -135.1 123.22 22.85 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.425 0.69 . . . . 0.0 109.431 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.514 ' HB2' HD11 ' A' ' 29' ' ' LEU . 12.9 p -71.14 108.43 4.66 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -93.35 -39.15 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 123.507 0.723 . . . . 0.0 109.707 -177.441 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -142.97 166.22 25.22 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.468 0.707 . . . . 0.0 109.59 -175.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -152.27 130.27 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.792 0.837 . . . . 0.0 108.819 173.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.411 ' HE1' HD11 ' A' ' 30' ' ' ILE . 3.4 p90 -142.22 134.3 27.45 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.05 -106.71 1.18 Allowed Glycine 0 CA--C 1.531 1.073 0 O-C-N 123.441 0.463 . . . . 0.0 113.277 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -119.63 18.14 12.74 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.778 0.831 . . . . 0.0 111.234 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.595 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 55.4 m-85 -126.08 113.17 16.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.927 0.491 . . . . 0.0 111.21 -175.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 21' ' ' SER . 62.6 tp -82.61 108.08 15.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.0 0.92 . . . . 0.0 109.219 171.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.411 HD11 ' HE1' ' A' ' 25' ' ' TYR . 39.2 mm -71.54 106.08 2.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.19 119.72 59.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.574 0.75 . . . . 0.0 109.861 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -74.31 109.18 7.59 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.285 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.6 m -116.15 103.19 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.521 1.128 . . . . 0.0 110.62 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.46 -89.03 0.05 OUTLIER Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.179 -0.919 . . . . 0.0 113.911 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.2 p -85.76 -41.19 15.3 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.222 1.009 . . . . 0.0 111.909 -174.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -150.03 -175.45 5.06 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -165.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -104.17 111.61 24.28 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.457 1.103 . . . . 0.0 110.686 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.1 mp -104.38 127.43 52.04 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -86.32 93.63 9.14 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.001 -175.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -72.14 115.54 39.66 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.586 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.5 149.97 89.14 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.735 2.29 . . . . 0.0 112.09 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.5 mmmm -67.26 -16.87 64.53 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -65.5 -30.9 71.72 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.085 0.554 . . . . 0.0 110.816 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' A' ' 58' ' ' PHE . 37.3 t -76.68 -32.62 58.03 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.649 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.58 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.8 mp -63.75 114.62 2.06 Favored 'Isoleucine or valine' 0 C--N 1.359 0.98 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -95.57 -53.55 3.69 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.36 1.064 . . . . 0.0 110.771 -172.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.0 t -150.09 134.26 17.13 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 122.998 0.519 . . . . 0.0 110.003 -173.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 p -98.66 111.75 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.466 0.65 . . . . 0.0 110.178 177.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 30.6 mm-40 -103.81 173.11 6.44 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.159 0.984 . . . . 0.0 111.07 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.31 101.06 1.43 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.153 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.76 12.5 83.49 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.446 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.655 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 61.5 mtp180 -141.42 135.7 30.63 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.645 0.778 . . . . 0.0 110.044 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.465 ' HB ' HG22 ' A' ' 11' ' ' VAL . 30.8 mm -109.11 103.04 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 167.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.8 t -78.36 112.06 15.92 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.6 pt -112.01 177.7 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.648 0.779 . . . . 0.0 109.826 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.05 -146.18 7.43 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 172.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.25 165.91 21.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.063 0.545 . . . . 0.0 110.072 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.51 ' HB3' ' HB2' ' A' ' 44' ' ' SER . 29.1 p90 -167.0 174.04 8.75 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.867 0.867 . . . . 0.0 109.209 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.14 86.28 1.38 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -70.86 -36.51 72.85 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.612 1.165 . . . . 0.0 112.417 -171.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -71.08 -33.83 70.58 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.045 0.538 . . . . 0.0 110.154 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -71.38 -40.56 70.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.093 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.98 -28.05 69.55 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.834 0.854 . . . . 0.0 111.303 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.36 -48.96 20.61 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.253 1.021 . . . . 0.0 110.414 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.09 -40.32 78.48 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.633 0.373 . . . . 0.0 111.561 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 pp -82.61 -17.18 45.68 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 122.185 -0.322 . . . . 0.0 110.441 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.05 -44.07 46.55 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.346 0.404 . . . . 0.0 112.362 174.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -71.02 -30.72 67.0 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 39.4 ttmt -62.2 -42.33 99.19 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.448 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 53.2 t90 -58.23 -44.97 88.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.889 0.743 . . . . 0.0 110.672 176.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.8 mt -57.54 -28.58 63.64 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.298 0.639 . . . . 0.0 111.686 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -82.87 -35.87 25.86 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.086 0.554 . . . . 0.0 111.242 172.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 44.3 mt-10 -65.86 -22.8 66.56 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 124.44 1.096 . . . . 0.0 111.217 -178.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 70' ' ' TRP . 27.3 mtpp -65.15 -38.66 91.29 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.5 172.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.7 t -85.27 -30.05 24.1 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.773 0.829 . . . . 0.0 111.145 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -84.42 154.49 62.68 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 123.893 0.877 . . . . 0.0 110.72 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.03 136.07 33.94 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 121.973 1.782 . . . . 0.0 109.875 163.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.4 p -64.71 93.31 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 CA-C-O 121.858 0.837 . . . . 0.0 109.87 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.4 t -80.54 76.89 7.38 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.813 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.8 tp -151.33 137.97 18.78 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.556 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.53 0.99 7.61 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.141 0.977 . . . . 0.0 111.132 176.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -66.46 -30.58 70.96 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.949 0.5 . . . . 0.0 111.389 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -66.39 -30.9 71.37 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.56 0.344 . . . . 0.0 110.577 173.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? 58.59 30.13 19.41 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.031 1.332 . . . . 0.0 111.228 172.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.7 t -88.44 98.42 11.62 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.477 -169.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -96.01 -61.05 1.51 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.173 0.589 . . . . 0.0 109.883 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.4 -58.53 0.09 OUTLIER Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.79 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 59.75 19.2 7.97 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.83 0.852 . . . . 0.0 111.676 -172.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -140.18 38.1 1.63 Allowed Glycine 0 C--N 1.343 0.919 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -128.78 106.75 9.14 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 113.902 -1.149 . . . . 0.0 109.76 -169.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -89.18 90.72 8.49 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -164.72 80.87 0.12 Allowed Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.61 -59.77 4.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.807 0.843 . . . . 0.0 110.223 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -87.87 73.57 2.3 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.137 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.7 m . . . . . 0 C--O 1.254 1.292 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.915 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.633 0.254 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.29 -173.62 41.01 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 116.124 -0.489 . . . . 0.0 113.223 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -140.89 -167.32 2.34 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.12 0.968 . . . . 0.0 109.683 -175.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.3 mtp -74.61 -179.07 3.88 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.357 0.663 . . . . 0.0 110.815 171.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.85 -18.25 26.56 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -170.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.5 -20.14 26.95 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.918 0.487 . . . . 0.0 111.909 -173.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.2 tt -67.52 137.58 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.424 0.69 . . . . 0.0 111.034 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 61.2 m -114.35 81.58 1.57 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.815 0.846 . . . . 0.0 109.652 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 71.1 mtm -70.23 154.06 42.36 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.791 0.836 . . . . 0.0 110.549 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -90.59 135.98 33.35 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.006 0.432 . . . . 0.0 111.165 -173.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.426 HG21 HG22 ' A' ' 31' ' ' VAL . 99.9 t -91.78 130.38 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.72 0.808 . . . . 0.0 109.719 -177.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -118.27 127.37 53.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.664 1.186 . . . . 0.0 109.576 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 28.5 tptp -78.26 91.16 4.37 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 172.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.97 -95.67 0.65 Allowed Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 -171.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.71 -21.48 7.85 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.421 0.689 . . . . 0.0 110.74 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 14.8 pt-20 -79.43 144.23 34.28 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.5 t -70.28 111.18 5.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.794 0.438 . . . . 0.0 110.345 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -82.32 -51.18 8.14 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.096 0.558 . . . . 0.0 110.531 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.462 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . -179.55 -143.2 5.35 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.885 -177.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -136.96 133.52 35.71 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.72 0.808 . . . . 0.0 109.956 -177.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.413 ' OG ' HD11 ' A' ' 29' ' ' LEU . 30.2 t -75.02 106.5 6.55 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 172.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.27 -40.82 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.294 0.638 . . . . 0.0 109.313 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.446 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 22.8 t70 -149.14 172.22 15.16 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.372 0.669 . . . . 0.0 109.815 -171.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.404 ' HB ' HD12 ' A' ' 29' ' ' LEU . 9.9 p -152.1 145.17 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 124.334 1.054 . . . . 0.0 108.538 172.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -143.12 127.22 17.46 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 171.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.2 -106.86 1.12 Allowed Glycine 0 C--N 1.343 0.938 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.728 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 28.7 t70 -107.05 -15.18 14.75 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.071 0.948 . . . . 0.0 111.114 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.493 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 95.3 m-85 -97.34 107.56 20.1 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.558 0.695 . . . . 0.0 111.186 -171.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.413 HD11 ' OG ' ' A' ' 21' ' ' SER . 41.7 tp -76.31 113.29 13.72 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.956 174.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 49.7 mm -75.44 107.77 6.6 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.015 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.426 HG22 HG21 ' A' ' 11' ' ' VAL . 43.0 t -103.76 113.63 41.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 123.992 0.917 . . . . 0.0 109.314 178.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -75.94 114.99 15.19 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.462 HG12 ' HA3' ' A' ' 19' ' ' GLY . 34.1 m -127.45 129.84 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.959 0.904 . . . . 0.0 109.36 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.9 -100.11 0.27 Allowed Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.848 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.6 p -126.1 5.15 7.16 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.214 1.005 . . . . 0.0 112.008 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -134.21 169.65 16.87 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.154 0.582 . . . . 0.0 112.164 -173.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -112.9 123.87 51.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.364 1.065 . . . . 0.0 109.457 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.8 mp -107.22 115.61 30.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.964 0.906 . . . . 0.0 109.008 175.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.493 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -78.97 93.63 5.11 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.786 0.835 . . . . 0.0 109.724 177.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.484 HG12 ' CE2' ' A' ' 58' ' ' PHE . 4.0 m -89.04 134.5 33.21 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -176.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 97.9 Cg_endo -73.45 153.05 49.84 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.254 1.969 . . . . 0.0 111.242 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.584 ' HA ' HD13 ' A' ' 45' ' ' ILE . 13.8 mmmm -65.77 -24.28 66.91 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.487 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 7.8 ptpp? -66.38 -25.83 66.97 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.713 0.405 . . . . 0.0 111.361 173.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.3 t -69.1 -41.22 77.75 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.584 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.7 mp -66.71 114.49 3.69 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -78.71 -48.79 14.25 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.474 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.2 t -158.46 139.53 13.11 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.301 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 p -77.89 133.18 31.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 168.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.803 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 17.8 mm-40 -116.23 177.58 4.64 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.187 0.995 . . . . 0.0 110.04 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -64.02 93.14 0.08 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.858 0.863 . . . . 0.0 110.463 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.86 5.72 88.66 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 114.906 -1.043 . . . . 0.0 114.213 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.803 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 69.9 mtt85 -127.71 162.21 27.1 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.079 0.552 . . . . 0.0 110.728 -174.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.0 mm -133.27 103.34 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 174.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.5 t -83.45 120.64 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.0 pt -109.06 145.21 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 123.943 0.897 . . . . 0.0 109.174 170.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.26 -55.03 1.88 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 112.135 -0.386 . . . . 0.0 112.135 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 9.9 pt-20 -174.03 159.27 3.26 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.949 0.9 . . . . 0.0 110.552 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.484 ' CE2' HG12 ' A' ' 40' ' ' VAL . 8.1 p90 -171.11 174.18 4.75 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.463 0.705 . . . . 0.0 110.779 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -74.44 86.51 2.03 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.495 0.718 . . . . 0.0 109.483 172.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.15 -38.73 72.22 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.285 0.634 . . . . 0.0 112.669 -174.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.487 ' HG3' ' HG3' ' A' ' 62' ' ' GLU . 7.4 pt-20 -65.4 -38.24 89.37 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.491 0.717 . . . . 0.0 110.817 177.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.523 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 44.6 mt-10 -80.88 -32.79 34.74 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.809 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.75 -26.31 66.92 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.276 0.631 . . . . 0.0 110.611 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -72.69 -51.87 17.54 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.243 1.017 . . . . 0.0 111.179 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.523 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.7 pt-20 -69.84 -35.74 74.99 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.311 0.577 . . . . 0.0 110.809 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.22 -13.79 54.64 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.66 -27.53 69.09 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 165.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -69.96 -37.44 75.81 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.83 0.852 . . . . 0.0 108.854 167.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -59.59 -36.52 76.42 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 122.912 0.485 . . . . 0.0 110.875 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.545 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 59.7 t90 -60.95 -54.21 47.79 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 173.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.7 mt -54.92 -35.11 63.81 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.48 0.712 . . . . 0.0 111.447 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.16 -35.44 66.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.224 1.01 . . . . 0.0 110.452 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -77.07 -23.67 51.94 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.818 0.447 . . . . 0.0 109.864 175.342 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 70' ' ' TRP . 31.1 mmmt -68.74 -5.95 23.52 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.746 0.418 . . . . 0.0 111.097 171.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.4 m 69.94 40.07 1.32 Allowed 'General case' 0 C--N 1.354 0.762 0 C-N-CA 125.001 1.32 . . . . 0.0 110.251 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.548 ' HB3' HD11 ' A' ' 83' ' ' LEU . 71.2 mmtt -59.99 131.97 89.51 Favored Pre-proline 0 C--N 1.355 0.843 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.048 173.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.46 138.98 68.29 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.507 2.138 . . . . 0.0 112.809 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 84' ' ' LYS . 34.3 m -76.62 10.22 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 C-N-CA 124.156 0.982 . . . . 0.0 112.356 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.4 m -51.85 -42.92 62.98 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.414 1.086 . . . . 0.0 111.592 176.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.64 135.17 48.19 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 171.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -66.42 -39.87 89.19 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 123.457 0.473 . . . . 0.0 110.955 -173.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -62.41 -37.1 84.52 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.702 0.801 . . . . 0.0 111.06 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.548 HD11 ' HB3' ' A' ' 76' ' ' LYS . 1.5 tt -77.9 -22.6 49.45 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.986 0.914 . . . . 0.0 110.203 -176.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.425 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 4.4 ttmp? -72.03 -10.78 60.25 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.704 0.802 . . . . 0.0 112.419 -176.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.9 p -63.39 92.07 0.06 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.117 0.567 . . . . 0.0 110.944 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -73.96 124.18 25.7 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.15 0.98 . . . . 0.0 108.92 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -81.76 -78.66 0.98 Allowed Glycine 0 C--N 1.339 0.747 0 O-C-N 123.349 0.406 . . . . 0.0 112.147 -176.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -139.06 -59.53 0.59 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.681 0.792 . . . . 0.0 110.792 -171.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.04 62.34 0.17 Allowed Glycine 0 C--N 1.339 0.726 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -173.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -96.46 -9.36 29.92 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.598 0.759 . . . . 0.0 111.042 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -123.45 122.27 37.82 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.29 -92.74 0.09 OUTLIER Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 58.68 28.38 17.15 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.59 1.156 . . . . 0.0 112.512 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.51 -158.38 17.95 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.674 -0.693 . . . . 0.0 113.21 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.7 m . . . . . 0 C--O 1.251 1.134 0 C-N-CA 123.007 0.523 . . . . 0.0 110.24 178.229 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.678 0.275 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.19 18.56 49.48 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 113.648 176.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -109.98 96.23 6.1 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.631 0.772 . . . . 0.0 109.018 177.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.429 ' SD ' ' N ' ' A' ' 4' ' ' MET . 1.4 mpt? -82.05 95.62 7.5 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.58 0.752 . . . . 0.0 109.512 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -82.27 -5.4 58.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.616 0.766 . . . . 0.0 111.332 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.6 12.9 11.4 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.889 0.876 . . . . 0.0 110.574 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.0 tp -72.27 154.74 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 C-N-CA 123.841 0.856 . . . . 0.0 110.701 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 80.6 m -67.75 88.57 0.25 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.195 0.598 . . . . 0.0 109.628 174.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.453 ' SD ' HD11 ' A' ' 53' ' ' ILE . 61.0 mtt -70.52 141.66 51.9 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.093 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -84.28 130.33 34.82 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.403 0.681 . . . . 0.0 109.475 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.0 t -86.62 115.24 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.076 0.55 . . . . 0.0 109.937 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.64 117.58 35.19 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.116 0.967 . . . . 0.0 109.692 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 85.3 tttt -77.94 94.41 4.58 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.12 -94.85 0.47 Allowed Glycine 0 C--N 1.344 1.002 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -102.5 -42.91 5.8 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.735 0.814 . . . . 0.0 110.824 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.35 145.42 37.33 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.959 0.504 . . . . 0.0 110.935 -168.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.7 t -69.8 104.87 2.58 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 13' ' ' LYS . 46.9 t80 -74.95 -50.05 18.02 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.713 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.73 -141.4 3.94 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.82 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -140.18 130.73 25.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.371 0.668 . . . . 0.0 110.221 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.418 ' OG ' HD11 ' A' ' 29' ' ' LEU . 25.9 t -68.07 109.96 3.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.155 0.982 . . . . 0.0 109.542 174.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.05 -43.71 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.028 0.531 . . . . 0.0 109.851 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.428 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 22.6 t70 -143.35 167.61 21.75 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.74 0.416 . . . . 0.0 110.466 -171.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.2 t -139.71 140.97 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 124.421 1.089 . . . . 0.0 108.133 174.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -141.39 129.91 22.61 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 169.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.36 -107.4 1.35 Allowed Glycine 0 C--N 1.35 1.326 0 O-C-N 123.304 0.378 . . . . 0.0 113.268 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -119.21 24.53 10.7 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.55 0.74 . . . . 0.0 110.918 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.53 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 96.0 m-85 -133.39 124.85 27.9 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.247 0.619 . . . . 0.0 111.375 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.418 HD11 ' OG ' ' A' ' 21' ' ' SER . 55.8 tp -80.55 113.99 19.13 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.406 1.083 . . . . 0.0 109.562 170.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 42.8 mm -72.74 106.07 2.69 Favored 'Isoleucine or valine' 0 C--O 1.249 1.063 0 C-N-CA 123.234 0.614 . . . . 0.0 109.51 175.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.0 t -103.28 118.42 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.151 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -74.97 116.87 16.18 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 m -126.05 99.2 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.953 0.901 . . . . 0.0 110.614 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.29 -89.53 0.1 Allowed Glycine 0 CA--C 1.531 1.073 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.873 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 72.5 p -114.91 -21.99 9.83 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.121 0.968 . . . . 0.0 111.272 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -109.07 174.44 5.87 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.647 0.737 . . . . 0.0 111.363 -172.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -120.96 108.6 14.07 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.238 173.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -96.66 106.07 18.28 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -82.83 93.33 7.44 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.297 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.6 m -77.67 136.7 63.2 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.554 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 35.8 Cg_endo -62.4 149.37 91.06 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 121.905 1.737 . . . . 0.0 111.289 176.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.566 ' HA ' HD13 ' A' ' 45' ' ' ILE . 32.0 mmmt -63.59 -26.21 68.58 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.013 0.525 . . . . 0.0 111.8 -178.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.554 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 0.4 OUTLIER -67.71 -23.43 65.28 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.677 0.791 . . . . 0.0 111.449 175.725 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -72.3 -27.36 62.41 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.784 0.434 . . . . 0.0 110.616 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.566 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.1 mp -67.91 115.65 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -92.03 -48.54 6.69 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.254 1.022 . . . . 0.0 110.974 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.1 t -138.49 147.63 43.4 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.402 -175.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.5 p -122.0 126.05 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.357 1.063 . . . . 0.0 109.099 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 40.5 mt-10 -138.11 168.54 19.52 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.286 1.035 . . . . 0.0 109.537 -175.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.72 99.87 0.25 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.124 0.57 . . . . 0.0 110.432 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.15 1.06 88.65 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 115.905 -0.589 . . . . 0.0 113.643 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 33.7 mtm180 -130.97 124.94 32.09 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.514 0.657 . . . . 0.0 110.284 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.453 HD11 ' SD ' ' A' ' 9' ' ' MET . 50.8 mm -115.06 102.14 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 170.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.9 t -86.11 115.23 27.02 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.7 pt -107.04 175.14 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 123.569 0.747 . . . . 0.0 109.357 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.04 -142.88 8.21 Favored Glycine 0 C--O 1.24 0.507 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -81.56 157.12 24.89 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 174.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -167.37 170.66 11.27 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.892 0.877 . . . . 0.0 109.201 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -81.16 93.52 6.47 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -71.23 -39.94 71.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.074 0.95 . . . . 0.0 112.74 -171.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -65.34 -37.88 88.41 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.009 0.433 . . . . 0.0 110.491 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -71.9 -37.64 70.09 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.568 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.12 -34.32 77.35 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.508 0.723 . . . . 0.0 111.333 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 6.7 ptp85 -74.39 -44.72 50.87 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 119.112 -0.47 . . . . 0.0 111.157 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.98 -37.57 86.32 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 118.275 0.489 . . . . 0.0 111.602 -175.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -81.63 -21.15 38.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 122.478 0.311 . . . . 0.0 110.399 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.43 -33.78 68.15 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.039 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' HA ' HD12 ' A' ' 71' ' ' LEU . 59.0 mtp180 -77.41 -30.55 53.55 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.359 1.064 . . . . 0.0 109.853 175.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -63.28 -39.51 94.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.141 0.576 . . . . 0.0 109.715 170.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -60.24 -45.36 93.52 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.985 0.514 . . . . 0.0 109.917 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 68' ' ' ARG . 50.4 mt -58.53 -23.41 58.18 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.797 0.839 . . . . 0.0 112.517 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -83.65 -53.4 5.68 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.706 0.402 . . . . 0.0 110.728 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.85 -15.37 60.23 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.991 0.916 . . . . 0.0 113.379 -170.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -57.33 -14.42 4.56 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.204 1.001 . . . . 0.0 112.947 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -64.63 4.85 0.35 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.288 1.435 . . . . 0.0 114.412 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.85 145.43 96.78 Favored Pre-proline 0 CA--C 1.551 1.009 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.58 137.73 60.96 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.106 1.871 . . . . 0.0 111.044 175.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.2 p -79.76 64.51 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 CA-C-O 123.209 1.48 . . . . 0.0 110.084 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.0 t -87.98 -11.24 48.0 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.315 177.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.47 HD22 ' HB2' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -79.21 81.93 5.42 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.017 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.47 -24.43 61.18 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.804 1.242 . . . . 0.0 110.949 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.99 -29.02 67.95 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.951 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.47 ' HB2' HD22 ' A' ' 80' ' ' LEU . 6.6 tt -70.13 -39.0 75.69 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -60.99 -70.61 0.17 Allowed 'General case' 0 C--N 1.353 0.739 0 O-C-N 123.835 0.709 . . . . 0.0 109.929 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.1 p -93.02 62.22 3.56 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.496 0.718 . . . . 0.0 109.532 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -71.43 127.21 31.82 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.057 -172.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.83 79.82 0.96 Allowed Glycine 0 C--N 1.35 1.358 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.331 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -133.99 -49.5 0.81 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.563 1.145 . . . . 0.0 108.177 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.02 136.43 8.82 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.734 173.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -66.49 115.13 6.04 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.46 111.94 3.82 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.333 176.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.06 -34.85 51.33 Favored Glycine 0 C--N 1.342 0.904 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 174.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -114.44 28.15 8.95 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.259 1.024 . . . . 0.0 110.491 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.96 80.25 1.1 Allowed Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.487 -0.324 . . . . 0.0 113.741 -174.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--O 1.248 1.02 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.323 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.529 ' HB3' ' HB3' ' A' ' 88' ' ' PHE . 8.2 pm0 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.34 138.53 3.93 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.19 0.307 . . . . 0.0 112.505 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -81.62 106.54 13.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 172.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 83.3 mtp -74.94 95.63 3.01 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.6 0.76 . . . . 0.0 110.196 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -91.11 62.41 4.82 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.6 0.715 . . . . 0.0 109.923 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.51 0.09 10.96 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.73 0.812 . . . . 0.0 109.506 173.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.1 tt -69.14 120.56 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 123.501 0.721 . . . . 0.0 111.298 -173.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.0 p -171.36 143.49 1.85 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.019 1.328 . . . . 0.0 107.758 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.406 ' SD ' HD11 ' A' ' 53' ' ' ILE . 18.5 ttt -149.0 140.67 23.51 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 109.875 -0.416 . . . . 0.0 109.875 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -72.82 141.27 48.02 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.6 t -119.49 127.75 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.578 0.751 . . . . 0.0 110.02 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -109.35 132.91 53.68 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.228 1.011 . . . . 0.0 109.044 171.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -83.98 82.39 8.37 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.83 -100.58 0.85 Allowed Glycine 0 C--N 1.344 0.986 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.239 -177.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -97.16 -28.07 14.27 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.851 0.86 . . . . 0.0 110.879 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -92.15 152.31 19.96 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.811 0.444 . . . . 0.0 110.119 -176.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.1 t -74.16 125.14 27.71 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.305 0.642 . . . . 0.0 109.349 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -98.46 -58.59 1.93 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 121.957 0.103 . . . . 0.0 110.848 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.53 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 172.66 -141.43 6.22 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.413 0.446 . . . . 0.0 112.196 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -144.86 137.98 26.68 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.826 0.85 . . . . 0.0 110.13 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.7 p -73.61 118.2 16.28 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 175.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.21 -37.82 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.589 0.756 . . . . 0.0 109.042 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -156.27 176.83 12.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.977 0.511 . . . . 0.0 110.822 -175.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.4 p -150.17 138.28 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.46 1.104 . . . . 0.0 108.868 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -136.21 133.69 37.36 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.67 -106.62 1.22 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 123.463 0.477 . . . . 0.0 113.793 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -117.14 11.63 14.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.903 0.881 . . . . 0.0 111.026 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.577 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 81.8 m-85 -125.15 111.56 15.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.039 0.535 . . . . 0.0 111.549 -173.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 57.7 tp -77.82 110.35 12.62 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.507 1.123 . . . . 0.0 109.485 173.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.0 mm -71.94 100.11 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.26 0.624 . . . . 0.0 109.606 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.06 113.22 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.428 0.691 . . . . 0.0 109.787 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -76.24 120.05 20.98 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.669 0.787 . . . . 0.0 109.882 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.53 HG12 ' HA3' ' A' ' 19' ' ' GLY . 1.3 m -132.45 142.04 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.7 -96.21 0.03 OUTLIER Glycine 0 CA--C 1.537 1.456 0 O-C-N 123.274 0.359 . . . . 0.0 113.966 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.3 m -124.49 -16.39 6.34 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.509 1.124 . . . . 0.0 111.023 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -114.72 166.88 11.27 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.934 0.893 . . . . 0.0 112.149 -170.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -113.65 112.25 23.18 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.211 1.004 . . . . 0.0 109.751 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.424 HD23 HG22 ' A' ' 33' ' ' VAL . 3.5 mm? -94.55 105.95 17.92 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.932 0.893 . . . . 0.0 109.175 176.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.577 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -77.82 92.37 4.22 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 172.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.9 m -86.22 136.63 35.54 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.65 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.542 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 37.7 Cg_endo -63.33 151.28 85.68 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.221 1.947 . . . . 0.0 111.36 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.565 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.4 mmmm -67.3 -23.26 65.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.953 0.501 . . . . 0.0 111.457 -176.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.542 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 22.4 ptmt -69.61 -26.55 64.5 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.686 0.794 . . . . 0.0 111.457 174.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.3 t -65.35 -31.29 72.33 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.269 0.628 . . . . 0.0 110.604 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.565 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.0 mp -64.95 116.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -92.28 -52.1 4.84 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.153 0.981 . . . . 0.0 110.936 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 t -148.83 139.87 23.02 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.566 -171.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.2 t -102.92 110.75 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 173.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.09 130.89 22.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 63.28 33.88 13.73 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.415 1.086 . . . . 0.0 112.944 166.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.92 15.98 80.71 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 121.316 0.398 . . . . 0.0 112.326 -177.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -125.15 158.21 34.48 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.68 1.192 . . . . 0.0 109.063 -175.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.406 HD11 ' SD ' ' A' ' 9' ' ' MET . 28.6 mm -120.47 104.91 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.634 0.774 . . . . 0.0 109.55 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.9 t -80.0 113.01 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' A' ' 45' ' ' ILE . 37.4 pt -109.49 142.75 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.79 -74.48 1.2 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -152.73 164.19 38.24 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.63 0.772 . . . . 0.0 109.685 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -170.51 163.89 8.43 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 124.377 1.071 . . . . 0.0 108.298 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -77.77 97.09 5.09 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.05 -35.99 82.92 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.589 0.756 . . . . 0.0 112.007 -174.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -62.6 -45.54 92.42 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.682 0.614 . . . . 0.0 110.484 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.412 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 35.1 mt-10 -70.29 -38.7 75.08 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.887 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.17 -38.55 91.46 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.569 0.748 . . . . 0.0 111.363 -176.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -74.41 -38.4 63.08 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.326 0.25 . . . . 0.0 111.582 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.412 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.8 pt-20 -76.75 -40.86 47.01 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -176.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 pp -82.47 -12.99 57.46 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.0 0.429 . . . . 0.0 109.996 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.99 -48.45 75.72 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 162.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.0 mtt-85 -63.48 -31.94 73.25 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.901 0.881 . . . . 0.0 111.511 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 22.8 ttmm -55.9 -48.78 75.01 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.115 0.566 . . . . 0.0 109.514 172.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.577 ' HE3' HD12 ' A' ' 71' ' ' LEU . 79.9 t90 -60.25 -42.56 95.57 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 123.309 0.38 . . . . 0.0 110.663 174.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.577 HD12 ' HE3' ' A' ' 70' ' ' TRP . 10.6 mp -57.0 -28.95 62.89 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 122.666 0.387 . . . . 0.0 112.027 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -77.91 -54.43 6.32 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 122.958 0.503 . . . . 0.0 110.285 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 33.7 mt-10 -76.45 -18.24 58.89 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.472 1.109 . . . . 0.0 113.04 -168.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -61.21 -19.19 61.35 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.356 0.662 . . . . 0.0 112.263 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.3 m -66.48 83.51 0.1 Allowed 'General case' 0 C--N 1.354 0.764 0 C-N-CA 124.378 1.071 . . . . 0.0 112.05 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -96.07 143.69 26.55 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.468 0.707 . . . . 0.0 109.145 167.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -80.22 -161.72 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.888 2.392 . . . . 0.0 113.103 -174.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.32 -29.95 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.339 0.656 . . . . 0.0 110.552 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.9 p -76.71 92.08 3.51 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 168.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.01 26.0 1.72 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.445 0.641 . . . . 0.0 109.779 174.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.67 -4.45 0.28 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.402 1.481 . . . . 0.0 114.191 177.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -49.41 -46.14 47.12 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 125.318 1.447 . . . . 0.0 113.246 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -84.91 -12.65 52.94 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 122.778 0.431 . . . . 0.0 111.022 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -74.75 -23.4 58.54 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.518 0.727 . . . . 0.0 109.911 172.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.2 t -78.96 87.98 4.76 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -104.38 -38.4 6.84 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.358 1.063 . . . . 0.0 110.78 -174.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.35 64.97 0.2 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 112.264 -0.334 . . . . 0.0 112.264 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.529 ' HB3' ' HB3' ' A' ' 1' ' ' GLN . 25.3 p90 -83.21 88.18 6.92 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.333 0.587 . . . . 0.0 109.658 176.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.98 -78.89 0.08 OUTLIER Glycine 0 C--N 1.344 0.98 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.193 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -63.4 -34.88 78.71 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.571 0.748 . . . . 0.0 111.06 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -73.04 106.33 4.87 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.43 -178.39 48.34 Favored Glycine 0 C--O 1.241 0.55 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.145 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.79 -32.77 69.97 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.871 0.468 . . . . 0.0 110.524 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 159.16 -116.11 0.7 Allowed Glycine 0 C--N 1.34 0.788 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 CA--C 1.548 0.88 0 C-N-CA 124.221 1.008 . . . . 0.0 108.511 177.466 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.46 40.83 2.29 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 116.518 -0.31 . . . . 0.0 112.619 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -96.54 -45.51 6.71 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.469 0.708 . . . . 0.0 110.399 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.1 mmt -93.13 95.46 9.43 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -65.55 -20.42 66.32 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.557 1.143 . . . . 0.0 110.894 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 mp -81.49 33.32 0.36 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.342 1.057 . . . . 0.0 111.534 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -37.25 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 169.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' SER . 60.7 m -90.56 82.54 5.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.61 0.764 . . . . 0.0 109.939 176.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.2 mtt -94.87 143.62 26.31 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.271 0.628 . . . . 0.0 109.857 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -71.65 110.88 6.5 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.304 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.4 HG22 ' HB ' ' A' ' 53' ' ' ILE . 58.5 t -79.27 124.7 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.813 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -113.61 121.89 45.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.032 0.933 . . . . 0.0 109.035 175.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 52.6 tttm -84.1 79.3 9.56 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.65 0.738 . . . . 0.0 109.624 175.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.61 -94.26 0.41 Allowed Glycine 0 C--N 1.342 0.9 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.831 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -96.9 -13.26 22.57 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.71 0.804 . . . . 0.0 111.591 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 10.0 pt-20 -116.09 153.6 31.45 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.533 0.733 . . . . 0.0 109.609 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.3 t -85.02 112.73 20.88 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -80.34 -56.8 3.94 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.531 0.333 . . . . 0.0 110.535 -172.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 178.18 -135.43 2.67 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.124 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -148.91 142.79 25.72 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.986 0.914 . . . . 0.0 109.985 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 39.1 p -74.52 108.3 7.19 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.497 0.719 . . . . 0.0 110.69 -178.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.87 -38.72 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.193 0.597 . . . . 0.0 110.117 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -153.66 172.4 17.31 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.39 0.676 . . . . 0.0 109.888 -172.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 p -155.66 132.68 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.888 0.875 . . . . 0.0 109.069 173.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.457 ' CE1' HD11 ' A' ' 30' ' ' ILE . 3.9 p90 -135.66 133.63 38.35 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.64 -105.43 1.23 Allowed Glycine 0 C--N 1.346 1.116 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -117.57 -0.85 11.78 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.841 0.856 . . . . 0.0 110.083 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.562 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 30.5 m-85 -104.1 106.21 16.64 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.706 -166.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 50.1 tp -75.84 105.65 6.99 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.457 HD11 ' CE1' ' A' ' 25' ' ' TYR . 38.0 mm -68.51 106.69 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.895 176.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.2 t -99.66 116.24 42.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -72.7 107.65 5.28 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 174.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.43 HG23 ' HB2' ' A' ' 36' ' ' GLU . 19.1 m -113.63 83.6 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.434 1.094 . . . . 0.0 110.579 -173.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.61 -82.06 0.5 Allowed Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.066 -0.97 . . . . 0.0 113.612 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 t -122.48 -11.08 8.35 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.853 0.861 . . . . 0.0 110.847 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.43 ' HB2' HG23 ' A' ' 33' ' ' VAL . 65.0 mm-40 -111.62 177.91 4.5 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.605 0.762 . . . . 0.0 110.55 -178.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.568 ' HB2' HD11 ' A' ' 71' ' ' LEU . 42.7 m-85 -134.29 110.93 9.82 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 169.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -105.54 126.82 52.56 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.562 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -95.37 100.74 12.47 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.971 0.908 . . . . 0.0 110.472 -173.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.1 m -85.32 137.47 36.9 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 122.95 0.5 . . . . 0.0 109.896 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.16 160.47 41.82 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.392 2.061 . . . . 0.0 111.565 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -67.07 -23.69 65.89 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.504 0.322 . . . . 0.0 111.671 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -70.81 -22.78 62.3 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.262 0.625 . . . . 0.0 111.933 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.2 t -64.1 -32.44 74.0 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.079 0.552 . . . . 0.0 110.932 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mp -68.32 114.0 4.71 Favored 'Isoleucine or valine' 0 C--N 1.356 0.856 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -87.11 -41.26 13.94 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.596 1.158 . . . . 0.0 111.268 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.9 m -149.68 147.89 28.62 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.517 0.727 . . . . 0.0 110.594 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 p -110.48 117.09 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.624 0.77 . . . . 0.0 109.516 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 9.7 mm-40 -98.91 166.82 11.11 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.91 -26.98 39.55 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.198 0.999 . . . . 0.0 113.413 -174.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.49 22.27 1.2 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 112.148 -0.381 . . . . 0.0 112.148 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.64 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 95.4 mtt180 -136.53 159.08 42.87 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.444 0.698 . . . . 0.0 109.78 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.4 ' HB ' HG22 ' A' ' 11' ' ' VAL . 48.0 mm -126.58 103.22 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 172.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.1 t -82.03 113.17 20.93 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.425 HG13 ' HA ' ' A' ' 13' ' ' LYS . 37.4 pt -106.51 162.25 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 168.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -123.33 -65.17 0.21 Allowed Glycine 0 CA--C 1.503 -0.706 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -177.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -128.4 143.21 50.97 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.379 0.672 . . . . 0.0 110.16 -170.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -173.85 150.92 1.72 Allowed 'General case' 0 C--O 1.246 0.92 0 C-N-CA 125.578 1.551 . . . . 0.0 107.192 173.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -71.5 106.12 3.85 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -70.07 -35.53 74.29 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.096 0.958 . . . . 0.0 112.429 -169.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -69.18 -36.0 76.86 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.962 0.505 . . . . 0.0 110.735 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -67.69 -43.01 81.14 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.306 175.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.83 -25.67 66.55 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.68 0.792 . . . . 0.0 111.145 175.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -49.03 25.37 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.642 0.777 . . . . 0.0 109.33 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.61 -41.04 66.01 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.759 0.424 . . . . 0.0 111.738 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 69' ' ' LYS . 2.6 pp -82.46 -15.86 50.98 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 120.889 0.376 . . . . 0.0 110.25 176.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.5 -54.25 13.66 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.863 170.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.415 ' HA ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -68.27 -23.08 64.73 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.461 0.704 . . . . 0.0 110.874 178.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 38.7 tttm -57.85 -48.81 78.7 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.93 0.892 . . . . 0.0 109.978 168.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -60.22 -35.71 76.06 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.225 0.61 . . . . 0.0 111.251 174.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 37' ' ' PHE . 10.7 mp -63.16 -30.32 71.49 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 122.976 0.511 . . . . 0.0 111.647 174.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -78.59 -39.16 38.26 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 46.1 mt-10 -70.72 -36.9 73.44 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.819 0.848 . . . . 0.0 112.269 -175.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -32.24 72.34 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.103 0.477 . . . . 0.0 110.524 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.8 t -84.13 86.75 7.17 Favored 'General case' 0 C--N 1.348 0.528 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -73.19 136.63 78.96 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.555 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -46.32 -47.5 14.97 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 124.445 3.43 . . . . 0.0 115.01 -169.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.6 p -148.98 -34.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.523 0.329 . . . . 0.0 111.544 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -59.29 -30.29 68.22 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.628 0.771 . . . . 0.0 112.806 -174.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.2 tp -102.43 107.26 18.18 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -16.89 51.51 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.258 1.023 . . . . 0.0 110.928 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.28 -35.35 80.75 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.044 0.938 . . . . 0.0 112.16 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -91.21 9.34 31.65 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.965 0.506 . . . . 0.0 111.926 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -90.62 93.24 9.18 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.7 t -136.25 146.19 46.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.184 0.594 . . . . 0.0 110.142 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -90.48 176.68 6.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.901 0.88 . . . . 0.0 111.05 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.87 -78.4 1.81 Allowed Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -175.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -84.72 107.69 17.04 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.6 74.49 0.06 OUTLIER Glycine 0 C--N 1.345 1.028 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -175.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.13 37.39 1.27 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.934 0.894 . . . . 0.0 110.48 -170.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -73.97 77.64 1.68 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.27 34.15 2.87 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.056 -174.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -79.41 -9.52 59.62 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.3 0.64 . . . . 0.0 111.954 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.39 82.81 0.14 Allowed Glycine 0 C--N 1.349 1.267 0 N-CA-C 111.881 -0.487 . . . . 0.0 111.881 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 CA--C 1.552 1.035 0 C-N-CA 124.868 1.267 . . . . 0.0 111.416 -172.41 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.783 0.325 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.64 -60.93 0.01 OUTLIER Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -84.71 102.13 12.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.02 0.528 . . . . 0.0 110.424 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.4 mtm -70.49 -46.73 63.15 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 167.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.6 t70 59.82 94.61 0.03 OUTLIER 'General case' 0 C--N 1.356 0.889 0 C-N-CA 125.49 1.516 . . . . 0.0 111.922 170.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.4 mt -98.65 8.95 44.32 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.208 0.603 . . . . 0.0 112.272 -171.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.0 tt -66.94 -47.1 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -172.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 67.1 m -124.72 34.7 4.95 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.86 0.864 . . . . 0.0 111.262 -171.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.552 ' HB3' HG12 ' A' ' 53' ' ' ILE . 14.7 mmt -61.94 118.52 7.36 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.76 0.824 . . . . 0.0 111.182 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -85.65 121.17 27.94 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.516 0.726 . . . . 0.0 109.388 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.433 HG21 HG22 ' A' ' 31' ' ' VAL . 88.0 t -86.4 124.75 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.26 0.624 . . . . 0.0 110.67 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.02 124.01 48.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.327 1.051 . . . . 0.0 110.262 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 63.9 tttm -82.78 93.92 7.53 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.67 -100.48 1.32 Allowed Glycine 0 C--N 1.34 0.767 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -167.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.46 -1.33 9.11 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.493 0.717 . . . . 0.0 111.741 177.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 10.8 pt-20 -90.4 148.42 22.81 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 118.682 0.674 . . . . 0.0 110.995 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 t -67.42 97.79 0.6 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.844 0.857 . . . . 0.0 109.703 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -85.7 -53.29 5.24 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.637 0.375 . . . . 0.0 110.245 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.58 -152.5 10.1 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.344 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -141.96 134.07 27.59 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.778 0.831 . . . . 0.0 109.815 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.7 t -66.76 105.63 1.62 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.15 -34.28 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.592 0.757 . . . . 0.0 109.596 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -158.39 178.21 10.41 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.406 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.1 p -155.52 142.22 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.739 0.816 . . . . 0.0 109.206 173.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -139.9 128.29 22.73 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.52 -105.78 0.9 Allowed Glycine 0 CA--C 1.531 1.045 0 O-C-N 123.512 0.507 . . . . 0.0 113.786 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -116.95 11.49 14.36 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.204 1.001 . . . . 0.0 111.723 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.546 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 57.3 m-85 -125.29 115.93 21.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.727 0.411 . . . . 0.0 110.457 -176.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.406 HD12 ' HB ' ' A' ' 24' ' ' VAL . 45.0 tp -78.63 111.66 14.93 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.285 1.034 . . . . 0.0 109.255 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' A' ' 39' ' ' ALA . 39.8 mm -71.19 109.42 3.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 123.105 0.562 . . . . 0.0 109.635 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.433 HG22 HG21 ' A' ' 11' ' ' VAL . 60.8 t -107.43 114.63 46.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.306 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -74.85 109.6 8.45 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.2 m -107.1 85.41 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 124.494 1.118 . . . . 0.0 110.459 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.91 -83.09 0.31 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.207 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.4 p -110.37 -27.51 9.02 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.207 1.003 . . . . 0.0 111.889 -176.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -111.23 162.25 15.16 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.112 0.565 . . . . 0.0 111.356 -173.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -108.78 109.32 20.43 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 170.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.6 mt -105.36 118.73 37.3 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.546 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -83.47 97.36 8.95 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.608 -177.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.1 t -78.64 115.93 55.61 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.168 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.77 145.48 49.66 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.015 2.477 . . . . 0.0 112.779 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -68.92 -21.12 64.23 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.953 0.901 . . . . 0.0 112.032 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.422 ' HB2' ' NZ ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -74.58 -13.64 60.68 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.048 0.539 . . . . 0.0 111.635 174.498 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.8 m -94.89 3.46 54.95 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.127 0.971 . . . . 0.0 111.99 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.0 mm -82.36 122.78 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.418 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 72.8 mmtt -72.55 -51.2 20.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.61 0.764 . . . . 0.0 110.067 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.1 t -166.03 149.02 7.38 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.43 0.692 . . . . 0.0 110.38 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.3 t -97.6 111.19 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.671 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 31.8 mt-10 -91.6 179.14 5.73 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.065 0.546 . . . . 0.0 110.655 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -40.07 -53.29 2.43 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.782 1.633 . . . . 0.0 113.429 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -140.5 33.24 2.08 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.671 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 68.9 mtt180 -135.26 147.55 49.3 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.449 0.699 . . . . 0.0 110.138 -175.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.552 HG12 ' HB3' ' A' ' 9' ' ' MET . 35.9 mm -116.71 101.63 12.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 168.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 50.8 t -80.17 115.06 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.6 pt -109.58 159.33 9.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.881 0.872 . . . . 0.0 109.207 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.418 ' HA3' ' HE2' ' A' ' 46' ' ' LYS . . . -90.45 -81.77 1.38 Allowed Glycine 0 C--O 1.242 0.629 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -159.87 176.25 12.12 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.061 0.945 . . . . 0.0 109.309 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -164.44 165.35 21.53 Favored 'General case' 0 C--O 1.25 1.127 0 C-N-CA 124.663 1.185 . . . . 0.0 108.13 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -82.1 108.45 15.59 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.61 -20.43 65.35 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.85 -173.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -69.21 -43.67 73.64 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.507 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 50.2 mt-10 -64.26 -55.97 17.78 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.857 175.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.67 -25.05 59.67 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.594 0.758 . . . . 0.0 112.532 -176.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -70.61 -52.67 19.85 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.909 0.884 . . . . 0.0 110.865 175.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -76.38 -38.19 56.11 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -171.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 62' ' ' GLU . 4.6 pp -81.83 -25.13 35.42 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 122.274 -0.266 . . . . 0.0 110.473 174.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.9 -44.67 94.27 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.547 ' HA ' HD23 ' A' ' 71' ' ' LEU . 3.5 ptm180 -74.75 -21.16 59.5 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.411 0.685 . . . . 0.0 110.605 178.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -67.57 -31.87 72.23 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.467 ' HE3' HD22 ' A' ' 71' ' ' LEU . 85.4 t90 -69.71 -36.85 76.27 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 171.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.3 mm? -59.32 -29.81 67.9 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 172.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -75.4 -33.05 60.95 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.104 0.562 . . . . 0.0 110.712 173.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -66.16 -36.51 83.3 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.568 0.747 . . . . 0.0 111.647 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.417 ' HE2' HD12 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -81.45 1.13 34.55 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.68 0.392 . . . . 0.0 111.111 175.824 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.7 t 77.08 93.24 0.07 Allowed 'General case' 0 C--N 1.357 0.902 0 C-N-CA 126.005 1.722 . . . . 0.0 110.906 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -70.26 148.47 95.73 Favored Pre-proline 0 N--CA 1.48 1.071 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.061 166.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.39 -161.54 0.1 OUTLIER 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.001 2.467 . . . . 0.0 111.928 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.87 40.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.556 0.742 . . . . 0.0 111.578 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.9 m -65.47 -51.03 62.99 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.355 1.062 . . . . 0.0 111.598 -174.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 pp -134.97 150.03 50.3 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.497 0.665 . . . . 0.0 111.744 -177.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.507 ' HA ' ' HE2' ' A' ' 84' ' ' LYS . 8.9 mm-40 -91.16 -21.44 21.16 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.822 1.249 . . . . 0.0 110.529 174.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.03 -40.3 84.6 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.496 1.518 . . . . 0.0 113.878 -166.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.3 tt -75.66 -29.94 59.27 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 118.026 0.375 . . . . 0.0 110.773 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' A' ' 81' ' ' GLU . 38.1 mtmt -63.23 91.51 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.389 0.676 . . . . 0.0 111.587 -172.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.8 p -147.98 -71.19 0.22 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -142.46 148.82 38.36 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.777 0.831 . . . . 0.0 109.838 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.36 70.35 0.38 Allowed Glycine 0 C--N 1.341 0.857 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -73.45 110.04 7.42 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.546 0.739 . . . . 0.0 109.597 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.8 -32.71 0.02 OUTLIER Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.476 -176.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -63.16 97.51 0.12 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.147 0.579 . . . . 0.0 109.714 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -160.39 141.91 12.41 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.868 0.867 . . . . 0.0 109.946 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 133.02 104.09 0.87 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -77.41 130.4 37.02 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.707 0.803 . . . . 0.0 111.191 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.74 131.95 1.66 Allowed Glycine 0 CA--C 1.528 0.902 0 O-C-N 124.021 0.826 . . . . 0.0 111.275 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 C--O 1.249 1.07 0 C-N-CA 123.722 0.809 . . . . 0.0 110.005 178.614 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 121.064 0.459 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.14 -84.18 0.87 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 173.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 62.26 16.92 8.85 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.544 1.138 . . . . 0.0 111.929 174.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 87.8 mtp -95.14 178.02 5.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.949 0.9 . . . . 0.0 110.72 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.477 ' HB3' HG22 ' A' ' 7' ' ' ILE . 7.1 m-20 -58.54 -48.79 79.71 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.849 0.86 . . . . 0.0 111.865 -177.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.7 mt 65.31 7.04 3.96 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 125.233 1.413 . . . . 0.0 112.586 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.477 HG22 ' HB3' ' A' ' 5' ' ' ASP . 9.9 tt -77.07 -41.13 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.387 1.075 . . . . 0.0 111.171 -174.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 60.7 m -90.8 49.41 1.65 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.075 0.95 . . . . 0.0 110.293 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.0 mtt -137.29 133.09 34.59 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.886 0.874 . . . . 0.0 109.498 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -83.87 123.79 30.29 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.754 0.822 . . . . 0.0 109.945 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.444 HG21 HG22 ' A' ' 31' ' ' VAL . 54.5 t -85.47 105.57 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.352 0.661 . . . . 0.0 110.533 -175.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -100.41 123.73 45.0 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.837 0.855 . . . . 0.0 109.898 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -78.44 89.45 4.42 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.3 -96.85 0.57 Allowed Glycine 0 C--N 1.346 1.086 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.807 -170.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -107.69 -32.12 7.78 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.887 0.875 . . . . 0.0 110.692 177.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -74.68 142.33 44.47 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -174.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.3 t -76.3 104.29 6.75 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -76.19 -53.49 8.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.85 -163.32 28.9 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.594 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -120.27 144.22 47.9 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -74.9 147.42 41.02 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.39 -32.21 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -164.63 168.81 17.72 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.79 0.436 . . . . 0.0 110.373 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.501 ' HB ' HD12 ' A' ' 29' ' ' LEU . 3.1 p -150.52 140.2 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.342 1.057 . . . . 0.0 108.884 172.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.646 ' HE1' HD11 ' A' ' 30' ' ' ILE . 42.3 p90 -145.87 136.37 24.09 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.767 0.827 . . . . 0.0 109.608 174.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.79 -106.96 1.1 Allowed Glycine 0 C--N 1.344 0.999 0 O-C-N 123.826 0.703 . . . . 0.0 113.942 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -115.68 19.47 15.25 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.946 0.898 . . . . 0.0 110.682 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.534 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 73.9 m-85 -138.0 118.46 13.82 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.779 0.431 . . . . 0.0 111.802 -172.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.501 HD12 ' HB ' ' A' ' 24' ' ' VAL . 44.2 tp -88.32 116.53 26.6 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.133 0.973 . . . . 0.0 109.403 172.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.646 HD11 ' HE1' ' A' ' 25' ' ' TYR . 33.5 mm -78.8 111.8 16.09 Favored 'Isoleucine or valine' 0 C--O 1.251 1.182 0 C-N-CA 123.05 0.54 . . . . 0.0 109.857 176.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.444 HG22 HG21 ' A' ' 11' ' ' VAL . 44.5 t -111.19 125.0 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.65 1.18 . . . . 0.0 109.847 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -74.49 124.9 27.45 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.352 0.661 . . . . 0.0 109.514 170.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 m -135.47 107.78 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 125.309 1.443 . . . . 0.0 108.945 176.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.29 -105.17 1.5 Allowed Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.549 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 77.8 p -110.54 -5.7 15.05 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.18 0.992 . . . . 0.0 110.823 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -109.7 165.38 11.73 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.769 0.828 . . . . 0.0 110.872 -166.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.17 110.71 15.61 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.0 mp -102.96 117.27 34.22 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.306 1.042 . . . . 0.0 109.418 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.534 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -77.81 91.41 4.12 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.438 0.695 . . . . 0.0 109.986 176.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.05 118.81 73.39 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.095 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.489 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 36.3 Cg_endo -60.71 145.05 99.54 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.488 2.125 . . . . 0.0 111.672 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.621 ' HA ' HD13 ' A' ' 45' ' ' ILE . 12.5 mmmm -61.68 -24.13 66.55 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.196 0.999 . . . . 0.0 112.205 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.489 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 14.9 ptmm? -72.96 -21.43 60.86 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.575 0.75 . . . . 0.0 111.865 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.1 t -78.24 -28.02 47.73 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.058 0.543 . . . . 0.0 110.49 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.621 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.7 mp -65.14 115.02 2.95 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.537 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 75.1 mmtt -68.76 -53.73 20.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.974 0.91 . . . . 0.0 109.784 175.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 73.6 m -159.25 143.48 15.23 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.68 0.792 . . . . 0.0 110.844 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.4 p -85.92 115.76 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 168.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.756 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 8.2 mm-40 -107.68 178.71 4.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.12 0.968 . . . . 0.0 110.67 -175.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -66.54 95.41 0.33 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.223 0.609 . . . . 0.0 110.187 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.46 13.81 81.46 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.315 -0.402 . . . . 0.0 113.354 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.756 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 25.3 mtp180 -130.01 149.61 51.66 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.526 0.73 . . . . 0.0 110.189 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.1 mm -119.62 103.95 15.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 164.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.474 HG22 HH21 ' A' ' 52' ' ' ARG . 92.5 t -84.22 113.26 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.9 pt -109.51 179.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.53 1.132 . . . . 0.0 109.434 174.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' HA3' ' HE2' ' A' ' 46' ' ' LYS . . . -144.54 -112.74 0.83 Allowed Glycine 0 C--N 1.343 0.958 0 N-CA-C 112.138 -0.385 . . . . 0.0 112.138 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -89.26 136.23 33.14 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.469 0.708 . . . . 0.0 110.634 -172.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -167.0 174.24 8.57 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.821 1.248 . . . . 0.0 108.21 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -99.64 119.46 38.13 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.22 -28.05 66.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.717 0.807 . . . . 0.0 111.821 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -74.29 -37.21 63.74 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.57 0.544 . . . . 0.0 110.652 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -58.26 -50.6 73.03 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.24 -31.49 72.71 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.581 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -75.66 -48.75 20.76 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.138 0.575 . . . . 0.0 110.237 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.48 -38.98 74.47 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.389 0.614 . . . . 0.0 111.22 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.422 ' HG ' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -84.55 -20.0 32.23 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.394 0.678 . . . . 0.0 109.95 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -74.57 -41.97 34.25 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 172.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.612 ' HA ' HD23 ' A' ' 71' ' ' LEU . 8.5 ptm180 -74.35 -17.45 60.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.993 0.517 . . . . 0.0 109.834 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 3.1 tppp? -65.78 -40.04 91.56 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 123.217 0.607 . . . . 0.0 109.484 169.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.446 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 78.2 t90 -60.34 -42.95 96.75 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.94 0.896 . . . . 0.0 111.188 174.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.698 HD12 ' HD3' ' A' ' 76' ' ' LYS . 3.2 mm? -59.99 -37.1 78.68 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.548 171.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -75.29 -24.45 57.5 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.131 0.972 . . . . 0.0 111.371 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 69' ' ' LYS . 34.6 mm-40 -64.68 -38.95 92.75 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.195 0.521 . . . . 0.0 109.908 174.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -84.89 -18.5 34.56 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.933 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.2 m 67.26 52.7 0.82 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.982 1.313 . . . . 0.0 110.671 173.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.698 ' HD3' HD12 ' A' ' 71' ' ' LEU . 26.2 mtpp -72.15 127.07 90.89 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.85 -176.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -81.59 -158.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.386 2.724 . . . . 0.0 113.737 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.1 t -59.87 92.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 C-N-CA 125.043 1.337 . . . . 0.0 111.015 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.6 t -149.64 -1.68 0.44 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.598 0.759 . . . . 0.0 111.752 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.7 tp -84.75 -52.08 6.32 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.251 0.62 . . . . 0.0 111.229 -171.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.443 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -62.82 -28.65 70.15 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.442 0.697 . . . . 0.0 111.3 174.598 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -59.73 -40.47 88.15 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.06 0.944 . . . . 0.0 111.822 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 pp -84.25 1.14 46.08 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.623 0.369 . . . . 0.0 111.926 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.443 ' HE3' ' HA ' ' A' ' 81' ' ' GLU . 10.0 mtmp? -104.47 55.34 0.72 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.769 0.828 . . . . 0.0 108.847 174.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.1 t -67.34 -20.16 65.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.327 1.051 . . . . 0.0 112.944 -173.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -70.45 -24.92 62.97 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.394 0.678 . . . . 0.0 111.599 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.18 -106.97 2.09 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 123.495 0.497 . . . . 0.0 111.995 -177.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -157.7 166.37 32.98 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.163 0.985 . . . . 0.0 109.856 176.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.94 -47.55 0.52 Allowed Glycine 0 C--N 1.346 1.091 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -90.3 0.74 57.1 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.962 0.905 . . . . 0.0 111.782 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.22 113.42 6.55 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.043 0.537 . . . . 0.0 110.145 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -164.23 -126.46 0.82 Allowed Glycine 0 C--N 1.347 1.193 0 CA-C-N 116.236 -0.438 . . . . 0.0 113.006 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.23 -35.5 73.89 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.858 0.863 . . . . 0.0 112.215 -171.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.48 -88.51 1.0 Allowed Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 C--O 1.253 1.271 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.189 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.71 -113.31 3.62 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -174.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -159.33 -0.65 0.08 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.142 0.577 . . . . 0.0 110.9 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.0 mtt -88.54 -65.57 1.0 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.65 17.63 6.41 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.416 1.087 . . . . 0.0 112.895 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.5 mt -90.12 -27.96 19.28 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.382 0.673 . . . . 0.0 110.176 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.2 pt -111.61 177.29 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.321 1.049 . . . . 0.0 111.243 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 57.9 m 65.67 2.9 2.25 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.404 1.481 . . . . 0.0 113.537 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 47.7 mtt -92.26 145.72 24.27 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.371 0.605 . . . . 0.0 110.361 -177.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -84.86 108.79 17.69 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.985 -170.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' A' ' 53' ' ' ILE . 97.0 t -80.55 117.91 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.948 0.899 . . . . 0.0 110.994 -175.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -112.9 117.7 32.84 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.229 1.012 . . . . 0.0 109.552 175.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 51.3 tttm -77.92 91.04 4.15 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.22 -92.22 0.85 Allowed Glycine 0 C--N 1.345 1.066 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -170.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -118.95 -23.64 6.83 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.889 0.876 . . . . 0.0 111.353 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 12.6 pt-20 -78.94 142.11 36.98 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.528 0.331 . . . . 0.0 110.159 -172.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.6 t -69.11 99.11 1.07 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.538 0.735 . . . . 0.0 109.262 176.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -79.48 -57.53 3.65 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.05 -137.41 3.17 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.413 0.446 . . . . 0.0 112.639 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -148.3 136.91 21.55 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.962 0.905 . . . . 0.0 110.51 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.5 p -72.55 108.54 5.66 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.91 -32.57 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.177 0.591 . . . . 0.0 110.174 -176.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -160.35 178.49 9.54 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.704 0.402 . . . . 0.0 110.423 -174.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.8 p -154.6 139.6 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 124.299 1.04 . . . . 0.0 109.593 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -141.47 132.4 26.0 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.372 0.669 . . . . 0.0 109.203 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.36 -103.86 0.46 Allowed Glycine 0 C--N 1.349 1.288 0 O-C-N 123.548 0.53 . . . . 0.0 113.814 170.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -115.07 16.74 17.01 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.519 1.128 . . . . 0.0 111.228 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.51 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 84.1 m-85 -141.64 125.64 17.23 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.619 -0.676 . . . . 0.0 111.97 -174.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 60.6 tp -82.59 111.7 18.81 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.222 1.009 . . . . 0.0 109.11 170.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 39' ' ' ALA . 28.1 mm -70.94 112.96 6.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 122.899 0.48 . . . . 0.0 109.725 177.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 88.4 t -112.47 118.11 56.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 123.186 0.594 . . . . 0.0 109.643 176.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -77.79 126.12 30.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.444 0.698 . . . . 0.0 109.792 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 m -131.99 74.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 C-N-CA 124.612 1.165 . . . . 0.0 109.886 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.63 -81.08 0.02 OUTLIER Glycine 0 C--N 1.354 1.55 0 CA-C-N 115.148 -0.933 . . . . 0.0 114.393 173.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.4 p -70.54 -49.46 47.85 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.272 1.029 . . . . 0.0 111.577 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -138.9 176.55 8.6 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.503 0.668 . . . . 0.0 112.258 -166.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -105.87 108.67 20.3 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.955 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 mp -95.39 105.5 17.47 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -80.07 94.35 5.95 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.848 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.18 124.59 91.04 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.137 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -56.77 141.56 92.24 Favored 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 122.732 2.288 . . . . 0.0 111.411 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.534 ' HA ' HD13 ' A' ' 45' ' ' ILE . 2.2 mmmp? -60.74 -34.34 74.28 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -172.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.434 ' H ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -68.47 -21.49 64.62 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.404 0.282 . . . . 0.0 111.576 177.792 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.2 t -75.0 -27.75 60.26 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 122.733 0.413 . . . . 0.0 111.081 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.57 HG13 HG22 ' A' ' 55' ' ' ILE . 2.0 mp -64.66 113.45 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.187 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -79.88 -50.05 11.04 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.859 0.864 . . . . 0.0 110.177 -175.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.7 m -148.22 126.84 12.48 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.241 -175.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.96 109.75 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 166.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -110.07 172.53 6.81 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.471 1.108 . . . . 0.0 110.415 -174.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.54 97.12 0.41 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.24 0.616 . . . . 0.0 110.423 -175.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.06 4.83 84.18 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.454 -0.794 . . . . 0.0 113.994 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -131.58 132.97 44.53 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.084 0.953 . . . . 0.0 109.053 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.534 ' HB ' HG22 ' A' ' 11' ' ' VAL . 43.4 mm -109.32 103.2 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.6 t -81.95 114.04 22.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.57 HG22 HG13 ' A' ' 45' ' ' ILE . 34.0 pt -109.25 170.41 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.552 0.741 . . . . 0.0 109.012 175.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.95 -159.27 14.92 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 116.611 -0.268 . . . . 0.0 112.877 -173.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -85.71 120.15 26.83 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.655 0.74 . . . . 0.0 109.562 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -142.29 171.3 14.24 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.989 1.316 . . . . 0.0 107.478 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -86.97 111.87 21.26 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.79 -23.44 63.34 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.414 0.686 . . . . 0.0 112.05 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -69.87 -37.29 76.03 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 123.86 0.725 . . . . 0.0 109.905 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -60.71 -54.86 40.1 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 170.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.03 77.03 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.258 -173.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.03 -44.45 54.33 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.947 -176.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.19 -40.21 86.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.917 0.326 . . . . 0.0 111.264 -174.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 pp -82.38 -16.31 49.57 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.704 0.401 . . . . 0.0 110.58 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.29 -32.75 57.74 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 168.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 -76.72 -28.45 55.82 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.246 1.019 . . . . 0.0 110.174 173.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -65.18 -34.98 79.67 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 169.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.447 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 56.8 t90 -65.27 -38.19 89.52 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.312 175.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.24 -27.79 67.52 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.313 0.645 . . . . 0.0 111.486 173.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -78.68 -42.05 29.55 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.724 0.81 . . . . 0.0 111.315 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.447 ' HG2' ' HA ' ' A' ' 70' ' ' TRP . 11.8 pt-20 -76.37 -32.6 58.68 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.307 0.643 . . . . 0.0 111.757 -173.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -24.79 63.42 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.584 0.353 . . . . 0.0 110.623 177.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.6 t -62.35 -31.51 72.16 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.693 0.797 . . . . 0.0 110.691 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -85.32 146.13 44.14 Favored Pre-proline 0 N--CA 1.478 0.93 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 169.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.58 157.07 43.67 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.611 2.208 . . . . 0.0 111.805 174.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 p -65.8 88.38 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-O 121.966 0.889 . . . . 0.0 109.768 176.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.2 t -80.08 -32.17 39.27 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.784 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tt -172.26 97.3 0.15 Allowed 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -95.54 -11.63 27.08 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.199 0.6 . . . . 0.0 111.543 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -68.9 -26.65 65.21 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.713 0.405 . . . . 0.0 110.949 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.5 tp -74.46 -22.43 59.11 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.275 0.63 . . . . 0.0 110.581 175.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -77.62 -28.15 51.37 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.348 0.659 . . . . 0.0 109.995 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.8 m -70.7 116.02 10.53 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.756 0.822 . . . . 0.0 109.358 176.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -77.48 143.88 38.17 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.934 0.494 . . . . 0.0 111.585 -175.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -137.25 -52.4 0.06 OUTLIER Glycine 0 C--N 1.338 0.682 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 173.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.1 t80 67.53 12.36 8.85 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.825 1.25 . . . . 0.0 111.833 166.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.07 71.78 0.05 OUTLIER Glycine 0 C--N 1.343 0.941 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -80.41 69.54 6.89 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.639 0.776 . . . . 0.0 109.954 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -171.2 146.68 2.41 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.804 1.242 . . . . 0.0 108.347 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.43 142.22 8.73 Favored Glycine 0 C--N 1.341 0.827 0 O-C-N 123.239 0.337 . . . . 0.0 112.519 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.57 -28.42 60.93 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.502 0.721 . . . . 0.0 110.717 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.33 113.81 0.53 Allowed Glycine 0 C--N 1.343 0.966 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.969 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.25 1.086 0 C-N-CA 123.688 0.795 . . . . 0.0 109.158 177.531 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.604 0.24 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.71 -142.96 3.59 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.337 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -116.0 81.69 1.65 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.239 0.616 . . . . 0.0 110.919 -175.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 95.6 mmm -88.4 97.49 11.08 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 172.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -83.87 84.28 7.63 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.314 0.578 . . . . 0.0 111.399 -174.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.0 mt -103.69 11.19 36.28 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.323 1.049 . . . . 0.0 108.576 166.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.44 HG23 ' SG ' ' A' ' 8' ' ' CYS . 10.4 tp -73.2 -30.2 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 125.37 1.468 . . . . 0.0 111.425 -171.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.44 ' SG ' HG23 ' A' ' 7' ' ' ILE . 19.0 m -135.71 92.69 2.85 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.427 0.691 . . . . 0.0 109.784 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.0 mtt -148.76 157.69 43.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.636 1.174 . . . . 0.0 109.122 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -78.67 110.94 14.26 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.915 0.486 . . . . 0.0 109.878 176.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.52 130.7 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.061 0.544 . . . . 0.0 109.838 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -116.97 124.74 50.12 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.61 1.164 . . . . 0.0 110.023 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -79.73 92.61 5.44 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.87 -96.08 0.58 Allowed Glycine 0 C--N 1.342 0.914 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -173.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.03 -21.92 10.32 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.47 0.708 . . . . 0.0 111.572 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.02 155.68 19.7 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 122.861 0.464 . . . . 0.0 110.396 -176.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.7 t -71.13 112.44 7.28 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.054 0.542 . . . . 0.0 110.134 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -80.74 -52.55 7.4 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.29 -139.85 5.14 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.844 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -139.23 132.32 29.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.137 0.975 . . . . 0.0 108.869 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.408 ' HB2' HD11 ' A' ' 29' ' ' LEU . 73.4 p -69.8 124.13 23.22 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 172.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.55 -37.6 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.64 0.776 . . . . 0.0 109.195 -177.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.414 ' HA ' HD11 ' A' ' 7' ' ' ILE . 20.8 t70 -150.46 167.91 25.75 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.357 -171.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.3 p -127.61 138.96 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -148.67 100.29 3.09 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.144 0.978 . . . . 0.0 109.486 -169.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.86 -109.14 2.72 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.741 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 21.1 t70 -104.67 -5.5 21.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.188 0.595 . . . . 0.0 109.413 171.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.445 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 64.8 m-85 -100.04 113.67 26.43 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.306 0.642 . . . . 0.0 111.089 -171.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 21' ' ' SER . 66.0 tp -74.1 106.69 5.89 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.0 mm -68.28 106.51 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.177 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.7 t -100.33 117.68 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.83 111.09 7.65 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 173.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.463 HG21 HD23 ' A' ' 38' ' ' LEU . 18.9 m -111.18 85.55 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-O 122.04 0.924 . . . . 0.0 110.48 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.35 -91.16 0.24 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.062 -0.972 . . . . 0.0 113.3 176.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.0 p -105.43 -10.29 17.03 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.824 0.85 . . . . 0.0 111.389 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -124.51 -176.68 3.58 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.505 0.722 . . . . 0.0 111.49 -173.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -131.22 110.25 11.0 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.966 1.307 . . . . 0.0 109.308 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.463 HD23 HG21 ' A' ' 33' ' ' VAL . 2.4 mm? -102.9 109.25 20.74 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.648 1.179 . . . . 0.0 108.821 174.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -87.02 93.74 9.44 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.262 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.31 131.81 51.97 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.515 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 54.9 Cg_endo -65.3 159.83 45.37 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.359 2.04 . . . . 0.0 112.129 177.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 27' ' ' ASP . 31.0 mmmt -66.75 -22.45 66.04 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.724 0.81 . . . . 0.0 111.433 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.515 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 8.6 ptpp? -76.01 -18.99 59.04 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.99 0.916 . . . . 0.0 112.065 175.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.7 t -71.71 -29.26 64.36 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.712 0.405 . . . . 0.0 110.747 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.517 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.2 mp -70.22 118.45 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.068 0.547 . . . . 0.0 109.911 -177.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -85.67 -54.5 4.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.272 1.029 . . . . 0.0 111.046 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.2 m -134.26 146.93 50.51 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.788 -172.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.5 p -114.91 126.4 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.061 0.944 . . . . 0.0 109.297 173.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.799 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 42.3 mm-40 -121.85 173.22 7.63 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.986 0.914 . . . . 0.0 109.171 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.03 97.47 1.17 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.822 0.82 . . . . 0.0 110.271 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.56 18.12 71.63 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.272 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.799 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 54.1 mtt180 -140.63 149.76 42.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.631 0.772 . . . . 0.0 110.516 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.5 mm -134.81 104.24 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.484 1.114 . . . . 0.0 108.822 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.08 122.31 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.4 pt -112.4 153.99 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.109 0.963 . . . . 0.0 109.442 174.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -104.1 -64.36 0.68 Allowed Glycine 0 C--N 1.344 1.004 0 CA-C-O 120.158 -0.246 . . . . 0.0 112.537 -173.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -157.26 159.76 37.93 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.106 0.562 . . . . 0.0 110.034 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -166.26 173.07 10.47 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.519 1.128 . . . . 0.0 109.239 -177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.78 99.66 7.58 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -67.86 -57.51 6.13 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.263 1.025 . . . . 0.0 112.702 -167.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.89 -30.32 69.65 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.151 0.58 . . . . 0.0 110.776 -176.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 43.7 mt-10 -70.25 -39.61 74.9 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.795 173.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.12 -25.55 65.35 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.021 0.528 . . . . 0.0 110.734 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -74.53 -45.81 43.27 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.678 0.791 . . . . 0.0 109.838 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.9 pt-20 -72.72 -36.42 67.78 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.445 0.298 . . . . 0.0 111.779 -177.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 69' ' ' LYS . 4.1 pp -83.39 -13.6 54.53 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 122.157 -0.339 . . . . 0.0 110.529 174.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.04 -46.27 52.34 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.747 168.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.471 ' HA ' HD13 ' A' ' 71' ' ' LEU . 34.6 ptt180 -72.05 -23.89 61.44 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 175.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.479 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 22.4 ttmm -62.3 -39.21 92.25 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 123.087 0.555 . . . . 0.0 109.715 170.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.462 ' HE3' HD12 ' A' ' 71' ' ' LEU . 70.6 t90 -60.87 -38.29 85.1 Favored 'General case' 0 CA--C 1.553 1.088 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 172.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' A' ' 68' ' ' ARG . 11.2 mp -60.83 -39.73 90.12 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 177.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.56 -29.14 46.16 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.701 -0.625 . . . . 0.0 111.194 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 69.2 mt-10 -77.8 -31.1 51.6 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -6.8 47.73 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 171.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.6 t 73.45 82.12 0.12 Allowed 'General case' 0 C--N 1.363 1.159 0 C-N-CA 126.152 1.781 . . . . 0.0 110.023 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -83.2 158.41 64.1 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.802 171.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.92 146.05 87.02 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.153 1.902 . . . . 0.0 111.347 168.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.0 m -71.68 -19.96 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.707 0.403 . . . . 0.0 110.96 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.7 t 50.17 23.42 1.16 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 126.659 1.983 . . . . 0.0 114.088 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 1.0 OUTLIER -163.28 124.77 2.44 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -171.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -71.55 -27.84 63.45 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.737 0.815 . . . . 0.0 111.748 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -72.57 -28.41 62.8 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.108 0.48 . . . . 0.0 110.28 174.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -78.37 -5.83 53.42 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 123.692 0.797 . . . . 0.0 110.365 177.709 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -60.56 -43.91 96.73 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.542 0.737 . . . . 0.0 111.01 176.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 91.0 p -92.04 14.42 15.94 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.157 0.583 . . . . 0.0 111.473 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -127.96 151.59 48.94 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.714 0.806 . . . . 0.0 110.408 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 159.15 87.76 0.06 OUTLIER Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -126.77 165.86 18.5 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.158 0.583 . . . . 0.0 110.458 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.46 -159.37 27.9 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -92.66 134.48 34.97 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 175.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.72 107.15 16.76 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 117.988 0.358 . . . . 0.0 111.011 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.49 -167.37 32.94 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 124.076 0.86 . . . . 0.0 114.889 168.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.31 -5.36 15.89 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.134 0.974 . . . . 0.0 109.97 170.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.69 18.05 80.03 Favored Glycine 0 C--N 1.356 1.658 0 CA-C-O 119.182 -0.788 . . . . 0.0 114.424 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.4 t . . . . . 0 C--O 1.254 1.322 0 C-N-CA 124.76 1.224 . . . . 0.0 109.866 -176.442 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.44 178.64 34.04 Favored Glycine 0 C--N 1.344 1.004 0 O-C-N 123.369 0.418 . . . . 0.0 113.157 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -136.04 133.05 37.01 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.742 0.817 . . . . 0.0 109.685 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 7' ' ' ILE . 64.9 mtt -84.51 98.37 10.08 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.44 -1.0 14.06 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.21 1.004 . . . . 0.0 112.151 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -90.03 -5.62 56.42 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.172 0.989 . . . . 0.0 111.493 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 4' ' ' MET . 10.9 tp -80.79 142.59 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 122.973 0.509 . . . . 0.0 111.129 -176.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 59.1 m -85.0 94.88 8.91 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 79.4 mtp -72.08 108.4 5.26 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.176 0.59 . . . . 0.0 110.102 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -62.42 123.07 17.32 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.162 0.585 . . . . 0.0 110.889 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.6 t -93.85 131.25 41.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 124.075 0.95 . . . . 0.0 110.076 -173.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.567 ' HE1' ' HD2' ' A' ' 52' ' ' ARG . 70.0 m-85 -118.93 127.01 53.08 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.536 1.134 . . . . 0.0 108.625 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -78.43 87.34 4.44 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.105 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.36 -94.75 0.74 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -172.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.85 -27.27 8.54 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.84 0.856 . . . . 0.0 111.785 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 12.0 pt-20 -81.42 145.82 30.59 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -174.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 t -69.78 113.75 7.32 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -93.83 -50.21 5.46 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.078 0.551 . . . . 0.0 110.524 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.18 -137.93 4.06 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.766 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.581 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 8.9 pt-20 -141.13 144.11 34.66 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.238 1.015 . . . . 0.0 109.966 -177.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.8 t -77.17 149.83 35.56 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.24 -40.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -151.52 170.01 20.68 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -176.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' A' ' 29' ' ' LEU . 2.8 p -155.8 123.07 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.067 0.947 . . . . 0.0 109.069 172.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.442 ' CE1' HD11 ' A' ' 30' ' ' ILE . 7.3 p90 -124.29 132.8 53.59 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 88' ' ' PHE . . . 60.89 -105.87 0.95 Allowed Glycine 0 C--N 1.338 0.686 0 O-C-N 123.543 0.527 . . . . 0.0 114.044 178.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -118.94 17.96 13.29 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.615 0.766 . . . . 0.0 111.527 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.511 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 80.8 m-85 -133.03 112.79 12.11 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.142 0.496 . . . . 0.0 111.427 -175.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.493 HD12 ' HB ' ' A' ' 24' ' ' VAL . 44.8 tp -78.21 111.68 14.4 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.12 1.368 . . . . 0.0 109.552 173.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.442 HD11 ' CE1' ' A' ' 25' ' ' TYR . 33.2 mm -72.38 112.05 7.53 Favored 'Isoleucine or valine' 0 C--O 1.249 1.053 0 C-N-CA 123.578 0.751 . . . . 0.0 109.832 178.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.8 t -110.72 125.9 68.04 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 C-N-CA 124.369 1.068 . . . . 0.0 109.879 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.581 ' HB3' ' HG3' ' A' ' 20' ' ' GLU . 4.2 tppp? -73.96 120.02 18.96 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.92 0.888 . . . . 0.0 109.25 171.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.8 m -137.73 133.83 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.499 1.119 . . . . 0.0 109.627 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.58 -100.15 0.46 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.023 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.3 p -124.84 -11.53 7.17 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.602 1.161 . . . . 0.0 111.021 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -124.41 -171.98 2.46 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.562 0.745 . . . . 0.0 111.829 -171.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -121.11 111.37 17.35 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.144 0.977 . . . . 0.0 110.474 -174.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 mp -102.08 117.17 34.23 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 171.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.511 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -89.68 108.59 19.77 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.698 0.799 . . . . 0.0 110.954 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.469 HG21 HG21 ' A' ' 55' ' ' ILE . 16.5 m -83.52 139.28 41.2 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.405 0.682 . . . . 0.0 109.896 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.528 ' HG2' ' HB2' ' A' ' 44' ' ' SER . 56.9 Cg_endo -69.89 156.2 63.59 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 122.146 1.897 . . . . 0.0 112.624 176.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -68.24 -28.53 67.3 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.206 1.002 . . . . 0.0 111.39 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.498 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 21.5 pttp -74.9 -9.37 58.48 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.775 0.83 . . . . 0.0 111.572 176.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.528 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 28.5 t -88.43 -18.67 27.82 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.056 0.543 . . . . 0.0 111.083 175.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.531 HD13 HG22 ' A' ' 55' ' ' ILE . 29.5 mm -64.46 112.91 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 11.1 mmpt? -70.5 -45.46 65.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.534 0.734 . . . . 0.0 110.194 177.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.5 t -160.0 145.88 15.57 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.64 -176.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.8 p -110.02 119.69 59.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.782 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 20.7 mm-40 -104.23 166.51 10.35 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.84 0.856 . . . . 0.0 109.423 176.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -65.04 102.8 0.66 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.312 0.577 . . . . 0.0 109.572 174.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.44 4.92 90.06 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.605 -0.725 . . . . 0.0 114.363 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.782 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 77.5 mmt-85 -131.92 147.98 52.5 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 117.57 0.685 . . . . 0.0 110.171 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.82 132.43 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.923 0.889 . . . . 0.0 108.845 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.13 123.42 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.531 HG22 HD13 ' A' ' 45' ' ' ILE . 49.4 pt -118.95 164.82 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.648 0.779 . . . . 0.0 110.641 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.93 -171.99 22.58 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.31 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.69 130.51 41.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.824 0.449 . . . . 0.0 109.946 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -135.46 166.51 23.02 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.94 1.296 . . . . 0.0 108.826 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.01 109.16 14.2 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -67.01 -28.56 68.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.724 0.81 . . . . 0.0 111.284 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -67.33 -43.3 81.91 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.475 1.11 . . . . 0.0 110.722 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -68.63 -42.35 78.16 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.675 0.274 . . . . 0.0 110.475 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.64 89.93 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.74 0.816 . . . . 0.0 112.006 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -76.19 -34.28 59.3 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.465 0.478 . . . . 0.0 112.057 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 12.9 pt-20 -77.71 -40.71 40.38 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -177.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 pp -80.7 -25.5 38.11 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -69.05 -34.62 76.67 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.815 171.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -77.05 -18.02 58.37 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 117.296 0.548 . . . . 0.0 110.205 175.776 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 6.3 ttpm? -68.85 -32.17 71.66 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.162 0.506 . . . . 0.0 109.787 166.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.416 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 85.5 t90 -67.09 -32.74 74.1 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 169.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.598 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 8.8 mp -66.92 -31.6 72.29 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.161 0.584 . . . . 0.0 112.133 173.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER -81.34 -25.7 36.19 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.38 0.537 . . . . 0.0 109.942 174.727 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -66.25 -30.99 71.54 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.463 0.705 . . . . 0.0 110.188 170.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.598 ' HD3' ' HA ' ' A' ' 71' ' ' LEU . 52.8 mtpt -61.73 -54.58 40.57 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.233 0.613 . . . . 0.0 110.194 173.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -109.23 100.5 9.63 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.534 0.734 . . . . 0.0 109.447 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -61.04 145.98 88.6 Favored Pre-proline 0 N--CA 1.484 1.237 0 C-N-CA 125.036 1.334 . . . . 0.0 112.224 -171.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.36 177.05 8.09 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.747 2.298 . . . . 0.0 112.955 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.39 -24.09 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-O 120.989 0.423 . . . . 0.0 110.621 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.8 m -69.66 138.44 53.0 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.324 0.649 . . . . 0.0 109.836 171.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.2 tp -56.02 117.23 3.53 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.84 0.856 . . . . 0.0 109.523 174.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -74.78 -6.07 46.93 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 120.738 0.304 . . . . 0.0 111.328 -174.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -66.73 -30.22 70.39 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.209 0.528 . . . . 0.0 109.922 169.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.17 -25.43 62.54 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.998 0.919 . . . . 0.0 111.162 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -64.69 89.72 0.07 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.6 t -103.83 124.25 48.59 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.723 0.809 . . . . 0.0 109.3 -174.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -179.41 -39.57 0.01 OUTLIER 'General case' 0 C--O 1.245 0.823 0 C-N-CA 125.384 1.474 . . . . 0.0 107.904 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.41 -106.71 1.92 Allowed Glycine 0 C--N 1.349 1.273 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.152 -172.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.453 ' HB3' ' HA2' ' A' ' 26' ' ' GLY . 89.8 m-85 -137.41 -9.76 1.68 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.058 0.943 . . . . 0.0 110.013 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.37 38.91 81.26 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -61.73 109.89 1.35 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.432 1.093 . . . . 0.0 110.988 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -159.14 128.07 5.32 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.02 160.91 31.6 Favored Glycine 0 C--N 1.346 1.122 0 N-CA-C 112.148 -0.381 . . . . 0.0 112.148 -174.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.76 -179.37 6.94 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.444 0.697 . . . . 0.0 110.783 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 164.01 -60.63 0.26 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.5 p . . . . . 0 C--O 1.251 1.167 0 C-N-CA 124.079 0.952 . . . . 0.0 108.628 176.442 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 C--O 1.24 0.578 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -76.49 111.88 12.42 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.359 0.664 . . . . 0.0 110.124 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.16 111.65 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.097 0.559 . . . . 0.0 109.908 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -103.0 124.59 48.79 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.817 0.847 . . . . 0.0 110.135 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 51.1 tttm -77.67 85.43 3.99 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.86 -94.99 0.89 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -173.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -110.63 -30.15 7.73 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.97 0.908 . . . . 0.0 110.658 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 12.9 pt-20 -77.58 141.02 39.76 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -175.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.9 t -70.68 108.77 4.56 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -85.26 -55.55 3.97 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.866 0.466 . . . . 0.0 110.44 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.24 -146.88 5.98 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.282 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -140.1 145.34 37.49 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.75 0.82 . . . . 0.0 110.346 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.7 p -77.0 111.89 13.05 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.805 0.442 . . . . 0.0 109.839 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.65 -40.37 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.452 0.701 . . . . 0.0 110.25 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 18.0 t70 -148.36 160.66 42.78 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.919 0.487 . . . . 0.0 109.817 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.419 HG22 HD12 ' A' ' 29' ' ' LEU . 20.6 t -139.59 118.78 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -132.5 126.99 34.24 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.643 0.656 . . . . 0.0 109.503 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.04 -119.76 19.8 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.487 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -102.24 22.81 12.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.592 0.757 . . . . 0.0 111.347 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.423 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 66.3 m-85 -133.29 124.86 28.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.834 0.454 . . . . 0.0 111.357 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.419 HD12 HG22 ' A' ' 24' ' ' VAL . 45.2 tp -85.2 109.6 18.42 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 167.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 39' ' ' ALA . 23.5 mm -70.85 107.1 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.04 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.64 119.31 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.337 177.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -75.99 113.65 13.75 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.171 0.588 . . . . 0.0 109.496 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.35 126.56 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 124.124 0.97 . . . . 0.0 109.481 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.95 -91.44 0.05 OUTLIER Glycine 0 CA--C 1.535 1.316 0 CA-C-N 116.57 -0.287 . . . . 0.0 113.429 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.9 m -125.2 -23.82 4.11 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.404 1.082 . . . . 0.0 110.778 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -110.82 179.16 4.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.72 0.808 . . . . 0.0 111.319 -171.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.413 ' HB3' HG23 ' A' ' 30' ' ' ILE . 87.6 m-85 -119.23 110.35 16.92 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.515 0.726 . . . . 0.0 109.887 -175.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -91.55 105.9 18.09 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.299 1.04 . . . . 0.0 109.151 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.503 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -83.23 92.49 7.49 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.193 0.597 . . . . 0.0 109.83 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.3 m -80.18 134.66 55.38 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.414 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 48.0 Cg_endo -65.59 154.44 73.77 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.621 2.214 . . . . 0.0 111.674 176.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.561 ' HA ' HD13 ' A' ' 45' ' ' ILE . 13.7 mmmm -63.16 -28.1 69.83 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.591 0.756 . . . . 0.0 111.652 -176.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.414 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 7.7 ptpp? -65.72 -21.89 66.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.413 0.685 . . . . 0.0 111.583 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 t -74.33 -43.61 55.95 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.561 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.8 mp -61.73 112.47 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.442 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HE3' ' HA3' ' A' ' 56' ' ' GLY . 32.1 mmtp -78.51 -63.13 1.48 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.881 0.872 . . . . 0.0 110.154 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 t -146.02 132.83 20.05 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 122.915 0.486 . . . . 0.0 110.094 -175.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.8 p -77.68 109.61 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.65 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 5.8 mm-40 -86.16 174.3 9.23 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.324 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.56 86.5 2.09 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.166 0.508 . . . . 0.0 109.719 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.21 13.44 63.9 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.979 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.65 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 2.4 mpt_? -135.6 159.67 40.91 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.444 0.622 . . . . 0.0 109.64 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 mm -124.25 103.96 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 69.7 t -79.14 116.45 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.409 HG22 HG13 ' A' ' 45' ' ' ILE . 40.7 pt -105.87 164.0 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.499 ' HA3' ' HE3' ' A' ' 46' ' ' LYS . . . -104.4 -107.01 3.16 Favored Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -122.69 156.82 33.6 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.837 0.855 . . . . 0.0 109.807 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -167.09 160.17 13.71 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.723 1.209 . . . . 0.0 108.715 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -75.17 98.23 3.68 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -43.29 96.08 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.373 1.069 . . . . 0.0 112.896 -175.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -67.92 -33.87 75.53 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.341 0.401 . . . . 0.0 110.747 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 37.7 mt-10 -69.65 -49.44 53.66 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.366 174.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.01 -28.51 66.46 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.597 0.759 . . . . 0.0 111.383 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.59 -45.26 46.42 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.762 1.225 . . . . 0.0 110.867 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.415 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 2.9 pp20? -75.37 -36.93 60.85 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -175.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.523 ' HA ' ' HB3' ' A' ' 69' ' ' LYS . 4.4 pp -81.84 -15.14 55.08 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.846 0.355 . . . . 0.0 110.441 174.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -66.5 -47.82 67.13 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.747 166.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.494 ' HA ' HD23 ' A' ' 71' ' ' LEU . 9.2 ptp180 -76.32 -21.49 56.13 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 117.344 0.572 . . . . 0.0 111.458 177.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -68.18 -32.87 73.41 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.139 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.418 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 74.2 t90 -67.1 -40.49 86.91 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.196 169.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.1 mm? -57.89 -24.89 59.72 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.503 0.321 . . . . 0.0 111.232 175.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 CA--C 1.55 0.974 0 C-N-CA 122.478 0.311 . . . . 0.0 111.19 173.134 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.549 ' HB2' HG12 ' A' ' 53' ' ' ILE . 2.1 mpt? . . . . . 0 CA--C 1.554 1.103 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -75.13 110.46 9.46 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.307 1.043 . . . . 0.0 109.89 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.518 HG22 ' HB ' ' A' ' 53' ' ' ILE . 75.5 t -79.28 127.5 39.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 122.878 0.471 . . . . 0.0 110.814 -173.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -110.56 129.71 55.73 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.623 1.169 . . . . 0.0 110.045 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -78.01 85.01 4.25 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.561 1.144 . . . . 0.0 108.011 172.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.25 -96.64 0.34 Allowed Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.623 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -94.91 -40.71 9.55 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.496 0.719 . . . . 0.0 110.474 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -83.66 151.63 25.19 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.946 -170.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 t -75.72 119.08 19.25 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -87.51 -48.89 7.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.521 0.728 . . . . 0.0 110.456 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.51 -150.54 12.15 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -176.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -127.43 146.32 50.52 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 171.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 68.7 p -70.55 162.79 28.2 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 168.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.38 -39.56 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -153.24 171.92 17.79 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.608 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.485 ' HB ' HD12 ' A' ' 29' ' ' LEU . 2.4 p -151.72 133.75 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 172.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.489 ' CE2' HD11 ' A' ' 30' ' ' ILE . 50.6 p90 -135.81 135.24 39.69 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 172.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.48 -107.23 1.29 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 123.886 0.741 . . . . 0.0 112.704 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -116.11 12.84 15.66 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.764 0.826 . . . . 0.0 110.996 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.589 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 89.7 m-85 -123.17 109.34 13.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.198 0.599 . . . . 0.0 111.426 -172.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.485 HD12 ' HB ' ' A' ' 24' ' ' VAL . 45.5 tp -80.37 106.87 12.71 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 169.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.489 HD11 ' CE2' ' A' ' 25' ' ' TYR . 28.4 mm -71.24 108.81 3.07 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 C-N-CA 123.698 0.799 . . . . 0.0 110.041 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 65.6 t -102.72 119.44 51.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 O-C-N 124.263 0.977 . . . . 0.0 109.575 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.46 118.66 18.57 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.41 124.01 64.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.688 0.795 . . . . 0.0 108.99 172.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.81 -90.44 0.05 OUTLIER Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.493 0.496 . . . . 0.0 114.334 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.3 p -123.5 -21.71 5.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.187 0.995 . . . . 0.0 111.5 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -110.37 171.62 7.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.641 0.776 . . . . 0.0 111.612 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -120.05 110.17 16.35 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.253 1.021 . . . . 0.0 108.942 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.1 mp -106.76 115.18 29.75 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.371 1.069 . . . . 0.0 108.381 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -79.94 103.82 10.09 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.619 0.768 . . . . 0.0 111.021 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 m -78.13 132.58 66.51 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 172.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.483 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 37.4 Cg_endo -65.62 150.22 86.63 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 121.714 1.609 . . . . 0.0 110.286 172.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.566 ' HA ' HD13 ' A' ' 45' ' ' ILE . 31.6 mmmt -61.13 -29.98 70.1 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.116 0.566 . . . . 0.0 111.409 -176.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.483 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 60.1 pttt -68.97 -23.09 64.08 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.052 0.941 . . . . 0.0 111.902 177.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.8 t -68.9 -29.72 68.06 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.759 0.424 . . . . 0.0 110.714 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.566 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.9 mp -64.06 114.58 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.488 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 75.1 mmtt -71.69 -45.98 60.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.394 1.078 . . . . 0.0 110.0 176.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 44.1 p -157.14 155.15 30.5 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.952 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 p -113.12 114.2 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.916 0.886 . . . . 0.0 110.175 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 6.5 mm-40 -97.74 163.66 12.72 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.765 0.826 . . . . 0.0 109.1 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.75 -35.34 74.4 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.715 0.806 . . . . 0.0 111.301 -171.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -133.07 19.35 4.37 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.484 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.602 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 44.1 mtm180 -143.62 156.09 44.46 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 117.486 0.643 . . . . 0.0 110.85 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.549 HG12 ' HB2' ' A' ' 9' ' ' MET . 41.3 mm -126.43 104.37 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 173.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.7 t -83.24 114.89 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.9 pt -108.22 163.99 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.539 0.736 . . . . 0.0 109.499 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.488 ' HA3' ' HE2' ' A' ' 46' ' ' LYS . . . -92.87 -86.51 1.56 Allowed Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 175.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -160.5 168.44 25.07 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.563 0.745 . . . . 0.0 110.474 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -164.89 -179.03 5.54 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.898 1.279 . . . . 0.0 108.905 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -93.52 110.38 21.97 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -64.44 -37.22 86.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.12 0.968 . . . . 0.0 111.595 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.31 -50.39 60.4 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.044 0.84 . . . . 0.0 110.167 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.425 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 37.6 mt-10 -64.16 -38.87 92.63 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.07 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.21 -40.84 86.48 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.416 0.686 . . . . 0.0 111.93 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 9.9 ptp85 -75.3 -31.5 60.68 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 118.97 -0.538 . . . . 0.0 112.266 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -75.98 -38.8 57.06 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.394 0.543 . . . . 0.0 111.349 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 62' ' ' GLU . 4.4 pp -81.76 -13.26 57.99 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.25 0.548 . . . . 0.0 109.828 170.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.82 -33.93 66.17 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.168 165.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 64' ' ' ARG . 78.5 mtm180 -64.85 -40.33 94.99 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 123.317 0.647 . . . . 0.0 109.682 172.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -55.09 -39.76 69.66 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.789 170.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.417 ' CD1' HG13 ' A' ' 30' ' ' ILE . 88.6 t90 -65.49 -34.92 79.4 Favored 'General case' 0 C--N 1.361 1.105 0 CA-C-O 119.316 -0.373 . . . . 0.0 111.681 174.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.2 mm? -57.22 -22.14 38.74 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 118.839 0.745 . . . . 0.0 110.634 173.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 CA--C 1.574 1.883 0 C-N-CA 123.397 0.679 . . . . 0.0 111.924 164.645 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.6 ttm . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -69.51 106.42 2.98 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.41 0.684 . . . . 0.0 109.823 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.09 132.82 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.029 0.532 . . . . 0.0 109.791 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -113.8 127.49 56.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.795 1.238 . . . . 0.0 110.337 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.98 88.49 3.52 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 171.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.4 -95.48 0.6 Allowed Glycine 0 C--N 1.342 0.91 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -121.25 1.3 10.23 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.073 0.949 . . . . 0.0 112.196 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -117.04 151.72 36.18 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.254 0.621 . . . . 0.0 110.456 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.5 t -67.43 112.8 4.83 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.733 0.813 . . . . 0.0 111.334 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -84.79 -54.65 4.55 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.438 0.695 . . . . 0.0 110.199 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.31 -137.83 3.99 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.877 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -138.28 136.48 36.51 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.192 0.997 . . . . 0.0 109.694 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.485 ' HB2' HD11 ' A' ' 29' ' ' LEU . 68.8 p -72.08 112.26 8.01 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.87 -36.43 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.054 0.541 . . . . 0.0 109.839 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -153.49 176.66 11.78 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.272 0.629 . . . . 0.0 109.338 -173.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.22 136.85 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.988 0.915 . . . . 0.0 108.951 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.408 ' CD1' HD11 ' A' ' 30' ' ' ILE . 9.6 p90 -137.11 127.64 26.8 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 173.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.37 -109.62 2.43 Favored Glycine 0 C--N 1.346 1.117 0 O-C-N 123.537 0.523 . . . . 0.0 113.501 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -109.92 19.2 19.32 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.04 0.936 . . . . 0.0 111.493 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.404 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 78.9 m-85 -131.91 115.41 15.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.876 0.47 . . . . 0.0 111.665 -176.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 21' ' ' SER . 64.6 tp -79.22 113.85 17.68 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.131 0.972 . . . . 0.0 109.528 169.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.408 HD11 ' CD1' ' A' ' 25' ' ' TYR . 26.3 mm -74.77 106.92 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.5 t -104.53 113.44 41.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -76.3 109.67 10.19 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.6 m -95.15 156.08 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.415 1.086 . . . . 0.0 108.794 169.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -43.61 -28.23 1.01 Allowed Glycine 0 N--CA 1.482 1.711 0 N-CA-C 116.544 1.378 . . . . 0.0 116.544 -174.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.0 p -95.04 -48.39 5.99 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.13 0.572 . . . . 0.0 111.625 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -139.83 -179.65 6.06 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.443 0.64 . . . . 0.0 112.715 -163.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -101.78 107.83 19.16 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 164.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.6 mt -104.05 106.76 17.37 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -80.35 95.19 6.3 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.269 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 m -80.61 134.41 54.27 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.527 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 38.2 Cg_endo -63.41 159.13 41.52 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.21 1.94 . . . . 0.0 112.011 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -59.16 -34.73 72.45 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.385 0.674 . . . . 0.0 110.78 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.527 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 19.9 ptmt -68.19 -26.99 66.01 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.339 1.056 . . . . 0.0 112.191 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.7 t -59.46 -38.52 80.98 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.811 0.444 . . . . 0.0 109.87 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.99 114.01 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.459 ' HD2' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -79.97 -53.8 6.4 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.571 1.149 . . . . 0.0 110.072 177.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.4 m -144.82 141.12 28.89 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.272 -171.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.0 p -99.19 110.62 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 169.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.788 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 11.7 mm-40 -105.21 174.25 5.96 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.555 0.742 . . . . 0.0 109.821 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.47 102.0 1.06 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.195 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.52 18.17 78.3 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 115.538 -0.755 . . . . 0.0 113.467 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.788 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 17.6 mtp180 -136.64 140.18 42.58 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.209 0.604 . . . . 0.0 110.359 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.1 mm -116.57 101.89 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 168.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.1 t -79.4 118.93 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.3 pt -112.13 146.38 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.716 0.806 . . . . 0.0 109.264 172.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.459 ' HA3' ' HD2' ' A' ' 46' ' ' LYS . . . -105.49 -56.33 0.69 Allowed Glycine 0 C--N 1.339 0.743 0 CA-C-N 116.362 -0.381 . . . . 0.0 112.418 -170.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.21 141.44 23.17 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.582 0.753 . . . . 0.0 110.627 -171.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -169.4 146.54 3.47 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 124.618 1.167 . . . . 0.0 108.011 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.66 106.79 7.4 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -64.15 -29.34 70.47 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.043 0.937 . . . . 0.0 111.706 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.437 ' HG2' ' NH1' ' A' ' 64' ' ' ARG . 38.8 mt-10 -67.08 -40.41 87.01 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.579 0.549 . . . . 0.0 110.584 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -68.73 -45.51 71.3 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.314 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.24 74.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.898 0.879 . . . . 0.0 111.865 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.437 ' NH1' ' HG2' ' A' ' 61' ' ' GLU . 6.2 ptp180 -75.69 -41.81 52.7 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.769 0.428 . . . . 0.0 111.765 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.44 -39.48 64.95 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 118.075 0.398 . . . . 0.0 111.902 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.55 -16.61 44.78 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.766 0.426 . . . . 0.0 110.466 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.81 -39.0 34.97 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.595 0.559 . . . . 0.0 112.487 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.406 ' HA ' HD12 ' A' ' 71' ' ' LEU . 54.3 ptt85 -77.06 -24.95 51.92 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.843 0.457 . . . . 0.0 109.981 173.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -65.63 -38.14 88.58 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.6 t90 -60.74 -49.39 77.68 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 123.513 0.508 . . . . 0.0 109.883 171.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 68' ' ' ARG . 75.4 mt -50.92 -34.68 29.58 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.954 0.902 . . . . 0.0 112.072 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 . . . . . 0 CA--C 1.553 1.094 0 C-N-CA 123.623 0.769 . . . . 0.0 111.074 175.504 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 53.0 mtt . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 120.899 0.38 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -101.75 130.08 48.08 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.418 HG22 ' HB ' ' A' ' 53' ' ' ILE . 85.4 t -91.54 126.27 44.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.346 0.659 . . . . 0.0 109.762 -177.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -115.46 118.52 33.43 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.782 1.233 . . . . 0.0 109.102 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 65.5 tttm -78.68 90.23 4.59 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.1 -95.56 0.66 Allowed Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -175.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -121.48 4.22 10.18 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.802 0.841 . . . . 0.0 112.406 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 11.5 pt-20 -111.84 147.41 35.81 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.997 0.519 . . . . 0.0 109.704 176.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.3 t -72.62 108.79 5.84 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -78.45 -49.34 13.64 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.358 0.663 . . . . 0.0 110.231 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.0 -136.54 3.33 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.521 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -142.33 136.93 30.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.138 0.975 . . . . 0.0 109.483 -178.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.41 ' HB2' HD11 ' A' ' 29' ' ' LEU . 62.2 p -71.58 106.96 4.22 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 175.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.424 HG21 ' HD2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -92.59 -40.31 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.083 0.553 . . . . 0.0 109.67 -176.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -160.35 168.91 24.23 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.438 0.295 . . . . 0.0 110.919 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.15 141.22 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.011 0.924 . . . . 0.0 109.102 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -138.91 97.41 3.31 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.457 1.103 . . . . 0.0 108.389 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.1 -109.01 2.3 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.771 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -107.17 16.85 23.65 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.104 0.962 . . . . 0.0 110.36 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.456 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 93.8 m-85 -127.81 117.86 22.64 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.447 0.699 . . . . 0.0 109.895 -174.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.41 HD11 ' HB2' ' A' ' 21' ' ' SER . 64.5 tp -76.62 111.0 11.66 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 172.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mm -71.02 112.88 6.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -107.26 120.02 57.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.355 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -74.84 109.18 8.09 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.05 89.56 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.577 1.151 . . . . 0.0 110.659 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.12 -76.02 1.68 Allowed Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.237 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.5 m -125.07 -29.47 3.32 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.141 0.977 . . . . 0.0 110.856 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -110.45 168.89 9.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 122.155 -0.341 . . . . 0.0 110.551 -172.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.424 ' HD2' HG21 ' A' ' 22' ' ' ILE . 64.5 m-85 -113.22 110.37 20.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.133 0.973 . . . . 0.0 109.466 177.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.0 mt -107.39 124.74 50.28 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.124 0.57 . . . . 0.0 109.63 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -89.62 99.49 12.48 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.016 -174.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.1 m -86.46 129.13 54.37 Favored Pre-proline 0 CA--C 1.552 1.056 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.13 158.42 54.65 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.363 2.042 . . . . 0.0 111.871 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.578 ' HA ' HD13 ' A' ' 45' ' ' ILE . 13.9 mmmm -64.6 -29.54 70.55 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.256 0.622 . . . . 0.0 112.166 -177.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.495 ' H ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -72.84 -17.79 61.51 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.142 0.177 . . . . 0.0 111.219 174.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.5 t -73.13 -34.9 66.38 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 171.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.9 mp -61.18 115.38 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.173 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 mmpm? -82.28 -61.28 1.94 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.212 1.005 . . . . 0.0 109.414 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.0 m -138.69 126.6 22.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.149 -172.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 p -92.53 109.37 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 171.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.653 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 22.0 mm-40 -98.63 177.01 5.44 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 124.546 1.138 . . . . 0.0 110.225 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -68.11 91.15 0.35 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.185 0.594 . . . . 0.0 110.452 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.36 17.81 77.23 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.303 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.653 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 49.7 mtt180 -137.33 129.55 29.43 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.54 0.736 . . . . 0.0 109.382 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.418 ' HB ' HG22 ' A' ' 11' ' ' VAL . 38.4 mm -105.03 103.37 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.76 115.93 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.8 pt -108.57 175.15 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.377 0.671 . . . . 0.0 109.457 173.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.43 -117.75 3.01 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -118.71 160.29 22.11 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.267 0.627 . . . . 0.0 110.602 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -159.8 179.21 9.02 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.156 1.382 . . . . 0.0 108.477 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.28 114.44 26.52 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -63.86 -36.2 83.13 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.844 0.858 . . . . 0.0 112.52 -175.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -69.21 -40.85 77.74 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.981 0.512 . . . . 0.0 110.185 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.42 -44.98 73.84 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 123.415 0.447 . . . . 0.0 110.33 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.04 -25.52 68.42 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.376 0.67 . . . . 0.0 111.292 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -73.89 -51.48 16.07 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.893 0.877 . . . . 0.0 110.971 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.11 -40.81 59.62 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.993 0.517 . . . . 0.0 111.799 -171.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 69' ' ' LYS . 2.4 pp -84.1 -20.77 31.99 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.06 -44.83 87.02 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 169.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.503 ' HA ' HD23 ' A' ' 71' ' ' LEU . 35.2 ptt180 -75.45 -14.2 60.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.508 0.723 . . . . 0.0 110.406 175.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 6.3 tppt? -67.74 -31.85 72.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.982 0.513 . . . . 0.0 109.831 167.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.422 ' HE3' HD22 ' A' ' 71' ' ' LEU . 81.8 t90 -71.37 -38.6 71.53 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.805 0.442 . . . . 0.0 110.795 170.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.503 HD23 ' HA ' ' A' ' 68' ' ' ARG . 3.8 mm? -65.55 -29.66 70.31 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 120.807 0.337 . . . . 0.0 110.163 171.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 . . . . . 0 N--CA 1.471 0.623 0 C-N-CA 123.78 0.832 . . . . 0.0 109.479 172.757 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 41.4 mtt . . . . . 0 N--CA 1.472 0.665 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -71.31 106.93 4.04 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.491 HG22 ' HB ' ' A' ' 53' ' ' ILE . 57.8 t -78.93 110.04 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.879 -177.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 54.5 m-85 -97.23 120.9 38.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.128 0.971 . . . . 0.0 109.163 174.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -78.21 87.71 4.29 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.02 -95.51 0.74 Allowed Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -107.63 -29.66 9.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.792 0.837 . . . . 0.0 111.11 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.65 146.54 28.2 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.57 0.348 . . . . 0.0 110.449 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.0 t -77.15 105.63 8.36 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -79.89 -55.71 4.78 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.527 0.731 . . . . 0.0 111.158 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.532 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . -179.03 -147.87 7.39 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.261 0.351 . . . . 0.0 112.456 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -137.49 135.36 36.73 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.843 0.857 . . . . 0.0 109.779 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.5 p -76.66 108.27 9.55 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.21 -37.73 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.349 0.659 . . . . 0.0 109.556 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -160.73 177.92 9.98 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -173.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.483 ' HB ' HD12 ' A' ' 29' ' ' LEU . 5.5 p -155.58 135.14 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 123.962 0.905 . . . . 0.0 109.056 173.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.444 ' CD2' HD11 ' A' ' 30' ' ' ILE . 34.3 p90 -132.13 131.81 42.65 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 171.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.19 -107.06 1.18 Allowed Glycine 0 C--N 1.343 0.958 0 O-C-N 123.764 0.665 . . . . 0.0 113.293 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -119.65 27.94 8.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.977 0.911 . . . . 0.0 111.261 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -133.29 108.97 9.07 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.063 0.545 . . . . 0.0 110.227 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.483 HD12 ' HB ' ' A' ' 24' ' ' VAL . 51.0 tp -81.37 113.47 19.49 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.356 0.662 . . . . 0.0 109.404 175.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.444 HD11 ' CD2' ' A' ' 25' ' ' TYR . 8.0 mm -80.1 104.79 8.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 C-N-CA 123.172 0.589 . . . . 0.0 109.685 -176.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.2 t -105.95 113.58 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.756 0.822 . . . . 0.0 109.834 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -75.86 117.0 17.13 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.387 0.675 . . . . 0.0 109.638 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.532 HG12 ' HA3' ' A' ' 19' ' ' GLY . 11.1 m -133.18 148.78 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.95 0.9 . . . . 0.0 109.409 176.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.23 -106.04 0.43 Allowed Glycine 0 CA--C 1.531 1.09 0 O-C-N 123.426 0.454 . . . . 0.0 113.04 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.8 m -109.53 -29.91 8.18 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.648 0.779 . . . . 0.0 110.888 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -116.44 176.5 5.08 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.623 0.725 . . . . 0.0 112.158 -169.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -104.28 109.92 21.94 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.653 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.12 102.97 15.51 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.208 1.003 . . . . 0.0 108.577 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB3' HD12 ' A' ' 66' ' ' LEU . . . -84.83 94.66 8.78 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.673 0.789 . . . . 0.0 109.526 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.1 m -75.35 128.66 83.96 Favored Pre-proline 0 CA--C 1.558 1.255 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.699 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -60.81 161.26 22.19 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.017 2.478 . . . . 0.0 112.192 174.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.504 ' HA ' HG12 ' A' ' 45' ' ' ILE . 14.6 mmmm -68.42 -21.27 64.68 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.69 -17.39 62.84 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.711 0.404 . . . . 0.0 111.014 174.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.8 t -80.5 -29.47 37.31 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.102 0.561 . . . . 0.0 110.353 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.513 HD13 HG22 ' A' ' 55' ' ' ILE . 25.5 mm -68.23 115.18 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 122.837 0.455 . . . . 0.0 110.406 -175.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -84.01 -66.69 0.86 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.596 0.758 . . . . 0.0 110.448 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.0 m -143.71 126.79 16.46 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.626 0.371 . . . . 0.0 110.654 -171.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -82.82 111.63 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.783 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 11.1 mm-40 -99.41 175.96 5.68 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.78 0.832 . . . . 0.0 109.986 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -70.31 97.55 1.26 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.12 0.568 . . . . 0.0 110.05 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.81 21.94 77.78 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.841 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.783 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 79.6 mtt180 -142.62 151.24 41.27 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.931 0.892 . . . . 0.0 110.031 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.491 ' HB ' HG22 ' A' ' 11' ' ' VAL . 43.5 mm -124.4 107.11 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 170.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 57.4 t -78.46 117.76 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.513 HG22 HD13 ' A' ' 45' ' ' ILE . 47.4 pt -108.81 171.4 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.698 0.799 . . . . 0.0 109.54 171.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.66 -81.08 0.68 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -139.75 146.11 39.12 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-O 121.846 0.831 . . . . 0.0 110.711 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -160.66 165.48 30.51 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.471 1.508 . . . . 0.0 107.589 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -94.1 108.6 20.43 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.63 -39.11 92.77 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.889 0.876 . . . . 0.0 112.952 -170.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.55 -33.09 75.11 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.3 0.64 . . . . 0.0 110.712 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -76.73 -45.9 27.47 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.435 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.91 -26.78 68.46 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.674 0.79 . . . . 0.0 110.671 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -74.7 -44.4 50.29 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.589 0.756 . . . . 0.0 110.609 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.86 -39.33 64.05 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 39' ' ' ALA . 4.3 pp -82.41 -13.67 56.44 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 121.702 0.763 . . . . 0.0 110.037 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.18 -43.08 96.0 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 161.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -70.07 -16.69 63.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.92 0.888 . . . . 0.0 111.582 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.512 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 4.0 tppp? -67.28 -38.78 85.62 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.692 0.797 . . . . 0.0 109.559 170.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.41 ' HE3' HD22 ' A' ' 71' ' ' LEU . 68.7 t90 -62.19 -45.29 94.05 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.344 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.41 HD22 ' HE3' ' A' ' 70' ' ' TRP . 3.7 mm? -63.22 -25.38 68.3 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.564 0.345 . . . . 0.0 111.209 174.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 N--CA 1.476 0.833 0 C-N-CA 123.867 0.867 . . . . 0.0 111.311 -179.328 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.4 ' HG2' ' HA2' ' A' ' 51' ' ' GLY . 58.2 mtt . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 120.342 0.115 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -66.43 113.81 4.96 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.513 0.725 . . . . 0.0 110.568 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.1 t -83.1 123.73 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.505 0.722 . . . . 0.0 110.386 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -108.55 120.73 43.3 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.161 0.984 . . . . 0.0 109.418 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 49.7 tttm -77.24 85.43 3.69 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.59 -94.18 0.84 Allowed Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -110.81 -23.58 10.93 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.313 1.045 . . . . 0.0 111.229 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 11.3 pt-20 -91.18 144.41 25.65 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.065 0.546 . . . . 0.0 110.451 -173.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.6 t -71.4 111.4 6.69 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.406 0.682 . . . . 0.0 109.507 176.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -91.35 -56.55 3.1 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.801 0.44 . . . . 0.0 111.166 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.434 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . -179.35 -140.35 4.03 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.57 -174.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.26 139.25 35.5 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.601 0.76 . . . . 0.0 110.619 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.0 t -79.16 108.87 12.97 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.664 0.785 . . . . 0.0 109.241 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.42 HD13 ' HB2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -92.18 -39.13 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.156 0.582 . . . . 0.0 109.599 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.42 ' HB2' HD13 ' A' ' 22' ' ' ILE . 19.0 t70 -154.26 169.11 24.43 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.743 0.306 . . . . 0.0 111.082 -174.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.407 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.7 p -151.17 137.9 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.352 1.061 . . . . 0.0 108.46 172.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.417 ' CE1' HD11 ' A' ' 30' ' ' ILE . 2.4 p90 -146.54 135.38 22.34 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.96 -106.8 1.08 Allowed Glycine 0 C--N 1.34 0.799 0 O-C-N 123.29 0.369 . . . . 0.0 113.955 174.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -119.51 13.07 12.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.099 0.959 . . . . 0.0 110.915 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.479 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 83.8 m-85 -130.74 150.14 52.06 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.509 0.723 . . . . 0.0 111.049 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.407 HD12 ' HB ' ' A' ' 24' ' ' VAL . 45.3 tp -117.25 112.46 20.81 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.592 1.557 . . . . 0.0 107.725 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.417 HD11 ' CE1' ' A' ' 25' ' ' TYR . 39.0 mm -76.52 109.15 10.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.816 0 C-N-CA 123.128 0.571 . . . . 0.0 109.757 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.5 t -110.13 117.94 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.053 0.941 . . . . 0.0 108.648 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.78 118.68 28.64 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.566 HG22 HD23 ' A' ' 38' ' ' LEU . 19.7 m -123.07 128.49 75.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 171.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.99 -99.71 0.21 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 116.604 -0.271 . . . . 0.0 113.305 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.0 m -125.05 -5.11 7.39 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.856 0.862 . . . . 0.0 111.081 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -116.83 154.2 31.15 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.246 0.618 . . . . 0.0 111.236 -173.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -112.01 109.66 19.54 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.31 1.044 . . . . 0.0 109.154 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.566 HD23 HG22 ' A' ' 33' ' ' VAL . 3.6 mm? -95.55 106.75 18.86 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.39 1.076 . . . . 0.0 109.131 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -79.84 95.29 6.0 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.086 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.4 m -87.06 126.42 62.99 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.497 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 38.2 Cg_endo -62.13 152.03 78.33 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.503 2.135 . . . . 0.0 112.492 -176.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.598 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.7 mmmm -64.94 -23.04 67.1 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.583 0.753 . . . . 0.0 111.808 -175.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.497 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 21.6 ptmt -70.88 -25.58 62.86 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.461 0.705 . . . . 0.0 111.307 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.9 t -72.22 -31.43 65.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.888 0.475 . . . . 0.0 110.094 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.598 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.6 mp -62.0 114.68 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.099 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -90.62 -55.6 3.51 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.824 1.25 . . . . 0.0 110.818 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.5 m -134.37 126.87 30.5 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.349 0.66 . . . . 0.0 110.108 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 p -96.04 109.88 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 172.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 47.4 mm-40 -111.39 168.47 9.51 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 124.224 1.01 . . . . 0.0 109.918 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -65.34 98.53 0.34 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.811 0.844 . . . . 0.0 110.803 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' A' ' 9' ' ' MET . . . 77.29 11.96 85.03 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 116.333 -0.394 . . . . 0.0 113.963 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.483 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 97.4 mtt180 -137.6 127.3 25.33 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.957 0.903 . . . . 0.0 109.48 178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.9 mm -110.37 102.99 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.9 t -80.71 113.48 20.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 33.3 pt -106.63 178.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.102 0.961 . . . . 0.0 108.466 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.43 -119.71 4.54 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -131.63 166.54 21.22 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.732 0.813 . . . . 0.0 109.165 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -163.53 168.5 20.03 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.115 0.966 . . . . 0.0 109.297 -168.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -81.75 99.57 9.03 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -62.95 -30.55 71.66 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.006 0.922 . . . . 0.0 111.883 -175.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -62.83 -51.84 65.46 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.688 0.756 . . . . 0.0 109.747 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.07 -35.17 76.23 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.972 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.3 -34.77 73.14 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.029 0.532 . . . . 0.0 111.867 -175.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -77.13 -34.27 56.65 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 177.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.97 -37.99 54.1 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 117.725 0.238 . . . . 0.0 111.048 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 pp -82.98 -15.53 50.85 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.06 -42.71 35.82 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.053 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.572 ' HA ' HD23 ' A' ' 71' ' ' LEU . 4.9 ptp180 -70.97 -27.06 63.45 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -63.56 -33.55 75.84 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 170.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -64.52 -37.1 86.36 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.696 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.572 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.0 mm? -61.52 -29.4 69.97 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 118.139 0.427 . . . . 0.0 110.717 173.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 . . . . . 0 CA--C 1.552 1.034 0 C-N-CA 123.314 0.645 . . . . 0.0 110.685 172.276 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 85.2 mtp . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 120.482 0.182 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -72.33 107.69 5.06 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.69 0.796 . . . . 0.0 109.929 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.59 116.23 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 122.92 0.488 . . . . 0.0 109.929 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -111.13 129.56 55.9 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.243 1.017 . . . . 0.0 109.262 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -85.19 92.25 8.35 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.55 -95.81 0.4 Allowed Glycine 0 C--N 1.351 1.4 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.014 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -104.51 -31.83 9.27 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.609 0.764 . . . . 0.0 111.479 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -83.4 144.2 29.78 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 120.659 0.266 . . . . 0.0 110.911 -172.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.5 t -72.41 111.09 7.29 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.561 0.745 . . . . 0.0 109.359 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -84.85 -57.04 3.27 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.56 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 178.15 -136.18 2.91 Favored Glycine 0 C--N 1.347 1.143 0 O-C-N 123.149 0.28 . . . . 0.0 112.465 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.79 139.13 24.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.238 1.015 . . . . 0.0 109.687 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.3 t -68.23 138.5 55.62 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.06 -38.11 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -156.14 164.55 38.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.732 0.413 . . . . 0.0 110.039 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.0 p -121.16 136.45 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.474 ' OH ' ' HD2' ' A' ' 69' ' ' LYS . 4.6 t80 -136.95 101.25 4.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.982 0.913 . . . . 0.0 109.602 -173.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.0 -113.04 5.37 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.423 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -98.57 21.53 11.12 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.027 0.931 . . . . 0.0 110.873 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -135.58 162.24 33.25 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.047 0.939 . . . . 0.0 109.792 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 59.0 tp -123.66 113.07 18.15 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' ' 39' ' ' ALA . 23.7 mm -70.43 106.88 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.0 t -108.32 117.71 54.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -76.22 115.85 16.35 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.638 HG22 HD23 ' A' ' 38' ' ' LEU . 4.0 m -123.38 121.19 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.86 -86.97 0.06 OUTLIER Glycine 0 CA--C 1.532 1.115 0 CA-C-N 116.326 -0.397 . . . . 0.0 113.487 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 m -124.56 -25.84 3.96 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.683 1.193 . . . . 0.0 110.663 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -106.88 163.78 12.67 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.579 0.752 . . . . 0.0 111.24 -167.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -111.0 109.07 19.02 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.156 0.982 . . . . 0.0 108.772 177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.638 HD23 HG22 ' A' ' 33' ' ' VAL . 4.3 mm? -105.73 111.95 24.82 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.572 1.149 . . . . 0.0 108.836 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.447 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -82.93 94.81 7.8 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.212 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.48 131.28 58.79 Favored Pre-proline 0 N--CA 1.473 0.723 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.574 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 35.8 Cg_endo -60.67 153.41 62.15 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.275 1.983 . . . . 0.0 111.703 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.543 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.4 mmmm -63.27 -27.13 69.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.603 0.761 . . . . 0.0 111.416 -178.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.574 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 20.9 ptmt -67.74 -21.7 65.27 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.676 0.79 . . . . 0.0 111.793 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.5 t -70.18 -43.15 71.38 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.543 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.3 mp -60.98 113.77 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.209 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.547 ' HE3' ' HA3' ' A' ' 56' ' ' GLY . 33.9 mmtp -79.17 -58.65 3.12 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.857 0.863 . . . . 0.0 109.421 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.8 m -154.45 156.72 37.27 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.378 0.671 . . . . 0.0 110.613 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.4 t -93.37 111.76 25.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.822 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 7.3 mm-40 -86.62 167.21 14.74 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.348 0.659 . . . . 0.0 109.363 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -69.13 93.85 0.63 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.57 -6.76 65.43 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.852 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.63 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 49.9 mtm180 -129.01 158.99 37.34 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.009 0.523 . . . . 0.0 110.952 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 mm -124.17 104.44 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.2 t -79.98 118.75 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.2 pt -108.81 174.08 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 123.893 0.877 . . . . 0.0 109.336 172.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.547 ' HA3' ' HE3' ' A' ' 46' ' ' LYS . . . -135.38 -90.04 0.31 Allowed Glycine 0 C--N 1.34 0.757 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.065 -173.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -107.73 130.45 54.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.09 0.472 . . . . 0.0 111.882 -168.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -164.12 -176.4 4.47 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.278 1.031 . . . . 0.0 108.768 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -128.79 122.72 31.14 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.98 -32.66 69.57 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.753 0.421 . . . . 0.0 112.114 -173.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.88 -34.62 69.33 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.43 -38.69 68.26 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.379 172.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.434 ' HB3' HD12 ' A' ' 38' ' ' LEU . . . -70.06 -28.47 65.47 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.926 0.49 . . . . 0.0 111.629 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -78.63 -36.25 44.33 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.037 0.535 . . . . 0.0 112.027 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.61 -41.96 59.49 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 120.838 0.352 . . . . 0.0 110.859 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 pp -81.46 -21.27 38.88 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.21 -41.38 86.49 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.959 170.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.523 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -73.59 -21.0 60.46 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 117.346 0.573 . . . . 0.0 111.032 177.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.474 ' HD2' ' OH ' ' A' ' 25' ' ' TYR . 2.6 ttmp? -57.98 -46.85 84.51 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 166.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.492 ' HE3' HD12 ' A' ' 71' ' ' LEU . 89.3 t90 -62.34 -42.64 99.55 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.117 174.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . 9.8 mp -54.55 -31.7 57.02 Favored 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 123.54 0.736 . . . . 0.0 111.879 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 . . . . . 0 CA--C 1.551 0.983 0 C-N-CA 122.924 0.49 . . . . 0.0 109.908 179.359 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.471 0.605 0 CA-C-O 120.878 0.371 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -74.13 108.41 6.91 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.34 1.056 . . . . 0.0 109.883 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.461 HG22 ' HB ' ' A' ' 53' ' ' ILE . 61.5 t -80.01 123.7 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.927 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -106.09 122.58 46.46 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.135 0.974 . . . . 0.0 109.836 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -78.82 80.76 5.15 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.57 -95.61 0.39 Allowed Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.786 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -104.3 0.38 29.17 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.844 0.858 . . . . 0.0 112.124 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -131.42 149.6 52.47 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.134 0.574 . . . . 0.0 110.422 -175.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.6 t -71.94 111.62 7.35 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.419 0.688 . . . . 0.0 109.762 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -77.37 -55.92 4.99 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.32 0.648 . . . . 0.0 109.327 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.88 -142.99 6.09 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.36 151.71 35.79 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.445 0.698 . . . . 0.0 109.748 172.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.2 t -71.62 146.9 48.04 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.955 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.42 -37.73 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.081 0.952 . . . . 0.0 109.405 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.73 173.24 14.42 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -173.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.418 ' HB ' HD12 ' A' ' 29' ' ' LEU . 8.9 p -155.96 134.1 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.565 0.746 . . . . 0.0 109.516 171.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.438 ' CE1' HD11 ' A' ' 30' ' ' ILE . 8.8 p90 -133.77 125.24 28.1 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.17 -107.07 1.18 Allowed Glycine 0 CA--C 1.531 1.072 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.398 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -102.93 -9.4 19.89 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.004 0.921 . . . . 0.0 111.603 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.599 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 86.6 m-85 -108.7 108.48 19.34 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.815 -0.553 . . . . 0.0 111.979 -169.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.418 HD12 ' HB ' ' A' ' 24' ' ' VAL . 26.8 tp -77.65 109.35 11.55 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.37 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.438 HD11 ' CE1' ' A' ' 25' ' ' TYR . 24.3 mm -72.03 99.73 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.2 t -96.1 112.71 28.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -85.89 113.91 22.39 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.95 86.86 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 CA-C-O 122.164 0.983 . . . . 0.0 110.532 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.53 -89.26 0.36 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.392 177.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.561 HG23 ' HG2' ' A' ' 36' ' ' GLU . 10.5 t -101.5 -16.71 16.72 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.39 0.676 . . . . 0.0 110.93 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.561 ' HG2' HG23 ' A' ' 35' ' ' THR . 6.3 mm-40 -109.6 162.73 14.13 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.443 0.697 . . . . 0.0 111.156 -167.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -121.39 108.48 13.73 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 170.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.85 106.68 17.29 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.501 1.121 . . . . 0.0 108.755 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.599 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -87.24 94.74 9.75 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.559 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.6 m -78.98 140.04 57.57 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.531 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.36 155.05 72.06 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.554 2.169 . . . . 0.0 110.767 172.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.419 ' HA ' HD13 ' A' ' 45' ' ' ILE . 31.8 mmmt -64.71 -22.94 67.1 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -76.57 -17.21 59.34 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.267 0.627 . . . . 0.0 111.921 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.1 t -66.66 -30.59 70.89 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.272 0.629 . . . . 0.0 110.727 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.6 mp -72.49 115.48 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.729 0.812 . . . . 0.0 109.733 -177.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -85.85 -44.35 12.52 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.765 0.826 . . . . 0.0 110.184 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.3 m -139.46 133.5 31.02 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.545 0.738 . . . . 0.0 111.436 -172.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.1 t -105.08 110.75 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 170.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 40.0 mm-40 -111.37 175.5 5.4 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.973 0.909 . . . . 0.0 110.488 -177.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -40.47 -56.6 2.01 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 125.648 1.579 . . . . 0.0 113.013 -171.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.541 ' H ' ' HD2' ' A' ' 52' ' ' ARG . . . -140.3 35.73 1.86 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HD2' ' H ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -137.86 151.56 48.19 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.524 0.73 . . . . 0.0 109.564 -176.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.461 ' HB ' HG22 ' A' ' 11' ' ' VAL . 31.1 mm -132.11 104.06 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 124.556 1.142 . . . . 0.0 108.432 172.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.8 t -84.48 115.88 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.1 pt -107.3 141.33 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.68 0.792 . . . . 0.0 109.518 173.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.82 -61.45 1.77 Allowed Glycine 0 C--N 1.345 1.047 0 N-CA-C 112.231 -0.348 . . . . 0.0 112.231 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -156.48 162.65 39.96 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.834 0.853 . . . . 0.0 109.451 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -171.01 162.72 7.28 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.76 0.824 . . . . 0.0 109.947 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.03 86.7 1.03 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.52 -36.55 71.08 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.98 0.912 . . . . 0.0 113.241 -171.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -68.05 -38.22 82.2 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 41.4 mt-10 -74.14 -34.66 63.93 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.842 176.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.21 -24.54 63.13 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.836 0.455 . . . . 0.0 110.959 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -74.2 -44.59 52.65 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.104 0.962 . . . . 0.0 110.161 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.7 pt-20 -70.11 -38.47 75.63 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 39' ' ' ALA . 4.5 pp -82.97 -13.41 56.04 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 120.983 0.42 . . . . 0.0 110.651 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.69 -43.77 50.63 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.133 169.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.518 ' HA ' HD23 ' A' ' 71' ' ' LEU . 25.7 ptt85 -73.83 -22.5 59.76 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 116.766 0.283 . . . . 0.0 110.542 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 72' ' ' GLU . 24.8 ttpp -64.82 -33.9 77.08 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 169.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -66.45 -35.6 80.7 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 119.638 -0.22 . . . . 0.0 110.832 170.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.4 mm? -61.43 -23.0 65.53 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.29 0.496 . . . . 0.0 111.407 173.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 69' ' ' LYS . 13.3 tp10 . . . . . 0 CA--C 1.56 1.345 0 C-N-CA 123.305 0.642 . . . . 0.0 110.47 169.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.403 ' HB2' HG12 ' A' ' 53' ' ' ILE . 59.0 mtt . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -79.13 111.22 15.13 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.443 HG22 ' HB ' ' A' ' 53' ' ' ILE . 61.6 t -86.78 127.93 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.702 0.801 . . . . 0.0 110.781 -175.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -108.82 123.02 48.39 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.323 1.449 . . . . 0.0 109.167 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 87.1 tttt -80.94 90.13 5.92 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.2 -95.58 0.59 Allowed Glycine 0 C--N 1.342 0.914 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.329 -173.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -117.65 -10.52 10.55 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.918 0.887 . . . . 0.0 111.887 -176.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 11.3 pt-20 -90.87 146.61 23.78 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.4 t -81.67 102.28 10.6 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -76.32 -55.64 5.37 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.443 0.697 . . . . 0.0 111.14 -172.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.589 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 178.75 -137.26 3.16 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-O 120.066 -0.297 . . . . 0.0 112.513 -177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -145.2 136.53 25.07 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.062 0.945 . . . . 0.0 109.68 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 31.6 p -76.85 118.25 19.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.729 0.812 . . . . 0.0 110.161 175.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.04 -35.05 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.965 0.906 . . . . 0.0 109.82 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -150.09 175.34 11.82 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.963 0.505 . . . . 0.0 110.455 -173.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.438 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.1 p -152.8 139.34 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.503 1.121 . . . . 0.0 108.773 171.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -141.46 127.12 19.04 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.99 -106.37 0.98 Allowed Glycine 0 CA--C 1.531 1.068 0 O-C-N 123.514 0.509 . . . . 0.0 113.733 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -109.81 15.12 22.92 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.154 0.982 . . . . 0.0 111.709 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.61 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 96.9 m-85 -135.16 113.82 11.74 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 118.302 0.501 . . . . 0.0 111.888 -172.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.438 HD12 ' HB ' ' A' ' 24' ' ' VAL . 42.8 tp -80.29 111.81 17.03 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.909 1.283 . . . . 0.0 109.367 172.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.6 mm -71.77 99.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.343 0.657 . . . . 0.0 109.72 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 47.6 t -100.34 112.42 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.762 0.825 . . . . 0.0 109.046 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -89.3 123.05 33.14 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.589 HG12 ' HA3' ' A' ' 19' ' ' GLY . 1.3 m -128.08 133.33 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 173.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.81 -91.64 0.05 OUTLIER Glycine 0 N--CA 1.474 1.171 0 C-N-CA 123.287 0.47 . . . . 0.0 113.82 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 t -125.03 -13.26 6.86 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.308 1.043 . . . . 0.0 112.039 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -111.25 156.13 21.94 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -170.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -104.39 108.77 20.35 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 172.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.23 104.53 14.67 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.61 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -83.55 93.99 7.96 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.442 HG12 ' CE2' ' A' ' 58' ' ' PHE . 3.9 m -78.04 137.34 61.34 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 44' ' ' SER . 31.1 Cg_endo -62.37 138.43 71.19 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.241 1.961 . . . . 0.0 111.287 175.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.514 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.5 mmmm -62.75 -29.94 71.06 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.653 0.781 . . . . 0.0 111.528 -177.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -70.82 -18.24 62.73 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.028 0.931 . . . . 0.0 112.244 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.516 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 26.0 t -72.55 -27.12 62.03 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.918 0.487 . . . . 0.0 111.186 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.6 mp -61.98 115.5 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.811 0.444 . . . . 0.0 110.25 -176.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -76.41 -47.69 22.34 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.326 1.05 . . . . 0.0 110.599 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.9 m -143.45 124.69 14.58 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.136 0.574 . . . . 0.0 110.676 -173.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.0 t -93.21 109.24 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 166.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.675 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 16.3 mm-40 -108.53 165.71 11.32 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.125 1.37 . . . . 0.0 108.607 174.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.08 99.48 1.11 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.829 0.452 . . . . 0.0 110.453 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.7 14.12 73.85 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.201 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.675 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 28.3 mtm180 -142.83 125.51 15.92 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.172 0.989 . . . . 0.0 108.761 -175.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.443 ' HB ' HG22 ' A' ' 11' ' ' VAL . 34.8 mm -118.86 101.2 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 63.8 t -84.26 117.57 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 12.9 pt -109.74 164.56 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.876 0.871 . . . . 0.0 109.648 176.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.59 -87.65 1.36 Allowed Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 -173.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -142.95 144.42 32.36 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.113 0.965 . . . . 0.0 108.95 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.442 ' CE2' HG12 ' A' ' 40' ' ' VAL . 6.1 p90 -167.19 150.97 6.6 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -87.14 99.7 12.12 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.66 -29.54 69.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.186 0.994 . . . . 0.0 112.707 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.83 -42.72 85.34 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.971 0.415 . . . . 0.0 110.188 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.72 -37.5 82.32 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.26 -24.6 65.81 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.042 0.937 . . . . 0.0 111.379 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.63 -46.36 38.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.47 1.108 . . . . 0.0 110.216 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.36 -37.95 74.7 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 123.237 0.335 . . . . 0.0 111.259 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 39' ' ' ALA . 4.3 pp -82.26 -16.28 50.05 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-O 120.647 0.26 . . . . 0.0 110.441 175.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -76.55 -35.95 39.77 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.653 173.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -77.89 -21.96 50.47 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 172.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -65.0 -35.62 81.79 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 169.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.416 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 59.9 t90 -59.89 -51.49 69.49 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 123.395 0.434 . . . . 0.0 109.87 170.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.4 mt -49.49 -38.63 30.87 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 123.616 0.766 . . . . 0.0 111.504 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 . . . . . 0 CA--C 1.55 0.948 0 C-N-CA 124.55 1.14 . . . . 0.0 111.593 179.869 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.407 ' SD ' ' HA2' ' A' ' 51' ' ' GLY . 42.1 tpp . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -69.9 128.96 38.2 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.0 t -100.21 139.06 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.228 0.611 . . . . 0.0 110.31 -177.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -130.1 127.54 40.05 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.205 1.402 . . . . 0.0 108.89 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -76.96 96.27 4.33 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.07 -95.25 0.34 Allowed Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -168.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -117.58 -23.45 7.66 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.746 0.818 . . . . 0.0 111.783 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -79.99 145.2 32.67 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.7 t -71.52 111.12 6.56 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.843 0.354 . . . . 0.0 110.586 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -83.91 -55.66 4.11 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.334 0.654 . . . . 0.0 109.729 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.28 -131.41 1.43 Allowed Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.827 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -148.82 137.12 21.03 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.202 1.401 . . . . 0.0 108.022 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.3 t -74.11 135.25 42.91 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 174.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.79 -35.42 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.761 0.824 . . . . 0.0 109.541 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -151.4 165.8 33.0 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.267 0.627 . . . . 0.0 110.205 -173.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.414 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.1 p -147.91 132.47 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.115 0.966 . . . . 0.0 108.461 169.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.422 ' CE1' HD11 ' A' ' 30' ' ' ILE . 1.4 p90 -141.1 138.98 33.91 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.55 -105.37 0.97 Allowed Glycine 0 CA--C 1.528 0.865 0 O-C-N 123.226 0.329 . . . . 0.0 112.527 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -120.07 5.25 10.84 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.71 0.804 . . . . 0.0 111.644 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -115.66 119.22 35.39 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.174 0.59 . . . . 0.0 111.53 -169.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.414 HD12 ' HB ' ' A' ' 24' ' ' VAL . 30.1 tp -79.52 109.14 13.62 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.871 0.868 . . . . 0.0 108.921 171.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.422 HD11 ' CE1' ' A' ' 25' ' ' TYR . 43.1 mm -73.53 104.39 2.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.3 t -99.52 112.56 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.952 0.901 . . . . 0.0 109.74 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -75.92 107.29 8.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.676 0.791 . . . . 0.0 109.2 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -91.8 155.92 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 167.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -44.98 -28.35 1.76 Allowed Glycine 0 CA--C 1.541 1.688 0 N-CA-C 116.258 1.263 . . . . 0.0 116.258 -172.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.9 p -96.16 -47.52 6.02 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.649 0.779 . . . . 0.0 112.339 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -143.1 -175.07 4.38 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.285 0.634 . . . . 0.0 111.714 -164.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.42 ' HB2' HD21 ' A' ' 71' ' ' LEU . 38.1 m-85 -115.43 109.84 18.44 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.097 0.959 . . . . 0.0 108.792 175.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.62 115.07 27.18 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.268 1.027 . . . . 0.0 108.467 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.503 ' HB3' HD12 ' A' ' 66' ' ' LEU . . . -82.2 92.96 6.98 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.409 0.623 . . . . 0.0 109.77 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.7 t -85.84 118.43 70.54 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.322 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.508 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 43.2 Cg_endo -62.07 148.66 92.75 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.215 1.943 . . . . 0.0 111.594 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.57 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.4 mmmm -66.1 -25.12 66.86 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.567 0.747 . . . . 0.0 112.04 -174.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.508 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 15.1 ptmm? -66.75 -23.38 66.08 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.894 0.878 . . . . 0.0 111.452 174.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.8 t -82.85 -30.11 28.9 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 123.034 0.534 . . . . 0.0 110.317 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.57 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.7 mp -62.77 114.05 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.264 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 174.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -85.68 -52.16 5.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.385 1.074 . . . . 0.0 110.161 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.0 m -144.22 154.24 42.91 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.059 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.19 109.37 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.429 1.092 . . . . 0.0 108.887 174.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.715 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 13.0 mm-40 -102.72 169.73 8.44 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.14 0.976 . . . . 0.0 109.644 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.87 93.63 1.35 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.952 0.501 . . . . 0.0 109.885 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.407 ' HA2' ' SD ' ' A' ' 9' ' ' MET . . . 93.32 2.77 65.59 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.261 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.715 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 92.7 mtt180 -133.6 141.19 47.55 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.355 0.662 . . . . 0.0 110.166 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.2 mm -118.16 103.72 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 168.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.7 t -76.7 113.78 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.428 HG22 HG13 ' A' ' 45' ' ' ILE . 31.4 pt -109.2 156.95 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.299 0.64 . . . . 0.0 109.492 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.67 -140.22 6.72 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.382 -168.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -78.49 123.03 26.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.389 0.676 . . . . 0.0 111.183 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -158.84 148.63 19.24 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 125.111 1.365 . . . . 0.0 108.035 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -72.19 101.75 2.89 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.18 -28.99 64.63 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.894 0.878 . . . . 0.0 112.154 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -72.21 -39.45 68.54 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.728 0.775 . . . . 0.0 110.094 176.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.19 -30.89 62.44 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.02 175.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.21 -25.02 64.11 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.271 0.629 . . . . 0.0 110.226 172.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -74.19 -41.12 61.94 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.486 0.714 . . . . 0.0 110.018 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.22 -42.22 69.19 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 118.128 0.422 . . . . 0.0 111.478 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 39' ' ' ALA . 4.5 pp -81.84 -14.54 56.14 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 120.839 0.352 . . . . 0.0 110.293 176.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -75.15 -44.4 23.22 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.469 171.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -28.57 63.17 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.318 0.559 . . . . 0.0 109.703 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -60.72 -39.66 89.42 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.619 170.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.483 ' HE3' HD22 ' A' ' 71' ' ' LEU . 86.1 t90 -59.46 -44.68 92.95 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.561 175.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.483 HD22 ' HE3' ' A' ' 70' ' ' TRP . 3.9 mm? -59.13 -32.15 69.6 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 176.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 CA--C 1.546 0.789 0 C-N-CA 122.826 0.45 . . . . 0.0 110.391 178.221 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.8 ttm . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -82.95 156.03 23.7 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.164 0.585 . . . . 0.0 109.737 170.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.465 HG22 ' HB ' ' A' ' 53' ' ' ILE . 81.3 t -121.7 129.72 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.986 0.915 . . . . 0.0 109.968 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -119.8 121.28 38.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.787 1.235 . . . . 0.0 108.726 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -78.86 86.48 4.77 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.38 -96.57 0.64 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.879 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -105.82 -18.74 13.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.635 0.774 . . . . 0.0 111.579 -176.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -98.25 156.45 16.7 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.832 0.453 . . . . 0.0 110.332 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 t -81.69 119.67 24.14 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -93.69 -55.75 3.15 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.263 0.625 . . . . 0.0 110.78 -173.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.05 -151.63 7.95 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.201 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -135.1 123.22 22.85 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.425 0.69 . . . . 0.0 109.431 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.514 ' HB2' HD11 ' A' ' 29' ' ' LEU . 12.9 p -71.14 108.43 4.66 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -39.15 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 123.507 0.723 . . . . 0.0 109.707 -177.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -142.97 166.22 25.22 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.468 0.707 . . . . 0.0 109.59 -175.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -152.27 130.27 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.792 0.837 . . . . 0.0 108.819 173.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.411 ' HE1' HD11 ' A' ' 30' ' ' ILE . 3.4 p90 -142.22 134.3 27.45 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.05 -106.71 1.18 Allowed Glycine 0 CA--C 1.531 1.073 0 O-C-N 123.441 0.463 . . . . 0.0 113.277 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -119.63 18.14 12.74 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.778 0.831 . . . . 0.0 111.234 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.595 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 55.4 m-85 -126.08 113.17 16.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.927 0.491 . . . . 0.0 111.21 -175.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 21' ' ' SER . 62.6 tp -82.61 108.08 15.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.0 0.92 . . . . 0.0 109.219 171.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.411 HD11 ' HE1' ' A' ' 25' ' ' TYR . 39.2 mm -71.54 106.08 2.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.19 119.72 59.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.574 0.75 . . . . 0.0 109.861 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -74.31 109.18 7.59 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.285 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.6 m -116.15 103.19 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.521 1.128 . . . . 0.0 110.62 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.46 -89.03 0.05 OUTLIER Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.179 -0.919 . . . . 0.0 113.911 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.2 p -85.76 -41.19 15.3 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.222 1.009 . . . . 0.0 111.909 -174.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -150.03 -175.45 5.06 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -165.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -104.17 111.61 24.28 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.457 1.103 . . . . 0.0 110.686 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.1 mp -104.38 127.43 52.04 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -86.32 93.63 9.14 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.001 -175.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -72.14 115.54 39.66 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.586 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.5 149.97 89.14 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.735 2.29 . . . . 0.0 112.09 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.5 mmmm -67.26 -16.87 64.53 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -65.5 -30.9 71.72 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.085 0.554 . . . . 0.0 110.816 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' A' ' 58' ' ' PHE . 37.3 t -76.68 -32.62 58.03 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.649 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.58 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.8 mp -63.75 114.62 2.06 Favored 'Isoleucine or valine' 0 C--N 1.359 0.98 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -95.57 -53.55 3.69 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.36 1.064 . . . . 0.0 110.771 -172.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.0 t -150.09 134.26 17.13 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 122.998 0.519 . . . . 0.0 110.003 -173.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 p -98.66 111.75 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.466 0.65 . . . . 0.0 110.178 177.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 30.6 mm-40 -103.81 173.11 6.44 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.159 0.984 . . . . 0.0 111.07 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.31 101.06 1.43 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.153 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.76 12.5 83.49 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.446 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.655 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 61.5 mtp180 -141.42 135.7 30.63 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.645 0.778 . . . . 0.0 110.044 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.465 ' HB ' HG22 ' A' ' 11' ' ' VAL . 30.8 mm -109.11 103.04 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 167.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.8 t -78.36 112.06 15.92 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.6 pt -112.01 177.7 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.648 0.779 . . . . 0.0 109.826 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.05 -146.18 7.43 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 172.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.25 165.91 21.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.063 0.545 . . . . 0.0 110.072 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.51 ' HB3' ' HB2' ' A' ' 44' ' ' SER . 29.1 p90 -167.0 174.04 8.75 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.867 0.867 . . . . 0.0 109.209 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.14 86.28 1.38 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -70.86 -36.51 72.85 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.612 1.165 . . . . 0.0 112.417 -171.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -71.08 -33.83 70.58 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.045 0.538 . . . . 0.0 110.154 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -71.38 -40.56 70.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.093 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.98 -28.05 69.55 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.834 0.854 . . . . 0.0 111.303 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.36 -48.96 20.61 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.253 1.021 . . . . 0.0 110.414 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.09 -40.32 78.48 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.633 0.373 . . . . 0.0 111.561 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 pp -82.61 -17.18 45.68 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 122.185 -0.322 . . . . 0.0 110.441 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.05 -44.07 46.55 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.346 0.404 . . . . 0.0 112.362 174.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -71.02 -30.72 67.0 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -62.2 -42.33 99.19 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 53.2 t90 -58.23 -44.97 88.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.889 0.743 . . . . 0.0 110.672 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.8 mt -57.54 -28.58 63.64 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.298 0.639 . . . . 0.0 111.686 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 . . . . . 0 CA--C 1.557 1.241 0 C-N-CA 123.086 0.554 . . . . 0.0 111.242 172.877 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 71.1 mtm . . . . . 0 N--CA 1.478 0.947 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -90.59 135.98 33.35 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.006 0.432 . . . . 0.0 111.165 -173.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.426 HG21 HG22 ' A' ' 31' ' ' VAL . 99.9 t -91.78 130.38 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.72 0.808 . . . . 0.0 109.719 -177.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -118.27 127.37 53.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.664 1.186 . . . . 0.0 109.576 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 28.5 tptp -78.26 91.16 4.37 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 172.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.97 -95.67 0.65 Allowed Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 -171.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.71 -21.48 7.85 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.421 0.689 . . . . 0.0 110.74 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 14.8 pt-20 -79.43 144.23 34.28 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.5 t -70.28 111.18 5.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.794 0.438 . . . . 0.0 110.345 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -82.32 -51.18 8.14 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.096 0.558 . . . . 0.0 110.531 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.462 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . -179.55 -143.2 5.35 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.885 -177.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -136.96 133.52 35.71 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.72 0.808 . . . . 0.0 109.956 -177.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.413 ' OG ' HD11 ' A' ' 29' ' ' LEU . 30.2 t -75.02 106.5 6.55 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 172.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.27 -40.82 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.294 0.638 . . . . 0.0 109.313 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.446 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 22.8 t70 -149.14 172.22 15.16 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.372 0.669 . . . . 0.0 109.815 -171.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.404 ' HB ' HD12 ' A' ' 29' ' ' LEU . 9.9 p -152.1 145.17 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 124.334 1.054 . . . . 0.0 108.538 172.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -143.12 127.22 17.46 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 171.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.2 -106.86 1.12 Allowed Glycine 0 C--N 1.343 0.938 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.728 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 28.7 t70 -107.05 -15.18 14.75 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.071 0.948 . . . . 0.0 111.114 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.493 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 95.3 m-85 -97.34 107.56 20.1 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.558 0.695 . . . . 0.0 111.186 -171.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.413 HD11 ' OG ' ' A' ' 21' ' ' SER . 41.7 tp -76.31 113.29 13.72 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.956 174.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 49.7 mm -75.44 107.77 6.6 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.015 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.426 HG22 HG21 ' A' ' 11' ' ' VAL . 43.0 t -103.76 113.63 41.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 123.992 0.917 . . . . 0.0 109.314 178.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -75.94 114.99 15.19 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.462 HG12 ' HA3' ' A' ' 19' ' ' GLY . 34.1 m -127.45 129.84 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.959 0.904 . . . . 0.0 109.36 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.9 -100.11 0.27 Allowed Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.848 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.6 p -126.1 5.15 7.16 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.214 1.005 . . . . 0.0 112.008 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -134.21 169.65 16.87 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.154 0.582 . . . . 0.0 112.164 -173.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -112.9 123.87 51.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.364 1.065 . . . . 0.0 109.457 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.8 mp -107.22 115.61 30.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.964 0.906 . . . . 0.0 109.008 175.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.493 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -78.97 93.63 5.11 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.786 0.835 . . . . 0.0 109.724 177.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.484 HG12 ' CE2' ' A' ' 58' ' ' PHE . 4.0 m -89.04 134.5 33.21 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -176.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 97.9 Cg_endo -73.45 153.05 49.84 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.254 1.969 . . . . 0.0 111.242 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.584 ' HA ' HD13 ' A' ' 45' ' ' ILE . 13.8 mmmm -65.77 -24.28 66.91 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.487 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 7.8 ptpp? -66.38 -25.83 66.97 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.713 0.405 . . . . 0.0 111.361 173.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.3 t -69.1 -41.22 77.75 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.584 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.7 mp -66.71 114.49 3.69 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -78.71 -48.79 14.25 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.474 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.2 t -158.46 139.53 13.11 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.301 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 p -77.89 133.18 31.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 168.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.803 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 17.8 mm-40 -116.23 177.58 4.64 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.187 0.995 . . . . 0.0 110.04 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -64.02 93.14 0.08 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.858 0.863 . . . . 0.0 110.463 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.86 5.72 88.66 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 114.906 -1.043 . . . . 0.0 114.213 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.803 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 69.9 mtt85 -127.71 162.21 27.1 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.079 0.552 . . . . 0.0 110.728 -174.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.0 mm -133.27 103.34 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 174.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.5 t -83.45 120.64 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.0 pt -109.06 145.21 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 123.943 0.897 . . . . 0.0 109.174 170.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.26 -55.03 1.88 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 112.135 -0.386 . . . . 0.0 112.135 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 9.9 pt-20 -174.03 159.27 3.26 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.949 0.9 . . . . 0.0 110.552 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.484 ' CE2' HG12 ' A' ' 40' ' ' VAL . 8.1 p90 -171.11 174.18 4.75 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.463 0.705 . . . . 0.0 110.779 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -74.44 86.51 2.03 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.495 0.718 . . . . 0.0 109.483 172.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.15 -38.73 72.22 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.285 0.634 . . . . 0.0 112.669 -174.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.487 ' HG3' ' HG3' ' A' ' 62' ' ' GLU . 7.4 pt-20 -65.4 -38.24 89.37 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.491 0.717 . . . . 0.0 110.817 177.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.523 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 44.6 mt-10 -80.88 -32.79 34.74 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.809 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.75 -26.31 66.92 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.276 0.631 . . . . 0.0 110.611 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -72.69 -51.87 17.54 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.243 1.017 . . . . 0.0 111.179 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.523 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.7 pt-20 -69.84 -35.74 74.99 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.311 0.577 . . . . 0.0 110.809 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.22 -13.79 54.64 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.66 -27.53 69.09 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 165.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -69.96 -37.44 75.81 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.83 0.852 . . . . 0.0 108.854 167.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -59.59 -36.52 76.42 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 122.912 0.485 . . . . 0.0 110.875 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 59.7 t90 -60.95 -54.21 47.79 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 173.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.7 mt -54.92 -35.11 63.81 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.48 0.712 . . . . 0.0 111.447 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 . . . . . 0 CA--C 1.546 0.816 0 C-N-CA 124.224 1.01 . . . . 0.0 110.452 -176.773 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.453 ' SD ' HD11 ' A' ' 53' ' ' ILE . 61.0 mtt . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -84.28 130.33 34.82 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.403 0.681 . . . . 0.0 109.475 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.0 t -86.62 115.24 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.076 0.55 . . . . 0.0 109.937 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.64 117.58 35.19 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.116 0.967 . . . . 0.0 109.692 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 85.3 tttt -77.94 94.41 4.58 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.12 -94.85 0.47 Allowed Glycine 0 C--N 1.344 1.002 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -102.5 -42.91 5.8 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.735 0.814 . . . . 0.0 110.824 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.35 145.42 37.33 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.959 0.504 . . . . 0.0 110.935 -168.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.7 t -69.8 104.87 2.58 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 13' ' ' LYS . 46.9 t80 -74.95 -50.05 18.02 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.713 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.73 -141.4 3.94 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.82 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -140.18 130.73 25.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.371 0.668 . . . . 0.0 110.221 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.418 ' OG ' HD11 ' A' ' 29' ' ' LEU . 25.9 t -68.07 109.96 3.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.155 0.982 . . . . 0.0 109.542 174.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.05 -43.71 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.028 0.531 . . . . 0.0 109.851 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.428 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 22.6 t70 -143.35 167.61 21.75 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.74 0.416 . . . . 0.0 110.466 -171.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.2 t -139.71 140.97 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 124.421 1.089 . . . . 0.0 108.133 174.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -141.39 129.91 22.61 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 169.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.36 -107.4 1.35 Allowed Glycine 0 C--N 1.35 1.326 0 O-C-N 123.304 0.378 . . . . 0.0 113.268 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -119.21 24.53 10.7 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.55 0.74 . . . . 0.0 110.918 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.53 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 96.0 m-85 -133.39 124.85 27.9 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.247 0.619 . . . . 0.0 111.375 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.418 HD11 ' OG ' ' A' ' 21' ' ' SER . 55.8 tp -80.55 113.99 19.13 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.406 1.083 . . . . 0.0 109.562 170.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 42.8 mm -72.74 106.07 2.69 Favored 'Isoleucine or valine' 0 C--O 1.249 1.063 0 C-N-CA 123.234 0.614 . . . . 0.0 109.51 175.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.0 t -103.28 118.42 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.151 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -74.97 116.87 16.18 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 m -126.05 99.2 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.953 0.901 . . . . 0.0 110.614 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.29 -89.53 0.1 Allowed Glycine 0 CA--C 1.531 1.073 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.873 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 72.5 p -114.91 -21.99 9.83 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.121 0.968 . . . . 0.0 111.272 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -109.07 174.44 5.87 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.647 0.737 . . . . 0.0 111.363 -172.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -120.96 108.6 14.07 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.238 173.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -96.66 106.07 18.28 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -82.83 93.33 7.44 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.297 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.6 m -77.67 136.7 63.2 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.554 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 35.8 Cg_endo -62.4 149.37 91.06 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 121.905 1.737 . . . . 0.0 111.289 176.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.566 ' HA ' HD13 ' A' ' 45' ' ' ILE . 32.0 mmmt -63.59 -26.21 68.58 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.013 0.525 . . . . 0.0 111.8 -178.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.554 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 0.4 OUTLIER -67.71 -23.43 65.28 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.677 0.791 . . . . 0.0 111.449 175.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -72.3 -27.36 62.41 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.784 0.434 . . . . 0.0 110.616 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.566 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.1 mp -67.91 115.65 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -92.03 -48.54 6.69 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.254 1.022 . . . . 0.0 110.974 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.1 t -138.49 147.63 43.4 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.402 -175.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.5 p -122.0 126.05 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.357 1.063 . . . . 0.0 109.099 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 40.5 mt-10 -138.11 168.54 19.52 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.286 1.035 . . . . 0.0 109.537 -175.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.72 99.87 0.25 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.124 0.57 . . . . 0.0 110.432 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.15 1.06 88.65 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 115.905 -0.589 . . . . 0.0 113.643 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 33.7 mtm180 -130.97 124.94 32.09 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.514 0.657 . . . . 0.0 110.284 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.453 HD11 ' SD ' ' A' ' 9' ' ' MET . 50.8 mm -115.06 102.14 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 170.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.9 t -86.11 115.23 27.02 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.7 pt -107.04 175.14 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 123.569 0.747 . . . . 0.0 109.357 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.04 -142.88 8.21 Favored Glycine 0 C--O 1.24 0.507 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -81.56 157.12 24.89 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 174.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -167.37 170.66 11.27 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.892 0.877 . . . . 0.0 109.201 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -81.16 93.52 6.47 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -71.23 -39.94 71.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.074 0.95 . . . . 0.0 112.74 -171.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -65.34 -37.88 88.41 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.009 0.433 . . . . 0.0 110.491 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -71.9 -37.64 70.09 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.568 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.12 -34.32 77.35 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.508 0.723 . . . . 0.0 111.333 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 6.7 ptp85 -74.39 -44.72 50.87 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 119.112 -0.47 . . . . 0.0 111.157 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.98 -37.57 86.32 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 118.275 0.489 . . . . 0.0 111.602 -175.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -81.63 -21.15 38.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 122.478 0.311 . . . . 0.0 110.399 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.43 -33.78 68.15 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.039 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.465 ' HA ' HD12 ' A' ' 71' ' ' LEU . 59.0 mtp180 -77.41 -30.55 53.55 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.359 1.064 . . . . 0.0 109.853 175.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -63.28 -39.51 94.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.141 0.576 . . . . 0.0 109.715 170.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -60.24 -45.36 93.52 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.985 0.514 . . . . 0.0 109.917 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 68' ' ' ARG . 50.4 mt -58.53 -23.41 58.18 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.797 0.839 . . . . 0.0 112.517 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 CA--C 1.554 1.115 0 C-N-CA 122.706 0.402 . . . . 0.0 110.728 174.719 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.406 ' SD ' HD11 ' A' ' 53' ' ' ILE . 18.5 ttt . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.875 -0.416 . . . . 0.0 109.875 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -72.82 141.27 48.02 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.6 t -119.49 127.75 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.578 0.751 . . . . 0.0 110.02 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -109.35 132.91 53.68 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.228 1.011 . . . . 0.0 109.044 171.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -83.98 82.39 8.37 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.83 -100.58 0.85 Allowed Glycine 0 C--N 1.344 0.986 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.239 -177.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -97.16 -28.07 14.27 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.851 0.86 . . . . 0.0 110.879 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -92.15 152.31 19.96 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.811 0.444 . . . . 0.0 110.119 -176.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.1 t -74.16 125.14 27.71 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.305 0.642 . . . . 0.0 109.349 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -98.46 -58.59 1.93 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 121.957 0.103 . . . . 0.0 110.848 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.53 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 172.66 -141.43 6.22 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.413 0.446 . . . . 0.0 112.196 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -144.86 137.98 26.68 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.826 0.85 . . . . 0.0 110.13 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.7 p -73.61 118.2 16.28 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 175.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.21 -37.82 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.589 0.756 . . . . 0.0 109.042 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -156.27 176.83 12.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.977 0.511 . . . . 0.0 110.822 -175.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.4 p -150.17 138.28 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.46 1.104 . . . . 0.0 108.868 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -136.21 133.69 37.36 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.67 -106.62 1.22 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 123.463 0.477 . . . . 0.0 113.793 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -117.14 11.63 14.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.903 0.881 . . . . 0.0 111.026 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.577 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 81.8 m-85 -125.15 111.56 15.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.039 0.535 . . . . 0.0 111.549 -173.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 57.7 tp -77.82 110.35 12.62 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.507 1.123 . . . . 0.0 109.485 173.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.0 mm -71.94 100.11 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.26 0.624 . . . . 0.0 109.606 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.06 113.22 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.428 0.691 . . . . 0.0 109.787 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -76.24 120.05 20.98 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.669 0.787 . . . . 0.0 109.882 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.53 HG12 ' HA3' ' A' ' 19' ' ' GLY . 1.3 m -132.45 142.04 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.7 -96.21 0.03 OUTLIER Glycine 0 CA--C 1.537 1.456 0 O-C-N 123.274 0.359 . . . . 0.0 113.966 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.3 m -124.49 -16.39 6.34 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.509 1.124 . . . . 0.0 111.023 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -114.72 166.88 11.27 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.934 0.893 . . . . 0.0 112.149 -170.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -113.65 112.25 23.18 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.211 1.004 . . . . 0.0 109.751 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.424 HD23 HG22 ' A' ' 33' ' ' VAL . 3.5 mm? -94.55 105.95 17.92 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.932 0.893 . . . . 0.0 109.175 176.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.577 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -77.82 92.37 4.22 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 172.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.9 m -86.22 136.63 35.54 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.65 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.542 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 37.7 Cg_endo -63.33 151.28 85.68 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.221 1.947 . . . . 0.0 111.36 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.565 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.4 mmmm -67.3 -23.26 65.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.953 0.501 . . . . 0.0 111.457 -176.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.542 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 22.4 ptmt -69.61 -26.55 64.5 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.686 0.794 . . . . 0.0 111.457 174.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.3 t -65.35 -31.29 72.33 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.269 0.628 . . . . 0.0 110.604 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.565 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.0 mp -64.95 116.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -92.28 -52.1 4.84 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.153 0.981 . . . . 0.0 110.936 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 t -148.83 139.87 23.02 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.566 -171.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.2 t -102.92 110.75 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 173.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.09 130.89 22.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 63.28 33.88 13.73 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.415 1.086 . . . . 0.0 112.944 166.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.92 15.98 80.71 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 121.316 0.398 . . . . 0.0 112.326 -177.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -125.15 158.21 34.48 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.68 1.192 . . . . 0.0 109.063 -175.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.406 HD11 ' SD ' ' A' ' 9' ' ' MET . 28.6 mm -120.47 104.91 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.634 0.774 . . . . 0.0 109.55 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.9 t -80.0 113.01 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' A' ' 45' ' ' ILE . 37.4 pt -109.49 142.75 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.79 -74.48 1.2 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -152.73 164.19 38.24 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.63 0.772 . . . . 0.0 109.685 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -170.51 163.89 8.43 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 124.377 1.071 . . . . 0.0 108.298 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -77.77 97.09 5.09 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.05 -35.99 82.92 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.589 0.756 . . . . 0.0 112.007 -174.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -62.6 -45.54 92.42 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.682 0.614 . . . . 0.0 110.484 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.412 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 35.1 mt-10 -70.29 -38.7 75.08 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.887 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.17 -38.55 91.46 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.569 0.748 . . . . 0.0 111.363 -176.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -74.41 -38.4 63.08 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.326 0.25 . . . . 0.0 111.582 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.412 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.8 pt-20 -76.75 -40.86 47.01 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -176.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 pp -82.47 -12.99 57.46 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.0 0.429 . . . . 0.0 109.996 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.99 -48.45 75.72 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 162.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.0 mtt-85 -63.48 -31.94 73.25 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.901 0.881 . . . . 0.0 111.511 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -55.9 -48.78 75.01 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.115 0.566 . . . . 0.0 109.514 172.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.577 ' HE3' HD12 ' A' ' 71' ' ' LEU . 79.9 t90 -60.25 -42.56 95.57 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 123.309 0.38 . . . . 0.0 110.663 174.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.577 HD12 ' HE3' ' A' ' 70' ' ' TRP . 10.6 mp -57.0 -28.95 62.89 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 122.666 0.387 . . . . 0.0 112.027 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 122.958 0.503 . . . . 0.0 110.285 176.444 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.2 mtt . . . . . 0 N--CA 1.479 1.015 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -71.65 110.88 6.5 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.304 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.4 HG22 ' HB ' ' A' ' 53' ' ' ILE . 58.5 t -79.27 124.7 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.813 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -113.61 121.89 45.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.032 0.933 . . . . 0.0 109.035 175.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 52.6 tttm -84.1 79.3 9.56 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.65 0.738 . . . . 0.0 109.624 175.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.61 -94.26 0.41 Allowed Glycine 0 C--N 1.342 0.9 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.831 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -96.9 -13.26 22.57 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.71 0.804 . . . . 0.0 111.591 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 10.0 pt-20 -116.09 153.6 31.45 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.533 0.733 . . . . 0.0 109.609 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.3 t -85.02 112.73 20.88 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -80.34 -56.8 3.94 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.531 0.333 . . . . 0.0 110.535 -172.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 178.18 -135.43 2.67 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.124 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -148.91 142.79 25.72 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.986 0.914 . . . . 0.0 109.985 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.1 p -74.52 108.3 7.19 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.497 0.719 . . . . 0.0 110.69 -178.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.87 -38.72 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.193 0.597 . . . . 0.0 110.117 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -153.66 172.4 17.31 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.39 0.676 . . . . 0.0 109.888 -172.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 p -155.66 132.68 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.888 0.875 . . . . 0.0 109.069 173.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.457 ' CE1' HD11 ' A' ' 30' ' ' ILE . 3.9 p90 -135.66 133.63 38.35 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.64 -105.43 1.23 Allowed Glycine 0 C--N 1.346 1.116 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -117.57 -0.85 11.78 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.841 0.856 . . . . 0.0 110.083 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.562 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 30.5 m-85 -104.1 106.21 16.64 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.706 -166.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 50.1 tp -75.84 105.65 6.99 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.457 HD11 ' CE1' ' A' ' 25' ' ' TYR . 38.0 mm -68.51 106.69 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.895 176.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.2 t -99.66 116.24 42.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -72.7 107.65 5.28 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 174.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.43 HG23 ' HB2' ' A' ' 36' ' ' GLU . 19.1 m -113.63 83.6 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.434 1.094 . . . . 0.0 110.579 -173.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.61 -82.06 0.5 Allowed Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.066 -0.97 . . . . 0.0 113.612 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 t -122.48 -11.08 8.35 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.853 0.861 . . . . 0.0 110.847 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.43 ' HB2' HG23 ' A' ' 33' ' ' VAL . 65.0 mm-40 -111.62 177.91 4.5 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.605 0.762 . . . . 0.0 110.55 -178.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.568 ' HB2' HD11 ' A' ' 71' ' ' LEU . 42.7 m-85 -134.29 110.93 9.82 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 169.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -105.54 126.82 52.56 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.562 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -95.37 100.74 12.47 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.971 0.908 . . . . 0.0 110.472 -173.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.1 m -85.32 137.47 36.9 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 122.95 0.5 . . . . 0.0 109.896 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.16 160.47 41.82 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.392 2.061 . . . . 0.0 111.565 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -67.07 -23.69 65.89 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.504 0.322 . . . . 0.0 111.671 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -70.81 -22.78 62.3 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.262 0.625 . . . . 0.0 111.933 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.2 t -64.1 -32.44 74.0 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.079 0.552 . . . . 0.0 110.932 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mp -68.32 114.0 4.71 Favored 'Isoleucine or valine' 0 C--N 1.356 0.856 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -87.11 -41.26 13.94 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.596 1.158 . . . . 0.0 111.268 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.9 m -149.68 147.89 28.62 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.517 0.727 . . . . 0.0 110.594 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 p -110.48 117.09 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.624 0.77 . . . . 0.0 109.516 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 9.7 mm-40 -98.91 166.82 11.11 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.91 -26.98 39.55 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.198 0.999 . . . . 0.0 113.413 -174.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.49 22.27 1.2 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 112.148 -0.381 . . . . 0.0 112.148 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.64 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 95.4 mtt180 -136.53 159.08 42.87 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.444 0.698 . . . . 0.0 109.78 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.4 ' HB ' HG22 ' A' ' 11' ' ' VAL . 48.0 mm -126.58 103.22 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 172.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.1 t -82.03 113.17 20.93 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.425 HG13 ' HA ' ' A' ' 13' ' ' LYS . 37.4 pt -106.51 162.25 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 168.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -123.33 -65.17 0.21 Allowed Glycine 0 CA--C 1.503 -0.706 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -177.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -128.4 143.21 50.97 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.379 0.672 . . . . 0.0 110.16 -170.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -173.85 150.92 1.72 Allowed 'General case' 0 C--O 1.246 0.92 0 C-N-CA 125.578 1.551 . . . . 0.0 107.192 173.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -71.5 106.12 3.85 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -70.07 -35.53 74.29 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.096 0.958 . . . . 0.0 112.429 -169.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -69.18 -36.0 76.86 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.962 0.505 . . . . 0.0 110.735 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -67.69 -43.01 81.14 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.306 175.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.83 -25.67 66.55 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.68 0.792 . . . . 0.0 111.145 175.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -49.03 25.37 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.642 0.777 . . . . 0.0 109.33 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.61 -41.04 66.01 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.759 0.424 . . . . 0.0 111.738 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 69' ' ' LYS . 2.6 pp -82.46 -15.86 50.98 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 120.889 0.376 . . . . 0.0 110.25 176.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.5 -54.25 13.66 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.863 170.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.415 ' HA ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -68.27 -23.08 64.73 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.461 0.704 . . . . 0.0 110.874 178.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 38.7 tttm -57.85 -48.81 78.7 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.93 0.892 . . . . 0.0 109.978 168.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -60.22 -35.71 76.06 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.225 0.61 . . . . 0.0 111.251 174.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 37' ' ' PHE . 10.7 mp -63.16 -30.32 71.49 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 122.976 0.511 . . . . 0.0 111.647 174.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 CA--C 1.549 0.928 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.642 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.552 ' HB3' HG12 ' A' ' 53' ' ' ILE . 14.7 mmt . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.34 0.114 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -85.65 121.17 27.94 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.516 0.726 . . . . 0.0 109.388 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.433 HG21 HG22 ' A' ' 31' ' ' VAL . 88.0 t -86.4 124.75 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.26 0.624 . . . . 0.0 110.67 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.02 124.01 48.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.327 1.051 . . . . 0.0 110.262 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 63.9 tttm -82.78 93.92 7.53 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.67 -100.48 1.32 Allowed Glycine 0 C--N 1.34 0.767 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -167.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.46 -1.33 9.11 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.493 0.717 . . . . 0.0 111.741 177.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 10.8 pt-20 -90.4 148.42 22.81 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 118.682 0.674 . . . . 0.0 110.995 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 t -67.42 97.79 0.6 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.844 0.857 . . . . 0.0 109.703 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -85.7 -53.29 5.24 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.637 0.375 . . . . 0.0 110.245 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.58 -152.5 10.1 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.344 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -141.96 134.07 27.59 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.778 0.831 . . . . 0.0 109.815 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.7 t -66.76 105.63 1.62 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.15 -34.28 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.592 0.757 . . . . 0.0 109.596 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -158.39 178.21 10.41 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.406 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.1 p -155.52 142.22 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.739 0.816 . . . . 0.0 109.206 173.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -139.9 128.29 22.73 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.52 -105.78 0.9 Allowed Glycine 0 CA--C 1.531 1.045 0 O-C-N 123.512 0.507 . . . . 0.0 113.786 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -116.95 11.49 14.36 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.204 1.001 . . . . 0.0 111.723 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.546 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 57.3 m-85 -125.29 115.93 21.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.727 0.411 . . . . 0.0 110.457 -176.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.406 HD12 ' HB ' ' A' ' 24' ' ' VAL . 45.0 tp -78.63 111.66 14.93 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.285 1.034 . . . . 0.0 109.255 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' A' ' 39' ' ' ALA . 39.8 mm -71.19 109.42 3.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 123.105 0.562 . . . . 0.0 109.635 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.433 HG22 HG21 ' A' ' 11' ' ' VAL . 60.8 t -107.43 114.63 46.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.306 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -74.85 109.6 8.45 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.2 m -107.1 85.41 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 124.494 1.118 . . . . 0.0 110.459 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.91 -83.09 0.31 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.207 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.4 p -110.37 -27.51 9.02 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.207 1.003 . . . . 0.0 111.889 -176.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -111.23 162.25 15.16 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.112 0.565 . . . . 0.0 111.356 -173.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -108.78 109.32 20.43 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 170.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.6 mt -105.36 118.73 37.3 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.546 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -83.47 97.36 8.95 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.608 -177.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.1 t -78.64 115.93 55.61 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.168 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.77 145.48 49.66 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.015 2.477 . . . . 0.0 112.779 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -68.92 -21.12 64.23 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.953 0.901 . . . . 0.0 112.032 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.422 ' NZ ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -74.58 -13.64 60.68 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.048 0.539 . . . . 0.0 111.635 174.498 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.8 m -94.89 3.46 54.95 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.127 0.971 . . . . 0.0 111.99 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.0 mm -82.36 122.78 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.418 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 72.8 mmtt -72.55 -51.2 20.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.61 0.764 . . . . 0.0 110.067 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.1 t -166.03 149.02 7.38 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.43 0.692 . . . . 0.0 110.38 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.3 t -97.6 111.19 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.671 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 31.8 mt-10 -91.6 179.14 5.73 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.065 0.546 . . . . 0.0 110.655 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -40.07 -53.29 2.43 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.782 1.633 . . . . 0.0 113.429 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -140.5 33.24 2.08 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.671 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 68.9 mtt180 -135.26 147.55 49.3 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.449 0.699 . . . . 0.0 110.138 -175.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.552 HG12 ' HB3' ' A' ' 9' ' ' MET . 35.9 mm -116.71 101.63 12.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 168.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 50.8 t -80.17 115.06 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.6 pt -109.58 159.33 9.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.881 0.872 . . . . 0.0 109.207 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.418 ' HA3' ' HE2' ' A' ' 46' ' ' LYS . . . -90.45 -81.77 1.38 Allowed Glycine 0 C--O 1.242 0.629 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -159.87 176.25 12.12 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.061 0.945 . . . . 0.0 109.309 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -164.44 165.35 21.53 Favored 'General case' 0 C--O 1.25 1.127 0 C-N-CA 124.663 1.185 . . . . 0.0 108.13 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -82.1 108.45 15.59 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.61 -20.43 65.35 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.85 -173.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -69.21 -43.67 73.64 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.507 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 50.2 mt-10 -64.26 -55.97 17.78 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.857 175.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.67 -25.05 59.67 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.594 0.758 . . . . 0.0 112.532 -176.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -70.61 -52.67 19.85 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.909 0.884 . . . . 0.0 110.865 175.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -76.38 -38.19 56.11 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -171.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 62' ' ' GLU . 4.6 pp -81.83 -25.13 35.42 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 122.274 -0.266 . . . . 0.0 110.473 174.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.9 -44.67 94.27 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.547 ' HA ' HD23 ' A' ' 71' ' ' LEU . 3.5 ptm180 -74.75 -21.16 59.5 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.411 0.685 . . . . 0.0 110.605 178.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -67.57 -31.87 72.23 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.467 ' HE3' HD22 ' A' ' 71' ' ' LEU . 85.4 t90 -69.71 -36.85 76.27 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 171.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.3 mm? -59.32 -29.81 67.9 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 172.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 CA--C 1.554 1.125 0 C-N-CA 123.104 0.562 . . . . 0.0 110.712 173.81 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -83.87 123.79 30.29 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.754 0.822 . . . . 0.0 109.945 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.444 HG21 HG22 ' A' ' 31' ' ' VAL . 54.5 t -85.47 105.57 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.352 0.661 . . . . 0.0 110.533 -175.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -100.41 123.73 45.0 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.837 0.855 . . . . 0.0 109.898 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -78.44 89.45 4.42 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.3 -96.85 0.57 Allowed Glycine 0 C--N 1.346 1.086 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.807 -170.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -107.69 -32.12 7.78 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.887 0.875 . . . . 0.0 110.692 177.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -74.68 142.33 44.47 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -174.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.3 t -76.3 104.29 6.75 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -76.19 -53.49 8.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.85 -163.32 28.9 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.594 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -120.27 144.22 47.9 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -74.9 147.42 41.02 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.39 -32.21 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -164.63 168.81 17.72 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.79 0.436 . . . . 0.0 110.373 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.501 ' HB ' HD12 ' A' ' 29' ' ' LEU . 3.1 p -150.52 140.2 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.342 1.057 . . . . 0.0 108.884 172.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.646 ' HE1' HD11 ' A' ' 30' ' ' ILE . 42.3 p90 -145.87 136.37 24.09 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.767 0.827 . . . . 0.0 109.608 174.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.79 -106.96 1.1 Allowed Glycine 0 C--N 1.344 0.999 0 O-C-N 123.826 0.703 . . . . 0.0 113.942 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -115.68 19.47 15.25 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.946 0.898 . . . . 0.0 110.682 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.534 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 73.9 m-85 -138.0 118.46 13.82 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.779 0.431 . . . . 0.0 111.802 -172.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.501 HD12 ' HB ' ' A' ' 24' ' ' VAL . 44.2 tp -88.32 116.53 26.6 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.133 0.973 . . . . 0.0 109.403 172.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.646 HD11 ' HE1' ' A' ' 25' ' ' TYR . 33.5 mm -78.8 111.8 16.09 Favored 'Isoleucine or valine' 0 C--O 1.251 1.182 0 C-N-CA 123.05 0.54 . . . . 0.0 109.857 176.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.444 HG22 HG21 ' A' ' 11' ' ' VAL . 44.5 t -111.19 125.0 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.65 1.18 . . . . 0.0 109.847 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -74.49 124.9 27.45 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.352 0.661 . . . . 0.0 109.514 170.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 m -135.47 107.78 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 125.309 1.443 . . . . 0.0 108.945 176.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.29 -105.17 1.5 Allowed Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.549 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 77.8 p -110.54 -5.7 15.05 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.18 0.992 . . . . 0.0 110.823 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -109.7 165.38 11.73 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.769 0.828 . . . . 0.0 110.872 -166.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.17 110.71 15.61 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.0 mp -102.96 117.27 34.22 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.306 1.042 . . . . 0.0 109.418 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.534 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -77.81 91.41 4.12 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.438 0.695 . . . . 0.0 109.986 176.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.05 118.81 73.39 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.095 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.489 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 36.3 Cg_endo -60.71 145.05 99.54 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.488 2.125 . . . . 0.0 111.672 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.621 ' HA ' HD13 ' A' ' 45' ' ' ILE . 12.5 mmmm -61.68 -24.13 66.55 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.196 0.999 . . . . 0.0 112.205 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.489 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 14.9 ptmm? -72.96 -21.43 60.86 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.575 0.75 . . . . 0.0 111.865 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.1 t -78.24 -28.02 47.73 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.058 0.543 . . . . 0.0 110.49 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.621 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.7 mp -65.14 115.02 2.95 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.537 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 75.1 mmtt -68.76 -53.73 20.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.974 0.91 . . . . 0.0 109.784 175.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 73.6 m -159.25 143.48 15.23 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.68 0.792 . . . . 0.0 110.844 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.4 p -85.92 115.76 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 168.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.756 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 8.2 mm-40 -107.68 178.71 4.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.12 0.968 . . . . 0.0 110.67 -175.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -66.54 95.41 0.33 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.223 0.609 . . . . 0.0 110.187 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.46 13.81 81.46 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.315 -0.402 . . . . 0.0 113.354 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.756 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 25.3 mtp180 -130.01 149.61 51.66 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.526 0.73 . . . . 0.0 110.189 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.1 mm -119.62 103.95 15.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 164.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.474 HG22 HH21 ' A' ' 52' ' ' ARG . 92.5 t -84.22 113.26 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.9 pt -109.51 179.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.53 1.132 . . . . 0.0 109.434 174.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' HA3' ' HE2' ' A' ' 46' ' ' LYS . . . -144.54 -112.74 0.83 Allowed Glycine 0 C--N 1.343 0.958 0 N-CA-C 112.138 -0.385 . . . . 0.0 112.138 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -89.26 136.23 33.14 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.469 0.708 . . . . 0.0 110.634 -172.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -167.0 174.24 8.57 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.821 1.248 . . . . 0.0 108.21 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -99.64 119.46 38.13 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.22 -28.05 66.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.717 0.807 . . . . 0.0 111.821 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -74.29 -37.21 63.74 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.57 0.544 . . . . 0.0 110.652 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -58.26 -50.6 73.03 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.24 -31.49 72.71 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.581 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -75.66 -48.75 20.76 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.138 0.575 . . . . 0.0 110.237 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.48 -38.98 74.47 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.389 0.614 . . . . 0.0 111.22 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.422 ' HG ' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -84.55 -20.0 32.23 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.394 0.678 . . . . 0.0 109.95 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -74.57 -41.97 34.25 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 172.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.612 ' HA ' HD23 ' A' ' 71' ' ' LEU . 8.5 ptm180 -74.35 -17.45 60.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.993 0.517 . . . . 0.0 109.834 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -65.78 -40.04 91.56 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 123.217 0.607 . . . . 0.0 109.484 169.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.446 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 78.2 t90 -60.34 -42.95 96.75 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.94 0.896 . . . . 0.0 111.188 174.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 68' ' ' ARG . 3.2 mm? -59.99 -37.1 78.68 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.548 171.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 . . . . . 0 CA--C 1.555 1.145 0 C-N-CA 124.131 0.972 . . . . 0.0 111.371 179.144 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 47.7 mtt . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.371 0.605 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -84.86 108.79 17.69 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.985 -170.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' A' ' 53' ' ' ILE . 97.0 t -80.55 117.91 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.948 0.899 . . . . 0.0 110.994 -175.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -112.9 117.7 32.84 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.229 1.012 . . . . 0.0 109.552 175.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 51.3 tttm -77.92 91.04 4.15 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.22 -92.22 0.85 Allowed Glycine 0 C--N 1.345 1.066 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -170.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -118.95 -23.64 6.83 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.889 0.876 . . . . 0.0 111.353 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 12.6 pt-20 -78.94 142.11 36.98 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.528 0.331 . . . . 0.0 110.159 -172.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.6 t -69.11 99.11 1.07 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.538 0.735 . . . . 0.0 109.262 176.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -79.48 -57.53 3.65 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.05 -137.41 3.17 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.413 0.446 . . . . 0.0 112.639 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -148.3 136.91 21.55 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.962 0.905 . . . . 0.0 110.51 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.5 p -72.55 108.54 5.66 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.91 -32.57 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.177 0.591 . . . . 0.0 110.174 -176.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -160.35 178.49 9.54 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.704 0.402 . . . . 0.0 110.423 -174.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.8 p -154.6 139.6 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 124.299 1.04 . . . . 0.0 109.593 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -141.47 132.4 26.0 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.372 0.669 . . . . 0.0 109.203 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.36 -103.86 0.46 Allowed Glycine 0 C--N 1.349 1.288 0 O-C-N 123.548 0.53 . . . . 0.0 113.814 170.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -115.07 16.74 17.01 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.519 1.128 . . . . 0.0 111.228 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.51 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 84.1 m-85 -141.64 125.64 17.23 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.619 -0.676 . . . . 0.0 111.97 -174.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 60.6 tp -82.59 111.7 18.81 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.222 1.009 . . . . 0.0 109.11 170.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 39' ' ' ALA . 28.1 mm -70.94 112.96 6.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 122.899 0.48 . . . . 0.0 109.725 177.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 88.4 t -112.47 118.11 56.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 123.186 0.594 . . . . 0.0 109.643 176.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -77.79 126.12 30.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.444 0.698 . . . . 0.0 109.792 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 m -131.99 74.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 C-N-CA 124.612 1.165 . . . . 0.0 109.886 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.63 -81.08 0.02 OUTLIER Glycine 0 C--N 1.354 1.55 0 CA-C-N 115.148 -0.933 . . . . 0.0 114.393 173.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.4 p -70.54 -49.46 47.85 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.272 1.029 . . . . 0.0 111.577 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -138.9 176.55 8.6 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.503 0.668 . . . . 0.0 112.258 -166.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -105.87 108.67 20.3 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.955 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 mp -95.39 105.5 17.47 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -80.07 94.35 5.95 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.848 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.18 124.59 91.04 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.137 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -56.77 141.56 92.24 Favored 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 122.732 2.288 . . . . 0.0 111.411 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.534 ' HA ' HD13 ' A' ' 45' ' ' ILE . 2.2 mmmp? -60.74 -34.34 74.28 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -172.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.434 ' H ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -68.47 -21.49 64.62 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.404 0.282 . . . . 0.0 111.576 177.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.2 t -75.0 -27.75 60.26 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 122.733 0.413 . . . . 0.0 111.081 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.57 HG13 HG22 ' A' ' 55' ' ' ILE . 2.0 mp -64.66 113.45 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.187 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -79.88 -50.05 11.04 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.859 0.864 . . . . 0.0 110.177 -175.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.7 m -148.22 126.84 12.48 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.241 -175.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.96 109.75 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 166.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -110.07 172.53 6.81 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.471 1.108 . . . . 0.0 110.415 -174.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.54 97.12 0.41 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.24 0.616 . . . . 0.0 110.423 -175.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.06 4.83 84.18 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.454 -0.794 . . . . 0.0 113.994 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -131.58 132.97 44.53 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.084 0.953 . . . . 0.0 109.053 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.534 ' HB ' HG22 ' A' ' 11' ' ' VAL . 43.4 mm -109.32 103.2 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.6 t -81.95 114.04 22.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.57 HG22 HG13 ' A' ' 45' ' ' ILE . 34.0 pt -109.25 170.41 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.552 0.741 . . . . 0.0 109.012 175.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.95 -159.27 14.92 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 116.611 -0.268 . . . . 0.0 112.877 -173.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -85.71 120.15 26.83 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.655 0.74 . . . . 0.0 109.562 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -142.29 171.3 14.24 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.989 1.316 . . . . 0.0 107.478 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -86.97 111.87 21.26 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.79 -23.44 63.34 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.414 0.686 . . . . 0.0 112.05 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -69.87 -37.29 76.03 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 123.86 0.725 . . . . 0.0 109.905 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -60.71 -54.86 40.1 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 170.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.03 77.03 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.258 -173.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.03 -44.45 54.33 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.947 -176.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.19 -40.21 86.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.917 0.326 . . . . 0.0 111.264 -174.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 pp -82.38 -16.31 49.57 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.704 0.401 . . . . 0.0 110.58 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.29 -32.75 57.74 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 168.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 -76.72 -28.45 55.82 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.246 1.019 . . . . 0.0 110.174 173.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -65.18 -34.98 79.67 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 169.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 56.8 t90 -65.27 -38.19 89.52 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.312 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.24 -27.79 67.52 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.313 0.645 . . . . 0.0 111.486 173.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 . . . . . 0 CA--C 1.554 1.133 0 C-N-CA 123.724 0.81 . . . . 0.0 111.315 179.004 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.0 mtt . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -78.67 110.94 14.26 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.915 0.486 . . . . 0.0 109.878 176.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.52 130.7 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.061 0.544 . . . . 0.0 109.838 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -116.97 124.74 50.12 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.61 1.164 . . . . 0.0 110.023 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -79.73 92.61 5.44 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.87 -96.08 0.58 Allowed Glycine 0 C--N 1.342 0.914 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -173.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.03 -21.92 10.32 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.47 0.708 . . . . 0.0 111.572 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.02 155.68 19.7 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 122.861 0.464 . . . . 0.0 110.396 -176.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.7 t -71.13 112.44 7.28 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.054 0.542 . . . . 0.0 110.134 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -80.74 -52.55 7.4 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.29 -139.85 5.14 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.844 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -139.23 132.32 29.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.137 0.975 . . . . 0.0 108.869 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.408 ' HB2' HD11 ' A' ' 29' ' ' LEU . 73.4 p -69.8 124.13 23.22 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 172.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.55 -37.6 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.64 0.776 . . . . 0.0 109.195 -177.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -150.46 167.91 25.75 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.357 -171.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.3 p -127.61 138.96 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -148.67 100.29 3.09 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.144 0.978 . . . . 0.0 109.486 -169.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.86 -109.14 2.72 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.741 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 21.1 t70 -104.67 -5.5 21.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.188 0.595 . . . . 0.0 109.413 171.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.445 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 64.8 m-85 -100.04 113.67 26.43 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.306 0.642 . . . . 0.0 111.089 -171.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 21' ' ' SER . 66.0 tp -74.1 106.69 5.89 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.0 mm -68.28 106.51 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.177 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.7 t -100.33 117.68 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.83 111.09 7.65 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 173.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.463 HG21 HD23 ' A' ' 38' ' ' LEU . 18.9 m -111.18 85.55 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-O 122.04 0.924 . . . . 0.0 110.48 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.35 -91.16 0.24 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.062 -0.972 . . . . 0.0 113.3 176.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.0 p -105.43 -10.29 17.03 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.824 0.85 . . . . 0.0 111.389 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -124.51 -176.68 3.58 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.505 0.722 . . . . 0.0 111.49 -173.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -131.22 110.25 11.0 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.966 1.307 . . . . 0.0 109.308 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.463 HD23 HG21 ' A' ' 33' ' ' VAL . 2.4 mm? -102.9 109.25 20.74 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.648 1.179 . . . . 0.0 108.821 174.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -87.02 93.74 9.44 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.262 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.31 131.81 51.97 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.515 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 54.9 Cg_endo -65.3 159.83 45.37 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.359 2.04 . . . . 0.0 112.129 177.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 27' ' ' ASP . 31.0 mmmt -66.75 -22.45 66.04 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.724 0.81 . . . . 0.0 111.433 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.515 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 8.6 ptpp? -76.01 -18.99 59.04 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.99 0.916 . . . . 0.0 112.065 175.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.7 t -71.71 -29.26 64.36 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.712 0.405 . . . . 0.0 110.747 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.517 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.2 mp -70.22 118.45 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.068 0.547 . . . . 0.0 109.911 -177.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -85.67 -54.5 4.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.272 1.029 . . . . 0.0 111.046 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.2 m -134.26 146.93 50.51 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.788 -172.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.5 p -114.91 126.4 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.061 0.944 . . . . 0.0 109.297 173.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.799 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 42.3 mm-40 -121.85 173.22 7.63 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.986 0.914 . . . . 0.0 109.171 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.03 97.47 1.17 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.822 0.82 . . . . 0.0 110.271 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.56 18.12 71.63 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.272 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.799 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 54.1 mtt180 -140.63 149.76 42.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.631 0.772 . . . . 0.0 110.516 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.5 mm -134.81 104.24 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.484 1.114 . . . . 0.0 108.822 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.08 122.31 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.4 pt -112.4 153.99 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.109 0.963 . . . . 0.0 109.442 174.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -104.1 -64.36 0.68 Allowed Glycine 0 C--N 1.344 1.004 0 CA-C-O 120.158 -0.246 . . . . 0.0 112.537 -173.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -157.26 159.76 37.93 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.106 0.562 . . . . 0.0 110.034 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -166.26 173.07 10.47 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.519 1.128 . . . . 0.0 109.239 -177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.78 99.66 7.58 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -67.86 -57.51 6.13 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.263 1.025 . . . . 0.0 112.702 -167.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.89 -30.32 69.65 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.151 0.58 . . . . 0.0 110.776 -176.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 43.7 mt-10 -70.25 -39.61 74.9 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.795 173.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.12 -25.55 65.35 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.021 0.528 . . . . 0.0 110.734 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -74.53 -45.81 43.27 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.678 0.791 . . . . 0.0 109.838 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.9 pt-20 -72.72 -36.42 67.78 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.445 0.298 . . . . 0.0 111.779 -177.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 69' ' ' LYS . 4.1 pp -83.39 -13.6 54.53 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 122.157 -0.339 . . . . 0.0 110.529 174.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.04 -46.27 52.34 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.747 168.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.471 ' HA ' HD13 ' A' ' 71' ' ' LEU . 34.6 ptt180 -72.05 -23.89 61.44 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 175.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.479 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 22.4 ttmm -62.3 -39.21 92.25 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 123.087 0.555 . . . . 0.0 109.715 170.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.462 ' HE3' HD12 ' A' ' 71' ' ' LEU . 70.6 t90 -60.87 -38.29 85.1 Favored 'General case' 0 CA--C 1.553 1.088 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 172.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' A' ' 68' ' ' ARG . 11.2 mp -60.83 -39.73 90.12 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 177.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 N--CA 1.485 1.31 0 O-C-N 121.701 -0.625 . . . . 0.0 111.194 -179.799 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 79.4 mtp . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -62.42 123.07 17.32 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.162 0.585 . . . . 0.0 110.889 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.6 t -93.85 131.25 41.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 124.075 0.95 . . . . 0.0 110.076 -173.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.567 ' HE1' ' HD2' ' A' ' 52' ' ' ARG . 70.0 m-85 -118.93 127.01 53.08 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.536 1.134 . . . . 0.0 108.625 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -78.43 87.34 4.44 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.105 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.36 -94.75 0.74 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -172.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.85 -27.27 8.54 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.84 0.856 . . . . 0.0 111.785 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 12.0 pt-20 -81.42 145.82 30.59 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -174.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 t -69.78 113.75 7.32 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -93.83 -50.21 5.46 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.078 0.551 . . . . 0.0 110.524 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.18 -137.93 4.06 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.766 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.581 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 8.9 pt-20 -141.13 144.11 34.66 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.238 1.015 . . . . 0.0 109.966 -177.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.8 t -77.17 149.83 35.56 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.24 -40.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -151.52 170.01 20.68 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -176.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' A' ' 29' ' ' LEU . 2.8 p -155.8 123.07 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.067 0.947 . . . . 0.0 109.069 172.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.442 ' CE1' HD11 ' A' ' 30' ' ' ILE . 7.3 p90 -124.29 132.8 53.59 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.89 -105.87 0.95 Allowed Glycine 0 C--N 1.338 0.686 0 O-C-N 123.543 0.527 . . . . 0.0 114.044 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -118.94 17.96 13.29 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.615 0.766 . . . . 0.0 111.527 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.511 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 80.8 m-85 -133.03 112.79 12.11 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.142 0.496 . . . . 0.0 111.427 -175.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.493 HD12 ' HB ' ' A' ' 24' ' ' VAL . 44.8 tp -78.21 111.68 14.4 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.12 1.368 . . . . 0.0 109.552 173.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.442 HD11 ' CE1' ' A' ' 25' ' ' TYR . 33.2 mm -72.38 112.05 7.53 Favored 'Isoleucine or valine' 0 C--O 1.249 1.053 0 C-N-CA 123.578 0.751 . . . . 0.0 109.832 178.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.8 t -110.72 125.9 68.04 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 C-N-CA 124.369 1.068 . . . . 0.0 109.879 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.581 ' HB3' ' HG3' ' A' ' 20' ' ' GLU . 4.2 tppp? -73.96 120.02 18.96 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.92 0.888 . . . . 0.0 109.25 171.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.8 m -137.73 133.83 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.499 1.119 . . . . 0.0 109.627 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.58 -100.15 0.46 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.023 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.3 p -124.84 -11.53 7.17 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.602 1.161 . . . . 0.0 111.021 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -124.41 -171.98 2.46 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.562 0.745 . . . . 0.0 111.829 -171.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -121.11 111.37 17.35 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.144 0.977 . . . . 0.0 110.474 -174.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 mp -102.08 117.17 34.23 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 171.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.511 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -89.68 108.59 19.77 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.698 0.799 . . . . 0.0 110.954 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.469 HG21 HG21 ' A' ' 55' ' ' ILE . 16.5 m -83.52 139.28 41.2 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.405 0.682 . . . . 0.0 109.896 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.528 ' HG2' ' HB2' ' A' ' 44' ' ' SER . 56.9 Cg_endo -69.89 156.2 63.59 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 122.146 1.897 . . . . 0.0 112.624 176.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -68.24 -28.53 67.3 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.206 1.002 . . . . 0.0 111.39 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.498 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 21.5 pttp -74.9 -9.37 58.48 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.775 0.83 . . . . 0.0 111.572 176.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.528 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 28.5 t -88.43 -18.67 27.82 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.056 0.543 . . . . 0.0 111.083 175.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.531 HD13 HG22 ' A' ' 55' ' ' ILE . 29.5 mm -64.46 112.91 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 46' ' ' LYS . 11.1 mmpt? -70.5 -45.46 65.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.534 0.734 . . . . 0.0 110.194 177.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.5 t -160.0 145.88 15.57 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.64 -176.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.8 p -110.02 119.69 59.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.782 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 20.7 mm-40 -104.23 166.51 10.35 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.84 0.856 . . . . 0.0 109.423 176.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -65.04 102.8 0.66 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.312 0.577 . . . . 0.0 109.572 174.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.44 4.92 90.06 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.605 -0.725 . . . . 0.0 114.363 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.782 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 77.5 mmt-85 -131.92 147.98 52.5 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 117.57 0.685 . . . . 0.0 110.171 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.82 132.43 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.923 0.889 . . . . 0.0 108.845 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.13 123.42 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.531 HG22 HD13 ' A' ' 45' ' ' ILE . 49.4 pt -118.95 164.82 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.648 0.779 . . . . 0.0 110.641 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.93 -171.99 22.58 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.31 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.69 130.51 41.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.824 0.449 . . . . 0.0 109.946 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -135.46 166.51 23.02 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.94 1.296 . . . . 0.0 108.826 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.01 109.16 14.2 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -67.01 -28.56 68.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.724 0.81 . . . . 0.0 111.284 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -67.33 -43.3 81.91 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.475 1.11 . . . . 0.0 110.722 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -68.63 -42.35 78.16 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.675 0.274 . . . . 0.0 110.475 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.64 89.93 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.74 0.816 . . . . 0.0 112.006 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -76.19 -34.28 59.3 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.465 0.478 . . . . 0.0 112.057 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 12.9 pt-20 -77.71 -40.71 40.38 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -177.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 pp -80.7 -25.5 38.11 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -69.05 -34.62 76.67 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.815 171.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -77.05 -18.02 58.37 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 117.296 0.548 . . . . 0.0 110.205 175.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 6.3 ttpm? -68.85 -32.17 71.66 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.162 0.506 . . . . 0.0 109.787 166.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.416 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 85.5 t90 -67.09 -32.74 74.1 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 169.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.8 mp -66.92 -31.6 72.29 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.161 0.584 . . . . 0.0 112.133 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-N 118.38 0.537 . . . . 0.0 109.942 174.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.51 -153.4 16.95 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 123.481 0.488 . . . . 0.0 111.895 -175.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -144.92 176.29 9.58 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 124.068 0.947 . . . . 0.0 110.824 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.1 mmt -94.35 177.27 6.0 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.89 0.876 . . . . 0.0 110.379 174.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.416 ' HB2' ' CA ' ' A' ' 51' ' ' GLY . 7.7 m-20 55.6 47.79 20.0 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 125.092 1.357 . . . . 0.0 111.753 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt -71.49 -16.24 62.34 Favored 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.11 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.7 tp -65.51 -38.4 82.34 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.424 1.089 . . . . 0.0 111.43 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.3 p -167.1 102.13 0.53 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.81 0.844 . . . . 0.0 109.318 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.7 mtt -82.47 126.84 32.69 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.307 0.643 . . . . 0.0 109.478 175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -76.49 111.88 12.42 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.359 0.664 . . . . 0.0 110.124 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 59.3 t -80.16 111.65 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.097 0.559 . . . . 0.0 109.908 -177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -103.0 124.59 48.79 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.817 0.847 . . . . 0.0 110.135 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 51.1 tttm -77.67 85.43 3.99 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.86 -94.99 0.89 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -173.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -110.63 -30.15 7.73 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.97 0.908 . . . . 0.0 110.658 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 12.9 pt-20 -77.58 141.02 39.76 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -175.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.9 t -70.68 108.77 4.56 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -85.26 -55.55 3.97 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 122.866 0.466 . . . . 0.0 110.44 -177.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.24 -146.88 5.98 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.282 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -140.1 145.34 37.49 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.75 0.82 . . . . 0.0 110.346 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.7 p -77.0 111.89 13.05 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.805 0.442 . . . . 0.0 109.839 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.65 -40.37 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.452 0.701 . . . . 0.0 110.25 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 18.0 t70 -148.36 160.66 42.78 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.919 0.487 . . . . 0.0 109.817 -175.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.462 ' HB ' ' HA ' ' A' ' 83' ' ' LEU . 20.6 t -139.59 118.78 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -132.5 126.99 34.24 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.643 0.656 . . . . 0.0 109.503 175.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.04 -119.76 19.8 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.28 -0.418 . . . . 0.0 113.487 176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -102.24 22.81 12.67 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.592 0.757 . . . . 0.0 111.347 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.423 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 66.3 m-85 -133.29 124.86 28.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.834 0.454 . . . . 0.0 111.357 -176.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.419 HD12 HG22 ' A' ' 24' ' ' VAL . 45.2 tp -85.2 109.6 18.42 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 167.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 39' ' ' ALA . 23.5 mm -70.85 107.1 1.99 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.04 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 174.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.1 t -101.64 119.31 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.337 177.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -75.99 113.65 13.75 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.171 0.588 . . . . 0.0 109.496 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.35 126.56 70.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 124.124 0.97 . . . . 0.0 109.481 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 59.95 -91.44 0.05 OUTLIER Glycine 0 CA--C 1.535 1.316 0 CA-C-N 116.57 -0.287 . . . . 0.0 113.429 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.9 m -125.2 -23.82 4.11 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.404 1.082 . . . . 0.0 110.778 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -110.82 179.16 4.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.72 0.808 . . . . 0.0 111.319 -171.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.413 ' HB3' HG23 ' A' ' 30' ' ' ILE . 87.6 m-85 -119.23 110.35 16.92 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.515 0.726 . . . . 0.0 109.887 -175.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -91.55 105.9 18.09 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.299 1.04 . . . . 0.0 109.151 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.503 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -83.23 92.49 7.49 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.193 0.597 . . . . 0.0 109.83 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.3 m -80.18 134.66 55.38 Favored Pre-proline 0 CA--C 1.55 0.971 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.414 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 48.0 Cg_endo -65.59 154.44 73.77 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.621 2.214 . . . . 0.0 111.674 176.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.561 ' HA ' HD13 ' A' ' 45' ' ' ILE . 13.7 mmmm -63.16 -28.1 69.83 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.591 0.756 . . . . 0.0 111.652 -176.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.414 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 7.7 ptpp? -65.72 -21.89 66.57 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.413 0.685 . . . . 0.0 111.583 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 t -74.33 -43.61 55.95 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.561 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.8 mp -61.73 112.47 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.442 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.499 ' HE3' ' HA3' ' A' ' 56' ' ' GLY . 32.1 mmtp -78.51 -63.13 1.48 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.881 0.872 . . . . 0.0 110.154 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 37.0 t -146.02 132.83 20.05 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 122.915 0.486 . . . . 0.0 110.094 -175.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.8 p -77.68 109.61 12.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.65 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 5.8 mm-40 -86.16 174.3 9.23 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.324 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -74.56 86.5 2.09 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.166 0.508 . . . . 0.0 109.719 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.416 ' CA ' ' HB2' ' A' ' 5' ' ' ASP . . . 88.21 13.44 63.9 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.979 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.65 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 2.4 mpt_? -135.6 159.67 40.91 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 117.444 0.622 . . . . 0.0 109.64 176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 mm -124.25 103.96 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 69.7 t -79.14 116.45 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.409 HG22 HG13 ' A' ' 45' ' ' ILE . 40.7 pt -105.87 164.0 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 169.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.499 ' HA3' ' HE3' ' A' ' 46' ' ' LYS . . . -104.4 -107.01 3.16 Favored Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -122.69 156.82 33.6 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.837 0.855 . . . . 0.0 109.807 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -167.09 160.17 13.71 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.723 1.209 . . . . 0.0 108.715 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -75.17 98.23 3.68 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -43.29 96.08 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.373 1.069 . . . . 0.0 112.896 -175.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -67.92 -33.87 75.53 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.341 0.401 . . . . 0.0 110.747 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 37.7 mt-10 -69.65 -49.44 53.66 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.366 174.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.01 -28.51 66.46 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.597 0.759 . . . . 0.0 111.383 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.59 -45.26 46.42 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.762 1.225 . . . . 0.0 110.867 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.415 ' HA ' ' HG2' ' A' ' 68' ' ' ARG . 2.9 pp20? -75.37 -36.93 60.85 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -175.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.523 ' HA ' ' HB3' ' A' ' 69' ' ' LYS . 4.4 pp -81.84 -15.14 55.08 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 120.846 0.355 . . . . 0.0 110.441 174.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -66.5 -47.82 67.13 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.747 166.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.494 ' HA ' HD23 ' A' ' 71' ' ' LEU . 9.2 ptp180 -76.32 -21.49 56.13 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-N 117.344 0.572 . . . . 0.0 111.458 177.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.523 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -68.18 -32.87 73.41 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.139 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.573 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 74.2 t90 -67.1 -40.49 86.91 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.196 169.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.1 mm? -57.89 -24.89 59.72 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.503 0.321 . . . . 0.0 111.232 175.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -79.33 -50.54 10.72 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 122.478 0.311 . . . . 0.0 111.19 173.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.573 ' HG2' ' HA ' ' A' ' 70' ' ' TRP . 10.1 pt-20 -75.79 -19.14 59.21 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -170.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -12.77 59.33 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.367 0.667 . . . . 0.0 112.258 -176.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.2 p -60.55 -20.79 61.42 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.653 1.181 . . . . 0.0 112.626 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -64.91 146.1 98.84 Favored Pre-proline 0 CA--C 1.555 1.151 0 C-N-CA 124.209 1.004 . . . . 0.0 110.326 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -65.54 152.0 83.13 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.736 2.291 . . . . 0.0 112.095 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.1 p -69.44 97.08 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-O 122.077 0.941 . . . . 0.0 112.054 -171.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.9 m -137.17 6.94 2.86 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.745 0.818 . . . . 0.0 109.68 172.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.55 108.94 4.02 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -96.31 -19.08 19.52 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.684 0.793 . . . . 0.0 110.668 -172.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -69.08 -19.54 64.07 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.86 1.264 . . . . 0.0 111.326 -173.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 24' ' ' VAL . 6.2 tt -58.74 -47.32 85.04 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.152 0.981 . . . . 0.0 109.218 172.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -64.81 94.73 0.13 Allowed 'General case' 0 C--N 1.349 0.582 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.185 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.6 p -118.62 141.93 48.13 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -68.35 -32.31 72.33 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.459 0.303 . . . . 0.0 111.369 -175.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.95 59.21 2.82 Favored Glycine 0 C--N 1.341 0.807 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -168.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -72.8 -0.87 14.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.129 0.971 . . . . 0.0 111.994 -174.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.97 86.38 0.22 Allowed Glycine 0 C--N 1.352 1.435 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.07 -24.15 63.19 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.061 0.944 . . . . 0.0 110.946 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -79.14 174.12 11.89 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.491 1.116 . . . . 0.0 110.679 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 153.47 -146.5 14.91 Favored Glycine 0 C--N 1.335 0.497 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.565 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.4 -23.99 52.69 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.607 1.163 . . . . 0.0 112.733 174.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -161.84 174.06 38.27 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.671 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.6 t . . . . . 0 C--O 1.252 1.211 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -179.897 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.2 151.77 21.56 Favored Glycine 0 C--N 1.344 0.975 0 O-C-N 123.571 0.545 . . . . 0.0 111.963 -178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -132.37 95.64 3.68 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.768 0.827 . . . . 0.0 109.515 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.519 ' SD ' HD13 ' A' ' 6' ' ' LEU . 40.3 tpp -76.4 95.34 3.79 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 168.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -67.76 -9.25 42.38 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.784 0.834 . . . . 0.0 112.87 -172.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.519 HD13 ' SD ' ' A' ' 4' ' ' MET . 9.8 mp -64.59 -19.46 65.67 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.849 0.86 . . . . 0.0 111.087 172.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.6 tp -52.02 -34.45 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 C-N-CA 124.007 0.923 . . . . 0.0 110.609 172.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.425 ' SG ' HD11 ' A' ' 83' ' ' LEU . 58.1 m -86.46 99.86 11.95 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 173.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.549 ' HB2' HG12 ' A' ' 53' ' ' ILE . 2.1 mpt? -61.37 153.62 26.3 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 123.994 0.918 . . . . 0.0 112.796 -170.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -75.13 110.46 9.46 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.307 1.043 . . . . 0.0 109.89 -176.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.518 HG22 ' HB ' ' A' ' 53' ' ' ILE . 75.5 t -79.28 127.5 39.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 122.878 0.471 . . . . 0.0 110.814 -173.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -110.56 129.71 55.73 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.623 1.169 . . . . 0.0 110.045 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.8 tptp -78.01 85.01 4.25 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.561 1.144 . . . . 0.0 108.011 172.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.25 -96.64 0.34 Allowed Glycine 0 C--N 1.347 1.145 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.623 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -94.91 -40.71 9.55 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.496 0.719 . . . . 0.0 110.474 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -83.66 151.63 25.19 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.946 -170.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.8 t -75.72 119.08 19.25 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -87.51 -48.89 7.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.521 0.728 . . . . 0.0 110.456 -176.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.51 -150.54 12.15 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -176.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -127.43 146.32 50.52 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 171.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 68.7 p -70.55 162.79 28.2 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 168.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.38 -39.56 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.56 ' HA ' HD13 ' A' ' 83' ' ' LEU . 36.1 t70 -153.24 171.92 17.79 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.608 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.527 HG13 ' HG3' ' A' ' 82' ' ' GLU . 2.4 p -151.72 133.75 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 172.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.489 ' CE2' HD11 ' A' ' 30' ' ' ILE . 50.6 p90 -135.81 135.24 39.69 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 172.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.48 -107.23 1.29 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 123.886 0.741 . . . . 0.0 112.704 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -116.11 12.84 15.66 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.764 0.826 . . . . 0.0 110.996 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.589 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 89.7 m-85 -123.17 109.34 13.89 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.198 0.599 . . . . 0.0 111.426 -172.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.485 HD12 ' HB ' ' A' ' 24' ' ' VAL . 45.5 tp -80.37 106.87 12.71 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 169.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.489 HD11 ' CE2' ' A' ' 25' ' ' TYR . 28.4 mm -71.24 108.81 3.07 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 C-N-CA 123.698 0.799 . . . . 0.0 110.041 178.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 65.6 t -102.72 119.44 51.09 Favored 'Isoleucine or valine' 0 C--O 1.24 0.583 0 O-C-N 124.263 0.977 . . . . 0.0 109.575 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -75.46 118.66 18.57 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.41 124.01 64.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 123.688 0.795 . . . . 0.0 108.99 172.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.81 -90.44 0.05 OUTLIER Glycine 0 CA--C 1.529 0.942 0 O-C-N 123.493 0.496 . . . . 0.0 114.334 175.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.3 p -123.5 -21.71 5.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.187 0.995 . . . . 0.0 111.5 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -110.37 171.62 7.35 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.641 0.776 . . . . 0.0 111.612 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -120.05 110.17 16.35 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.253 1.021 . . . . 0.0 108.942 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.1 mp -106.76 115.18 29.75 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.371 1.069 . . . . 0.0 108.381 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -79.94 103.82 10.09 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.619 0.768 . . . . 0.0 111.021 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 m -78.13 132.58 66.51 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 172.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.483 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 37.4 Cg_endo -65.62 150.22 86.63 Favored 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 121.714 1.609 . . . . 0.0 110.286 172.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.566 ' HA ' HD13 ' A' ' 45' ' ' ILE . 31.6 mmmt -61.13 -29.98 70.1 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.116 0.566 . . . . 0.0 111.409 -176.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.483 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 60.1 pttt -68.97 -23.09 64.08 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.052 0.941 . . . . 0.0 111.902 177.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.8 t -68.9 -29.72 68.06 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.759 0.424 . . . . 0.0 110.714 177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.566 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.9 mp -64.06 114.58 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.488 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 75.1 mmtt -71.69 -45.98 60.23 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.394 1.078 . . . . 0.0 110.0 176.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 44.1 p -157.14 155.15 30.5 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.952 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.8 p -113.12 114.2 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 123.916 0.886 . . . . 0.0 110.175 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 6.5 mm-40 -97.74 163.66 12.72 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.765 0.826 . . . . 0.0 109.1 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 91' ' ' GLU . 5.3 m-20 -59.75 -35.34 74.4 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.715 0.806 . . . . 0.0 111.301 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.476 ' HA2' ' HE1' ' A' ' 88' ' ' PHE . . . -133.07 19.35 4.37 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.484 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.602 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 44.1 mtm180 -143.62 156.09 44.46 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 117.486 0.643 . . . . 0.0 110.85 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.549 HG12 ' HB2' ' A' ' 9' ' ' MET . 41.3 mm -126.43 104.37 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 173.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.7 t -83.24 114.89 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 48.9 pt -108.22 163.99 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.539 0.736 . . . . 0.0 109.499 175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.488 ' HA3' ' HE2' ' A' ' 46' ' ' LYS . . . -92.87 -86.51 1.56 Allowed Glycine 0 CA--C 1.501 -0.817 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 175.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -160.5 168.44 25.07 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.563 0.745 . . . . 0.0 110.474 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -164.89 -179.03 5.54 Favored 'General case' 0 C--O 1.244 0.815 0 C-N-CA 124.898 1.279 . . . . 0.0 108.905 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -93.52 110.38 21.97 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -64.44 -37.22 86.77 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.12 0.968 . . . . 0.0 111.595 -175.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.31 -50.39 60.4 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.044 0.84 . . . . 0.0 110.167 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.425 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 37.6 mt-10 -64.16 -38.87 92.63 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.07 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.21 -40.84 86.48 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.416 0.686 . . . . 0.0 111.93 -176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 9.9 ptp85 -75.3 -31.5 60.68 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 118.97 -0.538 . . . . 0.0 112.266 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -75.98 -38.8 57.06 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.394 0.543 . . . . 0.0 111.349 -177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 62' ' ' GLU . 4.4 pp -81.76 -13.26 57.99 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.25 0.548 . . . . 0.0 109.828 170.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.82 -33.93 66.17 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.168 165.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 64' ' ' ARG . 78.5 mtm180 -64.85 -40.33 94.99 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 123.317 0.647 . . . . 0.0 109.682 172.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.535 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 38.4 ttpt -55.09 -39.76 69.66 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.789 170.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 73' ' ' GLU . 88.6 t90 -65.49 -34.92 79.4 Favored 'General case' 0 C--N 1.361 1.105 0 CA-C-O 119.316 -0.373 . . . . 0.0 111.681 174.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.2 mm? -57.22 -22.14 38.74 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 118.839 0.745 . . . . 0.0 110.634 173.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -85.71 -47.33 9.88 Favored 'General case' 0 CA--C 1.574 1.883 0 C-N-CA 123.397 0.679 . . . . 0.0 111.924 164.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 69' ' ' LYS . 11.1 mm-40 -63.12 -21.13 65.98 Favored 'General case' 0 N--CA 1.507 2.413 0 C-N-CA 124.532 1.133 . . . . 0.0 113.573 -172.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.13 -20.72 62.99 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.007 0.923 . . . . 0.0 111.737 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 t -85.25 12.39 8.17 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 124.125 0.97 . . . . 0.0 111.355 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -60.49 146.93 84.07 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 123.682 0.793 . . . . 0.0 110.978 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.16 161.93 42.36 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.484 2.123 . . . . 0.0 112.387 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.7 87.64 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.677 0.791 . . . . 0.0 108.951 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 39.8 m -146.1 -40.28 0.22 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.251 1.02 . . . . 0.0 109.699 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.93 128.59 35.95 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.954 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.483 ' HG3' ' HE3' ' A' ' 84' ' ' LYS . 43.9 tt0 -108.87 1.18 20.67 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.736 1.215 . . . . 0.0 109.285 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.527 ' HG3' HG13 ' A' ' 24' ' ' VAL . 11.6 tp10 -53.88 -38.11 64.42 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.006 1.322 . . . . 0.0 112.231 -176.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.56 HD13 ' HA ' ' A' ' 23' ' ' ASP . 41.5 tp -72.31 -38.64 68.65 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.958 0.503 . . . . 0.0 111.871 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.483 ' HE3' ' HG3' ' A' ' 81' ' ' GLU . 28.8 ttpp -77.9 126.57 31.04 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.637 0.375 . . . . 0.0 110.9 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.2 p -103.17 -158.94 0.7 Allowed 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.625 1.17 . . . . 0.0 109.689 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -67.88 -29.79 68.99 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.174 0.59 . . . . 0.0 109.971 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 147.9 162.85 10.34 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.906 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.476 ' HE1' ' HA2' ' A' ' 51' ' ' GLY . 32.3 t80 -69.87 130.56 42.58 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 122.942 0.497 . . . . 0.0 110.257 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -84.41 123.52 6.27 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -71.4 82.31 0.78 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.307 0.575 . . . . 0.0 109.602 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 50' ' ' ASP . 42.6 tt0 -81.5 -36.14 29.59 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.028 -177.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 140.25 -157.44 25.54 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.379 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -153.3 -61.19 0.14 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 65.5 26.26 71.78 Favored Glycine 0 C--N 1.355 1.614 0 O-C-N 124.097 0.873 . . . . 0.0 114.164 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.9 t . . . . . 0 C--O 1.254 1.307 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.256 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.751 0.31 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -161.07 174.89 37.73 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -79.91 74.9 6.64 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.488 0.661 . . . . 0.0 109.402 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -19.43 61.87 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.734 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.29 94.76 0.06 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.057 165.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.0 mt -92.61 82.22 4.8 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.4 tp -65.94 83.49 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.064 174.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 21' ' ' SER . 26.3 p -141.43 115.77 9.46 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.51 -175.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.6 ttm -155.42 149.42 25.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.547 0.739 . . . . 0.0 109.257 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -69.51 106.42 2.98 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.41 0.684 . . . . 0.0 109.823 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.09 132.82 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.029 0.532 . . . . 0.0 109.791 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -113.8 127.49 56.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.795 1.238 . . . . 0.0 110.337 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.98 88.49 3.52 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 171.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.4 -95.48 0.6 Allowed Glycine 0 C--N 1.342 0.91 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -121.25 1.3 10.23 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.073 0.949 . . . . 0.0 112.196 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -117.04 151.72 36.18 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.254 0.621 . . . . 0.0 110.456 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.5 t -67.43 112.8 4.83 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.733 0.813 . . . . 0.0 111.334 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -84.79 -54.65 4.55 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.438 0.695 . . . . 0.0 110.199 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.31 -137.83 3.99 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.877 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -138.28 136.48 36.51 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.192 0.997 . . . . 0.0 109.694 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 68.8 p -72.08 112.26 8.01 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.87 -36.43 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.054 0.541 . . . . 0.0 109.839 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -153.49 176.66 11.78 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.272 0.629 . . . . 0.0 109.338 -173.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.22 136.85 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 C-N-CA 123.988 0.915 . . . . 0.0 108.951 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.408 ' CD1' HD11 ' A' ' 30' ' ' ILE . 9.6 p90 -137.11 127.64 26.8 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 173.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.37 -109.62 2.43 Favored Glycine 0 C--N 1.346 1.117 0 O-C-N 123.537 0.523 . . . . 0.0 113.501 176.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -109.92 19.2 19.32 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.04 0.936 . . . . 0.0 111.493 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.404 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 78.9 m-85 -131.91 115.41 15.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.876 0.47 . . . . 0.0 111.665 -176.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 21' ' ' SER . 64.6 tp -79.22 113.85 17.68 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.131 0.972 . . . . 0.0 109.528 169.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.408 HD11 ' CD1' ' A' ' 25' ' ' TYR . 26.3 mm -74.77 106.92 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.5 t -104.53 113.44 41.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -76.3 109.67 10.19 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 23.6 m -95.15 156.08 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.415 1.086 . . . . 0.0 108.794 169.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -43.61 -28.23 1.01 Allowed Glycine 0 N--CA 1.482 1.711 0 N-CA-C 116.544 1.378 . . . . 0.0 116.544 -174.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.0 p -95.04 -48.39 5.99 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.13 0.572 . . . . 0.0 111.625 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -139.83 -179.65 6.06 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.443 0.64 . . . . 0.0 112.715 -163.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -101.78 107.83 19.16 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 164.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.6 mt -104.05 106.76 17.37 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.404 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -80.35 95.19 6.3 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.269 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.2 m -80.61 134.41 54.27 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.527 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 38.2 Cg_endo -63.41 159.13 41.52 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.21 1.94 . . . . 0.0 112.011 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -59.16 -34.73 72.45 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.385 0.674 . . . . 0.0 110.78 -178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.527 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 19.9 ptmt -68.19 -26.99 66.01 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.339 1.056 . . . . 0.0 112.191 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.7 t -59.46 -38.52 80.98 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.811 0.444 . . . . 0.0 109.87 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 mp -64.99 114.01 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.459 ' HD2' ' HA3' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -79.97 -53.8 6.4 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.571 1.149 . . . . 0.0 110.072 177.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.4 m -144.82 141.12 28.89 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.272 -171.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.0 p -99.19 110.62 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 169.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.788 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 11.7 mm-40 -105.21 174.25 5.96 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.555 0.742 . . . . 0.0 109.821 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.47 102.0 1.06 Allowed 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.195 -178.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.52 18.17 78.3 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 115.538 -0.755 . . . . 0.0 113.467 -177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.788 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 17.6 mtp180 -136.64 140.18 42.58 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.209 0.604 . . . . 0.0 110.359 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.1 mm -116.57 101.89 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 168.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.1 t -79.4 118.93 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.3 pt -112.13 146.38 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 123.716 0.806 . . . . 0.0 109.264 172.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.459 ' HA3' ' HD2' ' A' ' 46' ' ' LYS . . . -105.49 -56.33 0.69 Allowed Glycine 0 C--N 1.339 0.743 0 CA-C-N 116.362 -0.381 . . . . 0.0 112.418 -170.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.21 141.44 23.17 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.582 0.753 . . . . 0.0 110.627 -171.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -169.4 146.54 3.47 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 124.618 1.167 . . . . 0.0 108.011 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.66 106.79 7.4 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 172.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -64.15 -29.34 70.47 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.043 0.937 . . . . 0.0 111.706 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.437 ' HG2' ' NH1' ' A' ' 64' ' ' ARG . 38.8 mt-10 -67.08 -40.41 87.01 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.579 0.549 . . . . 0.0 110.584 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -68.73 -45.51 71.3 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.314 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.24 74.65 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.898 0.879 . . . . 0.0 111.865 -175.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.437 ' NH1' ' HG2' ' A' ' 61' ' ' GLU . 6.2 ptp180 -75.69 -41.81 52.7 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.769 0.428 . . . . 0.0 111.765 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.44 -39.48 64.95 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 118.075 0.398 . . . . 0.0 111.902 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -83.55 -16.61 44.78 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.766 0.426 . . . . 0.0 110.466 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.81 -39.0 34.97 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.595 0.559 . . . . 0.0 112.487 172.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.406 ' HA ' HD12 ' A' ' 71' ' ' LEU . 54.3 ptt85 -77.06 -24.95 51.92 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.843 0.457 . . . . 0.0 109.981 173.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -65.63 -38.14 88.58 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.552 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 66.6 t90 -60.74 -49.39 77.68 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 123.513 0.508 . . . . 0.0 109.883 171.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 68' ' ' ARG . 75.4 mt -50.92 -34.68 29.58 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.954 0.902 . . . . 0.0 112.072 178.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -75.19 -56.8 4.36 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.623 0.769 . . . . 0.0 111.074 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.552 ' HG2' ' HA ' ' A' ' 70' ' ' TRP . 12.1 pt-20 -76.6 -20.3 56.91 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -167.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.45 -13.62 22.04 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.471 0.708 . . . . 0.0 112.362 -172.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.8 t -68.89 80.04 0.3 Allowed 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 164.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -92.56 146.0 31.52 Favored Pre-proline 0 N--CA 1.477 0.917 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.951 -177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.09 166.26 29.46 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.175 1.917 . . . . 0.0 112.193 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.4 p -64.17 -21.23 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 124.015 0.926 . . . . 0.0 111.364 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 81.7 p -69.53 -8.86 50.81 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.288 1.035 . . . . 0.0 112.716 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.71 106.71 0.43 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.102 0.961 . . . . 0.0 109.602 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -88.14 -24.95 23.22 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.423 0.689 . . . . 0.0 112.722 -169.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -72.41 -30.7 64.87 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 123.432 0.693 . . . . 0.0 110.799 -172.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 41.8 tp -69.88 -21.2 63.34 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.44 0.696 . . . . 0.0 111.529 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -69.68 155.7 40.11 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.144 0.577 . . . . 0.0 111.775 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.4 m -75.05 100.11 4.1 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.938 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -76.82 -49.17 16.44 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.614 0.766 . . . . 0.0 109.741 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 140.93 -69.77 0.45 Allowed Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.75 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -69.77 133.02 46.98 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.508 0.723 . . . . 0.0 110.054 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 177.1 -89.13 0.08 OUTLIER Glycine 0 C--N 1.342 0.874 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -74.99 93.99 2.78 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.395 0.678 . . . . 0.0 110.416 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -98.12 50.32 1.01 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.018 0.527 . . . . 0.0 110.921 -175.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.38 17.42 74.35 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 115.82 -0.627 . . . . 0.0 113.187 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.73 -41.12 19.64 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.347 1.059 . . . . 0.0 111.2 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -100.59 85.55 0.6 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.1 t . . . . . 0 C--O 1.251 1.179 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.084 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -96.23 -129.72 6.14 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 173.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -97.08 147.75 23.71 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.93 0.492 . . . . 0.0 109.754 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 59.7 mtt -123.8 166.22 15.97 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.147 0.979 . . . . 0.0 109.466 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.7 t70 77.09 -26.36 0.19 Allowed 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 125.597 1.559 . . . . 0.0 113.047 176.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -71.28 -4.9 28.37 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.011 0.925 . . . . 0.0 112.356 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tt -55.47 -32.76 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 124.205 1.002 . . . . 0.0 111.419 174.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.8 p -135.5 91.21 2.69 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.889 0.876 . . . . 0.0 109.389 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 53.0 mtt -84.1 171.79 12.56 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.374 0.669 . . . . 0.0 110.578 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -101.75 130.08 48.08 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 169.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.418 HG22 ' HB ' ' A' ' 53' ' ' ILE . 85.4 t -91.54 126.27 44.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.346 0.659 . . . . 0.0 109.762 -177.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -115.46 118.52 33.43 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.782 1.233 . . . . 0.0 109.102 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 65.5 tttm -78.68 90.23 4.59 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 175.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.1 -95.56 0.66 Allowed Glycine 0 C--N 1.344 0.981 0 N-CA-C 111.061 -0.815 . . . . 0.0 111.061 -175.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -121.48 4.22 10.18 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.802 0.841 . . . . 0.0 112.406 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 11.5 pt-20 -111.84 147.41 35.81 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.997 0.519 . . . . 0.0 109.704 176.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.3 t -72.62 108.79 5.84 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -78.45 -49.34 13.64 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.358 0.663 . . . . 0.0 110.231 -178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.0 -136.54 3.33 Favored Glycine 0 C--N 1.342 0.886 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.521 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -142.33 136.93 30.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.138 0.975 . . . . 0.0 109.483 -178.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.41 ' HB2' HD11 ' A' ' 29' ' ' LEU . 62.2 p -71.58 106.96 4.22 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 175.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.424 HG21 ' HD2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -92.59 -40.31 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.083 0.553 . . . . 0.0 109.67 -176.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -160.35 168.91 24.23 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.438 0.295 . . . . 0.0 110.919 -176.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.15 141.22 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.011 0.924 . . . . 0.0 109.102 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -138.91 97.41 3.31 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.457 1.103 . . . . 0.0 108.389 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.1 -109.01 2.3 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.771 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -107.17 16.85 23.65 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.104 0.962 . . . . 0.0 110.36 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.456 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 93.8 m-85 -127.81 117.86 22.64 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.447 0.699 . . . . 0.0 109.895 -174.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.41 HD11 ' HB2' ' A' ' 21' ' ' SER . 64.5 tp -76.62 111.0 11.66 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 172.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.2 mm -71.02 112.88 6.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -107.26 120.02 57.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.355 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -74.84 109.18 8.09 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.05 89.56 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 124.577 1.151 . . . . 0.0 110.659 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.12 -76.02 1.68 Allowed Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.237 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.5 m -125.07 -29.47 3.32 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.141 0.977 . . . . 0.0 110.856 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -110.45 168.89 9.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 122.155 -0.341 . . . . 0.0 110.551 -172.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.424 ' HD2' HG21 ' A' ' 22' ' ' ILE . 64.5 m-85 -113.22 110.37 20.28 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.133 0.973 . . . . 0.0 109.466 177.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.0 mt -107.39 124.74 50.28 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.124 0.57 . . . . 0.0 109.63 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -89.62 99.49 12.48 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.016 -174.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.1 m -86.46 129.13 54.37 Favored Pre-proline 0 CA--C 1.552 1.056 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.13 158.42 54.65 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 122.363 2.042 . . . . 0.0 111.871 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.578 ' HA ' HD13 ' A' ' 45' ' ' ILE . 13.9 mmmm -64.6 -29.54 70.55 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.256 0.622 . . . . 0.0 112.166 -177.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.495 ' H ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -72.84 -17.79 61.51 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.142 0.177 . . . . 0.0 111.219 174.664 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.5 t -73.13 -34.9 66.38 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 171.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.578 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.9 mp -61.18 115.38 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.173 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 mmpm? -82.28 -61.28 1.94 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.212 1.005 . . . . 0.0 109.414 179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.0 m -138.69 126.6 22.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.149 -172.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.6 p -92.53 109.37 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 171.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.653 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 22.0 mm-40 -98.63 177.01 5.44 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 124.546 1.138 . . . . 0.0 110.225 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -68.11 91.15 0.35 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.185 0.594 . . . . 0.0 110.452 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.36 17.81 77.23 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.303 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.653 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 49.7 mtt180 -137.33 129.55 29.43 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.54 0.736 . . . . 0.0 109.382 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.418 ' HB ' HG22 ' A' ' 11' ' ' VAL . 38.4 mm -105.03 103.37 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.8 t -83.76 115.93 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 34.8 pt -108.57 175.15 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.377 0.671 . . . . 0.0 109.457 173.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.43 -117.75 3.01 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -118.71 160.29 22.11 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.267 0.627 . . . . 0.0 110.602 -175.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -159.8 179.21 9.02 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.156 1.382 . . . . 0.0 108.477 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -94.28 114.44 26.52 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -63.86 -36.2 83.13 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.844 0.858 . . . . 0.0 112.52 -175.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -69.21 -40.85 77.74 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.981 0.512 . . . . 0.0 110.185 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -68.42 -44.98 73.84 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 123.415 0.447 . . . . 0.0 110.33 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.04 -25.52 68.42 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.376 0.67 . . . . 0.0 111.292 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -73.89 -51.48 16.07 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.893 0.877 . . . . 0.0 110.971 176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.11 -40.81 59.62 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.993 0.517 . . . . 0.0 111.799 -171.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 69' ' ' LYS . 2.4 pp -84.1 -20.77 31.99 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.06 -44.83 87.02 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 169.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.503 ' HA ' HD23 ' A' ' 71' ' ' LEU . 35.2 ptt180 -75.45 -14.2 60.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.508 0.723 . . . . 0.0 110.406 175.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 6.3 tppt? -67.74 -31.85 72.04 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 122.982 0.513 . . . . 0.0 109.831 167.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.422 ' HE3' HD22 ' A' ' 71' ' ' LEU . 81.8 t90 -71.37 -38.6 71.53 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.805 0.442 . . . . 0.0 110.795 170.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.503 HD23 ' HA ' ' A' ' 68' ' ' ARG . 3.8 mm? -65.55 -29.66 70.31 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 120.807 0.337 . . . . 0.0 110.163 171.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.43 -35.8 65.85 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.78 0.832 . . . . 0.0 109.479 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.453 ' HA ' ' HG2' ' A' ' 76' ' ' LYS . 14.2 tp10 -63.54 -23.67 67.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.29 1.036 . . . . 0.0 110.791 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -76.74 -35.6 57.66 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 123.879 0.871 . . . . 0.0 112.113 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 24.7 p -84.17 -27.83 27.79 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.453 ' HG2' ' HA ' ' A' ' 73' ' ' GLU . 16.4 ptmt -86.74 168.52 18.0 Favored Pre-proline 0 N--CA 1.488 1.471 0 C-N-CA 123.759 0.824 . . . . 0.0 109.341 177.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.15 162.02 37.41 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.176 1.917 . . . . 0.0 112.058 166.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.0 m -81.97 27.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 123.784 0.833 . . . . 0.0 112.765 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.3 t -68.2 104.34 1.79 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.629 0.772 . . . . 0.0 110.52 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.9 tt -168.4 -43.95 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.557 1.143 . . . . 0.0 107.944 -177.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -71.46 -2.66 17.45 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.398 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -60.84 -35.73 77.32 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.535 0.734 . . . . 0.0 110.173 170.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 tt -59.61 -42.92 93.72 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.496 1.118 . . . . 0.0 109.472 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -70.76 86.83 0.68 Allowed 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.66 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.4 t -77.45 -23.48 50.48 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.762 0.825 . . . . 0.0 110.9 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -137.07 145.82 44.43 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.106 0.962 . . . . 0.0 108.809 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.31 79.83 0.07 OUTLIER Glycine 0 C--N 1.339 0.749 0 N-CA-C 112.027 -0.429 . . . . 0.0 112.027 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -118.05 114.4 23.06 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.021 0.928 . . . . 0.0 109.861 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -161.3 41.76 0.41 Allowed Glycine 0 C--N 1.335 0.497 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 175.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -108.47 88.54 2.75 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.964 0.906 . . . . 0.0 110.168 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -88.98 166.19 14.07 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.518 0.727 . . . . 0.0 109.834 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.75 123.65 7.25 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.111 -175.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 64.41 84.75 0.15 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.779 1.231 . . . . 0.0 111.767 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -110.33 129.39 9.31 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 173.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.9 t . . . . . 0 C--O 1.255 1.359 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -175.633 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -125.53 55.6 0.72 Allowed Glycine 0 C--N 1.341 0.837 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -175.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -66.2 92.94 0.19 Allowed 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.433 0.693 . . . . 0.0 110.037 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.1 ttt -76.33 108.29 9.17 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 166.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -71.2 89.92 0.88 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 -175.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 pp -114.59 1.57 14.3 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.744 1.218 . . . . 0.0 110.711 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.5 tt -74.07 140.6 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.353 0.661 . . . . 0.0 109.539 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 47.5 t 60.14 49.92 6.94 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 124.174 0.99 . . . . 0.0 111.514 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 41.4 mtt -67.61 124.46 23.3 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.49 173.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -71.31 106.93 4.04 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.491 HG22 ' HB ' ' A' ' 53' ' ' ILE . 57.8 t -78.93 110.04 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.879 -177.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 54.5 m-85 -97.23 120.9 38.45 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.128 0.971 . . . . 0.0 109.163 174.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -78.21 87.71 4.29 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 173.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.02 -95.51 0.74 Allowed Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -107.63 -29.66 9.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.792 0.837 . . . . 0.0 111.11 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.65 146.54 28.2 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 122.57 0.348 . . . . 0.0 110.449 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.0 t -77.15 105.63 8.36 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 176.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -79.89 -55.71 4.78 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.527 0.731 . . . . 0.0 111.158 -176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.532 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . -179.03 -147.87 7.39 Favored Glycine 0 C--N 1.347 1.145 0 O-C-N 123.261 0.351 . . . . 0.0 112.456 -177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -137.49 135.36 36.73 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.843 0.857 . . . . 0.0 109.779 -175.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.5 p -76.66 108.27 9.55 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -82.21 -37.73 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.349 0.659 . . . . 0.0 109.556 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -160.73 177.92 9.98 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -173.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.483 ' HB ' HD12 ' A' ' 29' ' ' LEU . 5.5 p -155.58 135.14 3.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 123.962 0.905 . . . . 0.0 109.056 173.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.444 ' CD2' HD11 ' A' ' 30' ' ' ILE . 34.3 p90 -132.13 131.81 42.65 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 171.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.19 -107.06 1.18 Allowed Glycine 0 C--N 1.343 0.958 0 O-C-N 123.764 0.665 . . . . 0.0 113.293 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -119.65 27.94 8.45 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.977 0.911 . . . . 0.0 111.261 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -133.29 108.97 9.07 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.063 0.545 . . . . 0.0 110.227 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.483 HD12 ' HB ' ' A' ' 24' ' ' VAL . 51.0 tp -81.37 113.47 19.49 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.356 0.662 . . . . 0.0 109.404 175.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.444 HD11 ' CD2' ' A' ' 25' ' ' TYR . 8.0 mm -80.1 104.79 8.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 C-N-CA 123.172 0.589 . . . . 0.0 109.685 -176.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.2 t -105.95 113.58 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 123.756 0.822 . . . . 0.0 109.834 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -75.86 117.0 17.13 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.387 0.675 . . . . 0.0 109.638 176.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.532 HG12 ' HA3' ' A' ' 19' ' ' GLY . 11.1 m -133.18 148.78 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.95 0.9 . . . . 0.0 109.409 176.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.23 -106.04 0.43 Allowed Glycine 0 CA--C 1.531 1.09 0 O-C-N 123.426 0.454 . . . . 0.0 113.04 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 31.8 m -109.53 -29.91 8.18 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.648 0.779 . . . . 0.0 110.888 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -116.44 176.5 5.08 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.623 0.725 . . . . 0.0 112.158 -169.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -104.28 109.92 21.94 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.653 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -92.12 102.97 15.51 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.208 1.003 . . . . 0.0 108.577 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' HB3' HD12 ' A' ' 66' ' ' LEU . . . -84.83 94.66 8.78 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.673 0.789 . . . . 0.0 109.526 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.1 m -75.35 128.66 83.96 Favored Pre-proline 0 CA--C 1.558 1.255 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.699 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -60.81 161.26 22.19 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 123.017 2.478 . . . . 0.0 112.192 174.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.504 ' HA ' HG12 ' A' ' 45' ' ' ILE . 14.6 mmmm -68.42 -21.27 64.68 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.69 -17.39 62.84 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.711 0.404 . . . . 0.0 111.014 174.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.8 t -80.5 -29.47 37.31 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.102 0.561 . . . . 0.0 110.353 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.513 HD13 HG22 ' A' ' 55' ' ' ILE . 25.5 mm -68.23 115.18 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 122.837 0.455 . . . . 0.0 110.406 -175.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -84.01 -66.69 0.86 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.596 0.758 . . . . 0.0 110.448 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.0 m -143.71 126.79 16.46 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.626 0.371 . . . . 0.0 110.654 -171.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.6 t -82.82 111.63 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 173.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.783 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 11.1 mm-40 -99.41 175.96 5.68 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.78 0.832 . . . . 0.0 109.986 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -70.31 97.55 1.26 Allowed 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.12 0.568 . . . . 0.0 110.05 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.81 21.94 77.78 Favored Glycine 0 C--N 1.348 1.25 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.841 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.783 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 79.6 mtt180 -142.62 151.24 41.27 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.931 0.892 . . . . 0.0 110.031 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.491 ' HB ' HG22 ' A' ' 11' ' ' VAL . 43.5 mm -124.4 107.11 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 170.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 57.4 t -78.46 117.76 24.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 170.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.513 HG22 HD13 ' A' ' 45' ' ' ILE . 47.4 pt -108.81 171.4 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.698 0.799 . . . . 0.0 109.54 171.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -119.66 -81.08 0.68 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.747 -0.541 . . . . 0.0 111.747 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -139.75 146.11 39.12 Favored 'General case' 0 C--O 1.242 0.711 0 CA-C-O 121.846 0.831 . . . . 0.0 110.711 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -160.66 165.48 30.51 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 125.471 1.508 . . . . 0.0 107.589 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -94.1 108.6 20.43 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.63 -39.11 92.77 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.889 0.876 . . . . 0.0 112.952 -170.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.55 -33.09 75.11 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.3 0.64 . . . . 0.0 110.712 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -76.73 -45.9 27.47 Favored 'General case' 0 C--N 1.346 0.439 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.435 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.91 -26.78 68.46 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.674 0.79 . . . . 0.0 110.671 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -74.7 -44.4 50.29 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.589 0.756 . . . . 0.0 110.609 178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -73.86 -39.33 64.05 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -177.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 39' ' ' ALA . 4.3 pp -82.41 -13.67 56.44 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-O 121.702 0.763 . . . . 0.0 110.037 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.18 -43.08 96.0 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 161.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -70.07 -16.69 63.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.92 0.888 . . . . 0.0 111.582 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.512 ' HB2' ' HA ' ' A' ' 66' ' ' LEU . 4.0 tppp? -67.28 -38.78 85.62 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.692 0.797 . . . . 0.0 109.559 170.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.438 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 68.7 t90 -62.19 -45.29 94.05 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.344 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.483 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 3.7 mm? -63.22 -25.38 68.3 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.564 0.345 . . . . 0.0 111.209 174.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -74.67 -35.78 62.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.867 0.867 . . . . 0.0 111.311 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.635 ' HA ' ' HG2' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -71.52 -28.74 64.1 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.483 ' HD3' ' HA ' ' A' ' 71' ' ' LEU . 28.0 mtpp -69.01 -23.93 64.15 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.747 0.819 . . . . 0.0 111.686 172.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 20.2 m -83.12 -44.84 14.66 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.613 0.765 . . . . 0.0 111.106 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.635 ' HG2' ' HA ' ' A' ' 73' ' ' GLU . 15.8 ptpt -81.51 170.89 13.59 Favored Pre-proline 0 N--CA 1.487 1.408 0 C-N-CA 123.917 0.887 . . . . 0.0 109.364 177.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 76' ' ' LYS . 18.9 Cg_endo -55.65 138.84 82.18 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 122.071 1.847 . . . . 0.0 111.145 173.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.16 90.21 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.664 0.786 . . . . 0.0 109.897 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 40.2 p -130.26 29.2 4.91 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.914 1.286 . . . . 0.0 109.813 -175.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.6 tp -73.5 92.11 1.86 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.78 0.832 . . . . 0.0 110.31 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -11.2 59.73 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.979 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -61.48 -25.33 67.18 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.224 1.01 . . . . 0.0 110.964 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -58.03 -32.52 68.04 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.496 1.118 . . . . 0.0 110.129 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -71.44 139.11 49.54 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.823 0.849 . . . . 0.0 111.363 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.5 t -168.59 176.7 5.55 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.092 1.357 . . . . 0.0 108.685 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -72.72 179.43 3.62 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.399 0.68 . . . . 0.0 111.61 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 96.57 33.06 6.3 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.041 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -72.0 109.54 5.88 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.185 0.994 . . . . 0.0 110.033 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 121.63 167.31 13.13 Favored Glycine 0 C--N 1.343 0.955 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -134.21 21.39 3.74 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.599 0.76 . . . . 0.0 111.035 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -71.0 -41.2 71.24 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 132.69 -167.98 22.97 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.826 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -157.62 -56.86 0.08 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.502 1.121 . . . . 0.0 108.08 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 150.95 175.69 23.11 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.333 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.2 p . . . . . 0 C--O 1.254 1.338 0 C-N-CA 123.535 0.734 . . . . 0.0 109.303 178.73 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.11 153.43 28.09 Favored Glycine 0 C--N 1.353 1.483 0 O-C-N 123.609 0.568 . . . . 0.0 112.513 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.1 m170 -103.0 144.8 30.8 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.117 0.967 . . . . 0.0 109.394 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.426 ' HB3' ' HG ' ' A' ' 6' ' ' LEU . 63.1 mtt -136.21 167.8 20.59 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.451 1.1 . . . . 0.0 108.901 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -122.9 44.66 2.59 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.879 0.872 . . . . 0.0 109.252 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.426 ' HG ' ' HB3' ' A' ' 4' ' ' MET . 86.3 mt -86.07 -51.69 6.16 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.022 -172.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.8 tp -69.94 114.71 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-O 121.504 0.669 . . . . 0.0 111.902 -171.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.3 m -86.97 93.4 9.33 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 175.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.4 ' HG2' ' HA2' ' A' ' 51' ' ' GLY . 58.2 mtt -71.64 126.51 29.89 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.976 -173.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -66.43 113.81 4.96 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.513 0.725 . . . . 0.0 110.568 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 91.1 t -83.1 123.73 38.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 123.505 0.722 . . . . 0.0 110.386 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -108.55 120.73 43.3 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.161 0.984 . . . . 0.0 109.418 175.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 49.7 tttm -77.24 85.43 3.69 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 175.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.59 -94.18 0.84 Allowed Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -110.81 -23.58 10.93 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.313 1.045 . . . . 0.0 111.229 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 11.3 pt-20 -91.18 144.41 25.65 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.065 0.546 . . . . 0.0 110.451 -173.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.6 t -71.4 111.4 6.69 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.406 0.682 . . . . 0.0 109.507 176.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -91.35 -56.55 3.1 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.801 0.44 . . . . 0.0 111.166 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.434 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . -179.35 -140.35 4.03 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 116.324 -0.398 . . . . 0.0 112.57 -174.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -140.26 139.25 35.5 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.601 0.76 . . . . 0.0 110.619 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.0 t -79.16 108.87 12.97 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.664 0.785 . . . . 0.0 109.241 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.42 HD13 ' HB2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -92.18 -39.13 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.156 0.582 . . . . 0.0 109.599 178.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' HB2' HD13 ' A' ' 22' ' ' ILE . 19.0 t70 -154.26 169.11 24.43 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 120.743 0.306 . . . . 0.0 111.082 -174.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.407 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.7 p -151.17 137.9 12.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.352 1.061 . . . . 0.0 108.46 172.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.417 ' CE1' HD11 ' A' ' 30' ' ' ILE . 2.4 p90 -146.54 135.38 22.34 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.96 -106.8 1.08 Allowed Glycine 0 C--N 1.34 0.799 0 O-C-N 123.29 0.369 . . . . 0.0 113.955 174.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -119.51 13.07 12.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.099 0.959 . . . . 0.0 110.915 -175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.479 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 83.8 m-85 -130.74 150.14 52.06 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.509 0.723 . . . . 0.0 111.049 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.407 HD12 ' HB ' ' A' ' 24' ' ' VAL . 45.3 tp -117.25 112.46 20.81 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 125.592 1.557 . . . . 0.0 107.725 -179.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.417 HD11 ' CE1' ' A' ' 25' ' ' TYR . 39.0 mm -76.52 109.15 10.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.816 0 C-N-CA 123.128 0.571 . . . . 0.0 109.757 -178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.5 t -110.13 117.94 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.053 0.941 . . . . 0.0 108.648 177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.78 118.68 28.64 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.566 HG22 HD23 ' A' ' 38' ' ' LEU . 19.7 m -123.07 128.49 75.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 171.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.99 -99.71 0.21 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 116.604 -0.271 . . . . 0.0 113.305 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 21.0 m -125.05 -5.11 7.39 Favored 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 123.856 0.862 . . . . 0.0 111.081 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -116.83 154.2 31.15 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.246 0.618 . . . . 0.0 111.236 -173.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -112.01 109.66 19.54 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.31 1.044 . . . . 0.0 109.154 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.566 HD23 HG22 ' A' ' 33' ' ' VAL . 3.6 mm? -95.55 106.75 18.86 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 124.39 1.076 . . . . 0.0 109.131 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -79.84 95.29 6.0 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.086 177.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.4 m -87.06 126.42 62.99 Favored Pre-proline 0 CA--C 1.554 1.118 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.497 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 38.2 Cg_endo -62.13 152.03 78.33 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.503 2.135 . . . . 0.0 112.492 -176.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.598 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.7 mmmm -64.94 -23.04 67.1 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.583 0.753 . . . . 0.0 111.808 -175.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.497 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 21.6 ptmt -70.88 -25.58 62.86 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.461 0.705 . . . . 0.0 111.307 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.9 t -72.22 -31.43 65.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.888 0.475 . . . . 0.0 110.094 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.598 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.6 mp -62.0 114.68 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.099 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -90.62 -55.6 3.51 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.824 1.25 . . . . 0.0 110.818 -176.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.5 m -134.37 126.87 30.5 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.349 0.66 . . . . 0.0 110.108 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 p -96.04 109.88 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 172.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 47.4 mm-40 -111.39 168.47 9.51 Favored 'General case' 0 C--O 1.245 0.856 0 C-N-CA 124.224 1.01 . . . . 0.0 109.918 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -65.34 98.53 0.34 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.811 0.844 . . . . 0.0 110.803 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.4 ' HA2' ' HG2' ' A' ' 9' ' ' MET . . . 77.29 11.96 85.03 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 116.333 -0.394 . . . . 0.0 113.963 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.483 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 97.4 mtt180 -137.6 127.3 25.33 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.957 0.903 . . . . 0.0 109.48 178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.9 mm -110.37 102.99 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 172.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.9 t -80.71 113.48 20.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.273 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 174.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 33.3 pt -106.63 178.61 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.102 0.961 . . . . 0.0 108.466 174.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -101.43 -119.71 4.54 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -131.63 166.54 21.22 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.732 0.813 . . . . 0.0 109.165 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -163.53 168.5 20.03 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.115 0.966 . . . . 0.0 109.297 -168.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -81.75 99.57 9.03 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -62.95 -30.55 71.66 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.006 0.922 . . . . 0.0 111.883 -175.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -62.83 -51.84 65.46 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.688 0.756 . . . . 0.0 109.747 176.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.07 -35.17 76.23 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.972 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.3 -34.77 73.14 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.029 0.532 . . . . 0.0 111.867 -175.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.5 ptp85 -77.13 -34.27 56.65 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 177.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.97 -37.99 54.1 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 117.725 0.238 . . . . 0.0 111.048 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.7 pp -82.98 -15.53 50.85 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.06 -42.71 35.82 Favored Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.053 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.572 ' HA ' HD23 ' A' ' 71' ' ' LEU . 4.9 ptp180 -70.97 -27.06 63.45 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 24.2 ttmm -63.56 -33.55 75.84 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 170.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -64.52 -37.1 86.36 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 119.565 -0.255 . . . . 0.0 110.696 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.572 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.0 mm? -61.52 -29.4 69.97 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 118.139 0.427 . . . . 0.0 110.717 173.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -77.01 -33.9 57.46 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.314 0.645 . . . . 0.0 110.685 172.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 44.1 mt-10 -71.61 -44.06 65.1 Favored 'General case' 0 C--O 1.206 -1.196 0 C-N-CA 123.57 0.748 . . . . 0.0 111.764 -176.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -14.16 61.99 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.738 -0.601 . . . . 0.0 110.974 177.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.8 t -101.01 31.45 3.6 Favored 'General case' 0 CA--C 1.559 1.326 0 C-N-CA 124.618 1.167 . . . . 0.0 109.893 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt -65.46 159.99 62.96 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 123.547 0.739 . . . . 0.0 112.02 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -61.7 -177.38 0.24 Allowed 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 122.832 2.354 . . . . 0.0 113.168 176.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.5 m -71.94 8.91 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -173.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.3 t -60.45 129.46 41.72 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.316 0.646 . . . . 0.0 110.844 168.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.528 HD13 ' HB3' ' A' ' 82' ' ' GLU . 1.5 pp -83.75 157.08 22.24 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.349 172.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -104.12 4.96 34.74 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.272 0.629 . . . . 0.0 111.259 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.528 ' HB3' HD13 ' A' ' 80' ' ' LEU . 12.2 tp10 -54.88 -35.66 64.3 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.244 1.018 . . . . 0.0 111.078 170.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -70.83 -51.09 28.79 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.2 0.6 . . . . 0.0 110.425 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -83.86 171.06 13.44 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.522 0.677 . . . . 0.0 111.638 -175.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.3 m -87.93 158.77 18.59 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.679 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -104.9 155.75 18.65 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.727 0.811 . . . . 0.0 109.073 174.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.76 145.5 49.85 Favored Glycine 0 C--N 1.341 0.806 0 O-C-N 123.564 0.54 . . . . 0.0 113.359 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -67.07 133.91 50.81 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.493 0.717 . . . . 0.0 110.294 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -111.69 -115.01 3.45 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -89.13 83.03 6.52 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.092 0.557 . . . . 0.0 109.695 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -76.43 95.86 3.92 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -168.61 -174.73 37.55 Favored Glycine 0 C--O 1.242 0.605 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.027 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -77.39 78.1 3.91 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.822 0.849 . . . . 0.0 109.062 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.44 134.57 18.11 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.126 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.301 -0.856 . . . . 0.0 109.24 179.026 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.763 0.316 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -145.95 -106.47 0.49 Allowed Glycine 0 C--N 1.341 0.82 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 177.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -79.75 86.31 5.34 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 172.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.0 ttt -77.68 89.73 3.97 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -78.3 -8.25 58.18 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.105 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mp -90.75 55.08 2.85 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.045 1.338 . . . . 0.0 107.55 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.464 ' HB ' ' HG3' ' A' ' 9' ' ' MET . 41.3 pt -69.61 133.59 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.479 -170.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 21' ' ' SER . 23.2 p -116.01 30.34 7.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.608 1.163 . . . . 0.0 109.582 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.464 ' HG3' ' HB ' ' A' ' 7' ' ' ILE . 85.2 mtp -65.12 142.97 58.19 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.651 -173.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -72.33 107.69 5.06 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.69 0.796 . . . . 0.0 109.929 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.59 116.23 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 122.92 0.488 . . . . 0.0 109.929 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -111.13 129.56 55.9 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.243 1.017 . . . . 0.0 109.262 175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -85.19 92.25 8.35 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.55 -95.81 0.4 Allowed Glycine 0 C--N 1.351 1.4 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.014 -174.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -104.51 -31.83 9.27 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.609 0.764 . . . . 0.0 111.479 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -83.4 144.2 29.78 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 120.659 0.266 . . . . 0.0 110.911 -172.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.5 t -72.41 111.09 7.29 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.561 0.745 . . . . 0.0 109.359 175.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -84.85 -57.04 3.27 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.56 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 178.15 -136.18 2.91 Favored Glycine 0 C--N 1.347 1.143 0 O-C-N 123.149 0.28 . . . . 0.0 112.465 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.79 139.13 24.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.238 1.015 . . . . 0.0 109.687 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 47.3 t -68.23 138.5 55.62 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.06 -38.11 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -156.14 164.55 38.25 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.732 0.413 . . . . 0.0 110.039 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.0 p -121.16 136.45 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 173.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.474 ' OH ' ' HD2' ' A' ' 69' ' ' LYS . 4.6 t80 -136.95 101.25 4.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.982 0.913 . . . . 0.0 109.602 -173.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.0 -113.04 5.37 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 113.423 173.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -98.57 21.53 11.12 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 124.027 0.931 . . . . 0.0 110.873 176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -135.58 162.24 33.25 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.047 0.939 . . . . 0.0 109.792 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 59.0 tp -123.66 113.07 18.15 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' ' 39' ' ' ALA . 23.7 mm -70.43 106.88 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.0 t -108.32 117.71 54.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -76.22 115.85 16.35 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 175.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.638 HG22 HD23 ' A' ' 38' ' ' LEU . 4.0 m -123.38 121.19 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.86 -86.97 0.06 OUTLIER Glycine 0 CA--C 1.532 1.115 0 CA-C-N 116.326 -0.397 . . . . 0.0 113.487 178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.8 m -124.56 -25.84 3.96 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.683 1.193 . . . . 0.0 110.663 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -106.88 163.78 12.67 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.579 0.752 . . . . 0.0 111.24 -167.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -111.0 109.07 19.02 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.156 0.982 . . . . 0.0 108.772 177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.638 HD23 HG22 ' A' ' 33' ' ' VAL . 4.3 mm? -105.73 111.95 24.82 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.572 1.149 . . . . 0.0 108.836 -178.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.447 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -82.93 94.81 7.8 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.212 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.6 m -81.48 131.28 58.79 Favored Pre-proline 0 N--CA 1.473 0.723 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.574 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 35.8 Cg_endo -60.67 153.41 62.15 Favored 'Trans proline' 0 C--N 1.373 1.863 0 C-N-CA 122.275 1.983 . . . . 0.0 111.703 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.543 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.4 mmmm -63.27 -27.13 69.13 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.603 0.761 . . . . 0.0 111.416 -178.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.574 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 20.9 ptmt -67.74 -21.7 65.27 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.676 0.79 . . . . 0.0 111.793 175.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.5 t -70.18 -43.15 71.38 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.543 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.3 mp -60.98 113.77 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.364 1.209 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.547 ' HE3' ' HA3' ' A' ' 56' ' ' GLY . 33.9 mmtp -79.17 -58.65 3.12 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.857 0.863 . . . . 0.0 109.421 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.8 m -154.45 156.72 37.27 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.378 0.671 . . . . 0.0 110.613 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.4 t -93.37 111.76 25.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.822 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 7.3 mm-40 -86.62 167.21 14.74 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.348 0.659 . . . . 0.0 109.363 175.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -69.13 93.85 0.63 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.57 -6.76 65.43 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.852 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.63 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 49.9 mtm180 -129.01 158.99 37.34 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.009 0.523 . . . . 0.0 110.952 -176.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 mm -124.17 104.44 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.2 t -79.98 118.75 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 45.2 pt -108.81 174.08 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.54 0 C-N-CA 123.893 0.877 . . . . 0.0 109.336 172.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.547 ' HA3' ' HE3' ' A' ' 46' ' ' LYS . . . -135.38 -90.04 0.31 Allowed Glycine 0 C--N 1.34 0.757 0 CA-C-N 116.196 -0.456 . . . . 0.0 112.065 -173.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -107.73 130.45 54.95 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-O 121.09 0.472 . . . . 0.0 111.882 -168.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -164.12 -176.4 4.47 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.278 1.031 . . . . 0.0 108.768 174.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -128.79 122.72 31.14 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 173.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -70.98 -32.66 69.57 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 122.753 0.421 . . . . 0.0 112.114 -173.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.88 -34.62 69.33 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.43 -38.69 68.26 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.379 172.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.434 ' HB3' HD12 ' A' ' 38' ' ' LEU . . . -70.06 -28.47 65.47 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.926 0.49 . . . . 0.0 111.629 -177.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -78.63 -36.25 44.33 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.037 0.535 . . . . 0.0 112.027 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -74.61 -41.96 59.49 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 120.838 0.352 . . . . 0.0 110.859 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 pp -81.46 -21.27 38.88 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.21 -41.38 86.49 Favored Glycine 0 C--N 1.347 1.14 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.959 170.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.523 ' HA ' ' HB2' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -73.59 -21.0 60.46 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 117.346 0.573 . . . . 0.0 111.032 177.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.474 ' HD2' ' OH ' ' A' ' 25' ' ' TYR . 2.6 ttmp? -57.98 -46.85 84.51 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 166.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.492 ' HE3' HD12 ' A' ' 71' ' ' LEU . 89.3 t90 -62.34 -42.64 99.55 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.117 174.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 68' ' ' ARG . 9.8 mp -54.55 -31.7 57.02 Favored 'General case' 0 N--CA 1.506 2.366 0 C-N-CA 123.54 0.736 . . . . 0.0 111.879 177.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -80.3 -54.09 6.04 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 122.924 0.49 . . . . 0.0 109.908 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.488 ' HG2' ' HA ' ' A' ' 70' ' ' TRP . 12.7 pt-20 -75.92 -17.15 59.87 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -170.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.14 -25.34 66.93 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 123.566 0.746 . . . . 0.0 111.802 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 m -59.7 -26.46 65.61 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.934 0.894 . . . . 0.0 111.396 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -89.35 120.12 69.7 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.078 0.951 . . . . 0.0 109.481 174.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.83 143.5 55.68 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.691 2.26 . . . . 0.0 112.254 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.8 p -69.86 101.79 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 C-N-CA 123.49 0.716 . . . . 0.0 111.261 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.1 t -76.03 102.15 5.54 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.622 0.725 . . . . 0.0 110.168 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.6 tp -67.0 -35.35 79.76 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.952 -176.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -62.65 -38.35 89.95 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.672 0.789 . . . . 0.0 111.891 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -83.01 -22.45 33.61 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.853 0.461 . . . . 0.0 110.911 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.5 tp -65.8 -32.58 74.19 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 123.583 0.753 . . . . 0.0 110.701 176.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -75.8 96.23 3.63 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.175 0.59 . . . . 0.0 110.001 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.9 t -154.48 135.79 14.08 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.023 0.929 . . . . 0.0 109.441 176.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -77.76 137.08 38.26 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.582 0.753 . . . . 0.0 111.12 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -80.12 -172.49 44.5 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-N 115.784 -0.644 . . . . 0.0 113.155 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -83.6 97.37 9.02 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.473 0.709 . . . . 0.0 111.272 -173.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -100.53 92.33 1.07 Allowed Glycine 0 C--N 1.345 1.047 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 175.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -70.94 -20.8 62.43 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.401 0.68 . . . . 0.0 111.337 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.25 134.8 57.01 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.879 0.872 . . . . 0.0 110.218 174.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 154.29 82.93 0.04 OUTLIER Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -175.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -87.14 -20.8 26.51 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.365 0.666 . . . . 0.0 111.159 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 93.99 -96.66 2.09 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 119.911 -0.383 . . . . 0.0 112.176 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 C--O 1.248 1.026 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.049 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 120.682 0.277 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.83 168.44 44.46 Favored Glycine 0 C--N 1.346 1.113 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.186 -172.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -80.52 87.0 5.74 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.011 0.524 . . . . 0.0 110.754 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.9 ttt -101.15 15.26 29.31 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.62 0.724 . . . . 0.0 109.777 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -85.01 45.24 1.15 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.07 0.948 . . . . 0.0 111.88 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.45 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.6 pt? -124.12 6.52 8.54 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.789 0.836 . . . . 0.0 109.709 171.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.658 HG13 ' H ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -80.05 89.19 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 CA-C-O 122.209 1.004 . . . . 0.0 108.805 -179.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.9 p -166.47 79.26 0.24 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.253 -1.34 . . . . 0.0 107.489 -178.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -66.14 134.38 52.66 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.713 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -74.13 108.41 6.91 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.34 1.056 . . . . 0.0 109.883 178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.461 HG22 ' HB ' ' A' ' 53' ' ' ILE . 61.5 t -80.01 123.7 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.927 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -106.09 122.58 46.46 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.135 0.974 . . . . 0.0 109.836 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -78.82 80.76 5.15 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.57 -95.61 0.39 Allowed Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.786 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -104.3 0.38 29.17 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.844 0.858 . . . . 0.0 112.124 -173.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -131.42 149.6 52.47 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.134 0.574 . . . . 0.0 110.422 -175.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.6 t -71.94 111.62 7.35 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.419 0.688 . . . . 0.0 109.762 177.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -77.37 -55.92 4.99 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.32 0.648 . . . . 0.0 109.327 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 176.88 -142.99 6.09 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.36 151.71 35.79 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.445 0.698 . . . . 0.0 109.748 172.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.2 t -71.62 146.9 48.04 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.955 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.42 -37.73 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.081 0.952 . . . . 0.0 109.405 -179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -150.73 173.24 14.42 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -173.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.418 ' HB ' HD12 ' A' ' 29' ' ' LEU . 8.9 p -155.96 134.1 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.565 0.746 . . . . 0.0 109.516 171.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.438 ' CE1' HD11 ' A' ' 30' ' ' ILE . 8.8 p90 -133.77 125.24 28.1 Favored 'General case' 0 C--O 1.245 0.849 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.17 -107.07 1.18 Allowed Glycine 0 CA--C 1.531 1.072 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.398 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -102.93 -9.4 19.89 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.004 0.921 . . . . 0.0 111.603 -176.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.599 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 86.6 m-85 -108.7 108.48 19.34 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.815 -0.553 . . . . 0.0 111.979 -169.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.418 HD12 ' HB ' ' A' ' 24' ' ' VAL . 26.8 tp -77.65 109.35 11.55 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 114.537 -1.211 . . . . 0.0 108.37 173.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.438 HD11 ' CE1' ' A' ' 25' ' ' TYR . 24.3 mm -72.03 99.73 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.645 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.2 t -96.1 112.71 28.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.418 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -85.89 113.91 22.39 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.95 86.86 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.139 0 CA-C-O 122.164 0.983 . . . . 0.0 110.532 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.53 -89.26 0.36 Allowed Glycine 0 C--N 1.349 1.279 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.392 177.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.561 HG23 ' HG2' ' A' ' 36' ' ' GLU . 10.5 t -101.5 -16.71 16.72 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.39 0.676 . . . . 0.0 110.93 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.561 ' HG2' HG23 ' A' ' 35' ' ' THR . 6.3 mm-40 -109.6 162.73 14.13 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.443 0.697 . . . . 0.0 111.156 -167.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -121.39 108.48 13.73 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 170.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.85 106.68 17.29 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.501 1.121 . . . . 0.0 108.755 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.599 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -87.24 94.74 9.75 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.559 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.6 m -78.98 140.04 57.57 Favored Pre-proline 0 CA--C 1.552 1.042 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.531 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.36 155.05 72.06 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.554 2.169 . . . . 0.0 110.767 172.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.419 ' HA ' HD13 ' A' ' 45' ' ' ILE . 31.8 mmmt -64.71 -22.94 67.1 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -76.57 -17.21 59.34 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.267 0.627 . . . . 0.0 111.921 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.1 t -66.66 -30.59 70.89 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.272 0.629 . . . . 0.0 110.727 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.6 mp -72.49 115.48 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 123.729 0.812 . . . . 0.0 109.733 -177.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -85.85 -44.35 12.52 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.765 0.826 . . . . 0.0 110.184 175.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 49.3 m -139.46 133.5 31.02 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.545 0.738 . . . . 0.0 111.436 -172.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.1 t -105.08 110.75 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 170.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 40.0 mm-40 -111.37 175.5 5.4 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.973 0.909 . . . . 0.0 110.488 -177.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -40.47 -56.6 2.01 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 125.648 1.579 . . . . 0.0 113.013 -171.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.541 ' H ' ' HD2' ' A' ' 52' ' ' ARG . . . -140.3 35.73 1.86 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HD2' ' H ' ' A' ' 51' ' ' GLY . 0.0 OUTLIER -137.86 151.56 48.19 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.524 0.73 . . . . 0.0 109.564 -176.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.461 ' HB ' HG22 ' A' ' 11' ' ' VAL . 31.1 mm -132.11 104.06 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 124.556 1.142 . . . . 0.0 108.432 172.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.8 t -84.48 115.88 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.1 pt -107.3 141.33 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.68 0.792 . . . . 0.0 109.518 173.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -84.82 -61.45 1.77 Allowed Glycine 0 C--N 1.345 1.047 0 N-CA-C 112.231 -0.348 . . . . 0.0 112.231 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -156.48 162.65 39.96 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.834 0.853 . . . . 0.0 109.451 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -171.01 162.72 7.28 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.76 0.824 . . . . 0.0 109.947 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.03 86.7 1.03 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -71.52 -36.55 71.08 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.98 0.912 . . . . 0.0 113.241 -171.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -68.05 -38.22 82.2 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 41.4 mt-10 -74.14 -34.66 63.93 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.842 176.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.21 -24.54 63.13 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.836 0.455 . . . . 0.0 110.959 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -74.2 -44.59 52.65 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.104 0.962 . . . . 0.0 110.161 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.7 pt-20 -70.11 -38.47 75.63 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 39' ' ' ALA . 4.5 pp -82.97 -13.41 56.04 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 120.983 0.42 . . . . 0.0 110.651 175.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.69 -43.77 50.63 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.133 169.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.518 ' HA ' HD23 ' A' ' 71' ' ' LEU . 25.7 ptt85 -73.83 -22.5 59.76 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 116.766 0.283 . . . . 0.0 110.542 174.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 24.8 ttpp -64.82 -33.9 77.08 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 169.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -66.45 -35.6 80.7 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 119.638 -0.22 . . . . 0.0 110.832 170.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.4 mm? -61.43 -23.0 65.53 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 118.29 0.496 . . . . 0.0 111.407 173.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.43 ' HB3' ' O ' ' A' ' 69' ' ' LYS . 13.3 tp10 -77.28 -40.03 45.98 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 123.305 0.642 . . . . 0.0 110.47 169.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 69' ' ' LYS . 9.6 mm-40 -75.26 -29.17 60.09 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -174.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.424 ' HE3' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -64.4 -21.73 66.73 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 120.861 0.362 . . . . 0.0 111.936 -179.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.6 m -75.02 -10.85 59.86 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.303 0.641 . . . . 0.0 111.738 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 73' ' ' GLU . 11.1 mptt -89.92 144.69 31.87 Favored Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 170.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.34 168.59 4.79 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.158 2.572 . . . . 0.0 112.674 170.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.3 t -73.31 80.63 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -91.32 -29.47 17.11 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.894 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.6 tp -75.02 99.92 4.02 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 172.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -70.49 -24.6 62.88 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.551 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -64.3 -18.61 64.77 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.914 0.885 . . . . 0.0 112.305 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.9 tt -61.12 -24.89 66.6 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.875 0.87 . . . . 0.0 110.299 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -54.56 107.43 0.28 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.545 1.138 . . . . 0.0 110.404 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.5 p -136.53 127.8 28.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.764 0.825 . . . . 0.0 110.62 -173.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -135.56 116.95 14.67 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.15 0.98 . . . . 0.0 109.032 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.658 ' H ' HG13 ' A' ' 7' ' ' ILE . . . -88.64 70.05 2.64 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -93.44 -173.72 3.29 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.729 0.811 . . . . 0.0 110.03 176.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.92 28.64 73.82 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.63 95.44 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.195 1.398 . . . . 0.0 111.269 -177.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -153.16 140.16 19.24 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.504 -175.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 116.74 145.23 8.15 Favored Glycine 0 C--O 1.24 0.499 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -150.79 165.83 32.35 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 123.627 0.771 . . . . 0.0 110.513 -169.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -139.69 102.35 0.34 Allowed Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 CA--C 1.559 1.325 0 C-N-CA 124.286 1.034 . . . . 0.0 111.318 -178.094 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.51 156.77 9.42 Favored Glycine 0 C--N 1.345 1.03 0 C-N-CA 121.565 -0.35 . . . . 0.0 113.784 177.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -163.86 126.79 2.55 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.068 1.347 . . . . 0.0 108.874 173.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.1 mmt 61.77 28.2 17.31 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.849 1.26 . . . . 0.0 112.628 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -73.49 -8.83 57.54 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.896 0.878 . . . . 0.0 111.163 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.6 mt -69.74 96.16 0.95 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.469 1.107 . . . . 0.0 110.785 -176.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.83 -42.8 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.346 1.058 . . . . 0.0 108.398 174.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.2 t -77.36 100.49 5.95 Favored 'General case' 0 C--N 1.35 0.597 0 C-N-CA 123.76 0.824 . . . . 0.0 109.609 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.403 ' HB2' HG12 ' A' ' 53' ' ' ILE . 59.0 mtt -134.69 161.25 35.68 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.319 1.048 . . . . 0.0 109.935 -175.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -79.13 111.22 15.13 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.443 HG22 ' HB ' ' A' ' 53' ' ' ILE . 61.6 t -86.78 127.93 40.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.702 0.801 . . . . 0.0 110.781 -175.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -108.82 123.02 48.39 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.323 1.449 . . . . 0.0 109.167 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 87.1 tttt -80.94 90.13 5.92 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 172.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.2 -95.58 0.59 Allowed Glycine 0 C--N 1.342 0.914 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.329 -173.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -117.65 -10.52 10.55 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.918 0.887 . . . . 0.0 111.887 -176.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 11.3 pt-20 -90.87 146.61 23.78 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 176.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.4 t -81.67 102.28 10.6 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -76.32 -55.64 5.37 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.443 0.697 . . . . 0.0 111.14 -172.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.589 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 178.75 -137.26 3.16 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-O 120.066 -0.297 . . . . 0.0 112.513 -177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -145.2 136.53 25.07 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.062 0.945 . . . . 0.0 109.68 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 31.6 p -76.85 118.25 19.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.729 0.812 . . . . 0.0 110.161 175.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.04 -35.05 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 123.965 0.906 . . . . 0.0 109.82 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -150.09 175.34 11.82 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.963 0.505 . . . . 0.0 110.455 -173.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.438 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.1 p -152.8 139.34 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.503 1.121 . . . . 0.0 108.773 171.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -141.46 127.12 19.04 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.99 -106.37 0.98 Allowed Glycine 0 CA--C 1.531 1.068 0 O-C-N 123.514 0.509 . . . . 0.0 113.733 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -109.81 15.12 22.92 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.154 0.982 . . . . 0.0 111.709 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.61 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 96.9 m-85 -135.16 113.82 11.74 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 118.302 0.501 . . . . 0.0 111.888 -172.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.438 HD12 ' HB ' ' A' ' 24' ' ' VAL . 42.8 tp -80.29 111.81 17.03 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.909 1.283 . . . . 0.0 109.367 172.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.6 mm -71.77 99.1 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.343 0.657 . . . . 0.0 109.72 178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 47.6 t -100.34 112.42 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.762 0.825 . . . . 0.0 109.046 176.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -89.3 123.05 33.14 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.589 HG12 ' HA3' ' A' ' 19' ' ' GLY . 1.3 m -128.08 133.33 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 173.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.81 -91.64 0.05 OUTLIER Glycine 0 N--CA 1.474 1.171 0 C-N-CA 123.287 0.47 . . . . 0.0 113.82 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.6 t -125.03 -13.26 6.86 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.308 1.043 . . . . 0.0 112.039 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -111.25 156.13 21.94 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -170.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -104.39 108.77 20.35 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 172.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.23 104.53 14.67 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.61 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -83.55 93.99 7.96 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.442 HG12 ' CE2' ' A' ' 58' ' ' PHE . 3.9 m -78.04 137.34 61.34 Favored Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.516 ' HG2' ' HB2' ' A' ' 44' ' ' SER . 31.1 Cg_endo -62.37 138.43 71.19 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 122.241 1.961 . . . . 0.0 111.287 175.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.514 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.5 mmmm -62.75 -29.94 71.06 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.653 0.781 . . . . 0.0 111.528 -177.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -70.82 -18.24 62.73 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.028 0.931 . . . . 0.0 112.244 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.516 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 26.0 t -72.55 -27.12 62.03 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.918 0.487 . . . . 0.0 111.186 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.6 mp -61.98 115.5 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.811 0.444 . . . . 0.0 110.25 -176.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -76.41 -47.69 22.34 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.326 1.05 . . . . 0.0 110.599 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.9 m -143.45 124.69 14.58 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.136 0.574 . . . . 0.0 110.676 -173.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 70.0 t -93.21 109.24 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 166.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.675 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 16.3 mm-40 -108.53 165.71 11.32 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.125 1.37 . . . . 0.0 108.607 174.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -69.08 99.48 1.11 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 122.829 0.452 . . . . 0.0 110.453 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.7 14.12 73.85 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.201 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.675 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 28.3 mtm180 -142.83 125.51 15.92 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.172 0.989 . . . . 0.0 108.761 -175.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.443 ' HB ' HG22 ' A' ' 11' ' ' VAL . 34.8 mm -118.86 101.2 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 63.8 t -84.26 117.57 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 12.9 pt -109.74 164.56 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.876 0.871 . . . . 0.0 109.648 176.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.59 -87.65 1.36 Allowed Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 -173.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -142.95 144.42 32.36 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.113 0.965 . . . . 0.0 108.95 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.442 ' CE2' HG12 ' A' ' 40' ' ' VAL . 6.1 p90 -167.19 150.97 6.6 Favored 'General case' 0 C--O 1.244 0.812 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -87.14 99.7 12.12 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.66 -29.54 69.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.186 0.994 . . . . 0.0 112.707 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.83 -42.72 85.34 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.971 0.415 . . . . 0.0 110.188 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -67.72 -37.5 82.32 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 175.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.26 -24.6 65.81 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.042 0.937 . . . . 0.0 111.379 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.63 -46.36 38.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.47 1.108 . . . . 0.0 110.216 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.36 -37.95 74.7 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 123.237 0.335 . . . . 0.0 111.259 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 39' ' ' ALA . 4.3 pp -82.26 -16.28 50.05 Favored 'General case' 0 CA--C 1.551 1.003 0 CA-C-O 120.647 0.26 . . . . 0.0 110.441 175.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -76.55 -35.95 39.77 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.653 173.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -77.89 -21.96 50.47 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 172.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -65.0 -35.62 81.79 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 169.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.434 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 59.9 t90 -59.89 -51.49 69.49 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 123.395 0.434 . . . . 0.0 109.87 170.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.4 mt -49.49 -38.63 30.87 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 123.616 0.766 . . . . 0.0 111.504 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -71.42 -52.31 19.25 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.55 1.14 . . . . 0.0 111.593 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 70' ' ' TRP . 12.8 pt-20 -76.52 -22.8 53.94 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.158 0.583 . . . . 0.0 112.365 -170.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.14 -23.58 23.61 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 45.3 t -75.98 79.78 2.85 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-O 121.791 0.805 . . . . 0.0 109.177 175.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -81.32 147.08 59.41 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.455 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.25 -167.73 0.3 Allowed 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.854 2.369 . . . . 0.0 112.208 174.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -61.19 -33.22 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.116 0.566 . . . . 0.0 112.03 -176.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.4 t -65.99 87.2 0.1 Allowed 'General case' 0 C--N 1.365 1.259 0 CA-C-O 122.49 1.138 . . . . 0.0 110.03 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.44 ' HB3' ' H ' ' A' ' 83' ' ' LEU . 13.2 mt -137.67 117.13 12.85 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.591 -174.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -64.84 -18.5 65.19 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.182 163.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.45 -47.85 71.8 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.392 1.077 . . . . 0.0 110.471 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.44 ' H ' ' HB3' ' A' ' 80' ' ' LEU . 3.3 tm? -67.93 -44.78 76.07 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -80.99 76.58 7.94 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.348 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 68.5 m -137.46 147.98 45.74 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.076 0.95 . . . . 0.0 109.628 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -76.85 92.39 3.62 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 85.04 -140.32 18.43 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.458 -174.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 70.48 3.96 4.73 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.179 1.392 . . . . 0.0 113.776 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.99 30.49 2.03 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 175.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.23 70.23 5.58 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 122.541 1.162 . . . . 0.0 109.54 -177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -162.78 168.7 21.05 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.868 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -142.07 90.44 0.18 Allowed Glycine 0 C--N 1.338 0.651 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -76.23 -29.65 57.62 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.253 0.549 . . . . 0.0 110.14 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 144.51 -35.13 1.56 Allowed Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 -175.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.245 0.852 0 C-N-CA 124.874 1.27 . . . . 0.0 108.227 173.556 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.86 -145.49 4.18 Favored Glycine 0 C--N 1.344 0.974 0 N-CA-C 111.664 -0.574 . . . . 0.0 111.664 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -158.0 108.04 2.13 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.219 0.608 . . . . 0.0 109.493 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.431 ' O ' HG22 ' A' ' 7' ' ' ILE . 47.0 tpp -100.15 55.52 0.92 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 174.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -75.68 -1.72 26.1 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.588 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.4 mp -63.72 -23.71 67.48 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.522 1.129 . . . . 0.0 110.542 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 4' ' ' MET . 12.8 tt -68.03 -33.43 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.223 0.609 . . . . 0.0 110.773 174.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 21' ' ' SER . 42.1 t -88.0 57.97 4.58 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.579 0.704 . . . . 0.0 110.075 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.407 ' SD ' ' HA2' ' A' ' 51' ' ' GLY . 42.1 tpp -100.68 147.13 26.35 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.338 1.055 . . . . 0.0 108.618 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -69.9 128.96 38.2 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 97.0 t -100.21 139.06 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.228 0.611 . . . . 0.0 110.31 -177.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -130.1 127.54 40.05 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.205 1.402 . . . . 0.0 108.89 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -76.96 96.27 4.33 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.07 -95.25 0.34 Allowed Glycine 0 CA--C 1.531 1.079 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -168.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -117.58 -23.45 7.66 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.746 0.818 . . . . 0.0 111.783 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -79.99 145.2 32.67 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.7 t -71.52 111.12 6.56 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.843 0.354 . . . . 0.0 110.586 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -83.91 -55.66 4.11 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.334 0.654 . . . . 0.0 109.729 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -175.28 -131.41 1.43 Allowed Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.827 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -148.82 137.12 21.03 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.202 1.401 . . . . 0.0 108.022 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 43.3 t -74.11 135.25 42.91 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 174.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.79 -35.42 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.761 0.824 . . . . 0.0 109.541 -176.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -151.4 165.8 33.0 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.267 0.627 . . . . 0.0 110.205 -173.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.414 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.1 p -147.91 132.47 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.115 0.966 . . . . 0.0 108.461 169.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.422 ' CE1' HD11 ' A' ' 30' ' ' ILE . 1.4 p90 -141.1 138.98 33.91 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.55 -105.37 0.97 Allowed Glycine 0 CA--C 1.528 0.865 0 O-C-N 123.226 0.329 . . . . 0.0 112.527 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -120.07 5.25 10.84 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.71 0.804 . . . . 0.0 111.644 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -115.66 119.22 35.39 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.174 0.59 . . . . 0.0 111.53 -169.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.414 HD12 ' HB ' ' A' ' 24' ' ' VAL . 30.1 tp -79.52 109.14 13.62 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.871 0.868 . . . . 0.0 108.921 171.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.422 HD11 ' CE1' ' A' ' 25' ' ' TYR . 43.1 mm -73.53 104.39 2.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 99.3 t -99.52 112.56 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 123.952 0.901 . . . . 0.0 109.74 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -75.92 107.29 8.02 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.676 0.791 . . . . 0.0 109.2 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.5 m -91.8 155.92 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 167.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -44.98 -28.35 1.76 Allowed Glycine 0 CA--C 1.541 1.688 0 N-CA-C 116.258 1.263 . . . . 0.0 116.258 -172.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.9 p -96.16 -47.52 6.02 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.649 0.779 . . . . 0.0 112.339 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -143.1 -175.07 4.38 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.285 0.634 . . . . 0.0 111.714 -164.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.42 ' HB2' HD21 ' A' ' 71' ' ' LEU . 38.1 m-85 -115.43 109.84 18.44 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.097 0.959 . . . . 0.0 108.792 175.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -97.62 115.07 27.18 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.268 1.027 . . . . 0.0 108.467 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.503 ' HB3' HD12 ' A' ' 66' ' ' LEU . . . -82.2 92.96 6.98 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.409 0.623 . . . . 0.0 109.77 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 40.7 t -85.84 118.43 70.54 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.322 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.508 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 43.2 Cg_endo -62.07 148.66 92.75 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.215 1.943 . . . . 0.0 111.594 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.57 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.4 mmmm -66.1 -25.12 66.86 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.567 0.747 . . . . 0.0 112.04 -174.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.508 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 15.1 ptmm? -66.75 -23.38 66.08 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.894 0.878 . . . . 0.0 111.452 174.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.8 t -82.85 -30.11 28.9 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 123.034 0.534 . . . . 0.0 110.317 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.57 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.7 mp -62.77 114.05 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.365 1.264 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 174.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -85.68 -52.16 5.98 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.385 1.074 . . . . 0.0 110.161 -175.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.0 m -144.22 154.24 42.91 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.059 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -117.19 109.37 27.52 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.429 1.092 . . . . 0.0 108.887 174.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.715 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 13.0 mm-40 -102.72 169.73 8.44 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.14 0.976 . . . . 0.0 109.644 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -71.87 93.63 1.35 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.952 0.501 . . . . 0.0 109.885 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.407 ' HA2' ' SD ' ' A' ' 9' ' ' MET . . . 93.32 2.77 65.59 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.031 -0.531 . . . . 0.0 113.261 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.715 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 92.7 mtt180 -133.6 141.19 47.55 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.355 0.662 . . . . 0.0 110.166 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.2 mm -118.16 103.72 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 168.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 76.7 t -76.7 113.78 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.428 HG22 HG13 ' A' ' 45' ' ' ILE . 31.4 pt -109.2 156.95 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.299 0.64 . . . . 0.0 109.492 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -116.67 -140.22 6.72 Favored Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.382 -168.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -78.49 123.03 26.61 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.389 0.676 . . . . 0.0 111.183 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -158.84 148.63 19.24 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 125.111 1.365 . . . . 0.0 108.035 175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -72.19 101.75 2.89 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 174.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.18 -28.99 64.63 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.894 0.878 . . . . 0.0 112.154 -176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -72.21 -39.45 68.54 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.728 0.775 . . . . 0.0 110.094 176.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.19 -30.89 62.44 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.02 175.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.21 -25.02 64.11 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.271 0.629 . . . . 0.0 110.226 172.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -74.19 -41.12 61.94 Favored 'General case' 0 C--N 1.353 0.741 0 C-N-CA 123.486 0.714 . . . . 0.0 110.018 177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.22 -42.22 69.19 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 118.128 0.422 . . . . 0.0 111.478 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 39' ' ' ALA . 4.5 pp -81.84 -14.54 56.14 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 120.839 0.352 . . . . 0.0 110.293 176.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -75.15 -44.4 23.22 Favored Glycine 0 C--N 1.35 1.319 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.469 171.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.3 -28.57 63.17 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.318 0.559 . . . . 0.0 109.703 177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -60.72 -39.66 89.42 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.619 170.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.512 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 86.1 t90 -59.46 -44.68 92.95 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.561 175.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.483 HD22 ' HE3' ' A' ' 70' ' ' TRP . 3.9 mm? -59.13 -32.15 69.6 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 176.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -72.75 -46.95 50.79 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.826 0.45 . . . . 0.0 110.391 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.543 ' O ' ' HG2' ' A' ' 76' ' ' LYS . 12.6 pt-20 -77.71 -31.28 52.24 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -173.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.88 -1.0 2.56 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -166.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.9 t -72.05 -3.96 26.01 Favored 'General case' 0 CA--C 1.557 1.22 0 C-N-CA 123.462 0.705 . . . . 0.0 111.468 174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.543 ' HG2' ' O ' ' A' ' 73' ' ' GLU . 28.5 mmtp -63.72 148.09 94.9 Favored Pre-proline 0 N--CA 1.484 1.272 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 169.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.5 139.8 66.24 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 121.974 1.783 . . . . 0.0 111.964 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.9 p -68.77 -21.05 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.84 173.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.541 ' HB ' HD21 ' A' ' 83' ' ' LEU . 36.3 p 64.83 172.23 0.2 Allowed 'General case' 0 C--N 1.361 1.068 0 C-N-CA 126.839 2.056 . . . . 0.0 112.154 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.472 ' HG ' ' H ' ' A' ' 82' ' ' GLU . 2.3 pt? -157.87 179.83 8.83 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.33 -172.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -23.96 63.71 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.419 0.688 . . . . 0.0 112.345 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.472 ' H ' ' HG ' ' A' ' 80' ' ' LEU . 37.2 tt0 -56.85 -39.89 75.11 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.171 0.989 . . . . 0.0 112.679 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.541 HD21 ' HB ' ' A' ' 79' ' ' THR . 2.7 pp -86.08 2.29 47.16 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -130.32 -169.97 2.24 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.147 0.579 . . . . 0.0 109.784 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.3 m -70.05 129.45 39.47 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -74.51 91.47 2.28 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.36 140.28 3.23 Favored Glycine 0 C--N 1.337 0.586 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.573 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -160.11 -42.24 0.05 OUTLIER 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.731 0.812 . . . . 0.0 108.907 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.78 64.9 2.44 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.795 -175.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -58.31 112.53 1.59 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.858 0.863 . . . . 0.0 111.544 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -109.41 91.97 3.86 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.774 0.83 . . . . 0.0 110.135 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.88 89.87 1.52 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 173.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.64 119.48 9.32 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.23 0.612 . . . . 0.0 110.552 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 111.45 -135.84 13.12 Favored Glycine 0 C--N 1.34 0.785 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -172.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.5 m . . . . . 0 C--O 1.252 1.207 0 C-N-CA 123.948 0.899 . . . . 0.0 108.685 177.907 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -60.79 98.3 0.15 Allowed Glycine 0 C--N 1.347 1.164 0 N-CA-C 112.265 -0.334 . . . . 0.0 112.265 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -63.22 101.26 0.28 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.548 0.739 . . . . 0.0 110.192 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 69.1 mtm -84.79 105.83 15.87 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.15 84.17 0.53 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.396 0.617 . . . . 0.0 110.318 177.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.7 mt -77.53 -19.25 56.05 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.48 168.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 35.3 pt -79.22 157.5 4.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.675 1.59 . . . . 0.0 110.425 173.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.5 p -79.89 -36.8 35.99 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.804 0.441 . . . . 0.0 110.03 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 51.8 ttm -166.93 165.13 16.14 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.395 0.678 . . . . 0.0 109.793 -174.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -82.95 156.03 23.7 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.164 0.585 . . . . 0.0 109.737 170.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.465 HG22 ' HB ' ' A' ' 53' ' ' ILE . 81.3 t -121.7 129.72 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 123.986 0.915 . . . . 0.0 109.968 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -119.8 121.28 38.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.787 1.235 . . . . 0.0 108.726 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -78.86 86.48 4.77 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.38 -96.57 0.64 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.879 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -105.82 -18.74 13.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.635 0.774 . . . . 0.0 111.579 -176.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -98.25 156.45 16.7 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.832 0.453 . . . . 0.0 110.332 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 t -81.69 119.67 24.14 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 173.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -93.69 -55.75 3.15 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.263 0.625 . . . . 0.0 110.78 -173.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -172.05 -151.63 7.95 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.201 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -135.1 123.22 22.85 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.425 0.69 . . . . 0.0 109.431 178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.514 ' HB2' HD11 ' A' ' 29' ' ' LEU . 12.9 p -71.14 108.43 4.66 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.59 ' HA ' ' HA ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -93.35 -39.15 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 123.507 0.723 . . . . 0.0 109.707 -177.441 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -142.97 166.22 25.22 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.468 0.707 . . . . 0.0 109.59 -175.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.5 p -152.27 130.27 2.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.792 0.837 . . . . 0.0 108.819 173.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.411 ' HE1' HD11 ' A' ' 30' ' ' ILE . 3.4 p90 -142.22 134.3 27.45 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.05 -106.71 1.18 Allowed Glycine 0 CA--C 1.531 1.073 0 O-C-N 123.441 0.463 . . . . 0.0 113.277 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -119.63 18.14 12.74 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.778 0.831 . . . . 0.0 111.234 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.595 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 55.4 m-85 -126.08 113.17 16.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 122.927 0.491 . . . . 0.0 111.21 -175.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 21' ' ' SER . 62.6 tp -82.61 108.08 15.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.0 0.92 . . . . 0.0 109.219 171.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.411 HD11 ' HE1' ' A' ' 25' ' ' TYR . 39.2 mm -71.54 106.08 2.04 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 177.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.6 t -109.19 119.72 59.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.574 0.75 . . . . 0.0 109.861 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -74.31 109.18 7.59 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.285 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.6 m -116.15 103.19 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 124.521 1.128 . . . . 0.0 110.62 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.46 -89.03 0.05 OUTLIER Glycine 0 CA--C 1.528 0.871 0 CA-C-N 115.179 -0.919 . . . . 0.0 113.911 174.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.2 p -85.76 -41.19 15.3 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.222 1.009 . . . . 0.0 111.909 -174.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -150.03 -175.45 5.06 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -165.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -104.17 111.61 24.28 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.457 1.103 . . . . 0.0 110.686 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.1 mp -104.38 127.43 52.04 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 172.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -86.32 93.63 9.14 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.001 -175.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -72.14 115.54 39.66 Favored Pre-proline 0 CA--C 1.554 1.112 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.586 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.5 149.97 89.14 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.735 2.29 . . . . 0.0 112.09 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.58 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.5 mmmm -67.26 -16.87 64.53 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -173.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -65.5 -30.9 71.72 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.085 0.554 . . . . 0.0 110.816 172.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' A' ' 58' ' ' PHE . 37.3 t -76.68 -32.62 58.03 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.649 177.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.58 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.8 mp -63.75 114.62 2.06 Favored 'Isoleucine or valine' 0 C--N 1.359 0.98 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -95.57 -53.55 3.69 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.36 1.064 . . . . 0.0 110.771 -172.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.0 t -150.09 134.26 17.13 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 122.998 0.519 . . . . 0.0 110.003 -173.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 p -98.66 111.75 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.466 0.65 . . . . 0.0 110.178 177.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.655 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 30.6 mm-40 -103.81 173.11 6.44 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.159 0.984 . . . . 0.0 111.07 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.31 101.06 1.43 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.153 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.76 12.5 83.49 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.446 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.655 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 61.5 mtp180 -141.42 135.7 30.63 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.645 0.778 . . . . 0.0 110.044 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.465 ' HB ' HG22 ' A' ' 11' ' ' VAL . 30.8 mm -109.11 103.04 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 167.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 96.8 t -78.36 112.06 15.92 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 30.6 pt -112.01 177.7 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 123.648 0.779 . . . . 0.0 109.826 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.05 -146.18 7.43 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 172.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -81.25 165.91 21.03 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.063 0.545 . . . . 0.0 110.072 172.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.51 ' HB3' ' HB2' ' A' ' 44' ' ' SER . 29.1 p90 -167.0 174.04 8.75 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.867 0.867 . . . . 0.0 109.209 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -73.14 86.28 1.38 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -70.86 -36.51 72.85 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.612 1.165 . . . . 0.0 112.417 -171.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -71.08 -33.83 70.58 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.045 0.538 . . . . 0.0 110.154 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -71.38 -40.56 70.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.093 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.98 -28.05 69.55 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.834 0.854 . . . . 0.0 111.303 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.36 -48.96 20.61 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.253 1.021 . . . . 0.0 110.414 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.09 -40.32 78.48 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.633 0.373 . . . . 0.0 111.561 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.1 pp -82.61 -17.18 45.68 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 122.185 -0.322 . . . . 0.0 110.441 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.05 -44.07 46.55 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.346 0.404 . . . . 0.0 112.362 174.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -71.02 -30.72 67.0 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 39.4 ttmt -62.2 -42.33 99.19 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.448 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 53.2 t90 -58.23 -44.97 88.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.889 0.743 . . . . 0.0 110.672 176.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.8 mt -57.54 -28.58 63.64 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.298 0.639 . . . . 0.0 111.686 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -82.87 -35.87 25.86 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.086 0.554 . . . . 0.0 111.242 172.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 44.3 mt-10 -65.86 -22.8 66.56 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 124.44 1.096 . . . . 0.0 111.217 -178.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 70' ' ' TRP . 27.3 mtpp -65.15 -38.66 91.29 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.5 172.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.7 t -85.27 -30.05 24.1 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.773 0.829 . . . . 0.0 111.145 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -84.42 154.49 62.68 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 123.893 0.877 . . . . 0.0 110.72 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.03 136.07 33.94 Favored 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 121.973 1.782 . . . . 0.0 109.875 163.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.4 p -64.71 93.31 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 CA-C-O 121.858 0.837 . . . . 0.0 109.87 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.4 t -80.54 76.89 7.38 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.813 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.8 tp -151.33 137.97 18.78 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.556 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.53 0.99 7.61 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.141 0.977 . . . . 0.0 111.132 176.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -66.46 -30.58 70.96 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.949 0.5 . . . . 0.0 111.389 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -66.39 -30.9 71.37 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.56 0.344 . . . . 0.0 110.577 173.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? 58.59 30.13 19.41 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.031 1.332 . . . . 0.0 111.228 172.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.7 t -88.44 98.42 11.62 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.477 -169.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -96.01 -61.05 1.51 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.173 0.589 . . . . 0.0 109.883 175.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.4 -58.53 0.09 OUTLIER Glycine 0 C--N 1.347 1.144 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.79 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 59.75 19.2 7.97 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.83 0.852 . . . . 0.0 111.676 -172.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -140.18 38.1 1.63 Allowed Glycine 0 C--N 1.343 0.919 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 177.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -128.78 106.75 9.14 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 113.902 -1.149 . . . . 0.0 109.76 -169.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -89.18 90.72 8.49 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 -178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -164.72 80.87 0.12 Allowed Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.61 -59.77 4.18 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.807 0.843 . . . . 0.0 110.223 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -87.87 73.57 2.3 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.137 177.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.7 m . . . . . 0 C--O 1.254 1.292 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.915 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 N--CA 1.481 1.082 0 CA-C-O 120.633 0.254 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.29 -173.62 41.01 Favored Glycine 0 C--N 1.344 0.996 0 CA-C-N 116.124 -0.489 . . . . 0.0 113.223 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -140.89 -167.32 2.34 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.12 0.968 . . . . 0.0 109.683 -175.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.3 mtp -74.61 -179.07 3.88 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.357 0.663 . . . . 0.0 110.815 171.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -89.85 -18.25 26.56 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -170.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.5 -20.14 26.95 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 122.918 0.487 . . . . 0.0 111.909 -173.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.2 tt -67.52 137.58 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.424 0.69 . . . . 0.0 111.034 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 61.2 m -114.35 81.58 1.57 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.815 0.846 . . . . 0.0 109.652 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 71.1 mtm -70.23 154.06 42.36 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.791 0.836 . . . . 0.0 110.549 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -90.59 135.98 33.35 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.006 0.432 . . . . 0.0 111.165 -173.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.426 HG21 HG22 ' A' ' 31' ' ' VAL . 99.9 t -91.78 130.38 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.72 0.808 . . . . 0.0 109.719 -177.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -118.27 127.37 53.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.664 1.186 . . . . 0.0 109.576 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 28.5 tptp -78.26 91.16 4.37 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 172.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.97 -95.67 0.65 Allowed Glycine 0 C--N 1.342 0.886 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 -171.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.71 -21.48 7.85 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.421 0.689 . . . . 0.0 110.74 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 14.8 pt-20 -79.43 144.23 34.28 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.5 t -70.28 111.18 5.69 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.794 0.438 . . . . 0.0 110.345 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -82.32 -51.18 8.14 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.096 0.558 . . . . 0.0 110.531 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.462 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . -179.55 -143.2 5.35 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.885 -177.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -136.96 133.52 35.71 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.72 0.808 . . . . 0.0 109.956 -177.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.413 ' OG ' HD11 ' A' ' 29' ' ' LEU . 30.2 t -75.02 106.5 6.55 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 172.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.27 -40.82 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.294 0.638 . . . . 0.0 109.313 -177.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.446 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 22.8 t70 -149.14 172.22 15.16 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.372 0.669 . . . . 0.0 109.815 -171.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.404 ' HB ' HD12 ' A' ' 29' ' ' LEU . 9.9 p -152.1 145.17 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 C-N-CA 124.334 1.054 . . . . 0.0 108.538 172.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -143.12 127.22 17.46 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 171.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.2 -106.86 1.12 Allowed Glycine 0 C--N 1.343 0.938 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.728 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 28.7 t70 -107.05 -15.18 14.75 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.071 0.948 . . . . 0.0 111.114 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.493 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 95.3 m-85 -97.34 107.56 20.1 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.558 0.695 . . . . 0.0 111.186 -171.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.413 HD11 ' OG ' ' A' ' 21' ' ' SER . 41.7 tp -76.31 113.29 13.72 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.956 174.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 49.7 mm -75.44 107.77 6.6 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.015 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.426 HG22 HG21 ' A' ' 11' ' ' VAL . 43.0 t -103.76 113.63 41.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 123.992 0.917 . . . . 0.0 109.314 178.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -75.94 114.99 15.19 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.462 HG12 ' HA3' ' A' ' 19' ' ' GLY . 34.1 m -127.45 129.84 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.959 0.904 . . . . 0.0 109.36 176.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.9 -100.11 0.27 Allowed Glycine 0 C--N 1.346 1.127 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.848 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.6 p -126.1 5.15 7.16 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.214 1.005 . . . . 0.0 112.008 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -134.21 169.65 16.87 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.154 0.582 . . . . 0.0 112.164 -173.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -112.9 123.87 51.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.364 1.065 . . . . 0.0 109.457 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.8 mp -107.22 115.61 30.48 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.964 0.906 . . . . 0.0 109.008 175.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.493 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -78.97 93.63 5.11 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.786 0.835 . . . . 0.0 109.724 177.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.484 HG12 ' CE2' ' A' ' 58' ' ' PHE . 4.0 m -89.04 134.5 33.21 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -176.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 97.9 Cg_endo -73.45 153.05 49.84 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 122.254 1.969 . . . . 0.0 111.242 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.584 ' HA ' HD13 ' A' ' 45' ' ' ILE . 13.8 mmmm -65.77 -24.28 66.91 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.487 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 7.8 ptpp? -66.38 -25.83 66.97 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 122.713 0.405 . . . . 0.0 111.361 173.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.3 t -69.1 -41.22 77.75 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 172.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.584 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.7 mp -66.71 114.49 3.69 Favored 'Isoleucine or valine' 0 C--N 1.36 1.044 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -78.71 -48.79 14.25 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.474 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 36.2 t -158.46 139.53 13.11 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.301 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 p -77.89 133.18 31.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 168.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.803 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 17.8 mm-40 -116.23 177.58 4.64 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.187 0.995 . . . . 0.0 110.04 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -64.02 93.14 0.08 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.858 0.863 . . . . 0.0 110.463 173.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.86 5.72 88.66 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-N 114.906 -1.043 . . . . 0.0 114.213 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.803 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 69.9 mtt85 -127.71 162.21 27.1 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.079 0.552 . . . . 0.0 110.728 -174.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.0 mm -133.27 103.34 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 174.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.5 t -83.45 120.64 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 42.0 pt -109.06 145.21 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 123.943 0.897 . . . . 0.0 109.174 170.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.26 -55.03 1.88 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 112.135 -0.386 . . . . 0.0 112.135 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 9.9 pt-20 -174.03 159.27 3.26 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.949 0.9 . . . . 0.0 110.552 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.484 ' CE2' HG12 ' A' ' 40' ' ' VAL . 8.1 p90 -171.11 174.18 4.75 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.463 0.705 . . . . 0.0 110.779 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -74.44 86.51 2.03 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.495 0.718 . . . . 0.0 109.483 172.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -71.15 -38.73 72.22 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.285 0.634 . . . . 0.0 112.669 -174.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.487 ' HG3' ' HG3' ' A' ' 62' ' ' GLU . 7.4 pt-20 -65.4 -38.24 89.37 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.491 0.717 . . . . 0.0 110.817 177.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.523 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 44.6 mt-10 -80.88 -32.79 34.74 Favored 'General case' 0 C--O 1.22 -0.489 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.809 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.75 -26.31 66.92 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.276 0.631 . . . . 0.0 110.611 174.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.1 ttt180 -72.69 -51.87 17.54 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.243 1.017 . . . . 0.0 111.179 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.523 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.7 pt-20 -69.84 -35.74 74.99 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.311 0.577 . . . . 0.0 110.809 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.22 -13.79 54.64 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.66 -27.53 69.09 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 165.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -69.96 -37.44 75.81 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.83 0.852 . . . . 0.0 108.854 167.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -59.59 -36.52 76.42 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 122.912 0.485 . . . . 0.0 110.875 173.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.545 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 59.7 t90 -60.95 -54.21 47.79 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 173.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.7 mt -54.92 -35.11 63.81 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.48 0.712 . . . . 0.0 111.447 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -73.16 -35.44 66.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.224 1.01 . . . . 0.0 110.452 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -77.07 -23.67 51.94 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.818 0.447 . . . . 0.0 109.864 175.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 70' ' ' TRP . 31.1 mmmt -68.74 -5.95 23.52 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.746 0.418 . . . . 0.0 111.097 171.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 50.4 m 69.94 40.07 1.32 Allowed 'General case' 0 C--N 1.354 0.762 0 C-N-CA 125.001 1.32 . . . . 0.0 110.251 176.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.548 ' HB3' HD11 ' A' ' 83' ' ' LEU . 71.2 mmtt -59.99 131.97 89.51 Favored Pre-proline 0 C--N 1.355 0.843 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.048 173.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.46 138.98 68.29 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.507 2.138 . . . . 0.0 112.809 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 84' ' ' LYS . 34.3 m -76.62 10.22 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.107 0 C-N-CA 124.156 0.982 . . . . 0.0 112.356 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.4 m -51.85 -42.92 62.98 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.414 1.086 . . . . 0.0 111.592 176.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.64 135.17 48.19 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 171.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -66.42 -39.87 89.19 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 123.457 0.473 . . . . 0.0 110.955 -173.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -62.41 -37.1 84.52 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.702 0.801 . . . . 0.0 111.06 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.548 HD11 ' HB3' ' A' ' 76' ' ' LYS . 1.5 tt -77.9 -22.6 49.45 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.986 0.914 . . . . 0.0 110.203 -176.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.425 ' HA ' ' HB ' ' A' ' 78' ' ' VAL . 4.4 ttmp? -72.03 -10.78 60.25 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.704 0.802 . . . . 0.0 112.419 -176.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.9 p -63.39 92.07 0.06 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.117 0.567 . . . . 0.0 110.944 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -73.96 124.18 25.7 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.15 0.98 . . . . 0.0 108.92 175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -81.76 -78.66 0.98 Allowed Glycine 0 C--N 1.339 0.747 0 O-C-N 123.349 0.406 . . . . 0.0 112.147 -176.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -139.06 -59.53 0.59 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.681 0.792 . . . . 0.0 110.792 -171.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -171.04 62.34 0.17 Allowed Glycine 0 C--N 1.339 0.726 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 -173.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -96.46 -9.36 29.92 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.598 0.759 . . . . 0.0 111.042 -177.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -123.45 122.27 37.82 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.29 -92.74 0.09 OUTLIER Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 58.68 28.38 17.15 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.59 1.156 . . . . 0.0 112.512 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.51 -158.38 17.95 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 115.674 -0.693 . . . . 0.0 113.21 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.7 m . . . . . 0 C--O 1.251 1.134 0 C-N-CA 123.007 0.523 . . . . 0.0 110.24 178.229 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.678 0.275 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.19 18.56 49.48 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 113.648 176.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.7 m-70 -109.98 96.23 6.1 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.631 0.772 . . . . 0.0 109.018 177.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.429 ' N ' ' SD ' ' A' ' 4' ' ' MET . 1.4 mpt? -82.05 95.62 7.5 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.58 0.752 . . . . 0.0 109.512 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -82.27 -5.4 58.52 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.616 0.766 . . . . 0.0 111.332 176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.1 mp -87.6 12.9 11.4 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.889 0.876 . . . . 0.0 110.574 174.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.0 tp -72.27 154.74 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.225 0 C-N-CA 123.841 0.856 . . . . 0.0 110.701 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 80.6 m -67.75 88.57 0.25 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.195 0.598 . . . . 0.0 109.628 174.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.453 ' SD ' HD11 ' A' ' 53' ' ' ILE . 61.0 mtt -70.52 141.66 51.9 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.093 -178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -84.28 130.33 34.82 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.403 0.681 . . . . 0.0 109.475 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.0 t -86.62 115.24 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.076 0.55 . . . . 0.0 109.937 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -101.64 117.58 35.19 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.116 0.967 . . . . 0.0 109.692 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 18' ' ' PHE . 85.3 tttt -77.94 94.41 4.58 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.12 -94.85 0.47 Allowed Glycine 0 C--N 1.344 1.002 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -102.5 -42.91 5.8 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.735 0.814 . . . . 0.0 110.824 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.35 145.42 37.33 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.959 0.504 . . . . 0.0 110.935 -168.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.7 t -69.8 104.87 2.58 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 13' ' ' LYS . 46.9 t80 -74.95 -50.05 18.02 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.713 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.73 -141.4 3.94 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.82 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -140.18 130.73 25.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.371 0.668 . . . . 0.0 110.221 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.418 ' OG ' HD11 ' A' ' 29' ' ' LEU . 25.9 t -68.07 109.96 3.74 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.155 0.982 . . . . 0.0 109.542 174.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.05 -43.71 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.028 0.531 . . . . 0.0 109.851 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.428 ' HB3' ' HB ' ' A' ' 30' ' ' ILE . 22.6 t70 -143.35 167.61 21.75 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.74 0.416 . . . . 0.0 110.466 -171.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.2 t -139.71 140.97 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 124.421 1.089 . . . . 0.0 108.133 174.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -141.39 129.91 22.61 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 169.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.36 -107.4 1.35 Allowed Glycine 0 C--N 1.35 1.326 0 O-C-N 123.304 0.378 . . . . 0.0 113.268 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -119.21 24.53 10.7 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.55 0.74 . . . . 0.0 110.918 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.53 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 96.0 m-85 -133.39 124.85 27.9 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.247 0.619 . . . . 0.0 111.375 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.418 HD11 ' OG ' ' A' ' 21' ' ' SER . 55.8 tp -80.55 113.99 19.13 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.406 1.083 . . . . 0.0 109.562 170.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.428 ' HB ' ' HB3' ' A' ' 23' ' ' ASP . 42.8 mm -72.74 106.07 2.69 Favored 'Isoleucine or valine' 0 C--O 1.249 1.063 0 C-N-CA 123.234 0.614 . . . . 0.0 109.51 175.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.0 t -103.28 118.42 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.151 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -74.97 116.87 16.18 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 m -126.05 99.2 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 123.953 0.901 . . . . 0.0 110.614 -177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.29 -89.53 0.1 Allowed Glycine 0 CA--C 1.531 1.073 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.873 177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 72.5 p -114.91 -21.99 9.83 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.121 0.968 . . . . 0.0 111.272 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -109.07 174.44 5.87 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 121.647 0.737 . . . . 0.0 111.363 -172.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -120.96 108.6 14.07 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.238 173.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -96.66 106.07 18.28 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -82.83 93.33 7.44 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.297 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.6 m -77.67 136.7 63.2 Favored Pre-proline 0 CA--C 1.548 0.894 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.554 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 35.8 Cg_endo -62.4 149.37 91.06 Favored 'Trans proline' 0 C--N 1.373 1.843 0 C-N-CA 121.905 1.737 . . . . 0.0 111.289 176.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.566 ' HA ' HD13 ' A' ' 45' ' ' ILE . 32.0 mmmt -63.59 -26.21 68.58 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.013 0.525 . . . . 0.0 111.8 -178.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.554 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 0.4 OUTLIER -67.71 -23.43 65.28 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.677 0.791 . . . . 0.0 111.449 175.725 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -72.3 -27.36 62.41 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.784 0.434 . . . . 0.0 110.616 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.566 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.1 mp -67.91 115.65 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -92.03 -48.54 6.69 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.254 1.022 . . . . 0.0 110.974 -178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 34.1 t -138.49 147.63 43.4 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.402 -175.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.5 p -122.0 126.05 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.357 1.063 . . . . 0.0 109.099 177.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 40.5 mt-10 -138.11 168.54 19.52 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.286 1.035 . . . . 0.0 109.537 -175.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.72 99.87 0.25 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.124 0.57 . . . . 0.0 110.432 175.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.15 1.06 88.65 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 115.905 -0.589 . . . . 0.0 113.643 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.544 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 33.7 mtm180 -130.97 124.94 32.09 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.514 0.657 . . . . 0.0 110.284 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.453 HD11 ' SD ' ' A' ' 9' ' ' MET . 50.8 mm -115.06 102.14 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 170.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.9 t -86.11 115.23 27.02 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.7 pt -107.04 175.14 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 123.569 0.747 . . . . 0.0 109.357 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -114.04 -142.88 8.21 Favored Glycine 0 C--O 1.24 0.507 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -81.56 157.12 24.89 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 174.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -167.37 170.66 11.27 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.892 0.877 . . . . 0.0 109.201 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -81.16 93.52 6.47 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -71.23 -39.94 71.37 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.074 0.95 . . . . 0.0 112.74 -171.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -65.34 -37.88 88.41 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-O 121.009 0.433 . . . . 0.0 110.491 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -71.9 -37.64 70.09 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.568 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.12 -34.32 77.35 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.508 0.723 . . . . 0.0 111.333 -176.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 6.7 ptp85 -74.39 -44.72 50.87 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 119.112 -0.47 . . . . 0.0 111.157 177.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.98 -37.57 86.32 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 118.275 0.489 . . . . 0.0 111.602 -175.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.0 pp -81.63 -21.15 38.41 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 122.478 0.311 . . . . 0.0 110.399 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.43 -33.78 68.15 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.039 170.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.465 ' HA ' HD12 ' A' ' 71' ' ' LEU . 59.0 mtp180 -77.41 -30.55 53.55 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.359 1.064 . . . . 0.0 109.853 175.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -63.28 -39.51 94.78 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.141 0.576 . . . . 0.0 109.715 170.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -60.24 -45.36 93.52 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.985 0.514 . . . . 0.0 109.917 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 68' ' ' ARG . 50.4 mt -58.53 -23.41 58.18 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.797 0.839 . . . . 0.0 112.517 177.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -83.65 -53.4 5.68 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.706 0.402 . . . . 0.0 110.728 174.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.85 -15.37 60.23 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.991 0.916 . . . . 0.0 113.379 -170.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -57.33 -14.42 4.56 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.204 1.001 . . . . 0.0 112.947 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -64.63 4.85 0.35 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.288 1.435 . . . . 0.0 114.412 -177.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.85 145.43 96.78 Favored Pre-proline 0 CA--C 1.551 1.009 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 171.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.58 137.73 60.96 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.106 1.871 . . . . 0.0 111.044 175.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.2 p -79.76 64.51 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 CA-C-O 123.209 1.48 . . . . 0.0 110.084 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.0 t -87.98 -11.24 48.0 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.315 177.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.47 HD22 ' HB2' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -79.21 81.93 5.42 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.017 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -72.47 -24.43 61.18 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.804 1.242 . . . . 0.0 110.949 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -67.99 -29.02 67.95 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.951 175.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.47 ' HB2' HD22 ' A' ' 80' ' ' LEU . 6.6 tt -70.13 -39.0 75.69 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -60.99 -70.61 0.17 Allowed 'General case' 0 C--N 1.353 0.739 0 O-C-N 123.835 0.709 . . . . 0.0 109.929 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.1 p -93.02 62.22 3.56 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.496 0.718 . . . . 0.0 109.532 -178.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -71.43 127.21 31.82 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.057 -172.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.83 79.82 0.96 Allowed Glycine 0 C--N 1.35 1.358 0 CA-C-N 115.15 -0.932 . . . . 0.0 112.331 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -133.99 -49.5 0.81 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.563 1.145 . . . . 0.0 108.177 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.02 136.43 8.82 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.734 173.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -66.49 115.13 6.04 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.46 111.94 3.82 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.333 176.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -75.06 -34.85 51.33 Favored Glycine 0 C--N 1.342 0.904 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 174.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -114.44 28.15 8.95 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.259 1.024 . . . . 0.0 110.491 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.96 80.25 1.1 Allowed Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.487 -0.324 . . . . 0.0 113.741 -174.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--O 1.248 1.02 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.323 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.529 ' HB3' ' HB3' ' A' ' 88' ' ' PHE . 8.2 pm0 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.34 138.53 3.93 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 123.19 0.307 . . . . 0.0 112.505 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -81.62 106.54 13.65 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 172.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 83.3 mtp -74.94 95.63 3.01 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.6 0.76 . . . . 0.0 110.196 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -91.11 62.41 4.82 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.6 0.715 . . . . 0.0 109.923 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -119.51 0.09 10.96 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.73 0.812 . . . . 0.0 109.506 173.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.1 tt -69.14 120.56 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 C-N-CA 123.501 0.721 . . . . 0.0 111.298 -173.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.0 p -171.36 143.49 1.85 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.019 1.328 . . . . 0.0 107.758 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.406 ' SD ' HD11 ' A' ' 53' ' ' ILE . 18.5 ttt -149.0 140.67 23.51 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 109.875 -0.416 . . . . 0.0 109.875 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -72.82 141.27 48.02 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.6 t -119.49 127.75 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.578 0.751 . . . . 0.0 110.02 -178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -109.35 132.91 53.68 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.228 1.011 . . . . 0.0 109.044 171.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -83.98 82.39 8.37 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.83 -100.58 0.85 Allowed Glycine 0 C--N 1.344 0.986 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.239 -177.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -97.16 -28.07 14.27 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 123.851 0.86 . . . . 0.0 110.879 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -92.15 152.31 19.96 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.811 0.444 . . . . 0.0 110.119 -176.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.1 t -74.16 125.14 27.71 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.305 0.642 . . . . 0.0 109.349 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -98.46 -58.59 1.93 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 121.957 0.103 . . . . 0.0 110.848 -174.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.53 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . 172.66 -141.43 6.22 Favored Glycine 0 C--N 1.345 1.031 0 O-C-N 123.413 0.446 . . . . 0.0 112.196 -173.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -144.86 137.98 26.68 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.826 0.85 . . . . 0.0 110.13 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.7 p -73.61 118.2 16.28 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 175.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.21 -37.82 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 123.589 0.756 . . . . 0.0 109.042 178.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -156.27 176.83 12.17 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.977 0.511 . . . . 0.0 110.822 -175.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.4 p -150.17 138.28 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 C-N-CA 124.46 1.104 . . . . 0.0 108.868 171.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -136.21 133.69 37.36 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 172.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 61.67 -106.62 1.22 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 123.463 0.477 . . . . 0.0 113.793 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -117.14 11.63 14.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.903 0.881 . . . . 0.0 111.026 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.577 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 81.8 m-85 -125.15 111.56 15.45 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.039 0.535 . . . . 0.0 111.549 -173.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 57.7 tp -77.82 110.35 12.62 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.507 1.123 . . . . 0.0 109.485 173.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.0 mm -71.94 100.11 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 123.26 0.624 . . . . 0.0 109.606 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.8 t -102.06 113.22 37.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.428 0.691 . . . . 0.0 109.787 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.7 tptm -76.24 120.05 20.98 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.669 0.787 . . . . 0.0 109.882 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.53 HG12 ' HA3' ' A' ' 19' ' ' GLY . 1.3 m -132.45 142.04 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.7 -96.21 0.03 OUTLIER Glycine 0 CA--C 1.537 1.456 0 O-C-N 123.274 0.359 . . . . 0.0 113.966 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.3 m -124.49 -16.39 6.34 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.509 1.124 . . . . 0.0 111.023 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -114.72 166.88 11.27 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.934 0.893 . . . . 0.0 112.149 -170.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -113.65 112.25 23.18 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.211 1.004 . . . . 0.0 109.751 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.424 HD23 HG22 ' A' ' 33' ' ' VAL . 3.5 mm? -94.55 105.95 17.92 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.932 0.893 . . . . 0.0 109.175 176.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.577 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -77.82 92.37 4.22 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 172.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.9 m -86.22 136.63 35.54 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.65 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.542 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 37.7 Cg_endo -63.33 151.28 85.68 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.221 1.947 . . . . 0.0 111.36 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.565 ' HA ' HD13 ' A' ' 45' ' ' ILE . 14.4 mmmm -67.3 -23.26 65.63 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 122.953 0.501 . . . . 0.0 111.457 -176.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.542 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 22.4 ptmt -69.61 -26.55 64.5 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.686 0.794 . . . . 0.0 111.457 174.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.3 t -65.35 -31.29 72.33 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.269 0.628 . . . . 0.0 110.604 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.565 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.0 mp -64.95 116.36 4.12 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 175.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -92.28 -52.1 4.84 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.153 0.981 . . . . 0.0 110.936 -177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.3 t -148.83 139.87 23.02 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.566 -171.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.2 t -102.92 110.75 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 173.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -142.09 130.89 22.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 63.28 33.88 13.73 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.415 1.086 . . . . 0.0 112.944 166.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.92 15.98 80.71 Favored Glycine 0 C--N 1.35 1.343 0 CA-C-O 121.316 0.398 . . . . 0.0 112.326 -177.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 38.4 mtt180 -125.15 158.21 34.48 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.68 1.192 . . . . 0.0 109.063 -175.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.406 HD11 ' SD ' ' A' ' 9' ' ' MET . 28.6 mm -120.47 104.91 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.634 0.774 . . . . 0.0 109.55 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.9 t -80.0 113.01 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' A' ' 45' ' ' ILE . 37.4 pt -109.49 142.75 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 172.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.79 -74.48 1.2 Allowed Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.982 -0.447 . . . . 0.0 111.982 -175.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -152.73 164.19 38.24 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.63 0.772 . . . . 0.0 109.685 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -170.51 163.89 8.43 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 124.377 1.071 . . . . 0.0 108.298 -175.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -77.77 97.09 5.09 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.05 -35.99 82.92 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.589 0.756 . . . . 0.0 112.007 -174.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -62.6 -45.54 92.42 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.682 0.614 . . . . 0.0 110.484 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.412 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 35.1 mt-10 -70.29 -38.7 75.08 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.887 177.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.17 -38.55 91.46 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.569 0.748 . . . . 0.0 111.363 -176.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -74.41 -38.4 63.08 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.326 0.25 . . . . 0.0 111.582 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.412 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.8 pt-20 -76.75 -40.86 47.01 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -176.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 pp -82.47 -12.99 57.46 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.0 0.429 . . . . 0.0 109.996 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.99 -48.45 75.72 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 162.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.0 mtt-85 -63.48 -31.94 73.25 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.901 0.881 . . . . 0.0 111.511 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 22.8 ttmm -55.9 -48.78 75.01 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.115 0.566 . . . . 0.0 109.514 172.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.577 ' HE3' HD12 ' A' ' 71' ' ' LEU . 79.9 t90 -60.25 -42.56 95.57 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 123.309 0.38 . . . . 0.0 110.663 174.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.577 HD12 ' HE3' ' A' ' 70' ' ' TRP . 10.6 mp -57.0 -28.95 62.89 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 122.666 0.387 . . . . 0.0 112.027 177.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -77.91 -54.43 6.32 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 122.958 0.503 . . . . 0.0 110.285 176.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 33.7 mt-10 -76.45 -18.24 58.89 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.472 1.109 . . . . 0.0 113.04 -168.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -61.21 -19.19 61.35 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.356 0.662 . . . . 0.0 112.263 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.3 m -66.48 83.51 0.1 Allowed 'General case' 0 C--N 1.354 0.764 0 C-N-CA 124.378 1.071 . . . . 0.0 112.05 -177.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -96.07 143.69 26.55 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 123.468 0.707 . . . . 0.0 109.145 167.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -80.22 -161.72 0.16 Allowed 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.888 2.392 . . . . 0.0 113.103 -174.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.32 -29.95 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 123.339 0.656 . . . . 0.0 110.552 177.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 49.9 p -76.71 92.08 3.51 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 168.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.01 26.0 1.72 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.445 0.641 . . . . 0.0 109.779 174.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.67 -4.45 0.28 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 125.402 1.481 . . . . 0.0 114.191 177.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -49.41 -46.14 47.12 Favored 'General case' 0 CA--C 1.565 1.522 0 C-N-CA 125.318 1.447 . . . . 0.0 113.246 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -84.91 -12.65 52.94 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 122.778 0.431 . . . . 0.0 111.022 -175.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.8 mmtm -74.75 -23.4 58.54 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.518 0.727 . . . . 0.0 109.911 172.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.2 t -78.96 87.98 4.76 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -104.38 -38.4 6.84 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.358 1.063 . . . . 0.0 110.78 -174.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 123.35 64.97 0.2 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 112.264 -0.334 . . . . 0.0 112.264 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.529 ' HB3' ' HB3' ' A' ' 1' ' ' GLN . 25.3 p90 -83.21 88.18 6.92 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.333 0.587 . . . . 0.0 109.658 176.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.98 -78.89 0.08 OUTLIER Glycine 0 C--N 1.344 0.98 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.193 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -63.4 -34.88 78.71 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.571 0.748 . . . . 0.0 111.06 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -73.04 106.33 4.87 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 170.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.43 -178.39 48.34 Favored Glycine 0 C--O 1.241 0.55 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.145 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.79 -32.77 69.97 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.871 0.468 . . . . 0.0 110.524 175.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 159.16 -116.11 0.7 Allowed Glycine 0 C--N 1.34 0.788 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 CA--C 1.548 0.88 0 C-N-CA 124.221 1.008 . . . . 0.0 108.511 177.466 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.46 40.83 2.29 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-N 116.518 -0.31 . . . . 0.0 112.619 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -96.54 -45.51 6.71 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.469 0.708 . . . . 0.0 110.399 -177.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.1 mmt -93.13 95.46 9.43 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -65.55 -20.42 66.32 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.557 1.143 . . . . 0.0 110.894 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 mp -81.49 33.32 0.36 Allowed 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.342 1.057 . . . . 0.0 111.534 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -37.25 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 169.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' SER . 60.7 m -90.56 82.54 5.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.61 0.764 . . . . 0.0 109.939 176.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.2 mtt -94.87 143.62 26.31 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.271 0.628 . . . . 0.0 109.857 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -71.65 110.88 6.5 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.304 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.4 HG22 ' HB ' ' A' ' 53' ' ' ILE . 58.5 t -79.27 124.7 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.813 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -113.61 121.89 45.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.032 0.933 . . . . 0.0 109.035 175.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 52.6 tttm -84.1 79.3 9.56 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.65 0.738 . . . . 0.0 109.624 175.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.61 -94.26 0.41 Allowed Glycine 0 C--N 1.342 0.9 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.831 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -96.9 -13.26 22.57 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.71 0.804 . . . . 0.0 111.591 -176.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 10.0 pt-20 -116.09 153.6 31.45 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.533 0.733 . . . . 0.0 109.609 -175.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.3 t -85.02 112.73 20.88 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 174.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -80.34 -56.8 3.94 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.531 0.333 . . . . 0.0 110.535 -172.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 178.18 -135.43 2.67 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.124 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -148.91 142.79 25.72 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.986 0.914 . . . . 0.0 109.985 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 39.1 p -74.52 108.3 7.19 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.497 0.719 . . . . 0.0 110.69 -178.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.87 -38.72 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.193 0.597 . . . . 0.0 110.117 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -153.66 172.4 17.31 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.39 0.676 . . . . 0.0 109.888 -172.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 p -155.66 132.68 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.888 0.875 . . . . 0.0 109.069 173.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.457 ' CE1' HD11 ' A' ' 30' ' ' ILE . 3.9 p90 -135.66 133.63 38.35 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.64 -105.43 1.23 Allowed Glycine 0 C--N 1.346 1.116 0 N-CA-C 111.926 -0.47 . . . . 0.0 111.926 -175.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -117.57 -0.85 11.78 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.841 0.856 . . . . 0.0 110.083 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.562 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 30.5 m-85 -104.1 106.21 16.64 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.706 -166.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 50.1 tp -75.84 105.65 6.99 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 173.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.457 HD11 ' CE1' ' A' ' 25' ' ' TYR . 38.0 mm -68.51 106.69 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.895 176.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.2 t -99.66 116.24 42.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -72.7 107.65 5.28 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 174.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.43 HG23 ' HB2' ' A' ' 36' ' ' GLU . 19.1 m -113.63 83.6 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 C-N-CA 124.434 1.094 . . . . 0.0 110.579 -173.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.61 -82.06 0.5 Allowed Glycine 0 C--N 1.348 1.23 0 CA-C-N 115.066 -0.97 . . . . 0.0 113.612 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 t -122.48 -11.08 8.35 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.853 0.861 . . . . 0.0 110.847 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.43 ' HB2' HG23 ' A' ' 33' ' ' VAL . 65.0 mm-40 -111.62 177.91 4.5 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.605 0.762 . . . . 0.0 110.55 -178.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.568 ' HB2' HD11 ' A' ' 71' ' ' LEU . 42.7 m-85 -134.29 110.93 9.82 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 169.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.5 mp -105.54 126.82 52.56 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.562 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -95.37 100.74 12.47 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.971 0.908 . . . . 0.0 110.472 -173.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.1 m -85.32 137.47 36.9 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 122.95 0.5 . . . . 0.0 109.896 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.16 160.47 41.82 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 122.392 2.061 . . . . 0.0 111.565 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -67.07 -23.69 65.89 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.504 0.322 . . . . 0.0 111.671 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.4 ptpp? -70.81 -22.78 62.3 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.262 0.625 . . . . 0.0 111.933 175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.2 t -64.1 -32.44 74.0 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.079 0.552 . . . . 0.0 110.932 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mp -68.32 114.0 4.71 Favored 'Isoleucine or valine' 0 C--N 1.356 0.856 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -87.11 -41.26 13.94 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.596 1.158 . . . . 0.0 111.268 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 68.9 m -149.68 147.89 28.62 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.517 0.727 . . . . 0.0 110.594 -178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 p -110.48 117.09 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.624 0.77 . . . . 0.0 109.516 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 9.7 mm-40 -98.91 166.82 11.11 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -54.91 -26.98 39.55 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.198 0.999 . . . . 0.0 113.413 -174.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -149.49 22.27 1.2 Allowed Glycine 0 C--N 1.344 0.982 0 N-CA-C 112.148 -0.381 . . . . 0.0 112.148 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.64 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 95.4 mtt180 -136.53 159.08 42.87 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.444 0.698 . . . . 0.0 109.78 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.4 ' HB ' HG22 ' A' ' 11' ' ' VAL . 48.0 mm -126.58 103.22 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 172.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 67.1 t -82.03 113.17 20.93 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.425 HG13 ' HA ' ' A' ' 13' ' ' LYS . 37.4 pt -106.51 162.25 5.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 168.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -123.33 -65.17 0.21 Allowed Glycine 0 CA--C 1.503 -0.706 0 N-CA-C 111.515 -0.634 . . . . 0.0 111.515 -177.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -128.4 143.21 50.97 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.379 0.672 . . . . 0.0 110.16 -170.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -173.85 150.92 1.72 Allowed 'General case' 0 C--O 1.246 0.92 0 C-N-CA 125.578 1.551 . . . . 0.0 107.192 173.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -71.5 106.12 3.85 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 174.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -70.07 -35.53 74.29 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.096 0.958 . . . . 0.0 112.429 -169.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -69.18 -36.0 76.86 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.962 0.505 . . . . 0.0 110.735 176.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -67.69 -43.01 81.14 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.306 175.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.83 -25.67 66.55 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.68 0.792 . . . . 0.0 111.145 175.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -49.03 25.37 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.642 0.777 . . . . 0.0 109.33 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -72.61 -41.04 66.01 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.759 0.424 . . . . 0.0 111.738 -173.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 69' ' ' LYS . 2.6 pp -82.46 -15.86 50.98 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 120.889 0.376 . . . . 0.0 110.25 176.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.5 -54.25 13.66 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.863 170.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.415 ' HA ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -68.27 -23.08 64.73 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.461 0.704 . . . . 0.0 110.874 178.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 73' ' ' GLU . 38.7 tttm -57.85 -48.81 78.7 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.93 0.892 . . . . 0.0 109.978 168.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 91.9 t90 -60.22 -35.71 76.06 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.225 0.61 . . . . 0.0 111.251 174.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.568 HD11 ' HB2' ' A' ' 37' ' ' PHE . 10.7 mp -63.16 -30.32 71.49 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 122.976 0.511 . . . . 0.0 111.647 174.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -78.59 -39.16 38.26 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 46.1 mt-10 -70.72 -36.9 73.44 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.819 0.848 . . . . 0.0 112.269 -175.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -32.24 72.34 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.103 0.477 . . . . 0.0 110.524 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 43.8 t -84.13 86.75 7.17 Favored 'General case' 0 C--N 1.348 0.528 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -73.19 136.63 78.96 Favored Pre-proline 0 CA--C 1.55 0.947 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.555 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -46.32 -47.5 14.97 Favored 'Trans proline' 0 C--N 1.386 2.528 0 C-N-CA 124.445 3.43 . . . . 0.0 115.01 -169.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.6 p -148.98 -34.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 122.523 0.329 . . . . 0.0 111.544 -176.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.8 t -59.29 -30.29 68.22 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.628 0.771 . . . . 0.0 112.806 -174.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.2 tp -102.43 107.26 18.18 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -16.89 51.51 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.258 1.023 . . . . 0.0 110.928 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.28 -35.35 80.75 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.044 0.938 . . . . 0.0 112.16 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -91.21 9.34 31.65 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.965 0.506 . . . . 0.0 111.926 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 48.6 mmtm -90.62 93.24 9.18 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.7 t -136.25 146.19 46.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.184 0.594 . . . . 0.0 110.142 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -90.48 176.68 6.61 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.901 0.88 . . . . 0.0 111.05 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.87 -78.4 1.81 Allowed Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -175.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -84.72 107.69 17.04 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 137.6 74.49 0.06 OUTLIER Glycine 0 C--N 1.345 1.028 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -175.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.13 37.39 1.27 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.934 0.894 . . . . 0.0 110.48 -170.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -73.97 77.64 1.68 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.27 34.15 2.87 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.056 -174.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -79.41 -9.52 59.62 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.3 0.64 . . . . 0.0 111.954 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.39 82.81 0.14 Allowed Glycine 0 C--N 1.349 1.267 0 N-CA-C 111.881 -0.487 . . . . 0.0 111.881 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 CA--C 1.552 1.035 0 C-N-CA 124.868 1.267 . . . . 0.0 111.416 -172.41 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.783 0.325 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -154.64 -60.93 0.01 OUTLIER Glycine 0 C--N 1.343 0.923 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -84.71 102.13 12.74 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.02 0.528 . . . . 0.0 110.424 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.4 mtm -70.49 -46.73 63.15 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 167.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 35.6 t70 59.82 94.61 0.03 OUTLIER 'General case' 0 C--N 1.356 0.889 0 C-N-CA 125.49 1.516 . . . . 0.0 111.922 170.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 78.4 mt -98.65 8.95 44.32 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.208 0.603 . . . . 0.0 112.272 -171.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.0 tt -66.94 -47.1 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -172.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 67.1 m -124.72 34.7 4.95 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.86 0.864 . . . . 0.0 111.262 -171.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.552 ' HB3' HG12 ' A' ' 53' ' ' ILE . 14.7 mmt -61.94 118.52 7.36 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.76 0.824 . . . . 0.0 111.182 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -85.65 121.17 27.94 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.516 0.726 . . . . 0.0 109.388 176.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.433 HG21 HG22 ' A' ' 31' ' ' VAL . 88.0 t -86.4 124.75 40.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.26 0.624 . . . . 0.0 110.67 -176.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.02 124.01 48.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.327 1.051 . . . . 0.0 110.262 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 63.9 tttm -82.78 93.92 7.53 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.67 -100.48 1.32 Allowed Glycine 0 C--N 1.34 0.767 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -167.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.46 -1.33 9.11 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.493 0.717 . . . . 0.0 111.741 177.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 10.8 pt-20 -90.4 148.42 22.81 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 118.682 0.674 . . . . 0.0 110.995 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 t -67.42 97.79 0.6 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.844 0.857 . . . . 0.0 109.703 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -85.7 -53.29 5.24 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.637 0.375 . . . . 0.0 110.245 -175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.58 -152.5 10.1 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.344 -175.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -141.96 134.07 27.59 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.778 0.831 . . . . 0.0 109.815 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.7 t -66.76 105.63 1.62 Allowed 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.15 -34.28 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.592 0.757 . . . . 0.0 109.596 -176.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -158.39 178.21 10.41 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.406 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.1 p -155.52 142.22 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.739 0.816 . . . . 0.0 109.206 173.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -139.9 128.29 22.73 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 174.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 60.52 -105.78 0.9 Allowed Glycine 0 CA--C 1.531 1.045 0 O-C-N 123.512 0.507 . . . . 0.0 113.786 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -116.95 11.49 14.36 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.204 1.001 . . . . 0.0 111.723 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.546 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 57.3 m-85 -125.29 115.93 21.14 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.727 0.411 . . . . 0.0 110.457 -176.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.406 HD12 ' HB ' ' A' ' 24' ' ' VAL . 45.0 tp -78.63 111.66 14.93 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.285 1.034 . . . . 0.0 109.255 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' A' ' 39' ' ' ALA . 39.8 mm -71.19 109.42 3.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 123.105 0.562 . . . . 0.0 109.635 178.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.433 HG22 HG21 ' A' ' 11' ' ' VAL . 60.8 t -107.43 114.63 46.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.306 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -74.85 109.6 8.45 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.2 m -107.1 85.41 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 124.494 1.118 . . . . 0.0 110.459 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.91 -83.09 0.31 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-N 115.74 -0.664 . . . . 0.0 113.207 176.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.4 p -110.37 -27.51 9.02 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.207 1.003 . . . . 0.0 111.889 -176.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -111.23 162.25 15.16 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.112 0.565 . . . . 0.0 111.356 -173.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -108.78 109.32 20.43 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 170.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.6 mt -105.36 118.73 37.3 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 174.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.546 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -83.47 97.36 8.95 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.608 -177.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.1 t -78.64 115.93 55.61 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.168 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.77 145.48 49.66 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 123.015 2.477 . . . . 0.0 112.779 174.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -68.92 -21.12 64.23 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.953 0.901 . . . . 0.0 112.032 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.422 ' NZ ' ' HB2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -74.58 -13.64 60.68 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.048 0.539 . . . . 0.0 111.635 174.498 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.8 m -94.89 3.46 54.95 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.127 0.971 . . . . 0.0 111.99 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.0 mm -82.36 122.78 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.418 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 72.8 mmtt -72.55 -51.2 20.85 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.61 0.764 . . . . 0.0 110.067 174.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 35.1 t -166.03 149.02 7.38 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.43 0.692 . . . . 0.0 110.38 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.3 t -97.6 111.19 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.671 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 31.8 mt-10 -91.6 179.14 5.73 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.065 0.546 . . . . 0.0 110.655 176.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -40.07 -53.29 2.43 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 125.782 1.633 . . . . 0.0 113.429 -175.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -140.5 33.24 2.08 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 174.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.671 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 68.9 mtt180 -135.26 147.55 49.3 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.449 0.699 . . . . 0.0 110.138 -175.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.552 HG12 ' HB3' ' A' ' 9' ' ' MET . 35.9 mm -116.71 101.63 12.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 168.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 50.8 t -80.17 115.06 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 31.6 pt -109.58 159.33 9.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.881 0.872 . . . . 0.0 109.207 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.418 ' HA3' ' HE2' ' A' ' 46' ' ' LYS . . . -90.45 -81.77 1.38 Allowed Glycine 0 C--O 1.242 0.629 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 176.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -159.87 176.25 12.12 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.061 0.945 . . . . 0.0 109.309 176.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -164.44 165.35 21.53 Favored 'General case' 0 C--O 1.25 1.127 0 C-N-CA 124.663 1.185 . . . . 0.0 108.13 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -82.1 108.45 15.59 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.61 -20.43 65.35 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.85 -173.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -69.21 -43.67 73.64 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.507 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 50.2 mt-10 -64.26 -55.97 17.78 Favored 'General case' 0 C--N 1.358 0.957 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.857 175.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.67 -25.05 59.67 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.594 0.758 . . . . 0.0 112.532 -176.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -70.61 -52.67 19.85 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.909 0.884 . . . . 0.0 110.865 175.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -76.38 -38.19 56.11 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -171.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 62' ' ' GLU . 4.6 pp -81.83 -25.13 35.42 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 122.274 -0.266 . . . . 0.0 110.473 174.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -64.9 -44.67 94.27 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.547 ' HA ' HD23 ' A' ' 71' ' ' LEU . 3.5 ptm180 -74.75 -21.16 59.5 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.411 0.685 . . . . 0.0 110.605 178.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -67.57 -31.87 72.23 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 169.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.467 ' HE3' HD22 ' A' ' 71' ' ' LEU . 85.4 t90 -69.71 -36.85 76.27 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 171.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 68' ' ' ARG . 4.3 mm? -59.32 -29.81 67.9 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 172.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -75.4 -33.05 60.95 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.104 0.562 . . . . 0.0 110.712 173.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -66.16 -36.51 83.3 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.568 0.747 . . . . 0.0 111.647 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.417 ' HE2' HD12 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -81.45 1.13 34.55 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.68 0.392 . . . . 0.0 111.111 175.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.7 t 77.08 93.24 0.07 Allowed 'General case' 0 C--N 1.357 0.902 0 C-N-CA 126.005 1.722 . . . . 0.0 110.906 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -70.26 148.47 95.73 Favored Pre-proline 0 N--CA 1.48 1.071 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.061 166.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.39 -161.54 0.1 OUTLIER 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.001 2.467 . . . . 0.0 111.928 170.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.87 40.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.556 0.742 . . . . 0.0 111.578 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 27.9 m -65.47 -51.03 62.99 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.355 1.062 . . . . 0.0 111.598 -174.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 pp -134.97 150.03 50.3 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.497 0.665 . . . . 0.0 111.744 -177.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.507 ' HA ' ' HE2' ' A' ' 84' ' ' LYS . 8.9 mm-40 -91.16 -21.44 21.16 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.822 1.249 . . . . 0.0 110.529 174.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.03 -40.3 84.6 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.496 1.518 . . . . 0.0 113.878 -166.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.3 tt -75.66 -29.94 59.27 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 118.026 0.375 . . . . 0.0 110.773 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.507 ' HE2' ' HA ' ' A' ' 81' ' ' GLU . 38.1 mtmt -63.23 91.51 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.389 0.676 . . . . 0.0 111.587 -172.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 22.8 p -147.98 -71.19 0.22 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -142.46 148.82 38.36 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.777 0.831 . . . . 0.0 109.838 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.36 70.35 0.38 Allowed Glycine 0 C--N 1.341 0.857 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -73.45 110.04 7.42 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.546 0.739 . . . . 0.0 109.597 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.8 -32.71 0.02 OUTLIER Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.943 -0.571 . . . . 0.0 112.476 -176.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -63.16 97.51 0.12 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.147 0.579 . . . . 0.0 109.714 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -160.39 141.91 12.41 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.868 0.867 . . . . 0.0 109.946 -174.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 133.02 104.09 0.87 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -77.41 130.4 37.02 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.707 0.803 . . . . 0.0 111.191 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.74 131.95 1.66 Allowed Glycine 0 CA--C 1.528 0.902 0 O-C-N 124.021 0.826 . . . . 0.0 111.275 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 40.6 m . . . . . 0 C--O 1.249 1.07 0 C-N-CA 123.722 0.809 . . . . 0.0 110.005 178.614 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 121.064 0.459 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.14 -84.18 0.87 Allowed Glycine 0 C--N 1.346 1.105 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 173.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 62.26 16.92 8.85 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 124.544 1.138 . . . . 0.0 111.929 174.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 87.8 mtp -95.14 178.02 5.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.949 0.9 . . . . 0.0 110.72 -179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.477 ' HB3' HG22 ' A' ' 7' ' ' ILE . 7.1 m-20 -58.54 -48.79 79.71 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.849 0.86 . . . . 0.0 111.865 -177.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.7 mt 65.31 7.04 3.96 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 125.233 1.413 . . . . 0.0 112.586 178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.477 HG22 ' HB3' ' A' ' 5' ' ' ASP . 9.9 tt -77.07 -41.13 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 124.387 1.075 . . . . 0.0 111.171 -174.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 60.7 m -90.8 49.41 1.65 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.075 0.95 . . . . 0.0 110.293 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.0 mtt -137.29 133.09 34.59 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.886 0.874 . . . . 0.0 109.498 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -83.87 123.79 30.29 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.754 0.822 . . . . 0.0 109.945 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.444 HG21 HG22 ' A' ' 31' ' ' VAL . 54.5 t -85.47 105.57 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 123.352 0.661 . . . . 0.0 110.533 -175.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -100.41 123.73 45.0 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.837 0.855 . . . . 0.0 109.898 175.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -78.44 89.45 4.42 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 171.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.3 -96.85 0.57 Allowed Glycine 0 C--N 1.346 1.086 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.807 -170.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -107.69 -32.12 7.78 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.887 0.875 . . . . 0.0 110.692 177.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -74.68 142.33 44.47 Favored 'General case' 0 N--CA 1.484 1.225 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -174.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.3 t -76.3 104.29 6.75 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -76.19 -53.49 8.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.85 -163.32 28.9 Favored Glycine 0 C--N 1.338 0.669 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.594 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -120.27 144.22 47.9 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.4 t -74.9 147.42 41.02 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.39 -32.21 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -164.63 168.81 17.72 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.79 0.436 . . . . 0.0 110.373 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.501 ' HB ' HD12 ' A' ' 29' ' ' LEU . 3.1 p -150.52 140.2 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.342 1.057 . . . . 0.0 108.884 172.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.646 ' HE1' HD11 ' A' ' 30' ' ' ILE . 42.3 p90 -145.87 136.37 24.09 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.767 0.827 . . . . 0.0 109.608 174.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.79 -106.96 1.1 Allowed Glycine 0 C--N 1.344 0.999 0 O-C-N 123.826 0.703 . . . . 0.0 113.942 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -115.68 19.47 15.25 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.946 0.898 . . . . 0.0 110.682 -177.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.534 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 73.9 m-85 -138.0 118.46 13.82 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 122.779 0.431 . . . . 0.0 111.802 -172.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.501 HD12 ' HB ' ' A' ' 24' ' ' VAL . 44.2 tp -88.32 116.53 26.6 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.133 0.973 . . . . 0.0 109.403 172.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.646 HD11 ' HE1' ' A' ' 25' ' ' TYR . 33.5 mm -78.8 111.8 16.09 Favored 'Isoleucine or valine' 0 C--O 1.251 1.182 0 C-N-CA 123.05 0.54 . . . . 0.0 109.857 176.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.444 HG22 HG21 ' A' ' 11' ' ' VAL . 44.5 t -111.19 125.0 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 124.65 1.18 . . . . 0.0 109.847 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.9 tppp? -74.49 124.9 27.45 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.352 0.661 . . . . 0.0 109.514 170.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 m -135.47 107.78 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 C-N-CA 125.309 1.443 . . . . 0.0 108.945 176.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.29 -105.17 1.5 Allowed Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.549 -177.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 77.8 p -110.54 -5.7 15.05 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.18 0.992 . . . . 0.0 110.823 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -109.7 165.38 11.73 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.769 0.828 . . . . 0.0 110.872 -166.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.17 110.71 15.61 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.0 mp -102.96 117.27 34.22 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.306 1.042 . . . . 0.0 109.418 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.534 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -77.81 91.41 4.12 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.438 0.695 . . . . 0.0 109.986 176.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.05 118.81 73.39 Favored Pre-proline 0 CA--C 1.546 0.8 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.095 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.489 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 36.3 Cg_endo -60.71 145.05 99.54 Favored 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.488 2.125 . . . . 0.0 111.672 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.621 ' HA ' HD13 ' A' ' 45' ' ' ILE . 12.5 mmmm -61.68 -24.13 66.55 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.196 0.999 . . . . 0.0 112.205 -176.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.489 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 14.9 ptmm? -72.96 -21.43 60.86 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.575 0.75 . . . . 0.0 111.865 176.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.1 t -78.24 -28.02 47.73 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.058 0.543 . . . . 0.0 110.49 173.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.621 HD13 ' HA ' ' A' ' 42' ' ' LYS . 1.7 mp -65.14 115.02 2.95 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 175.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.537 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 75.1 mmtt -68.76 -53.73 20.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.974 0.91 . . . . 0.0 109.784 175.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 73.6 m -159.25 143.48 15.23 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.68 0.792 . . . . 0.0 110.844 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.4 p -85.92 115.76 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 168.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.756 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 8.2 mm-40 -107.68 178.71 4.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.12 0.968 . . . . 0.0 110.67 -175.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -66.54 95.41 0.33 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.223 0.609 . . . . 0.0 110.187 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.46 13.81 81.46 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.315 -0.402 . . . . 0.0 113.354 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.756 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 25.3 mtp180 -130.01 149.61 51.66 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.526 0.73 . . . . 0.0 110.189 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.1 mm -119.62 103.95 15.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 164.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.474 HG22 HH21 ' A' ' 52' ' ' ARG . 92.5 t -84.22 113.26 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 29.9 pt -109.51 179.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.53 1.132 . . . . 0.0 109.434 174.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' HA3' ' HE2' ' A' ' 46' ' ' LYS . . . -144.54 -112.74 0.83 Allowed Glycine 0 C--N 1.343 0.958 0 N-CA-C 112.138 -0.385 . . . . 0.0 112.138 174.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -89.26 136.23 33.14 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.469 0.708 . . . . 0.0 110.634 -172.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -167.0 174.24 8.57 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 124.821 1.248 . . . . 0.0 108.21 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -99.64 119.46 38.13 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 176.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -68.22 -28.05 66.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.717 0.807 . . . . 0.0 111.821 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -74.29 -37.21 63.74 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.57 0.544 . . . . 0.0 110.652 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -58.26 -50.6 73.03 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 171.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.24 -31.49 72.71 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.997 -1.456 . . . . 0.0 111.581 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -75.66 -48.75 20.76 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.138 0.575 . . . . 0.0 110.237 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -70.48 -38.98 74.47 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.389 0.614 . . . . 0.0 111.22 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.422 ' HG ' ' HB3' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -84.55 -20.0 32.23 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 123.394 0.678 . . . . 0.0 109.95 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -74.57 -41.97 34.25 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 172.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.612 ' HA ' HD23 ' A' ' 71' ' ' LEU . 8.5 ptm180 -74.35 -17.45 60.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.993 0.517 . . . . 0.0 109.834 175.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 73' ' ' GLU . 3.1 tppp? -65.78 -40.04 91.56 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 123.217 0.607 . . . . 0.0 109.484 169.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.446 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 78.2 t90 -60.34 -42.95 96.75 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.94 0.896 . . . . 0.0 111.188 174.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.698 HD12 ' HD3' ' A' ' 76' ' ' LYS . 3.2 mm? -59.99 -37.1 78.68 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.548 171.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -75.29 -24.45 57.5 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 124.131 0.972 . . . . 0.0 111.371 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 69' ' ' LYS . 34.6 mm-40 -64.68 -38.95 92.75 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.195 0.521 . . . . 0.0 109.908 174.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -84.89 -18.5 34.56 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.933 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.2 m 67.26 52.7 0.82 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.982 1.313 . . . . 0.0 110.671 173.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.698 ' HD3' HD12 ' A' ' 71' ' ' LEU . 26.2 mtpp -72.15 127.07 90.89 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.85 -176.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -81.59 -158.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 123.386 2.724 . . . . 0.0 113.737 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.1 t -59.87 92.46 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.17 0 C-N-CA 125.043 1.337 . . . . 0.0 111.015 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.6 t -149.64 -1.68 0.44 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.598 0.759 . . . . 0.0 111.752 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.7 tp -84.75 -52.08 6.32 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.251 0.62 . . . . 0.0 111.229 -171.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.443 ' HA ' ' HE3' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -62.82 -28.65 70.15 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.442 0.697 . . . . 0.0 111.3 174.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -59.73 -40.47 88.15 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.06 0.944 . . . . 0.0 111.822 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.8 pp -84.25 1.14 46.08 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.623 0.369 . . . . 0.0 111.926 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.443 ' HE3' ' HA ' ' A' ' 81' ' ' GLU . 10.0 mtmp? -104.47 55.34 0.72 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.769 0.828 . . . . 0.0 108.847 174.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.1 t -67.34 -20.16 65.55 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.327 1.051 . . . . 0.0 112.944 -173.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -70.45 -24.92 62.97 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.394 0.678 . . . . 0.0 111.599 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.18 -106.97 2.09 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 123.495 0.497 . . . . 0.0 111.995 -177.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -157.7 166.37 32.98 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.163 0.985 . . . . 0.0 109.856 176.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.94 -47.55 0.52 Allowed Glycine 0 C--N 1.346 1.091 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -90.3 0.74 57.1 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.962 0.905 . . . . 0.0 111.782 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.22 113.42 6.55 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.043 0.537 . . . . 0.0 110.145 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -164.23 -126.46 0.82 Allowed Glycine 0 C--N 1.347 1.193 0 CA-C-N 116.236 -0.438 . . . . 0.0 113.006 -174.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.23 -35.5 73.89 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.858 0.863 . . . . 0.0 112.215 -171.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.48 -88.51 1.0 Allowed Glycine 0 C--N 1.348 1.225 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.0 t . . . . . 0 C--O 1.253 1.271 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.189 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.71 -113.31 3.62 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -174.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -159.33 -0.65 0.08 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.142 0.577 . . . . 0.0 110.9 178.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.0 mtt -88.54 -65.57 1.0 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.65 17.63 6.41 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.416 1.087 . . . . 0.0 112.895 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 82.5 mt -90.12 -27.96 19.28 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.382 0.673 . . . . 0.0 110.176 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 36.2 pt -111.61 177.29 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.321 1.049 . . . . 0.0 111.243 -175.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 57.9 m 65.67 2.9 2.25 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.404 1.481 . . . . 0.0 113.537 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 47.7 mtt -92.26 145.72 24.27 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.371 0.605 . . . . 0.0 110.361 -177.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -84.86 108.79 17.69 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.985 -170.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' A' ' 53' ' ' ILE . 97.0 t -80.55 117.91 27.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.948 0.899 . . . . 0.0 110.994 -175.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -112.9 117.7 32.84 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.229 1.012 . . . . 0.0 109.552 175.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 51.3 tttm -77.92 91.04 4.15 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 176.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.22 -92.22 0.85 Allowed Glycine 0 C--N 1.345 1.066 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -170.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -118.95 -23.64 6.83 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.889 0.876 . . . . 0.0 111.353 177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 12.6 pt-20 -78.94 142.11 36.98 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 122.528 0.331 . . . . 0.0 110.159 -172.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.6 t -69.11 99.11 1.07 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.538 0.735 . . . . 0.0 109.262 176.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -79.48 -57.53 3.65 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.05 -137.41 3.17 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.413 0.446 . . . . 0.0 112.639 -176.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -148.3 136.91 21.55 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.962 0.905 . . . . 0.0 110.51 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.5 p -72.55 108.54 5.66 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.91 -32.57 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.177 0.591 . . . . 0.0 110.174 -176.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -160.35 178.49 9.54 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.704 0.402 . . . . 0.0 110.423 -174.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.8 p -154.6 139.6 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 124.299 1.04 . . . . 0.0 109.593 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -141.47 132.4 26.0 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.372 0.669 . . . . 0.0 109.203 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.36 -103.86 0.46 Allowed Glycine 0 C--N 1.349 1.288 0 O-C-N 123.548 0.53 . . . . 0.0 113.814 170.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -115.07 16.74 17.01 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.519 1.128 . . . . 0.0 111.228 -174.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.51 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 84.1 m-85 -141.64 125.64 17.23 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.619 -0.676 . . . . 0.0 111.97 -174.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 60.6 tp -82.59 111.7 18.81 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.222 1.009 . . . . 0.0 109.11 170.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 39' ' ' ALA . 28.1 mm -70.94 112.96 6.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 C-N-CA 122.899 0.48 . . . . 0.0 109.725 177.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 88.4 t -112.47 118.11 56.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 123.186 0.594 . . . . 0.0 109.643 176.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -77.79 126.12 30.38 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.444 0.698 . . . . 0.0 109.792 177.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.2 m -131.99 74.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.292 0 C-N-CA 124.612 1.165 . . . . 0.0 109.886 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.63 -81.08 0.02 OUTLIER Glycine 0 C--N 1.354 1.55 0 CA-C-N 115.148 -0.933 . . . . 0.0 114.393 173.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.4 p -70.54 -49.46 47.85 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.272 1.029 . . . . 0.0 111.577 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -138.9 176.55 8.6 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.503 0.668 . . . . 0.0 112.258 -166.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -105.87 108.67 20.3 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.955 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 mp -95.39 105.5 17.47 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 175.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -80.07 94.35 5.95 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.848 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.18 124.59 91.04 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.137 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -56.77 141.56 92.24 Favored 'Trans proline' 0 C--N 1.38 2.224 0 C-N-CA 122.732 2.288 . . . . 0.0 111.411 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.534 ' HA ' HD13 ' A' ' 45' ' ' ILE . 2.2 mmmp? -60.74 -34.34 74.28 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -172.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.434 ' H ' ' HD2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -68.47 -21.49 64.62 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.404 0.282 . . . . 0.0 111.576 177.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.2 t -75.0 -27.75 60.26 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 122.733 0.413 . . . . 0.0 111.081 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.57 HG13 HG22 ' A' ' 55' ' ' ILE . 2.0 mp -64.66 113.45 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.187 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -79.88 -50.05 11.04 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.859 0.864 . . . . 0.0 110.177 -175.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.7 m -148.22 126.84 12.48 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.241 -175.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.96 109.75 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 166.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -110.07 172.53 6.81 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.471 1.108 . . . . 0.0 110.415 -174.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -66.54 97.12 0.41 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.24 0.616 . . . . 0.0 110.423 -175.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.06 4.83 84.18 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.454 -0.794 . . . . 0.0 113.994 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 10.1 mmt180 -131.58 132.97 44.53 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.084 0.953 . . . . 0.0 109.053 -175.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.534 ' HB ' HG22 ' A' ' 11' ' ' VAL . 43.4 mm -109.32 103.2 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 174.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 64.6 t -81.95 114.04 22.23 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.57 HG22 HG13 ' A' ' 45' ' ' ILE . 34.0 pt -109.25 170.41 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.552 0.741 . . . . 0.0 109.012 175.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -111.95 -159.27 14.92 Favored Glycine 0 C--N 1.334 0.437 0 CA-C-N 116.611 -0.268 . . . . 0.0 112.877 -173.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -85.71 120.15 26.83 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.655 0.74 . . . . 0.0 109.562 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -142.29 171.3 14.24 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 124.989 1.316 . . . . 0.0 107.478 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -86.97 111.87 21.26 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.79 -23.44 63.34 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.414 0.686 . . . . 0.0 112.05 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -69.87 -37.29 76.03 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 123.86 0.725 . . . . 0.0 109.905 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -60.71 -54.86 40.1 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 170.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.03 77.03 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.258 -173.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.03 -44.45 54.33 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-O 119.176 -0.44 . . . . 0.0 110.947 -176.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -67.19 -40.21 86.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 117.917 0.326 . . . . 0.0 111.264 -174.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.4 pp -82.38 -16.31 49.57 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.704 0.401 . . . . 0.0 110.58 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.29 -32.75 57.74 Favored Glycine 0 C--N 1.353 1.486 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 168.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 -76.72 -28.45 55.82 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.246 1.019 . . . . 0.0 110.174 173.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -65.18 -34.98 79.67 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 169.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.447 ' HA ' ' HG2' ' A' ' 73' ' ' GLU . 56.8 t90 -65.27 -38.19 89.52 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.312 175.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.24 -27.79 67.52 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.313 0.645 . . . . 0.0 111.486 173.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -78.68 -42.05 29.55 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.724 0.81 . . . . 0.0 111.315 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.447 ' HG2' ' HA ' ' A' ' 70' ' ' TRP . 11.8 pt-20 -76.37 -32.6 58.68 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.307 0.643 . . . . 0.0 111.757 -173.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.93 -24.79 63.42 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.584 0.353 . . . . 0.0 110.623 177.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 37.6 t -62.35 -31.51 72.16 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.693 0.797 . . . . 0.0 110.691 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -85.32 146.13 44.14 Favored Pre-proline 0 N--CA 1.478 0.93 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 169.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.58 157.07 43.67 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.611 2.208 . . . . 0.0 111.805 174.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 p -65.8 88.38 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-O 121.966 0.889 . . . . 0.0 109.768 176.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 7.2 t -80.08 -32.17 39.27 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.784 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 tt -172.26 97.3 0.15 Allowed 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 175.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -95.54 -11.63 27.08 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.199 0.6 . . . . 0.0 111.543 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -68.9 -26.65 65.21 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.713 0.405 . . . . 0.0 110.949 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.5 tp -74.46 -22.43 59.11 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.275 0.63 . . . . 0.0 110.581 175.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -77.62 -28.15 51.37 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.348 0.659 . . . . 0.0 109.995 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.8 m -70.7 116.02 10.53 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.756 0.822 . . . . 0.0 109.358 176.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -77.48 143.88 38.17 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 122.934 0.494 . . . . 0.0 111.585 -175.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -137.25 -52.4 0.06 OUTLIER Glycine 0 C--N 1.338 0.682 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 173.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 18.1 t80 67.53 12.36 8.85 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.825 1.25 . . . . 0.0 111.833 166.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 173.07 71.78 0.05 OUTLIER Glycine 0 C--N 1.343 0.941 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -80.41 69.54 6.89 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.639 0.776 . . . . 0.0 109.954 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -171.2 146.68 2.41 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.804 1.242 . . . . 0.0 108.347 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -155.43 142.22 8.73 Favored Glycine 0 C--N 1.341 0.827 0 O-C-N 123.239 0.337 . . . . 0.0 112.519 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.57 -28.42 60.93 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.502 0.721 . . . . 0.0 110.717 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 153.33 113.81 0.53 Allowed Glycine 0 C--N 1.343 0.966 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.969 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 C--O 1.25 1.086 0 C-N-CA 123.688 0.795 . . . . 0.0 109.158 177.531 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.604 0.24 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.71 -142.96 3.59 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.337 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -116.0 81.69 1.65 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.239 0.616 . . . . 0.0 110.919 -175.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 95.6 mmm -88.4 97.49 11.08 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 172.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -83.87 84.28 7.63 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.314 0.578 . . . . 0.0 111.399 -174.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.0 mt -103.69 11.19 36.28 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.323 1.049 . . . . 0.0 108.576 166.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.44 HG23 ' SG ' ' A' ' 8' ' ' CYS . 10.4 tp -73.2 -30.2 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 125.37 1.468 . . . . 0.0 111.425 -171.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.44 ' SG ' HG23 ' A' ' 7' ' ' ILE . 19.0 m -135.71 92.69 2.85 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.427 0.691 . . . . 0.0 109.784 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.0 mtt -148.76 157.69 43.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.636 1.174 . . . . 0.0 109.122 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -78.67 110.94 14.26 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.915 0.486 . . . . 0.0 109.878 176.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.52 130.7 35.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.061 0.544 . . . . 0.0 109.838 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -116.97 124.74 50.12 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.61 1.164 . . . . 0.0 110.023 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -79.73 92.61 5.44 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.87 -96.08 0.58 Allowed Glycine 0 C--N 1.342 0.914 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -173.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.03 -21.92 10.32 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.47 0.708 . . . . 0.0 111.572 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.02 155.68 19.7 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 122.861 0.464 . . . . 0.0 110.396 -176.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.7 t -71.13 112.44 7.28 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.054 0.542 . . . . 0.0 110.134 177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -80.74 -52.55 7.4 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.29 -139.85 5.14 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.844 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -139.23 132.32 29.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.137 0.975 . . . . 0.0 108.869 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.408 ' HB2' HD11 ' A' ' 29' ' ' LEU . 73.4 p -69.8 124.13 23.22 Favored 'General case' 0 CA--C 1.541 0.596 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 172.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.55 -37.6 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.64 0.776 . . . . 0.0 109.195 -177.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.414 ' HA ' HD11 ' A' ' 7' ' ' ILE . 20.8 t70 -150.46 167.91 25.75 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.357 -171.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.3 p -127.61 138.96 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 173.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -148.67 100.29 3.09 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.144 0.978 . . . . 0.0 109.486 -169.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.86 -109.14 2.72 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.741 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.522 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 21.1 t70 -104.67 -5.5 21.31 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.188 0.595 . . . . 0.0 109.413 171.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.445 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 64.8 m-85 -100.04 113.67 26.43 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.306 0.642 . . . . 0.0 111.089 -171.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 21' ' ' SER . 66.0 tp -74.1 106.69 5.89 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.0 mm -68.28 106.51 1.08 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.177 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.7 t -100.33 117.68 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.83 111.09 7.65 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 173.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.463 HG21 HD23 ' A' ' 38' ' ' LEU . 18.9 m -111.18 85.55 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-O 122.04 0.924 . . . . 0.0 110.48 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.35 -91.16 0.24 Allowed Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.062 -0.972 . . . . 0.0 113.3 176.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.0 p -105.43 -10.29 17.03 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.824 0.85 . . . . 0.0 111.389 -178.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -124.51 -176.68 3.58 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.505 0.722 . . . . 0.0 111.49 -173.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -131.22 110.25 11.0 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.966 1.307 . . . . 0.0 109.308 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.463 HD23 HG21 ' A' ' 33' ' ' VAL . 2.4 mm? -102.9 109.25 20.74 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.648 1.179 . . . . 0.0 108.821 174.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -87.02 93.74 9.44 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.262 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.31 131.81 51.97 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.515 ' HB2' ' HG2' ' A' ' 43' ' ' LYS . 54.9 Cg_endo -65.3 159.83 45.37 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.359 2.04 . . . . 0.0 112.129 177.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.522 ' HG2' ' O ' ' A' ' 27' ' ' ASP . 31.0 mmmt -66.75 -22.45 66.04 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.724 0.81 . . . . 0.0 111.433 -177.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.515 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 8.6 ptpp? -76.01 -18.99 59.04 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.99 0.916 . . . . 0.0 112.065 175.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.7 t -71.71 -29.26 64.36 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.712 0.405 . . . . 0.0 110.747 177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.517 HD13 ' HA ' ' A' ' 42' ' ' LYS . 2.2 mp -70.22 118.45 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.068 0.547 . . . . 0.0 109.911 -177.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -85.67 -54.5 4.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.272 1.029 . . . . 0.0 111.046 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.2 m -134.26 146.93 50.51 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.788 -172.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.5 p -114.91 126.4 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.061 0.944 . . . . 0.0 109.297 173.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.799 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 42.3 mm-40 -121.85 173.22 7.63 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.986 0.914 . . . . 0.0 109.171 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -70.03 97.47 1.17 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.822 0.82 . . . . 0.0 110.271 177.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.56 18.12 71.63 Favored Glycine 0 C--N 1.345 1.06 0 CA-C-N 115.513 -0.767 . . . . 0.0 113.272 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.799 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 54.1 mtt180 -140.63 149.76 42.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.631 0.772 . . . . 0.0 110.516 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.5 mm -134.81 104.24 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.484 1.114 . . . . 0.0 108.822 176.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.08 122.31 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.4 pt -112.4 153.99 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.109 0.963 . . . . 0.0 109.442 174.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -104.1 -64.36 0.68 Allowed Glycine 0 C--N 1.344 1.004 0 CA-C-O 120.158 -0.246 . . . . 0.0 112.537 -173.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -157.26 159.76 37.93 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.106 0.562 . . . . 0.0 110.034 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -166.26 173.07 10.47 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.519 1.128 . . . . 0.0 109.239 -177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -79.78 99.66 7.58 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -67.86 -57.51 6.13 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.263 1.025 . . . . 0.0 112.702 -167.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.89 -30.32 69.65 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.151 0.58 . . . . 0.0 110.776 -176.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HA ' ' HG2' ' A' ' 65' ' ' GLU . 43.7 mt-10 -70.25 -39.61 74.9 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.795 173.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.12 -25.55 65.35 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.021 0.528 . . . . 0.0 110.734 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -74.53 -45.81 43.27 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.678 0.791 . . . . 0.0 109.838 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.469 ' HG2' ' HA ' ' A' ' 62' ' ' GLU . 12.9 pt-20 -72.72 -36.42 67.78 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.445 0.298 . . . . 0.0 111.779 -177.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 69' ' ' LYS . 4.1 pp -83.39 -13.6 54.53 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 122.157 -0.339 . . . . 0.0 110.529 174.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.04 -46.27 52.34 Favored Glycine 0 C--N 1.345 1.078 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.747 168.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.471 ' HA ' HD13 ' A' ' 71' ' ' LEU . 34.6 ptt180 -72.05 -23.89 61.44 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 175.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.479 ' HB3' ' HA ' ' A' ' 66' ' ' LEU . 22.4 ttmm -62.3 -39.21 92.25 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 123.087 0.555 . . . . 0.0 109.715 170.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.462 ' HE3' HD12 ' A' ' 71' ' ' LEU . 70.6 t90 -60.87 -38.29 85.1 Favored 'General case' 0 CA--C 1.553 1.088 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 172.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' A' ' 68' ' ' ARG . 11.2 mp -60.83 -39.73 90.12 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 177.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -78.56 -29.14 46.16 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.701 -0.625 . . . . 0.0 111.194 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 69.2 mt-10 -77.8 -31.1 51.6 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.95 -6.8 47.73 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 171.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.6 t 73.45 82.12 0.12 Allowed 'General case' 0 C--N 1.363 1.159 0 C-N-CA 126.152 1.781 . . . . 0.0 110.023 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -83.2 158.41 64.1 Favored Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.802 171.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.92 146.05 87.02 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 122.153 1.902 . . . . 0.0 111.347 168.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.0 m -71.68 -19.96 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.707 0.403 . . . . 0.0 110.96 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.7 t 50.17 23.42 1.16 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 126.659 1.983 . . . . 0.0 114.088 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 83' ' ' LEU . 1.0 OUTLIER -163.28 124.77 2.44 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -171.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -71.55 -27.84 63.45 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.737 0.815 . . . . 0.0 111.748 -175.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -72.57 -28.41 62.8 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 121.108 0.48 . . . . 0.0 110.28 174.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -78.37 -5.83 53.42 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 123.692 0.797 . . . . 0.0 110.365 177.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -60.56 -43.91 96.73 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.542 0.737 . . . . 0.0 111.01 176.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 91.0 p -92.04 14.42 15.94 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.157 0.583 . . . . 0.0 111.473 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -127.96 151.59 48.94 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.714 0.806 . . . . 0.0 110.408 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 159.15 87.76 0.06 OUTLIER Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -126.77 165.86 18.5 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.158 0.583 . . . . 0.0 110.458 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.46 -159.37 27.9 Favored Glycine 0 C--N 1.34 0.802 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -92.66 134.48 34.97 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 175.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.72 107.15 16.76 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 117.988 0.358 . . . . 0.0 111.011 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.49 -167.37 32.94 Favored Glycine 0 C--N 1.348 1.249 0 O-C-N 124.076 0.86 . . . . 0.0 114.889 168.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.31 -5.36 15.89 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.134 0.974 . . . . 0.0 109.97 170.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 74.69 18.05 80.03 Favored Glycine 0 C--N 1.356 1.658 0 CA-C-O 119.182 -0.788 . . . . 0.0 114.424 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.4 t . . . . . 0 C--O 1.254 1.322 0 C-N-CA 124.76 1.224 . . . . 0.0 109.866 -176.442 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.44 178.64 34.04 Favored Glycine 0 C--N 1.344 1.004 0 O-C-N 123.369 0.418 . . . . 0.0 113.157 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -136.04 133.05 37.01 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.742 0.817 . . . . 0.0 109.685 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 7' ' ' ILE . 64.9 mtt -84.51 98.37 10.08 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 174.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.44 -1.0 14.06 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.21 1.004 . . . . 0.0 112.151 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -90.03 -5.62 56.42 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.172 0.989 . . . . 0.0 111.493 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 4' ' ' MET . 10.9 tp -80.79 142.59 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 122.973 0.509 . . . . 0.0 111.129 -176.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 59.1 m -85.0 94.88 8.91 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 79.4 mtp -72.08 108.4 5.26 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.176 0.59 . . . . 0.0 110.102 -175.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -62.42 123.07 17.32 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.162 0.585 . . . . 0.0 110.889 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.6 t -93.85 131.25 41.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 C-N-CA 124.075 0.95 . . . . 0.0 110.076 -173.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.567 ' HE1' ' HD2' ' A' ' 52' ' ' ARG . 70.0 m-85 -118.93 127.01 53.08 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.536 1.134 . . . . 0.0 108.625 177.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -78.43 87.34 4.44 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.105 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 73.36 -94.75 0.74 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -172.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -111.85 -27.27 8.54 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.84 0.856 . . . . 0.0 111.785 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 13' ' ' LYS . 12.0 pt-20 -81.42 145.82 30.59 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -174.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.0 t -69.78 113.75 7.32 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -93.83 -50.21 5.46 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.078 0.551 . . . . 0.0 110.524 -174.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.18 -137.93 4.06 Favored Glycine 0 C--N 1.343 0.943 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.766 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.581 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 8.9 pt-20 -141.13 144.11 34.66 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.238 1.015 . . . . 0.0 109.966 -177.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.8 t -77.17 149.83 35.56 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 171.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.24 -40.13 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -151.52 170.01 20.68 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -176.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' A' ' 29' ' ' LEU . 2.8 p -155.8 123.07 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 124.067 0.947 . . . . 0.0 109.069 172.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.442 ' CE1' HD11 ' A' ' 30' ' ' ILE . 7.3 p90 -124.29 132.8 53.59 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 88' ' ' PHE . . . 60.89 -105.87 0.95 Allowed Glycine 0 C--N 1.338 0.686 0 O-C-N 123.543 0.527 . . . . 0.0 114.044 178.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -118.94 17.96 13.29 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.615 0.766 . . . . 0.0 111.527 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.511 ' HB3' ' HB1' ' A' ' 39' ' ' ALA . 80.8 m-85 -133.03 112.79 12.11 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.142 0.496 . . . . 0.0 111.427 -175.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.493 HD12 ' HB ' ' A' ' 24' ' ' VAL . 44.8 tp -78.21 111.68 14.4 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.12 1.368 . . . . 0.0 109.552 173.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.442 HD11 ' CE1' ' A' ' 25' ' ' TYR . 33.2 mm -72.38 112.05 7.53 Favored 'Isoleucine or valine' 0 C--O 1.249 1.053 0 C-N-CA 123.578 0.751 . . . . 0.0 109.832 178.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.8 t -110.72 125.9 68.04 Favored 'Isoleucine or valine' 0 C--N 1.349 0.567 0 C-N-CA 124.369 1.068 . . . . 0.0 109.879 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.581 ' HB3' ' HG3' ' A' ' 20' ' ' GLU . 4.2 tppp? -73.96 120.02 18.96 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.92 0.888 . . . . 0.0 109.25 171.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.8 m -137.73 133.83 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.499 1.119 . . . . 0.0 109.627 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.58 -100.15 0.46 Allowed Glycine 0 C--N 1.348 1.222 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.023 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.3 p -124.84 -11.53 7.17 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.602 1.161 . . . . 0.0 111.021 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -124.41 -171.98 2.46 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.562 0.745 . . . . 0.0 111.829 -171.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -121.11 111.37 17.35 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.144 0.977 . . . . 0.0 110.474 -174.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.4 mp -102.08 117.17 34.23 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 171.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.511 ' HB1' ' HB3' ' A' ' 28' ' ' TYR . . . -89.68 108.59 19.77 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.698 0.799 . . . . 0.0 110.954 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.469 HG21 HG21 ' A' ' 55' ' ' ILE . 16.5 m -83.52 139.28 41.2 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 123.405 0.682 . . . . 0.0 109.896 179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.528 ' HG2' ' HB2' ' A' ' 44' ' ' SER . 56.9 Cg_endo -69.89 156.2 63.59 Favored 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 122.146 1.897 . . . . 0.0 112.624 176.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -68.24 -28.53 67.3 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.206 1.002 . . . . 0.0 111.39 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.498 ' HG2' ' HB2' ' A' ' 41' ' ' PRO . 21.5 pttp -74.9 -9.37 58.48 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.775 0.83 . . . . 0.0 111.572 176.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.528 ' HB2' ' HG2' ' A' ' 41' ' ' PRO . 28.5 t -88.43 -18.67 27.82 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.056 0.543 . . . . 0.0 111.083 175.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.531 HD13 HG22 ' A' ' 55' ' ' ILE . 29.5 mm -64.46 112.91 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 46' ' ' LYS . 11.1 mmpt? -70.5 -45.46 65.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.534 0.734 . . . . 0.0 110.194 177.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.5 t -160.0 145.88 15.57 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.64 -176.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.8 p -110.02 119.69 59.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 173.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.782 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 20.7 mm-40 -104.23 166.51 10.35 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.84 0.856 . . . . 0.0 109.423 176.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -65.04 102.8 0.66 Allowed 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.312 0.577 . . . . 0.0 109.572 174.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.44 4.92 90.06 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.605 -0.725 . . . . 0.0 114.363 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.782 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . 77.5 mmt-85 -131.92 147.98 52.5 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 117.57 0.685 . . . . 0.0 110.171 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.1 mm -120.82 132.43 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.923 0.889 . . . . 0.0 108.845 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.13 123.42 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 172.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.531 HG22 HD13 ' A' ' 45' ' ' ILE . 49.4 pt -118.95 164.82 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.648 0.779 . . . . 0.0 110.641 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -106.93 -171.99 22.58 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.31 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -70.69 130.51 41.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.824 0.449 . . . . 0.0 109.946 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -135.46 166.51 23.02 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.94 1.296 . . . . 0.0 108.826 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -80.01 109.16 14.2 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -67.01 -28.56 68.34 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.724 0.81 . . . . 0.0 111.284 -177.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -67.33 -43.3 81.91 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.475 1.11 . . . . 0.0 110.722 177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -68.63 -42.35 78.16 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.675 0.274 . . . . 0.0 110.475 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.64 89.93 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.74 0.816 . . . . 0.0 112.006 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -76.19 -34.28 59.3 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 123.465 0.478 . . . . 0.0 112.057 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 12.9 pt-20 -77.71 -40.71 40.38 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -177.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 pp -80.7 -25.5 38.11 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 70' ' ' TRP . . . -69.05 -34.62 76.67 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.815 171.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 65' ' ' GLU . 0.9 OUTLIER -77.05 -18.02 58.37 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 117.296 0.548 . . . . 0.0 110.205 175.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 72' ' ' GLU . 6.3 ttpm? -68.85 -32.17 71.66 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.162 0.506 . . . . 0.0 109.787 166.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.416 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 85.5 t90 -67.09 -32.74 74.1 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 169.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.598 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 8.8 mp -66.92 -31.6 72.29 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.161 0.584 . . . . 0.0 112.133 173.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER -81.34 -25.7 36.19 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 118.38 0.537 . . . . 0.0 109.942 174.727 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -66.25 -30.99 71.54 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.463 0.705 . . . . 0.0 110.188 170.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.598 ' HD3' ' HA ' ' A' ' 71' ' ' LEU . 52.8 mtpt -61.73 -54.58 40.57 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.233 0.613 . . . . 0.0 110.194 173.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -109.23 100.5 9.63 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.534 0.734 . . . . 0.0 109.447 -177.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -61.04 145.98 88.6 Favored Pre-proline 0 N--CA 1.484 1.237 0 C-N-CA 125.036 1.334 . . . . 0.0 112.224 -171.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -81.36 177.05 8.09 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.747 2.298 . . . . 0.0 112.955 -178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.39 -24.09 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-O 120.989 0.423 . . . . 0.0 110.621 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 87.8 m -69.66 138.44 53.0 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 123.324 0.649 . . . . 0.0 109.836 171.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.2 tp -56.02 117.23 3.53 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.84 0.856 . . . . 0.0 109.523 174.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -74.78 -6.07 46.93 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-O 120.738 0.304 . . . . 0.0 111.328 -174.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -66.73 -30.22 70.39 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.209 0.528 . . . . 0.0 109.922 169.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 55.9 tp -71.17 -25.43 62.54 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.998 0.919 . . . . 0.0 111.162 176.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -64.69 89.72 0.07 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.6 t -103.83 124.25 48.59 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.723 0.809 . . . . 0.0 109.3 -174.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -179.41 -39.57 0.01 OUTLIER 'General case' 0 C--O 1.245 0.823 0 C-N-CA 125.384 1.474 . . . . 0.0 107.904 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.41 -106.71 1.92 Allowed Glycine 0 C--N 1.349 1.273 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.152 -172.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.453 ' HB3' ' HA2' ' A' ' 26' ' ' GLY . 89.8 m-85 -137.41 -9.76 1.68 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.058 0.943 . . . . 0.0 110.013 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 69.37 38.91 81.26 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 112.108 -0.397 . . . . 0.0 112.108 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -61.73 109.89 1.35 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.432 1.093 . . . . 0.0 110.988 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -159.14 128.07 5.32 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.02 160.91 31.6 Favored Glycine 0 C--N 1.346 1.122 0 N-CA-C 112.148 -0.381 . . . . 0.0 112.148 -174.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.76 -179.37 6.94 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.444 0.697 . . . . 0.0 110.783 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 164.01 -60.63 0.26 Allowed Glycine 0 C--N 1.34 0.794 0 N-CA-C 110.676 -0.97 . . . . 0.0 110.676 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 35.5 p . . . . . 0 C--O 1.251 1.167 0 C-N-CA 124.079 0.952 . . . . 0.0 108.628 176.442 . . . . . . . . 0 0 . 1 stop_ save_